Clustering O 0 3.375498636160046e-07
of O 0 3.233091305787639e-08
missense O 0 5.937005198575207e-07
mutations O 0 9.708069903524574e-10
in O 0 5.5665951015360093e-11
the O 0 2.164583534636222e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 4.1183861299032287e-07
in O 0 1.1250329556844463e-09
a O 0 4.786912533027987e-11
sporadic B-Disease 0 3.037393526028609e-06
T I-Disease 1 0.9652894735336304
- I-Disease 0 4.649396032618824e-06
cell I-Disease 0 2.667732360350783e-06
leukaemia I-Disease 0 0.001269613509066403
. O 0 8.367271320253167e-09

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.5382935291418107e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.7733828728411227e-12
is O 0 5.844536145197324e-14
a O 0 1.6905404756194925e-13
recessive B-Disease 0 2.2266595678388512e-08
multi I-Disease 0 0.03029918111860752
- I-Disease 1 0.9999991655349731
system I-Disease 1 0.8367933630943298
disorder I-Disease 0 0.0001188949536299333
caused O 0 7.0703158883134165e-09
by O 0 4.6191054453581515e-11
mutations O 0 5.884870368788597e-11
in O 0 2.2336748770057646e-11
the O 0 1.204655958320089e-10
ATM O 0 1.4677540960406077e-08
gene O 0 1.3258441219909933e-11
at O 0 1.1404974881168428e-10
11q22 O 0 2.877250437904877e-07
- O 0 3.583501211323892e-07
q23 O 0 5.422431058832444e-06
( O 0 2.279743477329177e-10
ref O 0 2.273103234529117e-07
. O 0 3.5092831418559456e-10
3 O 0 1.170438412856356e-09
) O 0 1.5003708345173727e-11
. O 0 1.3764225315071599e-09

The O 0 7.953089209422615e-08
risk O 0 3.4553742978005175e-08
of O 0 3.825281424951754e-09
cancer B-Disease 0 1.4718730767526722e-07
, O 0 1.1597660332096638e-11
especially O 0 1.8579321414691208e-09
lymphoid B-Disease 0 1.8523287508287467e-05
neoplasias I-Disease 0 6.829724588897079e-05
, O 0 2.1291404403434022e-11
is O 0 4.839252913321768e-13
substantially O 0 2.6425470145419183e-10
elevated O 0 3.072682090987655e-07
in O 0 1.62657121105525e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 1 0.9997281432151794
and O 0 1.4633946832098843e-10
has O 0 1.6941113225796278e-12
long O 0 1.6781405908980473e-12
been O 0 7.167821024223198e-13
associated O 0 1.888723344389831e-10
with O 0 4.1023917596305637e-10
chromosomal O 1 1.0
instability O 1 1.0
. O 0 2.6366299152869033e-06

By O 0 1.552201212007276e-08
analysing O 0 4.4752471239917213e-07
tumour B-Disease 1 0.9999998807907104
DNA O 0 2.9629842401845963e-07
from O 0 2.062077619768843e-09
patients O 0 4.483370119601204e-09
with O 0 3.753148833385289e-12
sporadic B-Disease 0 7.982038852105688e-08
T I-Disease 0 4.159410764259519e-06
- I-Disease 0 3.231728840091819e-08
cell I-Disease 0 4.545522358512244e-08
prolymphocytic I-Disease 0 1.828934000513982e-05
leukaemia I-Disease 1 0.9788898229598999
( O 0 3.3834664237009093e-11
T B-Disease 0 4.4518348119026996e-08
- I-Disease 0 7.409231450594689e-09
PLL I-Disease 0 1.9977363763246103e-07
) O 0 2.046538719741031e-12
, O 0 3.269409753776237e-13
a O 0 1.6104749912121408e-13
rare O 0 4.088002159008397e-11
clonal B-Disease 0 3.625071087753895e-08
malignancy I-Disease 0 6.345146630337695e-08
with O 0 2.461436002937356e-12
similarities O 0 6.142650277318751e-11
to O 0 1.8427932790832102e-11
a O 0 6.766535942670515e-11
mature B-Disease 0 9.364863728933415e-08
T I-Disease 0 1.4884136589898844e-07
- I-Disease 0 2.044415525759291e-09
cell I-Disease 0 2.378036212391521e-09
leukaemia I-Disease 0 1.2324987608280935e-07
seen O 0 1.840899654936834e-11
in O 0 1.4562715616728283e-11
A B-Disease 1 0.9999176263809204
- I-Disease 0 0.0009443337912671268
T I-Disease 1 1.0
, O 0 2.890639463903888e-11
we O 0 7.507929824721038e-13
demonstrate O 0 6.096936757543636e-12
a O 0 1.059049834048649e-13
high O 0 6.464729793154156e-12
frequency O 0 9.242863419078873e-12
of O 0 1.0346113549219993e-10
ATM O 0 4.2078602291439893e-07
mutations O 0 2.3285927852612076e-08
in O 0 8.67098464141236e-08
T B-Disease 0 0.006943601183593273
- I-Disease 0 1.2819060430047102e-05
PLL I-Disease 0 0.0001720800792099908
. O 0 5.950377257590844e-08

In O 0 1.391554071972223e-08
marked O 0 1.4015482996398987e-08
contrast O 0 3.083541422199687e-09
to O 0 8.719382160737865e-11
the O 0 1.5767484540241128e-10
ATM O 0 3.478777443888248e-08
mutation O 0 1.674759497749534e-10
pattern O 0 4.3617706668719336e-10
in O 0 2.2543789057749564e-10
A B-Disease 1 1.0
- I-Disease 1 0.999998927116394
T I-Disease 1 1.0
, O 0 3.3092015239155614e-11
the O 0 4.776604025508169e-12
most O 0 4.5261233996840566e-13
frequent O 0 3.2352668721119526e-13
nucleotide O 0 2.4953258209725604e-11
changes O 0 4.096634836914248e-11
in O 0 5.832852256748566e-11
this O 0 1.0062998212490015e-09
leukaemia B-Disease 0 0.0003902761673089117
were O 0 2.906605267583018e-08
missense O 0 3.922283667634474e-06
mutations O 0 8.178609078868249e-08
. O 0 5.593701501993564e-08

These O 0 8.416975560976425e-08
clustered O 0 5.752109899503921e-08
in O 0 6.25186707958747e-11
the O 0 7.415614650119196e-11
region O 0 2.5517166157840165e-10
corresponding O 0 1.619910594552465e-10
to O 0 1.3773934770533458e-10
the O 0 1.2335018562126265e-09
kinase O 0 3.641396073561509e-09
domain O 0 6.426894572086894e-10
, O 0 3.156251518823816e-12
which O 0 1.3816915276840258e-12
is O 0 5.476536650388109e-13
highly O 0 1.003663749332695e-10
conserved O 0 2.1823698403977687e-10
in O 0 7.078566205409587e-11
ATM O 0 7.400745971608558e-07
- O 0 8.358115088924478e-09
related O 0 2.3758929046380217e-08
proteins O 0 7.28611226907816e-10
in O 0 1.3624347483531807e-10
mouse O 0 8.0040146732685e-10
, O 0 6.477937110338505e-12
yeast O 0 3.304746698518102e-08
and O 0 2.146619548781814e-09
Drosophila O 0 6.268843577572625e-08
. O 0 7.118107436809851e-09

The O 0 9.435900949483766e-08
resulting O 0 7.28732914012653e-08
amino O 0 2.880561034146467e-08
- O 0 8.047140731548552e-09
acid O 0 9.940361422877686e-09
substitutions O 0 3.6045317841626456e-08
are O 0 1.1399017146862533e-10
predicted O 0 7.1965757797443075e-09
to O 0 3.7634320659840625e-10
interfere O 0 9.119561994452852e-09
with O 0 5.5926478725876194e-11
ATP O 0 3.4560841868369607e-06
binding O 0 1.672596816604255e-08
or O 0 1.0038326836436795e-09
substrate O 0 2.543303345703407e-08
recognition O 0 9.776305986974876e-09
. O 0 1.4048750607287275e-08

Two O 0 1.23412373653764e-08
of O 0 1.9625705505177393e-08
seventeen O 0 1.0883425005658864e-07
mutated O 0 2.3304595231365965e-07
T B-Disease 0 2.6239447379339254e-06
- I-Disease 0 4.79809010300869e-08
PLL I-Disease 0 9.028801741806092e-07
samples O 0 2.7655138179483174e-09
had O 0 1.6064453586817073e-11
a O 0 6.206936548937281e-13
previously O 0 6.358270160378154e-11
reported O 0 2.3053101094738793e-10
A B-Disease 1 1.0
- I-Disease 1 0.9999939203262329
T I-Disease 1 1.0
allele O 0 5.951937964709941e-07
. O 0 9.38678468287435e-09

In O 0 8.413440610866019e-09
contrast O 0 6.533512841855327e-09
, O 0 4.9899782222917466e-11
no O 0 1.8827626957484966e-11
mutations O 0 3.906643758488926e-11
were O 0 3.136526802172135e-11
detected O 0 6.420841636156638e-10
in O 0 4.308198936486818e-11
the O 0 5.986777185107428e-10
p53 O 0 8.284467556407549e-10
gene O 0 7.99023694431078e-11
, O 0 3.3675623054008064e-12
suggesting O 0 3.1266416539166286e-11
that O 0 5.215750249233653e-13
this O 0 1.008803388047319e-10
tumour B-Disease 1 1.0
suppressor O 0 4.4282209273660555e-05
is O 0 2.2715563804953653e-11
not O 0 2.0453445794682557e-12
frequently O 0 4.0287378468006896e-12
altered O 0 6.959820497698388e-10
in O 0 4.710523637818653e-11
this O 0 7.948364744159164e-10
leukaemia B-Disease 0 0.0005091919447295368
. O 0 5.184510598610359e-08

Occasional O 0 1.358224722025625e-06
missense O 0 1.200891438202234e-05
mutations O 0 3.7541013853115146e-08
in O 0 3.45516837363391e-09
ATM O 0 9.979990863939747e-06
were O 0 1.7751665026821684e-08
also O 0 2.3769363213799188e-11
found O 0 1.773634190904705e-11
in O 0 4.1120256505378094e-11
tumour B-Disease 1 0.9999995231628418
DNA O 0 8.437980980602333e-09
from O 0 7.868026369317604e-11
patients O 0 4.3808720540106094e-10
with O 0 1.0250445240875261e-12
B B-Disease 0 8.621116649010219e-06
- I-Disease 0 1.8492348763388122e-09
cell I-Disease 0 4.489987404099338e-08
non I-Disease 0 1.8372902559349313e-05
- I-Disease 0 3.334231223561801e-05
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 1 0.999537467956543
( O 0 1.123740770575532e-11
B B-Disease 0 1.1050766346443197e-07
- I-Disease 0 6.768769572618183e-11
NHL I-Disease 0 3.8468161989158034e-08
) O 0 6.561648468496328e-13
and O 0 5.269027401888504e-12
a O 0 3.422951505571703e-11
B B-Disease 0 2.96394409815548e-06
- I-Disease 0 6.97925939263655e-09
NHL I-Disease 0 3.990046934632119e-06
cell O 0 1.829575637657399e-07
line O 0 2.2273098920777556e-07
. O 0 9.737876283111291e-09

The O 0 2.0139754308701185e-09
evidence O 0 3.4963085204786637e-10
of O 0 2.081983196955406e-10
a O 0 3.3932882545495424e-12
significant O 0 6.053822027007882e-11
proportion O 0 2.256728803828878e-09
of O 0 2.91426438536746e-09
loss O 0 8.013704366760521e-09
- O 0 8.955121977294311e-09
of O 0 1.2347010169833084e-07
- O 0 4.875543080373745e-09
function O 0 2.6889676596475454e-10
mutations O 0 1.2977619846810118e-11
and O 0 7.291454224254978e-13
a O 0 2.396929497331529e-13
complete O 0 1.0688978868689247e-10
absence O 0 3.9332421764015635e-09
of O 0 3.776446932945987e-10
the O 0 5.234910768758816e-11
normal O 0 1.301729141145458e-10
copy O 0 1.2631744261693e-10
of O 0 1.963448292841008e-10
ATM O 0 3.522598035488045e-08
in O 0 1.470029827033148e-11
the O 0 3.111933974397907e-11
majority O 0 1.2489479936372838e-11
of O 0 2.951873467882393e-10
mutated O 0 3.7101392535987543e-07
tumours B-Disease 1 1.0
establishes O 0 1.371025604157694e-08
somatic O 0 4.279639043147654e-08
inactivation O 0 5.141422434462584e-07
of O 0 2.8946631203119466e-10
this O 0 7.587167873135403e-12
gene O 0 7.458534657944771e-12
in O 0 7.2408307648375025e-12
the O 0 1.2654460812555612e-10
pathogenesis O 0 7.950477538543055e-07
of O 0 1.0460057708883141e-08
sporadic B-Disease 0 6.444222435675329e-06
T I-Disease 0 0.002948574023321271
- I-Disease 0 2.568047193562961e-06
PLL I-Disease 0 2.541155117796734e-05
and O 0 7.841986782164412e-11
suggests O 0 1.8805840565350174e-11
that O 0 3.8838680535557835e-13
ATM O 0 1.893768164507037e-08
acts O 0 4.0637954112909824e-10
as O 0 7.114751010561804e-10
a O 0 2.2826469603387523e-09
tumour B-Disease 1 1.0
suppressor O 0 0.00015952919784467667
. O 0 2.2204426386451814e-07

As O 0 9.760938723957224e-08
constitutional O 0 3.2031630325946026e-07
DNA O 0 2.5019826210836982e-08
was O 0 4.5628734124392167e-10
not O 0 1.478763617633605e-12
available O 0 1.135963892395786e-11
, O 0 9.734328143898296e-13
a O 0 1.1842701298780955e-11
putative O 0 1.3580886388808722e-06
hereditary O 1 0.9999984502792358
predisposition O 1 0.9999997615814209
to O 1 0.906005322933197
T B-Disease 1 1.0
- I-Disease 1 0.9173173904418945
PLL I-Disease 0 0.001389617333188653
will O 0 2.3929130898991957e-10
require O 0 4.0432587833372224e-11
further O 0 5.5354883871094884e-11
investigation O 0 2.320299924418734e-10
. O 0 1.6612794473402914e-10
. O 0 2.6698963040416857e-09

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 2.089961890305858e-05
kinase O 0 1.1571962232892474e-07
is O 0 1.0060666709443833e-11
involved O 0 3.8713047524618904e-12
in O 0 8.436804857167579e-13
the O 0 2.735684291946261e-12
modulation O 0 4.2825309271021794e-11
of O 0 2.0795134711426577e-11
the O 0 1.0153763940756733e-10
Ca2 O 0 2.185357450557035e-09
+ O 0 8.468808765371705e-09
homeostasis O 0 4.673070819194436e-08
in O 0 1.6378908229697231e-09
skeletal O 0 3.0711177601006057e-07
muscle O 0 2.168436594729428e-06
cells O 0 0.00010239725088467821
. O 0 4.177759365120437e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.984677843822283e-07
DM B-Disease 1 1.0
) O 0 5.003189529340091e-10
, O 0 3.834626192966706e-12
the O 0 6.568714322474634e-12
most O 0 7.048065603365572e-11
prevalent O 0 0.015595083124935627
muscular B-Disease 0 0.31863364577293396
disorder I-Disease 1 0.9744001626968384
in O 0 9.150335245067254e-08
adults O 0 1.7160308729557983e-08
, O 0 5.215540998214363e-13
is O 0 6.987260162821807e-14
caused O 0 1.6600401608890536e-11
by O 0 1.647486869149617e-10
( O 0 3.1283892143463277e-11
CTG O 0 9.152272184564936e-08
) O 0 1.7333072910991065e-12
n O 0 4.607534492828691e-11
- O 0 5.546183651228276e-11
repeat O 0 1.3684456345863794e-10
expansion O 0 1.1666360100193174e-09
in O 0 7.261784489703826e-12
a O 0 1.988691112828067e-12
gene O 0 1.7888808923754995e-12
encoding O 0 1.902012436438838e-10
a O 0 9.437076120555332e-11
protein O 0 3.716043250889811e-09
kinase O 0 2.2707366653662575e-08
( O 0 1.7321721834662185e-10
DM B-Disease 1 0.9999911785125732
protein O 0 1.1951230227680298e-08
kinase O 0 3.4608869103891493e-09
; O 0 4.538922709906856e-11
DMPK O 0 3.672226739581674e-05
) O 0 7.290859756203805e-12
and O 0 3.03187141191541e-12
involves O 0 1.397563401811519e-11
changes O 0 3.9314027033832133e-10
in O 0 9.22698528693644e-10
cytoarchitecture O 0 7.315479888347909e-05
and O 0 6.551046993763521e-08
ion O 0 7.326117156480905e-06
homeostasis O 0 2.5455718059674837e-05
. O 0 1.484304675614112e-06

To O 0 4.123001051681285e-09
obtain O 0 9.687709301431369e-09
clues O 0 2.6273820452615837e-08
to O 0 1.3896317256623103e-11
the O 0 1.8822275335561578e-11
normal O 0 5.076204456777589e-10
biological O 0 2.470441073931795e-10
role O 0 7.616430403034613e-11
of O 0 7.295141379870529e-09
DMPK O 1 1.0
in O 0 3.792490304022067e-07
cellular O 0 5.8457914065002115e-08
ion O 0 2.9740695239866e-08
homeostasis O 0 4.484133242499411e-08
, O 0 3.5458239122654334e-10
we O 0 1.4033336992458345e-10
have O 0 2.177292200700176e-11
compared O 0 1.1298090241140812e-09
the O 0 1.8321015538003138e-10
resting O 0 1.1995625825989009e-08
[ O 0 5.210018180767939e-11
Ca2 O 0 1.463257293110587e-11
+ O 0 1.506467173228998e-11
] O 0 2.553224472123805e-11
i O 0 2.4372461514265975e-12
, O 0 7.121946532951534e-14
the O 0 2.8771437814677225e-13
amplitude O 0 2.2402839999768887e-11
and O 0 3.5091994414482297e-12
shape O 0 6.075374647807052e-10
of O 0 9.262568489987189e-10
depolarization O 0 3.150201521862073e-08
- O 0 1.3574921631231973e-08
induced O 0 3.4956851635570274e-08
Ca2 O 0 4.3799450177850474e-10
+ O 0 7.943238428120836e-11
transients O 0 1.262060012052757e-09
, O 0 4.411235103325001e-13
and O 0 4.096529430779039e-13
the O 0 1.4405076523976712e-12
content O 0 3.874046916596541e-11
of O 0 8.075223822956445e-11
ATP O 0 1.968643800864811e-06
- O 0 4.6363066275034726e-08
driven O 0 3.705294204792153e-08
ion O 0 2.207461236025665e-08
pumps O 0 8.620634872613664e-09
in O 0 2.0993211335973427e-10
cultured O 0 8.737158196936434e-08
skeletal O 0 5.014764425936846e-08
muscle O 0 8.091836534163122e-09
cells O 0 5.4765401102940814e-08
of O 0 4.647805695867646e-09
wild O 0 4.303021494678205e-09
- O 0 1.485291403757749e-11
type O 0 5.908556283129585e-11
and O 0 2.144943250792508e-11
DMPK O 0 5.069535836810246e-05
[ O 0 5.224854149332714e-08
- O 0 9.089251307159429e-07
/ O 0 1.5378637954199803e-06
- O 0 1.269925542146666e-05
] O 0 1.253854634342133e-06
knockout O 0 2.5503441065666266e-05
mice O 0 1.0130893457471757e-07
. O 0 3.930062941748247e-09

In O 0 1.5084626170391857e-07
vitro O 0 1.6276850374197238e-06
- O 0 5.259810791358177e-07
differentiated O 0 4.009423719253391e-06
DMPK O 1 0.9848029017448425
[ O 0 1.843485506469733e-07
- O 0 1.5684601351040328e-07
/ O 0 4.9257963041782205e-08
- O 0 5.1796966715755843e-08
] O 0 1.0597052124694528e-08
myotubes O 0 1.7779628080916154e-07
exhibit O 0 2.933234488633474e-10
a O 0 5.39460620271881e-12
higher O 0 2.320920566845075e-09
resting O 0 2.194548187617329e-08
[ O 0 7.873175028594304e-11
Ca2 O 0 2.514508393169912e-11
+ O 0 7.322289302669205e-11
] O 0 2.2867899240885947e-10
i O 0 2.5528542821340316e-11
than O 0 5.069184655370762e-12
do O 0 1.5172809189611947e-11
wild O 0 1.1429284185737743e-09
- O 0 5.171455971786365e-11
type O 0 5.29836896578928e-10
myotubes O 0 3.9148480368567107e-07
because O 0 6.354660131435708e-10
of O 0 3.6387629021028545e-10
an O 0 3.971931561864289e-13
altered O 0 8.889123326305537e-10
open O 0 2.353627293061322e-10
probability O 0 1.0386923959826433e-10
of O 0 1.4982468043989172e-10
voltage O 0 1.947301768723264e-07
- O 0 2.0705877901150416e-08
dependent O 0 2.191594994371826e-08
l O 0 1.5755399762618083e-10
- O 0 2.1051993481790987e-10
type O 0 2.122925030212386e-10
Ca2 O 0 2.2466650761998608e-10
+ O 0 2.4200766390869433e-10
and O 0 9.249058463556281e-11
Na O 0 9.041380977237168e-09
+ O 0 1.0414383799783877e-09
channels O 0 3.9179059996286014e-10
. O 0 6.896537230183242e-10

The O 0 1.4235320122679695e-06
mutant O 0 6.100681275711395e-06
myotubes O 0 3.337081216159277e-05
exhibit O 0 7.885945763064228e-08
smaller O 0 3.4130651638264453e-09
and O 0 9.041751375393758e-11
slower O 0 5.174788952899689e-08
Ca2 O 0 8.313279842298016e-09
+ O 0 3.1553291091057645e-09
responses O 0 3.4384811664622816e-10
upon O 0 8.564939313338016e-10
triggering O 0 3.102023082846017e-09
by O 0 2.7116796655346498e-11
acetylcholine O 0 2.2324162518572166e-09
or O 0 6.42086606106318e-10
high O 0 9.52965972800257e-09
external O 0 7.344228336592096e-09
K O 0 2.0944642642461986e-07
+ O 0 2.0279795620581353e-09
. O 0 6.868615676225431e-10

In O 0 1.2039452101930692e-08
addition O 0 2.5022772742744337e-09
, O 0 1.2499758172968e-10
we O 0 2.3731943493698893e-11
observed O 0 4.856687968457507e-11
that O 0 5.066021387112318e-13
these O 0 1.3359115896838247e-11
Ca2 O 0 6.833072996315082e-10
+ O 0 2.164499690593402e-09
transients O 0 2.6927940766086067e-08
partially O 0 1.9834996145551287e-10
result O 0 2.6021029081446656e-11
from O 0 1.0876680632543323e-11
an O 0 9.586075829610616e-14
influx O 0 3.055238353977252e-11
of O 0 1.5263195221604242e-11
extracellular O 0 2.2592977835800276e-11
Ca2 O 0 1.0321160592852152e-10
+ O 0 7.615748309763859e-11
through O 0 2.4703124962277556e-11
the O 0 5.463240276837311e-11
l O 0 6.859420670357608e-11
- O 0 5.952460191416264e-10
type O 0 1.1775770358823934e-09
Ca2 O 0 2.870358173368004e-09
+ O 0 6.968617682900913e-09
channel O 0 1.1660710175220856e-09
. O 0 7.789130451740789e-10

Neither O 0 6.033322733856039e-06
the O 0 1.881982747420352e-08
content O 0 1.4235379985905183e-08
nor O 0 1.0534096261949344e-08
the O 0 1.6650449075061857e-10
activity O 0 9.804442813177161e-10
of O 0 6.450522893608479e-10
Na O 0 6.504692606768003e-08
+ O 0 3.392167657878531e-09
/ O 0 4.4346033511999394e-09
K O 0 1.0693007368445251e-08
+ O 0 1.8004148172323653e-10
ATPase O 0 3.736310982827007e-10
and O 0 1.7670765892208173e-11
sarcoplasmic O 0 9.91680249029514e-09
reticulum O 0 1.4550326277174008e-08
Ca2 O 0 2.587574376988755e-09
+ O 0 7.890963993339994e-10
- O 0 5.237500433352693e-10
ATPase O 0 4.864283420502602e-10
are O 0 1.2412150300622482e-12
affected O 0 1.9372035225950768e-11
by O 0 4.9104421917522956e-11
DMPK O 1 0.969931423664093
absence O 0 4.144583363085985e-05
. O 0 4.790427396983432e-07

In O 0 1.377520941758803e-08
conclusion O 0 8.355871727872e-08
, O 0 2.92885160568801e-10
our O 0 1.2657960790640743e-10
data O 0 2.1535396729777112e-11
suggest O 0 4.894956662226946e-11
that O 0 1.994149420245228e-12
DMPK O 1 0.6570588946342468
is O 0 1.005748175714194e-11
involved O 0 2.737129967123053e-12
in O 0 2.3990620687946995e-12
modulating O 0 6.099967198025524e-10
the O 0 4.350095283989219e-11
initial O 0 1.0550452872459815e-10
events O 0 1.5388678829483804e-12
of O 0 5.968529056404881e-12
excitation O 0 1.2559133288903013e-08
- O 0 1.102968294475204e-08
contraction O 0 7.833205195595383e-09
coupling O 0 1.320961739992299e-08
in O 0 3.8677433478184753e-10
skeletal O 0 1.4290415073503482e-08
muscle O 0 8.066088241776015e-09
. O 0 1.1984512049423302e-08
. O 0 3.2197373656117634e-08

Constitutional O 0 0.0006679933867417276
RB1 O 1 0.6720994114875793
- O 0 0.0007408492965623736
gene O 0 1.1523462006834961e-07
mutations O 0 2.358334683094654e-08
in O 0 5.799441482601253e-10
patients O 0 4.705286826833799e-08
with O 0 4.525972652213994e-11
isolated O 0 1.916515941502439e-07
unilateral B-Disease 0 1.2787693776772358e-05
retinoblastoma I-Disease 1 0.9999996423721313
. O 0 0.0006924334447830915

In O 0 2.3249580038964268e-08
most O 0 3.1891027596486765e-09
patients O 0 5.019402671280204e-09
with O 0 1.1165067134721873e-11
isolated O 0 5.0001990103965e-08
unilateral B-Disease 0 2.5394425392732956e-05
retinoblastoma I-Disease 1 1.0
, O 0 2.3656680241401773e-06
tumor B-Disease 1 0.9999892711639404
development O 0 2.317232805637559e-08
is O 0 1.8819323269886334e-12
initiated O 0 4.783507964734035e-11
by O 0 1.1265988142383776e-12
somatic O 0 4.884432414087314e-09
inactivation O 0 3.87369070153909e-08
of O 0 1.2492322454260574e-10
both O 0 2.9021857833599896e-11
alleles O 0 5.983041839741077e-11
of O 0 3.300932305272397e-10
the O 0 5.273649961168303e-09
RB1 O 0 3.336327426950447e-05
gene O 0 2.6486453919005726e-08
. O 0 4.6918081864077976e-08

However O 0 5.053290692558221e-07
, O 0 4.280450716098727e-10
some O 0 1.4550110248590098e-11
of O 0 6.569431804104298e-11
these O 0 6.330658219866336e-10
patients O 0 2.1050077236850484e-09
can O 0 4.88149347332989e-11
transmit O 0 7.294389536838253e-09
retinoblastoma B-Disease 0 0.0005549811758100986
predisposition O 0 0.00041203893488273025
to O 0 1.901855313235501e-07
their O 0 3.1070039767655544e-06
offspring O 0 6.315502105280757e-06
. O 0 2.8191726286763696e-08

To O 0 1.2985803543585916e-09
determine O 0 3.01734248697727e-10
the O 0 8.592096478743372e-11
frequency O 0 7.731080220452213e-10
and O 0 1.946689337506413e-11
nature O 0 1.1940508304331132e-10
of O 0 7.370298260589436e-10
constitutional O 0 8.89294551598141e-06
RB1 O 0 0.07605625689029694
- O 0 2.552074147388339e-05
gene O 0 7.262293877374759e-09
mutations O 0 2.240089669314216e-09
in O 0 8.730032668990972e-11
patients O 0 4.281726528887475e-09
with O 0 3.4857177907965387e-12
isolated O 0 2.292294709604903e-08
unilateral B-Disease 0 6.130533165560337e-07
retinoblastoma I-Disease 1 0.9999971389770508
, O 0 8.419380748136973e-09
we O 0 2.0563226121872447e-10
analyzed O 0 3.1609415085398496e-10
DNA O 0 4.2475775674510885e-10
from O 0 1.139286581741672e-10
peripheral O 0 3.764908171888237e-07
blood O 0 1.566486957926827e-07
and O 0 9.85750814308517e-10
from O 0 4.329554936788327e-09
tumor B-Disease 0 2.2999206521490123e-06
tissue O 0 2.1162288987852662e-07
. O 0 5.028307370480434e-08

The O 0 4.222232785622282e-09
analysis O 0 1.1641043684562646e-09
of O 0 3.818751537210119e-08
tumors B-Disease 1 1.0
from O 0 2.339089917313686e-07
54 O 0 1.2205397581510624e-07
( O 0 9.9657088137306e-12
71 O 0 1.6629255750189031e-09
% O 0 4.796863427303233e-12
) O 0 1.4289368570775257e-13
of O 0 2.3898560214119513e-11
76 O 0 2.248965458306884e-08
informative O 0 5.937087710350397e-09
patients O 0 4.476166992617436e-09
showed O 0 1.216199502218629e-10
loss O 0 2.615873628819543e-10
of O 0 3.647130597528303e-09
constitutional O 0 0.0007706852629780769
heterozygosity O 1 0.9999879598617554
( O 0 3.8673121594001714e-08
LOH O 1 0.9416255950927734
) O 0 1.6128413882210424e-10
at O 0 1.4774408363393832e-09
intragenic O 0 1.4406692798729637e-06
loci O 0 3.2418665796285495e-07
. O 0 9.222910790640526e-08

Three O 0 4.620293481139015e-08
of O 0 8.88297524426207e-09
13 O 0 6.577967326393264e-08
uninformative O 0 0.0019814425613731146
patients O 0 1.447069280402502e-05
had O 0 1.9667365513953428e-09
constitutional O 0 9.40944232752372e-07
deletions O 0 1.0552159437793307e-05
. O 0 5.017174771637656e-06

For O 0 1.6887503306861618e-07
39 O 0 2.3846473595767748e-06
randomly O 0 1.8762665376925725e-07
selected O 0 3.3024962249328382e-06
tumors B-Disease 1 1.0
, O 0 1.5585113644078774e-08
SSCP O 1 0.9999994039535522
, O 0 2.14055724256923e-08
hetero O 0 1.270924201435264e-07
- O 0 7.451319006257506e-10
duplex O 0 1.0083691659446004e-09
analysis O 0 1.820035615274218e-11
, O 0 2.1047074673374855e-12
sequencing O 0 1.6656745982501775e-09
, O 0 1.8891546313404284e-11
and O 0 3.0096730663231597e-11
Southern O 0 2.366979945378489e-10
blot O 0 7.728341522295068e-09
analysis O 0 1.1385278136932797e-11
were O 0 6.631670473183915e-12
used O 0 5.295059963411619e-12
to O 0 1.4345044596630885e-10
identify O 0 1.1486416262584953e-08
mutations O 0 1.249564007821391e-07
. O 0 2.0169582626294869e-07

Mutations O 0 4.723071924672695e-07
were O 0 3.590840513822968e-09
detected O 0 4.138167142286875e-09
in O 0 1.3246818919565584e-10
21 O 0 5.1431707781546265e-09
( O 0 4.442775140833799e-12
91 O 0 3.677362414578056e-09
% O 0 5.9131428052638935e-12
) O 0 4.132133003820204e-13
of O 0 2.935047760388443e-10
23 O 0 2.1971334717818536e-05
tumors B-Disease 1 1.0
with O 0 0.00010254323569824919
LOH O 1 1.0
. O 0 0.002103737322613597

In O 0 3.81631970469698e-08
6 O 0 6.821515796673339e-08
( O 0 2.346078366299853e-11
38 O 0 1.7177229638676295e-09
% O 0 1.8898863377025954e-11
) O 0 7.894730875979139e-13
of O 0 4.870076009133584e-10
16 O 0 1.3106352980685188e-06
tumors B-Disease 1 1.0
without O 1 0.9999995231628418
LOH O 1 1.0
, O 0 5.134829006436803e-09
one O 0 4.4070348065305964e-11
mutation O 0 9.82315184056004e-12
was O 0 9.406593559635468e-12
detected O 0 4.3524524262483766e-11
, O 0 7.880153235668985e-13
and O 0 3.4662060548196205e-12
in O 0 4.2502820707390754e-11
9 O 0 1.8859236394774825e-09
( O 0 7.499199286727098e-13
56 O 0 1.4522862079591192e-10
% O 0 1.126732062685376e-12
) O 0 9.172395102566983e-14
of O 0 6.483898140619004e-11
the O 0 1.042103079385015e-07
tumors B-Disease 1 1.0
without O 1 0.9999997615814209
LOH O 1 1.0
, O 0 8.791437267063884e-08
both O 0 1.1967653534838973e-08
mutations O 0 6.000407282158449e-09
were O 0 2.1852490927898316e-09
found O 0 3.221447830714652e-10
. O 0 7.164363324818623e-09

Thus O 0 9.746259621579156e-08
, O 0 1.0638638581195181e-10
a O 0 1.8526141992020184e-12
total O 0 7.44234882055217e-12
of O 0 5.018765958375582e-11
45 O 0 7.474292851306075e-10
mutations O 0 1.4524109692715115e-10
were O 0 1.5350000437397426e-10
identified O 0 5.061171481912652e-10
in O 0 1.2155630280119567e-08
tumors B-Disease 1 1.0
of O 0 9.538202903058846e-06
36 O 0 9.7057736638817e-06
patients O 0 2.8322911020950414e-06
. O 0 4.310474110980067e-08

Thirty O 0 4.5360488911683206e-06
- O 0 1.1676176825403672e-07
nine O 0 2.6790376583818443e-09
of O 0 5.094245025816235e-10
the O 0 1.5582756196508285e-09
mutations O 0 1.185252007651627e-09
- O 0 1.1907816066525356e-08
including O 0 1.7293340093260667e-09
34 O 0 1.0831115559994942e-07
small O 0 6.00232752390184e-10
mutations O 0 1.9191984113042793e-10
, O 0 1.6471435326792516e-11
2 O 0 1.0262393157489669e-09
large O 0 9.129037109589788e-11
structural O 0 3.3223974682528024e-09
alterations O 0 3.4848479117499664e-05
, O 0 2.5271718939734455e-08
and O 0 1.0254986904101315e-07
hypermethylation O 1 0.9999984502792358
in O 0 3.173717050231062e-05
3 O 0 0.0004192634078208357
tumors O 1 1.0
- O 0 1.625799761484359e-08
were O 0 1.4335908848917e-10
not O 0 3.844278194387041e-12
detected O 0 3.4034228213464246e-10
in O 0 4.0944144776011715e-12
the O 0 2.9067449835995518e-11
corresponding O 0 3.4426828054989755e-09
peripheral O 0 1.3553870985560934e-06
blood O 0 3.307241343009082e-07
DNA O 0 4.3969873786409153e-07
. O 0 6.843369959597112e-08

In O 0 9.173996318168065e-08
6 O 0 8.156783337653906e-08
( O 0 1.541559761786271e-11
17 O 0 2.9025801207005486e-10
% O 0 2.1607635385806345e-12
) O 0 6.203678792459505e-14
of O 0 8.576831952988861e-12
the O 0 2.6173258005357525e-10
36 O 0 8.792070183005762e-09
patients O 0 2.08243378096995e-08
, O 0 1.5110456288991436e-11
a O 0 1.9273079659987147e-11
mutation O 0 1.8381147992574398e-10
was O 0 1.6741621977622856e-10
detected O 0 2.4517967656123574e-09
in O 0 7.283093572674204e-11
constitutional O 0 1.674892047276444e-08
DNA O 0 1.0692231988684853e-08
, O 0 1.572333062360709e-11
and O 0 6.121570264583376e-12
1 O 0 3.8269579172300894e-10
of O 0 7.07011948986036e-11
these O 0 1.8711000804305655e-10
mutations O 0 3.9237595811369985e-11
is O 0 5.737533386764027e-13
known O 0 1.6548177758646254e-11
to O 0 7.08934516993609e-12
be O 0 5.498406591142313e-11
associated O 0 1.6800072444311809e-09
with O 0 1.1100986796463985e-10
reduced O 0 7.298838795577467e-07
expressivity O 0 3.1529561965726316e-05
. O 0 1.2225947898514278e-07

The O 0 1.016379158613745e-08
presence O 0 2.5978391660075317e-10
of O 0 7.055331874283866e-10
a O 0 1.9597845915542145e-11
constitutional O 0 8.280952101813455e-08
mutation O 0 6.494149107361125e-10
was O 0 4.4034387247648965e-11
not O 0 4.985207125579594e-13
associated O 0 1.2184046306595864e-11
with O 0 1.3944147757034148e-13
an O 0 4.7181507154990185e-14
early O 0 1.7763306381368693e-09
age O 0 9.941493184228989e-10
at O 0 9.189570632228694e-11
treatment O 0 7.009598590457244e-08
. O 0 4.6703529932301535e-08

In O 0 1.7958312170662794e-08
1 O 0 1.1338555339079903e-07
patient O 0 1.9799114170382381e-07
, O 0 2.318959191338621e-10
somatic O 0 1.64946850418346e-05
mosaicism O 0 0.20701982080936432
was O 0 4.088879457242456e-09
demonstrated O 0 3.033742979052789e-10
by O 0 1.823509659243383e-12
molecular O 0 2.382669235523327e-11
analysis O 0 6.506455096921826e-12
of O 0 1.469561625166982e-11
DNA O 0 8.268176698855711e-10
and O 0 1.1914369490995114e-10
RNA O 0 2.7985556094733965e-09
from O 0 3.072748999688457e-10
peripheral O 0 1.8984752614414901e-06
blood O 0 1.605573970664409e-06
. O 0 9.701432901465523e-08

In O 0 7.818371017265235e-08
2 O 0 6.559061205280159e-08
patients O 0 2.617017491601814e-09
without O 0 8.663895989524661e-11
a O 0 7.293213949433053e-11
detectable O 0 7.67177141369757e-07
mutation O 0 3.659905800645902e-08
in O 0 1.4645989976358464e-09
peripheral O 0 2.703271775317262e-06
blood O 0 3.6560342664415657e-07
, O 0 2.2035637203821068e-10
mosaicism O 0 3.869780812237877e-06
was O 0 2.956657141339747e-10
suggested O 0 2.6925331755855986e-11
because O 0 7.773776414254918e-12
1 O 0 2.0609362827439526e-10
of O 0 1.3943975314678614e-11
the O 0 2.0077303708454508e-10
patients O 0 2.3137483040613915e-08
showed O 0 2.0454773874689636e-08
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 6.055990411368839e-07
the O 0 3.2421937135040935e-08
other O 0 5.600507280156819e-10
later O 0 7.888229625052645e-09
developed O 0 3.5606493753448376e-08
bilateral B-Disease 0 3.681174712255597e-05
retinoblastoma I-Disease 0 0.05679440125823021
. O 0 1.2929998547406285e-06

In O 0 1.0746104450731764e-08
conclusion O 0 5.28892414308757e-08
, O 0 3.2421842988128446e-10
our O 0 3.7151623444309223e-10
results O 0 2.44032322127552e-10
emphasize O 0 3.0551700058722986e-10
that O 0 1.8988233023691653e-13
the O 0 1.6834504276697082e-11
manifestation O 0 1.2099767410234108e-08
and O 0 4.52373083437152e-10
transmissibility O 0 1.1790855296567315e-06
of O 0 5.306867389975878e-09
retinoblastoma B-Disease 0 1.6598944796442083e-07
depend O 0 1.0064846733826016e-08
on O 0 5.271073022505846e-10
the O 0 2.3611484295527063e-11
nature O 0 7.969685675290883e-12
of O 0 1.1013269289594785e-11
the O 0 9.045783219696624e-12
first O 0 1.6469896627069325e-11
mutation O 0 3.316643400891328e-12
, O 0 1.0310912415762222e-13
its O 0 1.4535837540140956e-13
time O 0 2.8746601453411014e-12
in O 0 5.230806239542307e-12
development O 0 1.3034508195008954e-10
, O 0 3.5295789728440052e-12
and O 0 9.105139385512384e-12
the O 0 1.799195341323223e-11
number O 0 1.3575573824808895e-11
and O 0 1.6311511603223083e-12
types O 0 9.167459846803894e-11
of O 0 5.525720159216263e-11
cells O 0 1.684157813208742e-10
that O 0 5.853475256584195e-13
are O 0 3.387849462771486e-12
affected O 0 2.7515850709036727e-10
. O 0 1.2600294418962932e-10
. O 0 3.7097687144438396e-09

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
of I-Disease 0 0.030036408454179764
the I-Disease 0 9.55591644924425e-07
fifth I-Disease 0 2.4634613282614737e-07
component I-Disease 0 1.7392517648318062e-08
of I-Disease 0 1.3556705980022343e-08
complement I-Disease 0 8.298502507386729e-08
in O 0 7.234784504817071e-08
man O 0 2.637183058595838e-07
. O 0 6.847665900977518e-08

I O 0 0.004599160980433226
. O 0 3.736343614946236e-06

Clinical O 0 4.545693172985921e-06
, O 0 1.4572260065293108e-09
immunochemical O 0 0.0004413873248267919
, O 0 3.469432519054294e-09
and O 0 2.47891951410395e-09
family O 0 3.099686729512996e-09
studies O 0 3.21838511396777e-09
. O 0 3.461276154581583e-09

The O 0 1.4000628212329502e-08
first O 0 1.0929283034144532e-09
recognized O 0 1.3831703560285291e-09
human O 0 4.727414015803788e-09
kindred O 0 0.001508121145889163
with O 0 1.0636620473292169e-08
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9995859265327454
the I-Disease 0 2.7077564368482854e-07
fifth I-Disease 0 3.0887228774645337e-08
component I-Disease 0 6.844908195802191e-09
of I-Disease 0 4.496131467135456e-08
complement I-Disease 0 1.8900065015259315e-06
( O 0 5.940961500527919e-09
C5 O 1 0.5608564019203186
) O 0 3.9579221844388e-11
is O 0 2.281795759284666e-11
described O 0 2.2049901904352964e-09
. O 0 2.827870027033441e-08

The O 0 1.2727556963909592e-07
proband O 0 4.5539352868217975e-05
, O 0 6.863782875399238e-10
a O 0 3.8209751335172015e-11
20 O 0 2.792667486151146e-10
- O 0 4.764059285955469e-11
year O 0 1.1734442584288018e-10
- O 0 7.563234483143333e-10
old O 0 4.04743488724435e-10
black O 0 3.486921472048432e-12
female O 0 2.092234534494669e-13
with O 0 5.717039797299706e-13
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 1 0.9999558925628662
age O 1 0.9984207153320312
11 O 0 2.148959765690961e-08
, O 0 3.120195768424594e-11
lacked O 0 3.1419386203879185e-08
serum O 0 8.740075685409465e-08
hemolytic O 0 0.08314749598503113
complement O 0 7.418001501946492e-08
activity O 0 4.93538898638235e-08
, O 0 1.2994412837419311e-11
even O 0 2.4533521048031304e-11
during O 0 8.799565520689612e-10
remission O 0 3.121915312931378e-07
. O 0 1.8495887488256813e-08

C5 O 1 0.8372730612754822
was O 0 2.2717641456893034e-07
undetectable O 0 1.6906903965718811e-06
in O 0 1.669039351170909e-09
her O 0 5.0649446442507795e-11
serum O 0 6.194480484111864e-10
by O 0 3.5665848746591067e-11
both O 0 3.675383053458603e-10
immunodiffusion O 0 3.155678496113978e-05
and O 0 5.594694130195421e-08
hemolytic O 1 0.9997592568397522
assays O 0 7.881788769736886e-05
. O 0 6.891362431815651e-07

Other O 0 7.979295446602919e-09
complement O 0 3.6279399484584474e-09
components O 0 4.225922722866926e-09
were O 0 1.3418573197032657e-10
normal O 0 6.196439195083059e-11
during O 0 4.6952386423271264e-11
remission O 0 3.2938036298446605e-08
of O 0 5.59404034206068e-09
lupus O 0 6.548875717271585e-06
, O 0 1.305668573259311e-09
but O 0 1.9297939246598617e-08
C1 O 0 6.802405550843105e-05
, O 0 8.743868962213242e-10
C4 O 0 8.300880836031865e-06
, O 0 1.9492875369397922e-10
C2 O 0 1.669286007199844e-07
, O 0 1.258468190767914e-10
and O 0 3.355212774280858e-09
C3 O 1 0.9985320568084717
levels O 0 1.113949383579893e-05
fell O 0 1.4319481124402955e-05
during O 0 1.222524872446229e-07
exacerbations O 0 0.0005722639616578817
. O 0 9.056639100890607e-07

A O 0 1.4418650380321196e-06
younger O 0 2.329962626390625e-06
half O 0 4.232595784969817e-08
- O 0 5.37181222171057e-07
sister O 0 2.239480494381496e-07
, O 0 4.1251602828085154e-11
who O 0 3.497858903564466e-12
had O 0 1.6557080359524967e-11
no O 0 9.827584301902448e-10
underlying O 1 0.8404382467269897
disease O 0 8.488271851092577e-05
, O 0 2.0727185592872566e-11
was O 0 1.7946114594380447e-09
also O 0 1.853866539447413e-11
found O 0 9.275960208277034e-12
to O 0 8.487915231780718e-11
lack O 0 9.021950404530799e-07
immunochemically O 0 0.0013371634995564818
detectable O 0 0.004225555807352066
C5 O 0 0.0005746984970755875
. O 0 6.985227685163409e-08

By O 0 2.1496531132925156e-07
hemolytic O 1 0.952034056186676
assay O 0 5.1760343922069296e-05
, O 0 7.207991536972713e-09
she O 0 5.8042411155145857e-11
exhibited O 0 2.3675758575869565e-10
1 O 0 6.455753709389e-10
- O 0 3.0613359069953106e-10
2 O 0 2.7251878531586726e-10
% O 0 1.7302154717638296e-12
of O 0 7.846347269829801e-13
the O 0 6.450602205165801e-12
normal O 0 3.309185814259763e-09
serum O 0 5.278513270923213e-08
C5 O 0 3.2929922326729866e-06
level O 0 1.68685920787226e-09
and O 0 3.4166944447300285e-12
normal O 0 1.0275706674445217e-10
concentrations O 0 5.11342301834361e-10
of O 0 2.4548313035110958e-11
other O 0 1.1633084252837822e-11
complement O 0 4.215843230070959e-09
components O 0 2.0107893305976177e-07
. O 0 1.5718384815954778e-07

C5 O 0 0.00014743753126822412
levels O 0 2.3706201091044932e-07
of O 0 5.75708991590318e-09
other O 0 1.338677085849227e-10
family O 0 3.0809400169973244e-11
members O 0 1.376441387083982e-12
were O 0 1.1799681023938469e-11
either O 0 2.920148151064339e-11
normal O 0 3.5114544605363562e-09
or O 0 1.0261032475089582e-11
approximately O 0 1.228681761368533e-12
half O 0 1.6038736311285717e-11
- O 0 5.898254107350454e-11
normal O 0 1.7155064035989653e-09
, O 0 2.099775431654849e-12
consistent O 0 4.818828669428399e-11
with O 0 5.83375849797646e-13
autosomal O 0 3.4922047476015905e-09
codominant O 0 2.320324767879356e-07
inheritance O 0 1.212890410329237e-08
of O 0 1.2088451073477557e-10
the O 0 1.450943393210835e-10
gene O 0 1.1062102345249514e-09
determining O 0 4.6304965508170426e-05
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.198426955146715e-06

Normal O 0 7.696166721871123e-05
hemolytic O 1 0.985072910785675
titers O 0 0.00040551196434535086
were O 0 7.853670602742113e-09
restored O 0 1.603778265746314e-08
to O 0 1.5633029593065118e-10
both O 0 1.5655774454614857e-09
homozygous O 0 0.00011979419650742784
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 2.7850477479773872e-08
C5D B-Disease 1 1.0
) O 0 1.025397988740906e-09
sera O 0 2.0088422036934617e-09
by O 0 2.320456760768197e-12
addition O 0 2.782903768538958e-11
of O 0 1.276934336047475e-09
highly O 0 1.413390464222175e-06
purified O 0 0.000152881839312613
human O 0 8.06895911864558e-07
C5 O 0 0.0036828278098255396
. O 0 1.2201721233395801e-07

In O 0 2.4071979964901402e-08
specific O 0 4.6250722363083696e-08
C5 O 0 3.421023939154111e-05
titrations O 0 8.595278586653876e-07
, O 0 5.928572216484795e-11
however O 0 3.9259548390013776e-10
, O 0 9.751728070883647e-12
it O 0 2.2907296719221204e-12
was O 0 6.110855710339536e-10
noted O 0 9.983921328560186e-11
that O 0 2.633044335949991e-13
when O 0 5.881243408945025e-12
limited O 0 2.3736472856694668e-11
amounts O 0 8.32007726603301e-11
of O 0 2.8687804909388603e-10
C5 O 0 8.157333581948478e-07
were O 0 3.620431177076e-10
assayed O 0 5.6691535910147195e-09
in O 0 1.516774553178557e-11
the O 0 3.0725465574588107e-12
presence O 0 4.027831453784492e-12
of O 0 4.70842184685516e-11
low O 0 1.2397671333985727e-08
dilutions O 0 1.3361119499677443e-06
of O 0 6.447844036472361e-09
either O 0 3.7066442359900975e-08
C5D B-Disease 1 1.0
serum O 0 9.765218464963255e-07
, O 0 6.640432648197248e-11
curving O 0 8.142320151449667e-10
rather O 0 5.008388235389072e-12
than O 0 4.1074438229989074e-13
linear O 0 9.925454555470559e-12
dose O 0 1.4282586224823035e-09
- O 0 7.928101924958852e-11
response O 0 7.62077553839724e-11
plots O 0 9.785499077707982e-10
were O 0 2.0620018192918366e-10
consistently O 0 4.477801809898985e-11
obtained O 0 2.059430230516579e-11
, O 0 2.2813289885653676e-12
suggesting O 0 8.404466705913549e-11
some O 0 9.545581339254205e-12
inhibitory O 0 9.329489181197914e-09
effect O 0 4.524460095467475e-08
. O 0 9.025308855825642e-08

Further O 0 5.807815739444777e-08
studies O 0 2.465259774098172e-09
suggested O 0 3.6465236386007405e-10
that O 0 2.5150489330050263e-12
low O 0 3.568468187609142e-08
dilutions O 0 3.413079321035184e-05
of O 0 4.1879474110828596e-07
C5D B-Disease 1 1.0
serum O 0 4.4578766278391413e-07
contain O 0 2.67264127495892e-10
a O 0 1.366980855767308e-12
factor O 0 9.544511708758918e-11
( O 0 1.3868341696386677e-13
or O 0 1.7891334030614714e-12
factors O 0 9.607836748415366e-11
) O 0 2.370477945878857e-13
interfering O 0 2.6810590206260976e-11
at O 0 6.581283434892171e-11
some O 0 4.932066473978258e-12
step O 0 1.2723709863493582e-09
in O 0 1.314350572823031e-10
the O 0 6.501077454146298e-10
hemolytic O 0 0.00034454165142960846
assay O 0 9.521607353235595e-06
of O 0 6.167960236780345e-05
C5 O 0 0.000956438307184726
, O 0 1.4946724413711365e-11
rather O 0 1.0308367007216823e-11
than O 0 1.565772251438391e-12
a O 0 1.2101963528521331e-11
true O 0 1.3276124199990136e-08
C5 O 0 3.2553536584600806e-05
inhibitor O 0 3.779376811507973e-07
or O 0 4.200448433522297e-09
inactivator O 0 7.227125934150536e-06
. O 0 1.5359276517301623e-07

Of O 0 2.755070340754173e-07
clinical O 0 1.2103515473427251e-05
interest O 0 5.571861265707412e-07
are O 0 2.8701105381223613e-10
( O 0 3.894759948580573e-12
a O 0 1.9525154063004813e-12
) O 0 9.901449912795915e-14
the O 0 1.0461512298803877e-12
documentation O 0 3.2370123248526284e-10
of O 0 1.5536726349907326e-09
membranous O 1 0.978086531162262
glomerulonephritis B-Disease 1 1.0
, O 0 9.82886660949589e-08
vasculitis B-Disease 1 1.0
, O 0 8.095589087986355e-09
and O 0 9.09394515247186e-08
arthritis B-Disease 1 1.0
in O 0 1.41514362894668e-07
an O 0 4.3261661614169e-11
individual O 0 2.6099937766588255e-09
lacking O 0 0.00012389139737933874
C5 O 0 0.0003643791424110532
( O 0 1.1297324187253821e-11
and O 0 4.638986677435453e-12
its O 0 1.3153833057499842e-11
biologic O 0 1.1187130155576597e-07
functions O 0 1.3324588654661795e-10
) O 0 2.7739076769069115e-13
, O 0 2.8063058062251234e-13
and O 0 1.6147635529054072e-12
( O 0 5.34882576598561e-13
b O 0 2.349420102909505e-10
) O 0 6.404561126230335e-14
a O 0 6.420072264610999e-13
remarkable O 0 8.666160150605506e-11
propensity O 0 9.07347885714671e-09
to O 0 1.9739736234480887e-10
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 1.3990363034732667e-10
the O 0 2.3965020939931136e-11
proband O 0 2.873486115717583e-09
, O 0 2.8489550670841857e-13
even O 0 1.714662076603493e-13
during O 0 3.806164151215485e-12
periods O 0 1.2007546068559805e-09
of O 0 2.0481651097359332e-10
low O 0 7.458930362247429e-09
- O 0 1.1538753980078198e-10
dose O 0 5.025610594344698e-09
or O 0 3.3357601403327664e-11
alternate O 0 4.3158028262269e-09
- O 0 1.7274844887893437e-09
day O 0 4.792417129806381e-09
corticosteroid O 0 9.596546988177579e-07
therapy O 0 1.3858544889444602e-07
. O 0 3.4085569922126524e-09

Other O 0 1.411345085244875e-08
observations O 0 6.681322606283402e-09
indicate O 0 3.5229505424005936e-10
that O 0 2.251072375378249e-12
the O 0 8.320732436395417e-10
C5D B-Disease 1 1.0
state O 0 9.811968126882675e-09
is O 0 1.2327197422556946e-11
compatible O 0 1.0984979592620903e-09
with O 0 8.617066478769364e-13
normal O 0 4.415821597270053e-10
coagulation O 0 1.108521363590853e-08
function O 0 1.2069743815512624e-10
and O 0 5.87606265728402e-12
the O 0 6.720268438953347e-12
capacity O 0 1.085529791056139e-10
to O 0 4.3773786678746873e-11
mount O 0 7.96588679463639e-08
a O 0 2.1876844780166493e-09
neutrophilic O 0 0.0003416322579141706
leukocytosis O 0 8.384558896068484e-05
during O 0 1.3154024145478616e-06
pyogenic B-Disease 0 8.8521781435702e-05
infection I-Disease 0 2.2369752059603343e-06
. O 0 5.399081626222824e-09
. O 0 2.0230855213299037e-08

Susceptibility O 0 0.00011399839422665536
to O 0 1.9851182742058882e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.0002505725424271077
twins O 0 1.5105922102520708e-05
: O 0 2.5917495146549063e-12
the O 0 2.2206748159087075e-12
role O 0 3.5109332975624685e-12
of O 0 3.873633011575173e-11
genes O 0 1.0783257620161635e-10
, O 0 4.6226661387649415e-11
HLA O 0 0.004027924500405788
, O 0 3.251196201148332e-09
and O 0 5.26229337882711e-10
the O 0 2.115585484574467e-09
environment O 0 2.530433391711995e-07
. O 0 3.9676027796531343e-08

OBJECTIVE O 0 3.280913006165065e-05
To O 0 6.397175567052216e-10
determine O 0 7.67873375995265e-10
the O 0 6.012751407880046e-11
relative O 0 9.457699512438467e-09
effects O 0 1.0214749046610905e-08
of O 0 2.541357568830449e-09
genetic O 0 9.998700534197269e-09
and O 0 4.198666067600776e-11
environmental O 0 1.3372334350947312e-09
factors O 0 1.1714025582865162e-10
in O 0 7.473558230608468e-12
susceptibility O 0 2.7192404772335976e-08
to O 0 1.2195689791383302e-08
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 0.00014639022992923856
AS B-Disease 1 1.0
) O 0 1.1820010525909197e-09
. O 0 4.5775112589296896e-09

METHODS O 0 0.002307774033397436
Twins O 0 0.002190662082284689
with O 0 9.244949250586387e-11
AS B-Disease 1 1.0
were O 0 1.446872621713169e-10
identified O 0 1.025302672624795e-12
from O 0 2.1249716125170542e-13
the O 0 2.160965633865586e-12
Royal O 0 5.2810587014562316e-09
National O 0 2.3911247981622807e-10
Hospital O 0 8.501439907604436e-08
for O 0 8.07615141429352e-10
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 0.9999992847442627
database O 0 3.7838307775928115e-07
. O 0 2.3441234020538104e-07

Clinical O 0 2.586675918792025e-06
and O 0 5.940032909990123e-09
radiographic O 0 4.499830538406968e-06
examinations O 0 2.545498091421905e-06
were O 0 1.5268480924035543e-09
performed O 0 1.7610714275750894e-10
to O 0 2.5601478402526023e-12
establish O 0 3.6856040441790583e-10
diagnoses O 0 0.04791632667183876
, O 0 1.1411117606385801e-09
and O 0 2.827248435366414e-09
disease O 0 9.871022257357254e-07
severity O 0 1.8766417269944213e-05
was O 0 3.87730336726122e-09
assessed O 0 3.5134439801964845e-09
using O 0 1.0437879727209776e-11
a O 0 2.7957237219711217e-12
combination O 0 1.4670502312963407e-10
of O 0 4.143859977379094e-10
validated O 0 4.875127501691168e-07
scoring O 0 1.8613599195305142e-07
systems O 0 6.110261665526195e-07
. O 0 3.6170249018141476e-08

HLA O 0 0.0003451597294770181
typing O 0 4.1670918449199235e-07
for O 0 2.7265776303408984e-09
HLA O 0 3.1673050671088276e-06
- O 0 6.326059178718424e-07
B27 O 0 7.068874765536748e-07
, O 0 1.0331993594014932e-10
HLA O 0 3.3396229781601505e-08
- O 0 4.877636072819769e-09
B60 O 0 4.6042121226719246e-08
, O 0 9.246990326228222e-12
and O 0 4.187661328813874e-11
HLA O 0 2.3682077880948782e-05
- O 0 0.00017992655921261758
DR1 O 1 0.9990420937538147
was O 0 3.5062056036316847e-10
performed O 0 2.0319072813190786e-11
by O 0 2.5804931108597273e-12
polymerase O 0 1.2467708809804634e-10
chain O 0 1.1323994519862879e-10
reaction O 0 1.171903268870622e-10
with O 0 1.1029513890745135e-12
sequence O 0 4.89843799203471e-12
- O 0 7.929761881853015e-12
specific O 0 1.7826249157359975e-11
primers O 0 1.599058330192804e-09
, O 0 6.438764885846604e-12
and O 0 1.078689308015024e-11
zygosity O 0 1.1984447212398663e-07
was O 0 7.645253319310541e-10
assessed O 0 1.80592305554228e-08
using O 0 3.5112937002423905e-09
microsatellite O 0 1.1495926628413144e-06
markers O 0 4.2862396298914973e-07
. O 0 2.3005122784525156e-07

Genetic O 0 6.13630618317984e-07
and O 0 2.2276981648250427e-10
environmental O 0 1.678866823340286e-09
variance O 0 1.5734056280081177e-09
components O 0 7.530849721604227e-09
were O 0 2.4166724177376864e-10
assessed O 0 2.9117752653462503e-09
with O 0 6.670960225191314e-12
the O 0 7.195337103915733e-10
program O 0 1.1363718993573357e-10
Mx O 0 1.0707942310617113e-09
, O 0 1.607277407954938e-13
using O 0 1.379810572440035e-13
data O 0 1.4670990117204852e-12
from O 0 2.2246925981093957e-13
this O 0 1.4435708759006488e-13
and O 0 4.089745035684711e-13
previous O 0 1.5743016265612475e-11
studies O 0 4.3717525259612255e-12
of O 0 2.0399302039231237e-11
twins O 0 1.2513301328453963e-07
with O 0 4.2440363723361685e-11
AS B-Disease 1 1.0
. O 0 1.4968463801778853e-07

RESULTS O 0 3.287399158580229e-05
Six O 0 1.8098401000088415e-08
of O 0 5.700544036812971e-09
8 O 0 2.0313530058047036e-07
monozygotic O 0 3.3205196814378724e-05
( O 0 7.175122163083358e-10
MZ O 0 7.295687828445807e-05
) O 0 2.1148542639348733e-10
twin O 0 1.8614729313526368e-08
pairs O 0 4.293007616062994e-11
were O 0 1.4909596127155034e-11
disease O 0 5.715075079848475e-10
concordant O 0 7.757748790027108e-07
, O 0 3.2468795013729235e-11
compared O 0 4.663218700073912e-10
with O 0 3.3652893839664078e-12
4 O 0 1.0200141842275912e-09
of O 0 8.15532502640437e-11
15 O 0 1.2369930080247116e-10
B27 O 0 1.0218626833591316e-08
- O 0 5.874197794852876e-10
positive O 0 2.9890684372091414e-10
dizygotic O 0 1.1811513189741163e-07
( O 0 4.017848987541983e-12
DZ O 0 5.2012790519029295e-08
) O 0 4.0206622753391486e-12
twin O 0 7.123686085463987e-10
pairs O 0 1.0606458419881726e-11
( O 0 5.628211655409054e-13
27 O 0 9.322831395763842e-10
% O 0 8.794572708969994e-12
) O 0 1.206187791790922e-13
and O 0 1.7516862526462118e-12
4 O 0 2.0126957045452087e-10
of O 0 1.5513679230139132e-10
32 O 0 1.1611024142155202e-08
DZ O 0 2.542170841479674e-05
twin O 0 7.045132122129871e-08
pairs O 0 1.2934529836083897e-10
overall O 0 2.341132399052981e-09
( O 0 2.28237350893834e-12
12 O 0 6.127671287048386e-11
. O 0 1.0818107694376966e-11
5 O 0 2.9492508435424725e-10
% O 0 8.676062472623425e-12
) O 0 2.2527732717464444e-12
. O 0 8.503605042342599e-10

Nonsignificant O 0 0.0002492406056262553
increases O 0 1.3835646939241997e-07
in O 0 3.339046539263535e-10
similarity O 0 1.772775815034322e-10
with O 0 9.012248954921864e-13
regard O 0 4.812603093817813e-10
to O 0 2.978354975841091e-12
age O 0 5.986663387247404e-10
at O 0 2.4297789474880815e-11
disease O 0 2.0284930679626e-10
onset O 0 4.674925264680496e-07
and O 0 4.5510789581371114e-10
all O 0 1.1446861514219364e-10
of O 0 1.796757881367128e-10
the O 0 1.5222818838811492e-10
disease O 0 5.310631934207777e-10
severity O 0 6.2726801530743614e-09
scores O 0 8.744682061800901e-11
assessed O 0 2.8583757583078295e-10
were O 0 5.96884000558795e-11
noted O 0 3.737634507450238e-11
in O 0 3.9896794201688124e-11
disease O 0 2.7820531656175262e-08
- O 0 1.1287868062481721e-07
concordant O 0 0.0018531536916270852
MZ O 1 0.8641523718833923
twins O 0 1.1854175454573124e-06
compared O 0 8.154411590410859e-10
with O 0 4.612573170637013e-11
concordant O 0 0.00012512960529420525
DZ O 1 0.5929774641990662
twins O 0 4.16402799601201e-05
. O 0 7.166526216906277e-08

HLA O 0 0.00027764684637077153
- O 0 7.647945494682062e-06
B27 O 0 2.1347609617805574e-06
and O 0 2.2157818635459847e-10
B60 O 0 2.9063611961532843e-08
were O 0 3.6255980856436665e-11
associated O 0 6.841086291203835e-12
with O 0 4.3587285473642434e-13
the O 0 7.2362366099199e-11
disease O 0 3.814920379596742e-09
in O 0 5.1963426617174235e-11
probands O 0 2.013366793107707e-05
, O 0 1.2441096763904369e-11
and O 0 2.203813737403082e-12
the O 0 1.5089172966664677e-11
rate O 0 2.0731069638735278e-10
of O 0 8.05578954238273e-12
disease O 0 5.0750164071189374e-09
concordance O 0 1.4340081122554693e-08
was O 0 4.602510733642262e-11
significantly O 0 2.9098082277023707e-10
increased O 0 9.292013269934785e-10
among O 0 7.23948456737844e-10
DZ O 0 1.3563025049734279e-06
twin O 0 2.1637649449957053e-09
pairs O 0 2.9919458837540658e-12
in O 0 3.5179427730278046e-13
which O 0 2.674207697731662e-13
the O 0 1.998224155586037e-11
co O 0 1.2501737145509395e-10
- O 0 4.291153210544962e-09
twin O 0 2.347751681952559e-08
was O 0 1.564054580294183e-10
positive O 0 2.37616575721189e-11
for O 0 6.049467350666138e-12
both O 0 1.249842312978089e-10
B27 O 0 6.006100647937274e-07
and O 0 1.1936991839434086e-08
DR1 O 0 0.0007607695297338068
. O 0 4.6389693864057335e-08

Additive O 0 5.694847459380981e-06
genetic O 0 1.0461039323672594e-07
effects O 0 9.348548601906259e-09
were O 0 7.016963676775845e-10
estimated O 0 1.1343378493455791e-11
to O 0 4.732900703297016e-12
contribute O 0 6.6457291059141e-11
97 O 0 9.684494095552054e-09
% O 0 3.0835956617986104e-12
of O 0 5.737751853501782e-13
the O 0 2.1923010282143274e-12
population O 0 7.098853297728136e-13
variance O 0 8.145908392265255e-10
. O 0 6.36915187257614e-09

CONCLUSION O 0 4.857791282120161e-05
Susceptibility O 0 5.688338933396153e-05
to O 0 1.0507166692264036e-08
AS B-Disease 1 1.0
is O 0 1.356183915168785e-10
largely O 0 8.574714271958328e-10
genetically O 0 4.2775780140225095e-10
determined O 0 6.690284437560479e-10
, O 0 5.496579320168893e-12
and O 0 1.4697887004699872e-11
the O 0 1.4300378936571434e-10
environmental O 0 3.764706590914102e-08
trigger O 0 9.774716591692822e-10
for O 0 1.2648035396800594e-11
the O 0 1.5454119095537067e-09
disease O 0 1.954405206561205e-07
is O 0 7.614019831292396e-11
probably O 0 1.7117125494792162e-08
ubiquitous O 0 1.59706331714915e-07
. O 0 5.243783007813363e-08

HLA O 0 9.197458712151274e-05
- O 0 1.97948020286276e-06
B27 O 0 2.8249948513803247e-07
accounts O 0 2.6682541592881748e-11
for O 0 2.794714600799081e-13
a O 0 3.3303720024802086e-13
minority O 0 5.958050350828026e-13
of O 0 1.8044696596317134e-12
the O 0 1.5923637408654656e-11
overall O 0 1.0888070889336632e-08
genetic O 0 4.1465977318466685e-09
susceptibility O 0 1.9703359157574596e-06
to O 0 4.619879234724067e-08
AS B-Disease 1 1.0
. O 0 9.398937436344568e-06

Cell O 0 1.522613729321165e-06
cycle O 0 9.684461588221893e-08
- O 0 9.240515908004454e-09
dependent O 0 3.83646092672052e-09
colocalization O 0 1.5726060098586458e-07
of O 0 8.877352186686949e-09
BARD1 O 1 0.9999991655349731
and O 0 7.849839533946579e-08
BRCA1 O 0 1.4486496446863839e-08
proteins O 0 3.7216573572917966e-11
in O 0 6.4280278148920456e-12
discrete O 0 1.2023427808927067e-09
nuclear O 0 6.217899795046833e-08
domains O 0 5.732188057550047e-08
. O 0 5.8741360220437855e-08

Germ O 0 0.0010103657841682434
- O 0 6.155933533591451e-06
line O 0 4.572914917844173e-07
mutations O 0 1.763576507052278e-09
of O 0 6.015541953452441e-10
the O 0 3.133845183356243e-09
BRCA1 O 0 4.1033487718777906e-09
gene O 0 6.031393440242283e-11
predispose O 0 2.0512596066168953e-08
women O 0 1.6271001906931204e-11
to O 0 2.547220680909623e-12
early O 0 1.3364509641178302e-06
- O 0 0.00021933703101240098
onset O 1 1.0
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 5.990521273480098e-11
compromising O 0 5.908607825233503e-09
the O 0 8.075320412359588e-10
genes O 0 2.1353679935387504e-10
presumptive O 0 1.8646254318355204e-07
function O 0 3.2125815896399956e-10
as O 0 1.942302707558241e-10
a O 0 1.6297659055641844e-10
tumor B-Disease 0 2.7711919869943813e-07
suppressor O 0 1.637550212763017e-06
. O 0 3.3208216621005704e-08

Although O 0 4.0920892274698417e-07
the O 0 3.247757618396463e-08
biochemical O 0 9.07029698282713e-06
properties O 0 7.406440090562683e-06
of O 0 2.430604808978387e-06
BRCA1 O 0 7.440616514031717e-07
polypeptides O 0 2.136869525770635e-08
are O 0 1.3290089515005654e-11
not O 0 6.487012316203078e-12
understood O 0 6.78121669928089e-10
, O 0 3.2613395491154495e-12
their O 0 2.3614623711337712e-12
expression O 0 3.400492994826143e-12
pattern O 0 1.902940478804016e-11
and O 0 5.437121022508484e-13
subcellular O 0 2.730553561036686e-09
localization O 0 4.8037835931324935e-09
suggest O 0 7.658836759238952e-11
a O 0 1.4531741695383849e-12
role O 0 1.8072366519961136e-11
in O 0 7.938755208769521e-11
cell O 0 4.025596922474506e-08
- O 0 8.172258425531709e-09
cycle O 0 2.5078689347424188e-08
regulation O 0 1.725240537098216e-07
. O 0 5.000711400526825e-09

When O 0 4.756394957894372e-07
resting O 0 1.8980298364112969e-06
cells O 0 5.538377312319653e-09
are O 0 5.945645451671533e-12
induced O 0 8.473296508881845e-10
to O 0 1.0513646377108277e-11
proliferate O 0 9.169789927376826e-10
, O 0 6.0201730753273175e-12
the O 0 1.7104370003684366e-11
steady O 0 5.8687210646724e-10
- O 0 2.5511641410513874e-12
state O 0 1.057135173669621e-12
levels O 0 1.1171804453757872e-10
of O 0 2.4473745946496095e-11
BRCA1 O 0 3.276204654789616e-11
increase O 0 2.1379332765941728e-12
in O 0 8.984636819253655e-12
late O 0 5.296050531455876e-08
G1 O 0 3.927749148147086e-08
and O 0 5.671113318533871e-12
reach O 0 1.2273191143941098e-11
a O 0 1.127991539691571e-13
maximum O 0 1.4141236792664102e-11
during O 0 1.271449168172012e-09
S O 0 2.290606744281831e-06
phase O 0 2.6913569399766857e-06
. O 0 9.310666371220577e-08

Moreover O 0 9.036045867105713e-07
, O 0 9.333115391640945e-10
in O 0 8.580456900553202e-10
S O 0 2.538191665735212e-06
phase O 0 1.3743870113103185e-06
cells O 0 3.4509024970930113e-08
, O 0 1.3073674087760168e-10
BRCA1 O 0 4.373060136231288e-09
polypeptides O 0 3.0624642821663883e-09
are O 0 4.0000881079693684e-11
hyperphosphorylated O 0 6.811582409227412e-08
and O 0 3.0170890785718996e-10
accumulate O 0 2.277680266615789e-09
into O 0 1.1661371868143533e-10
discrete O 0 1.0764732216728135e-08
subnuclear O 0 4.050647476105951e-06
foci O 0 8.792560038273223e-06
termed O 0 2.8510798983916175e-06
" O 0 6.41030567294365e-07
BRCA1 O 0 3.398208718863316e-07
nuclear O 0 1.844913697368611e-07
dots O 0 6.565394414792536e-07
. O 0 3.241754598093394e-08

" O 0 3.047983773285523e-05
BRCA1 O 0 1.8072989405482076e-05
associates O 0 1.649283731808282e-08
in O 0 4.294778421787271e-10
vivo O 0 4.696873556753189e-09
with O 0 1.999237364200268e-12
a O 0 4.267144970704351e-11
structurally O 0 2.547212147874234e-07
related O 0 1.257063331649988e-06
protein O 0 1.0423240382806398e-05
termed O 0 7.372374511760427e-06
BARD1 O 1 0.9999830722808838
. O 0 1.1893321243405808e-06

Here O 0 6.781921513265843e-08
we O 0 2.9464397588441216e-10
show O 0 1.8576645430257166e-11
that O 0 2.0016705849258687e-13
the O 0 4.539615211518466e-11
steady O 0 3.6025986638321683e-09
- O 0 3.724426669848846e-11
state O 0 1.0682777579207325e-11
levels O 0 7.060582118967318e-10
of O 0 6.838180022228357e-11
BARD1 O 0 5.795155811938457e-05
, O 0 1.2070059361712904e-11
unlike O 0 8.981506510741255e-11
those O 0 3.0815627827252e-11
of O 0 4.966906330672316e-10
BRCA1 O 0 2.066759430263687e-09
, O 0 6.682701701038463e-12
remain O 0 1.326213999730541e-10
relatively O 0 5.936107855264439e-11
constant O 0 2.3405853644131724e-11
during O 0 1.714857839063555e-10
cell O 0 1.4708060547263813e-08
cycle O 0 4.1825185093102846e-08
progression O 0 3.716087917382538e-07
. O 0 1.4947545423638076e-08

However O 0 7.497722549487662e-07
, O 0 5.843503458891064e-09
immunostaining O 0 7.452180398104247e-06
revealed O 0 5.162830518656847e-08
that O 0 1.7938951712981321e-10
BARD1 O 1 0.9994300007820129
resides O 0 4.4029999202166437e-08
within O 0 4.058073432844367e-09
BRCA1 O 0 3.831853945257535e-09
nuclear O 0 2.7770208355093473e-09
dots O 0 4.4607723070910765e-10
during O 0 3.4229077905401084e-10
S O 0 1.939883453871971e-08
phase O 0 1.6454032802926122e-08
of O 0 3.747994969938162e-10
the O 0 1.3050696807959117e-11
cell O 0 1.5376306131131834e-11
cycle O 0 6.961500386565289e-12
, O 0 1.8973526160035066e-14
but O 0 8.36530348572069e-14
not O 0 2.2080537539440753e-13
during O 0 1.0896786251102242e-10
the O 0 7.787139821857636e-10
G1 O 0 3.0639796477771597e-07
phase O 0 2.0847298287662852e-07
. O 0 2.2126545928813357e-08

Nevertheless O 0 1.6981535736704245e-05
, O 0 3.2091186596971966e-08
BARD1 O 0 0.00035954618942923844
polypeptides O 0 1.159294953367862e-07
are O 0 5.820305001846826e-11
found O 0 1.96782932830597e-12
exclusively O 0 7.552688509326888e-12
in O 0 1.3907951396455176e-12
the O 0 2.1612460085473906e-12
nuclear O 0 9.234978892713741e-10
fractions O 0 8.956952513017313e-08
of O 0 4.327185720853777e-09
both O 0 3.347393751074179e-10
G1 O 0 2.0576632664415229e-07
- O 0 1.0925517379689609e-08
and O 0 5.363483546183545e-10
S O 0 4.06846908163061e-07
- O 0 3.0991902377763836e-09
phase O 0 7.193051487774937e-08
cells O 0 5.035868166913815e-09
. O 0 7.66307850508241e-10

Therefore O 0 1.0034105457634723e-07
, O 0 2.9560934255989935e-10
progression O 0 1.0713197440281874e-08
to O 0 7.304197524593548e-11
S O 0 2.1068126443424262e-07
phase O 0 8.763779391074422e-08
is O 0 2.336043901721152e-12
accompanied O 0 1.638779736912177e-11
by O 0 8.874438727282663e-13
the O 0 1.008604744862085e-11
aggregation O 0 1.2964619378053044e-09
of O 0 2.351231431774181e-10
nuclear O 0 6.470731364061066e-07
BARD1 O 1 0.9890097975730896
polypeptides O 0 8.7389407781302e-06
into O 0 2.5338721343359794e-07
BRCA1 O 0 2.979117823542765e-07
nuclear O 0 2.0380126386498887e-07
dots O 0 2.6102350147994e-07
. O 0 2.499578499737254e-08

This O 0 2.597315473806816e-09
cell O 0 1.159542151185633e-08
cycle O 0 4.47120918067867e-09
- O 0 8.037917553771479e-10
dependent O 0 1.819322470453244e-09
colocalization O 0 4.4167524748672804e-08
of O 0 2.718735903073366e-09
BARD1 O 1 0.9991825222969055
and O 0 1.5948282694466798e-08
BRCA1 O 0 5.604356534405497e-09
indicates O 0 9.099327541450819e-11
a O 0 2.858284084677337e-13
role O 0 3.236212730087229e-12
for O 0 3.697854175643833e-11
BARD1 O 1 0.9999805688858032
in O 0 7.455428658431629e-06
BRCA1 O 0 3.204271342838183e-05
- O 0 2.9299776542757172e-06
mediated O 0 9.96776816464262e-06
tumor B-Disease 0 0.011611450463533401
suppression O 0 0.00011202035966562107
. O 0 3.8681244518556923e-07

Ethnic O 0 4.8188358192646774e-08
differences O 0 3.106909574057681e-08
in O 0 1.5420964505352686e-09
the O 0 4.759650451546804e-09
HFE O 0 0.0002474760403856635
codon O 0 2.913118578362628e-06
282 O 0 1.1055536788262543e-06
( O 0 2.9729223527397153e-09
Cys O 0 0.00012341976980678737
/ O 0 1.4038701010576915e-06
Tyr O 0 1.1153333616675809e-05
) O 0 1.6587694551262189e-09
polymorphism O 0 3.5503015283211425e-07
. O 0 4.310186341172084e-08

Recent O 0 2.860670065274462e-07
studies O 0 7.818099057033123e-09
have O 0 1.1092070838214507e-11
shown O 0 2.1506088576650484e-11
that O 0 1.2336588695038841e-10
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 2.8619473368962645e-07
HH B-Disease 1 0.9999992847442627
) O 0 4.589203669858044e-11
is O 0 3.239201658636337e-12
likely O 0 1.5244379369949712e-10
to O 0 4.032289693117752e-12
be O 0 1.107834917551953e-11
caused O 0 3.0626554070600776e-10
by O 0 5.0201828805107596e-11
homozygosity O 0 2.6738888436739217e-07
for O 0 4.304617426398316e-11
a O 0 2.8534064000496073e-11
Cys282Tyr O 0 1.317404496603558e-07
mutation O 0 7.308256222415821e-10
in O 0 4.55914785091327e-11
the O 0 6.172001243420766e-10
HFE O 0 7.891099085099995e-05
gene O 0 2.6893088644897034e-08
located O 0 3.5105500728604966e-09
4 O 0 4.45257377634789e-08
. O 0 1.9028561837330926e-08

5 O 0 2.1305304471752606e-06
Mb O 0 2.7584276267589303e-06
telomeric O 0 2.0867097191512585e-05
to O 0 1.932243804958489e-07
HLA O 1 0.9972953200340271
- O 0 0.007614981383085251
A O 0 4.290077413315885e-06
. O 0 5.533438596216911e-08

Population O 0 6.551953979361258e-10
studies O 0 7.144541902537327e-11
of O 0 9.730156784459876e-12
this O 0 4.365611604856268e-12
polymorphism O 0 2.9583342442407456e-09
are O 0 2.352327967830581e-12
facilitated O 0 3.6878524539707414e-11
by O 0 3.2582372130190995e-12
the O 0 2.104162677429855e-11
fact O 0 9.319195588830542e-12
that O 0 2.8226680433111884e-13
the O 0 1.7469234392386568e-10
Cys282Tyr O 0 1.1761850146285724e-05
mutation O 0 4.3596624976771636e-08
creates O 0 1.1118261866727153e-09
a O 0 1.1969650270948762e-10
Rsal O 0 3.360698883625446e-06
restriction O 0 7.680277462895901e-07
site O 0 1.276519014936639e-07
. O 0 3.697345007935837e-08

We O 0 2.004422583468113e-08
have O 0 5.469537669999802e-11
studied O 0 7.575043925456271e-10
the O 0 4.3316425446526807e-10
codon O 0 5.483982334908433e-08
282 O 0 1.8570797521988425e-07
( O 0 9.46995148964902e-10
Cys O 0 3.78660588467028e-05
/ O 0 2.0691868485300802e-07
Tyr O 0 7.175183327490231e-07
) O 0 6.334807244740004e-12
polymorphism O 0 4.357347260786071e-10
in O 0 1.4853904564682274e-11
different O 0 7.94670856896218e-11
ethnic O 0 1.8739465534878263e-10
groups O 0 8.296702908028308e-11
. O 0 1.1995390236663184e-09

In O 0 1.742791688741363e-08
agreement O 0 4.981930956660108e-08
with O 0 2.504224050348114e-10
previous O 0 7.06449512222207e-08
observations O 0 8.249769933854623e-08
the O 0 3.8684757619478205e-09
Tyr O 0 5.961298938927939e-06
allele O 0 1.700401597304335e-08
appeared O 0 2.9710292004381245e-09
to O 0 2.3817592863240034e-12
be O 0 1.9329138983836813e-12
rare O 0 3.999851491687245e-11
or O 0 4.7165923944270105e-11
absent O 0 2.4885471461288944e-08
in O 0 1.1414246631202829e-10
Asiatic O 0 5.8901125754573513e-08
( O 0 4.0542821378754257e-13
Indian O 0 1.1756817741570558e-11
, O 0 1.0468199657803767e-12
Chinese O 0 2.3283905359328116e-10
) O 0 9.335277342814585e-12
populations O 0 1.1644502029284354e-10
. O 0 8.543240004321717e-10

The O 0 1.2452796127604415e-08
highest O 0 7.366057097613066e-09
allele O 0 1.338250760207771e-10
frequency O 0 1.3163350964795484e-10
( O 0 6.015957588860477e-13
7 O 0 4.1412661494488745e-11
. O 0 1.5363809400051331e-12
5 O 0 7.401088769620756e-11
% O 0 2.271299467948573e-12
) O 0 7.79608514789136e-14
was O 0 3.6134064490545015e-11
found O 0 1.3241104393491021e-11
in O 0 4.1990524946022845e-10
Swedes O 0 6.20178388999193e-06
. O 0 1.9655885807878803e-07

Saamis O 0 0.00988734606653452
( O 0 3.767132383813987e-09
2 O 0 9.20907350376865e-09
% O 0 4.405858317069189e-11
) O 0 5.51776343799687e-13
and O 0 1.1979602206058093e-11
Mordvinians O 0 2.845609060386778e-06
( O 0 5.018189423028341e-12
1 O 0 4.547842380464573e-10
. O 0 8.453174792089069e-12
8 O 0 2.2420333645190027e-10
% O 0 2.5548016393400763e-12
) O 0 5.3809638223076967e-14
had O 0 3.502592313409103e-12
significantly O 0 5.972350392013936e-10
lower O 0 1.1166532587481015e-08
frequencies O 0 8.340386714600356e-10
of O 0 2.527525966300459e-10
the O 0 3.796787328980145e-09
Tyr O 0 1.3303292689670343e-05
allele O 0 1.2574311369917268e-07
. O 0 5.720184859114852e-08

Comparisons O 0 2.4573841983510647e-07
with O 0 2.4801100062532555e-10
allele O 0 1.9248742599842217e-09
frequencies O 0 3.7853820078481704e-10
based O 0 7.013731175703475e-12
on O 0 2.215886328593708e-11
prevalence O 0 1.266986932035863e-10
estimates O 0 7.130802458926722e-12
of O 0 3.017444627495536e-11
HH B-Disease 1 0.9999994039535522
showed O 0 6.941544370420161e-07
some O 0 1.7519953543487787e-10
disagreements O 0 9.525334299098631e-09
with O 0 5.995524389457163e-12
the O 0 9.677412343700453e-11
RFLP O 0 6.23116136466706e-08
data O 0 4.034763634308547e-10
, O 0 4.9519368640338346e-12
particularly O 0 3.898316669470603e-10
in O 0 2.559481515618245e-10
Finns O 0 3.542553201896226e-07
. O 0 1.2874436627896557e-08

The O 0 3.055657487038843e-07
newly O 0 1.2798557236237684e-06
described O 0 9.86184218731978e-08
HFE O 0 0.22539521753787994
marker O 0 3.357414186666574e-07
provides O 0 7.371869087391403e-11
a O 0 7.03749992309044e-13
new O 0 2.2321585552154133e-11
approach O 0 3.6655956048292637e-10
to O 0 2.027531571455188e-12
the O 0 7.1338083010297204e-12
screening O 0 1.5704583189446453e-09
of O 0 2.0242889586796764e-09
HH B-Disease 1 0.9999947547912598
as O 0 3.6144716109021147e-09
well O 0 1.608281910425724e-11
as O 0 4.97190342282211e-13
studies O 0 3.1353871864266136e-13
of O 0 2.7563083651420406e-13
the O 0 3.050805484974828e-12
relationship O 0 2.96478779027165e-11
between O 0 1.835389201731985e-10
the O 0 7.247169531154896e-09
HFE O 0 0.000733685796149075
Tyr O 0 1.4798459233134054e-05
allele O 0 2.9432802861606433e-08
and O 0 8.334642698226702e-11
different O 0 2.6149518106421965e-09
disorders O 0 1.1995098248007707e-05
including O 0 1.2481098110583844e-07
cancer B-Disease 1 0.9998531341552734

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.7999340891838074
associated O 0 7.843221183634341e-09
with O 0 3.989968772044605e-11
a O 0 1.4559861649665606e-10
missense O 0 2.9343787844027247e-08
mutation O 0 3.160061379237078e-10
encoding O 0 1.770043445148417e-09
Gly23 O 0 4.507329322223086e-06
- O 0 3.3608770877435745e-07
- O 0 9.75377361100982e-08
> O 0 1.4870275322209636e-07
Val O 0 1.3180700086934394e-08
in O 0 2.1390449134184308e-10
neurophysin O 0 5.5836239880591165e-06
II O 1 1.0
. O 0 1.8167057760365424e-06

Autosomal B-Disease 1 0.9999998807907104
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 1.8600958995307337e-08
ADNDI B-Disease 1 1.0
) O 0 1.6691659165957162e-10
is O 0 7.591408404672428e-12
an O 0 2.458611439437597e-12
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 5.3469702834263444e-05
by O 0 1.7237496763300442e-08
progressive O 1 0.9999958276748657
degeneration O 1 1.0
of O 0 2.9660393465746893e-06
the O 0 3.917768154337864e-08
magnocellular O 0 9.076145488506882e-07
neurons O 0 5.665810598465271e-10
of O 0 1.010648439936368e-10
the O 0 3.804019321762553e-10
hypothalamus O 0 7.11467329495008e-09
leading O 0 8.634754244951637e-09
to O 0 4.2675868394681515e-10
decreased O 0 1.1580843874980928e-06
ability O 0 2.674559906878926e-09
to O 0 3.424775463223284e-10
produce O 0 1.2280234606976137e-08
the O 0 1.1122256005080544e-08
hormone O 0 2.816662636462297e-08
arginine O 0 1.16340615363697e-07
vasopressin O 0 3.138189867968322e-07
( O 0 1.6532419877535176e-09
AVP O 0 4.256127795088105e-06
) O 0 6.068993640973019e-10
. O 0 1.1860554316456273e-08

Affected O 0 7.186133075265388e-07
individuals O 0 3.400249803942046e-10
are O 0 7.78600361267534e-12
not O 0 5.8666110164251606e-12
symptomatic O 0 3.143646765124686e-08
at O 0 5.904039063198141e-11
birth O 0 1.9718532584533932e-08
, O 0 7.30388752950839e-12
but O 0 4.933442543375577e-11
usually O 0 3.5274978493760045e-09
develop O 0 1.5982503498435108e-07
diabetes B-Disease 1 0.6604665517807007
insipidus I-Disease 0 2.7639003747026436e-05
at O 0 4.961407729098255e-09
1 O 0 9.888588436979262e-08
- O 0 1.2529636705949088e-07
6 O 0 2.133029965989408e-07
yr O 0 3.9873052060102054e-07
of O 0 5.148025894463615e-10
age O 0 9.023756852855058e-09
. O 0 4.019502952701259e-09

The O 0 2.7087152520977043e-09
genetic O 0 1.023428453095221e-09
locus O 0 5.856555240768557e-10
of O 0 3.468035025822047e-10
the O 0 2.381022490283158e-09
disease O 0 5.225621180215967e-07
is O 0 4.703682235374096e-11
the O 0 3.2884035494618047e-09
AVP O 0 3.897985152434558e-05
- O 0 1.7556760667503113e-07
neurophysin O 0 7.736402039881796e-05
II O 1 1.0
( O 0 1.1473053618260565e-09
NPII O 0 0.020881665870547295
) O 0 6.439357380649824e-11
gene O 0 5.019876528344902e-11
, O 0 9.065542587449738e-12
and O 0 5.025701382832537e-11
mutations O 0 7.414256708582201e-11
that O 0 6.8251207636926825e-12
cause O 0 1.5309903744764597e-07
ADNDI B-Disease 1 1.0
have O 0 1.1927175913584165e-09
been O 0 4.35517594210566e-11
found O 0 1.5666654171880845e-12
in O 0 8.764677351946748e-13
both O 0 5.471953185703926e-13
the O 0 2.0034937250890117e-12
signal O 0 2.7385517464839637e-11
peptide O 0 1.0072070781574904e-11
of O 0 1.9918021398890318e-10
the O 0 2.773997920257898e-09
prepro O 0 0.028835779055953026
- O 0 0.09761921316385269
AVP O 1 0.9189333319664001
- O 0 5.801443876407575e-06
NPII O 0 0.24348759651184082
precursor O 0 2.457576783854165e-06
and O 0 1.199836563436918e-09
within O 0 1.1573458635893985e-08
NPII O 1 0.9718658924102783
itself O 0 6.965471044395599e-08
. O 0 2.7193390650381843e-08

An O 0 4.82384532318747e-09
affected O 0 3.443854268425639e-07
girl O 0 2.968267551750614e-07
who O 0 1.1679313072221476e-10
presented O 0 1.1651105635834824e-09
at O 0 1.4751198873508287e-10
9 O 0 2.5261093217210373e-10
months O 0 2.039245335094808e-11
of O 0 2.7356910139997304e-11
age O 0 5.211551745709642e-10
and O 0 1.5268583272720626e-11
her O 0 3.826465186373973e-12
similarly O 0 5.9998291057628e-11
affected O 0 9.277544288366357e-10
younger O 0 6.729054291554348e-08
brother O 0 3.217993693738208e-08
and O 0 1.4951415661101919e-09
father O 0 1.345577427258604e-08
were O 0 5.1888009444667205e-09
all O 0 9.574468995410257e-11
found O 0 7.348225326830882e-12
to O 0 3.551106240659574e-12
have O 0 5.41833418410409e-12
a O 0 1.0246891876675157e-11
novel O 0 7.117482603291592e-09
missense O 0 2.1188016319229064e-07
mutation O 0 2.2178971992303786e-09
( O 0 5.7331825918660595e-12
G1758 O 0 1.7776093486077116e-08
- O 0 3.52825146876512e-09
- O 0 3.3122105058680518e-09
> O 0 7.726279172004524e-09
T O 0 1.286024398083896e-09
) O 0 3.5732999675505694e-14
encoding O 0 5.268635354382933e-12
the O 0 3.699185489175472e-12
amino O 0 9.788102620089667e-12
acid O 0 3.6349180609906995e-11
substitution O 0 2.5464084174586787e-09
Gly23 O 0 8.700587272869598e-07
- O 0 8.568493825578116e-08
- O 0 4.4275658694914455e-08
> O 0 1.6570696459439205e-07
Val O 0 4.836321565448998e-08
within O 0 7.917728694906145e-09
NPII O 0 0.3144966661930084
. O 0 2.464547037561715e-07

The O 0 3.2373617386838305e-07
mutation O 0 8.675649354472625e-08
was O 0 1.0534050298716124e-09
confirmed O 0 4.175922108107244e-10
by O 0 1.566224060167709e-11
restriction O 0 1.4457983255056206e-08
endonuclease O 0 5.002211977966908e-08
analysis O 0 3.1686215873349965e-09
. O 0 1.2398499116272887e-08

A O 0 6.7908472374256235e-06
T1 O 0 0.00322739384137094
- O 0 7.12902021859918e-07
weighted O 0 3.456726460626669e-07
magnetic O 0 1.2204322885622787e-08
resonance O 0 6.476538416677613e-09
imaging O 0 7.603146912060765e-08
of O 0 1.222377488119264e-08
the O 0 6.23736866600666e-07
fathers O 0 0.000131269043777138
pituitary O 0 4.566002462524921e-05
gland O 0 3.838626071228646e-06
demonstrates O 0 3.7954929865691156e-08
an O 0 1.337602667517146e-10
attenuated O 0 9.8395103123039e-06
posterior O 0 1.9576953036448685e-06
pituitary O 0 0.0008177489507943392
bright O 1 0.6698026061058044
spot O 0 8.222196811402682e-06
. O 0 7.679400226834332e-08

This O 0 2.0993597615870385e-07
mutation O 0 2.909529257522081e-07
may O 0 9.267520972855436e-09
be O 0 2.4660767872219935e-10
valuable O 0 2.8955535746888472e-09
for O 0 5.898386380015497e-12
developing O 0 4.895519545300431e-10
models O 0 8.351769276160326e-10
of O 0 3.916906798906439e-09
dominantly B-Disease 0 0.00023579024127684534
inherited I-Disease 1 0.8340474963188171
neurodegeneration I-Disease 1 1.0
, O 0 4.805008613217865e-10
as O 0 3.8960531849319135e-12
the O 0 8.310695339373841e-13
early O 0 1.1361162011169768e-10
age O 0 3.805047943394868e-11
of O 0 6.566346858610794e-12
onset O 0 1.1076442660851171e-06
of O 0 5.417683723862865e-08
symptoms O 0 0.05327451974153519
suggests O 0 1.0979825937340593e-09
that O 0 4.35558734262001e-13
this O 0 1.0694377675091182e-11
mutation O 0 2.03004127397044e-10
may O 0 5.566181196514641e-11
be O 0 1.5464955704924677e-11
particularly O 0 3.092645861624277e-10
deleterious O 0 1.9023373099003038e-08
to O 0 5.515972123504298e-10
the O 0 1.1898370289031845e-08
magnocellular O 0 2.589216092019342e-05
neuron O 0 5.372908731260395e-07
. O 0 3.3086873241217063e-09
. O 0 1.844107622162028e-08

Frequent O 0 5.417301451871026e-08
inactivation O 0 3.610362546169199e-05
of O 0 2.205585815318045e-06
PTEN O 1 0.9999997615814209
/ O 0 0.19065991044044495
MMAC1 O 1 1.0
in O 0 9.18012756301323e-06
primary O 1 1.0
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.8502017812570557e-06

Sporadic B-Disease 1 0.9999996423721313
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 1.1563132673586551e-08
the O 0 8.165243481350615e-10
most O 0 1.0827464619334037e-10
common O 0 2.8287464037823895e-10
male B-Disease 0 1.1950214429123918e-10
cancer I-Disease 0 9.706046383284317e-11
in O 0 3.156937601958565e-12
the O 0 9.615352958292078e-11
Western O 0 3.4352511946167397e-09
world O 0 3.3366939853479716e-12
, O 0 2.2019807310001693e-13
yet O 0 5.1729627525975985e-12
many O 0 1.288162420698749e-13
of O 0 9.703501023528016e-13
the O 0 1.5236340834834383e-12
major O 0 2.5517346916026362e-11
genetic O 0 6.519386593073495e-12
events O 0 4.634146798937477e-13
involved O 0 1.657710535681034e-12
in O 0 1.925385632178811e-12
the O 0 2.4471270496095876e-11
progression O 0 4.794446617495396e-09
of O 0 3.267729836720079e-11
this O 0 3.8938782753739076e-11
often O 0 4.024289790294233e-09
fatal O 0 4.6712448238395154e-06
cancer B-Disease 1 0.9871770143508911
remain O 0 7.349212864937726e-07
to O 0 9.669207656770595e-10
be O 0 2.170544988189249e-08
elucidated O 0 0.00013572305033449084
. O 0 5.168555503587413e-07

Numerous O 0 1.599203187652165e-07
cytogenetic O 0 6.738784577464685e-05
and O 0 7.728474749058023e-09
allelotype O 0 8.743243233766407e-05
studies O 0 1.703820196041761e-08
have O 0 8.683695255917723e-12
reported O 0 1.1413129989701343e-11
frequent O 0 5.0131024331712126e-11
loss O 0 4.5259659908758465e-10
of O 0 5.88515725041816e-09
heterozygosity O 0 0.0012300916714593768
on O 0 6.301135272224201e-06
chromosomal O 0 4.530394562607398e-06
arm O 0 2.3119143861549674e-06
10q O 0 4.50356601504609e-05
in O 0 1.0324577033316018e-06
sporadic B-Disease 1 0.9999992847442627
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.7345583930582507e-06

Deletion O 0 1.251964249604498e-06
mapping O 0 4.583175083894275e-08
studies O 0 5.440908612541762e-09
have O 0 9.226065744716294e-11
unambiguously O 0 1.2419296702148586e-09
identified O 0 1.0042650044894685e-10
a O 0 8.555151378986103e-12
region O 0 2.785331687515935e-10
of O 0 5.726914498183078e-10
chromosome O 0 4.973997880242109e-10
10q23 O 0 1.3943376586667e-07
to O 0 2.3550226005419894e-11
be O 0 8.29688834996789e-12
the O 0 9.438835130159973e-12
minimal O 0 8.299338993822403e-09
area O 0 8.194074863077105e-10
of O 0 9.065863060264689e-10
loss O 0 8.861267986048915e-08
. O 0 1.8483831354387803e-07

A O 0 1.12269685814681e-06
new O 0 1.1156829060610107e-07
tumor B-Disease 0 1.869231141427008e-06
suppressor O 0 1.0169715096708387e-06
gene O 0 3.0577540499621136e-09
, O 0 6.372454230962887e-10
PTEN O 0 0.0003397235122974962
/ O 0 1.2803673143935157e-06
MMAC1 O 1 0.9999996423721313
, O 0 1.6668824098786672e-09
was O 0 1.0714403586575827e-08
isolated O 0 3.80734599403354e-09
recently O 0 3.072876328391594e-11
at O 0 2.6040341757904706e-11
this O 0 4.9487258908798015e-12
region O 0 3.432479023235402e-10
of O 0 4.1227238289920365e-10
chromosome O 0 2.5386190372067574e-10
10q23 O 0 7.22723996204877e-08
and O 0 9.53353992971806e-11
found O 0 3.5953512302761004e-12
to O 0 3.2081187207634587e-13
be O 0 7.866487409385892e-13
inactivated O 0 1.0459593191569638e-09
by O 0 4.137926112868229e-11
mutation O 0 1.254797510341632e-08
in O 0 5.585084394965634e-09
three O 0 4.0448998817055326e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 1.6274882000288926e-05
lines O 0 6.155372034299944e-08
. O 0 1.5539075803872038e-08

We O 0 8.815362889436074e-06
screened O 0 8.400068327318877e-05
80 O 0 1.5113241715880577e-05
prostate B-Disease 1 0.9999551773071289
tumors I-Disease 1 1.0
by O 0 1.931848014891102e-09
microsatellite O 0 1.9173892695789618e-08
analysis O 0 7.380085431663019e-11
and O 0 8.000649621975331e-12
found O 0 4.456923545503866e-12
chromosome O 0 6.525124884859679e-11
10q23 O 0 3.1161679459046354e-08
to O 0 2.491403472415499e-10
be O 0 7.260240186823808e-10
deleted O 0 2.423015343921975e-09
in O 0 3.366345813216043e-10
23 O 0 4.027699507247462e-09
cases O 0 1.6162450267032114e-09
. O 0 1.0176750109280874e-08

We O 0 2.098978946207808e-08
then O 0 1.4236506418185968e-10
proceeded O 0 9.887108909367726e-10
with O 0 4.0379964725677925e-14
sequence O 0 6.923185169680629e-14
analysis O 0 2.2282002631879294e-13
of O 0 6.6483754265767026e-12
the O 0 1.4430391603870163e-10
entire O 0 2.348853556100039e-08
PTEN O 0 0.00031621436937712133
/ O 0 1.3922305015512393e-06
MMAC1 O 1 0.5848254561424255
coding O 0 7.4082734613512e-08
region O 0 1.07092130718911e-08
and O 0 8.010334062724667e-11
tested O 0 1.2124988790773727e-09
for O 0 1.414011130407289e-10
homozygous O 0 2.2736870164408174e-09
deletion O 0 5.869795760560237e-10
with O 0 6.1574972551325935e-12
new O 0 1.191149068269226e-09
intragenic O 0 3.1791678338777274e-06
markers O 0 1.902239255002769e-08
in O 0 6.434421745415975e-11
these O 0 6.542343923554572e-12
23 O 0 2.4684757710113914e-11
cases O 0 3.619053407649675e-12
with O 0 6.492307234352845e-13
10q23 O 0 4.3616464040496794e-07
loss O 0 1.0919062987113648e-07
of O 0 3.706015547777497e-07
heterozygosity O 0 0.06967607885599136
. O 0 1.909509819597588e-06

The O 0 1.0432594788056804e-09
identification O 0 1.9944452755993325e-09
of O 0 5.122940960333722e-10
the O 0 2.1733102817389494e-10
second O 0 4.716399271131877e-09
mutational O 0 1.1395054855256603e-07
event O 0 1.7219799197665253e-10
in O 0 1.977518843121473e-11
10 O 0 4.353847490867757e-11
( O 0 1.5932076621524849e-12
43 O 0 2.1670196748146964e-09
% O 0 2.8774718718871384e-10
) O 0 6.576267308489037e-10
tumors B-Disease 1 1.0
establishes O 0 3.448942879913375e-05
PTEN O 1 1.0
/ O 0 0.011477033607661724
MMAC1 O 1 0.9999998807907104
as O 0 3.795221636959667e-10
a O 0 1.833914096971423e-12
main O 0 3.115473851122985e-11
inactivation O 0 2.413771404974341e-09
target O 0 2.525067481495835e-11
of O 0 1.4215721655386204e-10
10q O 0 4.790546427102527e-06
loss O 0 2.3177647108241217e-06
in O 0 5.1046816906819e-07
sporadic B-Disease 1 0.9999988079071045
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.7396897195330894e-08
. O 0 7.741974172859045e-09

Risk O 0 1.2103099606974865e-06
reversals O 0 9.580510607065662e-08
in O 0 2.490025685641939e-10
predictive O 0 5.282126291916711e-09
testing O 0 2.0311354376190138e-08
for O 0 1.527327242456522e-07
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.5555970094283111e-06

The O 0 3.170175011391052e-09
first O 0 7.365403426051742e-11
predictive O 0 1.03036201792861e-09
testing O 0 6.253006112899584e-09
for O 0 3.415124538719283e-08
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 2.0487941898572615e-10
HD B-Disease 0 7.079723332026333e-07
) O 0 2.811702693589213e-12
was O 0 1.0555103319154213e-10
based O 0 1.5827891081121592e-11
on O 0 9.98138863228526e-11
analysis O 0 4.055098271060764e-11
of O 0 8.602722700867815e-11
linked O 0 3.6256848634508287e-09
polymorphic O 0 6.55380887337742e-08
DNA O 0 2.0013970924992464e-08
markers O 0 2.175787550129371e-09
to O 0 1.196115342189108e-11
estimate O 0 7.507150456831369e-11
the O 0 1.290022602629115e-11
likelihood O 0 6.560319509851809e-10
of O 0 2.695900447324817e-10
inheriting O 0 4.2350023932158365e-08
the O 0 5.9804805552232665e-09
mutation O 0 1.6627417220860252e-09
for O 0 5.840403161094798e-10
HD B-Disease 0 1.40543907036772e-05
. O 0 1.0128555771871106e-07

Limits O 0 9.549229389449465e-07
to O 0 1.2606645727331056e-09
accuracy O 0 1.2892916068096838e-08
included O 0 5.929570168206055e-10
recombination O 0 1.2400125370959358e-09
between O 0 1.7722316669743776e-10
the O 0 1.169420255076048e-10
DNA O 0 6.473286906505393e-10
markers O 0 1.305748287272479e-09
and O 0 1.8902287721167532e-11
the O 0 1.9133065964904716e-10
mutation O 0 2.0827536917344958e-10
, O 0 6.894807207807885e-12
pedigree O 0 1.9560744135560526e-09
structure O 0 7.286543590723227e-10
, O 0 8.240023247063633e-11
and O 0 3.701085965479578e-11
whether O 0 2.2057827786525763e-11
DNA O 0 4.878496218108097e-11
samples O 0 1.1914112925393017e-11
were O 0 1.2808231038274887e-12
available O 0 4.446428902155075e-12
from O 0 2.3101067933573027e-11
family O 0 6.07736569402384e-11
members O 0 8.32519990445757e-12
. O 0 1.7066716928582082e-09

With O 0 4.482555160389978e-10
direct O 0 4.928197294695735e-10
tests O 0 8.059102274415864e-10
for O 0 4.7769892208560094e-11
the O 0 3.674768045414112e-09
HD B-Disease 0 4.687032742367592e-06
mutation O 0 2.1623953738725277e-09
, O 0 1.532845898821744e-11
we O 0 6.949228952696229e-12
have O 0 1.0502418162569582e-12
assessed O 0 3.367295886569366e-10
the O 0 1.607226851607635e-11
accuracy O 0 3.269040593778527e-10
of O 0 3.560046354933455e-11
results O 0 5.2078525519805297e-11
obtained O 0 3.3797641768584796e-11
by O 0 4.0622492349096095e-12
linkage O 0 1.2929644854775546e-10
approaches O 0 6.337569358194628e-10
when O 0 1.0335536246297572e-11
requested O 0 8.794330264016992e-10
to O 0 4.86463591631292e-10
do O 0 2.0124768518314795e-10
so O 0 1.829321069624079e-11
by O 0 5.063444455388755e-12
the O 0 4.7880997777749457e-11
test O 0 8.7045981533862e-10
individuals O 0 3.292950634392611e-11
. O 0 5.450401907580726e-09

For O 0 1.1912972830430135e-08
six O 0 3.12138176417065e-10
such O 0 2.25770825645899e-11
individuals O 0 1.2452967476650478e-11
, O 0 2.71729058524961e-12
there O 0 9.792373075606653e-13
was O 0 2.140472347977873e-11
significant O 0 2.862806103287596e-10
disparity O 0 6.696160070873702e-09
between O 0 3.672271653432091e-10
the O 0 2.378925501034246e-09
tests O 0 1.8311739680143546e-08
. O 0 2.4142700283391605e-08

Three O 0 4.6602799841366505e-08
went O 0 1.085700684910762e-08
from O 0 5.264037469809857e-11
a O 0 8.615756545704567e-12
decreased O 0 8.377559623795605e-08
risk O 0 8.018500863293809e-10
to O 0 3.8181905553935636e-12
an O 0 3.8098935491908195e-14
increased O 0 2.631475246039905e-11
risk O 0 9.373606751905683e-11
, O 0 2.9036666192132354e-13
while O 0 2.608989630240033e-12
in O 0 3.0670951889355536e-12
another O 0 2.341088694429727e-12
three O 0 2.469679842576067e-12
the O 0 1.0489455831708128e-10
risk O 0 2.8037328014818286e-09
was O 0 3.050804275872565e-09
decreased O 0 9.690000979389879e-07
. O 0 9.040488180289685e-08

Knowledge O 0 7.545107223450032e-07
of O 0 5.289751214831995e-08
the O 0 2.8384927741598176e-09
potential O 0 1.3812905264032338e-09
reasons O 0 1.7639499860777619e-09
for O 0 2.886753553213439e-12
these O 0 6.565307325567815e-12
changes O 0 5.7552507898295246e-11
in O 0 3.650474367233869e-11
results O 0 2.5683390969533093e-09
and O 0 2.9038634344336067e-11
impact O 0 7.020456993522828e-10
of O 0 1.7598054957712606e-10
these O 0 6.540962216305957e-11
risk O 0 2.982223634706571e-10
reversals O 0 2.515542218972655e-09
on O 0 1.884384648320747e-09
both O 0 6.716940198492338e-11
patients O 0 5.2920090531927144e-09
and O 0 1.1406781075251615e-10
the O 0 3.46193651523663e-09
counseling O 0 2.516694186383006e-09
team O 0 8.929762311538081e-12
can O 0 2.408437815501485e-12
assist O 0 2.0624896235332812e-10
in O 0 2.5771051959111446e-11
the O 0 2.8233670956723245e-10
development O 0 8.021346364905924e-10
of O 0 2.7116087153444823e-10
strategies O 0 2.721515512948969e-10
for O 0 1.089841758505905e-12
the O 0 7.64091567795333e-12
prevention O 0 1.364239415879709e-10
and O 0 3.1134391397479033e-13
, O 0 2.3309320104506273e-14
where O 0 1.1800366998653e-13
necessary O 0 1.2872065913160924e-10
, O 0 4.875061725834184e-12
management O 0 9.505850273594518e-11
of O 0 1.2220614797886498e-10
a O 0 3.613599697249725e-11
risk O 0 2.2693888990232836e-09
reversal O 0 1.7979965294401268e-09
in O 0 3.3217220640757716e-11
any O 0 8.641500709449801e-11
predictive O 0 1.4228477285271879e-09
testing O 0 6.028030075100332e-09
program O 0 1.1674574640352375e-09
. O 0 1.0238730696610077e-10
. O 0 4.2385801535260725e-09

A O 0 6.683555398012686e-08
novel O 0 1.4457183006300056e-08
common O 0 4.1406620354678125e-09
missense O 0 7.89288350233619e-08
mutation O 0 8.962293684966482e-10
G301C O 0 1.1842153924135346e-08
in O 0 5.326962135288049e-11
the O 0 1.4924740610045006e-10
N O 0 2.9876066065526174e-08
- O 0 7.431820936432132e-09
acetylgalactosamine O 0 2.514764901206945e-06
- O 0 9.072236650808918e-08
6 O 0 8.053006261832252e-09
- O 0 5.230093580443906e-10
sulfate O 0 3.6450789053787958e-09
sulfatase O 0 5.932765816396568e-07
gene O 0 3.396038783520794e-09
in O 0 3.6158160909849357e-09
mucopolysaccharidosis B-Disease 1 0.5548716187477112
IVA I-Disease 1 0.9999998807907104
. O 0 4.071281637152424e-06

Mucopolysaccharidosis B-Disease 1 0.9999992847442627
IVA I-Disease 1 1.0
( O 0 0.00019640724349301308
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.6849042161481975e-09
is O 0 1.8052590672335e-11
an O 0 2.5528445676825662e-11
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 2.830134633313719e-07
by O 0 5.988673446033488e-10
a O 0 8.475320889544946e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 6.311988443030714e-08
N O 0 7.742818866063317e-07
- O 0 3.137967752309123e-08
acetylgalactosamine O 0 2.2258989247347927e-06
- O 0 1.371928703974845e-07
6 O 0 1.9121484839956793e-08
- O 0 2.1782331494080154e-09
sulfate O 0 1.6581534367787754e-08
sulfatase O 0 4.493646883929614e-06
( O 0 6.13427031392888e-10
GALNS O 1 0.8539646863937378
) O 0 3.1988500737156755e-09
. O 0 2.4598641346074146e-08

In O 0 2.5751782928296052e-08
previous O 0 1.5658328322842863e-07
studies O 0 1.181003383976531e-08
, O 0 6.591006213030326e-11
we O 0 4.789853236264463e-11
have O 0 4.795720244532564e-12
found O 0 6.468972926776395e-12
two O 0 1.4290848235690157e-12
common O 0 1.870104487933233e-10
mutations O 0 9.460757177670587e-11
in O 0 7.912692723266446e-11
Caucasians O 0 1.163410168203427e-08
and O 0 2.4045604049560687e-11
Japanese O 0 9.589318672453828e-09
, O 0 4.469226724812536e-11
respectively O 0 9.78363701165108e-09
. O 0 3.197540365817986e-08

To O 0 4.725243840653093e-08
characterize O 0 3.7597988011839334e-07
the O 0 6.014870734816213e-08
mutational O 0 3.9995284168981016e-05
spectrum O 0 2.799102048811619e-06
in O 0 1.3499332207622672e-10
various O 0 2.6722677889945423e-11
ethnic O 0 4.366286412288423e-12
groups O 0 1.5211650569810914e-13
, O 0 1.2827195902676003e-13
mutations O 0 8.150076208530976e-13
in O 0 6.1124000826084934e-12
the O 0 5.074394238135937e-10
GALNS O 1 0.6691741347312927
gene O 0 2.7648385803047404e-09
in O 0 2.595502923696813e-09
Colombian O 0 8.754755640438816e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.03177936002612114
were O 0 1.1176030101367473e-09
investigated O 0 2.7676876346305335e-09
, O 0 4.322957616875733e-11
and O 0 1.9184884236800315e-10
genetic O 0 8.990033606437464e-09
backgrounds O 0 4.802512165724693e-08
were O 0 1.227353108035345e-09
extensively O 0 8.277514090826443e-11
analyzed O 0 3.084422162125122e-10
to O 0 3.859149458329547e-11
identify O 0 2.8737584534255234e-10
racial O 0 2.3922365824380343e-11
origin O 0 1.696929957661908e-10
, O 0 1.4300883610998683e-12
based O 0 3.2027770192899485e-12
on O 0 1.815220196377254e-11
mitochondrial O 0 3.108080182112616e-10
DNA O 0 9.919050025786191e-10
( O 0 7.827308246000086e-12
mtDNA O 0 1.0727786020625629e-10
) O 0 1.3121208113087146e-11
lineages O 0 1.7721681899729447e-09
. O 0 2.829001477522297e-09

Three O 0 1.2359451773136243e-07
novel O 0 1.6402963183281827e-06
missense O 0 1.7491443941253237e-05
mutations O 0 2.8582323352566164e-07
never O 0 3.133398607246818e-08
identified O 0 1.171358454676863e-09
previously O 0 7.954674141608109e-10
in O 0 4.314983093056668e-11
other O 0 2.8263235501979622e-11
populations O 0 1.4543090690044558e-11
and O 0 3.760536586988605e-12
found O 0 6.238534428631981e-12
in O 0 2.1443092093620386e-11
16 O 0 7.66755270387165e-10
out O 0 1.7036191901631526e-11
of O 0 1.3170584067800917e-10
19 O 0 3.409466931003635e-09
Colombian O 0 1.725710419009374e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
unrelated O 0 5.485127303472837e-07
alleles O 0 1.2340901633933754e-09
account O 0 1.699380913766646e-11
for O 0 4.510219628328649e-11
84 O 0 8.198210110776927e-08
. O 0 2.4258605790805632e-08

2 O 0 6.237392824459675e-08
% O 0 2.835677248569368e-10
of O 0 6.962127402365681e-11
the O 0 1.1061843108173264e-10
alleles O 0 2.1848188536122137e-10
in O 0 3.757032879248001e-11
this O 0 3.305069412595785e-11
study O 0 2.1776547232121857e-10
. O 0 1.1015444112416617e-09

The O 0 1.636730644349882e-07
G301C O 0 2.7309956749377307e-06
and O 0 4.488982963124499e-09
S162F O 0 8.704338370080222e-07
mutations O 0 2.1190584842400995e-09
account O 0 1.1453326481669635e-10
for O 0 1.7193872714482694e-10
68 O 0 8.420845176715375e-08
. O 0 2.550702227210877e-08

4 O 0 4.990879915567348e-06
% O 0 2.4554859479053448e-08
and O 0 1.1604044392043988e-09
10 O 0 3.976874385358542e-09
. O 0 1.3281924005070778e-08

5 O 0 1.8067848372993467e-07
% O 0 9.801787159702258e-10
of O 0 3.24376747684596e-10
mutations O 0 1.8611019669823037e-10
, O 0 9.243004799042165e-12
respectively O 0 1.5528223151761722e-09
, O 0 2.8933147544485394e-11
whereas O 0 2.3529507231501157e-09
the O 0 4.527185737401851e-09
remaining O 0 2.1705739072785946e-06
F69V O 1 0.9995980858802795
is O 0 8.491995995285606e-11
limited O 0 6.72397693080029e-11
to O 0 6.5608629640223626e-12
a O 0 1.6165516841804006e-11
single O 0 1.218845135930735e-09
allele O 0 4.5423075079042974e-08
. O 0 2.90548545223146e-08

The O 0 6.828857834761948e-08
skewed O 0 6.940565810964472e-08
prevalence O 0 2.6617723136723725e-08
of O 0 5.096655320002696e-10
G301C O 0 1.74087887216956e-07
in O 0 1.7097596949344762e-10
only O 0 2.0303965106438504e-11
Colombian O 0 4.333617631413489e-10
patients O 0 4.717710111457052e-10
and O 0 4.092446867498545e-12
haplotype O 0 3.2367390018217534e-11
analysis O 0 2.1905873382604968e-12
by O 0 1.157882275303057e-12
restriction O 0 4.6229947647802305e-10
fragment O 0 2.2452771586412013e-10
length O 0 3.5964112243824786e-10
polymorphisms O 0 2.188585979112645e-09
in O 0 6.863006690727147e-11
the O 0 1.5393283314679707e-09
GALNS O 0 0.0002683966013137251
gene O 0 9.145301183011156e-10
suggest O 0 2.689362621488556e-10
that O 0 7.358375519149474e-13
G301C O 0 1.0230308156167212e-08
originated O 0 2.013505889797429e-10
from O 0 3.8605316859952055e-12
a O 0 1.0283931909174648e-12
common O 0 1.9848506171982194e-10
ancestor O 0 1.8756470154812632e-08
. O 0 2.820323530272617e-08

Investigation O 0 1.822526201067376e-07
of O 0 1.498239754482711e-08
the O 0 1.717336384210455e-09
genetic O 0 5.333105068672239e-10
background O 0 8.122569283841585e-11
by O 0 1.828755029353868e-12
means O 0 2.046056657434292e-10
of O 0 7.478457297871444e-10
mtDNA O 0 2.941593635341633e-10
lineages O 0 7.728864770406574e-11
indicate O 0 4.591013767069052e-12
that O 0 1.6041932593500313e-13
all O 0 5.564681961750528e-12
our O 0 3.290470673711354e-11
patients O 0 8.120896316521353e-11
are O 0 1.1832665381371343e-13
probably O 0 2.295962205078883e-11
of O 0 2.0461961985906996e-11
native O 0 1.609798683244179e-10
American O 0 8.896467451613432e-10
descent O 0 2.520481530154939e-07

Low O 0 2.516681547604094e-07
frequency O 0 6.413256148363189e-09
of O 0 3.644571533456542e-09
BRCA1 O 0 1.3079528571324772e-07
germline O 0 1.6369678235150786e-07
mutations O 0 2.368004958785974e-10
in O 0 1.3939215233460533e-11
45 O 0 1.2218570599742407e-09
German O 0 0.17305971682071686
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 8.339551271774326e-08
. O 0 1.6371327404840486e-08

In O 0 1.7940364749335913e-09
this O 0 3.1211838669165104e-11
study O 0 1.0981156088607502e-11
we O 0 9.600279555696534e-13
investigated O 0 1.1256462428832492e-10
45 O 0 2.488764083707906e-09
German O 0 0.27695363759994507
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 6.105694283498053e-10
for O 0 6.466151225570371e-11
germline O 0 4.731601777052674e-08
mutations O 0 9.277668633345115e-10
in O 0 2.347194105745132e-10
the O 0 6.527235196784886e-09
BRCA1 O 0 2.6099206351659632e-08
gene O 0 5.123576007903807e-10
. O 0 5.665619084993523e-09

We O 0 4.135904418944847e-08
identified O 0 1.544369609973728e-08
four O 0 1.2151288864004073e-09
germline O 0 4.91602577312733e-07
mutations O 0 4.62359706077109e-09
in O 0 6.089307946766098e-10
three O 0 6.067314983759786e-10
breast B-Disease 0 8.623341614111268e-07
cancer I-Disease 0 2.6746130288302083e-07
families O 0 2.7101970667686714e-10
and O 0 4.642930206966156e-10
in O 0 8.422033914712301e-08
one O 0 0.12820792198181152
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 3.241872192916162e-08
. O 0 4.128663036451208e-11
among O 0 2.6936003340999326e-12
these O 0 8.321592113308407e-13
were O 0 9.910019853343055e-12
one O 0 2.108826351390758e-12
frameshift O 0 5.705490524476886e-10
mutation O 0 2.1710883091330402e-11
, O 0 2.623710927338041e-12
one O 0 1.0077451893797384e-11
nonsense O 0 9.34188193468799e-09
mutation O 0 8.542295204527761e-10
, O 0 4.44916065794887e-12
one O 0 3.188575055032561e-12
novel O 0 2.260764492278966e-10
splice O 0 6.081246795019979e-08
site O 0 7.266298229779977e-09
mutation O 0 1.6187624574115489e-09
, O 0 1.097370198183123e-11
and O 0 7.58934234901254e-11
one O 0 2.8843238908393687e-10
missense O 0 1.0398092626928701e-06
mutation O 0 1.4308038487342856e-07
. O 0 1.279898214079367e-07

The O 0 8.339383157363045e-07
missense O 0 1.35486852741451e-05
mutation O 0 2.0664221267452376e-07
was O 0 2.3447711328117293e-08
also O 0 3.546194241033085e-11
found O 0 6.348963021984844e-11
in O 0 2.882503680190496e-10
2 O 0 6.320758672018201e-08
. O 0 8.948087604210286e-09

8 O 0 1.1104517483317977e-07
% O 0 2.0786422583185526e-10
of O 0 4.0716683497032946e-11
the O 0 4.433981654061725e-11
general O 0 8.838375364916828e-09
population O 0 1.9227074793404242e-11
, O 0 2.9228772180367457e-12
suggesting O 0 3.707762916138613e-11
that O 0 3.259696115462396e-13
it O 0 1.1580765643323665e-12
is O 0 1.1287217905123215e-12
not O 0 3.0008516505031224e-11
disease O 0 7.1403127854807735e-09
associated O 0 2.6224252991369212e-08
. O 0 2.029765084898827e-07

The O 0 1.3247287711237732e-08
average O 0 5.5147233446462e-09
age O 0 2.2644899289048226e-09
of O 0 1.4547618665261552e-10
disease O 0 1.8329981088527347e-08
onset O 0 3.871563876600703e-06
in O 0 2.9045404970062805e-10
those O 0 6.568617177959979e-11
families O 0 2.650116931457447e-11
harbouring O 0 3.973152029601579e-09
causative O 0 1.5373601058854547e-08
mutations O 0 3.1666942401642473e-09
was O 0 2.685186739626033e-09
between O 0 3.6519962609560253e-09
32 O 0 1.4151544291962637e-07
. O 0 3.962679073765685e-08

3 O 0 6.637315891566686e-06
and O 0 4.861514923959476e-08
37 O 0 7.376520443358459e-07
. O 0 6.446727951470166e-08

4 O 0 2.2706137770001078e-07
years O 0 5.746533249251229e-10
, O 0 2.6078963641373853e-11
whereas O 0 6.029245991356902e-10
the O 0 2.1153181983812885e-10
family O 0 6.332744745263241e-11
harbouring O 0 8.496054526574426e-09
the O 0 1.9166168652162696e-09
missense O 0 1.4329231134979636e-07
mutation O 0 2.1512061021411455e-09
had O 0 2.1108031988958942e-11
an O 0 4.0340625127475646e-14
average O 0 7.282854007362172e-12
age O 0 4.9287962600175206e-11
of O 0 2.865219173031619e-11
onset O 0 3.103545168414712e-06
of O 0 1.2826686770495144e-06
51 O 0 1.3792479194307816e-06
. O 0 1.0899753277726631e-07

2 O 0 5.638784841721645e-06
years O 0 5.672401570677721e-08
. O 0 1.3721093239382753e-07

These O 0 1.9824658181732957e-07
findings O 0 1.057038900853513e-07
show O 0 1.8333887741306398e-09
that O 0 1.1039542890944887e-10
BRCA1 O 0 3.618446342557036e-08
is O 0 2.7051087064799972e-11
implicated O 0 3.077940124995848e-10
in O 0 2.479508091901561e-11
a O 0 1.6137413670971879e-12
small O 0 1.7491021651883099e-12
fraction O 0 2.8751348524203024e-10
of O 0 2.144079189747572e-06
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.152572978341709e-11
suggesting O 0 2.582935384673468e-12
the O 0 3.326829371881612e-13
involvement O 0 1.5342432185816435e-12
of O 0 1.5162307173688383e-11
another O 0 1.6422530002557778e-11
susceptibility O 0 5.576048067723605e-09
gene O 0 1.941755645162857e-09
( O 0 4.4511683228165566e-10
s O 0 5.182661766411911e-07
) O 0 1.0236163916488294e-08

Paternal O 0 0.00010372041288064793
transmission O 0 4.3351188651286066e-05
of O 0 3.560942423064262e-05
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.28824132680892944

We O 0 5.3758611784360255e-08
report O 0 2.7858365614363834e-10
a O 0 2.0043459079965853e-12
rare O 0 1.5369122641217814e-11
case O 0 1.0466871813719081e-10
of O 0 3.255570923954565e-09
paternally O 1 0.9999842643737793
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.3849931690401718e-07
DM B-Disease 1 1.0
) O 0 1.6346294318125842e-09
. O 0 9.813839518812983e-09

The O 0 5.8503644595475635e-08
proband O 0 1.3581335224444047e-05
is O 0 6.459235923905737e-11
a O 0 2.848011106462711e-12
23 O 0 2.2962481915911326e-10
year O 0 7.893172920825364e-11
old O 0 3.57882186108327e-08
, O 0 4.05299926953262e-09
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 0.00016939766646828502
who O 0 1.382485237400033e-08
suffers O 0 2.3473552573705092e-05
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 1 0.9999998807907104

He O 0 6.40374642202346e-09
presented O 0 3.642982093765568e-08
with O 0 6.054321488591086e-10
respiratory O 1 1.0
and O 0 1.983558917117989e-07
feeding O 0 4.87944407723262e-06
difficulties O 0 1.055944736094716e-07
at O 0 6.574113697865869e-09
birth O 0 7.242968877108069e-06
. O 0 7.932318624170875e-08

His O 0 5.632908255392977e-07
two O 0 2.424403611200887e-08
sibs O 1 0.9999974966049194
suffer O 0 4.797733481609612e-07
from O 0 4.633121886143954e-09
childhood O 0 2.2105425614427077e-06
onset O 1 0.9999995231628418
DM B-Disease 1 1.0
. O 0 0.0001673409715294838

Their O 0 3.454280772530183e-08
late O 0 3.463158009253675e-06
father O 0 8.00779460519152e-08
had O 0 1.3437320700582234e-10
the O 0 6.190398887939708e-12
adult O 0 2.4574021203344065e-12
type O 0 1.1689491388744422e-11
of O 0 3.3987132552759647e-10
DM B-Disease 1 1.0
, O 0 4.692358723801249e-10
with O 0 4.875294178779965e-12
onset O 0 9.443223461857997e-06
around O 0 1.0612984935320924e-09
30 O 0 1.1566854141165095e-09
years O 0 2.0496464248065394e-10
. O 0 1.7785716233120752e-09

Only O 0 9.645358289844808e-09
six O 0 5.179007223077292e-11
other O 0 2.935519123788144e-13
cases O 0 1.164877764560368e-12
of O 0 1.1474442923598005e-11
paternal O 0 1.3701819057132525e-07
transmission O 0 4.0528976796849747e-07
of O 0 7.487920811399817e-05
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.04650887846946716
been O 0 7.439365568018275e-09
reported O 0 3.1973296232834514e-10
recently O 0 8.422733066559829e-10
. O 0 1.7867354262790514e-09

We O 0 3.179611240966551e-08
review O 0 1.3972750068091955e-08
the O 0 5.323612661811694e-10
sex O 0 9.603915579470268e-11
related O 0 7.21603499176382e-10
effects O 0 2.473153015714047e-09
on O 0 2.723235414947567e-09
transmission O 0 6.411265474071115e-08
of O 0 8.141923757420955e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 1 0.7793139219284058

Decreased O 0 2.967366299344576e-06
fertility O 0 1.750414782009102e-07
of O 0 1.3422259137474413e-10
males O 0 3.724204538507747e-12
with O 0 6.396735219424063e-14
adult O 0 2.5814640355892315e-11
onset O 0 9.231376196794372e-08
DM B-Disease 1 1.0
and O 0 1.3801291220971734e-09
contraction O 0 2.5255080249309003e-09
of O 0 1.0812569728457788e-09
the O 0 4.877789491763984e-11
repeat O 0 3.0672141909660056e-11
upon O 0 7.226389625580865e-11
male O 0 1.5718502888173447e-11
transmission O 0 3.2464569227341755e-12
contribute O 0 5.778806252965119e-13
to O 0 1.15002918212731e-12
the O 0 2.0499347011537772e-11
almost O 0 7.724808639975045e-12
absent O 0 6.742226221767567e-11
occurrence O 0 9.706744956428093e-12
of O 0 2.971434209797508e-11
paternal O 0 4.228972727560176e-08
transmission O 0 8.03548800831777e-08
of O 0 1.5930139340980531e-07
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.0017294661374762654

Also O 0 4.6723021007721854e-09
the O 0 8.861107403390633e-10
fathers O 0 8.675298701632528e-09
of O 0 6.900494758932396e-11
the O 0 8.977122517572766e-11
reported O 0 4.995218128023282e-10
congenitally O 0 3.314540663268417e-05
affected O 0 9.770344888693216e-08
children O 0 2.835158219305356e-10
showed O 0 6.617761894034402e-11
, O 0 1.2817713470475445e-12
on O 0 1.8714177429934864e-10
average O 0 2.255786446525576e-09
, O 0 1.0182933662949978e-10
shorter O 0 1.013890141621232e-06
CTG O 0 0.00013329424837138504
repeat O 0 3.126888259430416e-07
lengths O 0 1.0360736268921755e-06
and O 0 1.4984295748643461e-10
hence O 0 2.4301847201257942e-09
less O 0 9.854388416385973e-10
severe O 0 1.7993079026723535e-08
clinical O 0 1.6120587531531783e-08
symptoms O 0 2.7992511419938637e-08
than O 0 1.8473503976546013e-11
the O 0 1.6514226097719131e-10
mothers O 0 2.2864715676362835e-10
of O 0 1.3475299001641794e-11
children O 0 1.2305115260069499e-11
with O 0 4.084572957641086e-11
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.051666680723428726

We O 0 3.1874731742931317e-09
conclude O 0 1.7552308495538682e-09
that O 0 1.1703830179315977e-12
paternal O 0 8.189676492520448e-08
transmission O 0 1.7521885808946536e-07
of O 0 2.145701273548184e-06
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 6.029837607002264e-08
rare O 0 3.3314445646581703e-10
and O 0 2.8362043616447785e-12
preferentially O 0 1.1078962400268288e-11
occurs O 0 2.995181685137849e-13
with O 0 4.911219424441312e-15
onset O 0 5.969674199413078e-10
of O 0 4.750163817845987e-09
DM B-Disease 1 1.0
past O 0 5.827789806289729e-08
30 O 0 4.280385212940274e-10
years O 0 5.52601280706666e-12
in O 0 2.609547126997125e-12
the O 0 2.8134206769836467e-11
father O 0 4.958293220447274e-10
. O 0 3.2755942402928895e-10
. O 0 4.993353730498029e-09

The O 0 1.1363933936081594e-06
RB1 O 0 0.0001229735789820552
gene O 0 1.2550080974449429e-08
mutation O 0 7.936311163803111e-09
in O 0 2.2631718721299876e-10
a O 0 4.424741406605648e-10
child O 0 7.556636916206116e-08
with O 0 5.55610002450635e-09
ectopic B-Disease 1 0.9582437872886658
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 0.0009704747935757041

The O 0 1.6259505173366051e-06
RB1 O 0 0.00019562173110898584
gene O 0 2.1253176996083312e-08
mutation O 0 9.575026105324014e-09
was O 0 1.079180189655915e-09
investigated O 0 6.550507691827079e-09
in O 0 1.7658383644203468e-09
a O 0 4.360017680227202e-09
child O 0 3.970571071931772e-07
with O 0 6.258494611444121e-09
ectopic B-Disease 0 0.00024584439233876765
intracranial I-Disease 1 0.9999784231185913
retinoblastoma I-Disease 0 3.7644844269379973e-05
using O 0 2.3011104133274785e-10
DNA O 0 4.5430997852591304e-10
obtained O 0 2.9184835104167917e-11
from O 0 5.619733151052131e-11
both O 0 1.0611887063527448e-10
the O 0 2.345338145914866e-09
pineal B-Disease 0 0.00017602597654331475
and I-Disease 0 1.7126597029459845e-08
retinal I-Disease 1 0.9848451614379883
tumours I-Disease 1 1.0
of O 0 3.422185545787215e-05
the O 0 4.2775087649715715e-07
patient O 0 1.0474157534190454e-05
. O 0 5.34340429680924e-08

A O 0 4.283517966996442e-07
nonsense O 0 4.883703468294698e-07
mutation O 0 7.407860547203882e-09
in O 0 1.0884659840115773e-09
exon O 0 4.194334124463239e-08
17 O 0 3.717432806027432e-09
( O 0 8.780610787073595e-12
codon O 0 2.760180750627228e-09
556 O 0 4.0516621169217615e-09
) O 0 1.5765274285692299e-12
of O 0 2.222431405574099e-10
the O 0 5.04787900368342e-09
RB1 O 0 2.8079035473638214e-05
gene O 0 1.3995280490064488e-09
was O 0 3.246957369640313e-09
found O 0 1.2815518611597465e-11
to O 0 2.176701527356606e-12
be O 0 4.180532656161695e-12
present O 0 2.3973581453340387e-10
homozygously O 0 8.430450179730542e-06
in O 0 1.1697287582990157e-09
both O 0 2.622332628821056e-10
the O 0 5.9836380295053e-10
retinal B-Disease 0 1.576695240146364e-06
and I-Disease 0 5.889831555805358e-08
the I-Disease 0 5.134595539857401e-06
pineal I-Disease 1 0.9999998807907104
tumours I-Disease 1 1.0
. O 0 7.562579412478954e-06

The O 0 5.685537374233718e-09
same O 0 4.117914065293604e-10
mutation O 0 1.6811860237275766e-10
was O 0 9.293248809383314e-11
present O 0 1.4672264792015e-10
heterozygously O 0 3.815741536072892e-07
in O 0 1.890442524743463e-10
the O 0 4.25507580559259e-11
DNA O 0 7.145959518561895e-11
from O 0 5.480625502041203e-12
the O 0 1.1375921905865116e-11
constitutional O 0 1.2469022481198522e-09
cells O 0 6.992060264110478e-10
of O 0 1.6462554930374296e-10
the O 0 1.224908646735301e-10
patient O 0 4.4661994991201937e-08
, O 0 4.5079643143375314e-12
proving O 0 5.763646782064313e-10
it O 0 5.229207366598543e-13
to O 0 2.241363995444945e-12
be O 0 2.3312645217044015e-11
of O 0 1.1167357039099102e-09
germline O 0 9.98978322286348e-08
origin O 0 8.536744644516148e-09
. O 0 1.1039828606840274e-08

The O 0 6.866381596637439e-08
initial O 0 2.7726142093342787e-07
mutation O 0 1.9125568684330574e-08
was O 0 1.388763992693498e-09
shown O 0 8.607777685076812e-11
to O 0 3.3293211937346356e-11
have O 0 9.1168001967179e-12
occurred O 0 1.5444454604107705e-09
in O 0 2.4890227032225987e-11
the O 0 1.4274627313515253e-10
paternally O 0 2.2389507137177134e-07
derived O 0 2.7728310669772327e-07
RB1 O 0 0.00013066871906630695
allele O 0 3.236732197819947e-07
. O 0 4.7473310615941955e-08

The O 0 2.7896678744809833e-08
mutation O 0 1.82615400579067e-09
is O 0 4.871705903269907e-12
in O 0 1.8079803062662214e-12
an O 0 4.562890253893663e-14
area O 0 8.276219293223974e-11
of O 0 7.63899568601012e-11
the O 0 3.037784468418181e-10
gene O 0 1.9093719660912e-11
that O 0 2.8981461328014824e-12
encodes O 0 7.223229393088504e-12
the O 0 2.603170283499434e-11
protein O 0 6.563107002310886e-11
- O 0 1.0163510311134161e-10
binding O 0 1.1643640496217245e-09
region O 0 9.895829933270761e-09
known O 0 3.359142686232275e-10
as O 0 1.8121872058518562e-10
the O 0 7.080811492699013e-10
pocket O 0 6.965530019442667e-07
region O 0 4.225304195415447e-08
and O 0 4.088544169889019e-09
has O 0 4.3890162337856253e-11
been O 0 1.055113774128813e-10
detected O 0 5.077717801782455e-09
in O 0 4.12268240379543e-11
other O 0 6.685353659552362e-12
cases O 0 1.9130329265149015e-10
of O 0 3.181557017839509e-09
retinoblastoma B-Disease 0 0.000121994387882296
. O 0 1.2124733927976195e-07
. O 0 1.345331526181326e-07

Low O 0 1.278595618714462e-06
levels O 0 1.2151990524955636e-08
of O 0 5.972885519511806e-10
beta O 0 6.775674243897356e-09
hexosaminidase O 0 6.595114996343909e-07
A O 0 2.063391679740789e-09
in O 0 8.5306650632333e-11
healthy O 0 7.557466319418893e-10
individuals O 0 3.8336003750812087e-13
with O 0 1.5088674667346202e-12
apparent O 0 2.3291751858778298e-05
deficiency O 1 0.9084303975105286
of O 0 2.2663836716674268e-05
this O 0 7.321643380464593e-08
enzyme O 0 1.3189725223128335e-06
. O 0 7.720655048615299e-08

Appreciable O 0 5.4093688959255815e-06
beta O 0 2.26114252654952e-07
hexosaminidase O 0 5.942456118646078e-05
A O 0 3.6133128560322803e-06
( O 0 2.2770461072241233e-09
hex O 0 2.1294945327099413e-06
A O 0 2.8526054407507218e-08
) O 0 6.227920956725086e-11
activity O 0 1.132968741046625e-08
has O 0 1.0890069228330912e-11
been O 0 4.148523538582971e-11
detected O 0 6.634327576193755e-08
in O 0 1.1156823909175273e-08
cultured O 0 0.0001501642109360546
skin O 0 0.00012179445911897346
fibroblasts O 0 5.739512744185049e-06
and O 0 3.3988918346494756e-08
melanoma B-Disease 0 5.8632394939195365e-06
tissue O 0 2.9573483217859575e-08
from O 0 6.560444409942079e-10
healthy O 0 3.1469087335977974e-09
individuals O 0 9.848360191591632e-13
previously O 0 7.74157907917905e-12
reported O 0 5.213365763395705e-12
as O 0 1.0591545002158753e-10
having O 0 1.5478670789548232e-08
deficiency B-Disease 0 0.005593965761363506
of I-Disease 0 0.002122625708580017
hex I-Disease 0 2.8757203835994005e-05
A I-Disease 0 6.496915894160793e-09
activity O 0 1.1924379261785134e-09
indistinguishable O 0 2.627905670848918e-10
from O 0 9.585526952260795e-14
that O 0 1.1128434269266061e-15
of O 0 1.8262791994828886e-13
patients O 0 6.033636784641416e-11
with O 0 1.5391813379395103e-09
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 4.6308601397981874e-09
TSD B-Disease 0 0.21388596296310425
) O 0 1.0862510890774502e-09
. O 0 2.717876590452306e-08

Identification O 0 1.6069557773334964e-07
and O 0 2.159633805121075e-09
quantitation O 0 0.00019968458218500018
of O 0 0.00012165446969447657
hex O 0 0.0023670063819736242
A O 0 2.423204250590061e-07
, O 0 4.329996777796552e-11
amounting O 0 5.39395306198287e-10
to O 0 2.320733605287728e-10
3 O 0 2.3848233610124225e-08
. O 0 8.447997856819711e-09

5 O 0 1.9849869659083197e-06
% O 0 5.4633421342487054e-08
- O 0 1.2935471715991298e-07
6 O 0 1.6703083360880555e-07
. O 0 1.3286281408397826e-08

9 O 0 2.3605133492310415e-07
% O 0 5.5700921652857e-10
of O 0 1.4575450568710124e-10
total O 0 8.179704830135748e-11
beta O 0 6.6312124680223405e-09
hexosaminidase O 0 9.414199553248181e-07
activity O 0 9.540611500824525e-08
, O 0 5.197234656528771e-11
has O 0 1.5403362179505775e-12
been O 0 1.2737895590739234e-12
obtained O 0 3.2846263903207884e-11
by O 0 7.653361278059378e-11
cellulose O 0 1.0593111028356361e-06
acetate O 0 1.9274217777365266e-07
gel O 0 4.396371195980464e-07
electrophoresis O 0 8.393645778426162e-09
, O 0 1.6995081730808437e-10
DEAE O 0 7.178451778599992e-05
- O 0 3.0286578578397894e-08
cellulose O 0 1.9959099972766126e-07
ion O 0 1.0093283009382503e-07
- O 0 3.6783319501410006e-08
exchange O 0 2.4751269478429094e-08
chromatography O 0 2.3771756119117526e-08
, O 0 2.4031849427119667e-11
radial O 0 1.7929998596954988e-09
immunodiffusion O 0 7.985272532096133e-07
, O 0 3.593819131175735e-10
and O 0 8.732451983739509e-10
radioimmunoassay O 0 3.1557232432533056e-05
. O 0 2.9907144494245586e-07

Previous O 0 0.00010622791160130873
family O 0 5.621681964385061e-08
studies O 0 1.1261664933925886e-09
suggested O 0 1.8353472908128055e-10
that O 0 6.579619661606362e-13
these O 0 6.322325909330351e-12
individuals O 0 1.2956145488060566e-12
may O 0 2.5802778316763586e-11
be O 0 4.035983353078976e-12
compound O 0 4.482076654266365e-10
heterozygotes O 0 1.7012895536794304e-09
for O 0 2.1276535221159687e-12
the O 0 3.0225249386672814e-11
common O 0 1.4713047447045824e-09
mutant O 0 3.6599896446887215e-08
TSD B-Disease 0 1.0800312338687945e-05
gene O 0 1.6371163313877446e-09
and O 0 3.797420711215693e-11
a O 0 1.0202622600929967e-11
rare O 0 1.4036181106291679e-09
( O 0 8.492351960542877e-11
allelic O 0 1.0532753691450125e-07
) O 0 1.6198765939723359e-10
mutant O 0 3.14045855986933e-08
gene O 0 4.053795521485881e-09
. O 0 1.0434868968900446e-08

Thus O 0 3.3545464361850463e-07
, O 0 7.569887494618399e-10
the O 0 1.2165435325783847e-09
postulated O 0 3.259655159126851e-07
rate O 0 3.185736474620171e-08
mutant O 0 3.387473412885811e-09
gene O 0 1.0646839659900209e-10
appears O 0 3.319469421558807e-10
to O 0 1.7968486941410955e-12
code O 0 4.165711612463818e-12
for O 0 2.0686965595401174e-12
the O 0 5.346513596432567e-12
expression O 0 7.652700521887379e-12
of O 0 8.291256570203132e-12
low O 0 3.3686964329149305e-10
amounts O 0 1.7233370286362515e-10
of O 0 9.664266054087989e-10
hex O 0 2.3313741621677764e-06
A O 0 3.1842819225857966e-07
. O 0 1.3666830511738226e-07

Heterozygotes O 0 0.00010106332047143951
for O 0 2.9598146156217808e-08
the O 0 3.298380235605691e-08
rare O 0 3.2697297314143725e-08
mutant O 0 5.3640313524283556e-08
may O 0 2.7706970051610824e-10
be O 0 2.5479996584865106e-11
indistinguishable O 0 1.1718590542386664e-09
from O 0 1.4418278203309765e-11
heterozygotes O 0 2.9257987144148956e-09
for O 0 2.1568405048078e-11
the O 0 8.667487283453568e-10
common O 0 1.2055242848418857e-07
TSD B-Disease 0 0.004870932083576918
mutant O 0 3.995461156591773e-06
. O 0 1.1323124482487401e-07

However O 0 5.365760813447196e-08
, O 0 7.183403177846159e-11
direct O 0 4.28848172251417e-11
visualization O 0 1.4515344481935699e-08
and O 0 3.367411627319683e-10
quantitation O 0 0.05568898096680641
of O 1 0.8712969422340393
hex O 0 0.0011838776990771294
A O 0 9.563946967716674e-09
by O 0 9.917128750147608e-12
the O 0 7.338084133390321e-12
methods O 0 4.913405793338654e-10
described O 0 1.3046995428478425e-10
may O 0 8.553475289163615e-11
prevent O 0 1.8493787057316524e-10
false O 0 8.057288169993626e-10
- O 0 2.1737828204138054e-10
positive O 0 5.581383966113407e-11
prenatal O 0 5.5600217763185356e-09
diagnosis O 0 3.329782005678794e-09
of O 0 7.070257712626926e-10
TSD B-Disease 0 0.0022741572465747595
in O 0 1.1685116874105006e-08
fetuses O 0 9.202808115560401e-08
having O 0 6.825228576756714e-11
the O 0 6.161509635838058e-10
incomplete O 0 0.001231812289915979
hex B-Disease 0 9.773795318324119e-05
A I-Disease 0 2.1578154019152862e-07
deficiency I-Disease 0 1.8025545500677254e-07
of O 0 2.2986725856100065e-09
the O 0 2.1223096891009874e-10
type O 0 2.7240303346331984e-09
described O 0 4.843840328838667e-10
in O 0 1.185893605537558e-10
the O 0 1.317958631119609e-09
four O 0 6.25778762142204e-10
healthy O 0 5.8602928731943393e-08
individuals O 0 9.769217657051854e-10

The O 0 9.55631662691303e-07
tumor B-Disease 0 1.917794179462362e-05
suppressor O 0 7.99236568127526e-06
gene O 0 1.0118665016989326e-08
Smad4 O 0 2.8162785383756272e-05
/ O 0 1.476667534916487e-07
Dpc4 O 0 1.028030396810209e-06
is O 0 4.482909703173998e-12
required O 0 8.803669598878017e-12
for O 0 5.340408237158867e-12
gastrulation O 0 5.461914156512648e-07
and O 0 1.147296008197074e-10
later O 0 1.5903500738545517e-09
for O 0 4.591313787494222e-11
anterior O 0 3.6366554212463598e-09
development O 0 7.888199426986375e-09
of O 0 6.793765550128228e-09
the O 0 1.1359093221585681e-08
mouse O 0 2.3599005416485852e-08
embryo O 0 1.7320490997008164e-07
. O 0 2.300507162544818e-08

Mutations O 0 6.498876246041618e-07
in O 0 2.8705171573051302e-09
the O 0 9.28110654996317e-09
SMAD4 O 1 0.9997207522392273
/ O 0 1.1121214811282698e-05
DPC4 O 0 0.0038740106392651796
tumor B-Disease 0 7.932240805530455e-06
suppressor O 0 1.4608605169996736e-07
gene O 0 9.52180140290082e-11
, O 0 2.420498914149083e-12
a O 0 5.446143102466605e-12
key O 0 3.171283680103443e-08
signal O 0 1.0424131602349007e-07
transducer O 0 5.534578235710796e-07
in O 0 3.3592149062400267e-09
most O 0 5.7066800174254695e-09
TGFbeta O 0 0.0004458652110770345
- O 0 1.769423931818892e-07
related O 0 1.4788012094868463e-06
pathways O 0 3.8718880546184664e-08
, O 0 1.0691843460933215e-12
are O 0 2.023573569451785e-14
involved O 0 8.365064283616386e-14
in O 0 2.2496386264253543e-12
50 O 0 2.5931809477519607e-10
% O 0 2.1371525382729573e-10
of O 0 1.082664979890069e-08
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.0012502450263127685

Homozygous O 0 0.0003345151199027896
Smad4 O 0 0.01754090189933777
mutant O 0 4.875655213254504e-05
mice O 0 1.0823623597389087e-06
die O 0 1.9332569323182724e-08
before O 0 1.5226020444458754e-09
day O 0 2.411623611919822e-08
7 O 0 1.2125022408326913e-07
. O 0 1.3911347629402826e-08

5 O 0 2.58122281593387e-06
of O 0 6.689460718689588e-08
embryogenesis O 0 4.794080086867325e-05
. O 0 7.85632323641039e-07

Mutant O 0 1.713377787382342e-05
embryos O 0 3.871552962664282e-07
have O 0 1.0912884484959307e-10
reduced O 0 7.454674100237924e-10
size O 0 9.60196144816905e-10
, O 0 8.492319347741528e-11
fail O 0 1.4044759133469142e-08
to O 0 3.6696529148727564e-10
gastrulate O 0 7.47497915654094e-06
or O 0 1.3348304683802326e-09
express O 0 1.0213783985246749e-10
a O 0 3.656388993661386e-12
mesodermal O 0 8.965857745124595e-08
marker O 0 2.3243241997761288e-08
, O 0 5.4662420423401414e-11
and O 0 9.908190240492942e-11
show O 0 4.440941225869466e-10
abnormal O 0 2.2937598487260402e-08
visceral O 0 1.194159949591267e-06
endoderm O 0 0.0013447636738419533
development O 0 1.6587739082751796e-05
. O 0 4.608420454133011e-07

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 2.582039996923413e-06
the O 0 2.8079466574126855e-07
Smad4 O 1 0.9950196743011475
- O 0 3.153046054649167e-05
deficient O 0 1.3812077668262646e-06
embryos O 0 3.798353631623286e-08
results O 0 6.427740006920146e-10
from O 0 1.3538494110509891e-11
reduced O 0 5.323896878905998e-10
cell O 0 3.99456245858687e-10
proliferation O 0 1.791987891408553e-09
rather O 0 2.3865034948222785e-11
than O 0 6.12350881806778e-12
increased O 0 1.2282618255810007e-09
apoptosis O 0 2.548631243826094e-07
. O 0 4.065629255478598e-08

Aggregation O 0 1.845434326241957e-06
of O 0 1.7250596329176915e-07
mutant O 0 1.7766742530511692e-06
Smad4 O 0 0.00121779995970428
ES O 0 5.91340676692198e-06
cells O 0 2.203581761506257e-09
with O 0 1.6458551101855567e-12
wild O 0 7.248285860406156e-10
- O 0 3.1378014769822826e-11
type O 0 5.163376393113595e-10
tetraploid O 0 1.1536616284502088e-06
morulae O 0 1.4913472114130855e-05
rescues O 0 3.2666133620296023e-07
the O 0 4.194700142789998e-09
gastrulation B-Disease 0 4.036357859149575e-05
defect I-Disease 0 5.555081315833377e-06
. O 0 5.715549491469574e-07

These O 0 7.704252880103013e-08
results O 0 2.422887135367091e-08
indicate O 0 4.719044266465744e-09
that O 0 2.950070743246158e-11
Smad4 O 0 3.6356320833874634e-06
is O 0 1.201516316995388e-11
initially O 0 3.919040092448256e-11
required O 0 9.013748948627498e-12
for O 0 2.9521970805468367e-12
the O 0 2.852557599852812e-11
differentiation O 0 6.031615207291452e-10
of O 0 1.5283449505965052e-10
the O 0 6.853562162234539e-11
visceral O 0 2.244058050493436e-09
endoderm O 0 3.5478782933751063e-07
and O 0 5.470100761240104e-11
that O 0 4.936204982090853e-13
the O 0 4.487557200838488e-11
gastrulation B-Disease 0 1.842720820377508e-07
defect I-Disease 0 4.080854321131255e-09
in O 0 9.157375552293345e-11
the O 0 2.5984836504733266e-10
epiblast O 0 5.910673621656315e-07
is O 0 1.3261804848729852e-11
secondary O 0 1.3112395613745775e-08
and O 0 1.8779960225812076e-11
non O 0 1.846640458325055e-07
- O 0 1.2617242362011893e-07
cell O 0 6.029815153851814e-07
autonomous O 0 4.053920932278743e-08
. O 0 1.1900004537324094e-08

Rescued O 0 0.00019147455168422312
embryos O 0 7.874334187363274e-06
show O 0 2.4536742415648405e-08
severe O 0 5.989684837004461e-07
anterior O 0 3.2280252071359428e-06
truncations O 1 0.9991821646690369
, O 0 7.1002630441796555e-09
indicating O 0 5.0470539747493603e-08
a O 0 5.6491682859372006e-11
second O 0 1.431318508160473e-09
important O 0 9.131252975969062e-10
role O 0 3.491883171502508e-10
for O 0 8.981049237632988e-10
Smad4 O 0 0.00024627160746604204
in O 0 4.2358344387594116e-08
anterior O 0 2.2785555131576984e-07
patterning O 0 7.925081263238098e-06
during O 0 1.6751912426116178e-06
embryogenesis O 0 3.993194695794955e-05
. O 0 2.0920448662309354e-07

Prevalence O 0 4.410045221447945e-06
of O 0 1.7062689039448742e-08
p16 O 0 3.329618891712016e-07
and O 0 1.5896777227908387e-08
CDK4 O 1 0.9999014139175415
germline O 0 0.00025489486870355904
mutations O 0 7.659139811266868e-08
in O 0 1.1591810844535644e-09
48 O 0 6.256098572521296e-08
melanoma B-Disease 1 0.9706537127494812
- O 0 1.939003141160356e-06
prone O 0 4.063671440235339e-06
families O 0 1.3945717913799172e-09
in O 0 8.180364163834497e-10
France O 0 1.2266890614398562e-08
. O 0 4.268600406476253e-08

The O 0 5.804327329883563e-08
French O 0 5.029592102800962e-06
Familial B-Disease 0 0.26258254051208496
Melanoma I-Disease 1 1.0
Study O 0 5.600543886430387e-07
Group O 0 1.1972258739945119e-09
. O 0 1.5174357326230847e-09

Germline O 0 0.00030162688926793635
mutations O 0 1.5074948578330805e-07
in O 0 1.1110905528965986e-09
the O 0 2.414102917569494e-09
p16 O 0 8.951487018293847e-08
and O 0 1.773605373678322e-09
CDK4 O 1 0.9737278819084167
genes O 0 2.7898327203956796e-08
have O 0 3.5291498889922224e-11
been O 0 5.165646556337666e-12
reported O 0 5.105017103490539e-12
in O 0 3.3181493577089105e-12
a O 0 6.774539262899282e-12
subset O 0 4.290015898078536e-09
of O 0 1.9672616868859905e-09
melanoma B-Disease 0 1.09446446003858e-05
pedigrees O 0 6.247328201425262e-07
, O 0 2.5527035346639693e-11
but O 0 2.4901433345880797e-11
their O 0 3.60773876051379e-11
prevalence O 0 1.8273271784607914e-10
is O 0 1.6959597246533897e-13
not O 0 1.4644766519258945e-12
well O 0 1.4827558625363224e-10
known O 0 1.1626375417961299e-09
. O 0 2.0959705082645996e-08

We O 0 1.5731183466982657e-08
searched O 0 1.8738662177497645e-08
for O 0 1.605303806551106e-10
such O 0 5.1575623771782375e-09
germline O 0 1.2787608284270391e-05
mutations O 0 2.268498633384297e-08
in O 0 2.0343449147475212e-09
48 O 0 4.442351908551245e-08
French O 0 5.359082138056692e-07
melanoma B-Disease 1 0.9999940395355225
- O 0 4.83244402857963e-05
prone O 0 5.242350744083524e-05
families O 0 4.17093914961697e-10
selected O 0 2.786665620480022e-10
according O 0 5.3951105735694505e-12
to O 0 2.8217113975242958e-12
two O 0 6.732607093357101e-13
major O 0 2.0081861173970594e-10
criteria O 0 6.310663991371257e-08
families O 0 2.6974112180000454e-11
with O 0 2.2816934431256486e-13
at O 0 1.1788433944281973e-11
least O 0 1.5629226428684473e-12
three O 0 1.1472817054020146e-12
affected O 0 1.3119217934232097e-09
members O 0 6.313267963964364e-11
( O 0 1.523308497571041e-12
n O 0 5.136783359782626e-11
= O 0 8.79695448430251e-12
20 O 0 1.0792716546859094e-11
) O 0 3.264859018445136e-14
or O 0 1.852487130707403e-12
families O 0 2.593935266234637e-12
with O 0 3.5291192711228714e-13
two O 0 3.878983939609171e-12
affected O 0 1.8637458243375704e-09
members O 0 2.9518772842740404e-11
, O 0 5.639293719494898e-12
one O 0 1.260001651626208e-12
of O 0 5.1148443119819476e-11
them O 0 2.6664722947017383e-12
affected O 0 1.1668180310842047e-10
before O 0 1.9030430009614463e-10
the O 0 4.487283461473979e-11
age O 0 3.2563080010206136e-10
of O 0 9.836693265485863e-11
50 O 0 9.622838637035613e-11
( O 0 2.496627579152977e-13
n O 0 1.8739027690672927e-11
= O 0 1.637623717187786e-11
28 O 0 3.970793416296914e-10
) O 0 3.1755547085128566e-13
, O 0 1.3570312408506258e-12
and O 0 2.0187105025798457e-12
one O 0 4.4091827086124857e-13
additional O 0 8.596583514486333e-12
minor O 0 6.213347347738818e-08
criterion O 0 0.00034350118949078023
. O 0 1.0928350775429863e-06

Sixteen O 0 1.88606463780161e-05
different O 0 1.5143434950459778e-07
p16 O 0 4.6713967094547115e-06
germline O 0 3.7083952975081047e-06
mutations O 0 7.149484559931807e-09
were O 0 1.018979275957399e-10
found O 0 2.9298653347192838e-12
in O 0 2.1778228092433904e-12
21 O 0 4.132060249517622e-10
families O 0 1.3130169694564042e-11
, O 0 5.349284925605657e-13
while O 0 3.3856726016495697e-12
one O 0 2.6272514979525097e-12
germline O 0 3.1078088991165487e-09
mutation O 0 4.810740139582492e-10
, O 0 3.7014953602199085e-11
Arg24His O 0 2.3731547116767615e-05
, O 0 1.3976572676988042e-10
was O 0 6.632778215553969e-10
detected O 0 8.22260481925241e-09
in O 0 3.472396536974287e-10
the O 0 9.285567870165323e-09
CDK4 O 1 0.9950645565986633
gene O 0 2.028693018019112e-07
. O 0 1.709266541638499e-07

The O 0 1.3898882933460754e-08
frequency O 0 2.0587018756401676e-09
of O 0 1.6229732002770447e-09
p16 O 0 1.556927742285552e-08
gene O 0 1.209218697395542e-10
mutation O 0 1.4877503395904768e-10
in O 0 2.263796962387321e-11
our O 0 9.394709316046246e-11
sample O 0 7.313007838183339e-11
( O 0 5.161764028357996e-13
44 O 0 6.363912175011421e-11
% O 0 1.5467012436445882e-12
) O 0 4.5284695454226795e-14
is O 0 1.7030067677240024e-13
among O 0 8.519047012961467e-13
the O 0 2.2003150169924712e-12
highest O 0 4.2547451672980685e-10
rates O 0 1.9180236565663478e-10
yet O 0 1.3133000763276836e-11
reported O 0 3.793611258462448e-12
and O 0 9.271715339931319e-12
the O 0 1.0004909400951334e-10
CDK4 O 0 5.3463783842744306e-05
mutation O 0 8.023243736055008e-10
is O 0 1.54743882638253e-12
the O 0 6.566584515727003e-12
second O 0 1.0787803289558084e-10
mutation O 0 1.383807478327892e-11
detected O 0 1.0022500190887129e-10
in O 0 1.724523128465716e-11
this O 0 1.655847819970191e-10
gene O 0 3.3618814399005714e-09
worldwide O 0 2.4252346797482005e-09
. O 0 4.4539582688685186e-08

In O 0 5.884337905825987e-09
summary O 0 7.329450824045125e-09
, O 0 2.638346763284005e-10
our O 0 3.424494299242298e-10
results O 0 1.0310284848102924e-09
show O 0 2.4559645983579514e-11
frequent O 0 4.099736175544599e-12
involvement O 0 1.8246515409714448e-11
of O 0 1.3488292427421555e-10
the O 0 1.8085625219654844e-09
p16 O 0 1.972914276393567e-08
gene O 0 8.417497254775697e-10
in O 0 9.456594396439755e-10
familial B-Disease 0 2.1762581070561282e-07
melanoma I-Disease 0 7.567392458440736e-05
and O 0 1.251163617155271e-10
confirm O 0 3.3505748175954864e-10
the O 0 1.3064625770109473e-10
role O 0 1.7172561983525014e-11
of O 0 5.796643720579198e-10
the O 0 3.658361391600806e-09
CDK4 O 1 0.9997281432151794
gene O 0 4.315111379327163e-09
as O 0 9.866876204966957e-10
a O 0 3.5243821749908477e-10
melanoma B-Disease 0 0.0003320263931527734
- O 0 2.286854623889667e-06
predisposing O 0 1.1539463230292313e-05
gene O 0 1.0209411982486927e-08
. O 0 4.17600398705531e-09
. O 0 1.5812346987331694e-08

Progression O 0 1.73610733327223e-05
of O 0 2.3463555010039272e-07
somatic O 0 0.0001971260062418878
CTG O 0 7.132726750569418e-05
repeat O 0 1.336866883860921e-08
length O 0 8.606337309480239e-10
heterogeneity O 0 9.319848892630489e-09
in O 0 8.451046286384045e-12
the O 0 7.842132325464046e-12
blood O 0 8.898075332108846e-11
cells O 0 2.9101526743957606e-10
of O 0 6.864149248997364e-10
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9986889958381653
. O 0 1.4615028476328007e-07

The O 0 5.397609470492171e-09
genetic O 0 1.881109712442708e-09
basis O 0 2.6156752319650423e-09
of O 0 6.613468173100046e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.838165708534234e-08
DM B-Disease 1 1.0
) O 0 1.0627559596243508e-11
is O 0 1.9914496755205763e-13
the O 0 6.523189649033923e-13
expansion O 0 4.072470416449647e-10
of O 0 1.9334910061896693e-10
an O 0 1.2736226136234041e-11
unstable O 0 3.8168843730090884e-07
CTG O 0 4.002745299658272e-06
repeat O 0 4.834871170089627e-09
in O 0 1.3397524756264545e-10
the O 0 1.9346049762170026e-10
34 O 0 3.848421581409411e-09
UTR O 0 4.198278475087136e-05
of O 0 8.06642252992873e-10
the O 0 5.5767710449572405e-09
DM B-Disease 1 0.9999997615814209
protein O 0 1.8247105515456497e-07
kinase O 0 3.260973002738865e-08
gene O 0 8.850600807797093e-10
on O 0 3.2149736206577018e-09
chromosome O 0 6.407485209081187e-09
19 O 0 5.614084841454314e-08
. O 0 3.486628941118397e-08

One O 0 4.6882009385740275e-09
of O 0 6.391736029343065e-10
the O 0 3.120066427442225e-10
principal O 0 2.507418050967658e-09
features O 0 8.836776796417034e-12
of O 0 7.567876880720803e-11
the O 0 7.861253870089513e-09
DM B-Disease 1 1.0
mutation O 0 1.613315845361285e-07
is O 0 2.803195175982154e-11
an O 0 4.4965490749240833e-13
extraordinarily O 0 1.6135991431909247e-09
high O 0 1.1635138408294665e-09
level O 0 9.707884496279462e-10
of O 0 9.395682010193696e-10
somatic O 0 5.952936135145137e-06
mosaicism O 0 7.89490804891102e-05
, O 0 9.611300644252196e-11
due O 0 3.032548434589444e-08
to O 0 8.119951239171641e-11
an O 0 5.39978164178917e-13
extremely O 0 9.38047486909177e-11
high O 0 4.573387848982868e-11
degree O 0 1.9587093058603955e-10
of O 0 1.6405694858168118e-10
somatic O 0 7.453599550899526e-07
instability O 0 1.3584064539884366e-08
both O 0 1.6207325759243218e-10
within O 0 6.370169391978209e-10
and O 0 4.980754350625283e-11
between O 0 1.4056160402287077e-10
different O 0 1.989775455513154e-09
tissues O 0 6.643152232754801e-07
. O 0 5.478211306808589e-08

This O 0 1.0281191720196148e-07
instability O 0 1.9592684452618414e-07
appears O 0 8.661410255683677e-09
to O 0 1.799528234758263e-11
be O 0 2.2050172451826278e-11
biased O 0 2.2495981466530424e-10
towards O 0 1.447212211180826e-10
further O 0 2.4610523688406438e-11
expansion O 0 9.301623915547452e-10
and O 0 6.739021233409526e-12
continuous O 0 6.319376272267974e-11
throughout O 0 4.1949360651827305e-11
the O 0 4.36473947262872e-11
life O 0 2.3332719090163323e-10
of O 0 5.978835204700772e-10
an O 0 3.5633462326656318e-12
individual O 0 3.8544636232762386e-11
, O 0 3.937695221972737e-12
features O 0 3.741655856676074e-12
that O 0 8.792819310111596e-14
could O 0 2.3655467775579586e-12
be O 0 6.123015506079299e-13
associated O 0 2.95939800443179e-11
with O 0 1.478010747645031e-12
the O 0 1.24900401132777e-09
progressive O 0 1.3784318070975132e-05
nature O 0 1.891431677947253e-09
of O 0 6.778579364485893e-10
the O 0 4.341620396530743e-09
disease O 0 3.038072122762969e-07
. O 0 2.313293734346189e-08

Although O 0 1.4218366040097408e-08
increasing O 0 2.794416475992989e-09
measured O 0 1.895169132737351e-09
allele O 0 1.098338753280359e-09
size O 0 1.7438207822184637e-10
between O 0 1.8693592507279533e-10
patients O 0 4.130370712118747e-08
clearly O 0 7.321832029560937e-10
correlates O 0 1.902223933925029e-09
with O 0 4.0210283019925797e-13
an O 0 1.4765666377851254e-14
increased O 0 1.5000752376370663e-12
severity O 0 4.148314136642739e-09
of O 0 6.114586614813788e-10
symptoms O 0 5.170719532543444e-07
and O 0 8.712134486055234e-11
an O 0 9.43270662316989e-14
earlier O 0 2.390585299161252e-11
age O 0 1.5329927605112204e-10
of O 0 2.1206172234888854e-11
onset O 0 1.3769589024548168e-08
, O 0 3.470314096851168e-12
this O 0 1.2155953327264157e-12
correlation O 0 4.1745881924903916e-12
is O 0 7.47591753585096e-14
not O 0 1.878183887712645e-13
precise O 0 3.3365829543718917e-10
and O 0 2.4073965043669432e-11
measured O 0 8.927046879492195e-10
allele O 0 2.3422211392620795e-10
length O 0 8.240793464286966e-11
cannot O 0 5.0077886282196005e-11
be O 0 1.6370793609610246e-12
used O 0 3.0881631887108574e-12
as O 0 1.0397894567928945e-12
an O 0 1.0523903254920641e-14
accurate O 0 1.3424869549361063e-10
predictor O 0 6.50867661988741e-08
of O 0 2.5848748141932276e-10
age O 0 6.052720102900366e-09
of O 0 7.100665611048385e-10
onset O 0 2.7023568691220134e-05
. O 0 1.9957521146807267e-07

In O 0 2.570309076688204e-09
order O 0 1.024113793768322e-09
to O 0 1.8794294245894072e-11
further O 0 8.061880329979232e-11
characterize O 0 9.557728830600354e-09
the O 0 7.978910310235676e-10
dynamics O 0 2.250832054073726e-08
of O 0 1.8346986507822294e-07
DM B-Disease 1 1.0
CTG O 0 0.011319270357489586
repeat O 0 1.7028803256380343e-07
somatic O 0 3.028710125363432e-06
instability O 0 3.045908636423178e-09
, O 0 3.852087485795019e-12
we O 0 7.727442275472229e-13
have O 0 1.6185184160792676e-13
studied O 0 1.695757770314721e-11
repeat O 0 1.3002867879641222e-11
length O 0 9.134693002010863e-12
changes O 0 2.3678592073195226e-11
over O 0 1.6208092160074905e-11
time O 0 4.843006551347173e-11
in O 0 6.160228993579153e-10
111 O 0 2.268772732350044e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 3.4487186439946527e-07
with O 0 1.9323941318621918e-12
varying O 0 1.0330258870538955e-10
clinical O 0 5.027611660324283e-10
severity O 0 7.222595854727842e-08
and O 0 1.9155714792162826e-09
CTG O 0 3.7797664731442637e-07
repeat O 0 4.413766574451472e-10
size O 0 1.516010927904432e-11
over O 0 6.082890809978869e-13
time O 0 1.390219536712145e-12
intervals O 0 1.682404042468999e-11
of O 0 1.5119076129943565e-11
1 O 0 1.4709596873885289e-09
- O 0 1.283845585398069e-09
7 O 0 2.580083480197004e-09
years O 0 1.8450521666046882e-10
. O 0 1.5500229988418823e-09

We O 0 9.386394594912417e-08
have O 0 1.0670909988963473e-10
found O 0 4.603456504881365e-12
a O 0 1.541099469174953e-13
direct O 0 5.9994596096624164e-12
progression O 0 5.772506028733915e-09
of O 0 2.123605458148603e-10
the O 0 6.676386526960343e-11
size O 0 2.390549980191281e-10
heterogeneity O 0 3.3477527416891917e-09
over O 0 2.3815742780652904e-11
time O 0 3.696937200814432e-11
related O 0 3.376185553349842e-09
to O 0 7.027343151833065e-10
initial O 0 4.507569073552986e-08
CTG O 0 4.616659907696885e-07
repeat O 0 2.9543012480814923e-10
size O 0 5.071005421131147e-11
and O 0 4.84586849813784e-12
the O 0 5.633090782025674e-12
time O 0 1.5490610530410898e-11
interval O 0 4.411056797604118e-10
and O 0 1.726926067424639e-11
always O 0 5.376827455494393e-11
biased O 0 3.12123299428535e-10
towards O 0 1.607936894743034e-09
further O 0 2.9361690856433142e-09
expansion O 0 9.069673865269579e-07
. O 0 1.553614765725797e-07

Attempts O 0 5.794979642814724e-07
to O 0 7.603878637851835e-10
mathematically O 0 3.836433393189509e-08
model O 0 2.5994166819032216e-09
the O 0 3.7183900403192638e-09
dynamics O 0 5.205080242376425e-07
have O 0 4.460416924700894e-09
proved O 0 2.9869292461626173e-07
only O 0 1.4068284037715983e-10
partially O 0 5.766288779796014e-09
successful O 0 2.8625385395386616e-10
suggesting O 0 1.219525869178284e-10
that O 0 1.2540024628502483e-13
individual O 0 7.152975043875354e-13
specific O 0 1.1111764286475534e-11
genetic O 0 2.931936915473443e-10
and O 0 1.8458017059241882e-10
/ O 0 1.4976512474618175e-08
or O 0 1.4761331046386772e-10
environmental O 0 1.6950910008972642e-08
factors O 0 2.904132268000126e-09
also O 0 1.8712916632912524e-11
play O 0 7.950787250798896e-11
a O 0 7.45415448116793e-12
role O 0 3.1824173851724424e-10
in O 0 2.882939442727661e-09
somatic O 0 7.294130773516372e-05
mosaicism O 0 0.0005764947272837162
. O 0 1.9914242699314855e-08
. O 0 3.031125928032452e-08

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 4.921054141959758e-07
Palestinian O 0 7.273192181855848e-07
Arabs O 0 3.060212634409254e-07
. O 0 1.8309433968966005e-08

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.9999744892120361
AGU B-Disease 1 1.0
) O 0 2.8709168375939953e-09
is O 0 1.1315956852109288e-11
a O 0 4.249517838311734e-12
rare O 0 1.514579750505618e-08
disorder B-Disease 1 0.949569582939148
of I-Disease 0 0.0003271514142397791
glycoprotein I-Disease 0 0.03254363685846329
metabolism I-Disease 1 0.8593634963035583
caused O 0 2.4653504127059023e-08
by O 0 1.3445575208770322e-10
the O 0 5.1957854907414e-08
deficiency B-Disease 0 6.103236501076026e-06
of I-Disease 0 8.755955960282336e-09
the I-Disease 0 1.4088967770220506e-09
lysosomal I-Disease 0 1.8620839909999631e-06
enzyme I-Disease 0 1.0153003415780404e-07
aspartylglucosaminidase I-Disease 0 2.9499085940187797e-05
( O 0 4.58101168110403e-10
AGA O 0 0.00013286482135299593
) O 0 2.45389153441522e-10
. O 0 2.815119470866989e-09

AGU B-Disease 1 1.0
is O 0 1.9498254744121368e-07
inherited O 0 9.976064757211134e-05
as O 0 1.2260318094092781e-08
an O 0 2.0080252738363669e-10
autosomal O 0 2.333092015760485e-05
recessive O 0 0.00011617218842729926
trait O 0 7.058904998302751e-07
and O 0 5.530932378761122e-10
occurs O 0 3.8231987020687086e-11
with O 0 4.437139064917932e-14
a O 0 1.6697046848444808e-13
high O 0 1.7386621656290124e-11
frequency O 0 3.0828018089679166e-12
in O 0 2.1809320842336444e-12
Finland O 0 2.2101891150594355e-10
because O 0 1.8105071261653727e-11
of O 0 2.5653024149363546e-10
a O 0 8.879121049520933e-11
founder O 0 1.1698854329722508e-08
effect O 0 5.934316504863091e-08
. O 0 5.240323375232947e-08

While O 0 2.924557236383407e-07
very O 0 4.0898076036910425e-09
few O 0 3.1091131891258783e-09
patients O 0 5.112823231456787e-08
with O 0 1.3035285073570435e-09
AGU B-Disease 1 1.0
have O 0 3.9061802681317204e-08
been O 0 4.87784757030596e-10
reported O 0 1.706813163027121e-11
from O 0 3.100328327398927e-11
non O 0 3.785449287363463e-09
- O 0 9.720460547590903e-11
Finnish O 0 1.6121194379437043e-09
origin O 0 1.0426105812033626e-10
, O 0 5.307922504305118e-12
we O 0 6.684247599864079e-11
diagnosed O 0 2.3324391804635525e-06
the O 0 1.4682946414268372e-08
disorder O 0 0.00021663510415237397
in O 0 2.347102601163442e-08
8 O 0 5.1312291304839164e-08
patients O 0 2.088722084181427e-09
originating O 0 1.8982143634715953e-10
from O 0 1.56995076661115e-11
3 O 0 1.49003628879818e-10
unrelated O 0 4.5962142425359787e-10
families O 0 4.673221878914724e-12
, O 0 2.1915851295198352e-13
all O 0 3.861089236962406e-13
Palestinian O 0 2.41855396820867e-10
Arabs O 0 3.230842676726908e-11
from O 0 3.016361032476267e-12
the O 0 2.9866033691289262e-12
region O 0 1.4311832968738614e-11
of O 0 4.6812890369674065e-11
Jerusalem O 0 1.7619016716707847e-06
. O 0 5.331575181344306e-08

The O 0 2.4498302053643783e-08
clinical O 0 5.0464956302676e-07
diagnosis O 0 0.14791792631149292
of O 1 0.9958620071411133
AGU B-Disease 1 1.0
is O 0 8.054650280087117e-09
often O 0 7.173955179906599e-11
difficult O 0 6.833747456802541e-11
, O 0 3.2836586097775844e-13
in O 0 4.4622373287714345e-13
particular O 0 1.4064306143313221e-11
early O 0 2.078135885597021e-09
in O 0 8.997980312230869e-12
the O 0 2.0950480933423776e-11
course O 0 1.0718398391063033e-10
of O 0 4.820701129948368e-12
the O 0 4.06950237397119e-11
disease O 0 1.411155858832558e-09
, O 0 4.964457664402566e-12
and O 0 6.4433593009727286e-12
most O 0 1.6023722279601138e-11
of O 0 2.5020074553849803e-11
the O 0 1.153435263967495e-10
patients O 0 5.161783889207072e-09
are O 0 4.130212231251429e-12
diagnosed O 0 4.748892945549699e-10
after O 0 1.2481293776289704e-10
the O 0 9.316178384288776e-11
age O 0 7.228708187589916e-10
of O 0 3.3004160515659464e-10
5 O 0 1.1958908308074001e-09
years O 0 1.6002260627701048e-10
. O 0 2.7632147681089236e-09

However O 0 3.1183981263893656e-07
, O 0 4.930321706453356e-10
since O 0 6.980347411200682e-10
these O 0 1.3181045144250447e-09
patients O 0 1.2258587034352786e-08
excrete O 0 2.0196541328232342e-08
early O 0 3.1828317759163838e-09
large O 0 1.4589766894612666e-11
amounts O 0 5.174721762202239e-11
of O 0 4.5076761767681717e-10
aspartylglucosamine O 0 5.978549779683817e-06
in O 0 5.167763550417703e-09
urine O 0 3.804986548061606e-09
, O 0 9.843121326694182e-13
biochemical O 0 2.497236306631123e-10
screening O 0 9.339120587981142e-09
is O 0 1.690194165182568e-11
easy O 0 7.432893744940827e-10
by O 0 1.9278863228056053e-10
urine O 0 9.746873530502853e-08
chromatography O 0 2.5356996502523543e-07
. O 0 2.4436221934820423e-09
. O 0 1.1365075103242361e-08

Detection O 0 1.514635187049862e-06
of O 0 1.2146752936814664e-08
heterozygous O 0 7.15324521838312e-10
carriers O 0 2.8800510587512207e-11
of O 0 3.291374464642338e-11
the O 0 1.980046704375127e-08
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.552420141910261e-08
ATM O 0 2.2662727587885456e-06
) O 0 1.501739357867571e-11
gene O 0 1.0962530362645939e-11
by O 0 1.894177176220424e-11
G2 O 0 8.037440238695126e-06
phase O 0 6.877227178847534e-07
chromosomal O 0 2.444355970965262e-07
radiosensitivity O 0 2.7678728656610474e-05
of O 0 4.0821961988513067e-07
peripheral O 0 0.0009510637610219419
blood O 0 0.00013991782907396555
lymphocytes O 0 1.950334626599215e-05
. O 0 4.394392405515646e-08

In O 0 3.555991270332015e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.944677726191003e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 6.39775801780651e-11
patients O 0 4.074033999046378e-09
, O 0 7.120889706883904e-13
mutations O 0 2.586455572287094e-12
in O 0 1.7028971548843641e-12
a O 0 1.4493045435645668e-12
single O 0 2.441080844406418e-11
gene O 0 3.745454467407594e-12
, O 0 1.693187473908453e-12
ATM O 0 3.4237059853836627e-09
, O 0 4.381490016722861e-14
result O 0 1.7547996476047212e-12
in O 0 1.428118213964158e-11
an O 0 4.735921654841491e-10
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 2.0546506718233104e-08
embraces O 0 1.723907594453067e-08
a O 0 4.5679454142855125e-12
variety O 0 4.35364799766802e-11
of O 0 4.2483450785057997e-11
clinical O 0 9.019089364237232e-10
features O 0 2.0988636176277886e-11
and O 0 1.523919705703758e-11
manifests O 0 8.81120454376827e-10
extreme O 0 1.1524599941026281e-08
radiosensitivity O 0 1.1778874977608211e-06
and O 0 4.1946338069642763e-10
a O 0 9.218923541221002e-11
strong O 0 2.398049980811834e-09
pre O 0 6.691606358799618e-06
- O 0 2.5616628818170284e-07
disposition O 0 0.009421326220035553
to O 0 6.319010736888231e-08
malignancy B-Disease 0 0.0003097295993939042
. O 0 4.038278333950984e-08

Heterozygotes O 0 6.603236215596553e-06
for O 0 6.634223836954334e-09
the O 0 1.6620004927858645e-08
ATM O 0 4.7640577349739033e-07
gene O 0 1.5737709746499462e-10
have O 0 4.678126809543048e-12
no O 0 1.6023867345851817e-12
clinical O 0 8.00996699523715e-11
expression O 0 1.9263379086309484e-11
of O 0 7.811153501791068e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 8.578116550417292e-10
may O 0 1.0683293139024386e-10
be O 0 4.3155184287213544e-11
cancer B-Disease 0 1.1655534315480054e-08
prone O 0 4.349384186141947e-10
with O 0 3.7420676908712924e-13
a O 0 1.5961405808173623e-11
moderate O 0 4.597393399308203e-08
increase O 0 1.8001720114568798e-09
in O 0 6.18551876385709e-10
in O 0 1.5533435648862337e-09
vitro O 0 4.890256377620972e-07
radiosensitivity O 0 6.2248395806818735e-06
. O 0 9.10698005895938e-08

We O 0 1.7438932786717487e-07
performed O 0 4.2122202614791604e-08
a O 0 4.804367459421144e-10
blind O 0 1.2179440567194888e-08
chromosomal O 0 5.59365620489416e-09
analysis O 0 5.584168683014923e-09
on O 0 2.3240758650899807e-08
G2 O 0 2.717338020374882e-06
- O 0 3.4610454502370658e-09
phase O 0 1.0714754239415925e-07
lymphocytes O 0 3.4562099848756134e-09
from O 0 1.0694010781076013e-11
7 O 0 5.126762903095994e-10
unrelated O 0 1.856452236381756e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
patients O 0 0.00010791107342811301
, O 0 1.2782904075525625e-11
13 O 0 1.2708133156902335e-10
obligate O 0 1.5125292129880563e-09
A B-Disease 1 1.0
- I-Disease 1 0.9986252784729004
T I-Disease 1 1.0
heterozygotes O 0 6.251315198824159e-08
( O 0 5.121955919291932e-13
parents O 0 4.3085478761140106e-13
of O 0 2.1393027323582392e-13
the O 0 5.245790238826709e-13
patients O 0 9.488727512052542e-12
) O 0 5.161820135820422e-14
, O 0 5.508267995370242e-13
and O 0 1.0675384187752712e-11
14 O 0 8.952414504159734e-11
normal O 0 1.1578817904478456e-09
controls O 0 2.5463636754707863e-10
following O 0 6.134164842741541e-10
X O 0 2.140714059351012e-06
- O 0 1.2808110128048611e-08
irradiation O 0 2.2196263671503402e-06
with O 0 4.329377134570933e-11
1 O 0 2.6645394779478693e-09
Gy O 0 3.039718023956084e-07
in O 0 2.055238357973055e-12
order O 0 1.0999099200881268e-11
to O 0 2.458100346533487e-12
evaluate O 0 8.509506294052116e-11
this O 0 8.212373489580038e-12
cytogenetic O 0 8.47215702037829e-08
method O 0 1.2634672863498508e-08
as O 0 2.2230588203608903e-10
a O 0 1.2419947882646998e-11
tool O 0 1.8724244377210653e-10
for O 0 6.100194134550652e-12
detection O 0 4.453414348404294e-08
of O 0 4.3069153576880126e-08
ATM O 0 0.00015491600788664073
carriers O 0 3.433366941862914e-07
. O 0 3.7631561866646734e-08

Both O 0 2.31717899623618e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 8.057113154791296e-05
and O 0 5.704783867521712e-10
heterozygotes O 0 2.4338087101227757e-08
showed O 0 1.3120662889498647e-10
significantly O 0 1.8576476468190606e-10
increased O 0 3.6987215373818216e-11
levels O 0 3.743372556375135e-10
of O 0 5.582416473526308e-11
radiation O 0 2.73296268460399e-06
- O 0 5.8971611593960915e-08
induced O 0 2.7767528081312776e-06
chromatid O 0 1.3375448588703875e-06
damage O 0 1.2821740824620065e-07
relative O 0 6.365304727751209e-08
to O 0 3.9851011379710144e-11
that O 0 1.5754693556691013e-12
of O 0 3.355748734445996e-10
normal O 0 7.791500422626996e-08
controls O 0 2.292696876793343e-08
. O 0 2.313509916973544e-08

These O 0 1.207793154378578e-08
results O 0 4.2999793947728904e-08
show O 0 2.5150900806458765e-10
that O 0 2.899644717044292e-12
the O 0 1.213907974140227e-09
G2 O 0 4.985958003089763e-05
- O 0 7.246661226645301e-08
phase O 0 1.4103568446444115e-06
chromosomal O 0 5.619023468739215e-08
radiosensitivity O 0 3.457834338860266e-07
assay O 0 1.4969200989867204e-08
can O 0 1.0995218624465508e-11
be O 0 4.95012125907579e-13
used O 0 2.598886275455292e-13
for O 0 1.2071176306790998e-13
the O 0 1.314176306839443e-12
detection O 0 3.151287453206919e-09
of O 0 1.6550853132457632e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 2.3649083232157864e-05
. O 0 5.623376608809849e-08

In O 0 2.261728582197975e-08
combination O 0 2.5987242580072234e-08
with O 0 8.656941830054166e-11
molecular O 0 2.1335708311198687e-08
genetic O 0 1.0822581941738463e-08
analyses O 0 4.152137300650338e-09
, O 0 8.938180057205258e-12
this O 0 7.171858593113534e-12
test O 0 7.807038349127993e-10
may O 0 9.074976187184447e-11
be O 0 2.866502391354886e-12
of O 0 3.979129525877312e-12
value O 0 5.688913316120869e-12
in O 0 2.5669624845875427e-13
studies O 0 1.3338383132374676e-12
of O 0 2.49544807560953e-12
familial B-Disease 0 1.6806962488402633e-09
and I-Disease 0 2.911086482981773e-09
sporadic I-Disease 0 2.0536024294415256e-06
cancers I-Disease 0 2.030045152423554e-06
aimed O 0 5.507785338920712e-09
at O 0 5.509578904216994e-10
determination O 0 9.467423511821949e-10
of O 0 6.614762071421865e-10
the O 0 1.0298074892833853e-10
potential O 0 6.497838378471954e-11
involvement O 0 4.274623363609287e-11
of O 0 6.816190389891119e-10
ATM O 0 3.43514602718642e-06
mutations O 0 1.6981132944238198e-08
in O 0 2.0897104047179482e-09
tumor B-Disease 0 0.0031115261372178793
risk O 0 1.5156236088387232e-07
or O 0 3.1614905138255267e-10
development O 0 2.8456046408109614e-09
. O 0 8.930998163236836e-10
. O 0 8.6081479722111e-09

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 1.9900563419383843e-09
identification O 0 9.489098395931705e-10
and O 0 9.737707602069934e-13
detection O 0 1.689460793485864e-09
of O 0 9.60883150824543e-10
founder O 0 1.6990204798617015e-08
- O 0 1.8362873888122522e-08
effect O 0 3.5228677575105394e-07
mutations O 0 3.64280411391249e-10
in O 0 1.7237929833546772e-11
the O 0 8.259881667527225e-11
ATM O 0 5.554544912911297e-08
gene O 0 8.25688892258647e-11
in O 0 6.303352978465071e-11
ethnic O 0 1.935380189443947e-10
populations O 0 5.609444020393539e-10
. O 0 1.1634228025414473e-09

To O 0 7.2168231390890014e-09
facilitate O 0 1.1081028539194904e-08
the O 0 4.067401415674965e-10
evaluation O 0 3.9264531181970597e-08
of O 0 1.7249666584007173e-08
ATM O 0 9.816884812607896e-06
heterozygotes O 0 2.667455021310161e-07
for O 0 4.675491660499631e-10
susceptibility O 0 2.902202140830923e-07
to O 0 1.3778954366383545e-10
other O 0 1.721093406681362e-10
diseases O 0 1.2432574294507504e-06
, O 0 2.363405825211995e-11
such O 0 9.778557963358026e-10
as O 0 1.8027195380909689e-07
breast B-Disease 0 7.527203706558794e-05
cancer I-Disease 0 8.373850732823485e-07
, O 0 6.279054359792369e-11
we O 0 5.880259473789451e-11
have O 0 1.8736096007998526e-11
attempted O 0 3.966025008406149e-10
to O 0 4.383110194239315e-11
define O 0 2.989980762979627e-10
the O 0 1.924660431029679e-10
most O 0 1.596015680727092e-11
common O 0 2.6503646499698164e-11
mutations O 0 7.602127477870924e-13
and O 0 8.516004199564386e-14
their O 0 1.7645756275434799e-13
frequencies O 0 2.2852671144324432e-11
in O 0 1.9666304695853398e-10
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.284201061935164e-06
A B-Disease 1 1.0
- I-Disease 1 0.9999969005584717
T I-Disease 1 1.0
) O 0 7.161787829446098e-11
homozygotes O 0 3.190753261606005e-08
from O 0 4.587287147361785e-11
10 O 0 5.2904694514133155e-11
ethnic O 0 3.5287325145239024e-11
populations O 0 2.2459796522600328e-10
. O 0 1.972525698334948e-09

Both O 0 1.3444362423342682e-07
genomic O 0 3.250609097449342e-07
mutations O 0 4.044413870474273e-08
and O 0 5.485399912075195e-10
their O 0 9.398813671790407e-11
effects O 0 7.939879864693467e-10
on O 0 2.1761068502712533e-09
cDNA O 0 1.6083548715073448e-08
were O 0 3.6678896031538955e-10
characterized O 0 1.6558613369355157e-09
. O 0 6.6080567684423386e-09

Protein O 0 5.88124350997532e-07
- O 0 2.3817868566311517e-08
truncation O 0 6.687075426725642e-08
testing O 0 1.1875267880157026e-08
of O 0 2.8721653944074887e-09
the O 0 1.2059923060192546e-09
entire O 0 3.808827919726809e-09
ATM O 0 5.284940840510899e-08
cDNA O 0 1.4384587965210471e-09
detected O 0 4.8599546609295885e-09
92 O 0 1.3829335010484556e-08
( O 0 5.569619418444027e-12
66 O 0 9.036204007273341e-10
% O 0 2.6186627519186878e-11
) O 0 1.869974227547422e-12
truncating O 0 2.5520405344536812e-08
mutations O 0 1.7316443834403117e-09
in O 0 4.2187689452966026e-10
140 O 0 1.765650736729185e-08
mutant O 0 4.639111139681518e-08
alleles O 0 6.216521963864352e-09
screened O 0 4.92959379982949e-08
. O 0 1.494173140770272e-08

The O 0 1.4013376414823142e-07
haplotyping O 0 4.259207344148308e-05
of O 0 2.3890012812444184e-07
patients O 0 6.911963623679185e-07
with O 0 6.103106908739164e-11
identical O 0 3.314234788831527e-07
mutations O 0 5.830299354414592e-09
indicates O 0 9.687967761351501e-09
that O 0 3.5400560521176017e-12
almost O 0 1.5688131349556045e-11
all O 0 1.1131974248651533e-12
of O 0 3.81293607798483e-12
these O 0 1.848604385887298e-12
represent O 0 5.009448585113763e-12
common O 0 1.9129553843755254e-11
ancestry O 0 2.1053870452591994e-11
and O 0 2.8540962995760033e-12
that O 0 5.894401720191178e-13
very O 0 2.496402806695386e-10
few O 0 2.139911137177819e-09
spontaneously O 0 3.4457139008736704e-07
recurring O 0 1.0163814323504994e-07
ATM O 0 1.5466235709027387e-05
mutations O 0 7.016674885562679e-08
exist O 0 2.112804153853176e-08
. O 0 4.2199804539677643e-08

Assays O 0 1.1133078032798949e-06
requiring O 0 1.3000085452574695e-08
minimal O 0 1.0190758814587753e-07
amounts O 0 1.44032092919133e-08
of O 0 1.5073768899753759e-09
genomic O 0 3.6803793346251723e-09
DNA O 0 4.191749169990544e-09
were O 0 1.6741143193943486e-10
designed O 0 1.2396476900544684e-10
to O 0 2.654138540891804e-11
allow O 0 4.0605702827933854e-11
rapid O 0 5.113237055986986e-10
screening O 0 1.3437019275031048e-09
for O 0 4.1808456002767613e-11
common O 0 5.065509789403677e-09
ethnic O 0 1.060147414300161e-09
mutations O 0 9.649315124704572e-09
. O 0 1.1416652512252767e-08

These O 0 1.9137452511586162e-07
rapid O 0 3.7200024394223874e-07
assays O 0 3.560263053259405e-07
detected O 0 2.2285337308858288e-07
mutations O 0 4.380239726486934e-09
in O 0 2.86823315098772e-10
76 O 0 2.2921897269156943e-08
% O 0 4.2218981782804477e-11
of O 0 5.458063515040301e-11
Costa O 0 3.4299347806410196e-09
Rican O 0 9.805779654925573e-08
patients O 0 6.123941176383596e-08
( O 0 2.1183159393256545e-12
3 O 0 2.2033536106746965e-10
) O 0 4.2389030653622317e-13
, O 0 1.5569749265906263e-12
50 O 0 9.224090241621852e-12
% O 0 5.04727173684244e-13
of O 0 3.6161828739778024e-12
Norwegian O 0 3.8113949329954266e-08
patients O 0 2.6626661764339588e-08
( O 0 7.914526781345466e-13
1 O 0 1.8233860255012502e-10
) O 0 1.5120935374039052e-13
, O 0 3.448314225308613e-13
25 O 0 1.0561521275598285e-11
% O 0 3.3129870916949467e-13
of O 0 1.5668985206551689e-12
Polish O 0 1.3859576597496925e-07
patients O 0 4.937186986353481e-06
( O 0 2.341968416072482e-12
4 O 0 2.3776630664329446e-10
) O 0 1.6127004516964388e-13
, O 0 6.685197642859741e-13
and O 0 3.885100140904596e-12
14 O 0 4.192456451446169e-11
% O 0 4.966131672556884e-13
of O 0 2.2853791342009044e-12
Italian O 0 4.161627931154044e-09
patients O 0 1.2989592335088673e-07
( O 0 9.96773735599532e-13
1 O 0 8.097777448590193e-10
) O 0 1.4251923209293582e-12
, O 0 5.364870006574485e-12
as O 0 2.8201257301629923e-11
well O 0 2.5425089117403488e-11
as O 0 9.356632656165598e-12
in O 0 8.49063094138236e-12
patients O 0 3.9279024477423263e-10
of O 0 3.492036382279906e-10
Amish O 0 1.4835558204140398e-07
/ O 0 2.651961494848365e-08
Mennonite O 0 2.0258354993529792e-07
and O 0 4.6386970653511383e-11
Irish O 0 5.178903528246792e-09
English O 0 2.4225810246747415e-09
backgrounds O 0 1.7234079052741436e-08
. O 0 4.3989603071281635e-09

Additional O 0 6.615209713345394e-08
mutations O 0 1.5220569693497055e-08
were O 0 8.462943124065703e-10
observed O 0 1.6449623607694974e-10
in O 0 1.1727768929603588e-11
Japanese O 0 1.2025590301334432e-08
, O 0 2.1261169907971222e-11
Utah O 0 7.829499715228394e-09
Mormon O 0 6.782863604115619e-09
, O 0 1.924449098342218e-12
and O 0 3.468911139239972e-12
African O 0 1.9902784281766728e-11
American O 0 2.425523844273858e-11
patients O 0 2.3152788575231398e-09
. O 0 4.4254275799460174e-09

These O 0 1.4760951572156955e-08
assays O 0 2.1506737724052982e-08
should O 0 5.264359087542303e-11
facilitate O 0 2.46968251405022e-10
screening O 0 5.166866490213806e-09
for O 0 7.453394013090531e-10
A B-Disease 1 1.0
- I-Disease 1 0.9986262321472168
T I-Disease 1 1.0
heterozygotes O 0 1.5278867238066596e-07
in O 0 3.733929138105552e-11
the O 0 1.8690373901342205e-11
populations O 0 3.2648998522094574e-12
studied O 0 1.9131850617637447e-11
. O 0 3.678333332368666e-11
. O 0 3.867612896613082e-09

The O 0 8.216522928705672e-07
von B-Disease 1 0.9999985694885254
Hippel I-Disease 1 0.9999997615814209
- I-Disease 1 0.9999997615814209
Lindau I-Disease 1 0.9999233484268188
tumor I-Disease 0 0.31700581312179565
suppressor O 0 3.9720057429804e-06
gene O 0 1.0595323229889431e-10
is O 0 2.427599408386799e-13
required O 0 3.2453672995508276e-12
for O 0 3.097170306678998e-12
cell O 0 2.1413758266586314e-10
cycle O 0 6.066435687124283e-10
exit O 0 1.3024922251858584e-09
upon O 0 4.0116426847092157e-10
serum O 0 1.4994174790672332e-08
withdrawal O 0 4.247266005563688e-08
. O 0 3.586194807780885e-08

The O 0 3.6601202069164174e-09
inactivation O 0 5.0613825806067325e-06
of O 0 8.376277449428926e-09
the O 0 4.586209456647339e-08
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 9.282384638709118e-08
VHL I-Disease 1 0.9999788999557495
) I-Disease 0 1.5341585779538036e-08
tumor I-Disease 0 3.360287882969715e-05
suppressor O 0 7.796176760166418e-06
gene O 0 2.616223904183812e-09
predisposes O 0 3.020886651938781e-08
affected O 0 5.587652562866197e-09
individuals O 0 2.0682755855205848e-11
to O 0 3.9898927911563575e-11
the O 0 1.5899443539524327e-08
human O 1 0.9639966487884521
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 3.3668334786796095e-10
is O 0 7.276796352984061e-13
associated O 0 7.164653419156064e-12
with O 0 2.3928194495259625e-12
sporadic B-Disease 0 1.971001438505482e-06
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 6.225195470221934e-09
RCC B-Disease 0 0.2139246165752411
) O 0 7.556947290154881e-10
and O 0 2.3944405569409355e-08
brain B-Disease 0 1.130867804022273e-05
hemangioblastomas I-Disease 0 0.001628671307116747
. O 0 3.1670783755544107e-06

VHL O 1 0.9987378716468811
- O 0 0.0003337973903398961
negative O 0 3.4272438824700657e-06
786 O 0 2.350789691263344e-05
- O 0 3.1649740321881836e-06
0 O 0 3.033833309018519e-07
RCC B-Disease 0 6.219303486432182e-06
cells O 0 3.6481271337152066e-08
are O 0 1.40647951618611e-10
tumorigenic O 0 1.1049939530494157e-05
in O 0 7.666828594210529e-08
nude O 0 2.8767593107659195e-07
mice O 0 4.088996252704646e-09
which O 0 1.0024918178572206e-12
is O 0 3.3392199053593197e-13
suppressed O 0 1.3378144425590932e-10
by O 0 1.1517309675412868e-11
the O 0 4.888857096929655e-10
reintroduction O 0 2.1222476220827957e-07
of O 0 7.394971746066403e-09
VHL B-Disease 0 0.20484641194343567
. O 0 1.1845597782667028e-06

Remarkably O 0 1.9909623006242327e-05
, O 0 3.076840865423591e-11
this O 0 1.2366754755660514e-12
occurs O 0 2.393108107512365e-11
without O 0 8.601163531407607e-11
affecting O 0 7.452540806696106e-10
the O 0 1.5788671758887318e-10
growth O 0 1.0037312092592288e-09
rate O 0 8.454715261230206e-10
and O 0 1.794813971923992e-12
cell O 0 5.688286994209868e-11
cycle O 0 1.0157502616792158e-10
profile O 0 2.7399834137686874e-11
of O 0 9.915090970480378e-11
these O 0 9.074941492714927e-11
cells O 0 7.435035365155329e-10
in O 0 2.2428534723895055e-11
culture O 0 7.45581096861514e-10
. O 0 1.4740546561142764e-09

The O 0 2.1978914332976274e-07
786 O 0 1.0060433623948484e-06
- O 0 5.4546898553553547e-08
0 O 0 9.285603397302111e-09
cell O 0 1.7213044323227678e-09
line O 0 1.0780203396620891e-08
, O 0 1.2736906147836624e-11
like O 0 5.443612227651329e-11
many O 0 1.1345570316567688e-10
cancer B-Disease 0 5.835227856465508e-09
cells O 0 2.0836517233835394e-10
, O 0 3.6738446486384024e-12
fails O 0 3.1166996761200494e-10
to O 0 3.2674928734932607e-11
exit O 0 4.767545913608728e-09
the O 0 3.9047664407432237e-11
cell O 0 1.514323944018514e-10
cycle O 0 7.761128545391571e-11
upon O 0 6.094998117323058e-11
serum O 0 2.3905604162877125e-09
withdrawal O 0 7.882032804218397e-09
. O 0 1.3650711672141824e-08

Here O 0 1.6004297265226342e-07
, O 0 1.3491327499615124e-10
it O 0 1.1455674733470977e-12
is O 0 1.301265410529051e-13
shown O 0 1.6214320738925508e-13
that O 0 4.467881617518758e-14
reintroduction O 0 1.3505931928392556e-09
of O 0 1.012720879378648e-10
the O 0 2.522656805670209e-10
wild O 0 1.5869268565893435e-08
- O 0 9.04805230739214e-10
type O 0 1.4239997625509204e-08
VHL B-Disease 0 0.0001123890615417622
gene O 0 3.4385483349552715e-09
restores O 0 7.050469008618165e-08
the O 0 7.065674156869761e-10
ability O 0 3.478621279917604e-10
of O 0 1.1619687434460957e-08
VHL O 1 1.0
- O 1 1.0
negative O 0 0.3156762719154358
RCC B-Disease 1 0.9996685981750488
cancer I-Disease 0 6.295756520557916e-07
cells O 0 3.447333252193374e-10
to O 0 9.176901426266593e-12
exit O 0 5.618803200491129e-10
the O 0 7.197361196614738e-12
cell O 0 2.4507519277849887e-11
cycle O 0 5.5182743791126754e-11
and O 0 1.767069823799261e-11
enter O 0 2.333372250973298e-08
G0 O 0 0.000205187956453301
/ O 0 4.499065653362777e-08
quiescence O 0 2.5691346650091873e-07
in O 0 7.362205289851431e-10
low O 0 1.558983875327158e-08
serum O 0 2.203086779672958e-08
. O 0 6.57914389634584e-09

Both O 0 1.8631675402502879e-06
VHL O 1 0.9999980926513672
- O 0 0.00023400639474857599
positive O 0 1.418834187916218e-07
and O 0 1.5049847590375975e-08
VHL O 1 0.9999998807907104
- O 0 0.000261846580542624
negative O 0 8.247438927355688e-07
RCC B-Disease 0 6.899525760672987e-05
cells O 0 2.7118286283212e-08
exit O 0 8.76882566558379e-09
the O 0 1.6061513230525293e-11
cell O 0 7.758197556606561e-11
cycle O 0 2.936972887113143e-11
by O 0 3.648697663449774e-12
contact O 0 6.450399658852746e-10
inhibition O 0 2.225991266868732e-07
. O 0 9.509454201861445e-08

The O 0 1.9147835246258182e-06
cyclin O 0 1.6163947293534875e-05
- O 0 6.9436231342479e-07
dependent O 0 1.3510299368135747e-07
kinase O 0 9.696253044921832e-08
inhibitor O 0 1.516363710152291e-07
, O 0 2.188722952878308e-10
p27 O 0 1.8168896076531382e-07
, O 0 3.432280501480811e-11
accumulates O 0 1.7775837746203393e-10
upon O 0 2.1350331225189478e-11
serum O 0 5.934273905605636e-11
withdrawal O 0 2.63415317336424e-10
, O 0 1.345949393605217e-12
only O 0 5.705111947099106e-13
in O 0 1.1313640996268859e-12
the O 0 2.306983597211154e-12
presence O 0 7.512532262943239e-12
of O 0 2.8254638628766315e-09
VHL B-Disease 1 0.9999996423721313
, O 0 1.2938508042736885e-09
as O 0 2.228211191945828e-11
a O 0 1.6972153662943995e-13
result O 0 3.704827677281086e-12
of O 0 6.545102567562244e-12
the O 0 1.3797697359652084e-11
stabilization O 0 8.446837007625163e-09
of O 0 1.6126699975416159e-09
the O 0 4.6759303096166605e-09
protein O 0 5.329581753699131e-08
. O 0 2.538398824469823e-08

We O 0 6.859283807614247e-09
propose O 0 5.58885737689252e-09
that O 0 4.338211647553214e-12
the O 0 3.632321110558223e-10
loss O 0 7.867883233814155e-09
of O 0 4.80376538547489e-09
wild O 0 1.2180409214579413e-07
- O 0 2.5409263582076846e-09
type O 0 1.8453283345820637e-08
VHL B-Disease 0 4.429445107234642e-05
gene O 0 2.779186603074635e-10
results O 0 2.0300801317763018e-10
in O 0 5.767973772219381e-12
a O 0 8.76506224371798e-13
specific O 0 1.4387023516970743e-10
cellular O 0 9.781621734816781e-09
defect O 0 6.5987362241060055e-09
in O 0 1.500288504541203e-10
serum O 0 7.499460963344973e-08
- O 0 1.0801221606016043e-07
dependent O 0 1.109084379891101e-07
growth O 0 2.3916184588301803e-09
control O 0 5.899709054624225e-10
, O 0 3.2370399763448354e-12
which O 0 7.836211714240537e-12
may O 0 4.481377491316607e-09
initiate O 0 2.0463716055019177e-07
tumor B-Disease 0 1.053090818459168e-05
formation O 0 5.834284593220218e-07
. O 0 8.903028714257744e-08

This O 0 2.0431796254882784e-09
is O 0 3.150130503670745e-11
corrected O 0 1.2494066892188016e-09
by O 0 1.0817902129645063e-11
the O 0 6.110095068789789e-11
reintroduction O 0 1.7458193113384368e-08
of O 0 9.676859313856312e-11
wild O 0 4.08537159657385e-09
- O 0 6.453426681929386e-10
type O 0 2.7314614570173035e-08
VHL B-Disease 1 0.999702513217926
, O 0 2.8640472216068247e-09
implicating O 0 1.1804773976109573e-06
VHL B-Disease 1 1.0
as O 0 7.490655207220698e-08
the O 0 2.1349211287713388e-09
first O 0 1.7407868202479193e-10
tumor B-Disease 0 7.9867561453284e-09
suppressor O 0 7.663359724574548e-09
involved O 0 6.01905938285574e-12
in O 0 1.4153811803141458e-11
the O 0 2.9543392038311467e-11
regulation O 0 1.8431114412464922e-09
of O 0 1.17948262268186e-10
cell O 0 2.315277691788964e-10
cycle O 0 3.352160216074651e-10
exit O 0 9.140558310249958e-10
, O 0 2.1410335256013407e-13
which O 0 4.848803514733921e-14
is O 0 1.5106232237327433e-13
consistent O 0 4.308461573621081e-11
with O 0 6.641502669005317e-13
its O 0 2.5043755264020362e-11
gatekeeper O 0 2.483012684351138e-09
function O 0 1.570904101244608e-10
in O 0 8.492805764204192e-11
the O 0 1.681193073643783e-09
kidney O 0 3.0878329653205583e-06
. O 0 4.697751521121063e-09
. O 0 9.610320539366057e-09

Piebaldism B-Disease 1 1.0
with O 0 0.0007738888380117714
deafness B-Disease 1 1.0
: O 0 1.2683294414728152e-09
molecular O 0 3.937451198421371e-10
evidence O 0 4.166500477964519e-11
for O 0 3.835240718758071e-12
an O 0 4.4664463100252405e-12
expanded O 0 9.361589036416262e-06
syndrome O 1 0.9999977350234985
. O 0 9.933701221598312e-06

In O 0 1.6376252576222328e-09
a O 0 5.13314946104515e-11
South O 0 5.343746001251759e-10
African O 0 8.190602363011834e-11
girl O 0 1.7131220053645535e-10
of O 0 4.388179056236119e-11
Xhosa O 0 1.2456625597678794e-07
stock O 0 6.710940692045142e-09
with O 0 6.327606624431659e-13
severe O 0 3.1546267820203866e-08
piebaldism B-Disease 1 0.7629041075706482
and O 0 5.715941711059713e-07
profound O 1 0.9999991655349731
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 2.0011609080938797e-07
identified O 0 1.78516076920765e-10
a O 0 1.1769285632873272e-12
novel O 0 5.377863085409551e-11
missense O 0 2.055045467130867e-09
substitution O 0 3.959913996709474e-08
at O 0 9.899487896092296e-10
a O 0 2.3264629805952453e-11
highly O 0 9.45080569358936e-10
conserved O 0 1.6340621078470008e-09
residue O 0 7.951825864438433e-09
in O 0 5.1847401372207e-11
the O 0 2.670657445191793e-11
intracellular O 0 2.8968378043559007e-11
kinase O 0 2.8486007996875173e-10
domain O 0 4.0656875088807e-10
of O 0 9.100756259705634e-10
the O 0 4.952945609204562e-09
KIT O 0 0.08746856451034546
proto O 0 1.7148278857348487e-05
- O 0 7.22980075806845e-06
oncogene O 0 3.1564982236886863e-06
, O 0 3.0717176024985804e-10
R796G O 0 6.977663815632695e-07
. O 0 1.8240662313928624e-08

Though O 0 2.4196097001549788e-06
auditory B-Disease 0 0.0021941671147942543
anomalies I-Disease 0 0.0002547194599173963
have O 0 1.0882666989786571e-09
been O 0 1.5473547443356495e-10
observed O 0 4.872101611042012e-10
in O 0 3.439773188507189e-10
mice O 0 1.0425116325762929e-09
with O 0 9.57570567977628e-12
dominant O 0 1.8477572893971228e-07
white O 0 1.046299402673867e-07
spotting O 0 5.351188974600518e-06
( O 0 6.783102551866094e-11
W O 0 1.2605744359461823e-07
) O 0 3.4006614798437473e-12
due O 0 2.9940673584860633e-07
to O 0 4.030975375712842e-08
KIT O 1 1.0
mutations O 0 0.0002517665270715952
, O 0 1.6418709947174648e-07
deafness B-Disease 1 1.0
is O 0 2.9360444631088e-10
not O 0 1.935589535873028e-11
typical O 0 1.1725342918822435e-09
in O 0 3.522196423411117e-11
human O 0 2.697232437398611e-10
piebaldism B-Disease 0 4.229806108924095e-06
. O 0 9.37778708021142e-08

Thus O 0 1.4278998428096656e-08
, O 0 5.519702750422795e-12
the O 0 3.6860362852275674e-12
occurrence O 0 8.619528979458835e-10
of O 0 2.927548621300957e-07
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 0.00016233965288847685
this O 0 9.303420256401296e-09
patient O 0 1.1659652443540836e-07
extends O 0 2.0510111664595598e-10
considerably O 0 1.4292232952684003e-09
the O 0 6.611163699821176e-11
phenotypic O 0 4.812878984239433e-10
range O 0 1.896362622488823e-09
of O 0 2.588535774616929e-10
piebaldism B-Disease 0 1.921446113328784e-07
due O 0 4.848096750720288e-07
to O 0 4.757816807199333e-09
KIT O 0 0.0002503628493286669
gene O 0 1.0235715386386346e-08
mutation O 0 5.5466018444860765e-09
in O 0 4.917105958512913e-11
humans O 0 2.6862509439062876e-10
and O 0 1.3936955756133074e-11
tightens O 0 1.3530531139949176e-09
the O 0 7.489615871936195e-11
clinical O 0 1.235899271812002e-09
similarity O 0 5.557940774281178e-10
between O 0 1.4930328084972189e-09
piebaldism B-Disease 0 0.0001534283219370991
and O 0 1.2309722685621693e-10
the O 0 6.592385925346944e-12
various O 0 1.3337239299082704e-12
forms O 0 3.769660694707966e-10
of O 0 5.92787969821984e-08
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 0.6854672431945801
. O 0 9.307342452302692e-09
. O 0 1.6854706075264403e-08

Cycloheximide O 0 1.8156913938582875e-05
facilitates O 0 9.185899152441834e-09
the O 0 1.868200871779635e-10
identification O 0 1.6411837444607613e-09
of O 0 2.1640871317174515e-09
aberrant O 0 6.243546124551358e-08
transcripts O 0 1.8022127123984433e-09
resulting O 0 1.3200317505734915e-09
from O 0 1.910389346715391e-10
a O 0 3.071552040490033e-11
novel O 0 1.6419382520282966e-09
splice O 0 1.7791909101561032e-07
- O 0 5.0802944073780054e-09
site O 0 1.2208484223563687e-09
mutation O 0 8.094884484943776e-11
in O 0 1.3730229626862656e-11
COL17A1 O 1 0.8943055868148804
in O 0 1.7856714717989774e-10
a O 0 2.7694485593698914e-11
patient O 0 1.1974777613943388e-08
with O 0 7.046264266508118e-11
generalized O 0 0.05651741102337837
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999591112136841
bullosa I-Disease 0 0.015350724570453167
. O 0 1.301609586334962e-06

Patients O 0 1.715964754112065e-05
with O 0 2.012585431643288e-09
generalized O 0 0.08860205113887787
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999997615814209
bullosa I-Disease 1 0.9897997379302979
often O 0 1.9494259539953873e-09
show O 0 3.945824222917338e-11
decreased O 0 3.993115282874271e-10
expression O 0 3.405570617176501e-11
of O 0 9.81248207687635e-11
type O 0 1.3186689784561167e-07
XVII O 1 0.9999994039535522
collagen O 0 4.761468971992144e-06
, O 0 8.401169204752534e-10
a O 0 2.1061311028525154e-10
transmembrane O 0 1.6274929182102937e-09
hemidesmosomal O 0 5.209360764979465e-08
protein O 0 1.1949012890255517e-09
encoded O 0 2.6471577707631866e-10
by O 0 4.4219067296680237e-10
COL17A1 O 0 0.0024457986000925303
. O 0 7.326853506128828e-07

This O 0 8.53682635693076e-09
report O 0 7.338371577070291e-10
documents O 0 9.08248232178721e-09
a O 0 4.508054762819569e-10
novel O 0 1.5324857827181404e-08
splice O 0 9.8362909284333e-07
- O 0 8.850554955586176e-09
site O 0 1.8772816634538003e-09
mutation O 0 1.122967829836341e-10
in O 0 6.743907949441352e-12
COL17A1 O 1 0.9937665462493896
in O 0 3.701645656661867e-10
a O 0 4.4871550919367564e-11
patient O 0 1.7896352844104513e-08
with O 0 6.793524770509762e-11
generalized O 1 0.9988540410995483
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999713897705078
bullosa I-Disease 0 0.0002353758318349719
, O 0 1.781616243423656e-10
and O 0 1.873259360130053e-11
applies O 0 1.0927819760198076e-10
a O 0 2.4674435671750983e-12
new O 0 5.867610564092018e-11
methodology O 0 1.0919510851081782e-09
to O 0 3.0495328484647644e-11
define O 0 2.607421389910769e-09
and O 0 2.4841911860917776e-10
characterize O 0 1.872887089859887e-08
the O 0 2.3149124839250135e-09
resulting O 0 3.4136657944827675e-08
mRNA O 0 1.3543012755690143e-07
splice O 0 3.5618322158370574e-07
variants O 0 2.2015955281062816e-08
. O 0 2.1205153188930126e-08

Mutational O 0 9.87424482445931e-06
analysis O 0 5.241950429279996e-09
of O 0 1.4867929998274576e-08
COL17A1 O 1 0.9999008178710938
identified O 0 3.0690149088741236e-08
a O 0 3.931492631448208e-10
maternally O 0 4.719884145742981e-07
inherited O 0 2.589719315437833e-06
G O 0 0.00013635490904562175
- O 0 2.931840015207854e-07
to O 0 2.0835344116676424e-08
- O 0 3.227637535019312e-06
T O 0 3.510001079121139e-06
transversion O 0 1.5371321637758228e-07
at O 0 4.909131087749152e-11
the O 0 7.668392830451065e-12
- O 0 1.8583697081187012e-11
1 O 0 1.61074167892572e-10
position O 0 1.4276776982846684e-10
of O 0 2.668398280114559e-10
exon O 0 2.9964294157025506e-08
32 O 0 2.1596925137146172e-08
. O 0 2.075680782809286e-08

This O 0 1.3907209606145443e-08
acceptor O 0 1.0439970310471836e-07
splice O 0 3.774132721900969e-07
- O 0 6.1091691705428275e-09
site O 0 1.2105900726311347e-09
mutation O 0 5.86373061217671e-10
led O 0 2.8629590365092383e-10
to O 0 5.108660456470959e-12
the O 0 3.671870793531262e-11
formation O 0 7.4949113582079e-09
of O 0 2.9998246109386173e-09
aberrant O 0 3.6713366569074424e-08
transcripts O 0 2.6277464648671867e-09
present O 0 2.583066260886113e-10
at O 0 5.378922307563982e-10
extremely O 0 1.2372065150145772e-08
low O 0 5.023389704206238e-08
levels O 0 3.149738958541093e-08
. O 0 3.819026428431016e-09

Based O 0 1.9716583210538374e-07
on O 0 5.205060205071277e-08
our O 0 8.730436928949814e-10
recent O 0 1.4651710400492846e-10
finding O 0 4.38296177129871e-10
that O 0 7.394466983168257e-12
cycloheximide O 0 5.6276585382875055e-06
stabilized O 0 0.00016456945741083473
mutant O 0 1.084425775843556e-06
COL17A1 O 0 7.789880328346044e-05
transcripts O 0 1.3757014194482053e-08
in O 0 8.532878570388647e-11
keratinocytes O 0 2.753540684352629e-08
homozygous O 0 3.895031519540737e-10
for O 0 5.282813683032961e-12
a O 0 1.8838760412753786e-11
frameshift O 0 3.016137029021593e-08
mutation O 0 1.1325014259710997e-09
, O 0 3.8621814080208594e-12
the O 0 1.5633975017359525e-11
effects O 0 1.1319017723110392e-08
of O 0 7.446040939385057e-08
the O 0 7.894855258427924e-08
splice O 0 2.0396664694999345e-06
- O 0 4.486169302708731e-08
site O 0 6.45540021437796e-09
mutation O 0 1.1681762501769555e-10
on O 0 2.895998198193528e-11
splicing O 0 1.7975850807872007e-09
of O 0 2.7873952035406546e-09
COL17A1 O 0 0.4591415524482727
transcripts O 0 2.9006404389519957e-08
were O 0 1.0550253032315382e-10
determined O 0 4.034861333934714e-11
using O 0 1.1986984321810112e-11
reverse O 0 4.912974471693587e-10
transcriptase O 0 1.0012354140220836e-10
polymerase O 0 1.3022381784022485e-10
chain O 0 3.216098914959886e-11
reaction O 0 6.334617552727906e-11
of O 0 3.984700625014881e-10
total O 0 3.724838840146738e-11
RNA O 0 4.8862539014926654e-11
from O 0 4.490149571600988e-12
keratinocytes O 0 3.4924978464800915e-09
incubated O 0 1.570560925756581e-08
for O 0 4.756314786469318e-11
2 O 0 4.682954912738069e-09
. O 0 2.284868516611027e-09

5 O 0 6.259786573536985e-07
h O 0 2.5337600462194132e-08
in O 0 2.2903037799615333e-10
the O 0 1.2653471326284915e-10
presence O 0 1.1677263322962261e-10
or O 0 5.412875703214581e-10
absence O 0 2.6473432512830186e-07
of O 0 1.2044412578404717e-08
10 O 0 1.4023712191502113e-09
microg O 0 1.670451865720679e-07
cycloheximide O 0 4.691195556461025e-07
per O 0 8.720891742086678e-08
ml O 0 1.4890769080011523e-06
. O 0 6.264086493956711e-08

Using O 0 1.2948622729602732e-10
this O 0 3.826438124687748e-11
approach O 0 1.553308948132326e-08
, O 0 1.1432525759413892e-10
an O 0 1.683062023083437e-11
abnormally O 0 4.678653908740671e-08
spliced O 0 6.86081502720981e-09
transcript O 0 1.9166469300557765e-08
was O 0 1.216311495966238e-09
identified O 0 4.965899566555798e-11
that O 0 2.3496674983296273e-13
contains O 0 1.9073655415507984e-12
an O 0 9.410908060865711e-14
extra O 0 2.259552094041606e-11
264 O 0 3.7734304569880806e-10
bases O 0 1.1014388706653833e-10
upstream O 0 4.620388072140713e-09
from O 0 2.054391101680153e-09
exon O 0 1.9406531492904833e-08
32 O 0 1.41647371609821e-09
, O 0 1.8983282827622627e-12
resulting O 0 9.832978181689711e-11
in O 0 2.6859316853977688e-11
a O 0 5.902463240392564e-11
premature O 0 7.867497231472953e-08
termination O 0 7.417180540869595e-07
codon O 0 8.035730729716306e-07
27 O 0 9.263483207178069e-07
bp O 0 1.4232399792035721e-07
downstream O 0 8.091330983006628e-08
from O 0 7.622698583453769e-10
the O 0 4.1437275832834075e-09
cryptic O 0 4.561773039313266e-07
splice O 0 1.2971138403372606e-06
site O 0 2.354505852508737e-07
. O 0 6.061340229734924e-08

Three O 0 3.894745859156501e-08
other O 0 4.97009988720265e-10
splice O 0 6.176470179752869e-08
variants O 0 6.210276293217021e-09
, O 0 1.6685283363293557e-11
including O 0 2.9850772461509356e-12
one O 0 6.733325919397459e-13
derived O 0 2.6518615428572367e-11
from O 0 1.529049803439264e-11
the O 0 3.8097101862089033e-11
skipping O 0 4.8975579147736426e-09
of O 0 1.2902651169710566e-09
exon O 0 1.978091290766315e-08
32 O 0 6.651277750790996e-09
, O 0 5.617600482010765e-11
were O 0 8.444819288300209e-10
also O 0 8.848149296580843e-11
identified O 0 1.975236418871873e-09
. O 0 2.8692049625078653e-08

These O 0 8.63346993895675e-09
results O 0 2.794469988742776e-09
indicate O 0 9.520934041162832e-10
the O 0 8.906140408493357e-11
usefulness O 0 6.736255553363435e-09
of O 0 9.302843217984247e-11
cycloheximide O 0 9.718286264615017e-08
treatment O 0 8.141908125480768e-08
in O 0 8.270412132915794e-11
evaluating O 0 7.480568386952768e-10
the O 0 3.5918983065652554e-11
abnormal O 0 1.9984769394909563e-10
processing O 0 4.118843044409459e-09
of O 0 4.757862104298738e-09
mRNA O 0 1.1974731428665564e-08
due O 0 3.9022637565722107e-07
to O 0 3.77361752956773e-10
splice O 0 1.248569390099874e-07
- O 0 4.037837619819129e-09
site O 0 6.877936553628672e-10
mutations O 0 4.482877957734388e-11
, O 0 1.4622214029869074e-12
because O 0 3.299810077961318e-11
( O 0 8.367403124542871e-12
i O 0 1.8389634259818877e-10
) O 0 4.421008264338111e-12
aberrant O 0 1.27486832202095e-09
splicing O 0 7.194349005423817e-10
often O 0 1.4855039073835563e-11
generates O 0 4.812855409347394e-12
a O 0 4.563606437191225e-13
premature O 0 1.374190206071546e-09
termination O 0 2.616230254659513e-08
codon O 0 1.1408772593313188e-08
, O 0 9.81836070779174e-11
( O 0 2.92307801227909e-12
ii O 0 1.7414832598205976e-07
) O 0 2.8299322954450368e-11
transcripts O 0 1.6913502820514736e-09
with O 0 1.0851109941145687e-11
premature O 0 2.1551460349655827e-07
termination O 0 1.3011674582230626e-07
codons O 0 4.492211935769319e-09
can O 0 5.84236062306509e-11
occur O 0 2.419675015907785e-10
at O 0 1.908601054978476e-10
low O 0 2.48916776079966e-09
or O 0 9.392000198393813e-12
undetectable O 0 9.679596013612013e-10
levels O 0 4.1312803178428226e-10
due O 0 2.311836944102197e-09
to O 0 1.639925001351017e-10
nonsense O 0 2.734545923033238e-09
- O 0 3.364047651555069e-10
mediated O 0 2.043935687368048e-09
mRNA O 0 6.37574826267695e-10
decay O 0 1.3049547220589375e-08
, O 0 2.6095072283571774e-12
and O 0 7.15691882927777e-13
( O 0 1.027592656690883e-13
iii O 0 6.749142578144074e-09
) O 0 3.3710070325432273e-12
the O 0 6.649203410091786e-11
levels O 0 3.031760398286565e-09
of O 0 1.8073856300482305e-10
these O 0 7.05456179583841e-11
transcripts O 0 2.441161162103356e-10
can O 0 2.8662890203673408e-12
be O 0 2.7032816089789247e-12
increased O 0 1.8689920444625585e-10
by O 0 2.3803764515051284e-10
cycloheximide O 0 2.4403490897384472e-05
. O 0 4.544036187326128e-07

A O 0 6.138466233096551e-07
deletion O 0 2.2869716076456825e-07
mutation O 0 3.6997224839296905e-08
in O 0 8.441630727773486e-10
COL17A1 O 1 0.9998658895492554
in O 0 7.111440880613884e-10
five O 0 2.0790931476444285e-11
Austrian O 0 1.2390012571472653e-08
families O 0 5.758523172194607e-11
with O 0 1.06256141038652e-11
generalized O 0 1.8886385078076273e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9942360520362854
bullosa I-Disease 0 0.00010048855619970709
represents O 0 2.2486381645592246e-09
propagation O 0 1.2151526895820552e-08
of O 0 1.9609895651750975e-10
an O 0 7.46661933670456e-12
ancestral O 0 6.682179787276255e-08
allele O 0 1.2192485598916392e-07
. O 0 2.8673776242271742e-08

Patients O 0 1.1026003448932897e-05
with O 0 2.9798936651559416e-09
generalized O 0 0.08684449642896652
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999998807907104
bullosa I-Disease 1 0.9991298317909241
, O 0 2.8996820500282183e-09
a O 0 4.051704458052363e-11
usually O 0 1.1245453873653943e-10
nonlethal O 0 7.730999129762495e-08
form O 0 3.775987966747607e-09
of O 0 8.532533257721298e-08
junctional B-Disease 1 0.9360317587852478
epidermolysis I-Disease 0 0.004098542965948582
bullosa I-Disease 0 8.498120587319136e-05
, O 0 1.8690776704133327e-10
have O 0 2.104022164828301e-11
generalized O 0 9.306490689198199e-09
blistering B-Disease 0 4.834569153899793e-07
, O 0 1.6063429475465796e-09
nail B-Disease 0 0.20162303745746613
dystrophy I-Disease 1 0.9999998807907104
, O 0 8.759618140175007e-06
patchy B-Disease 1 1.0
alopecia I-Disease 1 0.9999997615814209
, O 0 1.3116097541399085e-08
and O 0 4.730798934815539e-07
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 0.12565763294696808

Skin B-Disease 1 0.9999998807907104
fragility I-Disease 1 0.726375162601471
in O 0 7.97126364915357e-09
most O 0 8.958631753097634e-11
cases O 0 2.8674059654454354e-11
is O 0 2.839428995746185e-13
due O 0 2.7558881843248173e-09
to O 0 1.3160940393053266e-10
mutations O 0 2.409115407164819e-10
in O 0 2.851061747799477e-11
the O 0 4.7172672018591655e-11
gene O 0 3.7571668866365204e-12
encoding O 0 1.6309733563701911e-09
type O 0 1.0704678743422846e-06
XVII O 1 0.9999985694885254
collagen O 0 5.700350448023528e-05
( O 0 6.715883404950773e-09
COL17A1 O 0 0.2553423047065735
) O 0 1.5427819022306721e-09
. O 0 8.424375863569367e-09

Recently O 0 1.279916773455625e-06
, O 0 1.6034837901912624e-09
we O 0 8.978046778240767e-11
reported O 0 3.0332784894948617e-11
five O 0 2.500389001749981e-12
Austrian O 0 3.4005307458784273e-09
families O 0 3.075162693932931e-11
with O 0 2.3533702764311215e-11
generalized O 0 0.00010456860036356375
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 0.9999997615814209
bullosa I-Disease 1 0.9999775886535645
who O 0 9.72407079302684e-08
share O 0 2.2539197175319714e-09
the O 0 3.4232863765915056e-10
same O 0 4.845848167178701e-09
COL17A1 O 1 0.7598766088485718
mutation O 0 6.000524876981217e-07
. O 0 2.911382601666901e-08

Affected O 0 3.087697450609994e-06
individuals O 0 9.58494283942457e-10
in O 0 9.274589429786317e-10
three O 0 3.3392039133772755e-11
families O 0 1.100783006413586e-11
are O 0 6.911630556077908e-13
homozygous O 0 6.91299231400655e-12
for O 0 3.1030302025808476e-12
4003delTC O 0 5.628566945858893e-09
, O 0 9.09946250293725e-12
whereas O 0 1.5485898119393937e-09
those O 0 2.623093131592924e-10
in O 0 1.3545861654584712e-10
two O 0 9.442832800410361e-12
others O 0 2.1433197230913414e-11
are O 0 2.600851391892922e-12
compound O 0 1.816714889635307e-09
heterozygotes O 0 1.791425461306062e-07
. O 0 3.6778409651105903e-08

To O 0 1.178912523158715e-08
determine O 0 4.933879971247279e-09
if O 0 9.67255928130406e-11
the O 0 9.330636263626957e-11
occurrence O 0 6.671858066020775e-10
of O 0 2.8120916706342314e-10
4003delTC O 0 1.5658381258276677e-08
in O 0 1.6943803998747953e-11
these O 0 5.427260203749729e-12
unrelated O 0 4.052541080490357e-10
families O 0 2.053764927220647e-12
signifies O 0 1.3105024877779758e-11
propagation O 0 4.485497528960991e-10
of O 0 6.449101235678212e-12
an O 0 3.916189204519749e-13
ancestral O 0 4.880195358936135e-09
allele O 0 1.371948443740223e-09
or O 0 2.236754115259032e-10
a O 0 1.264980342696731e-10
mutational O 0 2.1997923340677517e-06
hot O 0 9.4471233751392e-06
spot O 0 1.4614910170962503e-08
, O 0 9.450761354057313e-12
haplotypes O 0 3.2564695384706965e-10
were O 0 5.621523038734644e-11
determined O 0 5.43010303388769e-10
for O 0 1.2679128580384003e-10
polymorphisms O 0 3.197625630946277e-08
both O 0 1.1164418278752919e-09
within O 0 1.2762727763515613e-08
and O 0 1.588344034075817e-08
flanking O 0 1.0992196621373296e-05
COL17A1 O 1 0.9999948740005493
. O 0 5.7346765061083715e-06

Five O 0 1.0688769691569178e-07
intragenic O 0 1.1233191798964981e-05
polymorphisms O 0 4.5064686560181144e-07
were O 0 5.9463127755066125e-09
chosen O 0 8.183365096670059e-09
based O 0 8.239744442306574e-10
on O 0 4.901782091337736e-09
their O 0 2.6877280401294e-09
informativeness O 0 1.8268490748596378e-05
. O 0 1.6234437794082623e-07

One O 0 4.287987298567941e-09
of O 0 4.887178439716422e-10
these O 0 2.858439700215154e-11
, O 0 3.821250173924318e-12
not O 0 3.0030316341272956e-12
previously O 0 1.2165267404551372e-10
reported O 0 1.273263092183008e-11
, O 0 1.8948664252255165e-12
was O 0 4.4992581882397076e-10
2988 O 0 6.171489985717926e-07
A O 0 1.0567345043455134e-07
or O 0 1.6119420465088297e-08
C O 0 0.005284560844302177
that O 0 1.341383167735577e-11
introduces O 0 2.5558422045435236e-10
a O 0 4.027885230212247e-12
new O 0 2.6176389181231663e-11
restriction O 0 3.989637953338843e-09
site O 0 5.236222011539837e-10
for O 0 5.6181788388176557e-11
Eco0109 O 0 2.876687631214736e-06
I O 0 1.3676371054316405e-05
. O 0 1.2567164731080993e-07

All O 0 9.856403693220273e-09
the O 0 1.946524275098227e-09
4003delTC O 0 1.7927311546372948e-07
alleles O 0 2.093368589584088e-09
showed O 0 2.819901256945201e-10
the O 0 1.8784617958345073e-11
same O 0 2.328513770688545e-11
haplotype O 0 9.757933350229564e-10
for O 0 3.036890877661236e-11
these O 0 1.946991040613355e-10
five O 0 1.2808047678003476e-10
polymorphic O 0 8.431613451875819e-08
markers O 0 9.876882245407614e-08
. O 0 6.404115282521161e-08

Fourteen O 0 2.835864279404632e-06
microsatellite O 0 2.67970153799979e-06
polymorphisms O 0 3.4530197012827557e-07
were O 0 6.347213865609547e-09
selected O 0 4.473051706810338e-09
based O 0 1.1340745703636301e-10
on O 0 1.4183391128241851e-09
their O 0 2.2456198012221762e-10
high O 0 9.809648204850419e-09
heterozygosity O 0 5.774236910838226e-07
and O 0 9.475330936536963e-11
their O 0 6.30399066281484e-11
location O 0 3.908471879476849e-10
within O 0 8.800589146318316e-10
10q23 O 0 6.599569246645842e-07
- O 0 1.5917960638489603e-07
q25 O 0 5.185936970519833e-06
near O 0 4.5450113361766853e-07
COL17A1 O 0 0.021691229194402695
. O 0 3.0842787168694485e-07

Three O 0 3.863308961626899e-08
families O 0 3.741832621528829e-09
shared O 0 1.9600854272994184e-09
microsatellite O 0 4.0238549559035164e-07
polymorphisms O 0 1.310132518028695e-07
covering O 0 1.1311355407883639e-08
at O 0 1.1123374443755552e-09
most O 0 4.751656290657991e-10
19 O 0 9.317480120785149e-10
cM O 0 1.2021295070496762e-09
, O 0 2.888576747586691e-12
whereas O 0 7.892193842895523e-11
the O 0 1.7592283185763335e-10
others O 0 1.1928398546690033e-10
shared O 0 2.417497868556495e-10
smaller O 0 6.486424730667295e-10
regions O 0 2.0559629554384173e-09
consistent O 0 2.997902814882991e-09
with O 0 3.3703510902288736e-12
cross O 0 1.9564241893199608e-10
- O 0 7.224986720011373e-10
over O 0 2.1621950757610975e-11
events O 0 7.459185179248262e-13
during O 0 1.628838231827745e-12
passage O 0 2.8957660921924422e-11
of O 0 1.361609826625032e-12
this O 0 2.517011772618094e-12
mutation O 0 2.8415556366234718e-11
through O 0 9.685624698108075e-12
several O 0 1.268814567301213e-11
generations O 0 1.977034314037951e-09
. O 0 9.842840320573032e-09

These O 0 3.6828812000067046e-08
results O 0 1.564187357416813e-08
indicate O 0 1.9894186298330396e-09
that O 0 4.049739710243472e-12
4003delTC O 0 7.832189119483246e-09
occurs O 0 1.0209538076066949e-10
on O 0 1.766678817127776e-11
a O 0 6.08759136849768e-13
single O 0 1.302602730540725e-11
ancestral O 0 8.718360255954849e-09
allele O 0 3.772136825119787e-09
. O 0 6.50019704728777e-10
. O 0 4.556222954477107e-09

The O 0 7.945437232592667e-07
haptoglobin O 0 8.435436029685661e-05
- O 0 2.191977046095417e-06
gene O 0 6.2557976576727015e-09
deletion O 0 4.820552401696432e-09
responsible O 0 7.036061178133934e-10
for O 0 6.636372007484681e-10
anhaptoglobinemia B-Disease 0 0.001765581895597279
. O 0 2.384565505053615e-06

We O 0 9.766469588612381e-08
have O 0 2.4656629515895645e-10
found O 0 1.2125600870604991e-11
an O 0 4.48906780888339e-13
allelic O 0 2.3914725755247446e-09
deletion O 0 9.349756524557051e-10
of O 0 3.033483908509993e-09
the O 0 3.054648800571158e-08
haptoglobin O 0 6.991442933212966e-05
( O 0 1.2682030425814617e-10
Hp O 0 4.0024277225825244e-09
) O 0 1.619369222050082e-11
gene O 0 3.325056549541294e-11
from O 0 1.5075142523190976e-10
an O 0 2.9236242333335882e-12
individual O 0 3.152787406146551e-11
with O 0 2.2860473930519376e-11
anhaptoglobinemia B-Disease 0 0.00047708218335174024
. O 0 1.3559158560383366e-06

The O 0 4.719852597645513e-07
Hp O 0 3.943630133562692e-07
gene O 0 1.6379033684899014e-09
cluster O 0 6.768298366210956e-09
consists O 0 1.2545928185225819e-10
of O 0 1.1342800310121248e-10
coding O 0 3.66594710143886e-09
regions O 0 5.852507456438616e-08
of O 0 1.680433115325286e-06
the O 0 3.3736491786839906e-06
alpha O 0 2.0333746419964882e-07
chain O 0 1.246340530780543e-10
and O 0 9.364542127854314e-12
beta O 0 1.1939506328051408e-10
chain O 0 6.4245956644948254e-12
of O 0 1.189340639862202e-11
the O 0 6.590981233012272e-11
haptoglobin O 0 4.554122767785884e-08
gene O 0 4.1264977546084936e-11
( O 0 7.736924707672788e-13
Hp O 0 1.5888058924051762e-10
) O 0 2.7176416499130607e-13
and O 0 4.362806556995613e-12
of O 0 1.1655500176122047e-10
the O 0 6.928219109525457e-10
alpha O 0 4.126714525654052e-09
chain O 0 6.660411111525377e-11
and O 0 2.7910205396830534e-11
beta O 0 7.261750090137298e-10
chain O 0 6.6095372230901e-11
of O 0 5.925825108388239e-11
the O 0 3.0754168656166314e-10
haptoglobin O 0 1.5837282774100458e-07
- O 0 2.691765699225357e-09
related O 0 7.689909153896224e-08
gene O 0 1.243299685427246e-09
( O 0 1.3453649652661603e-11
Hpr O 0 8.292395392572871e-08
) O 0 5.569258595961024e-12
, O 0 1.0281877779738657e-11
in O 0 4.5991231656383746e-11
tandem O 0 6.159150967022242e-09
from O 0 4.878647485995202e-10
the O 0 4.9909445465345925e-09
5 O 0 2.093493201016372e-08
side O 0 3.0652184790369574e-08
. O 0 2.4122080333199847e-08

Southern O 0 7.710243153269403e-06
blot O 0 1.2319139386818279e-05
and O 0 7.078060360043992e-09
PCR O 0 1.8453201278134657e-07
analyses O 0 7.908175447823851e-09
have O 0 2.4646130622474338e-11
indicated O 0 5.6228098566091234e-11
that O 0 1.38436300183703e-13
the O 0 5.471611445179159e-12
individual O 0 3.4694007649410663e-12
with O 0 4.175183419483086e-13
anhaptoglobinemia B-Disease 0 7.836824522655661e-08
was O 0 1.609127275870037e-09
homozygous O 0 1.5981335699244426e-10
for O 0 1.003272725313975e-11
the O 0 2.420990907747722e-10
gene O 0 3.0500678371847556e-11
deletion O 0 2.7463051277543116e-10
and O 0 1.0657769805577644e-10
that O 0 2.090831414253147e-12
the O 0 2.0914159293283774e-10
gene O 0 7.89491562402933e-12
deletion O 0 7.113404310032934e-11
was O 0 1.7676639318953136e-10
included O 0 1.0899239150097273e-10
at O 0 4.7884283344012957e-11
least O 0 3.89636500147672e-12
from O 0 1.455927219062847e-11
the O 0 1.1445683290034481e-10
promoter O 0 4.977884060508586e-08
region O 0 1.7312622446752357e-08
of O 0 5.390328183807469e-08
Hp O 0 3.4795678516275075e-07
to O 0 1.1928756293855258e-07
Hpr O 0 5.26263247593306e-05
alpha O 0 2.060596493436151e-08
but O 0 3.3445902297701835e-11
not O 0 1.2323882365994354e-11
to O 0 2.9631441744726317e-10
Hpr O 0 4.5739716370007955e-06
beta O 0 1.8236389109915763e-07
( O 0 2.678709198900009e-10
Hpdel O 0 3.360628170412383e-06
) O 0 8.475705137733769e-10
. O 0 1.4501232215025084e-08

In O 0 1.3826962685925537e-08
addition O 0 2.0552375357141273e-09
, O 0 1.1345570316567688e-10
we O 0 3.975876919359855e-11
found O 0 2.0030553604666324e-11
seven O 0 4.3571019188448634e-12
individuals O 0 3.9966370057181733e-13
with O 0 7.491751359903209e-13
hypohaptoglobinemia B-Disease 0 5.695129857485881e-06
in O 0 2.7965441073973807e-09
three O 0 5.370841271723492e-11
families O 0 6.523068109970387e-12
, O 0 3.7517799739324176e-13
and O 0 1.8012854662713407e-12
the O 0 2.91175000777244e-11
genotypes O 0 8.920906680032203e-09
of O 0 6.4403224975251305e-09
six O 0 1.9984769394909563e-10
of O 0 6.971658250698454e-10
the O 0 3.561433925547419e-10
seven O 0 1.4517731634910991e-11
individuals O 0 5.853586387306875e-13
were O 0 4.8445220057757865e-11
found O 0 1.8418118592766763e-12
to O 0 4.832097829504667e-12
be O 0 1.0785483617326008e-09
Hp2 O 0 0.0012749054003506899
/ O 0 4.55589633929776e-06
Hpdel O 0 0.0002502544957678765
. O 0 5.083088581159245e-07

The O 0 3.782492399295734e-07
phenotypes O 0 8.610176678303105e-07
and O 0 2.351909778042227e-09
genotypes O 0 9.880331219846994e-08
in O 0 1.4678702697779045e-10
one O 0 4.381218478288762e-12
of O 0 7.228397568004308e-12
these O 0 2.670274158039776e-12
three O 0 6.783793904223401e-13
families O 0 1.8454337450540814e-12
showed O 0 1.1299285292143413e-11
the O 0 2.1069698069586806e-11
father O 0 4.532903497000973e-10
to O 0 1.2223226597551928e-10
be O 0 7.465135176687454e-09
hypohaptoglobinemic B-Disease 0 0.023893659934401512
( O 0 1.8876573915083128e-10
Hp2 O 0 7.510124646614713e-07
) O 0 4.781343723725406e-12
and O 0 3.384253988159003e-11
Hp2 O 0 3.9613385638403997e-07
/ O 0 7.893541820180872e-09
Hpdel O 0 2.2599792828259524e-06
, O 0 7.069634461176477e-11
the O 0 8.639264303944572e-10
mother O 0 1.3736818349485702e-09
to O 0 6.143598824115415e-11
be O 0 8.374483884132644e-10
Hp2 O 0 5.228905502008274e-05
- O 0 6.891967530009424e-08
1 O 0 8.087655878341593e-09
and O 0 1.5872634803737462e-11
Hp1 O 0 2.2673961552754918e-07
/ O 0 1.5485071003240591e-09
Hp2 O 0 8.106328550638864e-07
, O 0 2.4955352020961108e-11
one O 0 2.486155595629591e-12
of O 0 6.045894340722668e-11
the O 0 2.7905322497190355e-10
two O 0 5.156268467754188e-11
children O 0 2.37372864420049e-11
to O 0 3.4806951158122823e-12
be O 0 2.934420761935286e-10
hypohaptoglobinemic B-Disease 0 0.00020994471560698003
( O 0 2.4556004452058744e-10
Hp2 O 0 4.153651389060542e-06
) O 0 2.0520744825613946e-11
and O 0 1.206700434019936e-10
Hp2 O 0 5.879802301933523e-06
/ O 0 5.871324404438383e-08
Hpdel O 0 6.795844092266634e-05
, O 0 2.8825639097895817e-10
and O 0 9.739929002217096e-11
the O 0 6.160957299883307e-10
other O 0 1.3208671656439464e-10
child O 0 3.0806240891578796e-10
to O 0 1.1271667627044124e-11
be O 0 2.8980604027672996e-10
Hp1 O 0 1.827218511607498e-05
and O 0 4.305459544440282e-09
Hp1 O 0 7.807744259480387e-05
/ O 0 1.0816972917382373e-07
Hpdel O 0 6.1100272432668135e-06
, O 0 2.58631380201102e-11
showing O 0 3.19984767849224e-11
an O 0 8.19256229696308e-13
anomalous O 0 2.3312421149057627e-07
inheritance O 0 1.0742603990365751e-05
of O 0 1.5818475276319077e-06
Hp O 0 2.886765287257731e-06
phenotypes O 0 8.939764484239276e-06
in O 0 1.5067618264197336e-09
the O 0 4.755482674312361e-10
child O 0 6.530431750917387e-10
with O 0 1.892046762319577e-11
Hp1 O 0 0.00011711751722032204
. O 0 7.271811455211719e-07

The O 0 5.119102297612699e-07
Hp2 O 0 0.0005756628233939409
/ O 0 2.3963950752659002e-06
Hpdel O 0 4.720001379610039e-05
individuals O 0 9.429973468755293e-10
had O 0 9.159896174892879e-10
an O 0 1.878364000798549e-12
extremely O 0 1.402665428251737e-09
low O 0 1.2554534301045805e-08
level O 0 3.90265597616235e-09
of O 0 1.4806003090228614e-09
Hp O 0 3.3994492554256794e-08
( O 0 3.6683354270872215e-11
mean O 0 4.070950243573179e-09
+ O 0 3.1287550328329417e-10
/ O 0 2.4106416862679225e-10
- O 0 1.0319394228019974e-09
SD O 0 5.023389704206238e-08
= O 0 2.0434047509620967e-10
0 O 0 2.478270644257208e-10
. O 0 9.93075760513662e-12
049 O 0 7.391403933354468e-09
+ O 0 1.1064479887856749e-10
/ O 0 2.3264330739625194e-10
- O 0 3.90918741821622e-10
0 O 0 3.448483998358398e-10
. O 0 3.5147321251344232e-12
043 O 0 1.095234836157033e-08
mg O 0 2.3360742229527887e-09
/ O 0 2.6084448490060197e-10
ml O 0 7.447667482729514e-10
; O 0 1.1850247345901455e-11
n O 0 3.6018601295984e-11
= O 0 8.522544649169905e-12
6 O 0 2.987636180118436e-11
) O 0 6.839291638452774e-14
, O 0 3.032395840506241e-13
compared O 0 4.6971017353403255e-11
with O 0 1.912443727686286e-12
the O 0 8.953580099557712e-10
level O 0 1.9485495883486692e-08
( O 0 1.154023925031833e-12
1 O 0 1.2396217385912678e-10
. O 0 7.014159652402041e-12
64 O 0 1.38646857883451e-10
+ O 0 3.8430335302930274e-11
/ O 0 1.8271112400825018e-10
- O 0 3.3574387714452314e-10
1 O 0 1.7865844914588536e-10
. O 0 4.171595794494332e-12
07 O 0 1.051036924160087e-09
mg O 0 2.3874620058705887e-09
/ O 0 3.6582059603773587e-10
ml O 0 7.156438774913454e-10
) O 0 2.2232800182039186e-13
obtained O 0 1.3496081856245734e-11
from O 0 2.345645622181536e-10
52 O 0 3.131014736368343e-08
healthy O 0 1.6285991222275698e-08
volunteers O 0 3.3691976986105487e-10
having O 0 9.256206218166696e-11
phenotype O 0 6.659162465894042e-08
Hp2 O 0 3.919677055819193e-06
, O 0 6.83140141677363e-11
whereas O 0 4.669342135166232e-10
the O 0 1.1139165284612673e-10
serum O 0 1.3464984682798331e-09
Hp O 0 1.1167166080738866e-09
level O 0 1.1740693972583927e-09
of O 0 3.4531093262568646e-11
an O 0 3.962752706272027e-13
individual O 0 2.1197104401599054e-12
with O 0 2.2119157633976316e-12
Hp1 O 0 1.2111067007936072e-05
/ O 0 1.8262949197378475e-07
Hpdel O 0 1.1229346455365885e-05
was O 0 4.6041765955351366e-08
0 O 0 7.543949465116384e-08
. O 0 3.6094491839833154e-09

50 O 0 8.450950161886794e-08
mg O 0 2.088213761908264e-07
/ O 0 1.92174258728528e-08
ml O 0 7.866972140391226e-08
, O 0 1.1124211794777406e-11
which O 0 2.662446001513996e-13
was O 0 7.999519449630732e-12
approximately O 0 4.856099246677847e-13
half O 0 3.123743017724445e-12
the O 0 6.727706933218336e-12
level O 0 2.0302395320470623e-09
of O 0 1.3052452452200214e-09
Hp O 0 1.0185567056453237e-08
in O 0 1.5699342936770222e-09
control O 0 4.503126405097646e-08
sera O 0 6.175054689805393e-09
from O 0 8.468057505206517e-11
the O 0 6.067060742687147e-10
Hp1 O 0 6.582073183380999e-06
phenotype O 0 8.533379514119588e-08
( O 0 4.1248588746045645e-12
1 O 0 1.2542268612580898e-10
. O 0 3.555667696039655e-12
26 O 0 3.694902162010294e-10
+ O 0 9.73931560399599e-11
/ O 0 2.1094961888401542e-10
- O 0 5.288757209953587e-10
0 O 0 2.959456013584827e-10
. O 0 2.6219200421895295e-12
33 O 0 5.649211307079405e-11
mg O 0 1.59048885173263e-10
/ O 0 4.270320555499474e-11
ml O 0 2.849742108956832e-10
; O 0 3.6234533169060557e-12
n O 0 2.2989816647611683e-11
= O 0 8.793398301176758e-12
9 O 0 6.90842244521761e-11
) O 0 4.639541788947765e-13
, O 0 1.8672086446458458e-12
showing O 0 4.561940061820202e-11
a O 0 2.492813941379346e-11
gene O 0 4.333369496567485e-10
- O 0 1.3437897905532736e-08
dosage O 0 1.4530613043461926e-05
effect O 0 9.637712537369225e-06
. O 0 3.1121592769522977e-07

The O 0 4.295700506418143e-08
other O 0 1.8089556519385042e-09
allele O 0 2.1065540423137463e-09
( O 0 9.633448552759383e-12
Hp2 O 0 1.413980754705335e-07
) O 0 2.8164903135424746e-12
of O 0 2.1862475371725587e-11
individuals O 0 2.4988203780468288e-12
with O 0 1.1373449057550111e-11
Hp2 O 0 0.20199976861476898
/ O 0 1.5580438912365935e-06
Hpdel O 0 0.0011242792243137956
was O 0 7.930560208535553e-09
found O 0 1.8333451076713025e-11
to O 0 7.711162437751273e-12
have O 0 4.858066206259171e-12
, O 0 1.37696397253112e-12
in O 0 8.315963369309731e-12
all O 0 4.624050795043466e-11
exons O 0 3.435138007379379e-10
, O 0 1.906499914536286e-12
no O 0 1.0110912974925501e-11
mutation O 0 1.61047668256753e-11
, O 0 5.876127492573935e-13
by O 0 9.921783013233654e-12
DNA O 0 7.164281612404011e-09
sequencing O 0 2.1010140471844352e-07
. O 0 1.0632182778635979e-07

On O 0 1.1542886113602435e-07
the O 0 4.726960489698229e-10
basis O 0 8.802536477503509e-10
of O 0 1.318742615108448e-10
the O 0 5.1038125115088206e-11
present O 0 7.806528340426055e-11
study O 0 2.1508590047902842e-11
, O 0 2.0791662391338867e-13
the O 0 2.8180754171186484e-12
mechanism O 0 3.1390962051958127e-10
of O 0 5.293349092383437e-10
anhaptoglobinemia B-Disease 0 3.912348984158598e-05
and O 0 3.8830594295546916e-10
the O 0 1.305625607628258e-10
mechanism O 0 5.801277791483983e-10
of O 0 3.287229100035205e-10
anomalous O 0 7.190376436483348e-07
inheritance O 0 5.795708943878708e-07
of O 0 3.958003702564383e-08
Hp O 0 1.9229932490816282e-07
phenotypes O 0 3.877729795931373e-06
were O 0 1.2893703882355112e-08
well O 0 1.2922007908144906e-09
explained O 0 8.768189729835285e-09
. O 0 6.634122584614488e-09

However O 0 1.807949985277446e-07
, O 0 1.5561363309046783e-10
the O 0 8.388387900959415e-11
mechanism O 0 2.5744746334765978e-09
of O 0 2.0367674213872533e-09
hypohaptoglobinemia B-Disease 0 0.001496163080446422
remains O 0 8.076363883446902e-06
unknown O 0 2.8236822799954098e-06

ATM O 0 0.0004143720434512943
mutations O 0 4.5751616539746465e-07
and O 0 2.9556270764174997e-09
phenotypes O 0 1.8320284880246618e-06
in O 0 2.573627284618851e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 1.2879894484285614e-07
in O 0 2.3346153135705983e-11
the O 0 4.352965037035528e-12
British O 0 3.578379606516968e-11
Isles O 0 2.476173932564052e-09
: O 0 1.540433254045015e-12
expression O 0 1.514889429177213e-11
of O 0 2.438367910362338e-11
mutant O 0 3.416398275390975e-10
ATM O 0 7.365874576947817e-09
and O 0 5.32698722372632e-13
the O 0 6.237971836124678e-13
risk O 0 1.4840076867014829e-12
of O 0 8.965019698825571e-12
leukemia B-Disease 0 0.051471225917339325
, O 0 1.1947925315780594e-08
lymphoma B-Disease 1 1.0
, O 0 8.428367436863482e-06
and O 0 0.0014669604133814573
breast B-Disease 1 0.9999994039535522
cancer I-Disease 1 0.6536926031112671
. O 0 2.9477098451025086e-06

We O 0 1.7322662415608647e-08
report O 0 4.0741332529847796e-10
the O 0 2.3916857383454726e-10
spectrum O 0 2.3477204180721856e-08
of O 0 5.032619876388367e-10
59 O 0 5.704068328782341e-09
ATM O 0 1.1709592406816682e-08
mutations O 0 2.7121555001841102e-11
observed O 0 1.215858663750069e-10
in O 0 7.53699946898223e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.2137337762396783e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.054003577807052e-11
patients O 0 6.160722487713599e-10
in O 0 9.50308625194407e-13
the O 0 1.7073080796348172e-11
British O 0 1.1118028719891981e-09
Isles O 0 2.6315404966226197e-07
. O 0 5.028460847711358e-08

Of O 0 1.8662973161553964e-05
51 O 0 6.1333503253990784e-06
ATM O 0 2.538478838687297e-05
mutations O 0 3.021117578327903e-08
identified O 0 1.5563300648224754e-09
in O 0 3.7622549520222037e-10
families O 0 2.718392455580698e-10
native O 0 5.018679916091173e-11
to O 0 2.454137370752618e-12
the O 0 4.03663942549759e-11
British O 0 4.508278472759031e-10
Isles O 0 4.026050248739921e-08
, O 0 2.8151061343129058e-11
11 O 0 9.49528580762582e-11
were O 0 5.345753839591794e-10
founder O 0 3.992264296925896e-09
mutations O 0 1.1018674861418276e-10
, O 0 3.096558079396239e-11
and O 0 5.966540456148195e-11
2 O 0 1.8580383898125774e-09
of O 0 1.733851257013086e-10
these O 0 8.061404321857424e-11
11 O 0 3.5475875709289895e-11
conferred O 0 5.299218286403118e-10
a O 0 6.095216345536336e-12
milder O 0 6.499298024209565e-07
clinical O 0 4.001650921736655e-08
phenotype O 0 7.338781582433285e-09
with O 0 1.3619994888858233e-12
respect O 0 1.3226823802892085e-10
to O 0 1.8933474232873948e-10
both O 0 1.696430018682804e-08
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 0 6.795945409976412e-06
cellular O 0 9.001755785220666e-08
features O 0 4.224534611019237e-10
. O 0 2.1693851159909627e-09

We O 0 3.489528221933824e-09
report O 0 1.4059431396873379e-10
, O 0 1.0790391150039547e-11
in O 0 1.5765824409874618e-11
two O 0 1.8898646536591457e-11
A B-Disease 1 1.0
- I-Disease 1 0.9997952580451965
T I-Disease 1 1.0
families O 0 8.688839647774671e-10
, O 0 3.3181476229854345e-13
an O 0 7.962004672104964e-14
ATM O 0 6.362789850555828e-09
mutation O 0 1.3063206072416733e-10
( O 0 1.1873182558658213e-12
7271T O 0 1.1129087873484877e-08
- O 0 9.276646117939435e-09
- O 0 1.219913237093806e-08
> O 0 2.21552625134791e-08
G O 0 1.1536168464942875e-08
) O 0 7.397675408447185e-14
that O 0 1.9779947265600312e-14
may O 0 2.992276999097543e-12
be O 0 1.517499992852167e-12
associated O 0 1.1024539614545859e-10
with O 0 8.660880172761676e-13
an O 0 1.7870930158880166e-13
increased O 0 9.429451663933719e-10
risk O 0 7.302672688780376e-09
of O 0 5.729422625222469e-08
breast B-Disease 0 0.006012121681123972
cancer I-Disease 0 8.76824287843192e-06
in O 0 3.810048276875477e-09
both O 0 5.339285902294932e-09
homozygotes O 0 2.1569184127656627e-07
and O 0 3.0005270490462976e-10
heterozygotes O 0 6.6241336860173305e-09
( O 0 1.647214916550288e-12
relative O 0 1.0393369498373772e-09
risk O 0 9.408696738377742e-11
12 O 0 3.926819806820969e-12
. O 0 7.277698951292655e-13
7 O 0 4.743884104985163e-11
; O 0 7.658278525224382e-12
P O 0 2.58631267513465e-08
= O 0 2.243422461689626e-11
. O 0 5.414088448396637e-12
0025 O 0 1.2664269632978176e-09
) O 0 6.343421610471162e-14
, O 0 3.8819926548479267e-14
although O 0 1.3261190106098053e-12
there O 0 6.359743461026302e-13
is O 0 5.787948245683516e-14
a O 0 3.386303824154391e-13
less O 0 1.0280966078468623e-09
severe O 1 0.9805578589439392
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 1.4922306945663877e-08
in O 0 1.733309676343886e-13
terms O 0 4.800101288671144e-13
of O 0 6.57458638854587e-14
the O 0 7.626842544019088e-14
degree O 0 4.516193669035218e-11
of O 0 6.240266081647405e-10
cerebellar B-Disease 1 0.9999998807907104
degeneration I-Disease 1 1.0
. O 0 7.184916466940194e-05

This O 0 1.416128547759854e-08
mutation O 0 8.922047101123098e-09
( O 0 1.0899545155318435e-11
7271T O 0 1.5405214881525353e-08
- O 0 2.9613829166663663e-09
- O 0 2.481715277724561e-09
> O 0 6.774149241550731e-09
G O 0 8.959460728874546e-09
) O 0 1.3019331435420306e-13
also O 0 3.190068380894834e-14
allows O 0 3.704766934854373e-14
expression O 0 1.6359806304794278e-12
of O 0 1.3627278125372122e-11
full O 0 4.384648547017811e-11
- O 0 1.0323464305628249e-10
length O 0 1.0729955118859991e-10
ATM O 0 1.8253190958716914e-08
protein O 0 7.088618581008177e-11
at O 0 1.6547419684487252e-11
a O 0 5.895042483675117e-13
level O 0 3.937877454673888e-11
comparable O 0 4.650659024552084e-10
with O 0 3.444547435910855e-13
that O 0 6.683845642750652e-13
in O 0 5.2823325574768987e-11
unaffected O 0 1.935017337473255e-07
individuals O 0 1.1405628524974176e-10
. O 0 8.981926313822441e-09

In O 0 1.8801269430213097e-09
addition O 0 2.1193971577737614e-10
, O 0 8.61981666600009e-12
we O 0 1.6372355944940797e-12
have O 0 4.337480895288959e-13
studied O 0 7.020627829090742e-11
18 O 0 1.3877947679930003e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.5335535863414407e-05
, O 0 2.0076814017701283e-13
in O 0 1.0303914568365186e-13
15 O 0 2.613801102641089e-12
families O 0 3.384805727802559e-13
, O 0 1.2939345775397904e-13
who O 0 3.0892454393194324e-13
developed O 0 1.5487138238512443e-09
leukemia B-Disease 1 1.0
, O 0 1.9181884454155806e-06
lymphoma B-Disease 1 1.0
, O 0 5.018007982471318e-07
preleukemic O 1 0.9995724558830261
T O 0 0.017924755811691284
- O 0 2.5486984966960335e-08
cell O 0 1.7824600684335223e-09
proliferation O 0 3.2443943087656635e-09
, O 0 2.387767934763918e-12
or O 0 2.0935682076839157e-09
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 8.762208381085657e-08
mostly O 0 1.0336058675619597e-09
in O 0 9.705268533277689e-11
childhood O 0 2.8395119144875025e-08
. O 0 1.995557319389718e-08

A O 0 5.506839443114586e-06
wide O 0 3.215877484308294e-07
variety O 0 7.203043939085774e-09
of O 0 1.0081408596818164e-08
ATM O 0 8.186129321074986e-07
mutation O 0 1.3797817333127682e-09
types O 0 1.37841393854643e-09
, O 0 1.3113925743934995e-11
including O 0 1.777671898572919e-10
missense O 0 4.5647368551726686e-07
mutations O 0 4.51154935632303e-09
and O 0 5.091758126241075e-10
in O 0 1.107122060695076e-09
- O 0 9.221992947061608e-09
frame O 0 1.457090625933688e-08
deletions O 0 1.5409446163516805e-08
, O 0 8.76368283497797e-11
were O 0 7.057781026276189e-10
seen O 0 5.449556916836684e-10
in O 0 3.295545780712672e-11
these O 0 8.558391217938777e-10
patients O 0 1.5873354186624056e-08
. O 0 5.312721818029331e-09

We O 0 3.739829423921037e-08
also O 0 1.2496373380521675e-10
show O 0 3.362440534337985e-12
that O 0 4.647563394246171e-14
25 O 0 4.285854657282151e-12
% O 0 6.41008784680458e-13
of O 0 4.6212794875544194e-12
all O 0 1.137981306409408e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 0.00015860535495448858
carried O 0 4.968988068232427e-11
in O 0 1.3128591963562641e-11
- O 0 8.058852196679567e-11
frame O 0 3.0941402773265736e-09
deletions O 0 3.726250952240662e-08
or O 0 4.347961990447402e-08
missense O 0 2.370032916587661e-06
mutations O 0 3.891142963396987e-09
, O 0 1.8650346891857517e-11
many O 0 2.7627837084071016e-12
of O 0 1.92458236847326e-11
which O 0 1.6615185789714548e-12
were O 0 2.6245131068414196e-11
also O 0 2.676049757222715e-13
associated O 0 1.826267088944622e-11
with O 0 3.0749853618255996e-12
expression O 0 9.099644926457984e-10
of O 0 4.30182289790082e-09
mutant O 0 1.6858410845088656e-07
ATM O 0 4.490193987294333e-06
protein O 0 1.1397217036801521e-07
. O 0 2.787449915331308e-08

The O 0 2.4365454009966925e-07
DMPK O 1 0.9977127313613892
gene O 0 3.1503222430728783e-07
of O 0 2.869429920338007e-07
severely O 1 0.9999963045120239
affected O 1 0.9999957084655762
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.999548614025116
is O 0 1.7913172334349525e-10
hypermethylated O 0 2.6863926905207336e-07
proximal O 0 8.904358764993958e-06
to O 0 3.165999462595437e-09
the O 0 7.739095586600797e-09
largely O 0 1.6645995515318646e-07
expanded O 0 1.0219624613228007e-07
CTG O 0 0.00012727535795420408
repeat O 0 1.2822895314457128e-06
. O 0 2.1331764799015218e-07

Using O 0 6.186303380673053e-08
methylation O 0 2.3213572148961248e-06
- O 0 4.5169028339842043e-07
sensitive O 0 9.78920070338063e-07
restriction O 0 1.2039342323078017e-07
enzymes O 0 1.558110085397857e-08
, O 0 4.155151570039983e-11
we O 0 3.0140492966040933e-12
characterized O 0 2.1529030294620277e-11
the O 0 3.3854093139940034e-11
methylation O 0 1.6419257065081183e-09
pattern O 0 2.3896578049686923e-09
on O 0 1.0638542269347795e-09
the O 0 9.650777399450305e-11
5 O 0 6.808351799003631e-11
side O 0 6.631547394553294e-11
of O 0 1.4490848798676126e-10
the O 0 1.0921301640820502e-09
CTG O 0 1.9005983631359413e-06
repeat O 0 1.2400952487112704e-09
in O 0 7.888883296613969e-11
the O 0 1.8925314093642953e-10
DMPK O 0 4.9402860895497724e-06
gene O 0 5.5629230388820616e-11
of O 0 6.012487729911697e-11
normal O 0 2.49030751575674e-09
individuals O 0 1.2125409183660896e-12
and O 0 2.0627273760592812e-12
of O 0 5.772213609867016e-11
patients O 0 3.689748728774589e-09
affected O 0 3.1337374917228544e-09
with O 0 2.218950800880748e-09
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 1.1746965622450034e-09
showing O 0 1.9563009545642274e-10
expansions O 0 7.839687232724657e-10
of O 0 3.4684780048088726e-10
the O 0 8.490089187240812e-10
repetitive O 0 2.1301712394006245e-08
sequence O 0 4.805687514597423e-10
. O 0 6.232502069991597e-09

The O 0 3.364654901361064e-07
gene O 0 2.846701319114686e-09
segment O 0 2.594557679813647e-09
analyzed O 0 2.791746001040707e-10
corresponds O 0 3.0703820041999563e-10
to O 0 4.097861980301154e-11
the O 0 3.5181160762398633e-10
genomic O 0 8.770865811413842e-09
SacI O 0 1.0108404921993497e-06
- O 0 5.497384769626024e-09
HindIII O 0 9.273342271853835e-08
fragment O 0 1.8465562412472991e-09
carrying O 0 1.1799400345680056e-09
exons O 0 8.586781063968374e-09
11 O 0 1.8665420320473913e-09
- O 0 5.364038990762765e-09
15 O 0 6.056565471368458e-09
. O 0 3.332335962724642e-09

There O 0 1.9445362653414122e-08
is O 0 3.0869412581679967e-10
constitutive O 0 8.52862513056607e-07
methylation O 0 2.093913963108207e-06
in O 0 2.71053153255707e-07
intron O 0 5.081691142549971e-06
12 O 0 1.2056503351232095e-08
at O 0 1.4428189198945063e-10
restriction O 0 4.177167056695907e-09
sites O 0 1.5141399245521825e-09
of O 0 1.3147800626001072e-09
SacII O 0 1.6801554011180997e-05
and O 0 4.743146764241146e-09
HhaI O 0 7.38389280741103e-06
, O 0 8.053105404748351e-11
localized O 0 3.815975535559346e-09
1 O 0 2.840242041557417e-09
, O 0 4.753872642759838e-12
159 O 0 1.1046120684810035e-09
- O 0 4.324848534853487e-10
1 O 0 2.2733053217649513e-09
, O 0 1.0399129474203406e-11
232 O 0 1.3512425622863589e-09
bp O 0 1.3474439342076039e-09
upstream O 0 1.3385145214428462e-09
of O 0 5.312799644663357e-10
the O 0 2.9162827708262284e-09
CTG O 0 3.502804929667036e-06
repeat O 0 3.6357259425301436e-09
, O 0 1.869536470078259e-11
whereas O 0 1.52885801241176e-10
most O 0 6.580300974251552e-12
, O 0 2.536485561518975e-13
if O 0 5.249543746747853e-13
not O 0 4.0037652013213965e-12
all O 0 1.5315979387531264e-11
, O 0 1.9713829093465085e-12
of O 0 1.876327565542013e-11
the O 0 2.3479003463666714e-11
other O 0 1.80911167123321e-12
sites O 0 2.256911844911169e-11
of O 0 7.076460251109751e-11
SacII O 0 5.041334247835039e-07
, O 0 8.430604825360177e-11
HhaI O 0 2.0450852389330976e-06
, O 0 1.621913992000401e-10
and O 0 4.377205542471785e-10
HpaII O 0 6.960895461816108e-06
in O 0 7.970970550275069e-10
this O 0 1.3831062684044326e-10
region O 0 6.840522814854921e-09
are O 0 5.835489036432051e-11
unmethylated O 0 1.576260011404429e-08
, O 0 8.846351385802254e-13
in O 0 2.8281934086327176e-12
normal O 0 1.2594629783535538e-09
individuals O 0 2.8111716513651297e-12
and O 0 6.987453584489378e-12
most O 0 9.548421948946118e-12
of O 0 7.589603251423327e-11
the O 0 8.323240430208045e-10
patients O 0 4.286664534447482e-08
. O 0 4.248948748397652e-09

In O 0 2.7638999977597223e-09
a O 0 2.219473389797333e-11
number O 0 4.0308152648993456e-11
of O 0 1.1723821913278698e-09
young O 0 5.456445517637576e-09
and O 0 2.1124636762070992e-10
severely O 0 8.217792810683022e-07
affected O 0 6.220883506102837e-07
patients O 0 7.606723102071555e-06
, O 0 1.9902897038792666e-11
however O 0 7.922196232357237e-10
, O 0 2.074814799135627e-11
complete O 0 7.551644864989271e-10
methylation O 0 2.3418124328600243e-08
of O 0 3.962110639577077e-09
these O 0 9.079199891903755e-11
restriction O 0 9.032172232359414e-10
sites O 0 5.3203618594066526e-11
was O 0 2.6848509526722353e-11
found O 0 2.1949620940264758e-12
in O 0 8.122301442536894e-12
the O 0 2.409317745311057e-10
mutated O 0 4.4379142138950556e-08
allele O 0 8.206438906199764e-08
. O 0 3.965529771221554e-08

In O 0 1.6791815937722276e-08
most O 0 1.676542793482838e-10
of O 0 2.6955082263468988e-11
these O 0 1.3876478091590094e-11
patients O 0 1.8616558294937136e-10
, O 0 4.724544458998073e-14
the O 0 7.039043284882973e-13
onset O 0 7.399405888008914e-08
of O 0 1.2550009920175853e-08
the O 0 1.6840414218677324e-07
disease O 1 0.9246936440467834
was O 0 1.0247931641060859e-05
congenital O 1 1.0
. O 0 5.679780224454589e-05

Preliminary O 0 4.651692961488152e-06
in O 0 6.158437315662013e-08
vivo O 0 8.932520358939655e-07
footprinting O 0 2.647473411343526e-05
data O 0 3.292508043983844e-09
gave O 0 1.9921289617919058e-10
evidence O 0 1.9766561998313392e-10
for O 0 3.7432133781489796e-11
protein O 0 1.2360359402663335e-09
- O 0 1.1952773215639922e-09
DNA O 0 1.7264009111173095e-09
contact O 0 1.0905248232218057e-10
in O 0 1.3442576218825053e-10
normal O 0 3.3022584489117435e-07
genes O 0 9.136444933943721e-10
at O 0 7.907081239766356e-11
an O 0 1.282857283943506e-12
Sp1 O 0 1.0351254964291456e-08
consensus O 0 4.425680266706422e-09
binding O 0 5.963235683026369e-09
site O 0 4.309477219521796e-09
upstream O 0 3.307841556221547e-09
of O 0 2.965411249888916e-10
the O 0 1.62472002518399e-09
CTG O 0 2.8688821203104453e-06
repeat O 0 2.054441949894681e-09
and O 0 1.979092237314184e-11
for O 0 6.264656762094978e-13
a O 0 6.737305483471567e-14
significant O 0 1.5233551182644578e-12
reduction O 0 5.728225116463648e-10
of O 0 2.0143432755137525e-10
this O 0 1.2588060802065648e-11
interaction O 0 1.0868225069904369e-10
in O 0 3.035547160856744e-11
cells O 0 2.14196299586078e-11
with O 0 1.9415590283514833e-13
a O 0 1.1529441464042112e-11
hypermethylated O 0 2.126677600244875e-06
DMPK O 0 0.02051941491663456
gene O 0 1.2679527650050204e-08
. O 0 4.1416807761152086e-09
. O 0 1.5418914145470808e-08

The O 0 7.729517164989375e-06
hemochromatosis B-Disease 1 1.0
gene O 0 3.1949741696735146e-07
product O 0 1.2851110398059973e-07
complexes O 0 2.211477578839549e-08
with O 0 2.8721899858474842e-11
the O 0 4.986745461010855e-10
transferrin O 0 6.120112061580585e-07
receptor O 0 2.360994422190288e-08
and O 0 1.779062730467018e-10
lowers O 0 1.9244632554205054e-09
its O 0 3.746483158428848e-12
affinity O 0 1.6157903140467944e-11
for O 0 2.5613883843783603e-12
ligand O 0 1.400410010177211e-08
binding O 0 8.696375175532012e-08
. O 0 1.1240602049156223e-07

We O 0 2.0217747476181103e-07
recently O 0 5.081282949959132e-09
reported O 0 8.013757019087464e-11
the O 0 2.380030374171671e-11
positional O 0 3.328994413465125e-09
cloning O 0 4.801695041578569e-09
of O 0 4.5904034046140296e-11
a O 0 1.084254561134479e-11
candidate O 0 3.433632933536046e-09
gene O 0 7.943015134515008e-10
for O 0 5.8231419686194386e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.9999998807907104
HFE O 1 0.9999990463256836
. O 0 1.1829781669803197e-06

The O 0 5.896621146916914e-08
gene O 0 1.945302113837144e-10
product O 0 1.6190775387059375e-09
, O 0 1.9095796124912745e-11
a O 0 3.6070556264089504e-12
member O 0 4.9316713907066045e-12
of O 0 1.277759703599557e-10
the O 0 3.47037731884825e-10
major O 0 4.025827138320892e-08
histocompatibility O 0 8.193589019356295e-05
complex O 0 4.3174986785743386e-06
class O 0 2.3694125772522057e-08
I O 0 2.225661610566476e-08
- O 0 1.9498760384095704e-09
like O 0 1.1956370615795464e-10
family O 0 8.154994041165153e-12
, O 0 7.228849138209148e-13
was O 0 2.6550244641709853e-11
found O 0 2.3587570698729854e-12
to O 0 1.1349286961614968e-11
have O 0 2.9028222534033254e-11
a O 0 3.910468129864064e-11
mutation O 0 3.9713768384963544e-10
, O 0 1.0235334108044114e-10
Cys O 0 1.0647590897860937e-06
- O 0 1.0496074054344717e-07
282 O 0 4.1421252205964265e-08
- O 0 1.961425333263378e-08
- O 0 1.6508163724893166e-08
> O 0 6.190127521676914e-08
Tyr O 0 3.0506200232593983e-07
( O 0 1.4543110639364532e-12
C282Y O 0 8.710128729383371e-10
) O 0 1.1112388542981397e-13
, O 0 6.859318885457655e-14
in O 0 5.630338317970385e-13
85 O 0 2.0517544607745464e-10
% O 0 5.735522733835152e-12
of O 0 1.9771490000763947e-11
patient O 0 3.7866787039320116e-08
chromosomes O 0 4.307810996806438e-08
. O 0 1.3478666005539708e-07

This O 0 1.0359234359214042e-08
mutation O 0 6.643885885893042e-09
eliminates O 0 8.957888653071677e-09
the O 0 4.0542730284087725e-10
ability O 0 3.629107847569202e-10
of O 0 8.654326144608149e-09
HFE O 1 0.9592850208282471
to O 0 6.010831388181259e-09
associate O 0 8.874012635828876e-10
with O 0 5.2280835910467616e-12
beta2 O 0 2.379418037889991e-05
- O 0 1.514882228548231e-06
microglobulin O 0 0.005690982565283775
( O 0 2.2037990876633273e-10
beta2m O 0 5.082777079223888e-06
) O 0 4.917377963153946e-11
and O 0 9.996611177731651e-11
prevents O 0 8.099908521685961e-10
cell O 0 6.238487060272746e-08
- O 0 9.491203378786395e-09
surface O 0 7.098274750205746e-07
expression O 0 1.600223811237811e-07
. O 0 6.051221390634964e-08

A O 0 1.403829855917138e-06
second O 0 2.5259294034185586e-07
mutation O 0 4.053053004327012e-09
that O 0 6.4223539680829944e-12
has O 0 1.2105743924656354e-12
no O 0 8.695391954215148e-13
effect O 0 1.2209526445428054e-10
on O 0 1.5277102916044782e-09
beta2m O 0 3.972324066126021e-06
association O 0 1.092680279590752e-09
, O 0 2.6581509562917383e-11
H63D O 0 0.009750651195645332
, O 0 8.679791607679732e-11
was O 0 8.857271582840553e-10
found O 0 4.975665018891462e-11
in O 0 3.8013051040231005e-11
eight O 0 1.1582677872379321e-10
out O 0 1.7222223647195278e-11
of O 0 3.5451477864434366e-10
nine O 0 1.8430165171778867e-09
patients O 0 7.856757022750571e-09
heterozygous O 0 8.204063817185414e-11
for O 0 9.499466317730576e-12
the O 0 2.073163196669725e-09
C282Y O 0 3.4800232242560014e-06
mutant O 0 1.098391635423468e-06
. O 0 7.355306053113964e-08

In O 0 1.3736373150052827e-09
this O 0 2.068796349508073e-11
report O 0 4.561104965938867e-11
, O 0 8.190035455379885e-12
we O 0 6.515209812624212e-12
demonstrate O 0 1.4150958183023477e-10
in O 0 1.2157612416796582e-10
cultured O 0 3.72072634036158e-07
293 O 0 9.1992454542833e-08
cells O 0 4.597638891823408e-08
overexpressing O 0 4.6463813418995414e-07
wild O 0 1.4402742998242957e-08
- O 0 5.195443519845355e-10
type O 0 3.655752811582147e-09
or O 0 6.838392629937573e-10
mutant O 0 8.541000084960615e-08
HFE O 0 1.2279376278456766e-05
proteins O 0 2.5248184098991544e-10
that O 0 3.5162742943045666e-12
both O 0 2.0657840021920393e-11
the O 0 1.1353319673279572e-10
wild O 0 1.4165068229488043e-08
- O 0 1.0734054756156297e-09
type O 0 8.71589911355386e-09
and O 0 1.0118331728037333e-09
H63D O 1 0.897819459438324
HFE O 0 0.0006479639559984207
proteins O 0 5.03534947071671e-09
form O 0 1.0983303155853719e-09
stable O 0 3.4231963930153597e-09
complexes O 0 4.408127682320462e-11
with O 0 3.6096692583760526e-13
the O 0 3.470554399420678e-11
transferrin O 0 9.704653081143988e-08
receptor O 0 1.9262012429521747e-08
( O 0 7.279580410690656e-11
TfR O 0 5.178620767765096e-07
) O 0 7.26756571589604e-11
. O 0 1.6080012876784622e-09

The O 0 2.04860143071528e-07
C282Y O 0 1.1919120879611e-05
mutation O 0 8.758699721056473e-08
nearly O 0 2.0514256959813792e-10
completely O 0 2.9555410896442424e-10
prevents O 0 6.380015266094219e-11
the O 0 8.616894697777155e-11
association O 0 8.738095663707313e-11
of O 0 3.332575604364507e-10
the O 0 9.044653914713763e-10
mutant O 0 2.2040239855414256e-08
HFE O 0 9.871401744021568e-06
protein O 0 2.61852539651386e-09
with O 0 4.875907837209592e-12
the O 0 5.906013456069559e-10
TfR O 0 5.216541921981843e-06
. O 0 1.1664474719452755e-08

Studies O 0 8.848837040886792e-08
on O 0 3.1535962730089295e-09
cell O 0 2.319092917701937e-09
- O 0 1.521750642163866e-10
associated O 0 1.5954017273944743e-10
transferrin O 0 2.8503382054623216e-07
at O 0 2.2099542196230004e-09
37 O 0 5.523889679004412e-10
degrees O 0 4.231721639769148e-09
C O 0 1.8883399732771977e-08
suggest O 0 5.276280801158606e-11
that O 0 2.356696381013851e-13
the O 0 2.687357836261839e-10
overexpressed O 0 8.556364718970144e-07
wild O 0 7.538555735209229e-08
- O 0 3.1845259762519618e-09
type O 0 1.4485364019378721e-08
HFE O 0 7.186364655353827e-06
protein O 0 3.59755869538958e-09
decreases O 0 2.221559380899407e-09
the O 0 3.4301343015963326e-11
affinity O 0 1.1073368610947654e-10
of O 0 7.802181817284648e-11
the O 0 6.858639767237662e-10
TfR O 0 8.703657954356459e-07
for O 0 2.73205236211993e-10
transferrin O 0 1.6839753698150162e-06
. O 0 2.4297324330291303e-07

The O 0 1.776736644387711e-05
overexpressed O 0 0.0021014120429754257
H63D O 1 0.9490180611610413
protein O 0 6.392362905671689e-08
does O 0 3.37962408059056e-10
not O 0 2.0397820585382753e-11
have O 0 1.1198460778474861e-12
this O 0 6.63190747977882e-13
effect O 0 1.6806761538035175e-10
, O 0 3.779289815125653e-12
providing O 0 1.2717437346265736e-11
the O 0 3.0128078851165974e-12
first O 0 1.5101861818370144e-12
direct O 0 2.130427128113621e-12
evidence O 0 8.049967810397352e-12
for O 0 4.3756713747136744e-13
a O 0 1.7360269038285692e-12
functional O 0 3.966813988398599e-09
consequence O 0 1.8644328747541294e-08
of O 0 7.037796567743726e-09
the O 0 2.3704430418547418e-08
H63D O 0 0.34187906980514526
mutation O 0 4.069823660302063e-07
. O 0 3.378338675474879e-08

Addition O 0 8.23538499616916e-08
of O 0 6.065700119961548e-08
soluble O 1 0.772795557975769
wild O 0 3.0379032978089526e-06
- O 0 1.6818354708902916e-08
type O 0 8.671248963310063e-08
HFE O 1 0.9999499320983887
/ O 0 3.5014236345887184e-05
beta2m O 0 0.00013300641148816794
heterodimers O 0 9.233467608282808e-06
to O 0 2.841260560160208e-09
cultured O 0 2.0461004623939516e-07
cells O 0 3.4214731048365365e-09
also O 0 1.8655639099501853e-12
decreased O 0 1.4496764899618597e-10
the O 0 4.0152061363263325e-12
apparent O 0 1.1858167225931027e-10
affinity O 0 9.60919260828419e-11
of O 0 1.9343136814509165e-10
the O 0 9.797970074165718e-11
TfR O 0 7.749080488395066e-09
for O 0 3.169745282222136e-13
its O 0 8.029841169158308e-14
ligand O 0 2.6010063894355007e-11
under O 0 3.711316531873621e-10
steady O 0 2.5645892076653354e-09
- O 0 5.349420559297435e-12
state O 0 9.575847059739573e-13
conditions O 0 6.190526757876569e-09
, O 0 3.0646802370165593e-12
both O 0 2.6989690864176463e-12
in O 0 3.577164953139089e-11
293 O 0 1.0699040542405669e-09
cells O 0 4.6294715283501375e-10
and O 0 2.5502362374640875e-11
in O 0 4.373508499799783e-10
HeLa O 0 1.6479558553328388e-06
cells O 0 3.4946516791478643e-08
. O 0 5.986735107654795e-09

Furthermore O 0 7.553438052809724e-08
, O 0 9.695647756879922e-11
at O 0 5.387061977057961e-11
4 O 0 2.6317928392138867e-10
degrees O 0 4.1267952610724024e-08
C O 0 1.2975680192539585e-06
, O 0 4.103131463067955e-12
the O 0 1.7839209276448997e-11
added O 0 1.7647971972678533e-10
soluble O 0 3.979654366048635e-07
complex O 0 3.548513660689423e-08
of O 0 1.0494229485402684e-08
HFE O 0 0.0006824174197390676
/ O 0 2.4017734290282533e-07
beta2m O 0 4.965737048223673e-07
inhibited O 0 5.5847118041185695e-09
binding O 0 1.2373638780260876e-09
of O 0 6.474583646998155e-10
transferrin O 0 9.071337103705446e-08
to O 0 3.932702163922386e-09
HeLa O 0 1.8362439959673793e-06
cell O 0 1.3592332592793355e-08
TfR O 0 9.312690707474758e-08
in O 0 4.5915827563691725e-12
a O 0 9.317270262612642e-13
concentration O 0 3.590956865195949e-09
- O 0 1.8420571734623081e-09
dependent O 0 1.1787552267605861e-08
manner O 0 5.9109215300168216e-08
. O 0 2.998173087576106e-08

Scatchard O 0 0.0002062473795376718
plots O 0 3.5834054301631113e-07
of O 0 5.528888902261997e-09
these O 0 2.116492675563464e-10
data O 0 3.044240415306376e-10
indicate O 0 8.441904952860568e-10
that O 0 5.6300402707931685e-12
the O 0 2.6620539106403385e-10
added O 0 4.46971459844292e-10
heterodimer O 0 5.294532812172292e-09
substantially O 0 4.073932746706532e-09
reduced O 0 1.1491406715080643e-09
the O 0 1.0918922710434487e-10
affinity O 0 3.991683650284017e-10
of O 0 6.512209105302702e-10
TfR O 0 4.7139059233813896e-07
for O 0 1.4476538023888708e-10
transferrin O 0 1.0429038184156525e-06
. O 0 1.030999925433207e-07

These O 0 1.0973844055683912e-08
results O 0 6.465997515192612e-09
establish O 0 1.3478809179900963e-09
a O 0 8.208551893762461e-12
molecular O 0 1.7239321081774506e-10
link O 0 2.846341495832405e-10
between O 0 1.6678141090409326e-09
HFE O 1 1.0
and O 0 9.057643524101877e-08
a O 0 3.4203756493766946e-10
key O 0 8.539012696928694e-08
protein O 0 1.2985902353435108e-09
involved O 0 1.3382253638560826e-10
in O 0 5.239515765698144e-11
iron O 0 6.714131473017915e-08
transport O 0 2.7667900326378003e-07
, O 0 3.356636843476757e-11
the O 0 1.2498255208548414e-10
TfR O 0 2.91944104446884e-07
, O 0 2.717472080693284e-12
and O 0 5.173535211344671e-12
raise O 0 5.616325460255922e-11
the O 0 7.917761932207945e-12
possibility O 0 6.193473511828529e-11
that O 0 2.0065825628683143e-13
alterations O 0 1.9921232663477895e-08
in O 0 9.376002751970702e-11
this O 0 3.960714135137211e-12
regulatory O 0 5.863443064413332e-09
mechanism O 0 6.117086392976034e-09
may O 0 2.8300539689496418e-09
play O 0 3.193812714297195e-10
a O 0 1.2135126887732883e-12
role O 0 8.061522803470833e-12
in O 0 6.905217283387222e-12
the O 0 2.825678302453838e-10
pathogenesis O 0 7.169250602601096e-05
of O 0 2.856215132851503e-06
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.9438130855560303
. O 0 4.6680557375111675e-07

Genomic O 0 4.876216053162352e-07
organization O 0 5.001856262509818e-09
of O 0 3.507103718547455e-09
the O 0 9.745627949087066e-08
UBE3A O 1 0.999665379524231
/ O 0 3.283877595094964e-05
E6 O 0 0.002670180518180132
- O 0 7.747443078187644e-07
AP O 0 4.904795332549838e-06
gene O 0 9.774530074224685e-10
and O 0 4.631102792918007e-11
related O 0 3.1886056461871704e-08
pseudogenes O 0 1.2425032764440402e-05
. O 0 3.3719499015205656e-07

The O 0 1.167401137536217e-06
UBE3A O 0 0.00028310008929111063
gene O 0 9.320844540638973e-09
encodes O 0 1.0518169668571886e-09
the O 0 3.733911846381943e-09
E6 O 0 5.158358908374794e-05
- O 0 3.5270494436190347e-07
AP O 0 4.334157438279362e-06
ubiquitin O 0 2.626205173328344e-07
- O 0 1.647198644150194e-07
protein O 0 4.096217143256808e-09
ligase O 0 9.290634928049712e-09
and O 0 6.061708024418522e-09
has O 0 4.449103238601815e-11
recently O 0 1.793552112383523e-11
been O 0 2.61667445523861e-12
shown O 0 1.1321131749078561e-12
to O 0 4.976950926036117e-13
be O 0 1.1529353860506575e-11
mutated O 0 9.618344165573944e-07
in O 0 1.6520502867933828e-06
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.999733030796051
who O 0 1.5438673950374238e-10
lack O 0 3.338691545451411e-09
15q11 O 0 1.6041001060784765e-07
- O 0 2.608517313262837e-08
q13 O 0 5.357109671422222e-07
deletions O 0 2.294074796793666e-08
or O 0 8.692121467035463e-10
chromosome O 0 1.4429901717960547e-09
15 O 0 6.518551032286268e-09
paternal O 0 6.156461950013181e-06
uniparental B-Disease 0 0.03886255621910095
disomy I-Disease 0 0.21851584315299988
. O 0 1.007227911031805e-05

Previous O 0 1.4206854757503606e-05
UBE3A O 0 0.000305035529891029
cDNA O 0 1.9419793773067795e-07
analysis O 0 1.9201660261813913e-09
has O 0 9.47174803866968e-12
shown O 0 3.3965712187278285e-12
a O 0 1.4056387347485821e-12
coding O 0 1.5940490039056954e-09
region O 0 2.510231800201268e-09
of O 0 1.7902899163146913e-09
approximately O 0 2.568896206867066e-10
2 O 0 1.1395376198208851e-08
. O 0 5.353837817523299e-09

6 O 0 2.9690603696508333e-05
kb O 0 4.0553591134084854e-06
and O 0 3.901747813728207e-09
a O 0 4.0407319157331756e-10
3 O 0 5.0357744640905366e-08
- O 0 8.042434274102561e-08
untranslated O 0 0.461145281791687
region O 0 4.68444909529353e-08
( O 0 2.6222012408649853e-11
UTR O 0 3.281498356955126e-05
) O 0 5.119175049139724e-12
of O 0 3.172871410050959e-10
< O 0 1.8161614434575313e-08
50 O 0 1.2706490304381646e-09
bp O 0 6.976407229686288e-10
, O 0 4.559606598536492e-12
whereas O 0 1.4240091050776726e-10
Northern O 0 2.338480520336361e-10
analysis O 0 3.1397530408927565e-11
has O 0 2.07018083231425e-12
indicated O 0 2.8566629964310586e-11
mRNA O 0 9.666583505874016e-11
sizes O 0 5.369307776170729e-10
of O 0 5.0065307455327e-10
5 O 0 1.3924727149117189e-08
- O 0 6.732032176159919e-08
8 O 0 7.08604659394041e-08
kb O 0 4.0754588326308294e-07
. O 0 5.573031103267567e-08

We O 0 4.467878511604795e-07
have O 0 7.4986533649124e-10
analyzed O 0 2.223309980564636e-09
additional O 0 7.531807955096781e-10
cDNA O 0 7.185207806514882e-08
clones O 0 1.245432201812946e-07
and O 0 9.972216802323075e-11
provide O 0 5.465550755034965e-12
evidence O 0 1.511561535660899e-11
for O 0 2.6963297046489476e-12
an O 0 6.055212754818573e-13
additional O 0 1.1732451121737597e-10
0 O 0 3.651259916637173e-08
. O 0 7.927822842646037e-09

5 O 0 3.1445338208868634e-06
kb O 0 2.594767693153699e-06
of O 0 1.0347331169668905e-07
5 O 0 3.1451287441086606e-07
- O 0 1.8010835844961548e-07
UTR O 0 0.20963136851787567
and O 0 5.35682831426243e-10
> O 0 1.6231968658075857e-08
2 O 0 2.582619229585248e-09
kb O 0 6.315731049255646e-09
of O 0 2.5931921054933582e-09
3 O 0 5.959258828625025e-07
- O 0 3.322502152514062e-06
UTR O 1 0.9999052286148071
. O 0 3.14073474783072e-07

We O 0 3.5413801668937595e-08
have O 0 6.508630440160701e-11
established O 0 4.875045506169684e-11
the O 0 1.1330859861491405e-11
genomic O 0 1.4156031902246013e-10
organization O 0 3.522478836393006e-11
of O 0 3.899789102757012e-10
UBE3A O 0 5.8510355302132666e-05
and O 0 1.8266163581692751e-10
the O 0 1.566075463754757e-10
sequence O 0 6.569318700133664e-11
of O 0 5.135649683296606e-10
intron O 0 1.5322495983127737e-07
- O 0 8.143691729856073e-07
exon O 0 7.892211328908161e-07
borders O 0 5.3908010499981174e-08
. O 0 1.9034901299619378e-07

We O 0 1.311017854277452e-06
have O 0 5.6457700736700644e-09
also O 0 3.4203101462182417e-10
mapped O 0 7.97354449133536e-09
two O 0 1.2033378460341027e-10
highly O 0 1.1699389901309587e-08
homologous O 0 5.958517235171712e-09
processed O 0 1.1875318506326948e-07
pseudogenes O 0 1.643714767851634e-06
, O 0 6.627947080062313e-10
UBE3AP1 O 0 0.0007280912832356989
and O 0 9.019403002241688e-09
UBE3AP2 O 1 0.9952040910720825
, O 0 4.229073480299661e-10
to O 0 1.4353473964945351e-10
chromosomes O 0 3.914051860398615e-10
2 O 0 2.748511140904242e-10
and O 0 5.750595746117915e-12
21 O 0 2.979653468404564e-10
, O 0 1.3580617750155732e-12
respectively O 0 1.0586900106579478e-10
, O 0 1.6402862141468022e-12
and O 0 2.4804810982992365e-12
determined O 0 3.8025976811795204e-10
their O 0 3.550933991292027e-10
genomic O 0 4.649942653145445e-09
organization O 0 4.1145948870280336e-09
. O 0 1.553036277357478e-08

These O 0 7.035611560013422e-08
results O 0 1.0430491137469744e-08
will O 0 1.4836357142833378e-10
form O 0 5.7038665457476156e-11
the O 0 1.1007221176195792e-11
basis O 0 7.031143896274461e-12
for O 0 3.851385627518661e-14
studies O 0 1.0420051323525858e-12
of O 0 6.28097617319523e-13
mutation O 0 6.2503856257389856e-12
and O 0 8.818726998649495e-12
imprinting O 0 6.40109902860786e-08
of O 0 2.7568262339627836e-07
UBE3A O 1 0.9999490976333618
. O 0 4.336840902396943e-06

Mutation O 0 2.3703989882051246e-06
spectrum O 0 2.9120878934918437e-06
and O 0 3.5635350226215223e-09
genotype O 0 3.295087481092196e-06
- O 0 1.7271170804633584e-07
phenotype O 0 6.275423203305763e-08
analyses O 0 2.852450220469649e-10
in O 0 1.8991695369119377e-11
Cowden B-Disease 0 0.0014842191012576222
disease I-Disease 0 3.8582868455705466e-08
and O 0 5.214335629943889e-10
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 8.708218035557991e-10
two O 0 7.044023697666546e-10
hamartoma B-Disease 1 0.5127951502799988
syndromes I-Disease 0 0.02654021792113781
with O 0 1.496693755598244e-07
germline O 1 0.9972284436225891
PTEN O 1 0.997044026851654
mutation O 0 2.6537331905274186e-06
. O 0 4.685288956807199e-08

The O 0 2.2260994228417985e-05
tumour B-Disease 1 1.0
suppressor O 0 0.3219608962535858
gene O 0 6.129356279416243e-06
PTEN O 0 0.03265196457505226
, O 0 4.1805284234364137e-10
which O 0 1.0470081399094333e-11
maps O 0 4.4581352498518356e-10
to O 0 5.004697767319044e-10
10q23 O 0 6.667444267804967e-06
. O 0 2.069857885089732e-07

3 O 0 6.426507752621546e-07
and O 0 7.062413986957949e-10
encodes O 0 9.997278699325207e-11
a O 0 1.7793638090735087e-11
403 O 0 9.114601295934222e-10
amino O 0 1.5050147239570322e-10
acid O 0 3.3521665998570427e-10
dual O 0 1.0952927453899974e-09
specificity O 0 1.1204037697609692e-08
phosphatase O 0 4.519804406299954e-06
( O 0 3.3444835789708804e-10
protein O 0 1.4105773216144257e-09
tyrosine O 0 5.023943039361711e-09
phosphatase O 0 4.13071710170243e-08
; O 0 2.574949697908835e-10
PTPase O 0 3.69028953173256e-07
) O 0 8.714257614117482e-12
, O 0 4.8407970340558215e-12
was O 0 9.912633214259614e-11
shown O 0 1.269983944396369e-11
recently O 0 1.5879789150297086e-10
to O 0 7.866556017699367e-11
play O 0 1.1956975853877339e-08
a O 0 5.107875789001071e-10
broad O 0 2.5567280204086273e-07
role O 0 1.6768506583275666e-09
in O 0 1.383191450265997e-09
human O 0 2.3613546673573182e-08
malignancy B-Disease 0 0.00041903709643520415
. O 0 1.186551443765893e-07

Somatic O 0 0.019606225192546844
PTEN O 0 0.007892283610999584
deletions O 0 4.1568173401174136e-06
and O 0 1.1526402943218272e-08
mutations O 0 2.101437468482459e-09
were O 0 1.950265643424487e-10
observed O 0 1.2206848032381146e-10
in O 0 1.8807500001827293e-10
sporadic B-Disease 0 0.00011547605390660465
breast I-Disease 1 0.9999915361404419
, I-Disease 0 1.6025924765017407e-07
brain I-Disease 1 1.0
, I-Disease 0 8.220942618208937e-06
prostate I-Disease 1 1.0
and I-Disease 1 1.0
kidney I-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 3.806886979873525e-06
lines O 0 2.8805429153067053e-09
and O 0 2.1461464549954457e-11
in O 0 9.742748274810253e-12
several O 0 3.5917685492492524e-11
primary O 0 2.739434421528131e-07
tumours B-Disease 1 0.9999994039535522
such O 0 4.4437628576865507e-10
as O 0 2.460092503042688e-07
endometrial B-Disease 1 0.9999997615814209
carcinomas I-Disease 1 1.0
, O 0 0.0006539822206832469
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9998955726623535
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 1 0.5828332901000977

In O 0 5.506283429212999e-09
addition O 0 3.867848707983512e-09
, O 0 2.4602619941305193e-09
PTEN O 0 0.3563598692417145
was O 0 2.891002282012778e-08
identified O 0 1.5817525067518545e-09
as O 0 5.395133645391681e-11
the O 0 8.758770098094004e-11
susceptibility O 0 6.116258166599664e-09
gene O 0 6.977601829660784e-11
for O 0 3.4873753190778345e-11
two O 0 2.215381655901183e-09
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 0.9997766613960266
( O 0 6.388198303675097e-11
CD B-Disease 0 2.0393690647324547e-06
; O 0 2.791981756899986e-09
MIM O 0 2.4167607989511453e-05
158350 O 0 9.575358461688666e-08
) O 0 3.49471818671121e-12
and O 0 1.5664990138386514e-11
Bannayan B-Disease 0 9.411719474883284e-06
- I-Disease 0 4.614331828634022e-06
Zonana I-Disease 0 0.21727851033210754
( I-Disease 0 3.41688677352181e-10
BZS I-Disease 0 7.26907019270584e-05
) I-Disease 0 1.7262148307994885e-11
or I-Disease 0 1.7958089182368298e-10
Ruvalcaba I-Disease 0 3.379104100531549e-06
- I-Disease 0 5.480650884237548e-07
Riley I-Disease 0 2.011238393606618e-05
- I-Disease 1 0.9999909400939941
Smith I-Disease 1 0.9999992847442627
syndrome I-Disease 1 1.0
( O 0 6.714118683248671e-08
MIM O 1 0.9981614947319031
153480 O 0 4.278841879568063e-05
) O 0 9.169667247732605e-10
. O 0 1.68667977362702e-08

Constitutive O 0 2.5405250198673457e-05
DNA O 0 4.407390576943726e-07
from O 0 3.804355497294409e-09
37 O 0 3.631777190093999e-08
CD B-Disease 0 2.1016955997765763e-07
families O 0 1.8136084301012545e-10
and O 0 2.4931849987308574e-11
seven O 0 1.514526143386874e-10
BZS B-Disease 1 0.9745654463768005
families O 0 7.674400004376025e-10
was O 0 8.466963796749383e-10
screened O 0 8.475919521799824e-09
for O 0 6.565291865712197e-09
germline O 0 0.00015663891099393368
PTEN O 0 0.013882800936698914
mutations O 0 4.5305496314540505e-06
. O 0 4.658782870592404e-07

PTEN O 0 0.010346552357077599
mutations O 0 8.863412404025439e-07
were O 0 5.786759516013262e-09
identified O 0 1.38144273797991e-10
in O 0 2.1816904186011676e-11
30 O 0 6.15191564357076e-10
of O 0 6.94298230019541e-10
37 O 0 1.4242875323589033e-08
( O 0 1.081299199484631e-11
81 O 0 1.0827599261631349e-08
% O 0 5.331706430522498e-12
) O 0 1.1660885744415456e-13
CD B-Disease 0 9.314322646503115e-09
families O 0 5.461028330933093e-12
, O 0 7.408312244910897e-13
including O 0 2.4270137982673745e-11
missense O 0 1.7349090342122508e-07
and O 0 1.2936367532745408e-08
nonsense O 0 2.4354469587706262e-06
point O 0 4.263653252678523e-08
mutations O 0 2.705873858310781e-10
, O 0 1.1126567549257782e-11
deletions O 0 2.1211614686933444e-09
, O 0 7.947830588106441e-11
insertions O 0 6.325954871044814e-09
, O 0 3.117554478460072e-11
a O 0 7.473034691063418e-11
deletion O 0 1.6284374737551843e-08
/ O 0 5.7535803676955766e-08
insertion O 0 3.47083158658279e-07
and O 0 2.3227288536986634e-08
splice O 0 2.5457587980781682e-05
site O 0 1.2129167998864432e-06
mutations O 0 2.541131607358693e-07
. O 0 5.814732162434666e-08

These O 0 1.1285306555919306e-07
mutations O 0 1.446374753300006e-08
were O 0 2.354261452452988e-09
scattered O 0 1.7469377056045232e-09
over O 0 5.1638467807313404e-11
the O 0 2.636042772952152e-10
entire O 0 8.916972715766747e-10
length O 0 1.9585673360911215e-10
of O 0 7.20308479529308e-09
PTEN O 0 5.0212005589855835e-05
, O 0 2.377961196009526e-11
with O 0 1.5780126229152092e-13
the O 0 2.4484611386987876e-12
exception O 0 8.28509136296951e-12
of O 0 5.57874189552332e-12
the O 0 5.995307549022666e-12
first O 0 5.6450323582257766e-11
, O 0 1.825285235457219e-11
fourth O 0 1.8886424868469476e-08
and O 0 5.375189737755193e-10
last O 0 2.5201826403531413e-08
exons O 0 2.83573513115698e-07
. O 0 7.269961344036346e-08

A O 0 6.895175374665996e-06
hot O 0 6.606959505006671e-05
spot O 0 1.6986582807021477e-07
for O 0 2.1052646292929467e-09
PTEN O 0 2.360692451475188e-05
mutation O 0 5.69062574840018e-09
in O 0 1.878168870428354e-10
CD B-Disease 0 1.591704972270236e-07
was O 0 1.8777044363815776e-09
identified O 0 5.800315228121633e-10
in O 0 1.2907598323508296e-09
exon O 0 3.090779543413191e-08
5 O 0 8.928511263661676e-10
that O 0 6.122700003247106e-13
contains O 0 1.2065064225463829e-11
the O 0 2.61871385687229e-10
PTPase O 0 3.8345435314113274e-05
core O 0 2.3580800188938156e-05
motif O 0 3.50024698114737e-09
, O 0 2.999413868318146e-12
with O 0 2.7282261736219504e-13
13 O 0 7.784047018066786e-11
of O 0 1.0010520884451424e-10
30 O 0 8.438459375703644e-10
( O 0 5.179893840245864e-12
43 O 0 1.362331469856315e-09
% O 0 1.0077797971130842e-11
) O 0 6.195853292229048e-13
CD B-Disease 0 3.177307661417217e-08
mutations O 0 3.9045747191046587e-10
identified O 0 1.2895016998637487e-10
in O 0 1.2190885800844597e-10
this O 0 1.2445713348796517e-09
exon O 0 6.08443770033773e-07
. O 0 7.80317535031827e-08

Seven O 0 1.213182372339361e-07
of O 0 1.7253418249651986e-08
30 O 0 2.256811804102199e-08
( O 0 1.0551535339908824e-11
23 O 0 1.291796669633527e-09
% O 0 3.3267676807779978e-12
) O 0 5.249290856591121e-14
were O 0 1.4322154573420676e-11
within O 0 7.328535001072112e-11
the O 0 2.5167504191792034e-10
core O 0 6.647323402830807e-08
motif O 0 1.9878398926920227e-10
, O 0 6.768685004848729e-13
the O 0 1.6126098720259385e-11
majority O 0 9.387110880276772e-12
( O 0 1.1603495941869824e-12
five O 0 3.5877696646924306e-11
of O 0 1.1818748202330198e-09
seven O 0 4.305775180846183e-11
) O 0 3.0368646508106834e-13
of O 0 1.8457867179133558e-11
which O 0 1.6053672280413878e-11
were O 0 2.7732414142889183e-09
missense O 0 3.4668684634198144e-07
mutations O 0 3.564466499739183e-09
, O 0 4.758891891665229e-11
possibly O 0 4.2350083440112485e-09
pointing O 0 5.1266084710732684e-09
to O 0 2.1739974404022533e-11
the O 0 5.544470438323401e-11
functional O 0 6.156731569006979e-09
significance O 0 1.124737458724212e-08
of O 0 1.6815009384885116e-09
this O 0 5.796676472158424e-10
region O 0 2.4671896525774173e-08
. O 0 1.581644859527387e-08

Germline O 0 0.01234620250761509
PTEN O 0 0.002432118868455291
mutations O 0 6.136873764717166e-08
were O 0 2.3905786239453164e-09
identified O 0 1.7385337613973206e-10
in O 0 1.716830323739149e-11
four O 0 3.09509752896564e-12
of O 0 1.7734556878590269e-10
seven O 0 1.5067898317955297e-10
( O 0 6.6198799913985695e-12
57 O 0 6.0728750916894114e-09
% O 0 7.385548422833565e-11
) O 0 1.916494220266518e-11
BZS B-Disease 0 0.004853564780205488
families O 0 2.2997601600849293e-09
studied O 0 1.6976438033111663e-08
. O 0 2.3953907302143307e-08

Interestingly O 0 2.831481538123626e-07
, O 0 1.8347801056251e-10
none O 0 5.954696735699372e-10
of O 0 5.638156608256395e-11
these O 0 4.4565011403374655e-11
mutations O 0 8.662937728276532e-11
was O 0 6.429858034895375e-11
observed O 0 1.3001856535854728e-10
in O 0 8.522728356386011e-11
the O 0 2.8733655454971085e-09
PTPase O 0 0.00030906443134881556
core O 0 8.41526998556219e-05
motif O 0 1.8507360266539763e-07
. O 0 2.0541255807415837e-08

It O 0 2.191363979164862e-09
is O 0 4.834276381981972e-11
also O 0 8.77650816605291e-12
worthy O 0 4.837979794558578e-09
of O 0 1.0930924915220075e-10
note O 0 4.5382302082952464e-11
that O 0 4.221892068801206e-14
a O 0 2.1349617223848788e-13
single O 0 1.1952556132344139e-11
nonsense O 0 8.991144495595904e-10
point O 0 1.7482600089824274e-10
mutation O 0 9.752397674145374e-12
, O 0 1.0386121216537925e-12
R233X O 0 1.1087455398239854e-08
, O 0 1.515490510861639e-11
was O 0 2.36535513398195e-10
observed O 0 3.8115291478568736e-10
in O 0 1.464545151819152e-10
the O 0 1.378753111680453e-09
germline O 0 2.2978321467803653e-08
DNA O 0 4.093374084135348e-09
from O 0 1.8600941620317002e-10
two O 0 8.73925844885326e-12
unrelated O 0 5.458266727487171e-09
CD B-Disease 0 2.2613474470745132e-07
families O 0 2.6854450954627573e-11
and O 0 4.087877258918127e-11
one O 0 2.1196437660631062e-10
BZS B-Disease 1 0.9996535778045654
family O 0 1.649592107355602e-08
. O 0 4.296888533872334e-08

Genotype O 0 4.415709918248467e-05
- O 0 1.0536406307437574e-06
phenotype O 0 6.489623416428003e-08
studies O 0 1.5343121217981093e-10
were O 0 8.579744553705027e-12
not O 0 1.296915049311953e-12
performed O 0 3.6608428094497825e-11
on O 0 4.359290012301287e-11
this O 0 5.5177763400027224e-12
small O 0 6.421806142409281e-11
group O 0 1.5904932535934502e-12
of O 0 2.2741064586995208e-10
BZS B-Disease 1 0.9999990463256836
families O 0 8.861487543754265e-08
. O 0 1.24551533531303e-07

However O 0 2.3442485996838514e-07
, O 0 2.3693207396036087e-09
genotype O 0 1.2528967374692002e-07
- O 0 2.4805288489915256e-08
phenotype O 0 2.3662105164135028e-08
analysis O 0 2.8298635657009186e-10
inthe O 0 7.328251285798615e-07
group O 0 7.936238471950574e-12
of O 0 8.42581421300892e-11
CD B-Disease 0 1.7325050066574477e-05
families O 0 2.1384860549034101e-10
revealed O 0 1.570424623675848e-10
two O 0 8.123537649853962e-13
possible O 0 1.7583283787314663e-11
associations O 0 2.1500962468778972e-11
worthy O 0 5.067143149517506e-09
of O 0 1.2589099207538368e-10
follow O 0 1.5052594726228108e-09
- O 0 1.521295867057404e-09
up O 0 6.237098337802394e-11
in O 0 4.10942026934924e-12
independent O 0 1.666597762572941e-11
analyses O 0 2.9235269760619076e-10
. O 0 1.0642946524086483e-09

The O 0 6.546762421066887e-08
first O 0 4.708687217913621e-09
was O 0 1.2153265060987906e-08
an O 0 8.80820416604422e-12
association O 0 3.5810084064724634e-11
noted O 0 3.347602750558565e-11
in O 0 1.2845570961095287e-11
the O 0 6.63693822122724e-11
group O 0 4.744721325902757e-13
of O 0 4.409891722623183e-12
CD B-Disease 0 7.088657730491832e-05
families O 0 1.362024937279216e-09
with O 0 1.2204618426991942e-09
breast B-Disease 1 0.9999740123748779
disease I-Disease 0 0.022641748189926147
. O 0 1.2399960723996628e-05

A O 0 1.3433034951049194e-07
correlation O 0 2.477610117068707e-09
was O 0 2.851748559518086e-10
observed O 0 1.6176875117235312e-10
between O 0 1.0501962147135835e-11
the O 0 4.129552949594384e-11
presence O 0 2.4917315433192755e-10
/ O 0 4.751235493927197e-08
absence O 0 8.892224059309228e-07
of O 0 1.843091368414207e-08
a O 0 1.3256381548032437e-09
PTEN O 0 1.4008612197358161e-05
mutation O 0 1.9634494030640326e-09
and O 0 5.8975875398548094e-12
the O 0 1.4147813779882834e-12
type O 0 1.8491069786463754e-10
of O 0 1.6519055012764738e-09
breast O 0 9.534335276839556e-08
involvement O 0 3.3840896751513583e-09
( O 0 2.240934660058258e-10
unaffected O 0 6.251328159123659e-05
versus O 0 0.0003113499260507524
benign O 1 0.991466760635376
versus O 0 0.000423167715780437
malignant O 0 0.0005396896740421653
) O 0 9.41748123928221e-10
. O 0 1.1934145227598947e-08

Specifically O 0 2.9489783059943875e-08
and O 0 4.4642620156132296e-10
more O 0 3.068364789679534e-12
directly O 0 1.662936628676892e-11
, O 0 3.2452437005031642e-12
an O 0 4.235484304861842e-13
association O 0 7.013400277200432e-11
was O 0 6.445873834692861e-10
also O 0 2.7449670141066473e-12
observed O 0 2.99623034716312e-11
between O 0 1.8572808221928305e-12
the O 0 5.411527996546095e-12
presence O 0 3.5266312439774516e-12
of O 0 5.1332375849977296e-11
a O 0 3.126370273776047e-09
PTEN O 1 0.9999998807907104
mutation O 1 0.7687629461288452
and O 0 2.1260682842694223e-05
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 0 0.17871727049350739
. O 0 2.1309042494976893e-06

Secondly O 0 5.522376886801794e-05
, O 0 5.2086717161614615e-09
there O 0 1.9780629911814174e-10
appeared O 0 1.4397214531669533e-09
to O 0 7.1498145945425584e-12
be O 0 4.2300635216818705e-11
an O 0 1.771416173468321e-11
interdependent O 0 6.06371060030142e-08
association O 0 3.054752228948132e-09
between O 0 1.0612161815970467e-08
mutations O 0 1.5648080164964995e-08
upstream O 0 5.5710547286480505e-08
and O 0 9.958455587932846e-11
within O 0 4.808786702170664e-10
the O 0 1.9943082740780937e-09
PTPase O 0 0.0004154517373535782
core O 0 6.402415601769462e-05
motif O 0 1.3200122772616396e-08
, O 0 1.8954709329888075e-11
the O 0 5.599543051459932e-11
core O 0 6.644100825070609e-09
motif O 0 3.5031155060094576e-11
containing O 0 9.46533216389378e-13
the O 0 8.296256043260897e-12
majority O 0 7.775852878255662e-12
of O 0 1.3698800982453463e-09
missense O 0 3.144870959204127e-07
mutations O 0 8.431493281335634e-10
, O 0 1.1959580895060107e-11
and O 0 4.618565946357123e-12
the O 0 1.0712751866148729e-11
involvement O 0 7.243883010793484e-12
of O 0 1.6218512643995098e-11
all O 0 2.1873392853921647e-12
major O 0 4.6338971548820496e-10
organ O 0 1.4171142765917466e-06
systems O 1 0.9999908208847046
( O 0 8.089368286334775e-09
central O 0 5.6647641031304374e-05
nervous O 0 2.414539994788356e-05
system O 0 2.9814598747179843e-05
, O 0 1.7272571151139005e-09
thyroid O 1 0.9999959468841553
, O 0 0.0001913560990942642
breast O 1 1.0
, O 0 4.3398511479608715e-05
skin O 1 1.0
and O 1 1.0
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 9.587142635325563e-09
. O 0 3.789439233514713e-07

However O 0 1.4486201962427003e-06
, O 0 1.00531194480169e-09
these O 0 7.952728059423819e-11
observations O 0 1.5434677980152856e-09
would O 0 7.92761828405375e-11
need O 0 1.9523907490714976e-10
to O 0 1.8774518398267936e-11
be O 0 6.845589633347471e-12
confirmed O 0 7.968974785610428e-11
by O 0 1.5357664792658987e-11
studying O 0 1.5510751016911684e-10
a O 0 3.7732157350846285e-13
larger O 0 1.041663803824644e-11
number O 0 4.773834973159641e-12
of O 0 6.729738294408705e-11
CD B-Disease 0 2.6326149509259267e-06
families O 0 1.707287089480758e-09
. O 0 7.929683576435309e-09

Molecular O 0 0.00208512251265347
defects O 1 0.8456641435623169
leading O 0 8.998512157631922e-08
to O 0 1.3148539548812899e-11
human O 0 1.0694668761690451e-10
complement B-Disease 0 9.810968322199187e-07
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.1797234023003256e-10
an O 0 1.236420227269594e-13
African O 0 7.59502963992853e-12
- O 0 5.944526121348659e-11
American O 0 1.9749819835102045e-11
family O 0 4.626873884028271e-11
. O 0 9.194396910494618e-10

Complement B-Disease 0 4.88124987896299e-06
component I-Disease 1 0.9871980547904968
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 2.0814351631148753e-10
C6D B-Disease 0 2.915366530942265e-05
) O 0 6.1957852043326156e-12
was O 0 5.387290613612095e-10
diagnosed O 0 1.3166308576728625e-07
in O 0 1.0487720691898517e-09
a O 0 1.0762626900806538e-10
16 O 0 1.730871779237475e-09
- O 0 3.3560623724504524e-10
year O 0 3.1702898084517983e-09
- O 0 4.9482054009786225e-09
old O 0 1.6265378377511297e-08
African O 0 7.325753892395426e-11
- O 0 2.028580949053893e-11
American O 0 7.549530662079307e-13
male O 0 9.86671031336095e-13
with O 0 8.949247050880904e-13
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 6.405129511222185e-07

The O 0 4.1542069340039234e-08
patients O 0 2.357579518275088e-07
father O 0 1.8798230527750093e-08
and O 0 8.130684570062385e-09
two O 0 2.39635822296691e-09
brothers O 0 3.1759631724526116e-07
also O 0 4.146081533651369e-10
had O 0 2.282916744533736e-09
C6D B-Disease 1 0.9999995231628418
, O 0 5.132708841282252e-11
but O 0 1.6410475409123215e-11
gave O 0 1.1736966433473217e-11
no O 0 8.076278361357492e-13
history O 0 1.877108017633855e-11
of O 0 1.4294025685313017e-10
meningitis B-Disease 1 0.9999998807907104
or O 0 1.1501362084942457e-09
other O 0 3.2504565705693267e-10
neisserial B-Disease 0 1.0177323019888718e-05
infection I-Disease 0 1.8353883206145838e-05
. O 0 2.2356329054673552e-07

By O 0 2.1915322889753952e-08
using O 0 3.5675271625734695e-09
exon O 0 5.29099217772e-08
- O 0 5.94996274472237e-10
specific O 0 2.0602720918194706e-10
polymerase O 0 3.504774526152943e-10
chain O 0 9.256523325618105e-11
reaction O 0 1.853103642757148e-10
( O 0 9.090402584323309e-13
PCR O 0 1.347492672998385e-09
) O 0 2.6617974317744153e-12
/ O 0 9.28226523422282e-11
single O 0 3.418038768687737e-11
- O 0 1.1016447476475122e-10
strand O 0 2.4583937663358313e-10
conformation O 0 6.129331070470201e-11
polymorphism O 0 2.2237034436045633e-10
as O 0 2.2952169678736034e-12
a O 0 1.6332519104517162e-13
screening O 0 9.463103217699498e-11
step O 0 2.4225565997681997e-10
and O 0 5.48951769457906e-12
nucleotide O 0 1.5554241228343813e-10
sequencing O 0 1.2207831412425207e-09
of O 0 2.9108129795396565e-10
target O 0 1.3632022177745284e-09
exons O 0 1.4024300609705165e-09
, O 0 4.84054766755615e-12
we O 0 9.928441532455756e-13
determined O 0 1.2717680207552373e-11
that O 0 2.2842930888847257e-13
the O 0 2.7517989623082606e-11
proband O 0 3.168659929997375e-07
was O 0 9.747720408626037e-10
a O 0 8.509729379491127e-12
compound O 0 1.3050510672130144e-09
heterozygote O 0 1.1238523001111389e-07
for O 0 2.0168844372392414e-10
two O 0 1.0443426123885047e-09
C6 O 0 0.0002252609992865473
gene O 0 7.781683564189734e-08
mutations O 0 1.425281368483411e-07
. O 0 1.3367271378683654e-07

The O 0 5.3879844585935643e-08
first O 0 1.8973682625045285e-09
, O 0 4.770506212281589e-11
1195delC O 0 3.5199722248080434e-08
located O 0 5.90280435641688e-10
in O 0 1.6772593036673555e-10
exon O 0 1.9317198507451394e-08
7 O 0 2.4232154061110123e-08
, O 0 2.4152888022932473e-11
is O 0 1.1602079973832558e-12
a O 0 9.296944724485057e-13
novel O 0 5.0759212805173703e-11
mutation O 0 2.0831737376769688e-11
, O 0 1.2032357532207327e-12
while O 0 3.0506948963532343e-12
the O 0 2.037900057039188e-11
second O 0 3.732450459814629e-10
, O 0 1.0088875047886692e-11
1936delG O 0 6.665095142466271e-09
in O 0 1.1599441407383893e-09
exon O 0 1.2032702834119391e-08
12 O 0 1.7828818421605774e-09
, O 0 1.6867609739512623e-11
has O 0 3.313747280048185e-12
been O 0 5.806275599207211e-12
described O 0 2.8119400904969005e-11
before O 0 7.416155467510066e-10
to O 0 2.6133251118665157e-10
cause O 0 6.439661319745937e-07
C6D B-Disease 1 0.9999998807907104
in O 0 4.485645188623266e-09
an O 0 4.3219412423911585e-12
unrelated O 0 3.305161255795497e-09
African O 0 1.2932432902346136e-10
- O 0 1.8372244003916904e-10
American O 0 2.151987442411407e-11
individual O 0 7.591441364418472e-11
. O 0 1.5862541280498021e-09

Both O 0 1.1077841577389336e-07
mutations O 0 1.4033298079141332e-08
result O 0 3.555151062428763e-09
in O 0 1.4292996786124945e-09
premature O 0 1.1427380286477273e-06
termination O 0 2.1407793155958643e-06
codons O 0 2.8490339332165604e-07
and O 0 6.541732489040442e-08
C6 O 0 0.00015625030209776014
null O 0 1.5781086403876543e-05
alleles O 0 6.201460678312287e-08
. O 0 5.0163809106607005e-08

Allele O 0 7.107664146133175e-08
- O 0 3.6423128957352446e-09
specific O 0 1.0241660991505697e-10
PCR O 0 1.403490390572415e-08
indicated O 0 1.9003090212521556e-09
that O 0 9.403592271181593e-13
the O 0 9.597909272907046e-11
probands O 0 1.3775618754152674e-05
two O 0 1.1417866652152497e-09
brothers O 0 5.668397307090345e-09
also O 0 3.59789142923006e-11
inherited O 0 1.0095859259706685e-08
the O 0 1.2551009120898016e-09
1195delC O 0 2.5451084795236056e-08
mutation O 0 2.0018799118393105e-10
from O 0 4.664336972215466e-11
their O 0 2.545436084133712e-10
heterozygous O 0 3.772175974359193e-11
mother O 0 2.030032392186243e-11
and O 0 1.0780551798483806e-12
the O 0 3.0449299331936075e-11
1936delG O 0 7.013153613399936e-09
mutation O 0 1.4170295492554885e-10
from O 0 7.827984094266327e-11
their O 0 3.7173739086959756e-10
homozygous O 0 2.3765307499701294e-09
father O 0 2.86255108505884e-09
. O 0 9.083448992974752e-10
. O 0 1.0922808435509523e-08

PAX6 O 1 0.9258909225463867
mutations O 0 3.6700388591270894e-05
reviewed O 0 1.357926430500811e-05
. O 0 2.906225518017891e-06

Mutations O 0 6.433979706343962e-06
in O 0 4.6742474779648546e-08
PAX6 O 0 0.24798615276813507
are O 0 6.909163796642304e-10
responsible O 0 1.763656443110051e-10
for O 0 3.796841313574717e-11
human O 0 7.800849743944127e-09
aniridia B-Disease 1 1.0
and O 1 0.539557933807373
have O 0 8.311092258850294e-09
also O 0 2.8503767054988138e-11
been O 0 7.099886217137863e-12
found O 0 2.1292652970655856e-12
in O 0 2.2942234050027377e-12
patients O 0 8.891950370459867e-11
with O 0 1.0981485902908372e-12
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 2.6985254031330896e-09
with O 0 2.63262389665897e-08
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 2.807684325034643e-07
with O 0 1.3274351395864414e-08
autosomal B-Disease 1 0.9999994039535522
dominant I-Disease 1 0.9999961853027344
keratitis I-Disease 1 0.9999998807907104
, O 0 5.051568052749644e-09
and O 0 5.700845906453367e-10
with O 0 7.164660531522316e-10
isolated B-Disease 0 0.20334476232528687
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 1 0.8747805953025818

No O 0 5.6729533071120386e-08
locus O 0 4.490824156988538e-09
other O 0 2.9978824978016405e-11
than O 0 1.8725699810206997e-11
chromosome O 0 4.99352281746468e-10
11p13 O 0 4.3921340875385795e-07
has O 0 7.293353421200521e-11
been O 0 7.719760247715257e-11
implicated O 0 1.1912716368911447e-09
in O 0 1.6521701784455445e-09
aniridia B-Disease 1 1.0
, O 0 3.3472291605107785e-09
and O 0 1.6667902613676233e-09
PAX6 O 1 0.5954124927520752
is O 0 1.057555709671476e-10
clearly O 0 2.8522326167568224e-10
the O 0 6.005416303134226e-11
major O 0 2.5883986065622366e-09
, O 0 5.619429834652356e-12
if O 0 5.551007136589403e-12
not O 0 4.966124299982111e-12
only O 0 1.0353550482233853e-11
, O 0 6.39585129649789e-12
gene O 0 4.6896715677480216e-11
responsible O 0 1.0318410570420156e-09
. O 0 1.75335188146164e-07

Twenty O 0 3.538582404871704e-06
- O 0 3.0550569363185787e-07
eight O 0 2.6127033869727256e-09
percent O 0 5.342389863827179e-10
of O 0 1.0211894524436715e-10
identified O 0 2.823987932387695e-09
PAX6 O 0 0.01240663044154644
mutations O 0 6.563779209045606e-08
are O 0 1.0065360767086418e-09
C O 0 9.738742846820969e-06
- O 0 9.032680026166418e-08
T O 0 8.679025853552957e-08
changes O 0 4.0034944803757355e-10
at O 0 8.212349689173948e-10
CpG O 0 7.938584900557544e-08
dinucleotides O 0 1.1854238124442418e-07
, O 0 6.829291299137452e-11
20 O 0 1.1545005229596228e-10
% O 0 2.9646842706482213e-12
are O 0 1.1579214150014838e-13
splicing O 0 7.252075051589202e-10
errors O 0 5.185707152577379e-08
, O 0 1.1799732024808662e-10
and O 0 1.879946615046535e-10
more O 0 5.747821489598959e-12
than O 0 1.2254711134751517e-11
30 O 0 2.0456469851382053e-10
% O 0 1.3221899269888482e-11
are O 0 6.118882527397784e-13
deletion O 0 2.0601373038053872e-11
or O 0 2.179997501960962e-11
insertion O 0 4.1581604826035345e-09
events O 0 7.678884195172486e-09
. O 0 5.915455858485075e-08

There O 0 1.7058914281165016e-08
is O 0 1.07952542738321e-10
a O 0 5.8050717011148834e-11
noticeably O 0 3.862123492126557e-07
elevated O 0 1.125536755353096e-06
level O 0 9.75084990528785e-09
of O 0 4.1682354789962517e-10
mutation O 0 1.242701497261578e-10
in O 0 2.3231328319384126e-11
the O 0 6.254861212307006e-11
paired O 0 2.935807846826677e-11
domain O 0 1.840755672888328e-11
compared O 0 2.485237189653322e-11
with O 0 5.458381142908753e-13
the O 0 2.865825805831168e-11
rest O 0 4.569570832835268e-10
of O 0 8.932084238910676e-11
the O 0 4.950544418846903e-10
gene O 0 5.089981214290162e-10
. O 0 1.7444778066533217e-08

Increased O 0 7.104478783048762e-08
mutation O 0 8.122268191357307e-09
in O 0 1.563356666345328e-10
the O 0 3.501680889694825e-10
homeodomain O 0 3.5580023904913105e-07
is O 0 1.3765944113786066e-11
accounted O 0 2.887053929256922e-10
for O 0 9.933309600210216e-13
by O 0 1.2580931955941121e-11
the O 0 9.371180498263243e-10
hypermutable O 0 1.8598353790366673e-06
CpG O 0 1.115463192036259e-06
dinucleotide O 0 1.3212142846441566e-07
in O 0 5.219801035849514e-09
codon O 0 1.5967739841471484e-07
240 O 0 4.925514218712124e-08
. O 0 1.6218351106545015e-08

Very O 0 3.1931585908751003e-07
nearly O 0 1.6593801888120652e-09
all O 0 1.1457762516542402e-10
mutations O 0 6.490397108649404e-10
appear O 0 1.7848552635868487e-09
to O 0 5.0508791593628644e-11
cause O 0 1.5737665393089628e-08
loss O 0 1.366295432347897e-08
of O 0 1.9710852949827995e-09
function O 0 1.0886274520727213e-10
of O 0 1.1917983266940269e-10
the O 0 8.692813829869195e-11
mutant O 0 3.680258320315488e-10
allele O 0 4.3287578382900094e-11
, O 0 7.798707426370788e-13
and O 0 4.265366814089344e-13
more O 0 6.959421916790526e-14
than O 0 3.02413665940679e-13
80 O 0 9.682669596666749e-12
% O 0 5.206208185913608e-13
of O 0 1.0225021784132649e-12
exonic O 0 7.391009582136121e-09
substitutions O 0 2.0533137412570568e-09
result O 0 9.686188517932237e-10
in O 0 9.589093963313644e-10
nonsense O 0 1.4843284645849053e-07
codons O 0 8.76179058195703e-08
. O 0 3.209987653463031e-08

In O 0 3.955015159817776e-08
a O 0 6.679217179339503e-10
gene O 0 2.447441138642148e-10
with O 0 1.1526298145103642e-11
such O 0 8.156919584223488e-09
extraordinarily O 0 8.740031489651301e-07
high O 0 1.5241262474319228e-07
sequence O 0 3.2342720168720973e-10
conservation O 0 1.6227379440181267e-09
throughout O 0 3.503743475907761e-11
evolution O 0 2.095908308019645e-10
, O 0 5.251809837708565e-12
there O 0 1.786944724135875e-11
are O 0 6.58715998413939e-11
presumed O 0 4.0396270151177305e-07
undiscovered O 0 2.5610117518226616e-05
missense O 0 1.9194549167877994e-06
mutations O 0 9.367933095916214e-09
, O 0 4.2470731792532135e-11
these O 0 3.054608996300168e-11
are O 0 8.49082523041167e-12
hypothesized O 0 4.102900519331598e-10
to O 0 5.0451594291178736e-11
exist O 0 1.4367013134730655e-09
in O 0 2.797833631440483e-10
as O 0 2.305557522674917e-09
- O 0 9.006166479252897e-09
yet O 0 1.2677490168755412e-09
unidentified O 0 3.8593206408421565e-10
phenotypes O 0 2.378712116168913e-09
. O 0 1.0636305725064688e-10
. O 0 1.520518377873259e-09

Genetic O 0 1.0914800441241823e-06
heterogeneity O 0 2.5050775320778484e-07
and O 0 5.34627397907883e-10
penetrance O 0 7.021521497563299e-08
analysis O 0 6.893127735274618e-11
of O 0 1.151099549012713e-09
the O 0 8.054161781956282e-08
BRCA1 O 0 5.266082098387415e-06
and O 0 7.266467036970425e-07
BRCA2 O 0 8.653817531012464e-06
genes O 0 3.198864106934707e-08
in O 0 2.330178894283108e-08
breast B-Disease 1 0.5092854499816895
cancer I-Disease 0 9.528026566840708e-05
families O 0 2.691104761254337e-08
. O 0 2.5742556886143575e-07

The O 0 0.0011306465603411198
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 8.834242180455476e-05
Consortium O 0 4.6141551024447836e-07
. O 0 1.9916901905503437e-08

The O 0 2.86770429624994e-09
contribution O 0 9.454813820752861e-09
of O 0 1.837534746584879e-08
BRCA1 O 0 8.351304927600722e-07
and O 0 6.633290183799545e-08
BRCA2 O 0 6.847195618320256e-05
to O 0 2.436315753584495e-06
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 4.031894604850095e-07
assessed O 0 4.3432041962887524e-08
by O 0 2.0022616897819034e-10
linkage O 0 2.0001176270767473e-09
and O 0 9.130181853611585e-12
mutation O 0 3.360375996561138e-12
analysis O 0 1.715892375018721e-13
in O 0 5.486521068194528e-13
237 O 0 1.3986441171898178e-10
families O 0 2.166371682738033e-12
, O 0 2.398054357085483e-13
each O 0 2.5289339239810242e-14
with O 0 9.925142440770154e-14
at O 0 2.130761365959355e-11
least O 0 1.818403825952497e-12
four O 0 4.499320295676956e-13
cases O 0 3.993806327318161e-11
of O 0 2.1511494807668896e-08
breast B-Disease 0 0.20297516882419586
cancer I-Disease 0 1.5522745400176063e-07
, O 0 2.4655100010206876e-12
collected O 0 1.657038048441528e-11
by O 0 2.6415630099974052e-11
the O 0 7.533553230132384e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 1.3493945516529493e-07
Consortium O 0 6.155240761529512e-09
. O 0 1.3737945225855697e-09

Families O 0 3.905539358584065e-08
were O 0 2.836229029412607e-10
included O 0 2.4686546210017646e-11
without O 0 4.517692817063157e-11
regard O 0 1.4412903093230511e-09
to O 0 3.950996214224789e-12
the O 0 2.688555801599879e-11
occurrence O 0 6.226133830722347e-09
of O 0 2.1426340026664548e-06
ovarian B-Disease 1 0.9999998807907104
or I-Disease 0 2.9888326025684364e-05
other I-Disease 0 1.1317373719066381e-05
cancers I-Disease 1 0.9902026653289795
. O 0 9.833692047322984e-07

Overall O 0 0.00016031161067076027
, O 0 1.822397166506562e-08
disease O 0 8.348076335096266e-06
was O 0 2.3067249799169076e-07
linked O 0 1.71512999713741e-06
to O 0 1.6999385366034403e-07
BRCA1 O 0 2.106460215145489e-06
in O 0 9.491234465031084e-10
an O 0 5.150591324970533e-13
estimated O 0 2.1777978725934233e-12
52 O 0 1.9841571094469934e-11
% O 0 7.719045671747415e-13
of O 0 5.433277959487892e-12
families O 0 9.994395068491091e-12
, O 0 1.0558057900178497e-11
to O 0 6.178102474052594e-10
BRCA2 O 0 5.3278441214388295e-08
in O 0 5.063160446461268e-10
32 O 0 2.9128960354896094e-10
% O 0 1.2078481661029206e-12
of O 0 2.6809659093435245e-12
families O 0 8.561170435766874e-13
, O 0 3.7918293179818596e-13
and O 0 1.672082828099719e-12
to O 0 1.6639582073318948e-11
neither O 0 6.278997322084479e-10
gene O 0 2.137396336310271e-11
in O 0 1.1521731485553133e-10
16 O 0 1.1987751902253763e-09
% O 0 1.0334628985919636e-11
( O 0 6.494074212843454e-14
95 O 0 1.844489005975447e-10
% O 0 6.8986483192645665e-12
confidence O 0 2.627589534842656e-10
interval O 0 1.0360652336061094e-09
[ O 0 7.0322947465228935e-09
CI O 0 2.0100609617657028e-05
] O 0 1.1418040957167364e-09
6 O 0 4.740051684493096e-10
% O 0 7.0743380771454145e-12
- O 0 4.692078323098592e-11
28 O 0 4.802196418296489e-10
% O 0 5.516240242364745e-12
) O 0 2.936437443028239e-13
, O 0 1.6034323391603267e-12
suggesting O 0 5.823083681910646e-10
other O 0 1.3996187542275607e-09
predisposition O 0 4.3470623495522887e-05
genes O 0 2.1376661152316956e-06
. O 0 1.7478705558460206e-06

The O 0 2.271772103767944e-08
majority O 0 4.764706962312459e-10
( O 0 7.101525097141792e-12
81 O 0 3.342106591475158e-09
% O 0 6.32001092085166e-12
) O 0 1.8239572450052394e-13
of O 0 1.0548401041532429e-10
the O 0 1.2056927516823635e-05
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.607644488174856e-09
were O 0 1.0284883361633135e-10
due O 0 1.248325975922171e-08
to O 0 1.6373942202108083e-09
BRCA1 O 0 2.7598121565830525e-09
, O 0 1.531343086190462e-12
with O 0 1.0362963606810535e-13
most O 0 1.1223869923748797e-11
others O 0 5.0874040223580774e-12
( O 0 1.0468912520732176e-13
14 O 0 1.6221173709807246e-11
% O 0 1.2497480264203609e-12
) O 0 9.380693379197613e-14
due O 0 8.55095461105293e-09
to O 0 6.752067349680146e-08
BRCA2 O 0 2.036941805272363e-05
. O 0 5.149814228389005e-07

Conversely O 0 3.3386174891347764e-07
, O 0 9.365886538548196e-11
the O 0 3.23823329262396e-11
majority O 0 9.820528938664363e-12
of O 0 9.646544674168922e-11
families O 0 4.931391406337582e-11
with O 0 8.320850952703296e-12
male B-Disease 0 7.214094321916775e-10
and I-Disease 0 4.809831977148349e-10
female I-Disease 0 1.8374567423151689e-09
breast I-Disease 0 2.2292989854122425e-07
cancer I-Disease 0 2.4256246788922908e-08
were O 0 2.686887601299759e-09
due O 1 0.6667945981025696
to O 0 2.580738510005176e-05
BRCA2 O 0 1.3304155800142325e-05
( O 0 8.878680429758035e-11
76 O 0 5.886248999331656e-08
% O 0 7.580329419720755e-11
) O 0 4.005529415096465e-12
. O 0 9.088717001226598e-10

The O 0 1.1243754016732055e-07
largest O 0 2.06208650155304e-08
proportion O 0 5.99770721976256e-09
( O 0 7.562779395786645e-12
67 O 0 6.715906164522778e-10
% O 0 1.7267504700407832e-12
) O 0 2.097815837872035e-14
of O 0 6.3769462800566945e-12
families O 0 4.752412872954803e-12
due O 0 8.796133244004523e-08
to O 0 1.7243801941901893e-09
other O 0 1.0383521820145347e-09
genes O 0 1.8893214770443478e-10
was O 0 3.1960920021667505e-10
found O 0 7.182550127576848e-12
in O 0 1.8379596455897484e-11
families O 0 8.815128314798581e-12
with O 0 1.7105733062655615e-12
four O 0 3.777927189835273e-12
or O 0 2.144459523151232e-12
five O 0 6.936009926128417e-13
cases O 0 2.4070613557913845e-11
of O 0 5.6172413387400866e-09
female O 0 1.315398350243413e-07
breast B-Disease 0 0.00014339502376969904
cancer I-Disease 0 1.044665737026662e-06
only O 0 3.5264753339703248e-09
. O 0 2.242748422531804e-07

These O 0 1.1309867709030641e-08
estimates O 0 4.929571861822524e-09
were O 0 2.110341207339772e-10
not O 0 1.0223719440483059e-11
substantially O 0 9.237783871185457e-09
affected O 0 1.6518739709425745e-09
either O 0 1.6353231269139457e-11
by O 0 3.5517023350140065e-12
changing O 0 6.53976761633146e-10
the O 0 5.742115116724733e-11
assumed O 0 6.947512565247393e-10
penetrance O 0 6.37228936284373e-08
model O 0 6.033087918133617e-10
for O 0 4.097137074055013e-10
BRCA1 O 0 4.82668882639814e-09
or O 0 3.724510283520388e-12
by O 0 2.4335995458396598e-12
including O 0 1.7148601982874823e-11
or O 0 6.14707174051432e-10
excluding O 0 2.0363468138384633e-06
BRCA1 O 0 3.208871248716605e-07
mutation O 0 4.5409533910856226e-09
data O 0 1.8792987166449393e-09
. O 0 1.1021964674284845e-08

Among O 0 2.802114273947609e-08
those O 0 2.798047349372723e-10
families O 0 5.5866557907569003e-11
with O 0 2.360066786097348e-12
disease O 0 1.71413017113764e-08
due O 0 0.003081293310970068
to O 0 5.5924537889495696e-08
BRCA1 O 0 5.2799734362452e-08
that O 0 6.14686600231007e-12
were O 0 3.857648228633437e-11
tested O 0 1.934648274914963e-11
by O 0 2.1771083200117225e-12
one O 0 1.1429615934255288e-12
of O 0 3.4013883289801816e-12
the O 0 1.7745873130345369e-12
standard O 0 5.857007153581284e-12
screening O 0 1.5086208324244232e-11
methods O 0 1.7492775283844963e-10
, O 0 5.061098241887496e-12
mutations O 0 1.5994348206982423e-11
were O 0 3.060855388592465e-11
detected O 0 3.6551719984068143e-10
in O 0 2.9117666611178095e-11
the O 0 2.8256080808475303e-10
coding O 0 1.2666975246489187e-09
sequence O 0 2.0682214274536648e-10
or O 0 1.659486992267034e-10
splice O 0 2.2718067427263122e-08
sites O 0 1.1436872560111055e-09
in O 0 3.007796789411543e-11
an O 0 1.581465671309304e-13
estimated O 0 3.4727509496540465e-12
63 O 0 4.017784160925686e-10
% O 0 1.158103734438809e-11
( O 0 4.635260816669706e-13
95 O 0 3.6918255119644527e-09
% O 0 3.4018066141783265e-10
CI O 0 5.414509359980002e-06
51 O 0 3.3225369122646953e-09
% O 0 9.309339410457085e-11
- O 0 1.9601005263325533e-09
77 O 0 4.682186638405028e-09
% O 0 7.117543360246614e-11
) O 0 8.800210560266919e-12
. O 0 1.4113415991445777e-09

The O 0 1.454996567673561e-08
estimated O 0 9.395659944511081e-11
sensitivity O 0 1.3852877733810942e-09
was O 0 3.988783747743696e-10
identical O 0 2.449622171774024e-10
for O 0 3.8785476566549626e-12
direct O 0 1.749204114886993e-10
sequencing O 0 1.2199691035164051e-08
and O 0 4.256969499127905e-10
other O 0 1.1780010300554977e-10
techniques O 0 2.1000960970241067e-08
. O 0 1.6606948705089053e-08

The O 0 4.264060180503293e-07
penetrance O 0 0.0008789841085672379
of O 0 1.3840724022884388e-05
BRCA2 O 0 2.025039793807082e-05
was O 0 1.3953354027762543e-09
estimated O 0 2.6331558461434312e-12
by O 0 2.7978309773135646e-12
maximizing O 0 4.404652642620022e-09
the O 0 1.4467576026078177e-09
LOD O 0 0.051068179309368134
score O 0 1.0842214237527514e-07
in O 0 4.466188752161315e-09
BRCA2 O 0 1.0167033082097987e-07
- O 0 1.0148256457398475e-08
mutation O 0 1.756516709860989e-09
families O 0 3.918098484545496e-11
, O 0 1.6855114038424185e-13
over O 0 3.912687502553164e-13
all O 0 1.316828482193777e-12
possible O 0 3.714057117409908e-10
penetrance O 0 1.7122241615652456e-06
functions O 0 6.848081213206569e-09
. O 0 1.4515621593602646e-08

The O 0 1.7192645529462425e-08
estimated O 0 6.386398077040667e-10
cumulative O 0 1.4040044682417374e-08
risk O 0 1.2330978904628864e-08
of O 0 1.2691963924282845e-08
breast B-Disease 0 1.3646434126712848e-05
cancer I-Disease 0 1.2995916449654032e-06
reached O 0 5.613077860289195e-07
28 O 0 5.101883857605571e-07
% O 0 1.602996763105935e-10
( O 0 3.1183657544196774e-13
95 O 0 7.73196506820284e-10
% O 0 6.649836931105213e-11
CI O 0 2.1292619578616723e-07
9 O 0 2.850448765912006e-10
% O 0 5.832982534481612e-12
- O 0 2.2245719155655763e-11
44 O 0 3.739317189221936e-11
% O 0 2.1859451098185656e-13
) O 0 2.6122220807614765e-15
by O 0 8.524081505749403e-14
age O 0 9.060257405435479e-11
50 O 0 1.837763274892268e-11
years O 0 5.906604632482937e-12
and O 0 1.3892288361350147e-11
84 O 0 4.969467504167824e-09
% O 0 1.463650901867286e-11
( O 0 2.3023361103886864e-13
95 O 0 9.95914350987448e-10
% O 0 5.3450271986221765e-11
CI O 0 4.69886515475082e-07
43 O 0 6.91616486303559e-10
% O 0 7.651591166224492e-12
- O 0 3.520188307515326e-11
95 O 0 3.3432526191923273e-10
% O 0 1.0432978266028403e-12
) O 0 1.2522402108034857e-14
by O 0 1.5122557069438547e-12
age O 0 2.118452524513259e-09
70 O 0 1.0521078452896404e-09
years O 0 4.785171148213863e-10
. O 0 1.553196327108708e-08

The O 0 1.596275978954509e-06
corresponding O 1 0.9999866485595703
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 1.3266627547636745e-06
were O 0 3.97172739141638e-09
0 O 0 4.594781088940181e-08
. O 0 2.370441842813875e-09

4 O 0 1.8080136214848608e-06
% O 0 6.7159477978862014e-09
( O 0 3.402791243223291e-11
95 O 0 1.4646862389611215e-08
% O 0 9.908215359288874e-10
CI O 0 2.807957116601756e-06
0 O 0 1.192135390404303e-09
% O 0 1.2548099712073046e-11
- O 0 2.955308220364827e-11
1 O 0 6.645944905514511e-11
% O 0 5.286731881264106e-13
) O 0 3.157029437270706e-15
by O 0 2.2944629052626397e-13
age O 0 1.9814085094882472e-10
50 O 0 2.820550563942259e-11
years O 0 9.67893907383166e-12
and O 0 2.947230653971289e-11
27 O 0 3.5153073785210154e-09
% O 0 3.0295026903770506e-11
( O 0 2.4108314086376814e-13
95 O 0 4.635815620268602e-10
% O 0 1.7342870195502513e-11
CI O 0 4.752676474595319e-08
0 O 0 1.2675258065364403e-10
% O 0 3.6664313078638155e-12
- O 0 2.9700571863022773e-11
47 O 0 1.5103721051623609e-10
% O 0 1.017634110658805e-12
) O 0 2.2298913136451458e-14
by O 0 2.2473485745966304e-12
age O 0 3.6308474005153357e-09
70 O 0 1.6164546368102606e-09
years O 0 6.695518584010074e-10
. O 0 2.315841030053889e-08

The O 0 3.079834343111543e-08
lifetime O 0 9.73332987541653e-08
risk O 0 1.3424632072656095e-07
of O 0 4.2711661762950826e-07
breast B-Disease 1 0.9887145161628723
cancer I-Disease 0 6.022347224643454e-05
appears O 0 5.7075508763659855e-09
similar O 0 6.558505405429571e-10
to O 0 3.657578129256933e-10
the O 0 8.066365353442961e-09
risk O 0 9.390150879085013e-09
in O 0 2.8013902308998695e-10
BRCA1 O 0 2.351684402768228e-10
carriers O 0 8.523618443001535e-12
, O 0 1.7868477151464918e-13
but O 0 6.75724341932249e-13
there O 0 3.296623499356166e-13
was O 0 1.7797678261710637e-11
some O 0 1.431714881199031e-12
suggestion O 0 6.934829932525588e-10
of O 0 2.0250680299316315e-10
a O 0 9.330226868886626e-11
lower O 0 3.9457972889067605e-07
risk O 0 4.684169496727009e-09
in O 0 7.702130044862088e-10
BRCA2 O 0 6.119711848384668e-09
carriers O 0 2.1224960677912463e-10
< O 0 3.027876838146426e-09
50 O 0 6.288031206835853e-11
years O 0 2.503447752918997e-12
of O 0 2.6106833708738897e-11
age O 0 1.251539671898172e-08
. O 0 2.3413077698819507e-08

Eye B-Disease 1 0.9999653100967407
movement I-Disease 0 6.562292128364788e-06
abnormalities I-Disease 0 9.63787442742614e-07
correlate O 0 1.4594993658079147e-08
with O 0 2.109941735217724e-11
genotype O 0 2.0610255546671397e-07
in O 0 9.136584266933312e-10
autosomal O 0 0.0004802049952559173
dominant O 1 0.9841833710670471
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 0.9999983310699463
. O 0 4.682966334712546e-07

We O 0 9.097709607885918e-08
compared O 0 1.839165832961953e-07
horizontal O 0 8.861603646437288e-07
eye O 0 7.901821663836017e-05
movements O 0 1.9362405510037206e-06
( O 0 5.553904003363641e-10
visually O 0 1.1349304607222166e-08
guided O 0 4.187042268455343e-09
saccades O 0 1.0633419833538937e-07
, O 0 4.1768765529637264e-11
antisaccades O 0 1.2221775591569894e-07
, O 0 8.412871094209962e-11
and O 0 4.128938510539193e-11
smooth O 0 8.577200061310464e-10
pursuit O 0 4.4940975385543425e-09
) O 0 1.3875466530963165e-12
in O 0 1.849864358915987e-11
control O 0 5.829762783626791e-10
subjects O 0 1.097710988773315e-08
( O 0 4.121320038713572e-12
n O 0 3.9788752848046727e-10
= O 0 1.3984920166354442e-10
14 O 0 1.0991010185312788e-10
) O 0 1.2636381741329417e-12
and O 0 2.5629682404160192e-11
patients O 0 4.817645171684148e-10
with O 0 6.662106847091231e-13
three O 0 3.2117511775120455e-12
forms O 0 2.422386957690037e-09
of O 0 2.4986687208183866e-07
autosomal O 0 0.037211690098047256
dominant O 1 0.7270152568817139
cerebellar B-Disease 1 0.9999990463256836
ataxias I-Disease 0 0.0014928927412256598
type I-Disease 0 0.00014422216918319464
I I-Disease 0 5.947394674876705e-05
spinocerebellar B-Disease 0 0.0002612383686937392
ataxias I-Disease 0 1.564886224514339e-05
1 I-Disease 0 1.6777063649442425e-07
and I-Disease 0 6.234567861973517e-10
2 I-Disease 0 3.464922349039057e-09
( O 0 6.0687206128451354e-12
SCA1 B-Disease 0 1.750062256178353e-05
, O 0 8.616533181404762e-11
n O 0 1.299085006234435e-10
= O 0 2.7104592875693e-11
11 O 0 1.5169886180554926e-11
; O 0 2.8907978441572446e-12
SCA2 B-Disease 0 3.7654001516784774e-06
, O 0 5.921994145063891e-11
n O 0 1.8385530597964106e-10
= O 0 4.7415685960894294e-11
10 O 0 1.0571235727063755e-11
) O 0 4.561065609400006e-13
and O 0 1.0261252958443379e-10
SCA3 B-Disease 1 1.0
/ O 0 4.885997259407304e-05
Machado B-Disease 0 9.879178151095402e-07
- I-Disease 0 4.3347091605028254e-07
Joseph I-Disease 0 0.0003359135880600661
disease I-Disease 0 0.0012912036618217826
( O 0 3.127704761851646e-10
MJD B-Disease 1 1.0
) O 0 3.1778621401024054e-10
( O 0 6.8017804930042836e-12
n O 0 5.646456635588493e-10
= O 0 3.521573588294302e-10
16 O 0 5.806093383853295e-10
) O 0 1.267389925646567e-11
. O 0 3.928241731898652e-09

In O 0 8.443909393918148e-08
SCA1 B-Disease 0 0.00024595155264250934
, O 0 2.9947638813254684e-10
saccade O 0 2.279724142795203e-08
amplitude O 0 6.628885884651936e-09
was O 0 1.0678159051424885e-10
significantly O 0 1.9769351433662763e-10
increased O 0 6.606213354132251e-10
, O 0 1.0438437440807302e-11
resulting O 0 8.525822270399885e-10
in O 0 2.035847046499839e-09
hypermetria B-Disease 0 1.8475915567250922e-05
. O 0 3.1638649033993715e-07

The O 0 1.1337971983493844e-07
smooth O 0 7.460724873453728e-07
pursuit O 0 3.3722533316904446e-06
gain O 0 1.430180645911605e-06
was O 0 3.726066211129364e-08
decreased O 0 3.874909452861175e-06
. O 0 1.1772345231975123e-07

In O 0 2.416587960851757e-07
SCA2 B-Disease 0 0.0005710570840165019
, O 0 1.0044455267532726e-09
saccade O 0 5.448637807603518e-08
velocity O 0 2.1498534508168632e-08
was O 0 4.9115054245874035e-09
markedly O 0 4.229765636409866e-06
decreased O 0 1.709329808363691e-06
. O 0 5.497481581073771e-08

The O 0 2.874211268988347e-08
percentage O 0 4.857139757064033e-08
of O 0 1.71887670763482e-09
errors O 0 6.994346790634154e-07
in O 0 3.836975182025526e-08
antisaccades O 1 0.9810981750488281
was O 0 6.021137721745617e-08
greatly O 0 1.2934795279306854e-07
increased O 0 5.863018515128715e-09
and O 0 3.5565987654972986e-11
was O 0 8.350618113661668e-11
significantly O 0 9.043912285733313e-10
correlated O 0 2.412832378340113e-09
with O 0 1.4187482568969734e-12
age O 0 3.841615914268459e-09
at O 0 6.424541454386201e-10
disease O 0 1.1782359088385874e-08
onset O 0 2.480719331288128e-06
. O 0 1.8112184818619426e-07

In O 0 4.546846898989543e-09
addition O 0 6.963644660906709e-10
, O 0 1.1570880538436246e-11
a O 0 1.5174449153818048e-12
correlation O 0 1.3090635346546531e-11
between O 0 1.8948060134804656e-11
smooth O 0 7.579108007860214e-09
pursuit O 0 2.1093374158454026e-08
gain O 0 1.5531689268044602e-09
and O 0 5.084280219058712e-12
the O 0 8.77637459234526e-12
number O 0 2.3896006701162875e-11
of O 0 7.666631218761211e-10
trinucleotide O 0 2.245218865937204e-06
repeats O 0 1.7631628379533026e-09
was O 0 3.6317755469639224e-09
found O 0 9.906439002449474e-10
. O 0 1.8204550755740456e-08

In O 0 1.7506079075246817e-06
SCA3 B-Disease 1 1.0
, O 0 6.741810807397997e-07
gaze B-Disease 0 0.00018149404786527157
- I-Disease 0 3.279650172771653e-06
evoked I-Disease 0 5.325620804796927e-06
nystagmus I-Disease 0 5.077113655715948e-06
was O 0 4.042044476904039e-09
often O 0 2.8131578663770362e-11
present O 0 2.5666909569954655e-11
as O 0 1.4950886015330234e-11
was O 0 1.294045148814149e-10
saccade O 0 1.5711632883608218e-08
hypometria O 0 2.464533110924094e-07
and O 0 3.134525139447675e-10
smooth O 0 4.048959922897666e-08
pursuit O 0 2.7669088353832194e-07
gain O 0 1.0388463778099322e-07
was O 0 2.3315081421060313e-08
markedly O 0 2.2000309400027618e-05
decreased O 0 5.491211595654022e-06
. O 0 8.194645317871618e-08

Three O 0 1.2300136909004777e-08
major O 0 6.750712877590104e-09
criteria O 0 3.7819724241217045e-08
, O 0 1.20857546193065e-10
saccade O 0 1.4934636638486154e-08
amplitude O 0 1.5759646920798787e-09
, O 0 1.2056024581430513e-11
saccade O 0 2.4360367056885934e-09
velocity O 0 1.4625693989245292e-09
, O 0 2.0399144179394924e-11
and O 0 1.1050260532996514e-11
presence O 0 1.491847756440734e-10
of O 0 6.924367568217349e-08
gaze B-Disease 0 4.331871241447516e-05
- I-Disease 0 1.0249350452795625e-06
evoked I-Disease 0 1.2621133009815821e-06
nystagmus I-Disease 0 2.8347400871098216e-07
, O 0 6.117695326018913e-12
permitted O 0 5.243094847173779e-11
the O 0 6.202264830196258e-12
correct O 0 1.2000167526338146e-10
assignment O 0 1.241829694631491e-10
of O 0 1.0804091649108116e-10
90 O 0 4.877829251626054e-10
% O 0 8.736691925470552e-12
of O 0 1.9723693164830358e-11
the O 0 3.281515892350484e-10
SCA1 B-Disease 0 0.024257641285657883
, O 0 3.441735507703214e-10
90 O 0 6.158971666003765e-10
% O 0 3.5063894062575818e-12
of O 0 5.621048765336312e-12
the O 0 1.0124427685109794e-10
SCA2 B-Disease 0 0.0004372601688373834
, O 0 1.0405047656814048e-10
and O 0 3.195632994335007e-11
93 O 0 8.392728734207822e-10
% O 0 1.1356925599600998e-12
of O 0 5.303649229862484e-13
the O 0 5.84254693236641e-12
patients O 0 4.904875394728947e-10
with O 0 1.838240150375814e-11
SCA3 B-Disease 1 1.0
to O 0 9.228186172549613e-06
their O 0 5.499305757439288e-07
genetically O 0 1.3726199767916114e-06
confirmed O 0 6.026836274486413e-08
patient O 0 0.011971291154623032
group O 0 1.6953988560275413e-11
and O 0 3.1015981883514288e-12
, O 0 1.0904801367450645e-12
therefore O 0 1.539491867319498e-10
, O 0 2.1824217780186395e-12
may O 0 1.221136525231259e-10
help O 0 1.1412504274943558e-10
orient O 0 2.1643982961450092e-07
diagnoses O 0 6.643152232754801e-07
of O 0 1.031709651044821e-08
SCA1 B-Disease 1 0.999691367149353
, O 0 4.66916394437078e-10
SCA2 B-Disease 0 0.4246358573436737
, O 0 1.0464995536807464e-10
and O 0 1.4716744489717826e-10
SCA3 B-Disease 1 1.0
at O 0 1.796632176365165e-09
early O 0 7.731364881635727e-09
clinical O 0 1.9777435245060815e-09
stages O 0 6.49991527268412e-09
of O 0 7.337839780241495e-10
the O 0 1.009830530307454e-08
diseases O 0 2.868351430151961e-06
. O 0 3.1877407380420664e-09
. O 0 1.5945515130511012e-08

Genetic O 0 2.951916826532397e-07
basis O 0 3.511226642771703e-09
and O 0 2.26464767077994e-11
molecular O 0 6.183796252834384e-10
mechanism O 0 1.4531771341808053e-08
for O 0 8.092222891775691e-09
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 1.6574487744946964e-05

Ventricular B-Disease 1 0.9999823570251465
fibrillation I-Disease 1 0.8364802002906799
causes O 0 1.6471952903884812e-06
more O 0 1.0059540006546186e-10
than O 0 1.1222842100089281e-11
300 O 0 1.3379514510192259e-11
, O 0 4.762092413110319e-13
000 O 0 4.399635517016165e-11
sudden O 0 2.7167426294716357e-11
deaths O 0 1.047507566798167e-11
each O 0 3.972348166549067e-13
year O 0 6.527514639920184e-11
in O 0 4.469339898172109e-10
the O 0 1.913520186747064e-08
USA O 0 4.4422417744272025e-08
alone O 0 2.0838155645463985e-09
. O 0 3.1497131569580006e-09

In O 0 2.415559663404565e-08
approximately O 0 2.254322978290091e-10
5 O 0 4.246882845393429e-09
- O 0 3.227877076739105e-09
12 O 0 5.977615624708221e-10
% O 0 1.0118629892308384e-11
of O 0 1.7979697591874455e-12
these O 0 6.094178438796616e-13
cases O 0 7.268990097342165e-12
, O 0 5.172979557731272e-13
there O 0 4.111942719913636e-13
are O 0 2.8286287158049706e-13
no O 0 7.590323335138205e-12
demonstrable O 0 1.9729976941107452e-07
cardiac O 0 0.0012555065331980586
or O 0 3.5793064512290584e-08
non O 0 0.033592622727155685
- O 0 3.308666782686487e-05
cardiac O 1 0.9989259839057922
causes O 0 1.4827234551262336e-08
to O 0 1.3240978626039013e-11
account O 0 1.0370587201491421e-11
for O 0 3.15009476836714e-11
the O 0 5.8291873550331275e-09
episode O 0 3.4504465951101793e-09
, O 0 3.208193693343686e-12
which O 0 2.900295563608435e-13
is O 0 6.28744560755845e-14
therefore O 0 5.912082455539203e-12
classified O 0 2.8228756138171107e-11
as O 0 2.4587687441623984e-10
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 9.720547211600206e-08
IVF B-Disease 1 1.0
) O 0 2.1378550041362132e-09
. O 0 9.244464749258441e-09

A O 0 4.4638409235631116e-07
distinct O 0 2.5434003347868384e-08
group O 0 1.0764290153675304e-10
of O 0 1.2447785913138887e-08
IVF B-Disease 1 1.0
patients O 1 0.9999998807907104
has O 0 1.5651311843778437e-11
been O 0 6.576185342804797e-12
found O 0 1.201987836520202e-12
to O 0 1.6673217710996835e-12
present O 0 2.8828705048167258e-11
with O 0 1.5361377534578446e-12
a O 0 5.184581583494996e-11
characteristic O 0 1.535540405939173e-08
electrocardiographic O 0 1.0600265341054182e-06
pattern O 0 1.72541149368044e-07
. O 0 3.149462557416882e-08

Because O 0 4.5024737715948504e-08
of O 0 3.2622420320649326e-08
the O 0 2.1476720402091587e-09
small O 0 3.0980405740788086e-11
size O 0 4.003652964712501e-11
of O 0 1.8163846815522078e-10
most O 0 6.859695450556202e-11
pedigrees O 0 7.534613821746916e-09
and O 0 1.3527833367388276e-11
the O 0 1.1703210449354184e-11
high O 0 1.380391773109224e-10
incidence O 0 5.873959652014094e-11
of O 0 2.1838343633451274e-11
sudden B-Disease 0 6.59703403016465e-10
death I-Disease 0 6.721752487948152e-09
, O 0 2.2571441243846024e-11
however O 0 1.1245347014687823e-10
, O 0 1.2434092384189244e-12
molecular O 0 9.117234744948632e-12
genetic O 0 6.059548262465908e-12
studies O 0 1.6973974309442141e-12
of O 0 5.0082469421619535e-11
IVF B-Disease 1 1.0
have O 0 8.214543489870607e-10
not O 0 1.9744331170024054e-10
yet O 0 2.2895711992987344e-09
been O 0 1.6888575260498584e-10
done O 0 1.2333513099704874e-09
. O 0 8.295857334417178e-09

Because O 0 4.3346389588805323e-07
IVF B-Disease 1 1.0
causes O 0 0.024374566972255707
cardiac O 1 1.0
rhythm O 1 0.9998087286949158
disturbance O 0 0.0005682110204361379
, O 0 4.8281944414751976e-11
we O 0 1.3386713612617562e-11
investigated O 0 9.734157924157216e-10
whether O 0 1.649443470697065e-09
malfunction O 0 0.005888901650905609
of O 0 4.724766142771841e-07
ion O 0 3.25117762258742e-05
channels O 0 3.0963025920982545e-08
could O 0 2.734664439341117e-10
cause O 0 3.229036238394656e-08
the O 0 9.781131460329107e-10
disorder O 0 3.4312435115424478e-09
by O 0 2.7507284644512353e-11
studying O 0 1.0136663730619944e-09
mutations O 0 3.4291007533493456e-11
in O 0 4.8719106006400725e-12
the O 0 6.619592374246253e-11
cardiac O 0 5.089705013006096e-08
sodium O 0 2.739369051596441e-07
channel O 0 1.924023607102754e-08
gene O 0 2.0722934479522337e-09
SCN5A O 0 0.0006557357264682651
. O 0 7.616556558787124e-07

We O 0 1.1085345619221698e-07
have O 0 4.210561344031305e-10
now O 0 6.242977662607174e-11
identified O 0 4.480364690362393e-11
a O 0 4.5001141701916936e-11
missense O 0 3.0273764650701196e-07
mutation O 0 1.6453335360822052e-09
, O 0 1.6311209327657394e-11
a O 0 8.399687195792538e-12
splice O 0 3.1782835918647834e-08
- O 0 1.1777438579940736e-08
donor O 0 3.5316853885802857e-09
mutation O 0 7.291395265340839e-10
, O 0 6.007793546501661e-13
and O 0 4.3259306184949275e-13
a O 0 2.1050205849248993e-12
frameshift O 0 2.0878856421546743e-09
mutation O 0 2.973270935013872e-11
in O 0 1.3005719765035728e-11
the O 0 6.13581130348706e-11
coding O 0 5.056385310453493e-10
region O 0 1.085898926334039e-09
of O 0 2.9598696826838022e-09
SCN5A O 1 0.9999845027923584
in O 0 5.210758935447757e-09
three O 0 1.4245693513714741e-09
IVF B-Disease 1 1.0
families O 0 7.628986331553733e-09
. O 0 4.104491413414735e-09

We O 0 6.681057840296489e-08
show O 0 1.4175378926228888e-10
that O 0 3.9920733277236387e-13
sodium O 0 5.589280704931809e-10
channels O 0 1.6112999823292284e-11
with O 0 1.0578183836686128e-13
the O 0 3.776805257427185e-11
missense O 0 2.197249493463005e-08
mutation O 0 5.319379936530311e-10
recover O 0 4.546162113427954e-09
from O 0 6.453669543216023e-11
inactivation O 0 2.7691103241522796e-06
more O 0 1.0969725995624291e-11
rapidly O 0 1.3594425585239378e-09
than O 0 4.818917834215064e-12
normal O 0 3.2654573489665495e-10
and O 0 4.788845969078137e-12
that O 0 1.9152752571850035e-13
the O 0 1.4183004770629282e-10
frameshift O 0 2.5935349867722834e-08
mutation O 0 1.6529130841824724e-10
causes O 0 7.994704204206116e-11
the O 0 3.5936389281010506e-11
sodium O 0 2.5265152192588403e-09
channel O 0 9.738423956129338e-11
to O 0 5.4538981837659595e-12
be O 0 1.6246509693118583e-10
non O 0 5.654760570905637e-07
- O 0 1.8219752462300676e-07
functional O 0 1.9422400328039657e-06
. O 0 5.190991458903227e-08

Our O 0 3.759167555017484e-08
results O 0 3.234459144962898e-09
indicate O 0 1.518310033254977e-09
that O 0 3.680528538191341e-12
mutations O 0 1.6980759853790772e-10
in O 0 7.050054984247822e-11
cardiac O 0 1.8001081514285033e-07
ion O 0 4.5141939608583925e-07
- O 0 4.346815785538638e-06
channel O 0 7.68829266917237e-09
genes O 0 3.0023861868899715e-11
contribute O 0 5.7016227676676134e-12
to O 0 2.1697873532622314e-12
the O 0 1.9515260935021317e-11
risk O 0 2.2245390252084718e-10
of O 0 2.0174192871813545e-10
developing O 0 1.2883948841135862e-07
IVF B-Disease 1 1.0
. O 0 1.8687657643567945e-08
. O 0 3.725098451923259e-09

Molecular O 0 1.1384728395569255e-06
heterogeneity O 0 1.5616853943356546e-06
in O 0 3.1211168760592045e-08
mucopolysaccharidosis B-Disease 0 0.037887923419475555
IVA I-Disease 1 0.9999998807907104
in O 0 5.609717845800333e-08
Australia O 0 1.5413790244167558e-09
and O 0 1.3906106821615083e-10
Northern O 0 6.5081899869312565e-09
Ireland O 0 5.269115366246524e-09
: O 0 4.0046913701852205e-11
nine O 0 1.4455900365639707e-10
novel O 0 7.877159480251805e-10
mutations O 0 4.590840901874671e-11
including O 0 1.347756021369273e-11
T312S O 0 1.6375643951960228e-07
, O 0 1.895485331193658e-11
a O 0 3.2701222372338856e-12
common O 0 3.6790723245694323e-10
allele O 0 4.920870932956234e-10
that O 0 9.517125585875585e-13
confers O 0 3.953578298077076e-10
a O 0 2.921418315593449e-11
mild O 0 4.7515345613646787e-07
phenotype O 0 2.2733231162419543e-05
. O 0 9.952981372407521e-08

Mucopolysaccharidosis B-Disease 1 1.0
IVA I-Disease 1 1.0
( O 0 0.0005388379795476794
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 1.8277185320769718e-09
is O 0 1.7476225327994754e-11
an O 0 1.5719462190255662e-11
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 2.9299170023477927e-07
by O 0 1.512199671038772e-10
a O 0 2.2909123487124816e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 9.272139323002193e-08
N O 0 5.884284064450185e-07
- O 0 2.0620984031438638e-08
acetylgalactosamine O 0 1.4114575606072322e-06
- O 0 7.521062883597551e-08
6 O 0 1.491166656819587e-08
- O 0 2.613984584343143e-09
sulfate O 0 4.81681432518144e-08
sulfatase O 0 1.535432784294244e-05
( O 0 1.0588803167621563e-09
GALNS O 1 0.9859681129455566
) O 0 2.3979036534171883e-09
. O 0 2.4006551413435773e-08

Previous O 0 1.5939014019750175e-07
studies O 0 1.6345546027807245e-09
of O 0 4.51066073381412e-10
patients O 0 2.9400861745187967e-09
from O 0 1.705570060184236e-11
a O 0 1.5036875824353535e-12
British O 0 2.1213666934194464e-10
- O 0 2.5528421598863815e-09
Irish O 0 9.643463805275587e-09
population O 0 2.3239292434862335e-12
showed O 0 1.3591500971563142e-12
that O 0 1.1302823741787382e-14
the O 0 9.30172085189529e-12
I113F O 0 3.829568484547963e-08
mutation O 0 3.7083375259427953e-10
is O 0 6.449996244571599e-13
the O 0 1.1162761253541431e-12
most O 0 4.0680157267942996e-13
common O 0 1.6474136291244612e-11
single O 0 4.90067396385907e-11
mutation O 0 1.2318185360626899e-09
among O 0 2.5190041164080412e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.493499755859375
and O 0 1.0098372138500622e-10
produces O 0 2.3021848316595594e-11
a O 0 3.865003803116274e-12
severe O 0 7.564395332337881e-08
clinical O 0 3.4578481518110493e-06
phenotype O 0 2.1249958081170917e-05
. O 0 6.568012622665265e-08

We O 0 4.3359122514630144e-08
studied O 0 5.184273277336615e-08
mutations O 0 1.8779764410226107e-09
in O 0 1.2024087281403695e-10
the O 0 2.000293264359243e-09
GALNS O 0 0.021426264196634293
gene O 0 1.9673742635006874e-09
from O 0 7.050704464717228e-10
23 O 0 3.753970911901661e-09
additional O 0 4.732565006548839e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.0023342552594840527
( O 0 1.933035545867434e-12
15 O 0 2.600634117777556e-11
from O 0 4.150112111606097e-12
Australia O 0 3.881233875957513e-12
, O 0 2.9386226525068837e-13
8 O 0 1.6240181074933524e-11
from O 0 2.0853482135541057e-11
Northern O 0 1.3395615727773702e-09
Ireland O 0 6.734004465158705e-10
) O 0 1.1988008242341808e-12
, O 0 4.5298975074464787e-13
with O 0 6.101782761783886e-14
various O 0 1.2158099527148636e-10
clinical O 0 5.657457791130582e-07
phenotypes O 0 9.694034815765917e-05
( O 0 9.238515508158684e-11
severe O 0 6.384349035215564e-06
, O 0 1.3614190330635267e-10
16 O 0 7.696575321514132e-11
cases O 0 1.8486333991374337e-11
; O 0 4.108213769171698e-12
intermediate O 0 9.339967164123664e-07
, O 0 4.416642399029946e-12
4 O 0 3.298626996550702e-11
cases O 0 1.6556037790715905e-11
; O 0 4.4163582513245814e-11
mild O 0 1.74278397935268e-06
, O 0 5.472921005278408e-10
3 O 0 3.909391033118936e-09
cases O 0 6.782290284945702e-10
) O 0 6.153755283122564e-11
. O 0 1.4286734462132245e-08

We O 0 5.342039344213845e-07
found O 0 7.549171066045801e-09
two O 0 8.541117813010146e-11
common O 0 9.613505547179102e-10
mutations O 0 4.841005374345286e-10
that O 0 3.825479863439618e-12
together O 0 1.9149194382950263e-11
accounted O 0 8.711424359653108e-10
for O 0 1.906817238828129e-11
32 O 0 3.5593014646728705e-10
% O 0 4.836597702201351e-12
of O 0 3.7412273799775075e-12
the O 0 1.8623510719684155e-11
44 O 0 3.38028188773265e-10
unrelated O 0 3.690213468132697e-09
alleles O 0 2.5887531007739994e-10
in O 0 1.249725462004747e-10
these O 0 6.892394988078365e-10
patients O 0 2.3776202340286545e-08
. O 0 5.840829153669347e-09

One O 0 5.478511866385816e-09
is O 0 1.587675303726943e-11
the O 0 1.326689591518715e-10
T312S O 0 6.868751825095387e-07
mutation O 0 1.430134854984999e-08
, O 0 2.301227784717863e-11
a O 0 1.1723407834784982e-11
novel O 0 2.9843190141320974e-09
mutation O 0 2.5367423717170823e-09
found O 0 1.4667529343870278e-11
exclusively O 0 4.207179743476175e-11
in O 0 2.390685739650511e-11
milder O 1 0.7581862211227417
patients O 1 0.8209975957870483
. O 0 4.441665737431322e-07

The O 0 6.619576708999375e-08
other O 0 2.914007091181503e-10
is O 0 4.920030528821062e-12
the O 0 1.1302842342630903e-11
previously O 0 3.081504149071712e-11
described O 0 7.367567667060371e-11
I113F O 0 9.258319977334395e-08
that O 0 6.243224687230153e-12
produces O 0 8.578243670953611e-11
a O 0 3.244848834071945e-11
severe O 0 1.3481638916346128e-06
phenotype O 0 0.0009833486983552575
. O 0 5.603989734481729e-07

The O 0 7.244470339173859e-07
I113F O 0 1.579572017362807e-05
and O 0 1.7165874055535824e-08
T312S O 0 1.5392519117085612e-06
mutations O 0 2.3772970259017256e-09
accounted O 0 3.0044855492405986e-09
for O 0 3.651804553195248e-11
8 O 0 1.4836278872110142e-09
( O 0 9.562450657696342e-13
18 O 0 4.6043193563383156e-11
% O 0 1.0132917725377832e-12
) O 0 2.4211842180135203e-14
and O 0 2.893937043127459e-12
6 O 0 1.0192673371989258e-09
( O 0 9.45176554210947e-13
14 O 0 1.5691702104358995e-10
% O 0 1.5112004529693746e-12
) O 0 2.5564172632074056e-14
of O 0 5.705495537827732e-12
44 O 0 1.965557994143552e-10
unrelated O 0 2.5864888009152764e-09
alleles O 0 4.002150555404427e-10
, O 0 1.0846728376590065e-10
respectively O 0 1.765802259967586e-08
. O 0 6.015397957526147e-08

The O 0 5.727335405936174e-07
relatively O 0 3.607668759286753e-07
high O 0 4.83067026380013e-08
residual O 0 2.149379497495829e-06
GALNS O 0 0.011906728148460388
activity O 0 1.5054935431635386e-07
seen O 0 1.107810732037251e-09
when O 0 1.0074978351592989e-10
the O 0 2.3478030630741387e-10
T312S O 0 1.4683736537790537e-07
mutant O 0 2.494463480218201e-08
cDNA O 0 3.3418469769230796e-08
is O 0 1.5910227302295965e-10
overexpressed O 0 1.9562887132451579e-07
in O 0 2.7872024133124285e-10
mutant O 0 6.443086508767237e-09
cells O 0 2.7080113151889407e-10
provides O 0 5.424484104087079e-13
an O 0 5.6880583278401745e-15
explanation O 0 1.7431547524870972e-11
for O 0 3.142141928591524e-12
the O 0 3.152139382844865e-10
mild O 0 3.3872347557917237e-06
phenotype O 0 2.4813746222207556e-06
in O 0 3.800632586425934e-10
patients O 0 7.3094275077068e-10
with O 0 2.9153814236869413e-13
this O 0 4.174773721166147e-11
mutation O 0 2.9822135871881983e-09
. O 0 8.59994209179149e-09

The O 0 1.0111739001672504e-08
distribution O 0 6.939328556221369e-10
and O 0 1.8912458404907184e-11
relative O 0 2.618644190377495e-10
frequencies O 0 9.633839559430868e-11
of O 0 3.2948414829814254e-11
the O 0 5.6014016341920936e-11
I113F O 0 5.165578542687399e-08
and O 0 7.548245917199381e-10
T312S O 0 1.5427040978011064e-07
mutations O 0 8.853133226516263e-10
in O 0 1.4066996179007418e-10
Australia O 0 3.154712255315495e-11
corresponded O 0 2.615248642645618e-11
to O 0 4.322287319724616e-12
those O 0 1.2096563334340615e-11
observed O 0 1.1350331785564549e-10
in O 0 8.98957852601967e-11
Northern O 0 1.4827112870818837e-09
Ireland O 0 2.909464336120493e-10
and O 0 3.624526373480208e-11
are O 0 1.8289224301692997e-12
unique O 0 4.429828899532584e-12
to O 0 6.7955818923437494e-12
these O 0 4.3907495694828214e-11
two O 0 1.0970102430618578e-11
populations O 0 3.388633471046454e-11
, O 0 7.170501171993582e-13
suggesting O 0 1.6365745564295153e-11
that O 0 1.2855712588216717e-12
both O 0 4.6306347645241885e-11
mutations O 0 1.9000435946825434e-10
were O 0 7.548361380393942e-10
probably O 0 5.239958467129213e-10
introduced O 0 2.576148461219674e-10
to O 0 2.4211280549857328e-11
Australia O 0 2.0146804363685433e-11
by O 0 4.76327571136137e-12
Irish O 0 1.216531875236626e-09
migrants O 0 3.476490276210775e-11
during O 0 1.4965381364695496e-11
the O 0 1.2035667601439926e-11
19th O 0 2.1557664098281748e-08
century O 0 4.0525461031393206e-07
. O 0 2.1338520639346825e-07

Haplotype O 0 1.288821522393846e-06
analysis O 0 6.413329867172024e-09
using O 0 3.519091018588938e-09
6 O 0 1.2310233898915612e-07
RFLPs O 0 1.528736720501911e-05
provides O 0 4.0348537011514196e-11
additional O 0 3.1964240282400525e-12
data O 0 1.1598035899729187e-11
that O 0 2.800242405575498e-13
the O 0 7.894843806477425e-11
I113F O 0 2.0033301950661553e-07
mutation O 0 1.1211812589451142e-09
originated O 0 3.2491051515926017e-10
from O 0 5.115007809669558e-12
a O 0 2.3029082980852156e-12
common O 0 3.096600753593748e-10
ancestor O 0 2.7038282723879092e-08
. O 0 2.5788105872948108e-08

The O 0 7.3919568421843e-07
other O 0 8.947063534492372e-09
9 O 0 1.4870730069560523e-07
novel O 0 2.8917579442122587e-08
mutations O 0 2.6968995925358286e-09
identified O 0 1.0516038734253996e-10
in O 0 4.438152970132059e-11
these O 0 8.436556314661559e-11
23 O 0 2.20179607879345e-09
patients O 0 2.556062694836214e-09
were O 0 2.750235282567015e-11
each O 0 2.5996346460048503e-13
limited O 0 1.9908213966246535e-11
to O 0 7.452065006741115e-12
a O 0 6.718208628297972e-11
single O 0 6.403160224266458e-09
family O 0 3.1038636105762407e-09
. O 0 2.6011939269210416e-08

These O 0 4.0125041067540224e-08
data O 0 3.420846717006043e-09
provide O 0 2.390512440775261e-11
further O 0 1.3117329271394862e-11
evidence O 0 3.185828684193481e-11
for O 0 8.99461668341095e-12
extensive O 0 3.94616694876504e-09
allelic O 0 2.0415102142123942e-07
heterogeneity O 0 8.454253475065343e-07
in O 0 3.4316516916987894e-07
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 1.4562423489294929e-09
British O 0 1.4862505670620862e-09
- O 0 4.4938399668126294e-09
Irish O 0 1.957142714559268e-08
patients O 0 1.6091364907211414e-09
and O 0 1.3232765577742e-12
provide O 0 1.34361217898199e-13
evidence O 0 1.9151375364040435e-12
for O 0 2.768063772987106e-12
their O 0 2.943636723262699e-10
transmission O 0 1.3198530046665269e-09
to O 0 2.429941317605433e-11
Australia O 0 1.043127216548978e-11
by O 0 1.5372016810497047e-12
British O 0 9.776711662468074e-10
- O 0 5.966386940059465e-09
Irish O 0 1.6579067008137827e-08
migrants O 0 6.038394784191325e-10
. O 0 1.3725332502489973e-11
. O 0 2.6760588189844725e-10

Identification O 0 1.8146903357774136e-07
of O 0 8.94075427027019e-08
constitutional O 0 0.001980467699468136
WT1 O 1 0.9999997615814209
mutations O 0 2.6288114440831123e-06
, O 0 1.8378518151784817e-10
in O 0 8.56509863034205e-11
patients O 0 4.094357741735166e-09
with O 0 1.668951608857494e-11
isolated O 0 1.5441847835973022e-06
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 6.863586921035392e-10
and O 0 4.130661524631707e-12
analysis O 0 6.313577265160131e-12
of O 0 2.0062221328664975e-10
genotype O 0 2.7263925517218013e-07
/ O 0 1.852335351770762e-08
phenotype O 0 5.649702039534077e-09
correlations O 0 7.329722939708461e-11
by O 0 1.4062092690367983e-13
use O 0 2.1964196954271653e-12
of O 0 5.954887277725973e-11
a O 0 1.113740211167169e-10
computerized O 0 4.955220447300235e-07
mutation O 0 5.21200433922786e-08
database O 0 2.11290487328597e-08
. O 0 1.8946497704064313e-08

Constitutional O 0 1.3402798686001915e-05
mutations O 0 5.101153632836031e-08
of O 0 2.471739612985857e-08
the O 0 3.388205271903644e-08
WT1 O 0 3.627307523856871e-05
gene O 0 1.640260482993483e-09
, O 0 3.1752551976627075e-11
encoding O 0 2.705508705957982e-09
a O 0 6.95495050440087e-10
zinc O 0 1.6784919125711895e-06
- O 0 1.9953068886024994e-07
finger O 0 3.17365547175541e-08
transcription O 0 8.517832839061157e-08
factor O 0 1.4474234255601459e-08
involved O 0 5.806614078451844e-10
in O 0 1.3627031725249594e-09
renal O 1 1.0
and O 0 1.648627119266166e-07
gonadal O 0 0.3299392759799957
development O 0 3.248878329031868e-06
, O 0 5.1108554888212865e-11
are O 0 7.149878562470735e-13
found O 0 4.115685656863599e-13
in O 0 4.0347415621207194e-13
most O 0 8.834750422556659e-13
patients O 0 1.600835783377441e-11
with O 0 1.957317988243723e-12
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.91648223746688e-08
DDS B-Disease 1 1.0
) O 0 5.1847991178188835e-11
, O 0 1.0028900453151746e-11
or O 0 1.4311055673843498e-09
diffuse B-Disease 1 0.999998927116394
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 2.9735589990309563e-08
DMS B-Disease 0 0.00019643384439405054
) O 0 8.076082337604706e-12
associated O 0 1.844133734607567e-10
with O 0 2.8640444182936875e-11
pseudohermaphroditism B-Disease 1 1.0
and O 0 7.206411282822955e-06
/ O 0 1.5467932826140895e-05
or O 0 3.2550576634093886e-07
Wilms B-Disease 1 0.9999992847442627
tumor I-Disease 1 0.9997649788856506
( O 0 2.5845310336336524e-09
WT B-Disease 1 1.0
) O 0 8.015641483893887e-10
. O 0 1.0359511470880989e-08

Most O 0 1.1996385751444905e-07
mutations O 0 2.783581898313514e-08
in O 0 4.559448374408248e-09
DDS B-Disease 1 1.0
patients O 1 0.9630652070045471
lie O 0 8.724635591761398e-08
in O 0 7.302460303115765e-10
exon O 0 3.156426231498699e-08
8 O 0 9.867106243177659e-09
or O 0 6.386349227227583e-10
exon O 0 6.826500964507431e-08
9 O 0 1.8456699280022804e-08
, O 0 2.2607170302446633e-10
encoding O 0 8.715421273564061e-08
zinc O 0 0.00028791691875085235
finger O 0 0.0001284982281504199
2 O 0 2.5328783522127196e-05
or O 0 1.6830107085752388e-07
zinc O 0 2.165989462810103e-05
finger O 0 7.040691798465559e-07
3 O 0 5.537926028864604e-08
, O 0 2.063236213822872e-11
respectively O 0 1.2722496389727667e-09
, O 0 7.026880813332248e-12
with O 0 1.292314779494097e-12
a O 0 9.676194567820318e-11
hot O 0 4.964608706359286e-06
spot O 0 1.6419987147742177e-08
( O 0 1.8172908924224407e-12
R394W O 0 7.451776973255164e-09
) O 0 4.5653238134324425e-12
in O 0 3.9167552534635774e-10
exon O 0 6.490477488796387e-08
9 O 0 9.079472818029899e-08
. O 0 2.997589731990047e-08

We O 0 1.1848231729061354e-08
analyzed O 0 5.317688955841504e-09
a O 0 2.5280262258564612e-11
series O 0 2.1639858308053483e-11
of O 0 3.7846007577835294e-11
24 O 0 1.5309744583191787e-09
patients O 0 1.7481717407008546e-08
, O 0 7.198939794977877e-12
10 O 0 4.174534676271158e-11
with O 0 7.919815844803502e-12
isolated B-Disease 0 7.399863193313649e-07
DMS I-Disease 1 1.0
( O 0 3.4517910307840793e-08
IDMS B-Disease 1 0.9999994039535522
) O 0 2.263625259457669e-10
, O 0 4.107910192563402e-11
10 O 0 2.6978022246715305e-11
with O 0 5.508480824256701e-12
DDS B-Disease 1 1.0
, O 0 7.193127204985217e-10
and O 0 1.2812788330318625e-10
4 O 0 2.661608489162859e-09
with O 0 3.551074365115703e-11
urogenital B-Disease 0 0.0005203974433243275
abnormalities I-Disease 0 0.034644950181245804
and O 0 6.174763029775931e-07
/ O 0 1.4029802514414769e-05
or O 0 2.963734914374072e-06
WT B-Disease 1 1.0
. O 0 1.9056935229855299e-07

We O 0 5.354413019631465e-07
report O 0 1.3632477191549697e-07
WT1 O 0 0.0033784264232963324
heterozygous O 0 3.0462302902378724e-07
mutations O 0 7.026998538606222e-09
in O 0 1.3661245745755224e-10
16 O 0 1.6846920525281917e-09
patients O 0 2.760654593814138e-09
, O 0 3.6065876847513056e-12
4 O 0 4.6482911963963147e-10
of O 0 1.729907050940227e-10
whom O 0 1.0761236346468195e-09
presented O 0 5.8390384083395475e-08
with O 0 3.661572600677232e-09
IDMS B-Disease 1 0.9999963045120239
. O 0 6.984441370150307e-06

One O 0 6.779490036024072e-08
male O 0 3.980395568703443e-09
and O 0 8.876192142404093e-11
two O 0 2.3855294475905175e-11
female O 0 5.073010345135742e-10
IDMS B-Disease 1 0.9829277396202087
patients O 0 6.345117435557768e-05
with O 0 6.517944228789929e-08
WT1 O 1 1.0
mutations O 0 0.0010277966503053904
underwent O 0 0.00041879326454363763
normal O 0 0.0012150794500485063
puberty O 0 0.0005333531880751252
. O 0 3.588609942539733e-08

Two O 0 4.2739938521663134e-07
mutations O 0 7.975738469667704e-08
associated O 0 7.0327779155832104e-09
with O 0 6.78373968110435e-10
IDMS B-Disease 1 0.9999929666519165
are O 0 6.992513790216037e-10
different O 0 3.0931462252636877e-11
from O 0 3.4786926811358754e-11
those O 0 1.192698197149955e-11
described O 0 2.212310612481616e-10
in O 0 3.514704083329434e-09
DDS B-Disease 1 1.0
patients O 0 0.19352534413337708
. O 0 1.0162593611084958e-07

No O 0 2.0768429749296047e-06
WT1 O 0 0.0008961004787124693
mutations O 0 7.278535463228764e-08
were O 0 7.563407677935174e-10
detected O 0 6.879973035722742e-09
in O 0 6.508121125348154e-11
the O 0 2.738887450171035e-10
six O 0 1.0998224553304681e-10
other O 0 6.590820667007335e-10
IDMS B-Disease 1 1.0
patients O 0 0.00022676643857266754
, O 0 2.7741961505789448e-11
suggesting O 0 4.4785986030859704e-10
genetic O 0 2.8504771876214363e-09
heterogeneity O 0 9.12309658929189e-08
of O 0 1.0786291859687935e-08
this O 0 1.74325727186897e-08
disease O 0 2.679035060282331e-05
. O 0 1.4960302507915912e-07

We O 0 1.32345903125497e-07
analyzed O 0 2.8452703304537863e-07
genotype O 0 3.678539997054031e-06
/ O 0 3.137824649002141e-07
phenotype O 0 7.037704818912971e-08
correlations O 0 1.0056326438245833e-08
, O 0 2.932012055020805e-12
on O 0 6.9174900182988885e-12
the O 0 8.688230256764795e-13
basis O 0 1.5977486694795928e-11
of O 0 3.973570170817675e-12
the O 0 1.026669027570648e-11
constitution O 0 1.0843440034769003e-10
of O 0 2.092530149155891e-09
a O 0 8.061131206993366e-10
WT1 O 0 1.5496696505579166e-05
mutation O 0 5.592482477112526e-09
database O 0 2.955698741313739e-10
of O 0 4.684364007800923e-10
84 O 0 2.8051838185660927e-08
germ O 0 0.00013987447891850024
- O 0 7.29502244212199e-06
line O 0 3.131518678856082e-05
mutations O 0 7.094113629868559e-10
, O 0 3.090932891580689e-12
to O 0 2.895549251757945e-12
compare O 0 2.5265378678085426e-10
the O 0 2.373447965942077e-11
distribution O 0 3.662358263878396e-11
and O 0 2.7417491020587104e-12
type O 0 6.301937860442308e-10
of O 0 1.0273498718404994e-09
mutations O 0 8.423242658928132e-11
, O 0 6.303226712280063e-13
according O 0 5.3798510785130205e-12
to O 0 8.073001468711372e-12
the O 0 9.57470630558177e-11
different O 0 6.078759717809135e-10
symptoms O 0 4.098355475434801e-06
. O 0 6.787939099694995e-08

This O 0 1.0188733412519468e-08
demonstrated O 0 8.527895545284991e-08
( O 0 2.1086946425108444e-11
1 O 0 7.078961306028475e-10
) O 0 1.3358370399424446e-12
the O 0 2.1122126617201253e-11
association O 0 9.518309751488374e-12
between O 0 2.2807818134129576e-11
mutations O 0 2.1786807080648174e-10
in O 0 1.0485159407380706e-09
exons O 0 9.318355864706973e-09
8 O 0 1.5011880627469054e-09
and O 0 3.199579143298159e-11
9 O 0 1.6292508453474852e-09
and O 0 1.1581507280977732e-10
DMS B-Disease 0 0.00012223357043694705
; O 0 2.2169286406636957e-09
( O 0 3.610485521665652e-11
2 O 0 3.059924535975256e-09
) O 0 2.8423888676770703e-12
among O 0 2.8404936389114788e-11
patients O 0 3.016617233786434e-10
with O 0 3.812645078121735e-12
DMS B-Disease 0 3.930605817004107e-05
, O 0 2.5001374234778773e-11
a O 0 1.5019161045057294e-12
higher O 0 1.2591862275090904e-10
frequency O 0 5.831461702410223e-11
of O 0 6.456723350423133e-11
exon O 0 8.749644564431946e-09
8 O 0 4.596374392207281e-09
mutations O 0 6.562835275225609e-10
among O 0 1.182404035793283e-10
46 O 0 1.2667217275108555e-09
, O 0 1.1682564637904846e-10
XY O 0 3.7965032788633835e-06
patients O 0 2.412530086814968e-08
with O 0 9.19254602993469e-12
female O 0 4.0960020097902117e-11
phenotype O 0 1.636079938194257e-09
than O 0 2.718359912168289e-11
among O 0 2.8962410594801646e-11
46 O 0 1.3921772623604056e-09
, O 0 1.8621920672146075e-10
XY O 0 2.5336343242088333e-05
patients O 0 1.447424011757903e-07
with O 0 8.95333113204444e-12
sexual O 0 1.972306484798736e-10
ambiguity O 0 2.025718037756974e-09
or O 0 6.646214134597983e-10
male O 0 1.6211190723147695e-10
phenotype O 0 2.639786444991188e-10
; O 0 3.4348071262235713e-12
and O 0 1.8518273720014022e-11
( O 0 6.848484995249093e-13
3 O 0 1.1727641080483409e-10
) O 0 5.039518607106996e-13
statistically O 0 6.03256420511622e-12
significant O 0 4.0572389198301195e-12
evidence O 0 1.2034227780954865e-10
that O 0 4.881335266548881e-11
mutations O 0 4.417980203896832e-09
in O 0 3.2249616310764395e-08
exons O 0 2.10155519653199e-07
8 O 0 2.2927187259824677e-08
and O 0 1.5702748823454016e-10
9 O 0 2.330955650720057e-09
preferentially O 0 2.006770527529511e-09
affect O 0 1.6115722090148665e-09
amino O 0 3.3967756385422376e-10
acids O 0 1.669566984663362e-10
with O 0 1.8966165443723426e-12
different O 0 1.3930975296949644e-11
functions O 0 8.977122517572766e-11
. O 0 2.0238942466388465e-10
. O 0 5.33917399181405e-09

The O 0 9.425123721484852e-07
185delAG O 0 3.644195749075152e-05
BRCA1 O 0 6.585473784070928e-07
mutation O 0 1.3952262678529337e-09
originated O 0 1.825289364099092e-10
before O 0 1.569190263839282e-11
the O 0 1.335095662496899e-12
dispersion O 0 4.0069167428491426e-10
of O 0 1.315481751307246e-10
Jews O 0 3.696755956905662e-10
in O 0 2.3676604080091757e-11
the O 0 2.835129700451411e-11
diaspora O 0 7.725666634206263e-11
and O 0 2.4183760462953563e-12
is O 0 2.3153847545850925e-13
not O 0 1.5384335515580827e-12
limited O 0 2.3796320469671173e-10
to O 0 2.5173469975214857e-09
Ashkenazim O 0 0.0001271653309231624
. O 0 3.415894127556385e-07

The O 0 1.2443979358067736e-07
185delAG O 0 3.5922716961067636e-06
mutation O 0 7.730498197133784e-08
in O 0 6.9118430978676315e-09
BRCA1 O 0 1.6243612677158126e-08
is O 0 2.0109437118970286e-12
detected O 0 1.1326629217878192e-10
in O 0 1.482735462188245e-11
Ashkenazi O 0 4.954532784040566e-09
Jews O 0 3.4530714398961493e-10
both O 0 1.509236659258395e-11
in O 0 3.104152213051492e-10
familial B-Disease 0 0.13501188158988953
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 2.9647795329879045e-09
in O 0 4.884622914480552e-11
the O 0 5.8145464137959735e-11
general O 0 2.515024188909365e-09
population O 0 3.803321199646881e-11
. O 0 5.129031643846815e-10

All O 0 4.122098928860396e-08
tested O 0 3.958637861956049e-08
Ashkenazi O 0 8.449371335927935e-08
mutation O 0 1.4332116604620637e-09
carriers O 0 1.9289676800315902e-10
share O 0 4.430245059694471e-11
the O 0 3.4042566942477093e-12
same O 0 3.9328183071285494e-11
allelic O 0 1.540380445419487e-08
pattern O 0 4.529742358982958e-09
at O 0 3.926202141180113e-10
the O 0 3.0553348739914554e-09
BRCA1 O 0 8.876509838273705e-08
locus O 0 7.818964142813911e-09
. O 0 1.3221213457370595e-08

Our O 0 9.628815860196482e-07
previous O 0 9.158716096635544e-08
study O 0 3.106090495919034e-09
showed O 0 7.732078866062864e-11
that O 0 1.6311629239158798e-13
this O 0 4.456959801224514e-11
Ashkenazi O 0 1.5528563324096467e-07
mutation O 0 2.5628776878505732e-09
also O 0 2.285588385220194e-12
occurs O 0 7.24200473894987e-12
in O 0 3.356543558721836e-13
Iraqi O 0 1.7332585020013447e-11
Jews O 0 1.0077879503134213e-10
with O 0 3.760836043628646e-13
a O 0 2.094024389651117e-12
similar O 0 5.994478802229253e-10
allelic O 0 6.242450467652816e-07
pattern O 0 2.9744788321295346e-07
. O 0 4.60907116917042e-08

We O 0 5.505141587036633e-08
extended O 0 7.156567960464599e-08
our O 0 6.1303984111305e-10
analysis O 0 1.4413244903144218e-11
to O 0 1.795263417092574e-11
other O 0 5.856284207572671e-11
non O 0 3.117160574106492e-08
- O 0 3.7812202258180605e-09
Ashkenazi O 0 2.1229434210567888e-08
subsets O 0 6.212954151152417e-09
354 O 0 6.713241629263678e-10
of O 0 3.554792744886459e-12
Moroccan O 0 2.1112711579007737e-10
origin O 0 3.608860779658052e-11
, O 0 5.347961656854139e-12
200 O 0 3.2114037123998074e-11
Yemenites O 0 1.6009396119898156e-07
and O 0 3.17427438500939e-11
150 O 0 5.0462568151887766e-11
Iranian O 0 2.3478534671994566e-09
Jews O 0 2.423358758107952e-08
. O 0 1.5424795662966062e-08

Heteroduplex O 0 5.8021731092594564e-05
analysis O 0 9.519250276923685e-09
complemented O 0 3.309023099973274e-08
by O 0 1.1247620890220134e-10
direct O 0 5.405323411089569e-10
DNA O 0 5.534554592401264e-09
sequencing O 0 4.3152532214207895e-08
of O 0 5.114848988796439e-09
abnormally O 0 1.0480210477226137e-07
migrating O 0 5.987054851885887e-09
bands O 0 1.633868929040716e-09
were O 0 5.003454248142525e-11
employed O 0 3.5001249121258127e-10
. O 0 3.117795355223052e-09

Four O 0 2.0191034622030202e-08
of O 0 3.0491984492897473e-09
Moroccan O 0 3.6444482987008087e-08
origin O 0 1.3834023926406758e-09
( O 0 1.2295678798041054e-12
1 O 0 5.2156359092725424e-11
. O 0 5.528856452524655e-13
1 O 0 2.007266054759871e-11
% O 0 2.1267314081682698e-13
) O 0 1.5998321238738442e-14
and O 0 6.650223449179704e-13
none O 0 5.09171732554492e-11
of O 0 1.5720369450633598e-10
the O 0 1.0917137194255133e-09
Yemenites O 0 7.848139830457512e-06
or O 0 3.0323141220200966e-10
Iranians O 0 9.617338037060108e-10
was O 0 1.0119659277219029e-10
a O 0 5.953483691277517e-13
carrier O 0 1.3980060165064145e-11
of O 0 1.675806542145164e-11
the O 0 7.01681601711357e-10
185delAG O 0 1.147375769505743e-06
mutation O 0 8.013677188500878e-08
. O 0 1.860915688212117e-08

BRCA1 O 0 0.00018273404566571116
allelic O 0 1.2129491551604588e-05
patterns O 0 8.564294518009774e-08
were O 0 2.598266712894315e-09
determined O 0 2.1826040974559646e-09
for O 0 2.5020647012596875e-11
four O 0 5.318055891490037e-12
of O 0 1.1398314583854763e-11
these O 0 6.346247746064071e-12
individuals O 0 9.788900376048182e-13
and O 0 7.101146060062291e-12
for O 0 5.235927143243391e-12
12 O 0 1.7713823463605394e-11
additional O 0 1.2324047164724572e-11
non O 0 7.485210673507936e-09
- O 0 1.7870420698784528e-09
Ashkenazi O 0 4.346757176421079e-09
185delAG O 0 1.0148489160144436e-08
mutation O 0 6.260915119682409e-10
carriers O 0 6.411075559320523e-10
who O 0 1.8872398088731757e-10
had O 0 2.239262641978712e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.0556518645898905e-05

Six O 0 9.332158583674754e-07
non O 0 4.5264682739798445e-06
- O 0 1.4125009784038411e-07
Ashkenazi O 0 4.906059203335644e-08
individuals O 0 1.8479566835094552e-11
shared O 0 4.4413115546371174e-11
the O 0 1.6888374379520066e-11
common O 0 2.0166074365945974e-10
Ashkenazi O 0 4.2535788224995486e-09
haplotype O 0 2.288698119912169e-09
, O 0 9.838700687492263e-11
four O 0 1.8511386867814394e-11
had O 0 7.27047796966751e-11
a O 0 5.141436321826065e-12
closely O 0 7.5876194216562e-11
related O 0 8.7033402706993e-09
pattern O 0 2.3452454200878492e-08
, O 0 1.0263264196841426e-11
and O 0 4.245898771459977e-11
the O 0 1.645032221553322e-09
rest O 0 2.0616342411017285e-08
( O 0 1.2734737309810784e-12
n O 0 1.2953194072906626e-10
= O 0 6.284601311579152e-11
6 O 0 1.2406151106425511e-10
) O 0 1.8474756230055234e-13
displayed O 0 3.448212548828877e-11
a O 0 8.62343807472854e-11
distinct O 0 1.23805152796308e-08
BRCA1 O 0 6.333744408948405e-07
allelic O 0 2.9621608064189786e-06
pattern O 0 9.390088848704181e-07
. O 0 1.464249663740702e-07

We O 0 4.888470073183271e-08
conclude O 0 9.904388065251624e-08
that O 0 4.717789006680739e-11
the O 0 1.6585859352602483e-09
185delAG O 0 1.9855926893797005e-06
BRCA1 O 0 1.9130044393023127e-07
mutation O 0 6.675345831652635e-10
occurs O 0 6.930607476807182e-11
in O 0 7.948084031206282e-12
some O 0 4.8234515340195294e-12
non O 0 5.122721091765925e-08
- O 0 4.678064868812726e-08
Ashkenazi O 0 5.8471744779353685e-08
populations O 0 9.149187657486735e-11
at O 0 1.5100479460600225e-12
rates O 0 5.130073449377548e-12
comparable O 0 9.465156089460969e-12
with O 0 8.27825899192905e-14
that O 0 1.2866063466357436e-12
of O 0 3.922393965183346e-09
Ashkenazim O 0 0.00010503390512894839
. O 0 7.717989802813463e-08

The O 0 9.488636720789145e-08
majority O 0 2.121849362879402e-09
of O 0 1.5424259647289773e-09
Jewish O 0 2.992163317117047e-08
185delAG O 0 9.071215600897631e-08
mutation O 0 1.7508738903160292e-09
carriers O 0 1.2924245007539525e-10
have O 0 2.1509809992187323e-12
a O 0 1.0175487839478303e-12
common O 0 2.2747571881698292e-10
allelic O 0 4.003414488806811e-08
pattern O 0 2.3907793522681686e-09
, O 0 2.0987355950352615e-11
supporting O 0 5.2586185406156005e-11
the O 0 3.6243694157001016e-10
founder O 0 7.719546779583197e-09
effect O 0 1.4266693604270131e-08
notion O 0 1.9192002653767304e-08
, O 0 3.5830971436418002e-12
but O 0 1.802612096049594e-12
dating O 0 7.305103744137398e-11
the O 0 8.289896546997966e-12
mutations O 0 2.352902161301129e-12
origin O 0 1.5955287438473853e-11
to O 0 3.1395897166774933e-12
an O 0 5.739095451044035e-14
earlier O 0 2.183601216509956e-11
date O 0 4.1009176499073874e-08
than O 0 1.0567532265914892e-10
currently O 0 5.0681143309860843e-11
estimated O 0 4.385861118727519e-11
. O 0 2.6926025853413194e-09

However O 0 4.717913171248256e-08
, O 0 6.316881739909519e-11
the O 0 2.5059237671043455e-11
different O 0 3.619545288491288e-11
allelic O 0 1.6764806431979196e-08
pattern O 0 5.149000781301538e-09
at O 0 5.646919598589761e-10
the O 0 4.215167770382777e-09
BRCA1 O 0 2.4531079390044397e-08
locus O 0 7.030815929454093e-10
even O 0 6.317014272783084e-11
in O 0 2.9986473373821987e-12
some O 0 9.751294823695522e-13
Jewish O 0 6.191739343464064e-10
mutation O 0 1.0652934090416011e-10
carriers O 0 1.1070792199641133e-10
, O 0 2.6778993519188665e-12
might O 0 4.498157749055487e-11
suggest O 0 1.1020628853941616e-10
that O 0 7.468082684376764e-13
the O 0 6.917744155288119e-11
mutation O 0 1.301724145141847e-10
arose O 0 1.83239601270202e-09
independently O 0 4.868404568370011e-10
. O 0 4.715128287813286e-10
. O 0 5.825019577798685e-09

Crystal O 0 5.642479663947597e-06
structure O 0 1.898292936175494e-07
of O 0 2.6220286031275464e-07
the O 0 7.59116915105551e-07
hemochromatosis B-Disease 1 1.0
protein O 0 5.6240660342155024e-05
HFE O 0 0.16643312573432922
and O 0 1.7932623441740958e-10
characterization O 0 8.978929599834373e-09
of O 0 6.499800142556467e-10
its O 0 1.6085158205392247e-10
interaction O 0 4.470064596251433e-10
with O 0 2.4027953238192623e-11
transferrin O 0 7.912551609479124e-07
receptor O 0 9.287927582590783e-08
. O 0 2.646908114911639e-08

HFE O 1 0.9999815225601196
is O 0 1.3823376221466788e-08
an O 0 2.484423222703924e-10
MHC O 0 5.173315366846509e-05
- O 0 1.4931366649761912e-06
related O 0 1.0490575732546858e-06
protein O 0 5.9437272881268655e-09
that O 0 1.944631386257764e-13
is O 0 1.3861466499360403e-13
mutated O 0 1.4837488182539715e-10
in O 0 1.8294886439118585e-11
the O 0 1.8651753475040778e-09
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.05031786859035492

HFE O 0 0.0009820725535973907
binds O 0 9.646814902453116e-08
to O 0 6.026719567842065e-09
transferrin O 0 8.708922223377158e-07
receptor O 0 5.13508631172499e-08
( O 0 5.281285131442104e-11
TfR O 0 8.933936612720572e-08
) O 0 1.6652718700521651e-12
and O 0 2.0301011306039785e-12
reduces O 0 8.817369057112501e-11
its O 0 1.8655755759655612e-11
affinity O 0 6.438476418679784e-10
for O 0 2.6734925384630515e-10
iron O 0 6.270479389058892e-06
- O 0 7.683927805146595e-08
loaded O 0 1.1377241371235414e-08
transferrin O 0 9.937180323049688e-08
, O 0 7.338116225774627e-11
implicating O 0 3.367543044419108e-08
HFE O 1 0.9608105421066284
in O 0 2.1804171979056264e-07
iron O 1 0.5986263751983643
metabolism O 0 0.003496711142361164
. O 0 3.3288759482275054e-07

The O 0 1.619935915186943e-06
2 O 0 1.7461610468672006e-06
. O 0 8.333143597383241e-08

6 O 0 1.7399908756488003e-05
A O 0 1.1143472988806025e-07
crystal O 0 1.0928997653536499e-06
structure O 0 2.385108359703736e-07
of O 0 2.616508254504879e-06
HFE O 1 0.9999901056289673
reveals O 0 2.111575447827363e-08
the O 0 1.173462299552952e-10
locations O 0 3.204032594794626e-10
of O 0 9.110868504080827e-09
hemochromatosis B-Disease 1 1.0
mutations O 0 3.14367025566753e-06
and O 0 1.7788915229743907e-08
a O 0 2.879355087692659e-10
patch O 0 3.5218336051912047e-06
of O 0 0.00013127467536833137
histidines O 1 0.9999682903289795
that O 0 4.289520474931585e-11
could O 0 2.1833803862114642e-11
be O 0 1.5514640353680997e-12
involved O 0 4.9102900565034524e-12
in O 0 2.3576113283851896e-11
pH O 0 5.488287797561497e-07
- O 0 1.3119804975758598e-07
dependent O 0 3.0046077625911494e-08
interactions O 0 8.738804346819506e-09
. O 0 7.799228818328174e-09

We O 0 4.084844533736032e-07
also O 0 1.1291496626597564e-09
demonstrate O 0 2.3793700343333057e-09
that O 0 2.4760722985850414e-11
soluble O 0 1.0663052307791077e-05
TfR O 0 2.0668176148319617e-05
and O 0 1.1598357829711858e-09
HFE O 0 4.075006927450886e-06
bind O 0 1.0636717062695311e-09
tightly O 0 2.578745217363121e-09
at O 0 6.689579445939842e-11
the O 0 4.909599116142971e-11
basic O 0 4.460485314439211e-09
pH O 0 5.07864044152484e-08
of O 0 1.3673956189563796e-08
the O 0 7.560680970186695e-10
cell O 0 3.376363910678748e-10
surface O 0 1.0238091485703649e-09
, O 0 1.5003699237875479e-12
but O 0 7.693796988395007e-12
not O 0 1.8863174910954683e-11
at O 0 1.3401027509907237e-10
the O 0 1.6842702232899853e-10
acidic O 0 1.0923562143716481e-07
pH O 0 5.212407359067583e-07
of O 0 1.1158228119256819e-08
intracellular O 0 1.4588535712789508e-08
vesicles O 0 3.385576690106973e-07
. O 0 2.751440852932774e-08

TfR O 0 0.002541896654292941
HFE O 0 0.005916456691920757
stoichiometry O 0 1.547898500575684e-05
( O 0 2.6677737796632073e-09
2 O 0 6.762943538518584e-09
1 O 0 7.878932506422132e-10
) O 0 2.5086100731430694e-12
differs O 0 1.2265058968452536e-09
from O 0 2.3448581965013204e-10
TfR O 0 2.859742664895748e-07
transferrin O 0 3.701056172644712e-08
stoichiometry O 0 3.573487816765919e-08
( O 0 2.349961197856132e-11
2 O 0 2.3009437410959066e-10
2 O 0 7.435882465323118e-11
) O 0 2.804989313737183e-13
, O 0 5.775875112391804e-13
implying O 0 1.649775281664656e-11
a O 0 2.8180110155096028e-12
different O 0 1.0068997718937212e-11
mode O 0 9.705681813798606e-10
of O 0 2.5132135955674428e-11
binding O 0 7.981361682674049e-10
for O 0 8.033733123191666e-10
HFE O 0 0.00047502832603640854
and O 0 8.554099095725576e-10
transferrin O 0 7.014561020923793e-08
to O 0 6.722454259922017e-10
TfR O 0 9.868820143310586e-07
, O 0 9.377894294448907e-12
consistent O 0 1.9014358143554233e-10
with O 0 3.3103866869943488e-12
our O 0 2.1647134085256425e-10
demonstration O 0 3.719376140409736e-09
that O 0 1.761124232557698e-11
HFE O 0 2.8879032470285892e-05
, O 0 2.3132207260800897e-10
transferrin O 0 1.7665357177065744e-07
, O 0 1.2795009496358034e-10
and O 0 5.7966183936164484e-11
TfR O 0 1.625915047043236e-07
form O 0 9.9879784998258e-11
a O 0 4.92312128563821e-11
ternary O 0 9.5749999218242e-07
complex O 0 3.875408310705097e-06
. O 0 3.3684304412417987e-07

Identification O 0 9.634271691538743e-07
of O 0 9.29631056578728e-08
three O 0 8.247731941857239e-10
novel O 0 5.634958277767055e-09
mutations O 0 1.6875341402045052e-10
and O 0 1.2978337154967434e-11
a O 0 1.1093356051469772e-12
high O 0 3.845915599876015e-11
frequency O 0 1.500196147863342e-11
of O 0 1.1675497374463717e-11
the O 0 5.8075190489947914e-11
Arg778Leu O 0 8.963521622717963e-07
mutation O 0 1.1549724510118153e-09
in O 0 3.927481256882359e-11
Korean O 0 4.233088191085699e-08
patients O 0 2.494785711348868e-09
with O 0 4.958552665690341e-12
Wilson B-Disease 0 5.751638454398744e-08
disease I-Disease 0 6.857808898530493e-08
. O 0 4.4046799985153484e-08

Four O 0 6.328563983970525e-08
mutations O 0 2.741758375890413e-09
- O 0 5.53942358649806e-09
- O 0 4.763618832726024e-09
R778L O 0 6.411534059225232e-08
, O 0 7.117173170256841e-12
A874V O 0 1.3253094177656521e-09
, O 0 1.6203416646626279e-12
L1083F O 0 1.4017855765047216e-09
, O 0 1.8548702070825263e-12
and O 0 6.122968343284796e-13
2304delC O 0 1.4708895212933726e-09
- O 0 2.2969017798857294e-09
- O 0 8.171494592090767e-09
in O 0 1.0873455469351256e-09
the O 0 1.5338359471428475e-09
copper O 0 2.4790104191652063e-08
- O 0 3.186705621605057e-10
transporting O 0 4.5867492026729906e-09
enzyme O 0 2.0422992186297506e-09
, O 0 2.0606533146505512e-10
P O 0 6.392180580405693e-07
- O 0 6.573787292296629e-09
type O 0 9.595704675291472e-09
ATPase O 0 5.8434364014203766e-09
( O 0 4.820857688742075e-12
ATP7B O 0 3.821305654128082e-06
) O 0 2.5539000168134374e-12
, O 0 4.581432889311232e-13
were O 0 2.9588998352175766e-12
identified O 0 3.29380945261748e-12
in O 0 6.864063571004886e-12
Korean O 0 8.975833765134666e-08
Patients O 0 4.344041215631478e-08
with O 0 6.93497134718335e-11
Wilson B-Disease 0 7.774049208819633e-07
disease I-Disease 0 1.5461755538126454e-06
. O 0 1.5820678811451216e-07

Arg778Leu O 0 0.0013426635414361954
, O 0 4.799844965930333e-09
the O 0 1.2235524815551457e-09
most O 0 8.814998730954926e-11
frequently O 0 7.479476239746763e-12
reported O 0 1.3063042401256775e-12
mutation O 0 6.56866401549383e-12
of O 0 4.307689621674271e-11
this O 0 1.977959983301414e-11
enzyme O 0 9.639339326739105e-10
, O 0 5.514275841500549e-11
was O 0 3.863629416400727e-10
found O 0 2.618148232935713e-11
in O 0 4.323361460500941e-11
six O 0 4.174040973969895e-11
of O 0 2.1976748199037388e-10
eight O 0 2.6869168001653065e-10
unrelated O 0 1.1180192771576003e-08
patients O 0 3.316901642236303e-09
studied O 0 8.68254010355507e-11
, O 0 3.2271808923095557e-13
an O 0 9.247051231285261e-14
allele O 0 1.7106819433232445e-11
frequency O 0 3.421360694755293e-10
of O 0 7.007454061458418e-10
37 O 0 7.61313074804093e-08
. O 0 2.808696031308955e-08

5 O 0 7.200676463980926e-07
% O 0 3.707102180783295e-09
, O 0 1.2373296831569291e-11
which O 0 4.0178236714212556e-13
is O 0 5.881554466548311e-13
considerably O 0 3.7081839820984897e-09
higher O 0 2.7627615750702716e-09
than O 0 9.658321885319676e-12
those O 0 1.6133360272729824e-11
in O 0 2.825229286629316e-11
other O 0 1.6907139577249097e-10
Asian O 0 1.1343390671214593e-09
populations O 0 1.8827743530902552e-10
. O 0 4.3120979009714233e-10

The O 0 1.0213774714884494e-08
novel O 0 2.9895488307118967e-09
single O 0 1.6534872082640817e-10
nucleotide O 0 4.2786569842689914e-09
deletion O 0 1.2980800878636956e-09
, O 0 2.5796823011070558e-11
2304delC O 0 3.346943699966687e-08
, O 0 3.7875542979737276e-11
was O 0 2.7583846318179894e-10
found O 0 4.594336022734069e-11
in O 0 1.0882080653251691e-10
one O 0 2.2416571376915329e-10
patient O 0 4.5802215709045413e-07
. O 0 7.993740069878186e-08

Since O 0 2.3172283647454606e-08
a O 0 1.835385732285033e-10
mutation O 0 2.788627662120291e-10
at O 0 1.74592743040769e-10
cDNA O 0 3.422387040430408e-09
nucleotide O 0 1.3165096568457102e-08
2302 O 0 4.631680894817691e-06
( O 0 1.4459174309255918e-11
2302insC O 0 8.76156924789484e-09
) O 0 1.2616808639509536e-11
had O 0 8.878629775832536e-11
been O 0 1.7854185144217105e-11
previously O 0 6.425371346097108e-11
described O 0 1.004640468038609e-10
, O 0 3.0930793950417756e-12
this O 0 5.4301181606764004e-12
region O 0 9.493335006993675e-10
of O 0 6.228921822781786e-10
the O 0 1.045650677156118e-08
ATP7B O 1 0.9998052716255188
gene O 0 2.170891910679984e-09
may O 0 2.7962452353591516e-09
be O 0 2.212981603522124e-10
susceptible O 0 1.813434380437684e-07
to O 0 6.726417756119929e-10
gene O 0 1.6956342108187528e-08
rearrangements O 0 0.005871569737792015
causing O 0 0.20273128151893616
Wilson B-Disease 0 0.0008701704209670424
disease I-Disease 0 4.981632810086012e-05
. O 0 1.7276937569477013e-07

Disruption O 0 9.968908670998644e-06
of O 0 4.148735399667203e-08
splicing O 0 7.804663937349687e-08
regulated O 0 6.230041815769027e-09
by O 0 1.2337029835218782e-11
a O 0 2.14361011580122e-11
CUG O 0 5.167398921912536e-05
- O 0 1.9077621260521482e-08
binding O 0 2.787364827838701e-08
protein O 0 2.1418297535547026e-07
in O 0 1.1228640239835386e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 5.549076831812272e-06

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.676321176091733e-06
DM B-Disease 1 1.0
) O 0 2.3752981803681905e-09
is O 0 1.6209792189081362e-11
caused O 0 1.9826901231922989e-10
by O 0 4.0946662727137095e-11
a O 0 1.6099430122373803e-10
CTG O 0 5.457839051814517e-06
expansion O 0 5.9462362145268344e-08
in O 0 1.8195470130599745e-10
the O 0 2.8600663504185775e-10
3 O 0 1.5272237918750875e-09
untranslated O 0 6.394985234692285e-07
region O 0 1.733778537404973e-10
of O 0 1.8724673200853914e-10
the O 0 1.5829304089720608e-08
DM B-Disease 1 1.0
gene O 0 4.40940027601755e-07
. O 0 1.8101066245890252e-07

One O 0 3.003808035639821e-10
model O 0 3.359155731352814e-10
of O 0 7.402987556304197e-09
DM B-Disease 1 1.0
pathogenesis O 1 0.999377429485321
suggests O 0 5.3536237665241515e-09
that O 0 1.5981014254984327e-12
RNAs O 0 1.9607426793299965e-10
from O 0 6.1459752218051555e-12
the O 0 2.091107842439044e-11
expanded O 0 6.610372804694009e-10
allele O 0 1.7007013852765596e-10
create O 0 2.6067674060992196e-11
a O 0 7.303093893518131e-12
gain O 0 1.325868193013946e-09
- O 0 2.668769649716296e-10
of O 0 3.9370681714778755e-10
- O 0 1.5268822317615616e-10
function O 0 5.038194687834174e-12
mutation O 0 4.059033111795257e-13
by O 0 2.6097434082479262e-14
the O 0 2.3634756261478596e-13
inappropriate O 0 5.8954954633427814e-12
binding O 0 7.869076917854656e-11
of O 0 5.151444271156436e-10
proteins O 0 4.818249618732118e-11
to O 0 9.839732501015774e-11
the O 0 7.3263897171216286e-09
CUG O 1 0.9965370893478394
repeats O 0 2.3800528481388028e-07
. O 0 6.225340598575713e-08

Data O 0 4.543788989508357e-08
presented O 0 1.1015953482740315e-08
here O 0 6.041079303464869e-10
indicate O 0 3.954362670643974e-10
that O 0 1.4582637397966836e-12
the O 0 7.468731189064215e-11
conserved O 0 2.8945541519220797e-09
heterogeneous O 0 3.6994261876088785e-08
nuclear O 0 3.9085136904759565e-07
ribonucleoprotein O 0 6.37050902696501e-07
, O 0 1.2422939066336625e-10
CUG O 0 3.372616674823803e-06
- O 0 3.789284885868938e-09
binding O 0 4.708893719396201e-09
protein O 0 4.0884273744268285e-09
( O 0 1.015557950234669e-11
CUG O 0 0.0003709912416525185
- O 0 9.859999039463219e-08
BP O 0 1.6955542037067062e-07
) O 0 3.2777029788239043e-12
, O 0 3.19127038163336e-12
may O 0 2.2976720526202143e-10
mediate O 0 7.479883379346575e-10
the O 0 1.2226613055332791e-09
trans O 0 1.2827962692085748e-08
- O 0 1.4791042701745027e-07
dominant O 0 9.470844730685712e-08
effect O 0 3.3046081426846285e-08
of O 0 7.642034560717548e-09
the O 0 2.651656894059329e-09
RNA O 0 9.590269911541327e-09
. O 0 2.7738815688849172e-09

CUG O 1 1.0
- O 1 0.9994396567344666
BP O 0 0.0021327894646674395
was O 0 3.0007189621983343e-08
found O 0 5.702648422922785e-11
to O 0 2.5370092311682857e-12
bind O 0 1.7405235239187355e-11
to O 0 2.5498325673112276e-11
the O 0 1.6525381063559053e-10
human O 0 6.993713941305657e-10
cardiac O 0 3.420834764256142e-05
troponin O 0 0.0008123696898110211
T O 0 5.23130402143579e-05
( O 0 2.8591594369853368e-11
cTNT O 0 2.9666816558915343e-08
) O 0 6.366482861730471e-12
pre O 0 1.166743928138203e-07
- O 0 1.1057192494945411e-08
messenger O 0 9.12951669818085e-09
RNA O 0 1.5087230353927339e-09
and O 0 9.267913693433716e-12
regulate O 0 8.505936233138556e-11
its O 0 4.157387281655822e-11
alternative O 0 1.1845859404502335e-08
splicing O 0 1.708979624481799e-07
. O 0 4.716464374610041e-08

Splicing O 0 1.6711160810700676e-07
of O 0 5.4532538484863835e-08
cTNT O 0 4.8173886170843616e-05
was O 0 4.8755548931467274e-08
disrupted O 0 5.962748673482565e-06
in O 0 3.667809522767129e-08
DM B-Disease 1 1.0
striated O 0 8.494650501233991e-06
muscle O 0 1.9778742625931045e-06
and O 0 3.451000907261914e-08
in O 0 6.52307807769148e-09
normal O 0 5.769271638200735e-07
cells O 0 2.1488121504376068e-08
expressing O 0 4.327926350633504e-10
transcripts O 0 5.113812706625254e-10
that O 0 3.0098326175148626e-12
contain O 0 2.360434736559114e-09
CUG O 0 0.003737242892384529
repeats O 0 1.3810810628456238e-07
. O 0 2.9848102656160336e-08

Altered O 0 5.4744791668781545e-06
expression O 0 1.1224084062178008e-07
of O 0 3.741755705277683e-08
genes O 0 1.4641668322212809e-08
regulated O 0 5.496045218933432e-08
posttranscriptionally O 0 5.462424610414018e-07
by O 0 4.604605141622642e-09
CUG O 1 1.0
- O 0 0.0005060516996309161
BP O 0 4.631985575542785e-06
therefore O 0 5.412834069851158e-10
may O 0 6.831714360888697e-11
contribute O 0 1.475891076019309e-10
to O 0 1.1272303090947844e-09
DM B-Disease 1 1.0
pathogenesis O 1 0.5468407273292542
. O 0 1.3931793496624323e-08
. O 0 1.3574895874057802e-08

Identification O 0 9.614082330244855e-08
of O 0 3.187217822997468e-09
a O 0 9.984702648013766e-11
novel O 0 3.1028810631994475e-09
nonsense O 0 1.4537371306744262e-08
mutation O 0 2.0581511495088023e-10
and O 0 3.731179427923781e-12
a O 0 9.399377977337142e-13
missense O 0 4.6035836254176843e-10
substitution O 0 1.5517741536186236e-09
in O 0 1.0373342462788315e-10
the O 0 1.8487966713109927e-10
vasopressin O 0 1.422641560111515e-09
- O 0 2.049362013423206e-09
neurophysin O 0 4.3692361373359745e-07
II O 1 0.9999971389770508
gene O 0 1.874208566121638e-09
in O 0 6.685357128999314e-11
two O 0 4.59836639252198e-12
Spanish O 0 2.2662043075438731e-10
kindreds O 0 3.2745727907013134e-08
with O 0 4.9737106794234265e-11
familial B-Disease 0 6.663615931756794e-05
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999986886978149
. O 0 9.03285854292335e-06

Familial B-Disease 1 0.9999977350234985
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 1.0026372621041446e-08
FNDI B-Disease 1 1.0
) O 0 1.9214473068185356e-10
is O 0 5.530124969066463e-12
an O 0 3.2761781568885207e-12
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 0.053574539721012115
by O 0 2.693642215945147e-07
deficiency O 1 0.9993875026702881
in O 0 5.536468350442192e-08
the O 0 6.19443838445477e-08
antidiuretic O 0 3.2440252084597887e-07
hormone O 0 2.4077950300238626e-08
arginine O 0 3.893238087471218e-08
vasopressin O 0 4.104861872633592e-08
( O 0 6.221592685484723e-11
AVP O 0 1.5570471134651598e-07
) O 0 1.81848015378544e-12
encoded O 0 9.07114661163888e-12
by O 0 3.583659410888451e-11
the O 0 5.3079407535960854e-09
AVP O 0 3.4024622436845675e-05
- O 0 1.1332938356645172e-06
neurophysin O 0 0.013843283988535404
II O 1 1.0
( O 0 1.4392065850188374e-07
AVP O 0 0.000491278013214469
- O 0 2.14073861570796e-06
NPII O 0 0.0028661226388067007
) O 0 4.594820357528562e-10
gene O 0 4.5430303963200913e-10
on O 0 2.441195023905607e-09
chromosome O 0 7.479030728063663e-09
20p13 O 0 4.84257043353864e-06
. O 0 2.090935851128961e-07

In O 0 4.86154938528216e-09
this O 0 1.298658958148735e-10
study O 0 1.365798862895673e-10
, O 0 5.011312111807831e-12
we O 0 7.130597761556556e-12
analyzed O 0 8.18729473106572e-10
two O 0 4.0130316604491956e-12
families O 0 1.0214070908509676e-11
with O 0 3.451645653324009e-12
FNDI B-Disease 1 1.0
using O 0 3.2657998527696463e-10
direct O 0 2.713222702066531e-10
automated O 0 3.6243295031823664e-09
fluorescent O 0 1.2493454271123028e-08
, O 0 3.75281229703095e-12
solid O 0 1.9671331230597389e-10
phase O 0 1.7192308687796753e-09
, O 0 1.179771666644236e-12
single O 0 2.272166179165258e-12
- O 0 9.969168719703436e-12
stranded O 0 6.666676932720605e-11
DNA O 0 2.688267360453911e-12
sequencing O 0 4.747142609562438e-11
of O 0 2.799439152711969e-11
PCR O 0 5.619778562504507e-07
- O 0 1.8621871276991442e-05
amplified O 0 8.420648373430595e-05
AVP O 0 0.00048027385491877794
- O 0 1.478428885093308e-06
NPII O 0 0.0003026033518835902
DNA O 0 5.065411414761911e-07
. O 0 1.606506039308897e-08

In O 0 9.768011288713296e-09
one O 0 3.656160443843426e-11
of O 0 5.3739051403267624e-11
the O 0 7.45144293490263e-11
families O 0 1.1825411309895895e-11
, O 0 3.2302600264794146e-13
affected O 0 1.0167576849906546e-11
individuals O 0 4.234046652781126e-13
presented O 0 6.551613418448454e-11
a O 0 3.2894776312575313e-12
novel O 0 3.904500611717765e-10
nonsense O 0 1.6765819843556073e-09
mutation O 0 3.2913179126570213e-11
in O 0 2.5443621168297348e-11
exon O 0 4.3824102680112276e-10
3 O 0 1.1921302833783898e-10
of O 0 5.695365359881244e-11
the O 0 1.53364196342487e-10
gene O 0 1.0195035787807782e-11
, O 0 5.4502374835507794e-12
consisting O 0 9.984315457733928e-12
in O 0 8.189005029635155e-12
a O 0 1.5455402582742472e-11
G O 0 9.823188662494431e-08
to O 0 1.1773164665385139e-09
T O 0 1.2001443394638045e-07
transition O 0 5.898789012803718e-09
at O 0 7.263038503957375e-10
nucleotide O 0 1.0514865422805997e-08
2101 O 0 5.2882960517308675e-06
, O 0 4.3808366656516995e-11
which O 0 9.261600817864202e-13
produces O 0 4.2618214729853166e-13
a O 0 1.8862579412911445e-13
stop O 0 8.519051783451026e-12
signal O 0 5.049629048237136e-10
in O 0 1.6085249798791779e-10
codon O 0 4.619209192924245e-08
82 O 0 4.3644135416798235e-07
( O 0 2.358125084089835e-10
Glu O 0 2.45706110035826e-06
) O 0 7.853542122182589e-11
of O 0 3.378981316970453e-09
NPII O 1 0.9911564588546753
. O 0 1.4754386938875541e-06

The O 0 2.7744974318011373e-07
premature O 0 1.1558873893591226e-06
termination O 0 1.3349131222639699e-07
eliminates O 0 2.0391162536270713e-08
part O 0 6.507590022408749e-10
of O 0 1.921393266712812e-09
the O 0 2.833516088429633e-09
C O 0 7.470629270756035e-07
- O 0 8.402307183352775e-10
terminal O 0 6.369103466852266e-09
domain O 0 2.4039290003052827e-10
of O 0 1.917976055754167e-10
NPII O 0 9.050984954228625e-05
, O 0 1.8675156907010937e-11
including O 0 5.51414686481011e-12
a O 0 2.5643556288840186e-12
cysteine O 0 1.4296970551885835e-10
residue O 0 6.564390364616202e-09
in O 0 1.6366065447304123e-10
position O 0 2.7906987831727292e-09
85 O 0 4.32773861192004e-09
, O 0 3.999659110853759e-12
which O 0 8.138798337532782e-13
could O 0 5.891842135702374e-12
be O 0 4.651213008494137e-12
involved O 0 1.6368616531647895e-11
in O 0 3.0785197308036416e-11
the O 0 1.4023678052144106e-10
correct O 0 8.98273189164911e-09
folding O 0 4.2150013257469254e-08
of O 0 1.3477728932898003e-09
the O 0 3.454946195802222e-08
prohormone O 0 0.001217295415699482
. O 0 2.585455263215408e-07

In O 0 3.439328821741583e-09
the O 0 1.2161676110622466e-09
second O 0 4.249848917226018e-09
family O 0 3.958465499831476e-11
, O 0 8.543438309235873e-13
a O 0 2.955389839104372e-13
G279A O 0 8.478017177182551e-10
substitution O 0 7.417446656887705e-09
at O 0 4.613164572564443e-10
position O 0 2.754814709682307e-10
- O 0 5.953410681103222e-11
1 O 0 3.018574279423092e-10
of O 0 1.6813326772502357e-11
the O 0 1.478059341586402e-11
signal O 0 6.529295160095927e-11
peptide O 0 2.520746285317177e-11
was O 0 2.481211243410275e-11
observed O 0 6.377338934715482e-11
in O 0 2.63750011414432e-11
all O 0 4.623274679760314e-11
affected O 0 1.9799852868374046e-09
individuals O 0 1.0224505270217676e-10
. O 0 7.62034702006531e-09

This O 0 1.4511861934352055e-07
missense O 0 1.5911396985757165e-05
mutation O 0 8.058695044610431e-08
, O 0 1.422136297613008e-10
which O 0 1.4368813083809329e-10
replaces O 0 1.8183783367931028e-06
Ala O 0 4.2207034312014e-06
with O 0 8.650542504540226e-10
Thr O 0 2.1276808183756657e-05
, O 0 3.3005104205230396e-10
is O 0 8.723304197044701e-12
frequent O 0 3.685841215572694e-11
among O 0 1.6247811429614956e-10
FNDI B-Disease 1 1.0
patients O 1 1.0
and O 0 6.179295741759461e-09
is O 0 3.0662604399989135e-11
thought O 0 9.232191400254663e-11
to O 0 5.58600301431289e-12
reduce O 0 1.513206504544229e-10
the O 0 1.336075278191018e-10
efficiency O 0 5.8425477789114666e-08
of O 0 5.233605770982308e-10
cleavage O 0 7.316918182453946e-10
by O 0 9.02941194036444e-11
signal O 0 4.67631622314002e-08
peptidases O 0 6.04939884851774e-07
. O 0 8.923659033932552e-10
. O 0 9.580050530644257e-09

Genetic O 0 7.348911026383576e-07
heterogeneity O 0 1.2989880815439392e-06
of O 0 2.9316191785255796e-07
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.3518218489050327e-10
due O 0 5.848088591164924e-08
to O 0 1.0434186847874116e-09
TWIST O 0 0.025859519839286804
and O 0 7.908599997108468e-08
FGFR O 1 0.9999966621398926
mutations O 0 1.2400294053804828e-06
. O 0 6.878611458205341e-08

Thirty O 0 1.2927242096338887e-05
- O 0 5.877587341274193e-07
two O 0 1.011547165474802e-10
unrelated O 0 6.423395149113276e-08
patients O 0 3.603595200019072e-09
with O 0 2.441791072723548e-13
features O 0 2.0940494130372578e-11
of O 0 2.166256152236201e-08
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 5.564979033145789e-12
a O 0 2.075633068199245e-12
common O 0 4.9917918687469864e-09
autosomal B-Disease 0 0.000968224077951163
dominant I-Disease 0 0.0027873669750988483
condition I-Disease 0 0.021608848124742508
of O 1 0.8468530774116516
craniosynostosis B-Disease 1 1.0
and O 0 0.10412948578596115
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9999903440475464
, O 0 9.964331582068553e-10
were O 0 4.738008874127786e-10
screened O 0 5.363944288738764e-10
for O 0 2.2275608441146844e-11
mutations O 0 1.336954713604399e-10
in O 0 2.4863097691785185e-10
TWIST O 0 4.060122955706902e-05
, O 0 1.4569841999545474e-09
FGFR2 O 1 0.9999758005142212
, O 0 1.2748341271517916e-09
and O 0 1.9397603523430007e-09
FGFR3 O 1 0.9994173049926758
. O 0 5.801659881399246e-07

Nine O 0 3.6494500932349183e-07
novel O 0 7.350649866566528e-08
and O 0 1.6520786960683154e-09
three O 0 5.06788500054256e-10
recurrent O 0 2.412019739495008e-07
TWIST O 0 2.450685133226216e-05
mutations O 0 8.598827427874767e-09
were O 0 3.53672563457863e-10
found O 0 4.742714467681486e-12
in O 0 2.106158129844271e-11
12 O 0 1.2464409504531204e-09
families O 0 3.914119028891605e-10
. O 0 4.8892885295970245e-09

Seven O 0 5.815919124074753e-08
families O 0 8.24869228477354e-10
were O 0 5.559679938649253e-10
found O 0 1.1924115340955499e-11
to O 0 1.6697476734606198e-11
have O 0 8.055578426535703e-11
the O 0 1.6452142981293605e-09
FGFR3 O 0 0.012052603997290134
P250R O 0 2.249496674266993e-06
mutation O 0 3.2457685428255445e-09
, O 0 1.5502668593292412e-11
and O 0 1.8108388052939794e-11
one O 0 3.0428149149636097e-12
individual O 0 2.8584053526903297e-12
was O 0 1.5219277227362937e-10
found O 0 2.490338144034432e-11
to O 0 4.171032963462551e-11
have O 0 7.385351358246695e-11
an O 0 1.2619818384740356e-11
FGFR2 O 0 0.005047130864113569
VV269 O 0 2.1006302631576546e-05
- O 0 5.315552016327274e-07
270 O 0 4.877433923411445e-08
deletion O 0 1.9158939323915547e-08
. O 0 5.764364097160524e-09

To O 0 6.4247402953299115e-09
date O 0 1.5387499843200203e-06
, O 0 3.059047737341558e-10
our O 0 8.393941791640103e-11
detection O 0 1.4866334829832795e-09
rate O 0 3.494975142626089e-10
for O 0 2.210789711021288e-12
TWIST O 0 1.369417645946669e-07
or O 0 2.4339421589303356e-09
FGFR O 0 0.0010149619774892926
mutations O 0 4.143759113617307e-09
is O 0 1.6659207000002674e-11
68 O 0 3.322028208074812e-10
% O 0 4.0601575920784505e-12
in O 0 1.532523457095647e-12
our O 0 3.0836339037776384e-10
Saethre B-Disease 1 0.660865843296051
- I-Disease 1 0.9999663829803467
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 0.00011971450294367969
, O 0 9.773197008622336e-12
including O 0 6.458718282420506e-11
our O 0 5.459734886414935e-09
five O 0 7.183649508579748e-11
patients O 0 2.1676893613431503e-09
elsewhere O 0 3.195336217842737e-10
reported O 0 4.7426538390960005e-11
with O 0 7.187816314369044e-11
TWIST O 0 0.001355694024823606
mutations O 0 1.2269917988305679e-06
. O 0 2.004438641733941e-07

More O 0 1.1405117739116122e-08
than O 0 9.779379528396248e-10
35 O 0 2.0520765087184145e-09
different O 0 9.267635964205212e-11
TWIST O 0 9.906718787533464e-07
mutations O 0 2.2600068483313862e-09
are O 0 1.1612179967590563e-11
now O 0 2.837730484622769e-12
known O 0 1.6350509271165214e-12
in O 0 3.1415727224509693e-12
the O 0 3.462494180261899e-11
literature O 0 2.7719935236092397e-09
. O 0 1.3203161897124005e-09

The O 0 2.8845806809840724e-07
most O 0 2.0398231992402316e-09
common O 0 5.264973457208555e-10
phenotypic O 0 7.966031168038512e-10
features O 0 1.2780666802658658e-10
, O 0 2.855953104216602e-12
present O 0 3.076447777083935e-11
in O 0 1.8180580305116045e-11
more O 0 3.8965342454358454e-13
than O 0 3.661362662707446e-13
a O 0 8.128404091305164e-13
third O 0 3.787939129029638e-10
of O 0 1.3730924175447967e-09
our O 0 1.7176320810108336e-08
patients O 0 2.2298257462693982e-08
with O 0 1.611687346081414e-11
TWIST O 0 8.031263860175386e-06
mutations O 0 7.048556405209183e-09
, O 0 2.2829580240135705e-11
are O 0 1.2138350220791683e-11
coronal B-Disease 0 1.8466438405084773e-06
synostosis I-Disease 0 5.40530527359806e-06
, O 0 9.248957155705284e-10
brachycephaly B-Disease 0 1.301058910030406e-05
, O 0 2.165285550859153e-08
low B-Disease 0 0.00012611942656803876
frontal I-Disease 1 0.9999991655349731
hairline I-Disease 1 0.9999998807907104
, O 0 2.2597801319079736e-07
facial B-Disease 0 0.4813554286956787
asymmetry I-Disease 1 0.9998540878295898
, O 0 1.1648082676174454e-07
ptosis B-Disease 1 0.9834834337234497
, O 0 3.891335698114062e-09
hypertelorism B-Disease 0 1.8207752873422578e-05
, O 0 1.959218343117186e-09
broad B-Disease 0 4.2865278373938054e-05
great I-Disease 0 0.3019726872444153
toes I-Disease 0 0.06390681862831116
, O 0 2.1036632436022273e-09
and O 0 8.076664670397804e-09
clinodactyly B-Disease 0 0.0537712499499321
. O 0 3.7708368836320005e-06

Significant O 0 1.207328932650853e-05
intra O 0 0.00954420119524002
- O 0 0.00017485283024143428
and O 0 2.9349163099823272e-08
interfamilial O 0 1.5355029972852208e-05
phenotypic O 0 9.757324050951866e-07
variability O 0 1.0096371170220664e-06
is O 0 8.241056274893577e-12
present O 0 1.3773455466437046e-11
for O 0 9.672425187179368e-12
either O 0 1.901629076428435e-09
TWIST O 0 3.547452433849685e-05
mutations O 0 7.867887319434885e-08
or O 0 2.3334390419904594e-08
FGFR O 1 0.9423059225082397
mutations O 0 7.42805355002929e-07
. O 0 1.115380712235492e-07

The O 0 9.23588459045277e-08
overlap O 0 1.983399400273811e-08
in O 0 4.383965135357215e-10
clinical O 0 2.964423151397e-09
features O 0 1.0564308455807137e-10
and O 0 4.8850888612061993e-11
the O 0 6.22446469367155e-11
presence O 0 2.5004951234586237e-11
, O 0 4.426526419715193e-12
in O 0 5.953782172135602e-12
the O 0 8.114713762052972e-12
same O 0 7.721862212151098e-12
genes O 0 7.995233815283331e-12
, O 0 4.133157845923746e-13
of O 0 3.068401782657659e-11
mutations O 0 1.0417651984118148e-11
for O 0 8.040484944515924e-12
more O 0 4.421143139088368e-12
than O 0 2.2647989386670453e-11
one O 0 1.9389038985462292e-11
craniosynostotic B-Disease 0 1.1448057790630628e-07
condition I-Disease 0 1.9071879364673805e-07
- O 0 1.1948950273676928e-08
such O 0 2.70776467914402e-09
as O 0 1.1473491046132267e-09
Saethre B-Disease 0 2.7094972665508976e-06
- I-Disease 0 2.3390715142568297e-08
Chotzen I-Disease 0 2.790051212286926e-06
, I-Disease 0 6.840580879519109e-11
Crouzon I-Disease 0 6.459882570197806e-06
, I-Disease 0 4.229742667227754e-10
and I-Disease 0 5.335468511447061e-09
Pfeiffer I-Disease 0 0.060166195034980774
syndromes I-Disease 1 1.0
- O 0 0.1893676519393921
support O 0 4.5695060180150904e-08
the O 0 7.108786448384308e-09
hypothesis O 0 1.708923491605674e-08
that O 0 2.518875299312162e-12
TWIST O 0 4.896037921753305e-07
and O 0 3.3135610921775083e-10
FGFRs O 0 1.989933934964938e-06
are O 0 3.6319916258548135e-12
components O 0 7.751511932330146e-11
of O 0 2.9908745619033894e-11
the O 0 9.49441133352158e-12
same O 0 8.657268478484692e-12
molecular O 0 5.75516301282164e-11
pathway O 0 5.6325992481287557e-11
involved O 0 3.119174840290895e-13
in O 0 1.1053706100395619e-13
the O 0 8.314056366108546e-13
modulation O 0 1.602394605892954e-10
of O 0 5.413690606914656e-10
craniofacial O 1 1.0
and O 0 4.7470770368818194e-05
limb O 1 1.0
development O 0 0.06017279997467995
in O 0 1.5837066769108787e-08
humans O 0 4.0912824239569545e-09
. O 0 1.7504957205982663e-10
. O 0 1.463116405808762e-09

Mutation O 0 1.2703468499353221e-08
analysis O 0 5.777713307786314e-10
of O 0 7.017114000973379e-09
UBE3A O 1 1.0
in O 1 0.815654993057251
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.97376549243927
. O 0 8.866052780831524e-08

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 5.315777343639638e-06
AS B-Disease 1 1.0
) O 0 1.050114578626804e-10
is O 0 1.6617816064184998e-12
caused O 0 5.5602498300055814e-11
by O 0 4.833796557468517e-11
chromosome O 0 2.8620215086760936e-09
15q11 O 0 8.379763016819197e-07
- O 0 4.032436251577565e-08
q13 O 0 3.5401720310801466e-07
deletions O 0 7.692165127082262e-09
of O 0 2.3992063891142834e-10
maternal O 0 1.9831072339826505e-09
origin O 0 5.3726956911193113e-11
, O 0 3.792783957994733e-13
by O 0 3.794812120788693e-12
paternal O 0 8.081181022134842e-07
uniparental B-Disease 1 0.9912676215171814
disomy I-Disease 1 0.9999966621398926
( O 0 9.074694418131912e-08
UPD B-Disease 1 1.0
) O 0 3.8893743781187595e-10
15 O 0 6.332470103842525e-10
, O 0 8.323989284311772e-13
by O 0 2.1607562961101223e-11
imprinting O 0 5.826372216688469e-06
defects O 0 0.0008324597147293389
, O 0 6.339721525527864e-10
and O 0 4.0933076372873245e-11
by O 0 5.918041751096226e-11
mutations O 0 6.47453424207356e-10
in O 0 5.387434387493784e-10
the O 0 4.071418402418203e-08
UBE3A O 0 0.00040995850577019155
gene O 0 5.7297175004578094e-08
. O 0 7.651401290331705e-08

UBE3A O 0 0.00930639449506998
encodes O 0 1.4244089641124447e-07
a O 0 9.946444778918817e-10
ubiquitin O 0 2.1423099383355293e-07
- O 0 1.7501695026567177e-07
protein O 0 1.84290485094607e-08
ligase O 0 1.9854091704019083e-08
and O 0 4.346699444823798e-09
shows O 0 1.2088779977048603e-09
brain O 0 2.0264300459871265e-08
- O 0 2.941000554201878e-09
specific O 0 2.1852752496442918e-08
imprinting O 0 1.910552782646846e-05
. O 0 1.7270150465265033e-07

Here O 0 1.0208598411054481e-07
we O 0 2.067260140847793e-09
describe O 0 3.076059229556449e-08
UBE3A O 0 0.0003512908879201859
coding O 0 1.8469961560185766e-06
- O 0 3.0127735044516157e-06
region O 0 1.0673205963485088e-07
mutations O 0 1.2528119652799319e-09
detected O 0 1.5013799092855606e-09
by O 0 4.098135372720968e-11
SSCP O 0 0.0006242721574380994
analysis O 0 4.084637073020758e-10
in O 0 1.1465173255231775e-10
13 O 0 2.3776915991646774e-09
AS B-Disease 1 1.0
individuals O 0 4.464694239314504e-11
or O 0 1.7869117296953618e-10
families O 0 2.0330946648439152e-10
. O 0 1.6138945735377774e-09

Two O 0 2.044966329606268e-08
identical O 0 1.1119862364239452e-07
de O 0 7.771196663952651e-08
novo O 0 3.3396617027392494e-07
5 O 0 3.32010614556566e-07
- O 0 9.209446005797872e-08
bp O 0 1.1458762116944854e-07
duplications O 0 1.0130681005193765e-07
in O 0 7.946655777857359e-09
exon O 0 3.3847825875454873e-07
16 O 0 1.1862794302430757e-08
were O 0 1.3529962705760568e-09
found O 0 6.786211592668678e-10
. O 0 1.3393833597774574e-08

Among O 0 4.905516561848344e-07
the O 0 3.6084857324425457e-09
other O 0 3.6758668331415834e-10
11 O 0 7.477657937293714e-10
unique O 0 1.4600101683193145e-10
mutations O 0 1.6662393687028043e-10
, O 0 3.5332650000219346e-11
8 O 0 2.4447501800750615e-09
were O 0 4.823502153250558e-10
small O 0 7.039064470193424e-11
deletions O 0 1.8621325592604876e-09
or O 0 2.491038930685363e-09
insertions O 0 1.1371150065997426e-07
predicted O 0 1.0509676684478109e-07
to O 0 5.494855681575928e-10
cause O 0 3.9757128433848266e-07
frameshifts O 0 0.0015220923814922571
, O 0 2.8270313867651e-10
1 O 0 1.7608876579089383e-09
was O 0 1.3232097362259054e-10
a O 0 3.3652186939847617e-12
mutation O 0 1.0144970800929354e-11
to O 0 4.6787873055065266e-12
a O 0 4.781717556634479e-12
stop O 0 1.206909849837956e-10
codon O 0 1.1753622519705686e-09
, O 0 1.7640592112067033e-11
1 O 0 2.913523866610035e-10
was O 0 3.603633016990848e-11
a O 0 1.1386797754697753e-11
missense O 0 6.929544049683045e-09
mutation O 0 1.779751623853798e-10
, O 0 6.897569321262509e-12
and O 0 2.453146193126532e-11
1 O 0 4.133702269371042e-09
was O 0 1.551720973935744e-09
predicted O 0 3.898192435514147e-09
to O 0 2.5526986774382365e-11
cause O 0 5.196404417873168e-10
insertion O 0 2.026997236725947e-09
of O 0 5.982637052426298e-09
an O 0 3.077320516464699e-12
isoleucine O 0 2.1422796869785543e-09
in O 0 8.166500808926003e-11
the O 0 1.9655992111733411e-10
hect O 0 7.75025199573065e-08
domain O 0 3.0768674275094554e-09
of O 0 2.8098197102366385e-09
the O 0 1.2754161282657606e-08
UBE3A O 0 0.00024640385527163744
protein O 0 1.0991398902149285e-08
, O 0 1.2047197441023005e-11
which O 0 1.2824291325055914e-12
functions O 0 4.838196510092985e-11
in O 0 1.7270981866879254e-10
E2 O 0 6.802467282795988e-07
binding O 0 1.5786188356514685e-08
and O 0 1.0113045956217093e-09
ubiquitin O 0 6.265269547611751e-08
transfer O 0 5.65487516723806e-06
. O 0 3.596751412260346e-07

Eight O 0 3.3584480974013786e-08
of O 0 3.151965077829999e-10
the O 0 3.3013522471314616e-11
cases O 0 1.0832194863308331e-10
were O 0 3.3850366953913635e-10
familial O 0 1.7928092788110916e-08
, O 0 6.92570889526678e-10
and O 0 1.3247761776469247e-09
five O 0 3.852841101714688e-10
were O 0 1.9265455897254924e-09
sporadic O 0 3.1099398256628774e-07
. O 0 2.3631255174905164e-08

In O 0 3.555939187549484e-08
two O 0 2.758979156247676e-10
familial O 0 2.4932599984595072e-08
cases O 0 4.558006949650917e-08
and O 0 5.797332391921373e-09
one O 0 1.7074361369218138e-10
sporadic O 0 1.4401177139689025e-08
case O 0 3.358766376138078e-09
, O 0 2.379064723001534e-10
mosaicism O 0 5.982530637993477e-06
for O 0 2.4938449527667217e-08
UBE3A O 0 0.00030903349397704005
mutations O 0 3.632842471290587e-09
was O 0 2.719761638125817e-10
detected O 0 2.8842581101251596e-10
in O 0 9.85208442605412e-12
the O 0 3.61715067620505e-11
mother O 0 1.4339983367417375e-10
of O 0 4.409685672168706e-10
three O 0 1.0875440825675042e-10
AS B-Disease 1 1.0
sons O 0 4.844409318138787e-08
, O 0 6.779977512576252e-13
in O 0 2.3928501866575524e-13
the O 0 1.9749208778757632e-12
maternal O 0 6.800827123676356e-10
grandfather O 0 1.0460974309012272e-08
of O 0 3.448500862646142e-08
two O 0 3.924607583360995e-10
AS B-Disease 1 1.0
first O 0 9.955711810505363e-09
cousins O 0 1.423325457494684e-09
, O 0 1.530227658995409e-12
and O 0 5.731670021415225e-13
in O 0 1.564831814473977e-12
the O 0 1.1942051514335361e-11
mother O 0 1.1711881464648854e-10
of O 0 1.7280800401753282e-10
an O 0 1.8329044879084044e-11
AS B-Disease 1 1.0
daughter O 0 1.8134434867533855e-05
. O 0 1.8985390681791614e-07

The O 0 7.86602640800993e-08
frequencies O 0 5.861229723791439e-09
with O 0 9.063813935505927e-12
which O 0 5.7556212400278195e-12
we O 0 8.288442848725097e-12
detected O 0 4.994513136402645e-10
mutations O 0 1.391462500777152e-10
were O 0 5.938103342373324e-10
5 O 0 5.059443419774823e-10
( O 0 6.328487538696803e-13
14 O 0 1.886821254792892e-11
% O 0 3.8972400610501334e-13
) O 0 2.333601180674015e-14
of O 0 1.1570615993106159e-11
35 O 0 9.105230458494873e-11
in O 0 1.4680963042468242e-11
sporadic O 0 4.996488112141151e-09
cases O 0 1.3397123410641143e-09
and O 0 3.4895546452418102e-09
8 O 0 9.323032124086694e-09
( O 0 1.3818866840750732e-12
80 O 0 1.1557035189957432e-10
% O 0 3.838795329790673e-13
) O 0 1.8893894898597795e-14
of O 0 3.6752675555695724e-12
10 O 0 1.5309524481477155e-11
in O 0 2.5647040047260816e-11
familial O 0 3.6203982034521687e-09
cases O 0 1.7566851084893642e-08
. O 0 1.192122400794915e-08
. O 0 8.710352261687149e-08

The O 0 2.0391278212628094e-06
hemochromatosis B-Disease 1 1.0
845 O 0 6.606152055610437e-06
G O 0 1.149489548879501e-06
- O 0 1.7465421109363888e-08
- O 0 3.930212599811966e-09
> O 0 8.45244496616715e-09
A O 0 4.191115232643483e-10
and O 0 3.4414890642125995e-12
187 O 0 8.500357362439814e-11
C O 0 5.362665866925909e-10
- O 0 3.387858049652692e-11
- O 0 3.048388763637888e-10
> O 0 8.731423584151798e-09
G O 0 7.833955351088662e-08
mutations O 0 1.0467071653863513e-10
: O 0 6.972751911450692e-13
prevalence O 0 9.625225616538557e-11
in O 0 7.360568751724195e-12
non O 0 2.6790184293190578e-08
- O 0 8.572547471885628e-08
Caucasian O 0 1.8784072963740073e-08
populations O 0 1.3675461874029793e-09
. O 0 1.1161671586989996e-09

Hemochromatosis B-Disease 1 0.9999487400054932
, O 0 1.628524515240315e-08
the O 0 2.719689473451581e-05
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 1 1.0
, O 0 6.9869314778259195e-09
leads O 0 4.358371885615497e-09
, O 0 3.1017402188360244e-12
if O 0 1.1993508963747956e-10
untreated O 1 0.9878161549568176
, O 0 1.947071844032866e-11
to O 0 3.3409067179412943e-10
progressive O 1 0.9999997615814209
iron B-Disease 1 1.0
overload I-Disease 1 0.9999998807907104
and O 0 1.4101846090852632e-06
premature B-Disease 0 4.398591408971697e-05
death I-Disease 0 6.508540195682144e-07
. O 0 3.936697012818513e-08

The O 0 3.1074960133992136e-06
hemochromatosis B-Disease 1 1.0
gene O 0 6.487773021035537e-07
, O 0 1.8174608484855526e-08
HFE O 1 0.9999939203262329
, O 0 1.1372923935937251e-08
recently O 0 1.2619106870559449e-09
has O 0 6.449676404930715e-13
been O 0 5.644875842800157e-13
identified O 0 2.0139339414887436e-12
, O 0 4.3458617780822717e-13
and O 0 1.193041217033286e-12
characterization O 0 7.837713811298386e-10
of O 0 1.134757354748217e-08
this O 0 1.4419446747737652e-09
gene O 0 1.490978118745545e-09
has O 0 1.5280906748293965e-11
shown O 0 7.2225819075510955e-12
that O 0 1.1675197213092264e-13
it O 0 2.483642360783661e-13
contains O 0 3.202214968883732e-12
two O 0 5.167989517232408e-13
mutations O 0 2.671603823584112e-12
that O 0 1.8266345467449208e-13
result O 0 1.1198770383247236e-10
in O 0 1.09167987150105e-10
amino O 0 1.7283999231842984e-10
acid O 0 4.121332164430669e-10
substitutions O 0 2.4114614749493057e-09
- O 0 6.252585671440158e-10
cDNA O 0 1.7165832089105493e-09
nucleotides O 0 1.1232698798879781e-10
845 O 0 1.2338289279156811e-09
G O 0 2.9010318591815576e-09
- O 0 4.3513920244819815e-10
- O 0 3.576962059881339e-10
> O 0 1.4563673600420657e-09
A O 0 6.531141738541635e-10
( O 0 5.064842859350827e-13
C282Y O 0 1.0531659988544106e-09
) O 0 3.9613467671048563e-13
and O 0 5.497061573295214e-12
187 O 0 2.7659077805886056e-10
C O 0 2.4011073129770466e-09
- O 0 4.1118708438148133e-10
- O 0 1.7984765898759747e-09
> O 0 5.5826593126084845e-08
G O 0 2.3573172711621737e-06
( O 0 5.21302064016016e-11
H63D O 0 0.00013530050637200475
) O 0 3.4601527199029647e-10
. O 0 7.179602690143838e-09

Although O 0 5.885394784854725e-05
hemochromatosis B-Disease 1 1.0
is O 0 9.037898429653524e-09
common O 0 4.34192681808554e-09
in O 0 1.4417569915714523e-10
Caucasians O 0 6.303383592864975e-09
, O 0 4.7321881656292586e-12
affecting O 0 6.740657337855893e-11
> O 0 1.2511881530841151e-09
= O 0 3.1506533493264044e-11
1 O 0 9.212015178450272e-11
/ O 0 1.6638345215480577e-11
300 O 0 1.2816221608286105e-12
individuals O 0 2.228003616018895e-14
of O 0 8.854660928092617e-12
northern O 0 4.79027373323504e-11
European O 0 1.2390780068649576e-10
origin O 0 6.390589724070139e-10
, O 0 5.2638340734822986e-12
it O 0 4.622899827701199e-13
has O 0 5.680385225777587e-14
not O 0 5.144749643665181e-13
been O 0 4.320161416104806e-12
recognized O 0 3.7103733280252627e-11
in O 0 7.403276602868658e-11
other O 0 2.0992690918930634e-10
populations O 0 5.075952436150999e-10
. O 0 1.1120977472245386e-09

The O 0 4.5366707723815125e-08
present O 0 1.7899212112482132e-09
study O 0 8.587836691775763e-11
used O 0 9.39250153347837e-12
PCR O 0 2.340222948760129e-08
and O 0 1.1371329572407163e-10
restriction O 0 1.2495169343651469e-08
- O 0 4.5559078731827185e-10
enzyme O 0 2.0208006101807285e-10
digestion O 0 9.873017070560763e-09
to O 0 7.225971123542285e-12
analyze O 0 5.60391013107453e-12
the O 0 5.041556907191269e-13
frequency O 0 4.8403442712285916e-12
of O 0 8.553242315800791e-12
the O 0 6.090222076648999e-11
845 O 0 2.258494502527242e-09
G O 0 6.105115524235316e-09
- O 0 7.050368067140766e-10
- O 0 3.7267097741100486e-10
> O 0 9.966326652843804e-10
A O 0 7.058478107557775e-11
and O 0 5.517015880598941e-13
187 O 0 1.123380728718093e-11
C O 0 8.536573531392477e-11
- O 0 9.092592130610644e-12
- O 0 9.630476971445034e-11
> O 0 5.188049101434444e-09
G O 0 5.798971614012771e-08
mutations O 0 2.4152715938363656e-10
in O 0 1.114830450177351e-10
HLA O 0 4.741367831684329e-08
- O 0 2.2194427629074198e-08
typed O 0 9.09490815992342e-10
samples O 0 1.0828662272421852e-10
from O 0 8.472480529653215e-12
non O 0 4.213125848195887e-09
- O 0 2.569823687181838e-09
Caucasian O 0 9.77941616575606e-10
populations O 0 4.4034890317457e-11
, O 0 4.1865865158322024e-13
comprising O 0 2.34563432045809e-12
Australian O 0 4.033476330711494e-11
Aboriginal O 0 8.530339629109207e-11
, O 0 1.9870331779709566e-13
Chinese O 0 1.0082110146747425e-10
, O 0 7.028770794559325e-12
and O 0 1.4684331528513894e-10
Pacific O 0 9.950452906082319e-09
Islanders O 0 3.5771572015619313e-07
. O 0 2.162136603089948e-08

Results O 0 5.541073733184021e-07
showed O 0 4.938955022737446e-09
that O 0 4.670744693791029e-12
the O 0 3.4168021190161824e-10
845 O 0 2.1425506702144048e-08
G O 0 9.736375261581998e-08
- O 0 4.549414622800896e-09
- O 0 4.5373695911621326e-09
> O 0 1.0860754962038754e-08
A O 0 6.04850391994205e-10
mutation O 0 2.1398681437911904e-11
was O 0 4.070649199661158e-12
present O 0 6.080585254059079e-12
in O 0 6.669408081361183e-12
these O 0 7.4605833663699e-12
populations O 0 1.8452156035769773e-12
( O 0 1.8928452148779876e-14
allele O 0 4.857822586031013e-13
frequency O 0 4.480148457081112e-12
0 O 0 8.024016347196739e-12
. O 0 6.403403740411207e-13
32 O 0 1.393070988425782e-11
% O 0 3.2099184963697847e-13
) O 0 1.7719880128649022e-14
, O 0 1.1244407098140452e-13
and O 0 8.241806759637371e-13
, O 0 5.675449801963162e-13
furthermore O 0 2.2712151603876407e-10
, O 0 5.659626847037691e-12
it O 0 2.9120373647162356e-12
was O 0 3.5539711173981914e-09
always O 0 3.696981887291173e-10
seen O 0 6.192669987914456e-11
in O 0 6.52914224422152e-12
conjunction O 0 9.66046478922955e-11
with O 0 1.6845169356627387e-11
HLA O 0 5.534461706702132e-07
haplotypes O 0 1.4171553708308693e-08
common O 0 7.213254993310159e-10
in O 0 3.654208532988257e-11
Caucasians O 0 1.7255251671954852e-09
, O 0 1.0467421200643923e-12
suggesting O 0 1.3178669093505402e-11
that O 0 1.0517071154930724e-12
845 O 0 3.1952280821201384e-09
G O 0 1.2271458160739712e-07
- O 0 5.4822358208639344e-08
- O 0 9.286935664931661e-08
> O 0 4.0516570720683376e-07
A O 0 3.3749635974800185e-08
may O 0 8.324367861689552e-10
have O 0 8.862890456262651e-12
been O 0 2.4232612444441415e-12
introduced O 0 8.05049429897231e-11
into O 0 1.7255103595958943e-11
these O 0 3.115115587357109e-12
populations O 0 1.1034352685040938e-12
by O 0 3.4985131111553436e-12
Caucasian O 0 1.2112344460746272e-09
admixture O 0 2.524031117445702e-08
. O 0 3.548824878407686e-08

187 O 0 2.84832140096114e-06
C O 0 4.1135857031804335e-07
- O 0 7.047615380173511e-09
- O 0 2.3105144464352634e-09
> O 0 1.0839480424351677e-08
G O 0 4.0843605830787055e-08
was O 0 2.2783599659681464e-11
present O 0 3.0180760234727044e-12
at O 0 1.9239794219610973e-12
an O 0 2.923922836164418e-14
allele O 0 7.921326788951077e-12
frequency O 0 1.8930693124197262e-10
of O 0 3.157940575704288e-10
2 O 0 2.8578007515989157e-08
. O 0 1.4598556141720564e-08

68 O 0 1.795617549760209e-06
% O 0 1.3404305443387443e-09
in O 0 3.316512342532718e-11
the O 0 4.7717347434472757e-11
two O 0 1.978977962405204e-12
populations O 0 1.2217836117822678e-11
analyzed O 0 2.2636942320630737e-10
( O 0 1.7910386715391802e-12
Australian O 0 1.9054158251208264e-09
Aboriginal O 0 8.156592734565038e-09
and O 0 2.0658823610131272e-11
Chinese O 0 1.184097375706017e-09
) O 0 3.312801075128213e-11
. O 0 1.8962902359476175e-09

In O 0 2.731341552930644e-08
the O 0 3.5935674436160525e-09
Australian O 0 9.214326190942757e-09
Aboriginal O 0 2.6585034174075872e-09
samples O 0 5.594066529446273e-11
, O 0 2.234713499318919e-12
187 O 0 3.283801286446675e-10
C O 0 3.5934579756258245e-09
- O 0 1.9368462389479646e-10
- O 0 9.627505459519625e-10
> O 0 4.373146111902315e-08
G O 0 5.16673139827617e-07
was O 0 1.6910914335532823e-10
found O 0 1.987155665711393e-12
to O 0 4.3571659409831487e-13
be O 0 4.4434785712033076e-12
associated O 0 6.710182409719323e-10
with O 0 4.322514568499969e-10
HLA O 0 5.945727025391534e-05
haplotypes O 0 1.0816705042770991e-07
common O 0 1.6807411018504581e-09
in O 0 1.777986438633583e-11
Caucasians O 0 3.442391927066524e-10
, O 0 5.03262145498673e-13
suggesting O 0 6.3746967773892216e-12
that O 0 1.0687209174272197e-13
it O 0 5.086169658184703e-13
was O 0 5.939414932099041e-11
introduced O 0 2.5841798145798123e-10
by O 0 1.2667476789740562e-10
recent O 0 3.008924442937655e-09
admixture O 0 1.640418503257024e-07
. O 0 4.415160148596442e-08

In O 0 2.6477868786400904e-08
the O 0 9.881943041634145e-10
Chinese O 0 1.7302347332659451e-09
samples O 0 9.067501610671158e-11
analyzed O 0 3.2525322712917415e-11
, O 0 2.271186927763069e-12
187 O 0 1.454079495699645e-10
C O 0 5.78415260132914e-10
- O 0 2.8328377837949503e-11
- O 0 7.894873643721212e-11
> O 0 1.5068681857854926e-09
G O 0 8.336383139351256e-09
was O 0 2.5525232968948153e-11
present O 0 1.3596642041424634e-11
in O 0 6.700114074664754e-11
association O 0 7.305298727056098e-11
with O 0 2.347505219726931e-12
a O 0 1.594576380659074e-11
wide O 0 8.942452334181894e-10
variety O 0 4.380814044857573e-10
of O 0 1.2182524988801902e-09
HLA O 0 1.3181639815229573e-06
haplotypes O 0 1.9178610699555065e-08
, O 0 1.3733791014158836e-11
showing O 0 3.905978838980584e-12
this O 0 7.660246677428095e-13
mutation O 0 6.263094643604861e-12
to O 0 1.052034110868294e-12
be O 0 3.4860701565025964e-12
widespread O 0 1.2330313436947904e-09
and O 0 9.201988476759126e-11
likely O 0 4.88539164678059e-09
to O 0 1.950310329901228e-10
predate O 0 6.028659527146374e-07
the O 0 1.7080459269180892e-09
more O 0 2.43727520804482e-11
genetically O 0 1.0306180797670095e-08
restricted O 0 1.3039918478341406e-08
845 O 0 2.6116437013001814e-08
G O 0 1.1867346927374456e-07
- O 0 1.566414553622053e-08
- O 0 1.816532169129914e-08
> O 0 1.1209749573026784e-07
A O 0 1.200702559600586e-08
mutation O 0 3.3061133830614153e-09
. O 0 6.060514312622445e-10

Genotype O 0 9.266513370675966e-05
- O 0 5.653521839121822e-06
phenotype O 0 1.760086320246046e-06
correlations O 0 2.780695922410814e-07
in O 0 5.327069008131957e-09
attenuated B-Disease 1 0.9830209016799927
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999994039535522
coli I-Disease 1 1.0
. O 0 2.5247536541428417e-05

Germ O 0 0.006797161418944597
- O 0 2.469357059453614e-05
line O 0 1.8995345953953802e-06
mutations O 0 4.8239923167159304e-09
of O 0 3.604329057438349e-10
the O 0 1.3549512623001192e-09
tumor B-Disease 0 1.5361517853307305e-06
suppressor O 0 3.225788077543257e-06
APC O 0 1.9887293589704313e-08
are O 0 1.609910663981362e-12
implicated O 0 9.028636865915374e-11
in O 0 1.117892889368477e-09
attenuated B-Disease 1 0.9999887943267822
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 3.699218495967216e-06
AAPC B-Disease 1 1.0
) O 0 5.809546593793513e-11
, O 0 6.095503875952479e-13
a O 0 2.1471106143033936e-13
variant O 0 6.035969057904822e-09
of O 0 5.2046807468286715e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 2.346364595950945e-07
FAP B-Disease 0 1.71701904037036e-05
) O 0 1.1860118442896805e-09
. O 0 1.7307769439867116e-08

AAPC B-Disease 1 1.0
is O 0 1.0884811274536332e-08
recognized O 0 5.154018878350541e-10
by O 0 4.260401059719143e-12
the O 0 1.3221797788565137e-11
occurrence O 0 1.2507937741101927e-10
of O 0 1.0450319498644944e-09
< O 0 5.264989226816397e-07
100 O 0 5.777231137926719e-09
colonic B-Disease 0 8.846785021887626e-06
adenomas I-Disease 0 1.2278312624403043e-06
and O 0 2.9181105448694566e-11
a O 0 2.5972522743611393e-12
later O 0 2.4554694388889686e-10
onset O 0 3.797841782215983e-05
of O 1 0.690277099609375
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.722776861087018e-12
age O 0 8.805285667268237e-11
> O 0 2.7122604162599373e-10
40 O 0 1.4567048955971273e-11
years O 0 5.54381193729192e-12
) O 0 7.991346299973667e-12
. O 0 1.566721530288362e-09

The O 0 1.442005981289185e-08
aim O 0 6.919361084101183e-09
of O 0 7.622810715979256e-11
this O 0 1.329356243140456e-11
study O 0 8.254837785548474e-12
was O 0 7.196537636644518e-12
to O 0 6.4254166223798315e-12
assess O 0 3.961953609632474e-08
genotype O 0 1.8971768440678716e-05
- O 0 7.706346877967007e-06
phenotype O 0 7.77237528382102e-06
correlations O 0 5.541259042729507e-07
in O 0 6.352724568614576e-09
AAPC B-Disease 1 1.0
families O 0 6.350413173095149e-08
. O 0 2.017513622831757e-08

By O 0 1.5345388959531192e-08
protein O 0 2.921422925794559e-08
- O 0 1.6821820381096586e-08
truncation O 0 3.7192930335550045e-07
test O 0 2.335594757596482e-07
( O 0 6.597722368439918e-11
PTT O 0 9.716725202224552e-09
) O 0 6.367532911534524e-14
assay O 0 1.0352193408058596e-10
, O 0 1.060127571665681e-12
the O 0 3.637565726063996e-12
entire O 0 6.068284763571796e-11
coding O 0 7.148949210389333e-10
region O 0 2.970264034729553e-09
of O 0 3.4043480923173774e-08
the O 0 1.265548235096503e-06
APC B-Disease 0 3.071946537147596e-07
gene O 0 3.993724517759034e-10
was O 0 5.600635510916163e-10
screened O 0 1.0235338132602578e-09
in O 0 1.5200935996051435e-11
affected O 0 2.962370071468712e-10
individuals O 0 9.716673646242846e-12
from O 0 9.132768985509188e-10
11 O 0 5.093919952514625e-08
AAPC B-Disease 1 1.0
kindreds O 0 0.00021679341443814337
, O 0 6.622108972287322e-10
and O 0 1.765709523038339e-10
their O 0 3.9819045283273624e-10
phenotypic O 0 2.270927446090809e-08
differences O 0 2.495315811756882e-07
were O 0 5.485112097858291e-08
examined O 0 1.1559823178686202e-06
. O 0 9.143443691073116e-08

Five O 0 2.0661227040363883e-07
novel O 0 1.1083420758950524e-07
germ O 0 0.0003082084294874221
- O 0 1.6602552932454273e-05
line O 0 3.3449032343924046e-05
APC B-Disease 0 9.146284014605044e-07
mutations O 0 4.6032084810576634e-09
were O 0 1.870575361273552e-10
identified O 0 1.143651770507681e-10
in O 0 1.3590996383872067e-10
seven O 0 1.2399982152189182e-09
kindreds O 0 3.998762167611858e-06
. O 0 7.488898035035163e-08

Mutations O 0 4.290468211820553e-07
were O 0 1.2500962043304753e-08
located O 0 6.304317623495592e-10
in O 0 3.3969813073575494e-11
three O 0 2.343854277331303e-12
different O 0 5.090277158115164e-12
regions O 0 1.253538606249549e-09
of O 0 3.070057275067484e-08
the O 0 5.51004120552534e-07
APC B-Disease 0 9.059078109885377e-08
gene O 0 1.2367545876301733e-10
( O 0 9.177615264976957e-13
1 O 0 2.702222334782789e-10
) O 0 1.959035012119234e-13
at O 0 2.046687992696139e-11
the O 0 7.067139928818023e-11
5 O 0 4.1096517855443437e-10
end O 0 3.1431115488089745e-09
spanning O 0 4.643339934773394e-09
exons O 0 2.727929881984892e-09
4 O 0 1.8924095623873427e-09
and O 0 8.630398479203549e-11
5 O 0 9.238466658345601e-10
, O 0 1.3155262469644047e-11
( O 0 1.5441632347790168e-12
2 O 0 1.514881414754754e-10
) O 0 5.525029760956868e-13
within O 0 1.425835421953181e-10
exon O 0 1.5766290495378144e-09
9 O 0 1.7683831066150901e-09
, O 0 1.4225559966107859e-11
and O 0 6.687780190750559e-11
( O 0 1.5860642877188469e-12
3 O 0 2.205691462808801e-10
) O 0 1.3663545392773174e-13
at O 0 8.35056589848504e-12
the O 0 2.1040421141482746e-11
3 O 0 3.416254779065042e-10
distal O 0 7.239598698305372e-09
end O 0 6.281961617560228e-08
of O 0 7.553092729040145e-08
the O 0 7.547389913042934e-08
gene O 0 9.946373502600636e-09
. O 0 8.201853773925905e-08

Variability O 0 1.3223769201431423e-05
in O 0 1.6574476235931002e-09
the O 0 3.651611235611085e-10
number O 0 5.233525834924535e-10
of O 0 7.087681410666846e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 1.6901987009987351e-06
most O 0 1.41731612557372e-10
apparent O 0 4.671390496646666e-10
in O 0 1.7491631407184904e-11
individuals O 0 1.5663366870893869e-12
with O 0 3.2393933455804325e-12
mutations O 0 4.798222930091356e-10
in O 0 4.2259043486758685e-10
region O 0 2.532238241315099e-08
1 O 0 4.0455179828313703e-07
, O 0 1.4025576533516215e-10
and O 0 2.974357204976741e-09
upper O 1 0.9462496042251587
- O 0 1.8699138308875263e-05
gastrointestinal O 1 0.9991989731788635
manifestations O 1 0.9725725054740906
were O 0 1.078290168265994e-07
more O 0 9.478674789509256e-11
severe O 0 7.454808326201601e-08
in O 0 1.8739261253841732e-09
them O 0 7.075465768835443e-10
. O 0 7.0181047640005545e-09

In O 0 1.1780337594302637e-08
individuals O 0 1.1143521522205546e-10
with O 0 2.1480057316169976e-11
mutations O 0 3.3092031892500984e-10
in O 0 2.246232366776013e-10
either O 0 9.359677477505102e-10
region O 0 3.6525884539173603e-09
2 O 0 1.6050872853057285e-09
or O 0 2.6740623604304403e-11
region O 0 2.359339945634531e-10
3 O 0 3.981373009054323e-10
, O 0 6.567395282111588e-13
the O 0 6.576687111570223e-12
average O 0 3.957642893959168e-11
number O 0 1.977062263902596e-11
of O 0 3.5476707682668973e-10
adenomas B-Disease 0 3.790389200730715e-06
tended O 0 1.051081426339806e-06
to O 0 4.747272019933746e-10
be O 0 5.327919772035727e-10
lower O 0 1.2774788160641037e-07
than O 0 2.233955902208873e-11
those O 0 1.7346242497939812e-11
in O 0 7.309727476090266e-12
individuals O 0 5.2614027501105e-13
with O 0 1.884964189943772e-12
mutations O 0 6.026436988326722e-11
in O 0 2.3870769944034365e-11
region O 0 2.8257751694127364e-10
1 O 0 1.580702235770559e-10
, O 0 1.0379540380401481e-13
although O 0 1.8232834946702026e-12
age O 0 6.554775472400465e-11
at O 0 2.937656368162678e-11
diagnosis O 0 4.409908882507807e-08
was O 0 9.249098154029411e-10
similar O 0 3.8196530383061145e-09
. O 0 1.021346704987991e-07

In O 0 1.1091394469531224e-07
all O 0 1.0085104662493904e-07
AAPC B-Disease 1 1.0
kindreds O 0 7.224618002510397e-06
, O 0 1.6148506143398578e-11
a O 0 2.0023132457636095e-12
predominance O 0 6.19591355999205e-09
of O 0 6.91879691316899e-08
right O 1 0.9999973773956299
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9559515714645386
rectal B-Disease 1 1.0
polyp I-Disease 0 0.038992684334516525
sparing O 0 4.888186140306061e-07
was O 0 3.680297311348113e-08
observed O 0 2.576632773809706e-08
. O 0 5.689869198022279e-08

No O 0 0.00020226901688147336
desmoid B-Disease 1 0.9999997615814209
tumors I-Disease 1 1.0
were O 0 1.719017603818429e-07
found O 0 7.905697763099795e-10
in O 0 2.2922179432338652e-10
these O 0 4.215046978117698e-09
kindreds O 0 8.70558596943738e-06
. O 0 5.593381757762472e-08

Our O 0 7.225213494166383e-07
data O 0 7.137208601903922e-09
suggest O 0 1.944101324369285e-09
that O 0 1.706193996850458e-12
, O 0 1.2768331530965682e-11
in O 0 7.493420328685829e-10
AAPC B-Disease 1 1.0
families O 0 1.8552301916940905e-09
, O 0 4.012493462490774e-13
the O 0 3.082958693022275e-13
location O 0 4.290928029559993e-11
of O 0 5.942477621090347e-10
the O 0 1.6949543635291775e-07
APC B-Disease 0 8.676476682012435e-06
mutation O 0 6.823337628247828e-08
may O 0 9.461993855097717e-09
partially O 0 1.532593785213976e-08
predict O 0 4.808256903743313e-09
specific O 0 2.3822672723383675e-09
phenotypic O 0 1.340308983799332e-07
expression O 0 3.4316781238885596e-07
. O 0 1.3129056242178194e-07

This O 0 5.168562022817014e-09
should O 0 1.2533354354360426e-09
help O 0 1.2346569600030222e-10
in O 0 9.700452247018987e-12
the O 0 8.547110068313213e-12
design O 0 1.176284070147915e-09
of O 0 5.822073378958237e-10
tailored O 0 5.440194286165934e-07
clinical O 0 2.6128799390789936e-07
- O 0 4.675172249335446e-09
management O 0 8.508857507472101e-11
protocols O 0 2.404462184912859e-09
in O 0 6.555759841236908e-12
this O 0 1.0807378212837615e-12
subset O 0 2.309200469730044e-10
of O 0 3.135294801559496e-11
FAP B-Disease 0 3.7353314041865815e-07
patients O 0 2.7105100386393133e-08
. O 0 2.9418292801786095e-10
. O 0 5.353460341694927e-09

Wilms B-Disease 1 1.0
' I-Disease 0 0.4549575746059418
tumor I-Disease 0 4.3723859562305734e-05
1 O 0 9.44969755778402e-08
and O 0 9.673966072654139e-10
Dax O 0 4.5678578317165375e-05
- O 0 2.8450852340711208e-08
1 O 0 2.7279938308311102e-08
modulate O 0 1.3473776760974943e-08
the O 0 2.103442309220327e-09
orphan O 0 5.745224385123038e-08
nuclear O 0 3.995542030565957e-08
receptor O 0 3.0563271025130234e-08
SF O 0 0.0029202669393271208
- O 0 4.244407136866357e-08
1 O 0 3.470425502527519e-09
in O 0 6.3527876535685035e-12
sex O 0 8.930205533386193e-12
- O 0 2.6144706191666423e-11
specific O 0 6.69362551497521e-11
gene O 0 1.7305737398665144e-10
expression O 0 1.9393349148799643e-09
. O 0 6.999188784106991e-09

Products O 0 5.017978992327699e-07
of O 0 1.225948125238574e-07
steroidogenic O 0 0.18774905800819397
factor O 0 7.642227046744665e-07
1 O 0 7.86931266816282e-08
( O 0 3.971087000897988e-11
SF O 0 0.4743940234184265
- O 0 4.118732022106997e-07
1 O 0 5.094415556072818e-08
) O 0 3.593666683676666e-11
and O 0 9.348579688150949e-10
Wilms B-Disease 1 0.9999966621398926
tumor I-Disease 1 0.9958284497261047
1 O 0 2.211862693002331e-06
( O 0 3.3011463007603936e-10
WT1 O 0 7.107885721779894e-06
) O 0 4.6190790775613166e-11
genes O 0 6.873304009280545e-11
are O 0 7.64969034297569e-13
essential O 0 3.7982755829446546e-11
for O 0 5.5145571269121785e-12
mammalian O 0 3.321435926295635e-08
gonadogenesis O 0 2.773323046767473e-07
prior O 0 1.7933022888882988e-07
to O 0 2.4548618693387425e-09
sexual O 0 7.521475886562712e-09
differentiation O 0 4.911433393317566e-07
. O 0 4.98161725204227e-08

In O 0 1.3909278173684925e-08
males O 0 1.0082575885306255e-09
, O 0 1.614678807326797e-10
SF O 1 0.996441662311554
- O 0 3.1847878290136578e-06
1 O 0 2.858499499325262e-07
participates O 0 3.1074046114021314e-10
in O 0 4.533573169651639e-12
sexual O 0 1.587274799444427e-12
development O 0 1.0654919654906614e-11
by O 0 1.4688518413727425e-12
regulating O 0 1.1153264978247535e-09
expression O 0 3.571637707810993e-10
of O 0 2.2608205585417096e-10
the O 0 6.526783558058469e-10
polypeptide O 0 6.263620377922052e-08
hormone O 0 4.092296723712252e-09
Mullerian O 0 8.32752562018868e-07
inhibiting O 0 1.0772109959589216e-07
substance O 0 2.1489040591404773e-06
( O 0 3.879507826098916e-09
MIS O 0 9.723939001560211e-05
) O 0 1.266327931404021e-09
. O 0 1.740552768580983e-08

Here O 0 1.9755771063501015e-07
, O 0 1.1067082805737982e-09
we O 0 9.136805895204603e-11
show O 0 3.0308613258034356e-11
that O 0 5.5190396523741025e-12
WT1 O 0 3.583562283893116e-05
- O 0 3.910455234290566e-06
KTS O 0 0.004818047396838665
isoforms O 0 1.441078580910471e-07
associate O 0 3.099533074646388e-09
and O 0 4.064638556289246e-11
synergize O 0 1.977565773358947e-07
with O 0 1.6659661150608684e-10
SF O 1 0.9999998807907104
- O 0 1.5616406017215922e-05
1 O 0 3.7908884564785694e-07
to O 0 9.245200160989953e-10
promote O 0 1.0665127092579496e-07
MIS O 0 0.0010541309602558613
expression O 0 1.0178752773981614e-07
. O 0 2.39860931117164e-08

In O 0 2.3073095434256174e-08
contrast O 0 1.0910610370729046e-07
, O 0 5.913343148478134e-09
WT1 O 0 0.001641077222302556
missense O 0 2.162753116863314e-05
mutations O 0 1.3101170814877605e-08
, O 0 7.390137980733957e-12
associated O 0 6.982221745222006e-11
with O 0 1.0773856633228274e-11
male B-Disease 0 1.0343691458913895e-09
pseudohermaphroditism I-Disease 1 1.0
in O 0 1.4172154294556094e-07
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 3.097293310716509e-09
fail O 0 1.6026596938445437e-07
to O 0 5.146906789654793e-10
synergize O 0 1.1458883818704635e-05
with O 0 1.1387901288628655e-08
SF O 1 1.0
- O 0 0.00778744462877512
1 O 0 1.99315127247246e-06
. O 0 7.99617616564774e-09

Additionally O 0 1.387601571423147e-07
, O 0 1.593628701224148e-10
the O 0 1.38554862028073e-10
X O 0 3.1395777568832273e-06
- O 0 9.930889177667268e-08
linked O 0 1.3759040484728757e-07
, O 0 3.6709673495449735e-11
candidate O 0 6.610511582572087e-10
dosage O 0 2.6081242054942777e-08
- O 0 5.907861422294047e-10
sensitive O 0 2.4871281922855815e-08
sex O 0 1.0565275043727951e-10
- O 0 1.5692389054855482e-10
reversal O 0 4.453488688938023e-09
gene O 0 4.416672028106916e-10
, O 0 2.684371058769841e-10
Dax O 0 0.13696154952049255
- O 0 4.971555611632539e-08
1 O 0 3.4454963326879806e-08
, O 0 2.641991313223624e-11
antagonizes O 0 5.952656145780111e-09
synergy O 0 7.25168813886512e-10
between O 0 3.914992774411985e-10
SF O 0 0.0592951700091362
- O 0 5.433921046460455e-08
1 O 0 5.873841857351181e-09
and O 0 1.4032373873984483e-10
WT1 O 0 2.2253680072026327e-06
, O 0 2.871521770364538e-11
most O 0 1.9610557969174103e-11
likely O 0 7.558326881040855e-11
through O 0 9.920794654533216e-13
a O 0 1.6291108002539079e-13
direct O 0 3.7159524589325255e-12
interaction O 0 7.030664245233353e-11
with O 0 9.145122853437826e-11
SF O 1 1.0
- O 0 0.00014441952225752175
1 O 0 1.846295162977185e-06
. O 0 1.4601953424175917e-08

We O 0 1.983085979873067e-07
propose O 0 2.398317349161516e-07
that O 0 7.764374698737697e-10
WT1 O 0 0.13791531324386597
and O 0 2.6509002282182337e-07
Dax O 1 0.9306873679161072
- O 0 1.0433360841943795e-07
1 O 0 1.6651449996629708e-08
functionally O 0 1.108448999254108e-09
oppose O 0 2.0090482055756809e-10
each O 0 3.9272822190475343e-13
other O 0 1.6815401068098756e-12
in O 0 9.598636989405218e-12
testis O 0 8.123584471775303e-09
development O 0 2.6639317488030834e-11
by O 0 1.4734121908666076e-11
modulating O 0 9.830385749864945e-08
SF O 1 0.9998738765716553
- O 0 2.9543293749156874e-06
1 O 0 2.6619810000738653e-07
- O 0 4.550543053483125e-09
mediated O 0 2.350260608352528e-08
transactivation O 0 1.4196843949321192e-06
. O 0 2.6676005848713658e-09
. O 0 5.186722606964622e-09

A O 0 1.471763511062818e-07
mouse O 0 9.169864867430988e-09
model O 0 6.593499080054244e-10
for O 0 4.6750563420516755e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 1.0
- O 1 0.9991863369941711
centre O 0 2.6259993319399655e-05
mutations O 0 2.8396914331096923e-07
. O 0 3.240524648617793e-08

Imprinting O 0 1.0948423550871667e-05
in O 0 4.015763721554322e-09
the O 0 2.2631903018321964e-09
15q11 O 0 1.6136265230670688e-06
- O 0 9.954898416708602e-08
q13 O 0 8.361338359463844e-07
region O 0 2.7532400803664814e-09
involves O 0 2.2185009385111698e-10
an O 0 2.103086368249185e-12
imprinting O 0 1.3443018076486624e-07
centre O 0 1.3415852606613043e-07
( O 0 1.583800798843349e-11
IC O 0 6.611399498979154e-07
) O 0 3.5937674277425335e-12
, O 0 7.034896211573216e-13
mapping O 0 1.4893905553314823e-11
in O 0 4.25834584608098e-12
part O 0 6.777179512029718e-11
to O 0 1.366690233206569e-10
the O 0 2.6112736417616134e-09
promoter O 0 1.4744932741450612e-07
and O 0 9.172046455674376e-10
first O 0 6.442595346101143e-09
exon O 0 7.220130271434755e-08
of O 0 1.8340891472234944e-08
SNRPN O 1 0.9997431635856628
. O 0 1.3711585324927e-06

Deletion O 0 3.114463140718726e-07
of O 0 9.064916817180801e-09
this O 0 6.947102337839794e-10
IC O 0 1.477746081945952e-05
abolishes O 0 4.4339972760099045e-07
local O 0 3.4019838057730567e-09
paternally O 0 1.8916633592880316e-08
derived O 0 9.898727670876184e-11
gene O 0 6.5618396133393375e-12
expression O 0 1.8828369852813553e-12
and O 0 1.3367104190024903e-13
results O 0 2.204495787305749e-11
in O 0 1.394896309570015e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.8413320251274854e-05
PWS B-Disease 1 1.0
) O 0 6.3808371919549245e-09
. O 0 1.3572306833964376e-08

We O 0 1.630464794288855e-07
have O 0 4.6270526299352355e-10
created O 0 2.1174910713739337e-09
two O 0 2.1371282521442936e-10
deletion O 0 1.6060987206856225e-08
mutations O 0 5.739974273666348e-09
in O 0 8.566540254939525e-10
mice O 0 6.658131823655822e-09
to O 0 2.3800814097363343e-10
understand O 0 1.5724860702448495e-07
PWS B-Disease 1 1.0
and O 0 2.4704764456373596e-08
the O 0 1.9117597782614126e-10
mechanism O 0 1.9083389035667864e-10
of O 0 4.008229512186823e-11
this O 0 1.2101715463064266e-10
IC O 0 5.538631012313999e-05
. O 0 6.028376731137541e-08

Mice O 0 0.0004907881957478821
harbouring O 0 1.0767734238470439e-05
an O 0 8.712620624962142e-10
intragenic O 0 3.3928795346582774e-06
deletion O 0 6.898451232473235e-08
in O 0 3.022631922533492e-09
Snrpn O 0 9.622373909223825e-05
are O 0 1.4832119976659897e-09
phenotypically O 0 4.7152548177109566e-06
normal O 0 6.587484335796034e-08
, O 0 1.8189944342439368e-11
suggesting O 0 6.479002750969798e-11
that O 0 2.8006659491541797e-12
mutations O 0 1.0022811469667658e-09
of O 0 9.378481102828573e-09
SNRPN O 1 1.0
are O 0 3.512926061155497e-10
not O 0 5.3121482906925976e-11
sufficient O 0 4.039617085282998e-09
to O 0 4.022538413472887e-10
induce O 0 5.480758318299195e-06
PWS B-Disease 1 1.0
. O 0 1.3996475900057703e-05

Mice O 0 1.2678177881753072e-05
with O 0 1.5609014081263695e-10
a O 0 9.432469388892528e-11
larger O 0 1.3266371334808014e-09
deletion O 0 4.216566651393805e-09
involving O 0 1.0173833997484394e-09
both O 0 6.880179759249927e-10
Snrpn O 0 3.8025355024728924e-05
and O 0 9.529274036523816e-10
the O 0 2.3245267932736624e-09
putative O 0 1.9007362652700976e-06
PWS O 1 1.0
- O 0 1.3271892385091633e-05
IC O 0 0.00019345780310686678
lack O 0 5.9367962990108936e-08
expression O 0 3.206924448218018e-10
of O 0 5.5956246580723956e-11
the O 0 8.215134128519708e-11
imprinted O 0 1.0456047583318195e-08
genes O 0 1.677772032415703e-09
Zfp127 O 0 1.1292222552583553e-06
( O 0 9.002035922245355e-11
mouse O 0 4.582272339348492e-09
homologue O 0 6.208005487451373e-08
of O 0 1.5774691775050087e-08
ZNF127 O 1 0.9999994039535522
) O 0 4.289132160550935e-09
, O 0 2.688625322377902e-09
Ndn O 0 8.947149581217673e-07
and O 0 6.383670259069163e-10
Ipw O 0 1.7744356455295929e-06
, O 0 4.886051008234915e-10
and O 0 1.368349045183237e-10
manifest O 0 2.7701394955670366e-08
several O 0 1.9929612127267404e-10
phenotypes O 0 4.32051592724747e-07
common O 0 5.471653707900259e-08
to O 0 6.01219838358702e-08
PWS B-Disease 1 1.0
infants O 1 0.9999994039535522
. O 0 4.2687881318670406e-07

These O 0 1.0516790993619907e-08
data O 0 8.752294999858634e-10
demonstrate O 0 3.18422066492019e-10
that O 0 9.288277612318208e-13
both O 0 5.373328951924217e-12
the O 0 3.3974215801757524e-11
position O 0 6.222815318590591e-11
of O 0 6.397111312894666e-11
the O 0 7.401201179702e-11
IC O 0 7.4149556894553825e-06
and O 0 1.282736139529561e-10
its O 0 1.049973909900137e-11
role O 0 8.56934315174307e-12
in O 0 4.508583176937586e-12
the O 0 7.33973645750119e-12
coordinate O 0 4.303533918115221e-11
expression O 0 2.5131047243220905e-10
of O 0 2.113278663173901e-09
genes O 0 4.5794476544180895e-10
is O 0 7.2433031794716385e-12
conserved O 0 7.707166849169056e-11
between O 0 4.312621787461168e-11
mouse O 0 1.866121923654873e-09
and O 0 1.9364758060969045e-11
human O 0 1.8125700593230043e-11
, O 0 7.35491355319251e-12
and O 0 1.2059566886768458e-11
indicate O 0 3.422148328602326e-11
that O 0 1.2123235358305062e-12
the O 0 2.694933998181881e-10
mouse O 0 1.0551505225109281e-09
is O 0 3.5485855790287624e-13
a O 0 1.1351786481303416e-13
suitable O 0 2.889009587114799e-10
model O 0 1.5964214672425925e-10
system O 0 2.808147936406158e-09
in O 0 3.645151888664877e-11
which O 0 2.698953690746797e-12
to O 0 3.422532006067125e-12
investigate O 0 8.036502713304472e-11
the O 0 2.9954191904657534e-11
molecular O 0 1.7118936823656838e-10
mechanisms O 0 1.0300633679349858e-09
of O 0 8.404550944085543e-10
imprinting O 0 2.0657829225001478e-08
in O 0 1.4028191802628598e-11
this O 0 3.736207090238031e-12
region O 0 1.091038717704329e-10
of O 0 6.621411058338467e-11
the O 0 2.110429747625986e-10
genome O 0 9.993161159682629e-11
. O 0 7.045686256645922e-11
. O 0 2.6102129346838865e-09

Mutations O 0 6.031057750988111e-07
of O 0 2.0887588547680025e-08
the O 0 1.8007154878318943e-08
ATM O 0 1.471184191359498e-06
gene O 0 3.1339991712897586e-10
detected O 0 4.1006180673264225e-09
in O 0 1.6277712511225673e-10
Japanese O 0 0.0009626641985960305
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 0.9930099248886108
: O 0 2.9341713520675272e-12
possible O 0 3.057751274404552e-11
preponderance O 0 1.1555239431970676e-08
of O 0 6.584698064582284e-11
the O 0 1.3032544488034148e-10
two O 0 3.3008172584114703e-11
founder O 0 5.2724935528658534e-09
mutations O 0 1.1509042607826814e-09
4612del165 O 0 2.0705489589545323e-07
and O 0 2.809492860578189e-09
7883del5 O 0 4.067513600602979e-06
. O 0 9.106215514975702e-08

The O 0 4.6831357281007513e-07
ATM O 0 0.0003424256283324212
( O 0 9.084302199369176e-09
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 1.504543989394591e-10
mutated O 0 1.920122061349616e-09
) O 0 5.595568713240295e-12
gene O 0 1.3467615911366693e-11
on O 0 6.36360825145843e-11
human O 0 1.2129978965713661e-10
chromosome O 0 2.7982780537172403e-09
11q22 O 0 2.189152610299061e-06
. O 0 1.732250609620678e-07

3 O 0 2.600311563583091e-05
has O 0 9.773113429645264e-10
recently O 0 3.3592517656444443e-10
been O 0 2.4648340660182733e-11
identified O 0 4.639015560581328e-11
as O 0 9.21169477502426e-12
the O 0 5.248074978064787e-12
gene O 0 7.845120495071634e-13
responsible O 0 1.431643161225321e-13
for O 0 9.697113039853003e-14
the O 0 2.103480584159101e-11
human O 0 3.463970887906953e-09
recessive B-Disease 1 0.9999116659164429
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 7.771791570121422e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 6.685003661743849e-10
. O 0 6.350180381531345e-09

In O 0 4.184439905685622e-09
order O 0 1.6980736816663011e-09
to O 0 7.67433755433089e-11
define O 0 7.494449505429657e-10
the O 0 2.9679279867078634e-11
types O 0 6.421049802973755e-10
of O 0 3.316615038162496e-10
disease O 0 2.0903410558048563e-08
- O 0 2.857788450327803e-09
causing O 0 2.142959232287467e-08
ATM O 0 7.483306490030373e-07
mutations O 0 5.96766733251819e-11
in O 0 3.913055209719962e-12
Japanese O 0 2.0207099993285738e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
patients O 0 1.5810459444765e-05
as O 0 1.9233089079695453e-11
well O 0 1.864528713715896e-12
as O 0 9.42454664656922e-13
to O 0 1.6497272298243715e-12
look O 0 1.5850428608521483e-11
for O 0 1.7956734189861212e-12
possible O 0 1.1801674082434488e-09
mutational O 0 6.984668061704724e-07
hotspots O 0 5.327478191929913e-08
, O 0 4.0032175491200306e-11
reverse O 0 8.596083844736313e-10
- O 0 4.5753181798779963e-10
transcribed O 0 1.0606869549345532e-10
RNA O 0 1.801819110580638e-11
derived O 0 1.2348636002634805e-11
from O 0 2.611483945758053e-12
ten O 0 3.324067410215292e-11
patients O 0 3.692131669841281e-11
belonging O 0 2.450283465710301e-12
to O 0 1.309315177978887e-12
eight O 0 8.690703538760669e-12
unrelated O 0 2.0582777704447608e-09
Japanese O 0 1.943149754879414e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 1.8305330862222746e-10
was O 0 2.0744033227271252e-11
analyzed O 0 5.5349395206016894e-11
for O 0 6.593392064963011e-12
mutations O 0 8.428675118965501e-11
by O 0 1.358948630708623e-11
the O 0 1.386582376694534e-10
restriction O 0 6.761808002408998e-09
endonuclease O 0 1.613519806653585e-08
fingerprinting O 0 1.0247924286943544e-08
method O 0 3.8222204068460996e-08
. O 0 1.8437908977375628e-08

As O 0 8.839194265419792e-07
has O 0 1.4179867002805935e-10
been O 0 1.6740591551878126e-11
reported O 0 1.618760030533406e-12
by O 0 7.935875047382357e-12
others O 0 1.4766794731446709e-10
, O 0 1.1768932182965042e-11
mutations O 0 3.605413537166591e-11
that O 0 9.138039283596022e-12
lead O 0 2.83509482557065e-09
to O 0 6.48750519971486e-09
exon O 0 2.4716653115319787e-06
skipping O 0 3.115959543720237e-06
or O 0 1.7834463905685993e-09
premature O 0 4.4776207630548015e-08
protein O 0 4.834951328192005e-10
truncation O 0 3.135927428843388e-08
were O 0 8.157242659123654e-10
also O 0 2.4188847105865996e-11
predominant O 0 4.461593405835629e-08
in O 0 4.2237607855710735e-10
our O 0 6.296485999257584e-09
mutants O 0 2.321991701137449e-07
. O 0 9.957894953060986e-09

Six O 0 4.4742741067693714e-08
different O 0 7.790081912872893e-10
mutations O 0 6.903341231989657e-10
were O 0 1.9514562188405193e-10
identified O 0 3.472381757130272e-11
on O 0 1.268425503520021e-10
12 O 0 9.508951265280174e-11
of O 0 5.0809776525051475e-11
the O 0 5.729623997474675e-10
16 O 0 4.482959337082093e-09
alleles O 0 1.3877339277712508e-09
examined O 0 1.4418455407394504e-07
. O 0 5.153719939698931e-08

Four O 0 2.365217888211646e-08
were O 0 6.363991111868472e-09
deletions O 0 2.823973055399165e-08
involving O 0 3.2856823928284484e-09
a O 0 6.484668357842338e-10
loss O 0 3.312426954948933e-08
of O 0 5.2847290987756423e-08
a O 0 1.9752401936301567e-09
single O 0 1.0680023976306074e-08
exon O 0 8.681956842337968e-08
exon O 0 3.9318415190336964e-08
7 O 0 2.802199894347268e-08
, O 0 2.1740191591401725e-10
exon O 0 3.1266463196288896e-08
16 O 0 1.2770641433235141e-08
, O 0 1.1605748584386788e-09
exon O 0 2.8946558927600563e-07
33 O 0 2.510856234039238e-07
or O 0 3.449401830835086e-08
exon O 0 5.164788944966858e-06
35 O 0 9.467717632105632e-07
. O 0 1.7173773869672004e-07

The O 0 3.511550517032447e-07
others O 0 1.0408431450059652e-08
were O 0 1.2298980722746933e-09
minute O 0 9.08005848287985e-09
deletions O 0 8.046189492461053e-09
, O 0 1.3745224403116652e-10
4649delA O 0 6.435793409309554e-08
in O 0 3.1330980032606703e-09
exon O 0 1.2189973119802744e-07
33 O 0 1.2192782783415623e-08
and O 0 2.449042912910926e-10
7883del5 O 0 3.941930515338754e-07
in O 0 2.620495287430913e-08
exon O 0 1.4935468470866908e-06
55 O 0 5.591226113210723e-07
. O 0 6.00092491254145e-08

The O 0 9.631929742681677e-07
mutations O 0 1.2020090878195333e-07
4612del165 O 0 1.5973267863955698e-06
and O 0 2.6632334115817002e-09
7883del5 O 0 4.476327433167171e-07
were O 0 3.537125481400949e-09
found O 0 1.656200697419674e-11
in O 0 4.627215711289212e-12
more O 0 5.627041801264943e-13
than O 0 5.928927596272893e-13
two O 0 1.6033306409965475e-13
unrelated O 0 1.2259113169044156e-10
families O 0 3.3130269361247855e-12
; O 0 1.4584945664392057e-12
44 O 0 2.0389002985954363e-10
% O 0 4.030943981381263e-12
( O 0 4.515601082074813e-14
7 O 0 5.612010162137082e-11
of O 0 5.7965635763546075e-11
16 O 0 2.018855083107951e-10
) O 0 4.059497692426167e-13
of O 0 4.7203449482502435e-11
the O 0 1.4090249800258192e-10
mutant O 0 1.5725025725998876e-09
alleles O 0 1.5812871845266585e-10
had O 0 7.167991894485581e-11
one O 0 1.0804534350539186e-12
of O 0 2.316451544470688e-11
the O 0 3.261492187434101e-10
two O 0 2.2147128575511488e-10
mutations O 0 3.975645590514887e-09
. O 0 2.8835017928940943e-08

The O 0 5.688430633199459e-07
4612del165 O 0 5.616694124910282e-06
mutations O 0 4.623808447234978e-09
in O 0 4.778210119238402e-11
three O 0 9.86473489700268e-13
different O 0 3.964537031997395e-13
families O 0 7.403607891684483e-13
were O 0 4.509425818866042e-12
all O 0 2.9914365797835407e-13
ascribed O 0 1.018567313826324e-10
to O 0 2.077590703641885e-11
the O 0 4.591613755877688e-10
same O 0 4.804999731433668e-10
T O 0 1.9085229396864634e-08
- O 0 3.5253303054538776e-10
- O 0 1.3086098871184504e-10
> O 0 2.3026515416635362e-10
A O 0 7.010789084688218e-12
substitution O 0 5.2281259182995754e-11
at O 0 4.4078816117953945e-12
the O 0 5.62468431206109e-12
splice O 0 2.4637649698178166e-09
donor O 0 1.5121658369920965e-09
site O 0 1.2070393573537785e-09
in O 0 7.129503654113023e-10
intron O 0 7.363622671618941e-07
33 O 0 1.9946600104958634e-07
. O 0 7.072260643781192e-08

Microsatellite O 0 0.0002583295863587409
genotyping O 0 7.380970055237412e-05
around O 0 6.118007878086473e-09
the O 0 4.392873176328749e-09
ATM O 0 7.319601536437403e-06
locus O 0 6.9637282607004636e-09
also O 0 4.478365595028677e-11
indicated O 0 6.46236605894579e-11
that O 0 1.3016229261954282e-13
a O 0 5.738933633869792e-13
common O 0 1.0243009218591226e-10
haplotype O 0 2.5228217293005173e-09
was O 0 7.850879946147415e-10
shared O 0 1.9459803560217814e-11
by O 0 1.3383158513693982e-12
the O 0 2.497173128002128e-11
mutant O 0 1.5386765195302132e-09
alleles O 0 1.9254020600101285e-10
in O 0 1.4715396956521687e-10
both O 0 9.885373630780236e-10
mutations O 0 1.2816320449360319e-08
. O 0 1.4382538715551618e-08

This O 0 2.5409324422298596e-08
suggests O 0 1.951387496035295e-08
that O 0 8.009259921948342e-12
these O 0 3.626291489311484e-10
two O 0 6.460036672262248e-11
founder O 0 2.2066698690537123e-08
mutations O 0 1.4196896991336416e-09
may O 0 1.3384326980059313e-09
be O 0 1.8874882212749355e-10
predominant O 0 2.0346918461200403e-07
among O 0 5.931218710619746e-11
Japanese O 0 6.827683307619736e-09
ATM O 0 5.698187237612728e-07
mutant O 0 2.018445712792527e-07
alleles O 0 2.8250559225284633e-08
. O 0 3.0628573455260266e-08

W474C O 0 2.335689259780338e-06
amino O 0 3.2578382214154544e-09
acid O 0 4.6117923369060065e-10
substitution O 0 3.370504098043625e-09
affects O 0 6.727235435377565e-11
early O 0 1.717401082457215e-10
processing O 0 4.726762314888333e-10
of O 0 5.11738373898396e-10
the O 0 7.132183177382956e-10
alpha O 0 8.59593674018555e-10
- O 0 1.0098275687875358e-10
subunit O 0 6.908448813014445e-11
of O 0 9.310831272646425e-11
beta O 0 9.049450633291656e-10
- O 0 1.4718100072030893e-09
hexosaminidase O 0 4.3755991896432533e-07
A O 0 1.3717442737259944e-09
and O 0 2.5637443556991713e-12
is O 0 5.1993880799102235e-14
associated O 0 6.2746331568053204e-12
with O 0 2.935740539555809e-11
subacute O 1 0.9991849064826965
G B-Disease 1 0.9999992847442627
( I-Disease 0 4.346218496209531e-09
M2 I-Disease 0 0.000151256681419909
) I-Disease 0 5.892949461738795e-10
gangliosidosis I-Disease 0 8.801594958640635e-06
. O 0 2.5819809934546356e-07

Mutations O 0 4.323863151967089e-07
in O 0 2.8815263508619182e-09
the O 0 8.706727783192036e-09
HEXA O 0 1.4030097190698143e-05
gene O 0 3.55515589189892e-10
, O 0 1.5858170679394767e-11
encoding O 0 1.6525475432516146e-10
the O 0 3.915432977841249e-10
alpha O 0 2.3956350791998204e-10
- O 0 2.7146241851627728e-11
subunit O 0 4.7007025008594105e-12
of O 0 6.630987859496118e-12
beta O 0 6.356208614999304e-11
- O 0 3.656169256238684e-10
hexosaminidase O 0 3.947438074192178e-07
A O 0 5.962919402691114e-08
( O 0 2.9072496146587135e-11
Hex O 0 4.8562320387190994e-08
A O 0 4.778822892959056e-10
) O 0 7.748931704631978e-13
, O 0 3.740961533604814e-13
that O 0 2.749875793652684e-13
abolish O 0 2.2244520891945285e-08
Hex O 0 3.6368800238051335e-07
A O 0 7.456864015153997e-10
enzyme O 0 3.2831890539597453e-09
activity O 0 1.008829784154841e-07
cause O 1 0.9999831914901733
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 6.131275487319954e-10
TSD B-Disease 1 0.8907448053359985
) O 0 2.472876937942292e-11
, O 0 5.579263179927851e-12
the O 0 1.418630490856998e-10
fatal O 0 2.5936586212083057e-08
infantile B-Disease 0 2.6297490762772213e-07
form I-Disease 0 1.8046007355110305e-08
of I-Disease 0 0.0003437355626374483
G I-Disease 1 0.9968074560165405
( I-Disease 0 1.7757471881818532e-10
M2 I-Disease 0 1.6823315718283993e-06
) I-Disease 0 4.3578413447264985e-12
gangliosidosis I-Disease 0 3.2341521460921285e-08
, I-Disease 0 2.0755985472020733e-11
Type I-Disease 0 1.0702290609287957e-08
1 I-Disease 0 6.620346937324939e-08
. O 0 1.461379550704578e-08

Less O 0 1.2016033679174143e-07
severe O 0 2.6283601073373575e-06
, O 0 9.546706536411875e-09
subacute O 1 0.9878265261650085
( O 0 2.2869336979702837e-10
juvenile O 0 2.10571670322679e-05
- O 0 6.328416457535013e-09
onset O 0 0.3307119309902191
) O 0 5.387516543997606e-10
and O 0 6.386854778384077e-08
chronic O 1 0.9996670484542847
( O 0 6.234220084611053e-11
adult O 0 5.354267251789224e-09
- O 0 3.6523079005590375e-10
onset O 0 9.6441635832889e-07
) O 0 2.7005670269475424e-11
variants O 0 2.1968000751826366e-09
are O 0 2.0428268451833098e-11
characterized O 0 8.244735623386124e-12
by O 0 3.0355919600905112e-12
a O 0 1.4890129060307622e-11
broad O 0 2.3817812166981867e-09
spectrum O 0 3.455473418512156e-08
of O 0 8.654812283515056e-11
clinical O 0 1.1322509596567443e-09
manifestations O 0 6.92378376854208e-09
and O 0 1.5750945686621165e-11
are O 0 1.5867259491996605e-13
associated O 0 4.813810374620919e-12
with O 0 2.433268701546726e-13
residual O 0 3.608941412380773e-08
levels O 0 7.090332587722514e-08
of O 0 1.4154507788077808e-08
Hex O 0 5.833188424730906e-06
A O 0 3.695815209425746e-08
enzyme O 0 4.5410512683474735e-08
activity O 0 2.7679064373842266e-07
. O 0 1.774394675635449e-08

We O 0 1.9738701340088483e-08
identified O 0 1.4293459749126214e-09
a O 0 9.694279407002071e-11
1422 O 0 6.871864002278016e-07
G O 0 5.926568178438174e-07
- O 0 6.649820960547004e-08
- O 0 2.9176307592138073e-08
> O 0 1.1387558629394334e-07
C O 0 7.976437643719692e-08
( O 0 1.6398473833174887e-13
amino O 0 1.936050061587813e-12
acid O 0 5.097145795718294e-12
W474C O 0 1.4910228607334375e-10
) O 0 8.65187319709507e-15
substitution O 0 1.3113325529612307e-11
in O 0 2.807110230026999e-12
the O 0 7.0010338672210626e-12
first O 0 7.621847597505393e-12
position O 0 7.354677977744473e-11
of O 0 2.2735557880793067e-10
exon O 0 4.6675632248138754e-09
13 O 0 1.0406560058129344e-09
of O 0 4.266986763923342e-09
HEXA O 1 0.9990758895874023
of O 0 5.346442435438803e-07
a O 0 1.860471110504136e-09
non O 0 1.2811910892196465e-05
- O 0 8.222294667348251e-08
Jewish O 0 9.976987058735176e-08
proband O 0 5.121230424265377e-05
who O 0 1.5165033118158533e-10
manifested O 0 2.927953657305693e-09
a O 0 2.7224536860992465e-11
subacute O 0 4.849368906434393e-07
variant O 0 9.448039151038756e-08
of O 0 0.00029378177714534104
G B-Disease 1 0.9999912977218628
( I-Disease 0 2.123298648015748e-09
M2 I-Disease 0 5.395630796556361e-05
) I-Disease 0 4.2837586256005977e-10
gangliosidosis I-Disease 0 5.1857196012861095e-06
. O 0 1.2393515191888582e-07

On O 0 1.1849241587924553e-07
the O 0 2.613480765134568e-09
second O 0 1.2164350415844183e-08
maternally O 0 4.2835466729229665e-07
inherited O 0 4.520363177107356e-07
allele O 0 1.3888918459770139e-08
, O 0 2.079577135494226e-11
we O 0 9.197960318743648e-13
identified O 0 2.2304764372288455e-12
the O 0 1.6870217028897017e-11
common O 0 2.0064085504145623e-07
infantile O 0 0.009389177896082401
disease O 0 5.914099529036321e-05
- O 0 7.293154880017028e-08
causing O 0 3.644393302693061e-07
4 O 0 3.495185865176609e-07
- O 0 4.800779329627858e-09
bp O 0 8.299433140734891e-09
insertion O 0 3.051630725892096e-09
, O 0 6.580141292955588e-11
+ O 0 1.1619547546359854e-09
TATC O 0 1.0679263141355477e-05
1278 O 0 4.090015863766894e-06
, O 0 2.0080635765307164e-10
in O 0 9.140453394174131e-10
exon O 0 2.939146668268222e-07
11 O 0 2.167293544630411e-08
. O 0 3.8868570584327244e-08

Pulse O 0 2.677076008694712e-05
- O 0 2.2318985770652944e-07
chase O 0 4.670805520134991e-09
analysis O 0 2.139590588035034e-11
using O 0 8.414539898193851e-11
proband O 0 1.558168605697574e-06
fibroblasts O 0 1.0013896201144235e-07
revealed O 0 2.2947606037604373e-09
that O 0 2.8440375055005518e-12
the O 0 5.561448176982786e-11
W474C O 0 6.749618641777033e-09
- O 0 1.3675272025892582e-10
containing O 0 3.6607307463132344e-11
alpha O 0 2.0278974333098887e-10
- O 0 3.544070939498489e-11
subunit O 0 2.6749092524314122e-11
precursor O 0 7.686338787671332e-10
was O 0 5.2354603291560053e-11
normally O 0 6.540846423513935e-12
synthesized O 0 2.0731069638735278e-10
, O 0 1.5095066039153004e-12
but O 0 1.6033100411552703e-12
not O 0 3.4500726928121672e-12
phosphorylated O 0 2.4028219414162777e-08
or O 0 1.2741503685465005e-10
secreted O 0 6.049265532936943e-10
, O 0 1.100117653224375e-11
and O 0 2.0731295152787155e-11
the O 0 5.395476287972656e-10
mature O 0 5.0868127488001846e-08
lysosomal O 0 2.6334987524023745e-06
alpha O 0 1.0630905222797082e-07
- O 0 8.791499972460315e-09
subunit O 0 2.7575339789365216e-09
was O 0 1.025597495818431e-09
not O 0 2.2892686357689485e-10
detected O 0 3.623349797976516e-08
. O 0 1.9803714224053692e-08

When O 0 1.0919475101900389e-08
the O 0 1.082397949048186e-09
W474C O 0 4.120463970025412e-08
- O 0 6.945419239734463e-10
containing O 0 9.332576378362489e-11
alpha O 0 2.3435350882117234e-10
- O 0 3.633081335774335e-11
subunit O 0 3.5833381401007e-11
was O 0 8.197135331622363e-11
transiently O 0 1.0761836755079912e-08
co O 0 1.9744030022028625e-10
- O 0 2.225922640652911e-10
expressed O 0 3.420425748190681e-11
with O 0 3.6675274362601984e-13
the O 0 4.20327965142131e-12
beta O 0 1.291258419633401e-11
- O 0 6.827281795462881e-12
subunit O 0 2.993081910790396e-12
to O 0 3.0073593355189887e-12
produce O 0 1.189574966309337e-10
Hex O 0 7.022285331004241e-08
A O 0 1.3488015149221155e-09
( O 0 2.639169698753774e-12
alphabeta O 0 2.3199216769853592e-08
) O 0 4.4906118754073354e-12
in O 0 8.892713648789297e-11
COS O 0 4.3967986584902974e-07
- O 0 1.258606285858832e-08
7 O 0 2.072111815465405e-09
cells O 0 4.612915951995866e-11
, O 0 9.638957383997782e-13
the O 0 1.264123354605129e-11
mature O 0 2.8118607442451093e-10
alpha O 0 5.7587205837261735e-11
- O 0 4.828394628564325e-12
subunit O 0 2.1731505484012814e-12
was O 0 4.417131157369303e-12
present O 0 1.0847980499995025e-12
, O 0 1.4240855944567393e-13
but O 0 4.751631488449093e-13
its O 0 5.101860774125999e-13
level O 0 2.1811453684850157e-11
was O 0 1.1197483044955714e-11
much O 0 1.0154687854480038e-11
lower O 0 7.184996486664375e-10
than O 0 8.289275841254218e-13
that O 0 1.3612353431946556e-13
from O 0 1.4401896342164378e-11
normal O 0 1.3231044038164441e-09
alpha O 0 5.651111245619234e-10
- O 0 5.3482804990290234e-11
subunit O 0 4.400953212968517e-11
transfections O 0 4.486346849574829e-09
, O 0 1.1895282935742157e-12
although O 0 5.293737670442056e-12
higher O 0 1.0987447063293132e-10
than O 0 7.429282341230026e-13
in O 0 3.052219718288618e-12
those O 0 1.2845864996724465e-11
cells O 0 1.1692151413722485e-10
transfected O 0 6.706027289027361e-09
with O 0 3.754994362323294e-13
an O 0 1.8162747239362786e-13
alpha O 0 1.3158681089198154e-10
- O 0 1.5477739923053235e-10
subunit O 0 1.5972863309787755e-10
associated O 0 2.860333636611756e-10
with O 0 3.006496440693951e-10
infantile O 0 1.3392819710134063e-05
TSD B-Disease 0 0.0016816650750115514
. O 0 3.965349151258124e-07

Furthermore O 0 6.282848374894456e-08
, O 0 1.2353942868692513e-10
the O 0 3.523056499310506e-11
precursor O 0 1.4579960572191908e-09
level O 0 2.4837991663417824e-09
of O 0 5.439338979229547e-10
the O 0 4.6555845290008335e-10
W474C O 0 3.6919118429068476e-08
alpha O 0 2.234597396011395e-09
- O 0 1.324105963762534e-10
subunit O 0 5.362048999257851e-11
was O 0 4.11235490105355e-11
found O 0 1.606432326571594e-12
to O 0 1.2494120321671076e-12
accumulate O 0 7.77114136929491e-11
in O 0 4.407705103681714e-12
comparison O 0 2.450220304428541e-10
to O 0 1.7308831451456896e-11
the O 0 1.4916429202926906e-10
normal O 0 5.7264180952643073e-08
alpha O 0 2.6816257658879294e-08
- O 0 2.334265891690279e-09
subunit O 0 2.029473034070861e-09
precursor O 0 2.6108466499863425e-08
levels O 0 1.0455792676111741e-07
. O 0 1.213080125239685e-08

We O 0 1.8060848816503494e-08
conclude O 0 3.048292995799784e-08
that O 0 1.2053035652881405e-11
the O 0 3.1613517359474486e-10
1422 O 0 6.774686767130333e-07
G O 0 2.753793921783654e-07
- O 0 1.0291998364664323e-08
- O 0 3.3203322313823946e-09
> O 0 7.626731246546115e-09
C O 0 4.682954912738069e-09
mutation O 0 9.271886643874572e-13
is O 0 3.4594703861426162e-15
the O 0 7.09589857575757e-14
cause O 0 7.216705705248572e-11
of O 0 8.905995940722278e-09
Hex B-Disease 1 0.9974652528762817
A I-Disease 1 0.9845899343490601
enzyme I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 3.14299186676692e-09
the O 0 2.0600765537892585e-09
proband O 0 1.575615897309035e-06
. O 0 3.467806664048112e-08

The O 0 1.6777921274524488e-08
resulting O 0 1.3254212838376134e-08
W474C O 0 7.977820928317669e-07
substitution O 0 9.723567018227186e-07
clearly O 0 1.6971743121985128e-08
interferes O 0 2.221000050539601e-09
with O 0 8.702065977528317e-12
alpha O 0 3.5605643433633816e-10
- O 0 2.353774120056329e-11
subunit O 0 1.5201544883991502e-11
processing O 0 1.7992649037346098e-10
, O 0 1.003149820155702e-12
but O 0 2.1626630878918834e-13
because O 0 1.4225789600127992e-13
the O 0 6.21986565984417e-13
base O 0 4.332373435694814e-12
substitution O 0 4.379370643903258e-09
falls O 0 4.639969475306316e-08
at O 0 3.4232845724790906e-11
the O 0 1.683816627795487e-11
first O 0 3.238171536468215e-11
position O 0 1.025879270422081e-09
of O 0 9.451965432560883e-09
exon O 0 9.75161498217858e-08
13 O 0 2.538247612093869e-09
, O 0 1.1724481628616612e-11
aberrant O 0 2.0654666865738136e-09
splicing O 0 6.553694031907753e-09
may O 0 6.29377305827461e-09
also O 0 4.111241208581973e-11
contribute O 0 1.4941551329528124e-09
to O 0 1.3466454618082935e-08
Hex B-Disease 1 0.9999767541885376
A I-Disease 0 0.002392700407654047
deficiency I-Disease 0 0.00010766068589873612
in O 0 5.581269890697627e-10
this O 0 1.7325223200526096e-10
proband O 0 1.940496076713316e-06
. O 0 1.4291334782257081e-09
. O 0 3.0672226980499318e-09

Two O 0 1.0043828879702232e-08
frequent O 0 1.2432813001339582e-08
missense O 0 6.114084044384072e-06
mutations O 0 1.089881379812141e-06
in O 0 9.266937581742241e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.7433703507995233e-05

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 2.31946906126268e-09
an O 0 5.306878048116914e-09
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 1.15290461621953e-07
by O 0 9.996516114885168e-11
early O 1 0.9513921141624451
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 0.9999998807907104
goiter B-Disease 1 1.0
. O 1 0.9998058676719666

A O 0 8.488926894756332e-09
century O 0 8.046189492461053e-09
after O 0 5.203247832596958e-10
its O 0 1.2048599964953333e-11
recognition O 0 1.7388918083227622e-10
as O 0 1.5110521167649438e-10
a O 0 2.89760038879594e-11
syndrome O 0 1.872039856465335e-09
by O 0 2.286252437366798e-11
Vaughan O 0 3.778537120524561e-06
Pendred O 0 4.5235124161990825e-06
, O 0 6.353393505742488e-12
the O 0 3.086421743181411e-11
disease O 0 8.765882242300904e-09
gene O 0 1.3442044144440501e-09
( O 0 3.552085292568563e-10
PDS O 1 0.7377996444702148
) O 0 4.055121169410647e-11
was O 0 1.43925737994266e-09
mapped O 0 1.24845622728742e-09
to O 0 3.0913718807035195e-10
chromosome O 0 1.621717693467417e-08
7q22 O 0 3.612677028286271e-05
- O 0 9.26709526538616e-06
q31 O 0 3.539187673595734e-05
. O 0 2.7690205683938984e-07

1 O 0 3.294989937785431e-06
and O 0 8.163908660208108e-09
, O 0 2.99076763354833e-10
recently O 0 4.500168016008388e-10
, O 0 1.1567129198919446e-11
found O 0 1.3115052446832642e-11
to O 0 5.3855003789848865e-11
encode O 0 5.882205833529497e-09
a O 0 1.1086646045654902e-09
putative O 0 2.335110139028984e-06
sulfate O 0 4.333590823080158e-06
transporter O 0 2.2053791326470673e-05
. O 0 4.6818766463729844e-07

We O 0 1.4618283472600524e-08
performed O 0 6.179599609801301e-10
mutation O 0 3.5627500949431123e-11
analysis O 0 2.4665918179483937e-12
of O 0 1.8464532680617651e-10
the O 0 6.276414055150781e-09
PDS B-Disease 0 0.001863477285951376
gene O 0 1.2396577098172656e-09
in O 0 3.141575888321313e-10
patients O 0 7.776220556365843e-09
from O 0 5.0043896110407715e-11
14 O 0 3.343010313017203e-10
Pendred B-Disease 0 8.297408840007847e-07
families O 0 7.946480973242132e-11
originating O 0 1.1421780882203691e-10
from O 0 5.4048232903114446e-12
seven O 0 2.202553027116916e-12
countries O 0 5.71695251902482e-13
and O 0 4.634169090134144e-11
identified O 0 5.077637199590868e-10
all O 0 2.0419641533209187e-09
mutations O 0 8.963341180390216e-09
. O 0 2.7286858994557406e-08

The O 0 3.7215494330666843e-07
mutations O 0 1.8170899451774858e-08
include O 0 6.771923577453265e-10
three O 0 4.6177665857793926e-11
single O 0 1.7772888716294233e-10
base O 0 3.0026352515477583e-09
deletions O 0 8.397412898375478e-08
, O 0 1.8328817352752935e-09
one O 0 3.666777437238977e-10
splice O 0 6.334408340080699e-07
site O 0 4.740689618643046e-08
mutation O 0 1.4099136080858443e-08
and O 0 9.62926849368273e-10
10 O 0 1.891555356792196e-08
missense O 0 3.6379935863806168e-06
mutations O 0 2.3587602981933742e-07
. O 0 2.6950374376610853e-07

One O 0 7.000179635952009e-08
missense O 0 1.0622742365740123e-06
mutation O 0 6.681705411182293e-09
( O 0 1.8476113000653882e-11
L236P O 0 5.720184859114852e-08
) O 0 1.1872961815095895e-11
was O 0 4.725211888434444e-10
found O 0 1.4774731785238693e-11
in O 0 1.2979501154419815e-11
a O 0 6.082371585558466e-12
homozygous O 0 1.3662575237827213e-10
state O 0 3.111661275867483e-11
in O 0 3.1248052756449596e-11
two O 0 3.314151687458522e-12
consanguineous O 0 3.3070173799387703e-07
families O 0 7.18615722483662e-11
and O 0 9.550570403971115e-12
in O 0 3.5213502252995355e-11
a O 0 1.459224407973636e-11
heterozygous O 0 3.309378118765416e-11
state O 0 5.581551713873534e-12
in O 0 1.300676233384479e-11
five O 0 3.819749204436729e-12
additional O 0 7.185787381791542e-11
non O 0 6.622581736337452e-07
- O 0 7.025620334388805e-07
consanguineous O 0 0.0030851452611386776
families O 0 1.2990319042671672e-08
. O 0 8.93066154361577e-09

Another O 0 2.7971702820650535e-07
missense O 0 2.0575037069647806e-06
mutation O 0 8.984548216517396e-09
( O 0 2.976232801876755e-11
T416P O 0 2.2203149541155653e-08
) O 0 5.131394874985373e-12
was O 0 2.555281541916088e-10
found O 0 1.087962706036727e-11
in O 0 4.298109611278189e-12
a O 0 1.7116307286443866e-12
homozygous O 0 2.6462781618774578e-11
state O 0 2.3171497706697686e-11
in O 0 4.9121751805047964e-11
one O 0 5.410000572525497e-12
family O 0 2.2399196213107597e-12
and O 0 3.885470504366717e-12
in O 0 8.190175967981439e-12
a O 0 1.3651784563917246e-11
heterozygous O 0 4.108748410946994e-11
state O 0 1.4683093282896742e-11
in O 0 9.520675220420216e-11
four O 0 7.563417253608762e-11
families O 0 2.96435959112884e-10
. O 0 6.441354560848822e-09

Pendred B-Disease 1 0.9825342297554016
patients O 1 0.5697050094604492
in O 0 1.942964189538543e-08
three O 0 9.852715310287863e-10
non O 0 6.898029596413835e-07
- O 0 4.780906692758435e-07
consanguineous O 1 0.5391098260879517
families O 0 1.4896875955017208e-09
were O 0 9.598568467827917e-11
shown O 0 1.3408351035373856e-12
to O 0 3.9049262413014263e-13
be O 0 1.8119642071490194e-12
compound O 0 4.4813586175251885e-10
heterozygotes O 0 7.769993537465325e-09
for O 0 9.573226933401457e-11
L236P O 0 1.9959063024543866e-07
and O 0 1.1979842673426333e-09
T416P O 0 1.5033400586617063e-06
. O 0 9.96734357272544e-08

In O 0 1.0866079591664857e-08
total O 0 1.2544715266571416e-09
, O 0 6.724618084597012e-11
one O 0 8.451465222103494e-12
or O 0 2.421386702256001e-11
both O 0 1.2539869316541274e-11
of O 0 1.5882697934621604e-10
these O 0 2.883772387551886e-11
mutations O 0 1.4855576838113116e-11
were O 0 5.1123671268582527e-11
found O 0 4.145112204867463e-12
in O 0 5.836287616384217e-12
nine O 0 2.7742067323921482e-11
of O 0 7.060201728803506e-11
the O 0 4.747434667606854e-10
14 O 0 9.384882870833167e-10
families O 0 5.249839452048377e-11
analyzed O 0 3.811559956545807e-09
. O 0 3.923442015718592e-09

The O 0 6.4600067517517346e-09
identification O 0 5.417415138708748e-08
of O 0 1.5496750549459648e-08
two O 0 2.74816031042846e-10
frequent O 0 1.6090666576928925e-08
PDS B-Disease 1 0.5756314396858215
mutations O 0 4.268842612731305e-09
will O 0 7.012607508571911e-12
facilitate O 0 6.25110380125804e-11
the O 0 1.1638877361885847e-11
molecular O 0 9.141796764033927e-10
diagnosis O 0 4.944274110130209e-07
of O 0 5.043613668931357e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.0105096407642122e-05

Insertional O 0 5.231873001321219e-05
mutation O 0 1.5245381845829797e-08
by O 0 5.0135229301417894e-11
transposable O 0 3.785079911722278e-07
element O 0 2.1413574913253797e-08
, O 0 4.116013918586958e-10
L1 O 0 1.0996183874567578e-07
, O 0 5.165794441513993e-12
in O 0 8.233797324508352e-12
the O 0 7.836533644223209e-10
DMD B-Disease 1 1.0
gene O 0 2.22181784081954e-09
results O 0 2.3674292748410153e-08
in O 0 4.524665087046742e-09
X B-Disease 1 1.0
- I-Disease 1 0.5855617523193359
linked I-Disease 0 0.0007649160688742995
dilated I-Disease 1 0.9683636426925659
cardiomyopathy I-Disease 1 1.0
. O 0 5.4609008657280356e-06

X B-Disease 1 0.9999991655349731
- I-Disease 1 0.9999868869781494
linked I-Disease 0 0.3945934772491455
dilated I-Disease 1 0.9999997615814209
cardiomyopathy I-Disease 1 1.0
( O 0 4.3865291843303567e-08
XLDCM B-Disease 1 0.9999980926513672
) O 0 1.4992980815198287e-11
is O 0 4.3610154007965585e-13
a O 0 7.974136758889805e-13
clinical O 0 1.547022177028623e-09
phenotype O 0 3.106113126705168e-07
of O 0 1.1745721906208928e-07
dystrophinopathy B-Disease 1 0.9999282360076904
which O 0 3.036897955333018e-10
is O 0 1.5829333286851432e-12
characterized O 0 5.1605555766165434e-12
by O 0 6.1444039960167895e-12
preferential O 0 1.2139207683503628e-07
myocardial B-Disease 0 2.320571411473793e-06
involvement I-Disease 0 6.759999227057278e-10
without O 0 7.836200438537944e-11
any O 0 4.438068315626431e-11
overt O 0 1.2959674444701363e-09
clinical O 0 7.026435433488132e-09
signs O 0 4.6497589778482507e-08
of O 0 6.252978437260026e-07
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 1 0.9997941851615906

To O 0 9.060227568191692e-10
date O 0 1.4287694227732572e-07
, O 0 1.2217468703390466e-10
several O 0 4.595984010036247e-11
mutations O 0 2.6064803093639455e-10
in O 0 2.90725638008027e-10
the O 0 3.407194242299738e-07
Duchenne B-Disease 1 0.9999570846557617
muscular I-Disease 1 0.9999901056289673
dystrophy I-Disease 1 1.0
gene O 0 0.0010014352155849338
, O 0 5.980677428851777e-07
DMD O 1 1.0
, O 0 1.7552508335683115e-09
have O 0 1.1017281704994719e-11
been O 0 2.8686846734876648e-12
identified O 0 2.557844127476505e-12
in O 0 5.4058021080327645e-12
patients O 0 4.409206055822068e-10
with O 0 5.410330603666802e-12
XLDCM B-Disease 1 1.0
, O 0 4.74436601116679e-10
but O 0 3.084603059089197e-11
a O 0 2.643472029814631e-12
pathogenic O 0 1.7129233587098724e-09
correlation O 0 2.5083349286525447e-10
of O 0 3.3381599567894327e-11
these O 0 4.022597185904253e-11
cardiospecific O 0 1.1661454379918723e-07
mutations O 0 2.2218433759491063e-09
in O 0 3.29608174087781e-10
DMD O 1 1.0
with O 0 1.1550049111574978e-10
the O 0 1.610694155829151e-08
XLDCM B-Disease 1 1.0
phenotype O 0 0.00027552645769901574
has O 0 2.3248848679546796e-10
remained O 0 6.410981523430337e-09
to O 0 9.94649154706373e-12
be O 0 1.639205715608938e-10
elucidated O 0 4.829315912502352e-06
. O 0 1.197651755546758e-07

We O 0 5.9355734549626504e-08
report O 0 3.20991094815426e-10
here O 0 4.267373260313789e-11
the O 0 2.7830454954469452e-12
identification O 0 3.639177501013613e-11
of O 0 2.020664538471273e-11
a O 0 8.739958409775817e-12
unique O 0 1.8015175462515742e-10
de O 0 3.6449050444531395e-09
novo O 0 4.8977472744127226e-08
L1 O 0 8.34076061551059e-08
insertion O 0 4.559804533954548e-09
in O 0 9.53807477444002e-10
the O 0 8.897367287374891e-10
muscle O 0 1.3403237630882359e-08
exon O 0 1.4139079951291933e-07
1 O 0 2.907614415903481e-08
in O 0 1.5536429920359751e-09
DMD O 1 1.0
in O 0 1.3233599993611733e-08
three O 0 4.5944348325832607e-10
XLDCM B-Disease 1 0.9998648166656494
patients O 0 2.7241389943810645e-07
from O 0 6.504310978705519e-11
two O 0 2.808084710939629e-12
unrelated O 0 5.989065243738878e-09
Japanese O 0 7.298484661077964e-08
families O 0 1.1006602296248502e-09
. O 0 7.112977318257663e-09

The O 0 5.885362241997427e-08
insertion O 0 1.0391079285909655e-07
was O 0 2.7521284806653057e-08
a O 0 1.3220113892487007e-10
5 O 0 7.893462550256913e-10
- O 0 9.784448945504565e-11
truncated O 0 1.610257149842198e-09
form O 0 1.3283810162967313e-10
of O 0 3.4905581203226177e-10
human O 0 1.2019020501075062e-10
L1 O 0 1.623385692539614e-08
inversely O 0 1.6788811763035483e-07
integrated O 0 3.0710980425396883e-09
in O 0 2.6765933219818905e-11
the O 0 5.991058343868261e-11
5 O 0 4.6139389531241193e-10
- O 0 6.169694755087107e-10
untranslated O 0 2.7080766813014634e-05
region O 0 1.2252246994748361e-09
in O 0 9.847299364817985e-11
the O 0 2.435668611244779e-10
muscle O 0 2.315870606395265e-09
exon O 0 4.030598432791521e-08
1 O 0 4.109458107137698e-09
, O 0 1.1495861771196325e-12
which O 0 3.596213496263878e-13
affected O 0 4.1104415010595474e-11
the O 0 2.102381463364722e-11
transcription O 0 9.799502181939701e-11
or O 0 1.7188354906050307e-11
the O 0 1.12712866817688e-10
stability O 0 1.2048496644823103e-09
of O 0 8.144122043418633e-10
the O 0 2.2742280281207172e-10
muscle O 0 3.6689462579175824e-10
form O 0 4.334479442036354e-09
of O 0 6.672664909501691e-08
dystrophin O 0 4.187931068599937e-08
transcripts O 0 8.836179565818725e-10
but O 0 5.578326862931693e-12
not O 0 6.919439522225235e-13
that O 0 2.9288358305464e-13
of O 0 2.580082258951677e-10
the O 0 2.893913775281476e-09
brain O 0 5.5640352769614765e-08
or O 0 1.9176442656032577e-09
Purkinje O 0 5.129192231834168e-06
cell O 0 3.600848685891833e-08
form O 0 1.519237069480539e-09
, O 0 2.4140175969300515e-11
probably O 0 1.2659077119892004e-09
due O 0 1.7214931347098172e-07
to O 0 2.7999905172215733e-10
its O 0 5.548871431781954e-11
unique O 0 3.4590226516417744e-11
site O 0 3.0098357139962673e-10
of O 0 2.373304330838266e-10
integration O 0 3.536425907668672e-08
. O 0 4.569305644963606e-08

We O 0 3.843713969331475e-08
speculate O 0 4.05507138978578e-09
that O 0 3.094104291355426e-13
this O 0 9.356164931348387e-13
insertion O 0 4.455797397717731e-10
of O 0 8.06519129259442e-10
an O 0 1.6091931606676546e-11
L1 O 0 3.1237792796900976e-08
sequence O 0 2.8692277720399062e-11
in O 0 1.6081139198043104e-10
DMD O 1 1.0
is O 0 7.014350211775877e-11
responsible O 0 1.642932838386013e-11
for O 0 2.062861166607366e-12
some O 0 1.3741278080681152e-12
of O 0 4.520785221867607e-12
the O 0 1.4246160674746822e-12
population O 0 1.7162188553979107e-14
of O 0 1.5391225620386972e-13
Japanese O 0 7.038920002422344e-10
patients O 0 6.944704256106604e-10
with O 0 8.389423704346921e-12
XLDCM B-Disease 0 0.0245156679302454
. O 0 1.53575125949601e-08
. O 0 3.67700643266744e-08

Severe O 0 0.0003673851315397769
early O 1 0.9991843104362488
- O 1 0.8146423101425171
onset O 1 1.0
obesity B-Disease 1 1.0
, O 0 6.392534146471007e-08
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 1.6392955615174287e-07
red O 0 3.304573692730628e-05
hair O 0 3.4353553246546653e-07
pigmentation O 0 1.7693406334728934e-05
caused O 0 1.34996085421335e-07
by O 0 9.909263098961674e-08
POMC O 1 0.9999998807907104
mutations O 0 7.77230695803155e-07
in O 0 1.8596870710041458e-09
humans O 0 8.247059923860434e-09
. O 0 6.710351829752881e-09

Sequential O 0 1.2130041682212322e-07
cleavage O 0 1.1395435706162971e-07
of O 0 2.033143253754588e-08
the O 0 1.783497460827732e-09
precursor O 0 4.345888982015822e-08
protein O 0 5.28710586422676e-09
pre O 0 1.109617187466938e-05
- O 0 1.1364942338332185e-06
pro O 0 1.876278588497371e-06
- O 0 9.45164060794923e-07
opiomelanocortin O 0 0.00016470320406369865
( O 0 9.725250604830649e-10
POMC O 0 1.546080966363661e-05
) O 0 1.3004083053436144e-11
generates O 0 6.769234478509745e-11
the O 0 4.3575029001763355e-11
melanocortin O 0 6.0474548035927e-07
peptides O 0 1.0640476055812087e-08
adrenocorticotrophin O 0 1.331298904005962e-06
( O 0 1.1896067464434168e-10
ACTH O 0 1.7346327751965873e-07
) O 0 4.025875119384459e-11
, O 0 6.478285963229524e-11
melanocyte O 0 6.918829171809193e-07
- O 0 1.2754433953432454e-07
stimulating O 0 1.0675627493128559e-07
hormones O 0 1.3204150661749736e-08
( O 0 3.624408759228537e-11
MSH O 0 2.0729764855786925e-06
) O 0 1.6146441822462165e-11
alpha O 0 3.7159278432064013e-10
, O 0 1.37945080705415e-12
beta O 0 2.0173951051360994e-11
and O 0 9.591864628955005e-12
gamma O 0 1.7484134973155818e-10
as O 0 2.2619021239345116e-11
well O 0 3.266371201293694e-11
as O 0 1.3957945042830655e-11
the O 0 2.307961981251605e-11
opioid O 0 1.1977564717824407e-08
- O 0 3.2933182847472153e-09
receptor O 0 1.7152217424154514e-09
ligand O 0 1.239207421122046e-07
beta O 0 5.399912765824411e-07
- O 0 2.577301643214014e-07
endorphin O 0 1.749277907947544e-05
. O 0 3.1858153448638404e-08

While O 0 4.0969926118350486e-08
a O 0 7.226554771255778e-11
few O 0 4.6580513751726116e-11
cases O 0 4.5390030622982636e-10
of O 0 4.004762956810737e-07
isolated O 1 0.9999996423721313
ACTH B-Disease 1 1.0
deficiency I-Disease 1 1.0
have O 0 1.7934967289079395e-08
been O 0 4.515791074410913e-10
reported O 0 2.418526212633054e-10
( O 0 2.4748777679994838e-11
OMIM O 0 3.4604377106006723e-06
201400 O 0 9.675691359234406e-08
) O 0 3.8696511273084155e-12
, O 0 1.971793171448577e-12
an O 0 4.350043329021114e-12
inherited O 0 0.14738672971725464
POMC O 1 1.0
defect O 1 0.9999998807907104
has O 0 6.597175694622592e-09
not O 0 1.9534561468415035e-10
been O 0 2.4557783584455706e-10
described O 0 5.045893702870785e-10
so O 0 1.0657769805577644e-10
far O 0 2.2692416834502183e-09
. O 0 3.0065150369296134e-09

Recent O 0 1.344159414884416e-07
studies O 0 1.29864474729402e-09
in O 0 9.62824958650188e-12
animal O 0 3.7185921009097456e-11
models O 0 3.472818907446218e-11
elucidated O 0 7.772068322253745e-09
a O 0 9.820303424612487e-12
central O 0 1.4993674357643982e-10
role O 0 5.303229730357906e-11
of O 0 1.5727463775760953e-08
alpha O 0 1.448255204650195e-07
- O 0 6.794908813390066e-08
MSH O 0 0.0013069678097963333
in O 0 1.2065691501472742e-10
the O 0 9.74999768421636e-12
regulation O 0 2.510182339765521e-10
of O 0 5.634939129889327e-12
food O 0 3.371304277410836e-11
intake O 0 4.72956179428663e-12
by O 0 4.2193557133439474e-14
activation O 0 2.916080987791503e-10
of O 0 6.663696261455243e-09
the O 0 9.324457295178945e-08
brain O 0 2.9933044061181135e-06
melanocortin O 0 4.3049134546890855e-05
- O 0 2.4076014142337954e-06
4 O 0 2.830914525020489e-07
- O 0 1.0022338514659168e-08
receptor O 0 2.2760473505911705e-09
( O 0 1.657230776219709e-11
MC4 O 0 9.966950528905727e-06
- O 0 3.052045727258701e-08
R O 0 1.6268852931489164e-08
; O 0 2.158614259561986e-11
refs O 0 1.2895343681762483e-09
3 O 0 6.657201456761186e-10
- O 0 2.0675941514447516e-10
5 O 0 4.839424000424586e-11
) O 0 6.721146127717029e-14
and O 0 2.9912197393490436e-13
the O 0 4.365220424712435e-12
linkage O 0 6.374836769573733e-10
of O 0 1.5028661648486263e-10
human O 0 1.6483991949201027e-09
obesity B-Disease 1 1.0
to O 0 4.0080480601112356e-10
chromosome O 0 4.696504296575199e-10
2 O 0 2.1067427802279326e-09
in O 0 3.149673924451868e-11
close O 0 2.134431381639601e-10
proximity O 0 2.076812277707063e-09
to O 0 2.6409699427354383e-10
the O 0 1.1651022369107977e-08
POMC O 0 2.000385029532481e-05
locus O 0 1.6832916172049295e-09
, O 0 2.2863657148097793e-11
led O 0 1.5272404174648813e-10
to O 0 1.790075466329144e-12
the O 0 1.9449783797420572e-11
proposal O 0 6.957166509558022e-10
of O 0 4.8901042937199435e-11
an O 0 3.7038362828145655e-13
association O 0 3.458382191734444e-11
of O 0 7.002510238329762e-10
POMC O 1 0.9942126870155334
with O 0 9.457045146987753e-10
human O 0 1.2653503063120297e-06
obesity B-Disease 1 1.0
. O 0 2.850860028047464e-07

The O 0 5.625508503470655e-09
dual O 0 4.96287455575839e-09
role O 0 9.381737164915194e-09
of O 0 2.4041705160016136e-07
alpha O 0 1.0729672794695944e-05
- O 0 6.736297109455336e-06
MSH O 0 0.49884089827537537
in O 0 4.171981649037093e-10
regulating O 0 3.6048188878368137e-09
food O 0 3.8477607766651545e-09
intake O 0 5.340406339371384e-09
and O 0 7.330114987214031e-11
influencing O 0 1.7531179707930278e-07
hair O 0 6.096030915614392e-07
pigmentation O 0 7.174749043770134e-05
predicts O 0 5.040951656098969e-09
that O 0 2.5673018398675307e-12
the O 0 6.255158890855483e-11
phenotype O 0 1.7236041482959763e-09
associated O 0 8.372835064163198e-11
with O 0 1.9029612954857278e-12
a O 0 3.407747348194157e-11
defect O 0 1.2141707372848032e-07
in O 0 9.38352595625247e-09
POMC O 0 0.001432115095667541
function O 0 4.573076084479766e-10
would O 0 1.3491398102860597e-11
include O 0 5.030566518904322e-10
obesity B-Disease 1 0.9999995231628418
, O 0 1.764227479383873e-11
alteration O 0 1.5468599485757295e-06
in O 0 2.8042271082995285e-07
pigmentation O 1 1.0
and O 0 0.002008778741583228
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.999941349029541
. O 0 6.225754077604506e-06

The O 0 1.4430460382186538e-08
observation O 0 4.922246432670363e-08
of O 0 9.756425667362123e-10
these O 0 4.274073095444919e-09
symptoms O 0 0.006311343517154455
in O 0 7.966156623240295e-09
two O 0 2.140538579720186e-10
probands O 0 3.1643912734580226e-06
prompted O 0 2.7956707171483686e-08
us O 0 2.9040294474702577e-11
to O 0 4.223404265202291e-11
search O 0 5.011919212982718e-10
for O 0 3.679968829661817e-11
mutations O 0 1.1876282179912323e-09
within O 0 8.364112069614293e-09
their O 0 1.6350175258139643e-07
POMC O 0 0.0038563162088394165
genes O 0 2.0472110406899446e-07
. O 0 4.384872553941932e-08

Patient O 0 0.08812078088521957
1 O 0 1.2385012269078288e-06
was O 0 1.3888149297258678e-08
found O 0 1.0365529962141906e-10
to O 0 1.903891627685894e-11
be O 0 1.5774005365787325e-11
a O 0 7.680982586077967e-12
compound O 0 1.161287843665093e-09
heterozygote O 0 2.1014464834934188e-08
for O 0 2.28655774869857e-11
two O 0 9.805069083046458e-12
mutations O 0 7.559538411916478e-11
in O 0 8.388695849070871e-10
exon O 0 3.880079546547677e-08
3 O 0 1.0553442564287252e-08
( O 0 1.0687526384722812e-11
G7013T O 0 9.692703173413975e-08
, O 0 1.001319513416199e-10
C7133delta O 0 3.556347110134084e-07
) O 0 2.2786458050289005e-12
which O 0 4.300944637328913e-13
interfere O 0 7.35069210361372e-12
with O 0 5.4039516188698206e-14
appropriate O 0 7.849589728214923e-11
synthesis O 0 1.3753439498387365e-09
of O 0 6.5813026139949216e-09
ACTH O 0 1.2821138625440653e-05
and O 0 5.8778233835710125e-08
alpha O 0 2.7045300612371648e-06
- O 0 7.674933044654608e-07
MSH O 0 0.0006608293042518198
. O 0 1.461773280198031e-07

Patient O 0 0.004592326935380697
2 O 0 1.932048547814702e-07
was O 0 5.020905913255547e-09
homozygous O 0 4.421324695247364e-10
for O 0 1.0237632790122131e-11
a O 0 7.717283409536257e-12
mutation O 0 1.5782558593357976e-10
in O 0 3.91999155358036e-10
exon O 0 4.75574140068602e-08
2 O 0 1.6433146399208454e-08
( O 0 2.073991672846276e-11
C3804A O 0 7.617793329472988e-08
) O 0 1.1012513817520997e-11
which O 0 6.00959837449011e-11
abolishes O 0 1.114893052545085e-06
POMC O 0 0.0011345542734488845
translation O 0 3.5641289741761284e-07
. O 0 1.5762728367008094e-07

These O 0 6.463161561498509e-09
findings O 0 3.420207450588464e-09
represent O 0 5.027120039691191e-11
the O 0 2.083738043223704e-11
first O 0 3.706650871654338e-12
examples O 0 4.899813887959681e-11
of O 0 3.8339480895599465e-11
a O 0 2.1899422553151027e-10
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 8.126780670636435e-08
the O 0 1.4437425477353827e-08
POMC O 0 1.633946885704063e-05
gene O 0 7.49052972426334e-11
and O 0 2.549126057807549e-12
define O 0 2.16636864697195e-11
a O 0 2.2784285309135344e-12
new O 0 7.328769413561531e-08
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 0 0.054253414273262024
resulting O 0 1.036969621281969e-07
in O 0 4.4641004781631466e-10
early O 0 9.615788258088287e-06
- O 0 1.3881947324989596e-06
onset O 1 0.9999997615814209
obesity B-Disease 1 1.0
, O 0 1.3526821440734693e-08
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 2.930956668478757e-07
red O 0 7.3066157710854895e-06
hair O 0 7.030553916820281e-08
pigmentation O 0 9.284028124056931e-07
. O 0 4.534306707881797e-09
. O 0 1.4663439351636498e-08

A O 0 1.924119601426355e-07
European O 0 8.779305460393516e-08
multicenter O 0 7.997176908247638e-06
study O 0 3.832657746727364e-09
of O 0 1.4800427550198947e-07
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 7.296194759476293e-10
classification O 0 2.33923653780721e-08
of O 0 3.81161102680494e-09
105 O 0 8.243336679925051e-08
mutations O 0 1.1537477223599879e-10
and O 0 1.92764623707653e-11
a O 0 3.783812239227524e-12
general O 0 1.3074802351908943e-09
system O 0 9.951055535140085e-10
for O 0 2.4532913894814712e-11
genotype O 0 8.46435188606165e-09
- O 0 5.422568505331071e-10
based O 0 2.304495656801908e-11
prediction O 0 3.381910218536177e-08
of O 0 3.6390401803032546e-10
metabolic O 0 0.00011992586951237172
phenotype O 0 2.398690639893175e-06
. O 0 1.7575498389987843e-08

Phenylketonuria B-Disease 1 0.9699838161468506
( O 0 4.547803200694034e-08
PKU B-Disease 1 0.9990816116333008
) O 0 4.215519600059281e-10
and O 0 3.3936672916290433e-10
mild B-Disease 1 0.5414739847183228
hyperphenylalaninemia I-Disease 1 1.0
( O 0 0.0003772767959162593
MHP B-Disease 1 1.0
) O 0 4.000245024116111e-09
are O 0 2.5592923336148488e-09
allelic B-Disease 0 0.0014638297725468874
disorders I-Disease 0 1.7508433529656031e-06
caused O 0 3.2298723695589615e-09
by O 0 1.266752536199789e-10
mutations O 0 3.1433561309412994e-10
in O 0 4.584934515383665e-11
the O 0 2.3321197750725275e-10
gene O 0 5.9221523518449e-11
encoding O 0 2.3673750959574136e-08
phenylalanine O 0 2.584508911240846e-05
hydroxylase O 0 0.0020397931803017855
( O 0 8.985936439387388e-09
PAH O 1 0.9999998807907104
) O 0 7.337955576502964e-09
. O 0 2.5017154570150524e-08

Previous O 0 4.2878195927187335e-06
studies O 0 2.144235011769524e-08
have O 0 2.279294461504655e-11
suggested O 0 1.0287277973919373e-10
that O 0 2.6224486991688334e-13
the O 0 6.006994381080322e-12
highly O 0 3.523053404563825e-09
variable O 0 3.7292874566219325e-08
metabolic O 0 0.0017095634248107672
phenotypes O 0 3.399546767468564e-05
of O 0 8.648652510601096e-06
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9999996423721313
correlate O 0 2.1326639398466796e-05
with O 0 7.03460472095685e-08
PAH O 1 1.0
genotypes O 0 0.02013910934329033
. O 0 4.831149453821126e-07

We O 0 2.460647863244958e-08
identified O 0 1.2951766326096958e-09
both O 0 3.562683759117391e-10
causative O 0 3.3846342262222606e-07
mutations O 0 1.510045244401681e-08
in O 0 8.976459020537675e-10
686 O 0 6.855957508378197e-07
patients O 0 4.331506886501302e-07
from O 0 4.697462974156963e-10
seven O 0 1.3570325418932327e-10
European O 0 7.845780025661497e-09
centers O 0 2.3794438419599828e-08
. O 0 1.1177527348138483e-08

On O 0 1.1854091042096115e-07
the O 0 3.6604258513150967e-10
basis O 0 6.597210555625566e-10
of O 0 1.0043224585309929e-10
the O 0 1.4104178935880896e-10
phenotypic O 0 9.994733929374888e-09
characteristics O 0 1.6959957349627075e-07
of O 0 1.407905472206039e-07
297 O 0 3.610938961173815e-07
functionally O 0 4.943132836388031e-08
hemizygous O 0 9.261107152269688e-07
patients O 0 1.5314840595692658e-07
, O 0 3.168026257993617e-11
105 O 0 5.6644413604090005e-09
of O 0 1.569071400586708e-10
the O 0 1.8300340409727056e-10
mutations O 0 6.69217042892356e-11
were O 0 2.450126768138716e-10
assigned O 0 3.8236311339368e-10
to O 0 5.896229338109293e-11
one O 0 1.9659806768657084e-11
of O 0 7.261496959287683e-11
four O 0 9.257825409059173e-12
arbitrary O 0 2.0035502146242834e-09
phenotype O 0 2.3557457495826384e-07
categories O 0 3.695420147664663e-08
. O 0 1.9438983756003836e-08

We O 0 9.071406026350814e-08
proposed O 0 1.36792564831012e-07
and O 0 1.0240942538430886e-09
tested O 0 2.0982253712276133e-09
a O 0 5.836744282339268e-12
simple O 0 2.415906363850695e-11
model O 0 9.231623278316281e-12
for O 0 1.1836665545286729e-12
correlation O 0 2.5918593660190226e-11
between O 0 3.568993711677848e-11
genotype O 0 2.2314893044494966e-08
and O 0 1.4220005728482477e-10
phenotypic O 0 2.282099487160849e-08
outcome O 0 1.1651748536678497e-05
. O 0 6.001365591146168e-07

The O 0 4.694834032648032e-08
observed O 0 2.209508487283074e-08
phenotype O 0 4.1934384853448137e-07
matched O 0 6.772536664811923e-08
the O 0 1.4402020687143136e-09
predicted O 0 1.653356207498291e-08
phenotype O 0 1.9934233819185465e-08
in O 0 5.923338208813078e-11
79 O 0 1.3618820515759467e-09
% O 0 1.2525519900788429e-12
of O 0 5.621142115143363e-13
the O 0 1.0211534309106929e-12
cases O 0 1.8686916597454584e-11
, O 0 4.668268376029072e-12
and O 0 1.9078976246089674e-11
in O 0 2.2053706083546842e-11
only O 0 7.449975532314301e-12
5 O 0 3.558967009986702e-11
of O 0 7.640449037338293e-12
184 O 0 4.852431234603216e-10
patients O 0 8.920170713189179e-10
was O 0 5.9579542688315e-11
the O 0 4.078298462828478e-11
observed O 0 2.5184695995328354e-10
phenotype O 0 1.32242072847788e-09
more O 0 1.511704932240232e-12
than O 0 2.4942253123994007e-12
one O 0 1.0624918913432202e-12
category O 0 5.4778480362838167e-11
away O 0 1.3245423854946203e-11
from O 0 1.975184339003677e-12
that O 0 3.948402748418095e-13
expected O 0 1.0921204385283545e-08
. O 0 3.658140101947538e-08

Among O 0 6.966387218199088e-07
the O 0 2.328751635971571e-09
seven O 0 6.04378491697588e-11
contributing O 0 1.2000167526338146e-10
centers O 0 6.483357184450256e-10
, O 0 1.4053680094661125e-12
the O 0 1.735213361886423e-11
proportion O 0 3.203623200054295e-10
of O 0 1.7240274485796903e-10
patients O 0 1.6341900055394376e-09
for O 0 2.7517568085277944e-11
whom O 0 2.3552707006935236e-10
the O 0 2.8666091722584497e-10
observed O 0 6.347319891908398e-10
phenotype O 0 3.958968264328178e-09
did O 0 1.1383242959350781e-10
not O 0 1.0589923035708715e-11
match O 0 3.7507980055195844e-10
the O 0 1.8051944661312547e-10
predicted O 0 1.3235057494398461e-09
phenotype O 0 1.0022905838624752e-09
was O 0 6.600290453073754e-11
4 O 0 4.943672207713412e-11
% O 0 1.3659251681119589e-12
- O 0 1.1837957697435897e-11
23 O 0 1.2073796129552505e-10
% O 0 4.754797250372533e-12
( O 0 3.989903839176495e-13
P O 0 2.2029606583373607e-08
< O 0 1.6722289108983546e-09
. O 0 1.2562516131520152e-11
0001 O 0 6.031595223277009e-09
) O 0 3.1048121972715448e-12
, O 0 2.8775183191082077e-12
suggesting O 0 1.0117594262393226e-10
that O 0 1.0417592136158227e-11
differences O 0 3.6410419124166538e-09
in O 0 8.338140594643662e-11
methods O 0 1.2924818992843257e-09
used O 0 4.4806554300169665e-11
for O 0 2.5723808499966694e-11
mutation O 0 7.097550880352799e-10
detection O 0 1.856136151445753e-07
or O 0 1.6716964479357443e-09
phenotype O 0 1.6230211485890322e-07
classification O 0 2.004763111074226e-08
may O 0 6.949258529731495e-11
account O 0 2.1808488175067975e-12
for O 0 1.4618971452221713e-13
a O 0 1.093132610254996e-13
considerable O 0 9.005002472861623e-12
proportion O 0 2.0908973163979994e-10
of O 0 6.884695036291077e-10
genotype O 0 5.865274943062104e-06
- O 0 2.9311033358681016e-05
phenotype O 0 3.896717316820286e-05
inconsistencies O 0 4.314126158533327e-07
. O 0 1.4991229591032607e-08

Our O 0 6.420688123398577e-07
data O 0 3.4592304576364086e-09
indicate O 0 1.999911791727982e-09
that O 0 5.479496630739211e-12
the O 0 1.8005944513177496e-09
PAH O 1 1.0
- O 0 7.047596682241419e-06
mutation O 0 4.0162384529196515e-09
genotype O 0 1.4509524692840614e-09
is O 0 2.1684446637392982e-14
the O 0 3.6064328471285476e-14
main O 0 1.0768062656818511e-11
determinant O 0 1.4565452177706106e-09
of O 0 6.083515358135116e-10
metabolic O 1 0.9996645450592041
phenotype O 0 1.4637333833888988e-06
in O 0 1.1159834861773632e-10
most O 0 1.5011644705076321e-10
patients O 0 3.068096177116786e-08
with O 0 1.683093309168271e-08
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 1 0.6842536926269531

In O 0 6.23163431967555e-09
the O 0 2.098080181811568e-10
present O 0 8.189461608854032e-11
study O 0 2.3324342457442526e-11
, O 0 4.798004983770643e-13
the O 0 3.338336117958418e-12
classification O 0 1.34375897076211e-08
of O 0 2.0995553740021933e-08
105 O 0 2.045656947302632e-05
PAH O 1 1.0
mutations O 0 2.046972191749319e-08
may O 0 2.2731219684324344e-10
allow O 0 3.231101497469524e-11
the O 0 1.693511303413331e-11
prediction O 0 4.3150372164291184e-09
of O 0 1.3969158295379369e-11
the O 0 2.3763151169031715e-11
biochemical O 0 5.448801410068427e-09
phenotype O 0 4.457950453229387e-09
in O 0 5.4797603954437335e-11
> O 0 5.624682053451124e-09
10 O 0 4.5683748450819905e-11
, O 0 1.1462493280933739e-12
000 O 0 2.2217488959697107e-10
genotypes O 0 3.4384304292700563e-09
, O 0 1.9080858854741978e-12
which O 0 2.1089700081786122e-13
may O 0 2.3879787036662492e-11
be O 0 4.1735534299369714e-12
useful O 0 3.3232559065732303e-11
for O 0 1.6784031846642233e-12
the O 0 3.936390449710281e-11
management O 0 1.9281658214520547e-10
of O 0 3.542450777160866e-10
hyperphenylalaninemia B-Disease 1 1.0
in O 0 2.8330967438705557e-07
newborns O 0 7.364370503637474e-06
. O 0 1.1060208748858713e-08

Somatic O 0 6.40099315205589e-05
instability O 0 2.3657597125747998e-07
of O 0 3.866478692771125e-08
the O 0 4.804894615517696e-07
CTG O 1 0.9953645467758179
repeat O 0 1.808636284295062e-06
in O 0 1.1568691782315454e-08
mice O 0 3.701160489200106e-09
transgenic O 0 4.424228983168632e-09
for O 0 2.3683560321230424e-11
the O 0 5.60875470512201e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 7.574370215479576e-07
is O 0 1.2102841298600175e-11
age O 0 9.853161342388006e-11
dependent O 0 1.6111034381594003e-11
but O 0 8.886324971224893e-14
not O 0 1.8771204209067083e-13
correlated O 0 6.563457416453033e-11
to O 0 1.8494014913245094e-12
the O 0 2.165265709785924e-11
relative O 0 6.9300196692267946e-09
intertissue O 0 8.127646538014233e-07
transcription O 0 6.092322024642272e-08
levels O 0 5.531143187909038e-07
and O 0 7.95340326931182e-09
proliferative O 0 0.005828639958053827
capacities O 0 4.610571068042191e-06
. O 0 2.5622591692808783e-07

A O 0 2.36928080994403e-05
( O 0 1.156657347678447e-08
CTG O 0 2.0035005945828743e-05
) O 0 1.6493292842589824e-10
nexpansion O 0 4.2133373767683224e-07
in O 0 2.6482588344478586e-10
the O 0 2.838642654268142e-10
3 O 0 5.360561772249639e-09
- O 0 7.784798583543306e-09
untranslated O 0 0.030620159581303596
region O 0 1.0046875331681804e-08
( O 0 1.619613297643152e-11
UTR O 0 0.0008558097179047763
) O 0 2.4127275698171413e-12
of O 0 6.941337088450794e-11
the O 0 3.751315258426757e-09
DM O 1 1.0
protein O 0 4.814012868337159e-07
kinase O 0 4.7923919055392616e-08
gene O 0 8.973309317816813e-10
( O 0 1.1995287575727875e-11
DMPK O 1 0.9542682766914368
) O 0 6.084170060122185e-12
is O 0 2.1321983620977564e-13
responsible O 0 9.084855806008874e-13
for O 0 7.782885447227272e-12
causing O 0 1.873398218776856e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 8.603619221503322e-07
DM B-Disease 1 1.0
) O 0 7.884107589006817e-09
. O 0 1.690074036275746e-08

Major O 0 5.218369551585056e-05
instability O 0 8.493877317050647e-07
, O 0 1.1760417084616392e-09
with O 0 2.047718938857912e-11
very O 0 3.093654776797905e-10
large O 0 1.8047985328450977e-10
expansions O 0 2.967970536005282e-09
between O 0 8.598986522834196e-10
generations O 0 4.2559160640109894e-09
and O 0 2.3395051521046817e-11
high O 0 1.947436795157742e-10
levels O 0 9.337365602934966e-11
of O 0 2.0168332282022305e-11
somatic O 0 1.0170214181925985e-07
mosaicism O 0 1.5848448811084381e-06
, O 0 7.0109894452496935e-12
is O 0 6.270789551683642e-13
observed O 0 7.191230944059157e-11
in O 0 2.7957480774887244e-10
patients O 0 3.367806655774075e-08
. O 0 1.7498598126053366e-08

There O 0 1.4380508339684184e-08
is O 0 4.898991629032068e-11
a O 0 8.888232164161458e-12
good O 0 2.3724897046939475e-10
correlation O 0 1.2733456650204644e-11
between O 0 3.900231700104673e-12
repeat O 0 1.6748871733973658e-10
size O 0 1.4375611812056377e-10
( O 0 1.0751393265256981e-12
at O 0 1.1112208375685384e-11
least O 0 9.423719400311614e-13
in O 0 1.8103302060548665e-12
leucocytes O 0 2.9207042118173376e-08
) O 0 6.714409844094105e-13
, O 0 2.814689941624954e-13
clinical O 0 1.3924228089989832e-11
severity O 0 3.887774546740275e-09
and O 0 3.0070338580268086e-11
age O 0 6.299657684394333e-09
of O 0 1.7007673047686467e-09
onset O 0 0.0002778590132948011
. O 0 8.462465075353975e-07

The O 0 2.05934497898852e-06
trinucleotide O 0 0.0004959328798577189
repeat O 0 1.9161448960858252e-07
instability O 0 4.6774761841561485e-08
mechanisms O 0 1.7495661808197838e-08
involved O 0 7.038262195280254e-10
in O 0 1.3445614399643091e-08
DM B-Disease 1 1.0
and O 0 1.5877419912158075e-07
other O 0 3.2420253148757183e-09
human O 0 7.02834199728386e-08
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 1.209874006535827e-10
unknown O 0 3.389670988340754e-09
. O 0 8.345972801748758e-10

We O 0 2.1546892270407625e-08
studied O 0 3.0609708545625836e-08
somatic O 0 1.7993065739574376e-06
instability O 0 3.4981113561372013e-09
by O 0 8.814796809142322e-11
measuring O 0 1.0460779975574042e-07
the O 0 2.5061616781840712e-08
CTG O 0 1.0102224223373923e-05
repeat O 0 4.271627940255485e-09
length O 0 3.2189051424325044e-10
at O 0 1.9265620349040447e-11
several O 0 1.5986259625094812e-12
ages O 0 1.7330512025459655e-10
in O 0 9.236131824630345e-12
various O 0 6.027518067996951e-11
tissues O 0 3.833858741586482e-08
of O 0 1.1138623356998778e-08
transgenic O 0 8.340949761986849e-07
mice O 0 1.635415247669414e-09
carrying O 0 7.28235804992039e-11
a O 0 2.2190544540778845e-11
( O 0 1.5496609204190825e-11
CTG O 0 1.1636341241683112e-06
) O 0 4.7955941301358607e-11
55expansion O 0 3.3913451602529676e-07
surrounded O 0 4.175693568697625e-09
by O 0 6.044718198205956e-11
45 O 0 1.18722054409659e-09
kb O 0 6.818833053756634e-09
of O 0 1.5881855830457425e-09
the O 0 4.806936626522429e-09
human O 0 6.070121827406183e-08
DM B-Disease 1 1.0
region O 0 6.811230832681758e-07
, O 0 1.1710155414790258e-11
using O 0 1.1651271961121701e-11
small O 0 1.349644979109499e-10
- O 0 1.0393707006173258e-09
pool O 0 3.9044203425930846e-09
PCR O 0 1.455941003314365e-07
. O 0 2.907481189140526e-08

These O 0 1.1447743418102618e-05
mice O 0 1.0327196378057124e-06
have O 0 1.1338820854467357e-10
been O 0 6.009358288761035e-11
shown O 0 1.4623253996592922e-11
to O 0 1.1833939210503797e-11
reproduce O 0 6.332651070195539e-10
the O 0 1.9097190495642735e-10
intergenerational O 0 2.116885333691698e-09
and O 0 4.6461081509852065e-11
somatic O 0 1.2977051255802508e-07
instability O 0 2.710410340611702e-09
of O 0 1.6245961242944418e-09
the O 0 4.484712601282581e-09
55 O 0 3.437632045688588e-08
CTG O 0 5.198796770855552e-06
repeat O 0 4.499912886757329e-09
suggesting O 0 4.860286062502439e-10
that O 0 2.9334943762310273e-12
surrounding O 0 2.9708815407758493e-09
sequences O 0 6.512790307056093e-11
and O 0 1.6135389899196717e-11
the O 0 3.603316950373525e-11
chromatin O 0 1.8441889437781356e-07
environment O 0 9.356347163702594e-08
are O 0 2.1652077700218264e-11
involved O 0 2.599582875351114e-11
in O 0 1.0760964341827162e-10
instability O 0 3.565141071248945e-08
mechanisms O 0 7.324813395825913e-07
. O 0 1.7017715947531542e-07

As O 0 4.5386872926656e-08
observed O 0 4.582438428712976e-09
in O 0 7.234456089744157e-11
some O 0 5.7666978831028e-12
of O 0 2.7487040421547704e-11
the O 0 2.9020529035417297e-11
tissues O 0 4.351120352907856e-09
of O 0 2.8868806012383175e-08
DM B-Disease 1 1.0
patients O 1 0.9215628504753113
, O 0 6.409749033625678e-12
there O 0 8.839165835904106e-13
is O 0 2.4402916211190007e-13
a O 0 8.73112292101158e-13
tendency O 0 1.405128235987263e-10
for O 0 1.9494055675250976e-11
repeat O 0 3.8040048888632327e-10
length O 0 3.1660402077804406e-10
and O 0 6.960215737095155e-11
somatic O 0 1.1828095125565596e-07
mosaicism O 0 1.8528994871758186e-07
to O 0 1.0358666181764509e-11
increase O 0 3.89528730451727e-12
with O 0 3.3309818662022317e-13
the O 0 1.7996345733073404e-11
age O 0 5.049764495446141e-10
of O 0 1.1767233021320322e-10
the O 0 1.10660691721165e-09
mouse O 0 2.2113718856076048e-08
. O 0 1.0347445567049363e-08

Furthermore O 0 1.107792172660993e-06
, O 0 9.074253015661782e-10
we O 0 2.988839037376678e-11
observed O 0 5.490965668264458e-11
no O 0 4.544204422474163e-12
correlation O 0 2.811573890371122e-12
between O 0 2.766337723128509e-12
the O 0 5.504398326028337e-11
somatic O 0 8.42267468215141e-07
mutation O 0 1.923436698803016e-08
rate O 0 1.3406868504262093e-08
and O 0 4.1658964472501836e-11
tissue O 0 1.7753967185285546e-08
proliferation O 0 3.8562862414437404e-07
capacity O 0 1.2477883615247265e-07
. O 0 3.9831697051795345e-08

The O 0 3.6793218782804615e-07
somatic O 0 1.9974188035121188e-05
mutation O 0 7.016728886810597e-08
rates O 0 3.443510143696926e-09
in O 0 4.0197727958768414e-12
different O 0 7.2186154623232746e-12
tissues O 0 1.8383471411809182e-09
were O 0 1.4024024996839302e-10
also O 0 5.642281889102485e-13
not O 0 4.524241766813708e-13
correlated O 0 2.09795222860798e-10
to O 0 1.465159243929648e-11
the O 0 5.141559400456686e-10
relative O 0 1.6994685836380086e-07
inter O 0 1.1765970242549884e-07
- O 0 1.4803413606045979e-08
tissue O 0 3.711157603447646e-08
difference O 0 5.598873031864571e-10
in O 0 8.294985249894526e-13
transcriptional O 0 1.2930631565488682e-10
levels O 0 7.750554642527163e-10
of O 0 3.8257737255964486e-11
the O 0 7.01433702787746e-11
three O 0 2.6765933219818905e-11
genes O 0 7.543492913653083e-11
( O 0 2.944992773951105e-12
DMAHP O 0 0.0010126882698386908
, O 0 5.816301329453211e-10
DMPK O 1 0.7669310569763184
and O 0 4.8870227864483695e-09
59 O 0 1.1938493749141799e-08
) O 0 4.983792892265804e-12
surrounding O 0 6.085397963317973e-09
the O 0 1.7435788368658223e-09
repeat O 0 9.532167943859804e-09
. O 0 3.5457581315512243e-09
. O 0 1.7723010614645318e-08

A O 0 3.574429285890801e-07
novel O 0 1.8352130837229197e-07
missense O 0 3.4441407024132786e-06
mutation O 0 1.3958285194348719e-08
in O 0 2.767005513604204e-10
patients O 0 9.539043333006703e-09
from O 0 4.903553951773887e-11
a O 0 7.506634897014308e-11
retinoblastoma B-Disease 0 0.0001787705550668761
pedigree O 0 9.018440891850332e-07
showing O 0 8.727256695095775e-10
only O 0 1.493147966380448e-11
mild O 0 1.2304242069660631e-08
expression O 0 1.2150941364197365e-09
of O 0 1.028371166000852e-09
the O 0 2.6470128311473218e-09
tumor B-Disease 0 1.0997312074323418e-06
phenotype O 0 3.5256573482911335e-07
. O 0 4.629615357742978e-09

We O 0 4.347165827311983e-08
have O 0 3.600719722385293e-11
used O 0 8.484252363161193e-12
single O 0 4.7982291750958694e-11
strand O 0 9.369066633624357e-11
conformation O 0 9.970461088693039e-12
polymorphism O 0 3.046926860122978e-12
analysis O 0 2.670237078325477e-13
to O 0 6.050687294950619e-13
study O 0 5.328209227994929e-12
the O 0 1.3527806479174398e-11
27 O 0 7.3354087248844735e-09
exons O 0 6.611586389482227e-09
of O 0 1.3612795335404826e-09
the O 0 4.848612622510018e-09
RB1 O 0 2.5041390472324565e-06
gene O 0 8.22595255800529e-11
in O 0 1.3856140193557742e-11
individuals O 0 2.7979643341807803e-12
from O 0 8.22796136779047e-11
a O 0 2.853003770730833e-11
family O 0 5.707664549325919e-11
showing O 0 3.415199512080136e-10
mild O 0 3.9127914419623266e-07
expression O 0 9.04071200125145e-08
of O 0 6.531895024863843e-08
the O 0 8.770468440388868e-08
retinoblastoma B-Disease 0 0.00013174416380934417
phenotype O 0 9.913901521940716e-06
. O 0 5.278815251585911e-08

In O 0 3.774490053842783e-09
this O 0 1.3485951244618377e-10
family O 0 1.084441217380494e-10
affected O 0 1.110166958362413e-09
individuals O 0 4.435842665406753e-11
developed O 0 3.7683028608626046e-07
unilateral B-Disease 1 0.9999016523361206
tumors I-Disease 1 1.0
and O 0 1.1169928484378033e-06
, O 0 4.015100751875167e-11
as O 0 2.162709681480246e-12
a O 0 7.38255146576737e-14
result O 0 4.0104911579186275e-12
of O 0 2.735414325605312e-11
linkage O 0 1.7452184142285887e-10
analysis O 0 3.735124189108152e-12
, O 0 1.1817760312005099e-12
unaffected O 0 4.946469012168109e-09
mutation O 0 1.3977347057547718e-10
carriers O 0 6.003194469306194e-11
were O 0 5.0323387817963194e-11
also O 0 4.091057787675156e-12
identified O 0 1.860341568293844e-11
within O 0 3.7663977492385925e-10
the O 0 2.4842727874840875e-09
pedigree O 0 8.931642696552444e-07
. O 0 6.857887768774162e-08

A O 0 1.3397543341397977e-07
single O 0 1.2684358008385743e-09
band O 0 1.0898993929586709e-09
shift O 0 4.76708839070028e-10
using O 0 8.279377183839642e-11
SSCP O 0 0.00027800232055597007
was O 0 3.368813672466331e-09
identified O 0 5.025493354793298e-10
in O 0 4.646660001217384e-10
exon O 0 1.2206627708621909e-08
21 O 0 7.577644622891455e-10
which O 0 4.588604344581138e-13
resulted O 0 2.49941872754178e-10
in O 0 5.6555506805500144e-11
a O 0 2.3607352184207286e-10
missense O 0 1.9858680389006622e-07
mutation O 0 7.94703503004257e-09
converting O 0 5.2807187955750123e-08
a O 0 8.683869179293424e-10
cys O 0 1.203722149512032e-06
- O 0 6.332778212936319e-08
- O 0 2.6465245994700126e-08
> O 0 4.281786303295121e-08
arg O 0 4.014308441213643e-09
at O 0 2.8528023693352722e-11
nucleotide O 0 3.2396621496566524e-10
position O 0 1.0421060681053973e-09
28 O 0 5.062177343972962e-09
in O 0 6.530880281019336e-10
the O 0 1.1367069063794588e-08
exon O 0 6.318474561339826e-07
. O 0 9.752861984679839e-08

The O 0 5.598060965894547e-07
mutation O 0 3.138046338335698e-07
destroyed O 0 2.2231846230624797e-07
an O 0 1.2427536777437354e-10
NdeI O 0 2.0307721570134163e-05
restriction O 0 3.3774479106796207e-06
enzyme O 0 4.701981026755675e-07
site O 0 7.930215417673026e-08
. O 0 1.3929030373560636e-08

Analysis O 0 1.6108653300150877e-09
of O 0 1.2917703351433829e-08
all O 0 2.527184905787294e-09
family O 0 4.123085206586552e-10
members O 0 8.463886709553226e-12
demonstrated O 0 7.634422261038054e-11
that O 0 8.215361442347191e-13
the O 0 2.896247963679599e-10
missense O 0 4.5852209495933494e-07
mutation O 0 5.963044458212607e-08
co O 0 9.35186506012542e-09
- O 0 2.522198201404535e-07
segregated O 0 3.068839404818391e-08
with O 0 1.0964286770165366e-11
patients O 0 5.121832202803489e-08
with O 0 6.858168477563709e-10
tumors B-Disease 1 1.0
or O 0 0.15019874274730682
who O 0 1.2800782656086085e-08
, O 0 6.208123425055501e-12
as O 0 1.5788444770320487e-12
a O 0 5.473975154992976e-14
result O 0 3.736834192774596e-12
of O 0 1.907489964592113e-11
linkage O 0 7.182950761963625e-11
analysis O 0 5.47512946438844e-12
had O 0 1.0695704738550305e-11
been O 0 1.1811840568143328e-11
predicted O 0 4.743787029859448e-10
to O 0 2.2346464956246592e-11
carry O 0 2.187124509278604e-10
the O 0 7.285458902828168e-10
predisposing O 0 1.2279132306503016e-06
mutation O 0 7.362984177916587e-08
. O 0 3.193474995555334e-08

These O 0 2.1668181915401874e-08
observations O 0 4.0716514604355325e-08
point O 0 2.7831186244497985e-09
to O 0 2.7044533279507732e-11
another O 0 8.443735988183931e-11
region O 0 3.0250888460869874e-09
of O 0 7.3367383279787646e-09
the O 0 5.5749765692780784e-08
RB1 O 0 2.0118543034186587e-05
gene O 0 5.802306968227811e-10
where O 0 2.792363840153911e-10
mutations O 0 2.9564416886840306e-11
only O 0 2.6555853870069424e-12
modify O 0 3.905051559893735e-10
the O 0 5.995504787081885e-11
function O 0 4.005707571197448e-11
of O 0 5.789957957524905e-10
the O 0 8.248345895189857e-10
gene O 0 1.4089364397396054e-10
and O 0 3.2312694187019986e-10
raise O 0 5.6376969759242e-10
important O 0 9.162110653493372e-11
questions O 0 1.7147236408554534e-10
for O 0 2.5329720959588187e-12
genetic O 0 7.591184902899784e-10
counseling O 0 9.059208383455086e-10
in O 0 5.4010923337954875e-12
families O 0 7.920042226217117e-12
with O 0 7.235773937484813e-13
these O 0 1.8736892593018695e-10
distinctive O 0 1.1238239672195505e-08
phenotypes O 0 1.8931474699002138e-07
. O 0 2.740644822196714e-09
. O 0 1.0283462081872585e-08

Maternal B-Disease 0 7.005257066339254e-05
disomy I-Disease 0 0.0006756740622222424
and O 0 8.088442882581148e-06
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 3.956897671741899e-06
with O 0 3.3319829534361745e-11
gamete O 0 1.2943135629939206e-07
complementation O 0 0.0003641083021648228
in O 0 8.013879143620173e-11
a O 0 1.890948985935892e-12
case O 0 1.501047064422778e-10
of O 0 2.5072026677008807e-09
familial O 0 9.937850791175151e-07
translocation O 0 1.904209602798801e-05
( O 0 4.098073269620528e-11
3 O 0 1.1483102246856447e-09
; O 0 9.990982867413845e-12
15 O 0 1.5164801359102142e-10
) O 0 9.696489488078552e-13
( O 0 7.582837352818061e-13
p25 O 0 8.588205702153573e-09
; O 0 1.3601647586014565e-11
q11 O 0 1.4965547023848558e-08
. O 0 1.5977343059692117e-10
2 O 0 1.8095908105308922e-09
) O 0 2.7507860572706377e-11
. O 0 2.375071694871167e-09

Maternal B-Disease 1 0.6164196133613586
uniparental I-Disease 1 0.9999955892562866
disomy I-Disease 1 0.999998927116394
( I-Disease 0 9.432488354832458e-07
UPD I-Disease 1 1.0
) I-Disease 0 1.7361354576195254e-09
for I-Disease 0 6.648281369869835e-10
chromosome I-Disease 0 2.3197965770549445e-09
15 I-Disease 0 2.0876664841296133e-09
is O 0 5.015127202412373e-12
responsible O 0 3.735795700565703e-11
for O 0 1.5207170592224095e-11
an O 0 1.4093724288750248e-13
estimated O 0 2.089635322416461e-12
30 O 0 2.9520450754022542e-12
% O 0 4.6838895880352976e-14
of O 0 1.2405203241320963e-14
cases O 0 8.281390438853731e-13
of O 0 7.33423366483521e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 9.921108721755445e-05
PWS B-Disease 1 1.0
) O 0 3.3325138204531868e-09
. O 0 7.474296737086661e-09

We O 0 5.977734929274447e-08
report O 0 4.0946215862369684e-10
on O 0 1.1629031071436202e-10
an O 0 5.081716229998583e-14
unusual O 0 3.6279898356361695e-12
case O 0 4.8829648657822133e-11
of O 0 5.451490370234069e-10
maternal B-Disease 0 1.993681735257269e-06
disomy I-Disease 0 0.00107826036401093
15 I-Disease 0 1.8048559979888523e-07
in O 0 1.3480718763503319e-08
PWS B-Disease 1 1.0
that O 0 1.6093198995648095e-10
is O 0 1.1636169458539847e-11
most O 0 1.1467878729964909e-11
consistent O 0 1.3507935048284736e-10
with O 0 1.223814560975811e-12
adjacent O 0 3.347414345711286e-09
- O 0 1.8994539274785893e-09
1 O 0 6.102228500282081e-09
segregation O 0 4.912599216311264e-10
of O 0 4.017858615257275e-11
a O 0 1.5533539732270896e-11
paternal O 0 8.808523688230707e-08
t O 0 6.538698471558746e-09
( O 0 1.9658033881264636e-12
3 O 0 1.0289043228528527e-10
; O 0 2.290904445312325e-12
15 O 0 3.173947216161821e-11
) O 0 3.7208867172296156e-13
( O 0 5.452512356549089e-13
p25 O 0 6.65117605436194e-09
; O 0 4.3174595842909724e-12
q11 O 0 5.7678506415470565e-09
. O 0 2.1756773466163892e-11
2 O 0 5.860262275447781e-11
) O 0 6.260497084934966e-14
with O 0 7.24601788618627e-14
simultaneous O 0 9.835224648591101e-12
maternal O 0 1.435795216053748e-08
meiotic O 0 1.053108235282707e-06
nondisjunction O 0 2.2117439584690146e-05
for O 0 5.895574872738507e-08
chromosome O 0 4.9591584172503644e-08
15 O 0 4.960454802471759e-08
. O 0 2.044354019403727e-08

The O 0 2.1502476954537997e-07
patient O 0 2.4718704025872285e-06
( O 0 3.977879484140523e-11
J O 0 8.71075087616191e-08
. O 0 4.852623164408598e-11
B O 0 2.277793065275091e-09
. O 0 1.2823771179063664e-13
) O 0 1.7008277585265318e-14
, O 0 8.450989338664935e-14
a O 0 4.688164461676136e-13
17 O 0 7.005124952330632e-11
- O 0 6.950915537595748e-11
year O 0 2.1099679781144687e-09
- O 0 7.82521514253176e-09
old O 0 2.5114683666060955e-08
white O 0 1.1245737674414613e-09
male O 0 2.549073972735183e-11
with O 0 1.2951550639253573e-12
PWS B-Disease 1 1.0
, O 0 7.034746118961266e-10
was O 0 3.1285596335806076e-09
found O 0 1.2667959736756274e-10
to O 0 1.3475999482981393e-10
have O 0 1.0230322144977322e-09
47 O 0 1.4435470596652067e-08
chromosomes O 0 3.383119617783592e-10
with O 0 2.5050528058151444e-12
a O 0 2.8447442318446647e-11
supernumerary O 0 5.637062372443324e-07
, O 0 1.59770988106267e-10
paternal O 0 1.9382308380500035e-07
der O 0 1.4692898275825428e-07
( O 0 4.226230476689352e-12
15 O 0 6.536796798295441e-11
) O 0 1.4117830168802747e-13
consisting O 0 3.567508267965369e-12
of O 0 2.1308345712900412e-11
the O 0 6.015060671771266e-10
short O 0 1.1031977109610125e-08
arm O 0 1.0475530665132737e-08
and O 0 1.1360127283310817e-09
the O 0 2.863207626546682e-08
proximal O 0 0.12059925496578217
long O 0 9.440560688744881e-07
arm O 0 2.065853976773724e-08
of O 0 8.666996009765171e-09
chromosome O 0 6.415149522709385e-10
15 O 0 1.0285340357185646e-09
, O 0 1.4910961354530627e-11
and O 0 1.6212768627621443e-10
distal O 0 3.832838956441265e-06
chromosome O 0 3.101101356151048e-06
arm O 0 0.00010785767517518252
3p O 0 0.4096498489379883
. O 0 4.643609372578794e-06

The O 0 4.231581442581955e-06
t O 0 4.2312318981885255e-08
( O 0 1.2666696684593415e-11
3 O 0 8.632802112051863e-11
; O 0 2.049569932174866e-12
15 O 0 1.4474378293161116e-11
) O 0 8.67871855110558e-14
was O 0 2.1949716350055937e-11
present O 0 1.5927465943366137e-11
in O 0 2.707168170190677e-11
the O 0 4.332028832876311e-11
balanced O 0 9.868959816028422e-11
state O 0 5.6601776217413136e-12
in O 0 3.4857644114899555e-12
the O 0 3.5535404480091515e-11
patients O 0 5.836930938585283e-09
father O 0 1.3501142426264323e-09
and O 0 9.459354410878973e-10
a O 0 3.980774820888655e-09
sister O 0 2.015699919866165e-06
. O 0 4.484740827592759e-07

Fluorescent O 0 1.4258105693443213e-05
in O 0 7.2431207698286926e-09
situ O 0 8.336784418361276e-08
hybridization O 0 6.655664908095105e-10
analysis O 0 1.576591461549537e-11
demonstrated O 0 1.8625011255490875e-10
that O 0 2.0099891803043723e-12
the O 0 1.324121923218513e-09
PWS B-Disease 1 1.0
critical O 0 8.394405085709877e-06
region O 0 1.782658287652339e-08
resided O 0 7.551705927255625e-09
on O 0 1.3923040498298178e-10
the O 0 1.903089318078255e-11
derivative O 0 1.209212285857575e-09
chromosome O 0 4.0514102489508375e-11
3 O 0 8.453984734480002e-11
and O 0 8.938209872765002e-13
that O 0 6.180989829121172e-14
there O 0 1.4215434385178582e-12
was O 0 3.925968231066612e-11
no O 0 3.68007187223629e-12
deletion O 0 5.523729043610537e-11
of O 0 3.1972319236572844e-10
the O 0 1.5729144209331025e-08
PWS B-Disease 1 1.0
region O 0 1.8996148298811022e-07
on O 0 2.717699176812971e-09
the O 0 6.369048344279093e-11
normal O 0 4.11675971090375e-10
pair O 0 9.986835663999827e-11
of O 0 1.818099663875028e-11
15s O 0 1.981142183637985e-08
present O 0 1.7136096985836957e-09
in O 0 1.330078536199153e-08
J O 0 0.00015414465451613069
. O 0 2.0308861792273092e-07

B O 0 0.022168835625052452
. O 0 1.9708097624970833e-06

Methylation O 0 1.6996209240005555e-07
analysis O 0 2.611423077780728e-09
at O 0 6.52651310772967e-09
exon O 0 2.7537834057511645e-07
alpha O 0 1.4808891890538689e-08
of O 0 2.308056856747953e-09
the O 0 3.6127210112368857e-09
small O 0 4.4463233095370924e-10
nuclear O 0 3.437284590290801e-08
ribonucleoprotein O 0 3.2745984412940743e-07
- O 0 5.909036815410218e-09
associated O 0 7.48197059863287e-09
polypeptide O 0 1.3189583114581183e-07
N O 0 2.2267471422310336e-07
( O 0 3.438807225086826e-11
SNRPN O 0 1.4959367945266422e-05
) O 0 9.28883636674982e-11
gene O 0 1.0381120268965205e-10
showed O 0 7.372909227587598e-11
a O 0 1.0645772458017788e-12
pattern O 0 1.0000139605281788e-10
characteristic O 0 1.6986818895947664e-10
of O 0 5.41236673534673e-11
only O 0 8.688035534054617e-12
the O 0 4.3871663246708437e-11
maternal O 0 4.345936499561276e-09
chromosome O 0 2.1638135727641838e-10
15 O 0 1.1276043432317806e-09
in O 0 1.3378049779078083e-09
J O 0 7.659164839424193e-05
. O 0 2.4360153361158154e-07

B O 0 0.020684044808149338
. O 0 2.0764803139172727e-06

Maternal B-Disease 0 0.0013570425799116492
disomy I-Disease 0 0.0003037131391465664
was O 0 1.3633980167071513e-08
confirmed O 0 2.8833394005722823e-10
by O 0 6.689473627807807e-12
polymerase O 0 6.061482565877796e-11
chain O 0 1.409830932552758e-11
reaction O 0 6.189690253399771e-12
analysis O 0 1.1242251921061985e-11
of O 0 1.3387946307119591e-10
microsatellite O 0 2.9106551835411665e-08
repeats O 0 3.7548067433057497e-10
at O 0 6.786906453504216e-11
the O 0 4.122108210324882e-11
gamma O 0 1.4923351443485444e-09
- O 0 1.0221136159671573e-09
aminobutyric O 0 3.6271252668029774e-08
acid O 0 4.7590420493293095e-09
receptor O 0 1.367168045440792e-09
beta3 O 0 8.350518498900783e-08
subunit O 0 1.9987371757679284e-09
( O 0 4.7358200694347374e-11
GABRB3 O 0 1.2396236343192868e-05
) O 0 5.785145140713155e-10
locus O 0 4.0511674015419885e-09
. O 0 1.403046212544723e-08

A O 0 1.313747725362191e-05
niece O 0 6.150919944047928e-05
( O 0 9.841539805321986e-10
B O 0 1.2789723768946715e-06
. O 0 4.674864662046474e-11
B O 0 6.449628386917539e-09
. O 0 3.942111665312248e-13
) O 0 4.55506468590057e-14
with O 0 1.610929678498227e-13
45 O 0 8.135795509511823e-11
chromosomes O 0 4.323864530308974e-11
and O 0 1.387152979287487e-11
the O 0 5.01909173944437e-11
derivative O 0 3.9260147910447074e-10
3 O 0 4.862239777470023e-11
but O 0 9.037052248021815e-13
without O 0 1.8850730004738026e-11
the O 0 4.369739847742693e-10
der O 0 4.129440966949005e-08
( O 0 9.413449186812528e-12
15 O 0 1.8645128496697083e-10
) O 0 2.0257768986592373e-12
demonstrated O 0 6.092246707112281e-10
a O 0 5.915299500225402e-11
phenotype O 0 1.5141210951696848e-07
consistent O 0 1.5383193385787308e-08
with O 0 1.1517677003108906e-12
that O 0 1.6966262379389252e-13
reported O 0 1.4338246302064706e-12
for O 0 1.931881737915475e-12
haploinsufficiency O 0 3.0894304359208036e-07
of O 0 7.854228556425369e-08
distal O 0 0.00010934726742561907
3 O 0 6.796835805289447e-05
p O 0 2.88254796032561e-06
. O 0 3.9122870276742105e-08

Uniparental B-Disease 1 1.0
disomy I-Disease 1 0.9999992847442627
associated O 0 1.7878211622246454e-07
with O 0 4.164738831580195e-10
unbalanced O 0 4.5661258241125324e-07
segregation O 0 4.4862460413241934e-08
of O 0 9.658005062362918e-09
non O 0 2.212369054177543e-06
- O 0 3.0175618803696125e-07
Robertsonian O 0 4.724559039459564e-05
translocations O 0 6.622240675824287e-07
has O 0 1.4408717274871918e-10
been O 0 2.408944571596905e-11
reported O 0 3.266458631356883e-11
previously O 0 2.526080455922397e-10
but O 0 3.2989794923610205e-11
has O 0 2.899235105463527e-12
not O 0 4.012021184024439e-12
, O 0 5.8694537945214176e-12
to O 0 2.3771358145796562e-11
our O 0 1.1405568711708725e-09
knowledge O 0 7.391950385127188e-10
, O 0 1.4413458490972197e-12
been O 0 3.610972198336837e-12
observed O 0 3.476450724515523e-11
in O 0 4.048967758296662e-12
a O 0 5.044156498740238e-12
case O 0 1.658111536961826e-09
of O 0 1.061228687149196e-07
PWS B-Disease 1 1.0
. O 0 6.39816717011854e-05

Furthermore O 0 1.3362774552660994e-05
, O 0 6.189983636772922e-09
our O 0 1.6899507349066312e-09
findings O 0 1.9384660543408927e-09
are O 0 1.6941769168110632e-11
best O 0 1.4695028180411462e-11
interpreted O 0 6.534216223652578e-11
as O 0 1.0619089808872051e-11
true O 0 1.5761171534567353e-10
gamete O 0 3.340451115718679e-08
complementation O 0 1.5390185126307188e-06
resulting O 0 8.684056140850771e-09
in O 0 2.5776143441902377e-09
maternal B-Disease 0 2.7148536901222542e-05
UPD I-Disease 1 1.0
15 I-Disease 0 5.996467371005565e-05
and O 0 2.797476781779551e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9994188547134399
- I-Disease 1 0.9999990463256836
Jampel I-Disease 1 1.0
syndrome I-Disease 1 0.9999995231628418
type I-Disease 0 1.278416334571375e-06
2 I-Disease 0 1.6745820730079686e-08
and O 0 8.11405317935332e-11
Stuve B-Disease 1 0.9999774694442749
- I-Disease 1 0.999998927116394
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 2.0592024613241833e-11
a O 0 5.044971601933512e-13
case O 0 8.477571943055207e-12
for O 0 7.034792453425309e-12
" O 0 4.314549550965552e-10
lumping O 0 9.24263066082176e-09
" O 0 3.323139097233252e-09
. O 0 2.3946264970930997e-09

Recent O 0 1.3735331094721914e-08
studies O 0 4.807080289381815e-10
demonstrated O 0 3.1217986529163966e-10
the O 0 6.069742625181007e-11
existence O 0 2.427005818539385e-10
of O 0 2.713222702066531e-10
a O 0 7.678437052849318e-11
genetically O 0 8.595581562076404e-07
distinct O 0 1.0090849267285762e-09
, O 0 8.885041682428485e-13
usually O 0 2.301839816844231e-13
lethal O 0 1.8564495427031424e-11
form O 0 4.118380983464398e-12
of O 0 9.888644590672069e-12
the O 0 2.0472863682119424e-10
Schwartz B-Disease 0 4.224444637657143e-06
- I-Disease 0 0.0051689911633729935
Jampel I-Disease 1 1.0
syndrome I-Disease 1 0.9999967813491821
( O 0 2.1794788196416448e-10
SJS B-Disease 0 0.0025281680282205343
) O 0 1.6882295561515548e-10
of O 0 8.126936279495567e-08
myotonia B-Disease 1 1.0
and O 0 0.00010843434574780986
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 6.29672285867855e-07
which O 0 2.336555393611661e-09
we O 0 1.0452871901378558e-09
called O 0 3.5955214361393928e-09
SJS B-Disease 0 0.0002414560003671795
type I-Disease 0 3.6293411085353e-06
2 I-Disease 0 3.4962326367349306e-07
. O 0 8.315278243742341e-09

This O 0 1.7405304220119433e-07
disorder O 0 0.0018894484965130687
is O 0 4.3807052430011595e-10
reminiscent O 0 1.6630666266337357e-07
of O 0 1.8275722046823262e-09
another O 0 1.9170498521958734e-11
rare O 0 1.3091140671495083e-10
condition O 0 5.991373175362469e-09
, O 0 2.9833809034318648e-12
the O 0 1.1297070917626328e-10
Stuve B-Disease 1 0.9999980926513672
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 4.402395745728427e-07
SWS B-Disease 1 0.9999351501464844
) O 0 1.7334732607676706e-11
, O 0 5.1113306295813565e-12
which O 0 2.886230534085432e-12
comprises O 0 5.0210065272171533e-11
campomelia B-Disease 0 1.6601636332325143e-07
at O 0 3.806344128776118e-09
birth O 0 1.5858029655646533e-05
with O 0 2.4790283159603632e-09
skeletal B-Disease 0 0.28640955686569214
dysplasia I-Disease 1 0.9999998807907104
, O 0 6.158437315662013e-08
contractures B-Disease 1 0.9689937829971313
, O 0 1.9041115351114968e-09
and O 0 1.7180694367180394e-10
early B-Disease 0 6.298122201542355e-08
death I-Disease 0 4.253467622561402e-08
. O 0 4.470401293588111e-08

To O 0 1.2561863549365171e-08
test O 0 4.238005946177736e-09
for O 0 3.957967634193871e-11
possible O 0 4.525942731703481e-09
nosologic O 0 0.00011356180039001629
identity O 0 2.4130351050644094e-09
between O 0 3.325730801861937e-10
these O 0 2.2633199758814726e-09
disorders O 0 2.6735515135101195e-08
, O 0 3.5243249291161405e-12
we O 0 2.240834037423034e-12
reviewed O 0 6.03792293940586e-10
the O 0 4.126639308044133e-11
literature O 0 7.111722322150626e-11
and O 0 1.562397265600715e-13
obtained O 0 1.1340020719327604e-12
a O 0 4.909463677607584e-13
follow O 0 1.6239445899124405e-10
- O 0 4.719609147940673e-10
up O 0 1.1951103995322399e-10
of O 0 6.840358834914184e-11
the O 0 1.637011533273114e-11
only O 0 3.078347906443346e-12
two O 0 5.142865842390487e-13
surviving O 0 8.279001928457319e-10
patients O 0 7.551576253206349e-09
, O 0 1.3898649592336554e-11
one O 0 8.740425050390854e-12
with O 0 9.459164354574945e-12
SJS B-Disease 0 1.3221475455793552e-05
type I-Disease 0 1.0537170282987063e-06
2 I-Disease 0 2.2681481581798835e-08
at O 0 4.8877638048061556e-11
age O 0 7.058369860812874e-11
10 O 0 1.6331061936797342e-12
years O 0 3.040853810074018e-12
and O 0 2.1706401866911085e-12
another O 0 7.1016335173590406e-12
with O 0 3.6689234983455776e-11
SWS B-Disease 0 4.16068860431551e-06
at O 0 3.8584524464368997e-10
age O 0 3.751508437233042e-09
7 O 0 1.9592558686554185e-09
years O 0 2.5854912655276507e-10
. O 0 5.375940581586747e-09

Patients O 0 9.544356726109982e-05
reported O 0 1.93874208354039e-10
as O 0 3.4806039994617066e-11
having O 0 1.0559029345325044e-10
either O 0 1.5013034371236245e-08
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 1 0.872800350189209
SWS B-Disease 0 0.312307745218277
presented O 0 2.6901680882929213e-10
a O 0 8.308507961490852e-13
combination O 0 5.132904865035037e-11
of O 0 2.7041544350958624e-11
a O 0 5.327609881033979e-12
severe O 0 7.359614784263613e-08
, O 0 5.417399306928417e-10
prenatal O 1 0.9997608065605164
- O 0 0.05606916919350624
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 9.165182035530961e-08
with O 0 1.2507216240464913e-07
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9999715089797974
respiratory O 1 1.0
and O 0 0.006787263322621584
feeding O 1 0.9295029640197754
difficulties O 0 1.6671796174705378e-06
, O 0 6.343567893196678e-10
tendency O 0 4.436185641054635e-09
to O 0 2.8386859529661024e-10
hyperthermia B-Disease 0 0.02532603219151497
, O 0 4.5491149042176104e-11
and O 0 4.835057267754683e-12
frequent O 0 2.8862032121906855e-12
death O 0 1.928022325126122e-10
in O 0 2.889962991137196e-10
infancy O 0 2.170367707776677e-07
) O 0 3.01295555345249e-13
with O 0 1.1689369090739365e-13
a O 0 6.947293868658777e-12
distinct O 0 3.732416598012378e-09
campomelic B-Disease 1 0.7390313744544983
- I-Disease 1 0.9598121047019958
metaphyseal I-Disease 1 0.9999176263809204
skeletal I-Disease 1 0.9999109506607056
dysplasia I-Disease 1 1.0
. O 0 0.0003369897312950343

The O 0 1.8771178389442866e-08
similarity O 0 1.6045797579522514e-08
of O 0 7.355527742447521e-09
the O 0 3.4885698774189677e-09
clinical O 0 3.6008831472145175e-08
and O 0 2.00795644000884e-10
radiographic O 0 0.0008785774698480964
findings O 0 6.746121016476536e-06
is O 0 1.9095805492419515e-10
so O 0 3.482503174723206e-11
extensive O 0 1.24866519901623e-10
that O 0 2.2947572661524696e-12
these O 0 1.074694555569522e-08
disorders O 0 3.5691497032530606e-05
appear O 0 7.22719804002736e-08
to O 0 3.396495237839581e-11
be O 0 1.594406030813733e-11
a O 0 1.193280717293188e-11
single O 0 4.124438290897814e-10
entity O 0 8.65067839583844e-09
. O 0 5.573318162532814e-08

The O 0 1.606532862297172e-07
follow O 0 8.145092067479709e-08
- O 0 2.3859199060893843e-08
up O 0 1.7107153194029223e-10
observation O 0 4.963203736885191e-10
of O 0 5.656389419350649e-12
an O 0 4.2568633486879046e-14
identical O 0 3.2796560606174197e-11
and O 0 4.288095052651375e-12
unique O 0 1.9689678706913405e-11
pattern O 0 2.5958148963667327e-09
of O 0 1.6102586641864036e-07
progressive O 1 0.9999994039535522
bone B-Disease 1 0.9999996423721313
dysplasia I-Disease 1 1.0
in O 0 4.3515629499779607e-07
the O 0 3.447981100634934e-08
two O 0 6.090083298770921e-11
patients O 0 6.837196586673144e-09
( O 0 2.7389459515518577e-13
one O 0 1.4124031805229365e-12
with O 0 1.5458548070085287e-12
SJS B-Disease 0 7.107453257049201e-07
type I-Disease 0 2.0092232944080024e-07
2 I-Disease 0 4.315944579502684e-08
, O 0 9.849773774384118e-12
one O 0 4.4491688978853805e-12
with O 0 8.165017273409347e-12
SWS B-Disease 0 4.86268334043416e-07
) O 0 3.1767316641811982e-12
surviving O 0 4.061240232999808e-09
beyond O 0 1.2423952000517602e-07
infancy O 0 1.5325578317515465e-07
adds O 0 1.221816953167476e-10
to O 0 1.0997673258184015e-11
the O 0 1.1151467770031953e-11
evidence O 0 3.3812341815320224e-11
in O 0 2.8443481944750992e-11
favor O 0 9.294569558448984e-09
of O 0 6.591084900087196e-10
identity O 0 3.6624385746364396e-09
. O 0 1.0904697589353418e-08

The O 0 3.9118023664741486e-07
hypothesis O 0 4.0672148315934464e-06
that O 0 2.339891391756055e-09
SWS B-Disease 0 0.0020341393537819386
and O 0 1.1218664219825314e-08
SJS B-Disease 1 0.9972012042999268
type I-Disease 0 9.117687295656651e-05
2 I-Disease 0 4.993537459085928e-07
are O 0 6.270326272095339e-12
the O 0 1.4478519078098273e-11
same O 0 4.983018442317189e-10
disorder O 0 4.2361418195469014e-07
should O 0 7.628079834454127e-10
be O 0 1.491819445753606e-10
testable O 0 3.5225514949388526e-08
by O 0 4.448770345166775e-12
molecular O 0 6.514715850114428e-11
methods O 0 5.158838356500439e-10
. O 0 4.2162109914478663e-10
. O 0 7.400898116571852e-09

A O 0 3.5043836277282026e-08
mouse O 0 2.9969422499220855e-09
model O 0 6.44963388252151e-11
of O 0 7.121903067286439e-11
severe O 1 0.8313720226287842
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 4.879699986304331e-07
defects O 0 4.066334804520011e-05
in O 0 2.297468348899656e-08
hemostasis O 0 0.20568989217281342
and O 0 6.662567386683804e-08
thrombosis B-Disease 1 0.9850622415542603
. O 0 1.4124971130513586e-06

von B-Disease 0 0.04431256651878357
Willebrand I-Disease 1 0.9999935626983643
factor I-Disease 0 0.003852599300444126
( I-Disease 0 1.4698727568429604e-07
vWf I-Disease 1 0.9995318651199341
) I-Disease 0 3.182839805049298e-07
deficiency I-Disease 1 0.9999908208847046
causes O 0 8.388236892642453e-05
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 1.2201213394291699e-05
humans O 0 9.075092322063938e-08
. O 0 5.560435667462116e-09

We O 0 3.8347874209421207e-08
generated O 0 2.9457387640263732e-09
a O 0 2.7753604969760204e-11
mouse O 0 5.855337881222056e-10
model O 0 2.5295118430412877e-11
for O 0 2.435150388627183e-12
this O 0 2.0278148951669017e-11
disease O 0 1.0474906497748293e-09
by O 0 3.1324436100543807e-11
using O 0 3.4579358820785444e-10
gene O 0 1.0239498138275849e-09
targeting O 0 6.463408475099186e-09
. O 0 3.3732131754504735e-08

vWf B-Disease 1 0.999984622001648
- I-Disease 1 1.0
deficient I-Disease 1 0.9999996423721313
mice O 0 6.84178530718782e-06
appeared O 0 3.7072434011520272e-09
normal O 0 5.373364531102709e-10
at O 0 2.622766587245806e-11
birth O 0 6.33625207857591e-10
; O 0 6.2654243772330975e-12
they O 0 1.0381749279697594e-11
were O 0 4.000380304791662e-10
viable O 0 6.65278960809701e-08
and O 0 5.241787559562283e-10
fertile O 0 7.444647849297326e-07
. O 0 2.4019330524538418e-08

Neither O 0 9.714312000141945e-06
vWf O 0 0.00022402899048756808
nor O 0 8.218191396736074e-06
vWf O 0 0.0002026011934503913
propolypeptide O 0 0.00011310757690807804
( O 0 4.219350646650355e-09
von B-Disease 0 8.881120447767898e-05
Willebrand I-Disease 0 0.0007270461064763367
antigen O 0 5.620702268060995e-06
II O 1 1.0
) O 0 2.150253169963534e-10
were O 0 2.650300257034388e-10
detectable O 0 1.3304008561476621e-08
in O 0 3.6541387971045225e-11
plasma O 0 3.3417877354224856e-09
, O 0 3.7345686439149706e-12
platelets O 0 3.0934617090139227e-09
, O 0 3.783804866652751e-12
or O 0 5.282924271654554e-12
endothelial O 0 1.077534728111118e-09
cells O 0 5.454548479555399e-10
of O 0 1.1985093473221298e-10
the O 0 1.5890705418186712e-09
homozygous O 0 1.5612162940215057e-07
mutant O 0 1.1244080724281957e-06
mice O 0 1.3080551752864267e-07
. O 0 5.555972570903123e-09

The O 0 6.112556548032444e-06
mutant O 0 3.4865264751715586e-05
mice O 0 2.4384675612054707e-07
exhibited O 0 2.530934573030663e-08
defects O 0 7.020684051894932e-07
in O 0 1.2627444867518989e-08
hemostasis O 0 0.0001924072130350396
with O 0 1.502281493648283e-10
a O 0 3.8427278026276213e-10
highly O 0 5.406511718319962e-06
prolonged O 1 0.5006715655326843
bleeding O 0 0.016171099618077278
time O 0 7.187771444705504e-08
and O 0 5.075590081560222e-08
spontaneous O 0 1.0505943919270067e-06
bleeding O 0 4.281271515083063e-08
events O 0 4.202319395241183e-11
in O 0 9.224863928292137e-12
approximately O 0 2.5487856183253887e-12
10 O 0 1.0212746447135768e-11
% O 0 7.950449326665776e-12
of O 0 5.433488034500833e-11
neonates O 0 1.8388588785001048e-07
. O 0 8.841178100738034e-08

As O 0 1.0070645650728238e-08
in O 0 1.646114217157546e-10
the O 0 3.7749327969072155e-11
human O 0 1.0003644614065e-11
disease O 0 4.4987694125531164e-10
, O 0 7.4714307006854e-13
the O 0 1.5571717526530193e-11
factor O 0 2.077834349023533e-09
VIII O 1 0.9999746084213257
level O 0 2.667734861461213e-06
in O 0 5.314765849639969e-10
these O 0 1.0699544722436727e-10
mice O 0 1.1041943748235639e-10
was O 0 7.337945355512243e-12
reduced O 0 4.079568627357588e-10
strongly O 0 6.731342566679288e-11
as O 0 7.155912581241486e-12
a O 0 6.256310031670098e-13
result O 0 7.107817112661508e-11
of O 0 8.811876228698168e-10
the O 0 3.5652328311819304e-10
lack O 0 9.113979793085036e-09
of O 0 1.0974084835302378e-10
protection O 0 5.6770854683918515e-09
provided O 0 1.193531662391223e-10
by O 0 3.2630229074293027e-10
vWf O 0 7.433966857206542e-06
. O 0 9.289983182725337e-08

Defective O 1 0.9999368190765381
thrombosis B-Disease 1 1.0
in O 0 2.0127083189436235e-05
mutant O 0 1.2734777556033805e-05
mice O 0 5.3494005669563194e-08
was O 0 1.7089771264799936e-10
also O 0 5.721013073001213e-12
evident O 0 2.0199615313742925e-09
in O 0 8.753538692507501e-12
an O 0 6.78877391585217e-14
in O 0 1.1416607676589807e-12
vivo O 0 1.200930327405203e-10
model O 0 6.970484606183547e-11
of O 0 4.741111947481613e-09
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 1 0.8598154187202454

In O 0 9.034705206190097e-10
this O 0 1.375833214717348e-11
model O 0 2.2893167916926416e-10
, O 0 6.7344727884555144e-12
the O 0 8.523378530744807e-11
exteriorized O 0 1.1654110494419e-06
mesentery O 0 7.33048545953352e-06
was O 0 1.4824463434592872e-08
superfused O 0 3.527295575622702e-06
with O 0 4.0545128365820915e-10
ferric O 0 9.303818842454348e-06
chloride O 0 9.973616670322372e-07
and O 0 4.72290739850223e-09
the O 0 9.580447546397863e-10
accumulation O 0 2.172591706539606e-07
of O 0 1.0910605752201263e-08
fluorescently O 0 2.3881477773102233e-06
labeled O 0 2.2878349881239046e-08
platelets O 0 1.0306244035973577e-07
was O 0 7.116773281801159e-10
observed O 0 2.492415995813957e-10
by O 0 1.1051298071107496e-10
intravital O 0 1.2117593541915994e-06
microscopy O 0 7.920810958239599e-07
. O 0 1.693333899766003e-07

We O 0 3.0313574939100363e-07
conclude O 0 9.052693599187478e-07
that O 0 7.048536060372257e-11
these O 0 5.118916401869456e-10
mice O 0 6.6883996119315725e-09
very O 0 4.1827600411048493e-11
closely O 0 6.889451231728572e-10
mimic O 0 1.886875082846018e-07
severe O 0 6.897394632687792e-05
human O 0 0.0020969731267541647
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 5.837601975144935e-07
will O 0 1.4510180557092411e-10
be O 0 5.693733245298871e-12
very O 0 1.893363504174017e-12
useful O 0 5.218148504439191e-13
for O 0 2.222346113557594e-14
investigating O 0 2.2977923817141255e-12
the O 0 8.671315401831414e-12
role O 0 3.45535614010295e-11
of O 0 8.974097021052785e-10
vWf O 0 9.078690936803469e-07
in O 0 7.236612975525247e-10
normal O 0 1.3244606407170068e-06
physiology O 0 1.6641470779177325e-07
and O 0 3.7266793817547494e-11
in O 0 2.0468597303202607e-11
disease O 0 7.959561343362509e-10
models O 0 6.808186236995084e-10
. O 0 2.0044714776901174e-09
. O 0 1.7657214357313933e-08

Oral O 0 4.034961239085533e-05
contraceptives O 0 3.970740635850234e-06
and O 0 8.73707911575039e-11
the O 0 5.089175747485797e-10
risk O 0 4.6069618520050426e-07
of O 0 0.011365159414708614
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.508280274720164e-05

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 0 0.00010726442269515246
Study O 0 9.124244826352879e-08
Group O 0 1.1758488627222619e-09
. O 0 2.938208121250341e-09

BACKGROUND O 0 9.258608042728156e-05
Women O 0 2.042271907143345e-09
with O 0 3.3128372007446005e-12
mutations O 0 1.0311872883361772e-10
in O 0 4.138889231342091e-11
either O 0 9.760222630106341e-10
the O 0 1.7610766178677295e-08
BRCA1 O 0 4.852056534332405e-08
or O 0 1.1317802250943032e-09
the O 0 2.0811196321801617e-08
BRCA2 O 0 2.317188574352258e-08
gene O 0 1.9760897779219633e-11
have O 0 7.455998709063327e-13
a O 0 4.4988052996450256e-13
high O 0 6.551403863852556e-10
lifetime O 0 2.9032294346365006e-09
risk O 0 9.732161032616204e-08
of O 0 0.00023951620096340775
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.0150810087216087e-06

Oral O 1 0.9294469356536865
contraceptives O 1 0.9998348951339722
protect O 0 2.257440246467013e-05
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 6.6457994662982856e-09
general O 0 3.456007036106712e-08
, O 0 1.4411982024453707e-11
but O 0 4.795061483292562e-12
it O 0 1.9079902317375302e-13
is O 0 4.464074035014261e-14
not O 0 2.308950285741934e-13
known O 0 1.1214753951882539e-11
whether O 0 8.520095740038869e-11
they O 0 1.532946131144186e-10
also O 0 8.625490946490011e-12
protect O 0 3.190413905285183e-11
against O 0 6.906397120864938e-10
hereditary B-Disease 1 0.9957230091094971
forms I-Disease 1 1.0
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 8.582888000319144e-08

METHODS O 0 2.636383442222723e-06
We O 0 1.607471489251111e-08
enrolled O 0 3.896194655794716e-08
207 O 0 4.988593538257646e-09
women O 0 3.031121534324832e-11
with O 0 4.270556824836902e-11
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 3.2857433440725003e-10
161 O 0 1.1434821978184573e-09
of O 0 6.266829832846099e-10
their O 0 5.729354324301994e-09
sisters O 0 6.924193662882772e-09
as O 0 2.0999407074340226e-11
controls O 0 1.8088031072949207e-10
in O 0 4.978142897904547e-11
a O 0 1.6951466272341342e-11
case O 0 3.919343072311676e-09
- O 0 9.400454636931954e-09
control O 0 1.0086274038201282e-08
study O 0 5.413515746788278e-10
. O 0 7.647864008752947e-10

All O 0 1.0576903264336579e-07
the O 0 8.172570176157024e-09
patients O 0 4.049792057259083e-09
carried O 0 3.153954181156493e-11
a O 0 1.9675290043041915e-12
pathogenic O 0 8.657000449829866e-09
mutation O 0 1.2813020866531133e-08
in O 0 1.6117873702370389e-09
either O 0 1.930578186204457e-08
BRCA1 O 0 2.7443077144084782e-08
( O 0 3.356250824135265e-12
179 O 0 5.201861164039201e-09
women O 0 2.5771051959111446e-11
) O 0 3.0382914066595657e-12
or O 0 1.260568427419173e-09
BRCA2 O 0 3.8350074760273856e-07
( O 0 6.222695969615444e-11
28 O 0 1.7937537677426008e-07
women O 0 3.410662308134249e-10
) O 0 2.4299505116398556e-11
. O 0 4.0338958839925e-09

The O 0 1.1990209713985678e-07
control O 0 1.9466886769237135e-08
women O 0 6.84960282937297e-11
were O 0 2.6458894103464914e-11
enrolled O 0 1.0765439234505791e-10
regardless O 0 5.4338297750256004e-11
of O 0 6.922826201183341e-11
whether O 0 3.579710833312433e-11
or O 0 8.444734495016704e-11
not O 0 1.868763893630998e-10
they O 0 2.0733165184694258e-10
had O 0 3.135655346486743e-10
either O 0 4.320381830069664e-09
mutation O 0 7.649647137952797e-09
. O 0 1.1698944035742898e-08

Lifetime O 0 1.0530507097428199e-05
histories O 0 1.504464421486773e-06
of O 0 1.467094250529044e-07
oral O 0 8.071005140664056e-06
- O 0 1.233604081107842e-07
contraceptive O 0 6.655734097193999e-08
use O 0 2.223350149821446e-11
were O 0 1.982727003413398e-11
obtained O 0 7.52510900814407e-12
by O 0 8.996641973069153e-12
interview O 0 1.1323082228786863e-11
or O 0 9.395255840677352e-13
by O 0 1.308773402153296e-12
written O 0 7.657869130484052e-12
questionnaire O 0 1.074930682659625e-11
and O 0 8.340039813273248e-13
were O 0 4.1305431297544715e-12
compared O 0 1.5321063862039352e-11
between O 0 1.668331098270137e-11
patients O 0 2.9176012716902733e-09
and O 0 2.8242002486633666e-11
control O 0 4.833524691605362e-09
women O 0 2.074885922798142e-11
, O 0 4.810779053766867e-13
after O 0 1.9954097402186122e-11
adjustment O 0 1.1595592264157517e-09
for O 0 4.232465940223751e-12
year O 0 1.7178654332372645e-11
of O 0 1.4691166339009243e-10
birth O 0 2.9154945124787446e-08
and O 0 3.358963385213798e-10
parity O 0 7.918864497469258e-08
. O 0 1.2169802943162722e-08

RESULTS O 0 2.225554908363847e-06
The O 0 1.0412303907969545e-08
adjusted O 0 1.882184221813077e-07
odds O 0 5.726690801566292e-07
ratio O 0 2.6713041734183207e-07
for O 0 4.1722810806277266e-07
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 7.164978388374266e-09
with O 0 1.7360939075228288e-11
any O 0 1.920304193436806e-10
past O 0 3.133795722920496e-10
use O 0 3.66706248700055e-11
of O 0 4.437114009547827e-10
oral O 0 2.1056156640497647e-07
contraceptives O 0 1.5042046186408697e-07
was O 0 1.780679603768931e-09
0 O 0 7.080301678286105e-09
. O 0 1.268861793413123e-09

5 O 0 1.3282199233799474e-06
( O 0 4.864515457114749e-10
95 O 0 4.570752594190708e-07
percent O 0 1.4975769957459306e-08
confidence O 0 1.3286459932260186e-08
interval O 0 1.9420445251938645e-09
, O 0 6.725179441113838e-12
0 O 0 6.497912624636726e-11
. O 0 5.096394768873413e-13
3 O 0 6.85940497111015e-12
to O 0 1.7499430723932896e-12
0 O 0 2.0975840508974386e-10
. O 0 2.3550316211040645e-11
8 O 0 7.278611602323792e-10
) O 0 3.053595570845502e-11
. O 0 2.0849646453768855e-09

The O 0 2.8046440547768725e-07
risk O 0 4.399172226499104e-08
decreased O 0 1.3880285365530654e-08
with O 0 5.026762860127487e-12
increasing O 0 8.393893219382775e-11
duration O 0 1.3044687552365986e-09
of O 0 1.3951963195868444e-10
use O 0 4.158452193703255e-10
( O 0 3.8496879295468744e-11
P O 0 5.595013590209419e-07
for O 0 6.892838383398825e-11
trend O 0 1.5972810851749841e-09
, O 0 6.151225904506286e-13
< O 0 3.775221107948923e-11
0 O 0 1.4569911249706635e-11
. O 0 3.9208377213342804e-13
001 O 0 7.808271390574717e-11
) O 0 1.2363630017236775e-14
; O 0 4.90440682314984e-14
use O 0 1.4864014966781136e-12
for O 0 6.628951294135321e-12
six O 0 4.164339706402842e-11
or O 0 1.5327699179334964e-11
more O 0 1.4202642967947599e-12
years O 0 4.6594976141345334e-12
was O 0 7.917641368926365e-12
associated O 0 1.7242403685391317e-11
with O 0 1.2980162734585465e-12
a O 0 2.5743197504257687e-11
60 O 0 3.091413514066943e-10
percent O 0 1.1981796631255204e-11
reduction O 0 9.541385459499452e-10
in O 0 9.491325503319104e-10
risk O 0 7.214183739279179e-08
. O 0 4.023908317662972e-08

Oral O 0 0.022272329777479172
- O 0 0.00016214272181969136
contraceptive O 0 0.00010056313476525247
use O 0 5.135193958949458e-08
protected O 0 0.0009085061028599739
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 4.3275877326109935e-10
for O 0 8.04860171566002e-12
carriers O 0 6.003308961055609e-11
of O 0 3.3869548832221597e-10
the O 0 1.4354576416408804e-09
BRCA1 O 0 3.6922760404678456e-09
mutation O 0 5.27837461239411e-11
( O 0 3.7095063891261215e-13
odds O 0 1.0267757755144657e-09
ratio O 0 7.487544612105879e-11
, O 0 5.31242638854984e-13
0 O 0 6.346247746064071e-12
. O 0 2.8002903815216307e-13
5 O 0 4.16175687661946e-12
; O 0 8.08612725389235e-13
95 O 0 5.078434561767153e-09
percent O 0 5.746927933536483e-10
confidence O 0 4.975136413953862e-10
interval O 0 3.91172344516022e-10
, O 0 5.4016899460329615e-12
0 O 0 6.164445343070923e-11
. O 0 1.849870734024761e-12
3 O 0 1.523751090581893e-11
to O 0 3.0160045468019536e-12
0 O 0 1.0772361475064329e-10
. O 0 6.815182099217942e-12
9 O 0 1.8035906101943056e-10
) O 0 3.652657874515103e-13
and O 0 7.943609420420217e-13
for O 0 5.122454110190189e-13
carriers O 0 4.0272420814835286e-11
of O 0 1.996236786983019e-10
the O 0 1.879521960290731e-08
BRCA2 O 0 1.0104397318855263e-07
mutation O 0 1.3997869530157914e-09
( O 0 4.132348109531225e-12
odds O 0 7.550870151362687e-09
ratio O 0 4.702796485567262e-10
, O 0 1.1285193699667184e-12
0 O 0 2.0067838016335493e-11
. O 0 5.584178410476814e-13
4 O 0 2.0067721789862603e-11
; O 0 2.6208200106653257e-12
95 O 0 1.4347385501878307e-08
percent O 0 1.4975675144413003e-09
confidence O 0 1.5623825566635219e-09
interval O 0 6.881387126789207e-10
, O 0 3.5053860855671637e-12
0 O 0 4.859467689355412e-11
. O 0 1.0127120496361552e-12
2 O 0 1.186395252872341e-11
to O 0 1.2736413486369447e-12
1 O 0 1.3544725063763252e-10
. O 0 1.5879660433815168e-11
1 O 0 1.1836750468674495e-09
) O 0 2.0834479974585207e-11
. O 0 4.2615049267169525e-09

CONCLUSIONS O 0 0.002010706812143326
Oral O 0 0.003007229184731841
- O 0 9.671452971815597e-07
contraceptive O 0 1.9425608854817256e-07
use O 0 1.3793015340990422e-11
may O 0 6.650357348148006e-11
reduce O 0 1.474678296142784e-10
the O 0 1.3528819731156716e-10
risk O 0 6.589469592199748e-08
of O 0 0.004252954851835966
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.2009171435067856e-09
women O 0 1.1539534518906214e-12
with O 0 3.089550642230987e-14
pathogenic O 0 1.3038194968117978e-09
mutations O 0 1.278386840830592e-09
in O 0 2.8696561793495334e-10
the O 0 2.008038890721764e-08
BRCA1 O 0 4.5405835180645227e-07
or O 0 1.4430602846005058e-07
BRCA2 O 0 4.043422450195067e-06
gene O 0 1.3027914746999159e-07

A O 0 7.677467550593065e-08
Japanese O 0 6.777614771635854e-07
family O 0 9.346832197110189e-10
with O 0 2.179275093716626e-10
adrenoleukodystrophy B-Disease 1 1.0
with O 0 7.884510266897848e-10
a O 0 3.8759409570765513e-10
codon O 0 8.944405038846526e-08
291 O 0 7.957591030560707e-09
deletion O 0 2.0747406570542637e-10
: O 0 3.874840986267669e-13
a O 0 2.2508908528295207e-13
clinical O 0 6.546054670542034e-11
, O 0 8.548508038594416e-13
biochemical O 0 1.925815418246657e-08
, O 0 4.833354202982143e-11
pathological O 0 0.018016697838902473
, O 0 3.94298260708581e-10
and O 0 9.114861643233496e-10
genetic O 0 3.403075865548999e-08
report O 0 3.204547738278052e-09
. O 0 9.235709086397037e-08

We O 0 5.259747304364737e-09
report O 0 5.822070603400675e-11
a O 0 1.7788640569241232e-12
Japanese O 0 1.4836534223405806e-09
family O 0 3.8692764270376045e-11
with O 0 1.1961935608706398e-10
adrenoleukodystrophy B-Disease 1 1.0
( O 0 5.010834911445272e-07
ALD B-Disease 1 1.0
) O 0 4.8712159306241176e-11
with O 0 2.4878111723469765e-12
a O 0 8.361244856203154e-12
three O 0 9.13087834508719e-12
base O 0 2.8083554926006116e-10
pair O 0 7.30524585268455e-10
deletion O 0 9.272538292748322e-10
( O 0 8.338215534697824e-12
delGAG O 0 1.3881879112886963e-07
291 O 0 2.400960763537796e-09
) O 0 1.783368700110366e-12
in O 0 5.64648570955395e-11
the O 0 1.950301076192318e-08
ALD B-Disease 1 1.0
gene O 0 3.5658938486449188e-06
. O 0 1.5969870901244576e-06

A O 0 3.828985200016177e-07
variety O 0 1.0344623824209975e-08
of O 0 3.123259206816442e-09
phenotypes O 0 1.8625709685693437e-07
were O 0 6.153734743996608e-10
observed O 0 1.6378744194245343e-10
within O 0 9.103459652770596e-11
this O 0 5.426352076010055e-11
family O 0 3.3186337011770206e-10
. O 0 6.777871597307694e-09

While O 0 1.2910190250181586e-08
the O 0 3.6135479053456265e-09
proband O 0 3.448643474257551e-05
( O 0 6.657036033530517e-10
patient O 0 3.8056600715208333e-06
1 O 0 2.0123790633874705e-08
) O 0 2.8822807855710675e-12
was O 0 4.722202628926198e-10
classified O 0 8.486429892151648e-10
as O 0 1.4985211682638777e-10
having O 0 7.040487637333115e-11
a O 0 4.294847897462484e-12
rare O 0 8.015805380567897e-11
intermediate O 0 2.0018591229131744e-08
type O 0 1.7239395466717156e-09
of O 0 1.514249725609318e-09
adult O 0 8.055310196652954e-09
cerebral O 0 3.540819548675245e-08
and O 0 2.116053776646254e-09
cerebello O 0 2.429101732559502e-05
- O 0 1.6969013358902885e-06
brain O 0 4.640814381673408e-07
stem O 0 1.64806994717992e-08
forms O 0 1.1480233430560816e-09
, O 0 3.989890882960534e-12
his O 0 8.0473322450203e-11
younger O 0 1.5094865801756896e-08
brother O 0 1.919518766158035e-08
( O 0 5.7790300322935195e-12
patient O 0 1.1044714476327044e-08
2 O 0 1.2090987933088826e-10
) O 0 2.919599241188453e-13
and O 0 2.498345107182498e-11
nephew O 0 1.0260342833134928e-06
( O 0 1.1991588277915355e-10
patient O 0 2.5420255042263307e-05
3 O 0 1.9352231817038046e-08
) O 0 6.014904720130776e-12
had O 0 1.0286708290729862e-10
a O 0 5.80963777085941e-10
childhood O 0 1.924222851812374e-05
ALD B-Disease 1 1.0
type O 1 0.9768060445785522
. O 0 6.805803877796279e-06

Another O 0 4.027678812690283e-07
nephew O 0 0.0002526986936572939
( O 0 1.313952835424459e-09
patient O 0 2.167332468161476e-06
4 O 0 5.605489850069034e-09
) O 0 1.5991718583033276e-12
of O 0 4.4238721019773664e-10
patient O 0 1.883607751551608e-06
1 O 0 5.771705602342081e-08
was O 0 6.526384987992628e-10
classified O 0 5.197921537636319e-10
as O 0 1.629162915683935e-10
having O 0 2.390486142367365e-10
an O 0 1.000341563056617e-11
adolescent O 0 7.973954829765262e-09
form O 0 1.8278544233751859e-09
. O 0 4.016639110204778e-08

The O 0 4.403143094577899e-08
tau O 0 1.5209426607043497e-08
level O 0 1.7738049917781495e-09
in O 0 1.2727824003078148e-11
the O 0 6.356815074326505e-11
cerebrospinal O 0 6.749283798512806e-09
fluid O 0 9.765928865590467e-08
( O 0 2.758905603972295e-10
CSF O 0 3.343822072565672e-06
) O 0 1.2738704188719474e-11
in O 0 1.3393520736926234e-09
patient O 0 0.00157437683083117
1 O 0 6.523995352836209e-07
was O 0 2.264201803825472e-08
as O 0 7.487962472296772e-10
high O 0 1.198499166576994e-08
as O 0 1.998505310893406e-12
that O 0 2.4885916081757858e-14
of O 0 5.809732035733095e-12
patients O 0 8.301376808184102e-10
with O 0 1.4406100444508407e-11
Alzheimers B-Disease 1 0.9999998807907104
disease I-Disease 0 3.29219619743526e-05
( O 0 6.165892102449888e-11
AD B-Disease 0 2.8955835773558647e-07
) O 0 2.4079441218738395e-10
. O 0 1.140420469170067e-08

His O 0 1.4366521554620704e-06
brain O 0 3.4685118066590803e-07
magnetic O 0 3.271090065481985e-07
resonance O 0 7.662185907975072e-07
image O 0 9.437860057914804e-07
( O 0 2.8216080583121084e-09
MRI O 1 0.998651921749115
) O 0 1.0667476901815576e-09
showed O 0 3.493817013477951e-09
abnormalities B-Disease 0 1.942404814769816e-08
in I-Disease 0 6.323366830152111e-11
the I-Disease 0 3.316558139232484e-10
bilateral I-Disease 0 2.0767376554431394e-05
cerebellar I-Disease 1 1.0
hemispheres I-Disease 1 0.991168737411499
and O 0 1.2850496489136276e-07
brain O 0 7.574529803378027e-08
stem O 0 5.8398259561442956e-09
, O 0 1.375286711770285e-12
but O 0 1.5220510398913922e-12
not O 0 1.9747699569333532e-12
in O 0 1.0715571659158929e-11
the O 0 2.739481731739435e-11
cerebral O 0 4.352473048641059e-09
white O 0 4.459034530501782e-11
matter O 0 2.5235857847860643e-10
, O 0 1.6370130077880685e-13
where O 0 1.3224760642051997e-13
marked O 0 1.209910123478597e-11
reductions O 0 4.362130656687668e-09
of O 0 3.532999004463022e-09
the O 0 1.670008131782197e-08
cerebral O 0 2.139222260666429e-06
blood O 0 7.507711075049883e-07
flow O 0 1.4639132928095933e-07
and O 0 7.591908768311839e-10
oxygen O 0 2.360854800542711e-08
metabolism O 0 7.202359597613395e-08
were O 0 3.531097358955293e-10
clearly O 0 4.9581481281757434e-11
demonstrated O 0 1.8286164249481374e-11
by O 0 1.3287250640037218e-11
positron O 0 8.780008897701919e-08
emission O 0 7.806254984643601e-07
tomography O 0 4.151397661189549e-06
( O 0 1.2666202531264048e-09
PET O 0 1.0753715287137311e-05
) O 0 1.6177338635348093e-10
. O 0 3.512995006005326e-09

In O 0 1.0006774431303711e-07
patients O 0 7.246826498885639e-07
2 O 0 1.895477375057908e-08
and O 0 1.6677402514542194e-10
3 O 0 2.026185441650341e-09
, O 0 1.5327339007373264e-12
the O 0 7.273234098326142e-12
autopsy O 0 8.611498181210209e-09
findings O 0 4.612621395949645e-09
showed O 0 4.884113113945432e-10
massive O 0 1.1501455787765735e-08
demyelination B-Disease 1 1.0
of I-Disease 0 0.11081978678703308
the I-Disease 0 3.486140940367477e-07
cerebral I-Disease 0 3.922045266335772e-07
white I-Disease 0 1.472845456707006e-10
matter I-Disease 0 9.445594306711769e-11
with O 0 7.586566466190325e-14
sparing O 0 5.6552595939507455e-11
of O 0 2.4845572266229965e-09
the O 0 4.924349639168213e-08
U O 0 0.00010033287253463641
- O 0 3.0881935231263924e-07
fibers O 0 6.63901076336515e-08
, O 0 4.9118379502610665e-11
compatible O 0 1.092736678920403e-09
with O 0 5.316684050481191e-13
the O 0 6.687597958049407e-12
findings O 0 1.803573540515302e-10
of O 0 5.77258019163196e-10
childhood O 0 2.9489697226381395e-06
ALD B-Disease 1 1.0
. O 0 1.2164800864411518e-05

Oleic O 0 0.003507077693939209
and O 0 6.221553690011206e-07
erucic O 0 0.0035138435196131468
acids O 0 1.6027834135456942e-06
( O 0 5.58177004617022e-10
Lorenzos O 0 6.775916062906617e-06
Oil O 0 8.845714916105862e-08
) O 0 5.75680692352365e-12
were O 0 5.548849921210852e-11
administered O 0 6.818721975943021e-11
to O 0 4.3845146263654655e-11
patients O 0 8.287332597944896e-09
1 O 0 4.4679353550236556e-09
and O 0 1.293620627285108e-10
4 O 0 3.2527964766160267e-09
, O 0 2.197333027337267e-12
but O 0 3.7330728785978096e-12
sufficient O 0 3.828491412782853e-10
effectiveness O 0 1.3970344880931407e-09
was O 0 2.402251175759318e-10
not O 0 3.3953229117145156e-11
obtained O 0 1.8997436956880165e-09
. O 0 1.9405124618288028e-08

The O 0 2.1325216437162453e-07
findings O 0 2.8471154323028713e-08
in O 0 3.2284416806582783e-10
this O 0 5.693822843766405e-11
family O 0 2.1692671964279597e-11
suggest O 0 1.484161404885498e-11
that O 0 1.8313719681375962e-13
delGAG291 O 0 7.385373201884704e-09
is O 0 3.192713021044069e-12
part O 0 8.720792317451487e-12
of O 0 6.011662001537132e-11
the O 0 8.953131291900007e-11
cause O 0 1.5187330282273592e-09
of O 0 4.626137251051432e-09
Japanese O 0 2.1136678697075695e-05
ALD B-Disease 1 1.0
with O 0 2.5595070507478113e-09
phenotypic O 0 5.816772841171769e-07
variations O 0 6.785273399145808e-06
. O 0 2.4252597086160677e-07

Moreover O 0 5.77639582388656e-07
, O 0 7.906914706312662e-11
although O 0 3.923714825271318e-11
the O 0 1.1216294386329206e-11
scale O 0 2.264580745148237e-09
of O 0 2.475143423552595e-10
the O 0 9.258147720681009e-11
study O 0 1.4919836199833725e-11
is O 0 5.260416126133538e-14
limited O 0 5.8439516247010825e-12
, O 0 4.907085480142237e-13
there O 0 1.0365341397700067e-12
is O 0 4.41245510181959e-13
a O 0 2.5363996927069143e-12
possibility O 0 2.147573674449177e-09
that O 0 2.766973872248002e-10
PET O 1 0.9991389513015747
can O 0 6.623653625581483e-09
detect O 0 4.3587235154518567e-07
an O 0 2.1124958726748133e-10
insidious B-Disease 0 9.902460442390293e-05
lesion I-Disease 0 0.0028640085365623236
which O 0 2.2251926690142199e-10
is O 0 5.48001878250548e-12
undetectable O 0 1.969445717620033e-10
by O 0 1.0848419385034447e-11
computed O 0 4.162963662679431e-08
tomogram O 0 1.1388690836611204e-05
( O 0 1.8032639270693096e-10
CT O 0 3.0359046832018066e-06
) O 0 9.79770344716746e-12
or O 0 1.614906125491089e-11
MRI O 0 4.327757352484696e-08
analysis O 0 1.2075724101223706e-11
, O 0 1.8753891668776834e-12
and O 0 7.012122002839072e-13
that O 0 7.160383532845219e-14
the O 0 1.0682472267875553e-11
higher O 0 7.243338151496914e-10
level O 0 2.18523144024374e-10
of O 0 1.685162773212845e-11
tau O 0 1.0145652373783065e-10
reflects O 0 2.3978508414956856e-11
the O 0 6.266377390942712e-13
process O 0 7.742911867225644e-11
of O 0 9.875197326536522e-10
neuronal B-Disease 0 5.390395381255075e-05
degeneration I-Disease 1 0.9999997615814209
in O 0 3.1123242933972506e-06
ALD B-Disease 1 1.0
. O 0 6.725026196363615e-06

Lorenzos O 0 0.0001576292997924611
Oil O 0 2.625218655794015e-07
should O 0 5.1972943310163444e-11
be O 0 1.5281363414249016e-12
given O 0 8.430744817544689e-12
in O 0 2.7094448646486358e-12
the O 0 1.2888519244913521e-11
early O 0 1.5535362996033086e-09
stage O 0 2.615340832790025e-09
. O 0 1.235521546183449e-10
. O 0 3.2571423336236194e-09

Nonsense O 0 7.061537417030195e-06
mutation O 0 5.866970198553645e-08
in O 0 1.4557203220633141e-09
exon O 0 8.884334334879895e-08
4 O 0 3.3179898828450405e-09
of O 0 1.5165929623250918e-10
human O 0 3.2170086039506884e-10
complement O 0 1.22987330541946e-07
C9 O 1 0.9999983310699463
gene O 0 8.22340417983014e-09
is O 0 4.380917937446549e-12
the O 0 9.372547009334209e-12
major O 0 1.850253561475057e-10
cause O 0 2.765860318554303e-10
of O 0 3.2044056297309e-10
Japanese O 0 8.570411864639027e-07
complement B-Disease 0 1.8482067389413714e-05
C9 I-Disease 1 1.0
deficiency I-Disease 0 0.22737623751163483
. O 0 8.099976298581169e-07

Deficiency B-Disease 0 0.019783973693847656
of I-Disease 0 1.9683002392412163e-06
the I-Disease 0 2.4987022584355145e-07
ninth I-Disease 0 6.325851700239582e-06
component I-Disease 0 2.6849070877688064e-07
of I-Disease 0 3.695533123959649e-08
human I-Disease 0 4.0660150801841155e-09
complement I-Disease 0 1.3801807199342875e-06
( O 0 7.232073828689067e-10
C9 O 1 0.9999576807022095
) O 0 7.0993176615186115e-12
is O 0 5.457517033777282e-13
the O 0 1.421337440105086e-12
most O 0 4.830789414322911e-12
common O 0 1.3632238449190481e-08
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 3.826967187592345e-09
Japan O 0 2.946008548221357e-09
but O 0 1.937972178567282e-11
is O 0 1.4018609406987736e-12
rare O 0 2.7199209898243204e-11
in O 0 9.97810948449862e-12
other O 0 6.937895397074456e-11
countries O 0 1.3294482181791523e-10
. O 0 7.870195162240634e-09

We O 0 1.907881408413914e-09
studied O 0 4.130444875016792e-10
the O 0 7.193477150752026e-12
molecular O 0 9.560927743956782e-11
basis O 0 7.268248780611941e-10
of O 0 3.8225994813956277e-08
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9999983310699463
in O 0 1.0594282784381903e-08
four O 0 9.535468248333956e-11
Japanese O 0 5.07996773535524e-08
C9 B-Disease 1 1.0
- I-Disease 0 0.1209377646446228
deficient I-Disease 0 0.1297328770160675
patients O 0 0.005206169094890356
who O 0 3.1293517777086777e-10
had O 0 4.3937423144235765e-10
suffered O 0 1.1331572125072853e-07
from O 0 3.5780960843112553e-06
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 2.4672237941558706e-06

Direct O 0 8.57871427228929e-08
sequencing O 0 1.0439611486390277e-07
of O 0 2.1248879988888802e-08
amplified O 0 7.935676080705889e-07
C9 O 0 0.00024268939159810543
cDNA O 0 5.3779636743911396e-08
and O 0 9.016418167639983e-11
DNA O 0 9.174285775515045e-10
revealed O 0 3.727655129015517e-10
a O 0 1.7960613898915234e-11
nonsense O 0 3.011353166826325e-09
substitution O 0 5.169609806898734e-08
( O 0 3.35737965206917e-11
CGA O 0 2.733900750229168e-08
- O 0 3.7137475317194912e-09
- O 0 2.0308399406587796e-09
> O 0 3.1641764763890023e-09
TGA O 0 3.33016458853308e-08
) O 0 1.42590193125125e-12
at O 0 1.51337900544668e-11
codon O 0 2.507335450374626e-10
95 O 0 2.4209965143739964e-09
in O 0 1.4935104541979882e-10
exon O 0 8.34623126166889e-09
4 O 0 2.205284621581427e-09
in O 0 9.290927055483067e-11
the O 0 1.0342487977155201e-09
four O 0 1.2314097519450229e-09
C9 B-Disease 1 1.0
- I-Disease 0 0.0008194743422791362
deficient I-Disease 0 1.7170681530842558e-05
individuals O 0 3.2193918642065e-09
. O 0 2.473588445184305e-08

An O 0 1.5975371026044627e-09
allele O 0 8.377523563751765e-09
- O 0 1.8174912685964273e-09
specific O 0 6.944650965401422e-10
polymerase O 0 3.7128196073155095e-09
chain O 0 5.149931592285384e-10
reaction O 0 7.169663751582789e-10
system O 0 3.489368349818278e-09
designed O 0 2.10494333074962e-09
to O 0 2.4493371220124516e-10
detect O 0 1.0866614275073516e-09
exclusively O 0 2.865820254716045e-11
only O 0 3.820725420072835e-12
one O 0 5.333544478465513e-13
of O 0 7.247573634988624e-12
the O 0 2.147231524529669e-11
normal O 0 8.665916872985235e-10
and O 0 2.569350635028833e-11
mutant O 0 4.563804612001121e-10
alleles O 0 1.5759841348605974e-11
indicated O 0 6.375660416280127e-11
that O 0 3.590566158197944e-13
all O 0 3.338705614058801e-12
the O 0 1.1252357552671288e-11
four O 0 1.3008443064052577e-12
patients O 0 3.819882257727336e-11
were O 0 7.079156705280809e-12
homozygous O 0 1.0643342110427945e-11
for O 0 4.196934900307925e-12
the O 0 1.3910537999262118e-10
mutation O 0 1.4733793352039726e-10
in O 0 7.898146581197807e-10
exon O 0 2.1725911736325543e-08
4 O 0 3.921070579337993e-09
and O 0 5.84386228644207e-12
that O 0 1.0946765141486153e-13
the O 0 1.9725686362104256e-11
parents O 0 1.7696096324404387e-11
of O 0 5.952888182392257e-11
patient O 0 1.8254851852361753e-07
2 O 0 1.720990105980036e-08
were O 0 2.6307804823488823e-09
heterozygous O 0 7.295781312421923e-09
. O 0 3.534124548565387e-09

The O 0 5.1074042772825123e-08
common O 0 1.6064477748045647e-08
mutation O 0 1.4256349434305093e-09
at O 0 4.864774694190999e-10
codon O 0 7.908973920223161e-09
95 O 0 3.6462701302752976e-08
in O 0 1.8246290034440449e-09
exon O 0 4.0634354547819385e-08
4 O 0 2.1680119921541063e-09
might O 0 3.271858478592904e-11
be O 0 1.529398894854761e-12
responsible O 0 1.200439660870023e-11
for O 0 1.29162531364857e-11
most O 0 6.650107131633831e-10
Japanese O 0 9.055715963768307e-06
C9 B-Disease 1 1.0
deficiency I-Disease 0 0.0002872010809369385
. O 0 1.775742042298134e-08
. O 0 2.4351784588816372e-08

BRCA1 O 0 6.632075155721395e-07
required O 0 2.1290449403466027e-09
for O 0 3.4252523040123606e-10
transcription O 0 1.3894212997911382e-06
- O 0 1.3843146007275209e-06
coupled O 0 3.9398814806190785e-06
repair O 0 2.929527681772015e-06
of O 0 5.0538837115254864e-08
oxidative O 0 2.3114178475225344e-05
DNA O 0 1.024395623971941e-05
damage O 0 0.00021232639846857637
. O 0 4.178930623766064e-07

The O 0 1.944076757354196e-05
breast B-Disease 1 1.0
and I-Disease 1 0.9999905824661255
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 0.00855403020977974
gene O 0 1.0607086409208932e-07
BRCA1 O 0 1.5238093453717738e-07
encodes O 0 1.4237157286434154e-10
a O 0 5.570015282341245e-11
zinc O 0 3.952933624873367e-08
finger O 0 7.2262031913794544e-09
protein O 0 3.825047834027373e-09
of O 0 3.245124613471262e-09
unknown O 0 3.7996432666886903e-08
function O 0 2.790512487749197e-09
. O 0 3.793811931274149e-09

Association O 0 1.568056404721574e-07
of O 0 2.8884890923563944e-08
the O 0 7.884036534733241e-08
BRCA1 O 0 7.674316293559968e-09
protein O 0 4.994608615582763e-10
with O 0 2.479540010813519e-12
the O 0 1.4330141240304073e-10
DNA O 0 2.4242450269440496e-09
repair O 0 1.287701962837673e-07
protein O 0 8.367658210772788e-08
Rad51 O 0 5.119825345900608e-07
and O 0 6.981915046111453e-11
changes O 0 8.57911033880221e-11
in O 0 6.528967904512184e-12
the O 0 2.1612705115164887e-12
phosphorylation O 0 8.810090157407302e-11
and O 0 1.823531256550659e-11
cellular O 0 7.16118692123402e-11
localization O 0 3.5958780397749024e-09
of O 0 4.3700731922058367e-10
the O 0 2.168838025840003e-10
protein O 0 4.926609120659009e-10
after O 0 3.034103190913129e-09
exposure O 0 1.5351888649206558e-08
to O 0 8.902013848288703e-11
DNA O 0 7.874880303404552e-09
- O 0 1.6182994944102802e-09
damaging O 0 6.333041646655602e-09
agents O 0 1.2717031594444705e-10
are O 0 4.252809909788269e-12
consistent O 0 2.6354987636700855e-11
with O 0 8.593754370232395e-14
a O 0 7.774276556717086e-13
role O 0 3.331748071877527e-11
for O 0 4.048191781791388e-10
BRCA1 O 0 6.180547984513396e-08
in O 0 1.4158658689922277e-09
DNA O 0 3.917521951279923e-07
repair O 0 0.00023338249593507499
. O 0 1.1230351901758695e-06

Here O 0 1.9425850439347414e-07
, O 0 1.907185520622079e-10
it O 0 3.755784312026167e-12
is O 0 1.7287937574550494e-12
shown O 0 7.399744011982179e-12
that O 0 6.742492848765824e-12
mouse O 0 1.758726853040571e-08
embryonic O 0 1.0362880402681185e-06
stem O 0 1.8656002964689833e-07
cells O 0 5.9292819543088626e-08
deficient B-Disease 0 8.313727306585861e-08
in I-Disease 0 3.738420684129551e-10
BRCA1 I-Disease 0 1.150948114592154e-09
are O 0 1.0602570254050758e-12
defective O 0 1.5791180585367215e-09
in O 0 7.082968933591616e-11
the O 0 2.3455651310122505e-10
ability O 0 5.038908526544539e-11
to O 0 2.818636123114171e-11
carry O 0 4.112074569739832e-10
out O 0 5.2142932333021363e-11
transcription O 0 3.1670460032273695e-08
- O 0 3.831453554425934e-08
coupled O 0 4.5367656298367365e-07
repair O 0 1.1594954685278935e-06
of O 0 6.824024456619782e-09
oxidative O 0 4.5884144128649496e-07
DNA O 0 1.359184807370184e-06
damage O 0 0.00012295774649828672
, O 0 6.964203103088096e-10
and O 0 3.646140889213001e-10
are O 0 1.936310556338583e-10
hypersensitive O 0 2.4812251808725705e-07
to O 0 7.732585127762093e-10
ionizing O 0 1.0518392628000583e-05
radiation O 0 6.0818267229478806e-05
and O 0 6.499824567463008e-10
hydrogen O 0 7.743661711856475e-08
peroxide O 0 1.941473328770371e-06
. O 0 6.47743050308236e-08

These O 0 3.068406329020945e-08
results O 0 3.377288138040058e-08
suggest O 0 1.2063334331458009e-08
that O 0 2.055765696562517e-10
BRCA1 O 0 5.2760977808929965e-08
participates O 0 1.9647219962060092e-10
, O 0 9.307058162350001e-13
directly O 0 4.702101555342786e-12
or O 0 4.621782123681584e-12
indirectly O 0 1.9250852648089456e-11
, O 0 5.236516515544354e-12
in O 0 1.2284438744014636e-10
transcription O 0 6.342775122902822e-07
- O 0 1.1194210856046993e-06
coupled O 0 8.620483640697785e-06
repair O 0 1.4719223599968245e-06
of O 0 9.204086381942034e-09
oxidative O 0 9.064036134986964e-07
DNA O 0 7.304737437152653e-07
damage O 0 3.7389386307040695e-06
. O 0 1.1277404787790601e-08
. O 0 2.029671541947664e-08

Truncation O 0 1.7000818843371235e-05
mutations O 0 9.520942256813214e-08
in O 0 5.611391906690244e-10
the O 0 5.53534384994947e-10
transactivation O 0 3.3431831525376765e-07
region O 0 3.73125619290704e-09
of O 0 4.27854285334206e-09
PAX6 O 0 0.0005446587456390262
result O 0 5.534800351369995e-08
in O 0 7.744160868128347e-09
dominant O 0 2.4205330646509537e-06
- O 0 1.6612818853900535e-07
negative O 0 4.858594593315502e-08
mutants O 0 1.9124590266983432e-07
. O 0 2.323538250692536e-09

PAX6 O 1 0.9224329590797424
is O 0 2.4436221934820423e-09
a O 0 1.0151576107508831e-10
transcription O 0 1.8743167018442364e-08
factor O 0 6.768944071922078e-09
with O 0 1.3857064801170438e-11
two O 0 1.0114559363672004e-11
DNA O 0 7.212883623708422e-10
- O 0 1.34247224448103e-09
binding O 0 2.4775356877171362e-08
domains O 0 1.6398139734974393e-08
( O 0 1.6720392431723852e-11
paired O 0 4.3074119271402367e-10
box O 0 7.164756565813946e-10
and O 0 8.311686755524406e-11
homeobox O 0 8.633865178353517e-09
) O 0 2.4809640019468615e-12
and O 0 1.4471645236324715e-11
a O 0 3.783885704766732e-11
proline O 0 1.7451501577170347e-08
- O 0 5.754283094461243e-08
serine O 0 1.9413494101172546e-06
- O 0 2.0435138594621094e-06
threonine O 0 9.516282943877741e-07
( O 0 2.503378615514862e-10
PST O 0 2.4033293811953627e-05
) O 0 2.0015668289463662e-10
- O 0 7.999089390864356e-09
rich O 0 8.143131502436063e-09
transactivation O 0 3.765076826311997e-06
domain O 0 9.854790761210097e-08
. O 0 4.623581517648745e-08

PAX6 O 1 0.9999997615814209
regulates O 0 0.005719506181776524
eye O 1 0.9999988079071045
development O 0 2.9275252018123865e-06
in O 0 1.5449227452890568e-09
animals O 0 5.517171719482405e-10
ranging O 0 1.387752468495762e-09
from O 0 8.510285531837525e-11
jellyfish O 0 1.0657978943839908e-09
to O 0 3.187058394971132e-10
Drosophila O 0 2.3236591317754574e-08
to O 0 4.683863852328329e-10
humans O 0 1.4065267173180018e-08
. O 0 1.948389893868807e-08

Heterozygous O 0 2.8631450277316617e-06
mutations O 0 3.9586755207210444e-08
in O 0 1.385191961134069e-10
the O 0 4.695975830415478e-10
human O 0 4.5734269704666985e-09
PAX6 O 0 0.42405882477760315
gene O 0 1.4861805119892324e-08
result O 0 3.2732987875760955e-08
in O 0 3.720423968900377e-10
various O 0 4.1747916235124194e-10
phenotypes O 0 1.7194219381622133e-08
, O 0 1.247059747133683e-12
including O 0 2.1270854001775863e-12
aniridia B-Disease 1 1.0
, O 0 4.429844047137976e-09
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 1.6424550608462596e-09
autosomal B-Disease 0 2.1716505216318183e-05
dominant I-Disease 0 5.697203960153274e-05
keratitis I-Disease 1 0.9984082579612732
, O 0 5.951304782314537e-09
and O 0 4.8152344334084773e-08
familial B-Disease 1 0.999997615814209
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 1 0.9994655251502991

It O 0 3.728168884720162e-09
is O 0 2.502031221096601e-11
believed O 0 1.4424136364488138e-11
that O 0 1.31132883956879e-13
the O 0 9.758649617552795e-12
mutated O 0 1.7877409552724544e-09
allele O 0 5.8001523584039205e-09
of O 0 1.02108534960621e-08
PAX6 O 1 0.7916481494903564
produces O 0 3.2229843793807333e-10
an O 0 4.0673408109419273e-13
inactive O 0 1.1992874471289383e-09
protein O 0 4.382167684280347e-10
and O 0 5.707297412449464e-10
aniridia B-Disease 1 1.0
is O 0 7.443151095465339e-10
caused O 0 7.412142899454466e-09
due O 0 1.6900246464501834e-06
to O 0 1.0061027566621306e-08
genetic O 0 2.5947278459170775e-07
haploinsufficiency O 0 0.00010673998622223735
. O 0 5.655812174154562e-07

However O 0 1.1817874110420235e-06
, O 0 1.983825992368793e-09
several O 0 2.92039503690944e-10
truncation O 0 3.137405713005137e-07
mutations O 0 4.859926683309368e-09
have O 0 3.991871763697752e-11
been O 0 1.3395447945319106e-11
found O 0 8.098707251699699e-13
to O 0 2.5540743023126644e-13
occur O 0 5.800884512324744e-12
in O 0 1.142099175649447e-11
the O 0 1.9086265901080424e-10
C O 0 2.986481888456183e-07
- O 0 5.11314934836804e-10
terminal O 0 9.633095210404008e-09
half O 0 9.227631159181016e-11
of O 0 1.085442777326584e-10
PAX6 O 0 2.0581101125571877e-05
in O 0 3.0714600307568674e-10
patients O 0 2.6126036889451143e-09
with O 0 7.507546667673282e-12
Aniridia B-Disease 1 1.0
resulting O 0 1.2760581284965156e-06
in O 0 5.370314415387156e-09
mutant O 0 3.2691731544076674e-09
proteins O 0 3.2534631239089506e-11
that O 0 5.1059516857632214e-12
retain O 0 6.39429620363785e-10
the O 0 1.323194609437195e-10
DNA O 0 9.516195609293732e-10
- O 0 5.121699730992191e-10
binding O 0 2.161508749765062e-09
domains O 0 6.149956655043809e-10
but O 0 1.0510163572785558e-10
have O 0 3.2957529066957036e-11
lost O 0 3.2046745812586153e-10
most O 0 1.0079157560655139e-12
of O 0 6.538264721300813e-12
the O 0 1.947559336024085e-10
transactivation O 0 7.517089670727728e-07
domain O 0 7.25371336329772e-08
. O 0 3.375504320501932e-08

It O 0 1.0608613987272975e-09
is O 0 7.773242119424317e-12
not O 0 1.2762749841341292e-12
clear O 0 2.1081435208625265e-11
whether O 0 2.877189155328641e-12
such O 0 7.659611833688018e-11
mutants O 0 1.7994713061852963e-06
really O 0 4.968898625890006e-09
behave O 0 2.794974807152073e-10
as O 0 3.5526664943219544e-11
loss O 0 2.275421101538555e-10
- O 0 5.331315389156543e-10
of O 0 2.7885811437755592e-09
- O 0 1.1602147687028719e-08
function O 0 2.3472488397402458e-09
mutants O 0 8.41260661132992e-09
as O 0 1.3263322731771332e-11
predicted O 0 1.660275250614518e-10
by O 0 4.169855433167058e-11
haploinsufficiency O 0 6.029083124303725e-06
. O 0 1.129487827711273e-07

Contrary O 0 1.0375063084211433e-06
to O 0 1.5360748784054579e-10
this O 0 4.504055808873808e-11
theory O 0 4.3032695629108275e-08
, O 0 3.2968534152688633e-11
our O 0 1.382439024366633e-10
data O 0 9.922544730311955e-11
showed O 0 2.5195349279139023e-11
that O 0 8.104652474312524e-14
these O 0 3.441116835922742e-11
mutants O 0 1.589510745247935e-08
are O 0 1.4312685758799404e-10
dominant O 0 1.4756927235737294e-08
- O 0 2.1338382172331194e-09
negative O 0 1.6608906472370677e-09
in O 0 1.1312120684614513e-10
transient O 0 6.719637735130846e-09
transfection O 0 8.186252564712504e-09
assays O 0 2.5432100869693386e-09
when O 0 2.33150582173991e-10
they O 0 2.853253917856069e-11
are O 0 1.2967079666970083e-11
coexpressed O 0 1.7820097752974107e-07
with O 0 1.0723019000513645e-10
wild O 0 9.255614941139356e-07
- O 0 5.1072678530772464e-08
type O 0 6.381685579981422e-07
PAX6 O 1 0.9624143242835999
. O 0 6.563666943293356e-07

We O 0 4.363412298147296e-09
found O 0 2.782670101286744e-11
that O 0 8.086436251511508e-13
the O 0 1.6312773354343335e-10
dominant O 0 4.00228884700482e-07
- O 0 1.5650737594796738e-08
negative O 0 3.568561668387815e-09
effects O 0 3.85642318079249e-09
result O 0 7.641943744474133e-10
from O 0 7.489044107078513e-11
the O 0 1.581968236963327e-11
enhanced O 0 2.7645577493906615e-10
DNA O 0 1.7616803571485207e-09
binding O 0 4.0671941370362674e-09
ability O 0 2.5801623060317525e-09
of O 0 2.528814713187444e-09
these O 0 2.1302515307297654e-09
mutants O 0 6.785026585021114e-08
. O 0 1.4361423161801667e-09

Kinetic O 0 2.327772790522431e-06
studies O 0 3.817380633819312e-09
of O 0 1.1565326474283211e-10
binding O 0 7.2974231102307385e-09
and O 0 1.8491855824365189e-09
dissociation O 0 3.336744924808954e-08
revealed O 0 3.750312005390555e-10
that O 0 2.04325339742302e-13
various O 0 1.3823460605355553e-11
truncation O 0 2.1549729112280147e-08
mutants O 0 1.0319300969285905e-08
have O 0 2.0204603615181504e-11
3 O 0 9.736603884258344e-11
- O 0 6.561629711798744e-11
5 O 0 2.3116947245327424e-10
- O 0 1.1485418865975205e-10
fold O 0 6.058260559882456e-10
higher O 0 2.3088932987747057e-09
affinity O 0 9.750542040443122e-11
to O 0 6.967318215422846e-12
various O 0 3.88973610265797e-11
DNA O 0 3.0373964454710745e-10
- O 0 2.386476086191358e-11
binding O 0 5.213139989135307e-11
sites O 0 5.089309182415569e-11
when O 0 4.907762130718085e-12
compared O 0 3.879252127858557e-11
with O 0 5.913454947069352e-13
the O 0 1.7673672247919825e-10
wild O 0 3.638787404725008e-08
- O 0 5.744684283826018e-09
type O 0 1.00613185338716e-07
PAX6 O 0 0.010435991920530796
. O 0 3.6048453466719366e-07

These O 0 3.4590257325106677e-09
results O 0 1.701925822494843e-09
provide O 0 2.3492485734522006e-11
a O 0 1.7361395524342904e-12
new O 0 1.1570842894936817e-10
insight O 0 1.109065894677741e-10
into O 0 2.4208324581054264e-11
the O 0 1.3875816294584009e-11
role O 0 4.134983327963582e-11
of O 0 6.58413656928758e-10
mutant O 0 4.4254551312405965e-07
PAX6 O 1 0.8818209767341614
in O 0 1.3266049592175477e-08
causing O 0 4.3824064732689294e-07
aniridia B-Disease 1 1.0
. O 0 2.2476024241768755e-07
. O 0 7.7925555785896e-08

Reversal O 0 3.3820892895164434e-06
of O 0 2.2778861819006124e-07
severe O 0 0.1064043864607811
hypertrophic B-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
and O 0 1.5154283801166457e-06
excellent O 0 2.344467198156508e-08
neuropsychologic O 0 1.9813998619611084e-07
outcome O 0 6.3990387388912495e-06
in O 0 8.20480750007846e-09
very B-Disease 0 1.1938761090846128e-09
- I-Disease 0 2.1151134177443964e-09
long I-Disease 0 4.5987832986149613e-10
- I-Disease 0 6.441228106446317e-10
chain I-Disease 0 3.4471225873744515e-10
acyl I-Disease 0 6.406350649967862e-08
- I-Disease 0 5.048940820984171e-08
coenzyme I-Disease 0 1.3565815493166156e-07
A I-Disease 0 8.516809657521662e-08
dehydrogenase I-Disease 0 9.175910804515297e-07
deficiency I-Disease 0 4.6724318963242695e-05
. O 0 9.105903586714703e-08

Very B-Disease 0 1.1243319022469223e-06
- I-Disease 0 1.336431409981742e-07
long I-Disease 0 3.337029763628152e-09
- I-Disease 0 6.556529208445738e-10
chain I-Disease 0 1.0649277293328652e-10
acyl I-Disease 0 1.5103555073281427e-09
- I-Disease 0 2.6432578348334346e-10
coenzyme I-Disease 0 2.944074706245914e-10
A I-Disease 0 1.1593485893524047e-10
dehydrogenase I-Disease 0 1.5744315573495982e-10
( I-Disease 0 1.5269048178612188e-11
VLCAD I-Disease 1 0.9999934434890747
) I-Disease 0 2.0000527900521092e-09
deficiency I-Disease 0 6.970161621211446e-07
is O 0 1.2144904006083923e-11
a O 0 2.9755062996850157e-11
disorder O 0 6.816470704507083e-05
of O 0 0.0005093822255730629
fatty O 0 0.21619145572185516
acid O 0 2.0780751128768316e-06
beta O 0 2.0100161535197003e-08
oxidation O 0 7.338445406901428e-09
that O 0 2.809672286496756e-11
reportedly O 0 6.707699951036261e-10
has O 0 6.305270433375199e-13
high O 0 2.6058391555672245e-10
rates O 0 1.2237036384199484e-10
of O 0 1.505295194048628e-11
morbidity O 0 1.3271547061322053e-07
and O 0 1.0546474804584705e-09
mortality O 0 1.912324165687096e-07
. O 0 1.4268816350693214e-08

We O 0 6.514619399489163e-10
describe O 0 1.4354240018832343e-10
the O 0 2.0060527891607727e-11
outcome O 0 5.579909867492461e-09
of O 0 1.4331213993301617e-09
a O 0 8.119978647802562e-12
5 O 0 4.629910690945316e-11
- O 0 8.301051686310235e-12
year O 0 1.1010901912467119e-10
- O 0 1.4263094039179691e-09
old O 0 1.7592167722568774e-08
girl O 0 2.2357102835712794e-09
with O 0 4.4397704263010596e-11
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 2.263890763742893e-08
was O 0 1.0076731671304628e-09
first O 0 6.08411515612417e-11
seen O 0 2.604149673679501e-10
at O 0 1.5917777512752807e-11
5 O 0 8.579515570206198e-12
months O 0 1.0394126965379558e-12
of O 0 3.736413956012541e-12
age O 0 1.2444377472942136e-10
with O 0 8.36100069387391e-13
severe O 0 2.404830752311682e-07
hypertrophic B-Disease 1 0.9999608993530273
cardiomyopathy I-Disease 1 1.0
, O 0 9.54155475483276e-05
hepatomegaly B-Disease 1 1.0
, O 0 7.346791790041607e-06
encephalopathy B-Disease 1 0.5925468802452087
, O 0 2.457256975674227e-08
and O 0 1.1170754277145534e-07
hypotonia B-Disease 1 0.9999845027923584
. O 0 0.0003236489719711244

Biochemical O 0 1.3331169611774385e-05
studies O 0 9.800749012356391e-08
indicated O 0 6.008150376146659e-05
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 8.105701454041991e-06
by O 0 5.049927698230761e-10
a O 0 1.3964608636118925e-10
stable O 0 1.3938389997747436e-07
yet O 0 3.386305991170957e-08
inactive O 0 8.268876285910665e-07
enzyme O 0 2.2925226517145347e-07
. O 0 9.625825470038762e-08

Molecular O 0 1.614606759403614e-08
genetic O 0 1.182779096886577e-09
analysis O 0 1.57983709447862e-10
of O 0 1.625455503528883e-08
her O 0 4.0898488151697165e-08
VLCAD O 1 1.0
gene O 0 1.0516494342027727e-07
revealed O 0 1.910179925346256e-08
a O 0 1.3856120417710116e-10
T1372C O 0 3.251452653785236e-07
( O 0 3.0448657484249964e-11
F458L O 0 3.757124389380806e-08
) O 0 8.458275052580788e-11
missense O 0 1.188329363799312e-07
mutation O 0 3.8650758149572084e-09
and O 0 1.0360647062501727e-10
a O 0 5.999569174797159e-10
1668 O 0 0.0002301426138728857
ACAG O 1 0.9999918937683105
1669 O 0 0.0033658044412732124
splice O 0 3.7392459489637986e-05
site O 0 4.864529614678759e-07
mutation O 0 6.664105001163989e-08
. O 0 2.2552196554670445e-08

After O 0 2.1335061717309145e-07
initial O 0 3.6336280118121067e-07
treatment O 0 8.45077124722593e-07
with O 0 2.343964189410741e-10
intravenous O 0 6.048853862239412e-09
glucose O 0 1.690254514130629e-08
and O 0 5.4690783152233635e-11
carnitine O 0 8.825736252937588e-10
, O 0 3.0569331788132814e-12
the O 0 1.667018328932457e-10
patient O 0 1.9144772522849962e-07
has O 0 1.9236098824926273e-11
thrived O 0 1.8926622491477474e-09
on O 0 3.741145448987737e-10
a O 0 1.7690392553615375e-11
low O 0 8.81008688224938e-08
- O 0 2.9592146510992734e-09
fat O 0 2.7205641117689083e-07
diet O 0 7.66434311572084e-08
supplemented O 0 4.246864804269279e-10
with O 0 5.102797958483896e-12
medium O 0 8.04356901085157e-08
- O 0 1.202746569006763e-09
chain O 0 9.235031073195898e-10
triglyceride O 0 3.2519270121156296e-07
oil O 0 2.875428428694704e-08
and O 0 3.209750173982506e-11
carnitine O 0 3.736555065358971e-09
and O 0 1.9830824482536258e-11
avoidance O 0 2.5362501432368845e-08
of O 0 2.3563371254198273e-09
fasting O 0 4.7072211373233586e-07
. O 0 5.073808750921671e-08

Her O 0 2.400079665676458e-06
ventricular O 0 0.0006935423007234931
hypertrophy O 1 0.9899759888648987
resolved O 0 0.00011865946726175025
significantly O 0 2.3116689362723264e-07
over O 0 1.6459886231778853e-10
1 O 0 1.4473888754196196e-10
year O 0 7.773554369649993e-12
, O 0 1.2624144351408573e-12
and O 0 1.6368772656760733e-11
cognitively O 0 7.509630108870624e-07
, O 0 1.9602632017612365e-11
she O 0 2.4383108379599783e-12
is O 0 1.2062798134503117e-13
in O 0 3.3555788356287586e-12
the O 0 6.277257880160647e-11
superior O 0 9.445318482903531e-08
range O 0 1.6241413547390948e-08
for O 0 6.964069876325141e-10
age O 0 2.958511799988628e-07
. O 0 8.963139208617577e-08

Clinical O 0 1.2934846154166735e-06
recognition O 0 4.65829907625448e-06
of O 1 1.0
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 2.3796344450488505e-08
important O 0 2.5745569565138737e-10
because O 0 1.0787509774345949e-11
it O 0 4.632131809199913e-13
is O 0 4.4114622436801365e-13
one O 0 1.6311440859031329e-13
of O 0 5.5577127101857915e-12
the O 0 4.6234953365864584e-11
few O 0 1.1216343132058881e-10
directly O 0 2.196920423358506e-10
treatable O 0 0.00018594418361317366
causes O 0 3.4218845534894626e-09
of O 0 5.816360282295818e-09
cardiomyopathy B-Disease 1 1.0
in O 0 7.05922648194246e-05
children O 0 2.6139543862768733e-09
. O 0 9.053452432183917e-11
. O 0 1.2201406551781702e-09

Cloning O 0 1.502899976912886e-06
of O 0 1.0156253615889455e-08
a O 0 1.7925373685390156e-10
novel O 0 1.5863790281400725e-08
member O 0 1.435856711307082e-10
of O 0 5.412607029242622e-10
the O 0 9.702183501048012e-10
low O 0 9.754275254181266e-08
- O 0 1.463094090325967e-09
density O 0 1.1434065250170988e-08
lipoprotein O 0 8.392755262320861e-06
receptor O 0 6.827704623901809e-07
family O 0 1.6504701605413175e-08
. O 0 2.456685166407624e-08

A O 0 2.5776746070960144e-08
gene O 0 4.4375117469463987e-10
encoding O 0 8.042214894032895e-09
a O 0 4.673511577735212e-10
novel O 0 3.8645691091687695e-08
transmembrane O 0 1.5202747949416562e-09
protein O 0 4.0604797302279394e-10
was O 0 5.604412333520825e-12
identified O 0 2.9815817241367337e-13
by O 0 5.067836070498516e-14
DNA O 0 2.362525756624545e-12
sequence O 0 4.067612403586135e-13
analysis O 0 4.906486458441939e-13
within O 0 1.2789342501706713e-11
the O 0 2.73894990021617e-10
insulin B-Disease 0 0.0005861837998963892
- I-Disease 1 0.9997636675834656
dependent I-Disease 1 0.9998375177383423
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 6.353351178489675e-10
IDDM B-Disease 0 2.730708547460381e-05
) O 0 4.618092713792876e-11
locus O 0 4.467038683397817e-10
IDDM4 O 0 2.3625364065082977e-06
on O 0 5.795961044441356e-09
chromosome O 0 3.603547238384408e-09
11q13 O 0 1.1610690080487984e-06
. O 0 6.7955433280531e-08

Based O 0 3.499020451158685e-08
on O 0 3.2179001685506137e-09
its O 0 6.013520237324599e-11
chromosomal O 0 4.701910860660519e-09
position O 0 3.950303195665583e-08
, O 0 4.421761221062859e-11
this O 0 5.188172461090268e-11
gene O 0 3.7955957821189656e-11
is O 0 1.2504084139636218e-12
a O 0 1.060562445157065e-12
candidate O 0 2.3705626350789544e-10
for O 0 9.125063551995716e-12
conferring O 0 1.2886553690805158e-07
susceptibility O 0 2.8302683858782984e-05
to O 0 2.6024940424917986e-08
diabetes B-Disease 1 0.9999127388000488
. O 0 2.508281113478006e-06

The O 0 1.0329904398531653e-06
gene O 0 3.9019504072257405e-08
, O 0 4.914005313771952e-10
termed O 0 6.995027490575012e-08
low O 0 9.548145953885978e-07
- O 0 6.048115341883431e-09
density O 0 1.7337727920008206e-09
lipoprotein O 0 3.10072927334204e-08
receptor O 0 4.3718154096872297e-10
related O 0 1.1548183520559974e-09
protein O 0 4.511959972308688e-10
5 O 0 5.108392597819034e-10
( O 0 8.773006735136868e-13
LRP5 O 0 1.5215656503642094e-06
) O 0 3.385452942289424e-12
, O 0 1.849348582258492e-12
encodes O 0 8.370798086805575e-13
a O 0 5.391373653941545e-13
protein O 0 1.0838539094004673e-10
of O 0 1.7041767996772705e-09
1615 O 0 1.754306686052587e-05
amino O 0 4.533349340363202e-08
acids O 0 1.2977788621526543e-08
that O 0 1.4110547799650597e-11
contains O 0 3.139675325281033e-11
conserved O 0 4.056740499081002e-10
modules O 0 4.5518748492678895e-11
which O 0 2.5431561153851923e-13
are O 0 2.422848705517511e-13
characteristic O 0 9.610983883745483e-12
of O 0 1.5272951306433136e-11
the O 0 6.162412247157079e-11
low O 0 1.1674090139024429e-08
- O 0 3.2620087186963076e-10
density O 0 1.2961107742626155e-09
lipoprotein O 0 4.604273726727115e-07
( O 0 3.369364787175755e-10
LDL O 0 2.920698534580879e-06
) O 0 3.3969246859832936e-10
receptor O 0 9.185951554968597e-09
family O 0 1.5376849793469205e-09
. O 0 6.363893856331515e-09

These O 0 2.2907343577571737e-08
modules O 0 2.104366458866025e-08
include O 0 1.7768991833477799e-10
a O 0 2.5749877924363673e-11
putative O 0 6.548908526582409e-09
signal O 0 1.3442222890347466e-09
peptide O 0 5.220224252866501e-11
for O 0 1.5267147355363386e-12
protein O 0 1.0160680630200147e-10
export O 0 1.992100528980245e-08
, O 0 4.505860268233519e-11
four O 0 1.2497319151760777e-11
epidermal O 0 1.1912488773191399e-09
growth O 0 8.031848519607365e-10
factor O 0 1.5973572464744734e-09
( O 0 1.3057767540847198e-11
EGF O 0 2.9918151511765245e-08
) O 0 4.3974099535326605e-12
repeats O 0 7.1255679308379616e-12
with O 0 4.496094794213812e-13
associated O 0 7.360885234675152e-10
spacer O 0 7.665789780730847e-08
domains O 0 6.761643334129985e-08
, O 0 6.743927083441292e-10
three O 0 3.1626784524618756e-10
LDL O 0 2.3603854515386047e-06
- O 0 4.69007261472143e-07
receptor O 0 1.9191197964119056e-08
( O 0 4.0407142909426597e-11
LDLR O 0 0.00015480366710107774
) O 0 3.15633734426779e-11
repeats O 0 1.196739096709365e-10
, O 0 2.154569925250094e-12
a O 0 4.213513652567835e-12
single O 0 3.258277814222055e-10
transmembrane O 0 2.3092103784705387e-09
spanning O 0 6.016311338008506e-10
domain O 0 2.1684378737063525e-09
, O 0 3.6570812350644744e-11
and O 0 4.924642985071337e-11
a O 0 1.1425464047087885e-10
cytoplasmic O 0 1.0898959068583736e-08
domain O 0 1.2428307272216443e-08
. O 0 5.393369306716522e-09

The O 0 3.207157703855046e-07
encoded O 0 9.012562429688842e-08
protein O 0 2.9562883696598874e-08
has O 0 2.2180852640718562e-11
a O 0 2.7131786400902413e-12
unique O 0 3.699885883778897e-11
organization O 0 9.284142205023826e-11
of O 0 1.58838564523478e-09
EGF O 0 1.5801626432221383e-05
and O 0 2.000027166104701e-08
LDLR O 1 0.741276741027832
repeats O 0 1.6028049998340066e-09
; O 0 2.048375184748874e-11
therefore O 0 4.966953515150863e-10
, O 0 1.4696148811776943e-11
LRP5 O 0 0.00014902124530635774
likely O 0 4.457697500015456e-08
represents O 0 2.3571707086222915e-11
a O 0 3.247049710271982e-13
new O 0 6.660839848432465e-12
category O 0 4.876040543555504e-11
of O 0 4.035323117324019e-11
the O 0 9.312310367270982e-10
LDLR O 1 0.9999934434890747
family O 0 3.795551251073448e-08
. O 0 4.400322239916932e-08

Both O 0 1.4419762806028302e-07
human O 0 1.9112112781272117e-08
and O 0 3.585305563547081e-08
mouse O 0 1.0401485042166314e-06
LRP5 O 1 0.9999253749847412
cDNAs O 0 0.001411436009220779
have O 0 3.136739534781441e-09
been O 0 3.9373007632015344e-10
isolated O 0 1.6700997251817284e-09
and O 0 2.8275206828687338e-11
the O 0 4.731497971199872e-10
encoded O 0 1.870123389480227e-09
mature O 0 1.4175014051431845e-08
proteins O 0 1.032599960398839e-11
are O 0 6.51943288850626e-13
95 O 0 3.013590765821306e-11
% O 0 3.069235675074583e-13
identical O 0 7.437278874353193e-13
, O 0 5.0552755883302714e-14
indicating O 0 1.4710190530953238e-12
a O 0 1.362120865319033e-13
high O 0 3.6763557476060527e-11
degree O 0 2.0009675860688247e-10
of O 0 3.4506141000090196e-11
evolutionary O 0 4.1306127407381155e-09
conservation O 0 1.3301362233875125e-09
. O 0 5.319316861984724e-11
. O 0 1.839209784471052e-09

The O 0 8.7375815382984e-07
APC B-Disease 0 1.7556335478730034e-06
variants O 0 4.303138112504712e-08
I1307K O 0 1.4735151125933044e-06
and O 0 9.398766209756104e-10
E1317Q O 0 1.6331381402778788e-07
are O 0 1.0516520293490927e-10
associated O 0 1.303362751059467e-08
with O 0 2.104404074998456e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 9.571520465101457e-09
but O 0 9.041786763752668e-11
not O 0 2.994990713767187e-11
always O 0 4.9577418559376696e-11
with O 0 3.396239181812505e-13
a O 0 8.20808265106221e-12
family O 0 4.8528635970823686e-11
history O 0 7.805222024259706e-10
. O 0 7.468468510296589e-09

Classical O 0 7.390422251773998e-05
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 6.512787109613782e-08
FAP B-Disease 0 8.960385457612574e-06
) O 0 1.0858025416282668e-11
is O 0 4.757652605213991e-13
a O 0 3.29639874424581e-12
high O 0 3.167558588756947e-06
- O 1 0.9999810457229614
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
that O 0 1.0652309034853147e-09
predisposes O 0 1.5467314540273946e-07
to O 0 2.2603852123381785e-10
hundreds O 0 3.8215236530803054e-10
or O 0 6.792631040974939e-11
thousands O 0 3.665148462506096e-10
of O 0 3.59977804009759e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9999986886978149
carcinoma I-Disease 1 1.0
and O 0 4.678613607644877e-10
that O 0 9.22359302650555e-13
results O 0 8.070557416806068e-11
from O 0 1.0593707161499211e-10
truncating O 0 1.4851887719657952e-08
mutations O 0 1.6584901507687988e-10
in O 0 8.364710313291113e-11
the O 0 2.5072743881082715e-09
APC B-Disease 0 1.5473644054964097e-07
gene O 0 5.837866190461227e-09
. O 0 3.6382111545663065e-08

A O 0 1.372710745073391e-08
variant O 0 5.6690918626145503e-08
of O 0 3.544941762356757e-08
FAP B-Disease 0 3.0461587812169455e-05
is O 0 6.317441680891989e-09
attenuated B-Disease 0 0.12489492446184158
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 0.9999982118606567
coli I-Disease 1 1.0
, O 0 1.262445259442302e-09
which O 0 2.9241765259202523e-12
results O 0 2.2567836488462945e-10
from O 0 1.0586091725439672e-10
germ O 0 3.854032456729328e-06
- O 0 1.0712648901289867e-07
line O 0 4.771819703819347e-07
mutations O 0 2.0379711807017031e-10
in O 0 3.895921085739218e-11
the O 0 4.926465485555198e-11
5 O 0 7.299476301181329e-11
and O 0 2.781304917279237e-12
3 O 0 5.1854916194304934e-11
regions O 0 4.043505114070811e-11
of O 0 4.500571582077839e-10
the O 0 2.3944405569409355e-08
APC B-Disease 0 3.738806526598637e-07
gene O 0 9.760748653775408e-09
. O 0 6.627826820704286e-08

Attenuated B-Disease 1 0.9999983310699463
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 1 1.0
have O 0 2.3557674921903526e-08
" O 0 1.6412409209465295e-08
multiple O 0 2.2317703241014897e-08
" O 0 9.282104292651638e-05
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 1.7306925337301493e-10
typically O 0 5.975412525893731e-11
fewer O 0 1.2912362151729084e-11
than O 0 3.048134119242041e-13
100 O 0 1.6605902850713727e-12
) O 0 6.130488200146566e-15
without O 0 2.13843894848742e-12
the O 0 5.4506458374570244e-11
florid O 0 1.0605609901404023e-07
phenotype O 0 3.4053549313739495e-08
of O 0 1.0302971809039718e-09
classical O 0 7.989806505293018e-08
FAP B-Disease 0 1.923585386975901e-06
. O 0 4.556207855443972e-08

Another O 0 1.6066907448930579e-07
group O 0 7.682190994451332e-10
of O 0 1.2251311076738602e-09
patients O 0 9.457775718146877e-08
with O 0 2.9697130865535826e-10
multiple O 0 4.2776966324709065e-07
adenomas B-Disease 1 0.9999995231628418
has O 0 4.5070830401172657e-10
no O 0 1.1947205724727183e-10
mutations O 0 5.945422626441044e-11
in O 0 4.1020770114030825e-11
the O 0 8.689801100913996e-10
APC B-Disease 0 4.12135792160484e-09
gene O 0 4.554037355553042e-11
, O 0 1.1318914555635828e-11
and O 0 2.8752538544507544e-11
their O 0 1.0245685549969963e-10
phenotype O 0 1.2673501137427934e-09
probably O 0 2.0578126008752307e-11
results O 0 9.809876869160128e-12
from O 0 2.246602860342395e-12
variation O 0 6.085580928072432e-10
at O 0 6.176623448816976e-12
a O 0 1.6973748795390264e-12
locus O 0 1.454286951280137e-11
, O 0 7.734992117300332e-13
or O 0 1.1418791259765193e-11
loci O 0 3.67444380477977e-10
, O 0 5.7215916032804515e-12
elsewhere O 0 1.5704845757191777e-10
in O 0 3.251608357568436e-11
the O 0 9.850178450676594e-10
genome O 0 3.888197319668052e-09
. O 0 1.2417929795560667e-08

Recently O 0 4.339031249855907e-07
, O 0 1.7466102175678344e-10
however O 0 2.98517710550783e-10
, O 0 1.831970339316591e-12
a O 0 1.0807172214424843e-12
missense O 0 2.59811816505362e-09
variant O 0 9.262819844479964e-09
of O 0 5.186080670682713e-06
APC B-Disease 0 1.3630422472488135e-05
( O 0 2.0608852124848198e-10
I1307K O 0 4.783442477673816e-07
) O 0 1.2945679250808695e-11
was O 0 2.689619083007244e-10
described O 0 7.362623011264446e-11
that O 0 1.1854627522678296e-12
confers O 0 1.5466172786915422e-10
an O 0 7.723165097901774e-14
increased O 0 2.0417527391014545e-10
risk O 0 8.951675312118823e-08
of O 0 0.008510297164320946
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 4.8767361704449286e-08
including O 0 1.2485872336043258e-09
multiple O 0 2.3673571547533356e-08
adenomas B-Disease 0 0.0007264377200044692
, O 0 1.3920576913406535e-09
in O 0 1.6407305736265698e-08
Ashkenazim O 0 0.00045693526044487953
. O 0 1.9826171637760126e-07

We O 0 4.472089898399645e-08
have O 0 1.3575011947875026e-10
studied O 0 3.572802886875337e-10
a O 0 3.588035034016168e-12
set O 0 5.973748579135574e-11
of O 0 3.939875509173518e-11
164 O 0 5.5496287565404145e-09
patients O 0 1.265936688810143e-09
with O 0 1.7306454880294808e-11
multiple O 0 4.185681973467581e-06
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9993860721588135
/ I-Disease 1 0.7584591507911682
or I-Disease 0 1.0865958756767213e-05
carcinoma I-Disease 1 1.0
and O 0 2.6622379856178213e-09
analyzed O 0 2.2135737687278834e-09
codons O 0 3.78228781627854e-09
1263 O 0 7.790118417005942e-08
- O 0 2.0589414617688817e-09
1377 O 0 3.6357079125082237e-07
( O 0 7.60445525993525e-11
exon O 0 1.2270166216410416e-08
15G O 0 4.286983568135838e-08
) O 0 2.476973270590377e-12
of O 0 1.132421031946329e-10
the O 0 2.7624242893153905e-09
APC B-Disease 0 6.19627016362756e-08
gene O 0 2.113866304220835e-10
for O 0 2.1638876801510776e-10
germ O 0 0.016151461750268936
- O 0 4.509797690843698e-06
line O 0 4.485199042392196e-06
variants O 0 1.902428437006165e-07
. O 0 3.9109814053972514e-08

Three O 0 7.18529022947223e-08
patients O 0 1.6624538190512794e-08
with O 0 7.191954497220987e-12
the O 0 7.06812719464267e-10
I1307K O 0 2.7612335884441563e-07
allele O 0 1.5109492546017123e-09
were O 0 3.9189505807168956e-11
detected O 0 1.706045998917105e-10
, O 0 2.9052785567931783e-13
each O 0 1.1617529854790476e-13
of O 0 2.8597102116889594e-11
Ashkenazi O 0 1.214286555750732e-07
descent O 0 1.0394429494908763e-07
. O 0 3.949474347564319e-08

Four O 0 2.892481347771536e-07
patients O 0 4.179004918114515e-06
had O 0 1.1133393096329769e-09
a O 0 9.687144836290074e-11
germ O 0 7.238728358061053e-06
- O 0 1.228419819199189e-07
line O 0 4.931450803269399e-07
E1317Q O 0 3.248551649903675e-07
missense O 0 1.9740848955507317e-08
variant O 0 4.3894057277782395e-09
of O 0 1.0721803889168768e-08
APC O 0 5.528467017512639e-09
that O 0 1.4809229146803271e-12
was O 0 8.464504791527716e-11
not O 0 3.082196173634366e-12
present O 0 6.415574321794182e-11
in O 0 1.781085348651068e-11
controls O 0 7.6935520454402e-11
; O 0 6.682447130368363e-12
one O 0 2.886759191064736e-12
of O 0 1.5199485767225518e-11
these O 0 5.236798494845374e-11
individuals O 0 1.084233831188941e-11
had O 0 1.2066889154560556e-10
an O 0 4.751422779530889e-13
unusually O 0 5.475385145281564e-10
large O 0 3.945267029736854e-11
number O 0 1.7140296126871846e-11
of O 0 2.791437359039861e-10
metaplastic B-Disease 0 6.395659875124693e-05
polyps I-Disease 0 8.734639891372353e-07
of I-Disease 0 1.5758939753141021e-07
the I-Disease 0 6.09982180321822e-08
colorectum I-Disease 0 4.783421536558308e-05
. O 0 3.3826916023826925e-07

There O 0 2.2577374636512104e-08
is O 0 7.100580540209123e-11
increasing O 0 1.0294578384195674e-10
evidence O 0 8.179923405293721e-11
that O 0 8.594857681468171e-13
there O 0 7.055351528700848e-12
exist O 0 3.5678775905934046e-11
germ O 0 5.8425808191486794e-08
- O 0 1.730713350411861e-09
line O 0 4.007836285069288e-09
variants O 0 4.839610934226357e-10
of O 0 5.230781363607662e-10
the O 0 1.0433470754023233e-09
APC B-Disease 0 4.603305292505411e-09
gene O 0 1.6916065770367084e-11
that O 0 4.0583283803831416e-13
predispose O 0 5.3978053138337145e-09
to O 0 6.751156578221895e-11
the O 0 2.416737088228871e-10
development O 0 3.796063019478879e-09
of O 0 3.612998256130595e-08
multiple O 0 0.11725173145532608
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 2.0236470832379894e-10
but O 0 9.900308003962799e-12
without O 0 5.259250326905551e-11
the O 0 1.2978888797032795e-10
florid O 0 3.044794993911637e-08
phenotype O 0 3.440175255775557e-09
of O 0 1.636044633102074e-10
classical O 0 4.112908236209023e-09
FAP B-Disease 0 2.610966198801634e-08
, O 0 4.9514264216510284e-12
and O 0 1.1664274147255016e-12
possibly O 0 1.1976449346140505e-11
with O 0 2.4564120811206014e-13
importance O 0 5.9374953842450395e-09
for O 0 4.351073243924475e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 2.2481576422705984e-07
in O 0 3.920054818945529e-12
the O 0 3.497098661001119e-12
general O 0 1.1515118719662709e-10
population O 0 1.906947039512219e-12
. O 0 1.3664079416553232e-11
. O 0 1.0212620749072698e-09

Genomic O 0 1.1945753897180111e-07
structure O 0 5.7639679695853374e-09
of O 0 1.4308381146577176e-09
the O 0 1.033314678267061e-08
human O 0 8.166355200955877e-07
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 4.4181095404383086e-07
CLD B-Disease 1 0.9999607801437378
) O 0 3.535176373858917e-09
gene O 0 8.085156544268557e-09
. O 0 4.598077296691372e-08

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 9.280875019612722e-06
CLD B-Disease 1 1.0
) O 0 1.6663156965357473e-10
is O 0 2.473649323569971e-12
caused O 0 4.536153397349807e-11
by O 0 2.7542247996170666e-11
mutations O 0 5.349119480690945e-10
in O 0 1.2997790344027038e-10
a O 0 3.335359419209816e-11
gene O 0 8.712682658673643e-11
which O 0 3.022605776781262e-11
encodes O 0 4.899627231713666e-11
an O 0 3.8117070264021e-12
intestinal O 0 3.071403853027732e-06
anion O 0 3.224201009288663e-06
transporter O 0 3.968730652559316e-06
. O 0 1.275219574381481e-07

We O 0 1.5154610011336445e-08
report O 0 1.5247897389158993e-10
here O 0 2.24623548927827e-11
the O 0 4.945536601769218e-12
complete O 0 6.134992514006399e-11
genomic O 0 7.847062444277242e-10
organization O 0 2.943870841543017e-11
of O 0 7.09643802054849e-11
the O 0 5.164883520869523e-10
human O 0 1.2663986304062291e-08
CLD B-Disease 1 0.9998501539230347
gene O 0 7.494110221273331e-09
which O 0 1.452369335908088e-10
spans O 0 2.640461183034404e-10
approximately O 0 4.457136049129673e-12
39kb O 0 9.930965205739994e-08
, O 0 1.381345177131621e-10
and O 0 7.47772899156729e-10
comprises O 0 1.3194074721667448e-09
21 O 0 2.861422387923085e-08
exons O 0 6.278308717355685e-08
. O 0 2.8326528678235263e-08

All O 0 5.439794676931342e-07
exon O 0 2.207439592893934e-06
/ O 0 1.7770879878753476e-07
intron O 0 1.4477470244855795e-07
boundaries O 0 3.9507761506740735e-09
conform O 0 1.212573419451246e-08
to O 0 5.000995173531919e-10
the O 0 7.652945832603564e-09
GT O 0 3.332152118673548e-05
/ O 0 1.1233287295908667e-06
AG O 0 2.185326775361318e-05
rule O 0 6.615347842853225e-07
. O 0 3.2184732390305726e-07

An O 0 1.7525024834097458e-11
analysis O 0 1.119244454061974e-11
of O 0 1.0546308965020401e-10
the O 0 1.9384547300660415e-09
putative O 0 3.502533445498557e-07
promoter O 0 1.8961270598083502e-07
region O 0 3.42904526995369e-09
sequence O 0 1.6451004447581852e-10
shows O 0 9.68055080541319e-11
a O 0 8.196822387507297e-11
putative O 0 1.068247092916863e-05
TATA O 1 0.6382763385772705
box O 0 7.063375733196153e-07
and O 0 5.095887600781168e-10
predicts O 0 3.15559400831944e-09
multiple O 0 2.1120688531439669e-10
transcription O 0 1.513075176262646e-08
factor O 0 2.0712196402428162e-08
binding O 0 1.1842537617212656e-08
sites O 0 5.3104347585986034e-08
. O 0 3.3322358206078206e-08

The O 0 6.178213851626424e-08
genomic O 0 2.6036905964588186e-08
structure O 0 1.6076739939308027e-08
was O 0 6.1041842691622605e-09
determined O 0 9.786805810207966e-10
using O 0 1.0962181162810225e-10
DNA O 0 1.0159218355454414e-08
from O 0 1.883068839747537e-10
several O 0 1.3070351224941934e-11
sources O 0 1.1950584966058386e-09
including O 0 5.467305427830915e-11
multiple O 0 2.438703960994104e-10
large O 0 1.5747334103366484e-08
- O 0 4.640668294086936e-08
insert O 0 7.157728987294831e-08
libaries O 0 1.5019003512861673e-05
and O 0 1.356197487645261e-09
genomic O 0 2.1619663836958125e-09
DNA O 0 2.5328648067812765e-09
from O 0 3.1323435512042863e-10
Finnish O 0 4.641473788069561e-05
CLD B-Disease 1 1.0
patients O 0 0.0009449723293073475
and O 0 7.698814030732137e-09
controls O 0 9.638593923000371e-08
. O 0 1.5561950306164363e-07

Exon O 0 1.5947978681651875e-05
- O 0 1.7211912961556664e-07
specific O 0 1.419646977751654e-08
primers O 0 5.066585231361387e-07
developed O 0 2.273696786403434e-08
in O 0 1.3446396773808544e-10
this O 0 2.291499975881628e-11
study O 0 9.013027303661492e-12
will O 0 4.414391215849106e-13
facilitate O 0 1.969557503200825e-11
mutation O 0 2.4044308211124132e-12
screening O 0 5.301004774027618e-11
studies O 0 3.1981741473868786e-12
of O 0 2.4305149906589385e-12
patients O 0 6.136107177923122e-10
with O 0 2.2735361770304108e-12
the O 0 2.7433537663767993e-09
disease O 0 7.989614232428721e-07
. O 0 8.378277982501459e-08

Genomic O 0 1.1736138105788996e-07
sequencing O 0 1.202220119012054e-07
of O 0 2.506310003980161e-08
a O 0 7.698314874460266e-09
BAC O 0 0.00013657363888341933
clone O 0 6.3744500948814675e-06
H O 1 1.0
_ O 0 6.846722744313638e-09
RG364P16 O 0 3.9775361670990605e-08
revealed O 0 3.7592493007387873e-10
the O 0 1.0666164132477896e-11
presence O 0 1.1643207231681885e-11
of O 0 1.064700203001756e-10
another O 0 1.9708124021633466e-11
, O 0 5.587676588786339e-12
highly O 0 2.451580605189463e-10
homologous O 0 3.844543780551213e-11
gene O 0 2.945971591672425e-11
3 O 0 9.243278364934326e-10
of O 0 6.395381446644421e-10
the O 0 1.128975846143021e-08
CLD B-Disease 1 0.9975110292434692
gene O 0 1.2452415987240784e-08
, O 0 5.5294841622144375e-11
with O 0 8.345514492143213e-13
a O 0 8.832829216307014e-13
similar O 0 1.8327086376279667e-11
genomic O 0 7.019895220672367e-10
structure O 0 3.431021022848313e-09
, O 0 8.481760432887953e-12
recently O 0 1.7036127716862914e-11
identified O 0 3.5440151247706497e-12
as O 0 5.003279908433189e-12
the O 0 1.6613215247929247e-09
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 8.993227140763338e-08
( O 0 2.6115362650180884e-10
PDS B-Disease 0 4.9395930545870215e-05
) O 0 7.940965940367306e-11
. O 0 8.992327438228642e-10
. O 0 9.452343796567675e-09

The O 0 4.2383805975987343e-07
APCI1307K O 1 0.8745230436325073
allele O 0 1.1043081258321763e-06
and O 0 1.8173951232824948e-08
cancer B-Disease 0 1.104880175262224e-05
risk O 0 1.9875006529446182e-08
in O 0 1.4619161436968398e-10
a O 0 4.654934077086281e-11
community O 0 9.718420512783155e-11
- O 0 7.963201625882377e-11
based O 0 1.533299182066017e-11
study O 0 3.941963509085378e-12
of O 0 4.94972682632544e-12
Ashkenazi O 0 2.566704715434298e-08
Jews O 0 1.3549984245742053e-08
. O 0 7.576752558691169e-09

Mutations O 0 3.876687515003141e-06
in O 0 4.7580526185697636e-09
APC O 0 1.6292584348320815e-07
are O 0 6.346405172219516e-12
classically O 0 4.1634204417384524e-10
associated O 0 5.932779961748125e-11
with O 0 3.204460585770619e-10
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.621919475449431e-08
FAP B-Disease 0 1.0055177881440613e-06
) O 0 1.7817299285266541e-12
, O 0 1.8018171590167276e-13
a O 0 1.3583025763180823e-12
highly O 0 9.593686627340503e-06
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.9994221925735474
by O 0 8.297187719108479e-07
multiple O 0 0.00044256317778490484
intestinal O 1 1.0
polyps B-Disease 0 1.6446743757114746e-05
and O 0 6.843376976206628e-10
, O 0 1.1928590710683085e-12
without O 0 1.069580621987365e-11
surgical O 0 4.873858756582194e-07
intervention O 0 1.03273889440203e-09
, O 0 2.616878935768341e-12
the O 0 3.137531900954116e-11
development O 0 1.1682621092745649e-08
of O 0 0.12783624231815338
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.973998209336969e-08
CRC B-Disease 0 0.0002915448567364365
) O 0 2.6918053896984873e-10
. O 0 1.213651668052762e-08

APC B-Disease 0 8.719829202163965e-05
is O 0 2.6138649023010885e-09
a O 0 7.298212589823549e-10
tumour O 1 1.0
- O 0 3.139434056720347e-06
suppressor O 0 9.75202169684053e-07
gene O 0 2.6364652128130217e-10
, O 0 5.326421161772066e-12
and O 0 4.004065135010393e-11
somatic O 0 1.0062256478704512e-05
loss O 0 5.179143727218616e-07
occurs O 0 3.416399181332963e-07
in O 0 2.2035496272110322e-07
tumours B-Disease 1 1.0
. O 0 3.045624907827005e-06

The O 0 4.935854576615384e-06
germline O 0 1.5409676052513532e-05
T O 0 3.2196962820307817e-06
- O 0 9.933140532325524e-09
to O 0 1.0978962183827434e-10
- O 0 5.437730821178377e-10
A O 0 1.9197107792301438e-10
transversion O 0 7.998036899437011e-09
responsible O 0 1.653227728326545e-11
for O 0 8.153205541261421e-12
the O 0 4.019945487598875e-10
APC O 0 1.9553704433405983e-08
I1307K O 0 9.936820077882658e-08
allele O 0 9.144499601987377e-10
converts O 0 7.561113957166299e-10
the O 0 2.3302332285979332e-11
wild O 0 1.0658461613299863e-10
- O 0 3.0039768415812684e-12
type O 0 5.209678174966648e-12
sequence O 0 1.0178185334483447e-12
to O 0 1.866823969715048e-12
a O 0 5.472584538313008e-11
homopolymer O 1 0.9999597072601318
tract O 1 0.9999966621398926
( O 0 4.104567519203073e-10
A8 O 0 1.1809806892415509e-06
) O 0 9.112240042380426e-13
that O 0 1.8234600027838832e-13
is O 0 4.4431056056559726e-12
genetically O 0 1.371813596051652e-07
unstable O 0 1.8748134607449174e-05
and O 0 2.4455676594925535e-08
prone O 0 2.718063797146897e-06
to O 0 2.5639842249347566e-08
somatic O 0 0.0014352984726428986
mutation O 0 2.207626948802499e-06
. O 0 7.745094166011768e-08

The O 0 4.244544626885727e-08
I1307K O 0 8.212472835111839e-07
allele O 0 7.58163842817794e-09
was O 0 6.689544473914566e-10
found O 0 4.3021797929698735e-11
in O 0 8.520875671713668e-11
6 O 0 3.850361807167246e-08
. O 0 1.0214359136284656e-08

1 O 0 3.3368920071552566e-07
% O 0 2.835192081107607e-09
of O 0 1.2013067207661265e-09
unselected O 0 0.00029707231442444026
Ashkenazi O 0 1.1378917719184756e-07
Jews O 0 3.2614815292930643e-09
and O 0 1.307189686355903e-11
higher O 0 3.1046790138766767e-10
proportions O 0 8.072378876455844e-10
of O 0 1.5547279019756388e-09
Ashkenazim O 0 3.4117176710424246e-06
with O 0 1.5842964093404355e-11
family O 0 3.243995003177069e-11
or O 0 1.472049912520923e-11
personal O 0 9.194063288475718e-10
histories O 0 5.880896125631807e-08
of O 0 1.6027804576879134e-06
CRC B-Disease 1 1.0
( O 0 9.338972928318867e-10
ref O 0 1.2490950211940799e-06
. O 0 1.3934018383565672e-09
2 O 0 3.3882747718649853e-09
) O 0 2.16156016696889e-11
. O 0 2.4141997290172412e-09

To O 0 8.291015873851393e-09
evaluate O 0 1.865695864466943e-08
the O 0 5.998344598800998e-10
role O 0 8.599445600054878e-10
of O 0 6.647853378893842e-09
I1307K O 0 7.152301805035677e-06
in O 0 1.2005788363467218e-08
cancer B-Disease 0 2.7252693257651117e-07
, O 0 1.6649456119344208e-11
we O 0 5.927588281329221e-11
genotyped O 0 5.82512768687593e-07
5 O 0 8.160514930466434e-09
, O 0 8.663252060170379e-11
081 O 0 9.34781780870253e-07
Ashkenazi O 0 6.563842447349089e-08
volunteers O 0 3.3880551697507144e-09
in O 0 2.4436151019324726e-11
a O 0 4.195624056513303e-11
community O 0 2.9970495529774155e-10
survey O 0 1.0462446464742925e-09
. O 0 3.3250093789405355e-09

Risk O 0 4.724189784610644e-05
of O 0 1.954000481418916e-06
developing O 1 0.99973064661026
colorectal B-Disease 1 1.0
, I-Disease 1 0.9999901056289673
breast I-Disease 1 1.0
and I-Disease 0 1.907997102534864e-06
other I-Disease 0 3.5843490309162007e-07
cancers I-Disease 1 0.8111681938171387
were O 0 4.6458734637155885e-09
compared O 0 1.8035435367380614e-09
between O 0 1.1896390539334334e-09
genotyped O 0 2.9570041988336015e-06
I1307K O 0 2.3316245290061488e-07
carriers O 0 7.791270406620754e-10
and O 0 2.309948066159251e-11
non O 0 4.682836340919039e-10
- O 0 8.521656297277858e-11
carriers O 0 4.6189205238356124e-11
and O 0 2.252609990899268e-12
their O 0 3.3862086312036466e-12
first O 0 1.0078163130422535e-11
- O 0 4.493741490030345e-11
degree O 0 1.9084016589232533e-09
relatives O 0 6.365748483894151e-10
. O 0 4.788869301108889e-10

Sperm O 0 2.7382949241427923e-08
DNA O 0 6.969584354088454e-10
analysis O 0 4.178198759197116e-11
in O 0 2.9653193095446895e-11
a O 0 7.804835111535624e-10
Friedreich B-Disease 1 0.9999814033508301
ataxia I-Disease 1 1.0
premutation O 1 0.9999995231628418
carrier O 0 3.4428403523634188e-06
suggests O 0 5.2694900887217955e-08
both O 0 3.3500827112398213e-10
meiotic O 0 1.6248424117293325e-07
and O 0 3.070692589091095e-10
mitotic O 0 3.546179172531083e-08
expansion O 0 2.640366290052043e-07
in O 0 6.425349696748128e-10
the O 0 3.168440176892773e-09
FRDA B-Disease 0 0.0007270353380590677
gene O 0 4.183683444125563e-08
. O 0 3.3531737386738314e-08

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 1.0290215612940301e-07
usually O 0 2.634465978701428e-09
caused O 0 6.416581155299639e-10
by O 0 6.421814902762835e-12
an O 0 3.0674215337894717e-13
expansion O 0 3.036951801149712e-09
of O 0 2.062026327465105e-09
a O 0 1.0040739351069305e-09
GAA O 0 3.6249090840101417e-07
trinucleotide O 0 1.3587183502750122e-06
repeat O 0 4.214146809289332e-09
in O 0 1.306445840398851e-09
intron O 0 1.502211333104242e-08
1 O 0 1.634074653367179e-09
of O 0 3.842610396542767e-10
the O 0 9.833363456834832e-09
FRDA B-Disease 1 0.9937531352043152
gene O 0 2.6003340281022247e-07
. O 0 1.774283902022944e-07

Occasionally O 0 3.388377365354245e-07
, O 0 8.216924363146916e-10
a O 0 1.1235977426249377e-10
fully O 0 9.61697654844329e-09
expanded O 0 5.663590485482928e-08
allele O 0 2.0584595361583524e-08
has O 0 1.952643081948313e-11
been O 0 7.231514432409769e-12
found O 0 1.5213167097599678e-12
to O 0 4.108448390521824e-12
arise O 0 1.6411710879182806e-09
from O 0 3.7835106575512256e-11
a O 0 8.415755939350511e-12
premutation O 0 7.625178000125743e-08
of O 0 9.094578423685107e-10
100 O 0 3.6165867522974793e-10
or O 0 1.5933299818415847e-11
less O 0 1.2419795192286642e-09
triplet O 0 5.502458293449308e-07
repeats O 0 3.766409051308983e-08
. O 0 4.489558946829675e-08

We O 0 9.706985082402753e-08
have O 0 3.907629497756915e-10
examined O 0 6.292200538382531e-09
the O 0 1.0209227213620053e-10
sperm O 0 7.644548882801416e-11
DNA O 0 7.705696497550818e-11
of O 0 3.5240442508577274e-11
a O 0 5.603431954548377e-11
premutation O 0 2.057703932223376e-05
carrier O 0 2.3145389604906086e-07
. O 0 5.6353592015057075e-08

This O 0 8.333938694704557e-08
mans O 0 9.108183803618886e-06
leucocyte O 0 7.319294581975555e-06
DNA O 0 1.5753259674511355e-07
showed O 0 1.1072002203960096e-09
one O 0 1.3181125028266516e-12
normal O 0 9.659174848852814e-11
allele O 0 1.055399587168715e-10
and O 0 7.905176513389733e-12
one O 0 2.358437663912971e-12
allele O 0 4.3122599241440795e-11
of O 0 2.7835830862521505e-11
approximately O 0 1.4578751400540213e-11
100 O 0 2.687449984772883e-10
repeats O 0 6.94410806634238e-10
. O 0 3.6709149053848478e-09

His O 0 3.83875459419869e-07
sperm O 0 2.8602057611237797e-08
showed O 0 2.154991324276878e-10
an O 0 1.263943783620311e-13
expanded O 0 1.3532949760808322e-10
allele O 0 3.2713798336914124e-10
in O 0 1.218977002670485e-10
a O 0 1.2803236248970506e-10
tight O 0 1.324766003563127e-07
range O 0 2.595345982570052e-08
centering O 0 1.3960522515787943e-08
on O 0 1.0693790991611607e-10
a O 0 1.25017953888501e-12
size O 0 3.349576171984836e-11
of O 0 2.073897859000695e-10
approximately O 0 2.4011473365170843e-10
320 O 0 8.711777077508032e-09
trinucleotide O 0 2.6300201625417685e-06
repeats O 0 1.8813652857829766e-08
. O 0 3.848622043278738e-08

His O 0 6.38704023003811e-06
affected O 0 7.379591261269525e-05
son O 0 8.021686517167836e-05
has O 0 1.803573540515302e-10
repeat O 0 5.838330929819335e-10
sizes O 0 3.834010442460567e-09
of O 0 7.244940758432961e-10
1040 O 0 2.91402137975183e-08
and O 0 2.9551913693914855e-10
540 O 0 1.2457880060878779e-08
. O 0 2.90911073008715e-09

These O 0 1.747071820545898e-08
data O 0 3.6349772081223364e-09
suggest O 0 5.543986936196177e-10
that O 0 3.812519690140487e-13
expansion O 0 3.7394620733266493e-10
occurs O 0 3.097467421442346e-11
in O 0 5.010337197214332e-12
two O 0 3.0749133708013465e-13
stages O 0 1.296488472135593e-10
, O 0 2.1452602877707755e-13
the O 0 1.3117547412871966e-12
first O 0 1.7697470008556926e-12
during O 0 1.7890491171845824e-11
meiosis O 0 1.9330265166317417e-10
followed O 0 2.3153350070526102e-10
by O 0 2.0222993418750335e-11
a O 0 2.9168029103132653e-11
second O 0 1.0134209027512497e-09
mitotic O 0 8.45475511823679e-08
expansion O 0 1.895916852845403e-06
. O 0 1.3473987792167463e-07

We O 0 1.5684273080296407e-07
also O 0 6.370278748946134e-10
show O 0 6.066290698936161e-12
that O 0 9.054007679221501e-14
in O 0 2.9023116375481717e-12
all O 0 2.099351074924538e-12
informative O 0 4.299726893974842e-11
carrier O 0 2.143990367187154e-11
father O 0 1.2721440220686553e-11
to O 0 8.883843313767237e-12
affected O 0 4.752402027463631e-09
child O 0 8.383821636925859e-09
transmissions O 0 2.6177264800253397e-09
, O 0 1.2712871120396096e-12
with O 0 3.8230764311687065e-14
the O 0 3.672632510609564e-12
notable O 0 2.323159373207595e-11
exception O 0 5.863828866914389e-11
of O 0 1.0964042174155253e-10
the O 0 1.0972536074183026e-10
premutation O 0 6.668251018027149e-08
carrier O 0 9.61260737675218e-10
, O 0 4.580081106042577e-12
the O 0 1.3221772635074736e-11
expansion O 0 1.8087591424631455e-09
size O 0 2.4958601851921003e-10
decreases O 0 1.4809682369332222e-08
. O 0 1.0045624332377656e-09
. O 0 1.7831240484156297e-08

The O 0 8.921505667558449e-08
R496H O 0 1.142647533924901e-06
mutation O 0 1.3791089159553849e-08
of O 0 2.4639434936801763e-09
arylsulfatase O 0 0.0006181696662679315
A O 0 2.362936726285625e-07
does O 0 1.6900658650342848e-10
not O 0 3.5300737333265886e-10
cause O 0 1.8637646235220018e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 1.001819214252464e-06

Deficiency B-Disease 0 0.06563711911439896
of I-Disease 0 5.0987205213459674e-06
arylsulfatase I-Disease 1 1.0
A I-Disease 1 0.9996939897537231
( O 0 3.1222302965261406e-08
ARSA O 0 0.12117619067430496
) O 0 1.0463578614672286e-10
enzyme O 0 4.571421463595016e-09
activity O 0 1.5795706076460192e-08
causes O 0 6.967052001982665e-08
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.3217253069797152e-08
MLD B-Disease 1 1.0
) O 0 3.2612141875887346e-09
. O 0 1.6946577474641344e-08

A O 0 1.1038169134280906e-07
number O 0 2.0803407885239267e-09
of O 0 8.752198965567004e-09
ARSA O 0 0.000522929651197046
gene O 0 1.907238456055893e-08
mutations O 0 2.3037376450929514e-09
responsible O 0 2.6929300456224325e-10
for O 0 3.743188869975711e-09
MLD B-Disease 1 1.0
have O 0 8.014777108655835e-08
been O 0 9.909727483048414e-10
identified O 0 1.3513636876183455e-09
. O 0 6.6029288703362e-09

Recently O 0 4.989519197806658e-08
, O 0 9.858180244348702e-11
the O 0 1.6647432043992438e-10
R496H O 0 1.4353179267345695e-07
mutation O 0 6.8120087348688685e-09
of O 0 1.86689543824059e-08
ARSA O 0 0.02617877908051014
was O 0 1.104052227418606e-08
proposed O 0 9.974167269888312e-09
to O 0 4.5686711358516874e-11
be O 0 9.559975207296123e-12
a O 0 2.596563805981611e-12
cause O 0 3.0641805759401564e-10
of O 0 1.1932529631053512e-08
MLD B-Disease 1 1.0
( O 0 1.541049732267652e-09
Draghia O 0 4.5500955820898525e-06
et O 0 4.9575290539394246e-09
al O 0 2.551818756302282e-10
. O 0 6.115105383869279e-12
, O 0 4.31524434241215e-12
1997 O 0 6.527405838063771e-10
) O 0 1.5496852412422157e-10
. O 0 1.681546812903889e-08

We O 0 1.6945971026416373e-07
have O 0 9.238572684644453e-10
investigated O 0 4.750906779094066e-09
the O 0 2.0757826568740256e-09
R496H O 0 4.2026303503917006e-07
mutation O 0 1.3092745776432935e-09
and O 0 1.3852915342615901e-11
found O 0 1.5988637280459073e-12
this O 0 1.1133566941642914e-12
mutation O 0 3.1125990673785964e-11
at O 0 2.8427375037276548e-11
a O 0 1.5206960040162198e-12
relatively O 0 7.035762250584554e-11
high O 0 2.840396147452129e-11
frequency O 0 5.526466437255628e-12
in O 0 7.25579915161062e-13
an O 0 5.687323442055137e-14
African O 0 1.4128020585021939e-12
American O 0 7.610237310121115e-13
population O 0 4.217625733252475e-14
( O 0 6.592505539951624e-14
f O 0 1.4442451401475154e-10
= O 0 1.5448239909510164e-11
0 O 0 5.845582351504675e-11
. O 0 3.0016230386648024e-12
09 O 0 3.7813843722922513e-10
, O 0 4.00178024398401e-12
n O 0 2.15370513090285e-10
= O 0 1.144324413004938e-09
61 O 0 8.608706636437091e-09
subjects O 0 5.74074077164255e-09
) O 0 1.2896221590619206e-10
. O 0 1.5068602365886363e-08

The O 0 1.2913565115013625e-05
ARSA O 0 0.0009199116611853242
enzyme O 0 8.623993608125602e-08
activity O 0 2.2051972692338495e-08
in O 0 1.822989537103581e-10
subjects O 0 8.646698357317462e-10
with O 0 1.5385560664035736e-13
and O 0 1.9223726343414738e-12
without O 0 2.502713834784398e-11
the O 0 1.3748002736235776e-10
R496H O 0 1.8074047147820238e-08
mutation O 0 1.2940994109644777e-10
was O 0 8.903337789245569e-11
determined O 0 5.808740710655513e-10
and O 0 6.563845994511652e-11
found O 0 1.9233089079695453e-11
to O 0 2.521246406095301e-11
be O 0 3.734102194119515e-10
normal O 0 9.65784010986681e-07
. O 0 7.100915411228925e-08

It O 0 3.3005058686086386e-09
is O 0 2.5821978236195697e-11
therefore O 0 2.971781432048459e-10
concluded O 0 3.3517702502372515e-10
that O 0 4.737297251526662e-13
the O 0 3.4491468708930384e-11
R496H O 0 5.913278755542706e-08
mutation O 0 3.343241239406325e-09
of O 0 4.386509822040807e-09
ARSA O 0 2.1391351765487343e-05
does O 0 2.780225771825684e-10
not O 0 5.7772470835049106e-11
negatively O 0 3.1652389598235686e-09
influence O 0 3.4047362706957074e-09
the O 0 1.0699605784703081e-10
activity O 0 4.05492484034653e-09
of O 0 2.360232453924027e-09
ARSA O 0 0.423671156167984
and O 0 1.287781270509214e-10
is O 0 1.5025464596488125e-12
not O 0 2.568349829687455e-12
a O 0 5.589083449525356e-12
cause O 0 7.706263183138162e-09
of O 0 3.4637818657756725e-07
MLD B-Disease 1 1.0

Down O 0 4.4609573706111405e-06
- O 0 4.8111580497334216e-08
regulation O 0 8.30320487921199e-08
of O 0 6.081986914097115e-09
transmembrane O 0 4.4381511798974316e-08
carbonic O 0 5.011923349229619e-06
anhydrases O 0 3.7126294046174735e-05
in O 0 6.026067467246321e-07
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 5.917186626902549e-06
lines O 0 1.7352549397386952e-09
by O 0 4.7770530586799254e-11
wild O 0 4.782749556397903e-07
- O 0 8.564062348170864e-09
type O 0 2.329684036794788e-07
von B-Disease 1 0.9999996423721313
Hippel I-Disease 1 0.999998927116394
- I-Disease 0 0.13231949508190155
Lindau I-Disease 0 0.007756887935101986
transgenes O 0 0.00027228204999119043
. O 0 1.7745477975950052e-07

To O 0 3.068429776931225e-08
discover O 0 3.244895685483584e-09
genes O 0 7.882626495980816e-11
involved O 0 8.589241297374262e-12
in O 0 2.2535534549561476e-10
von B-Disease 1 1.0
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( O 0 7.850917427276727e-08
VHL B-Disease 1 1.0
) O 0 9.095831643435304e-09
- O 0 3.865764028887497e-07
mediated O 0 5.644351404043846e-07
carcinogenesis O 0 0.4192209541797638
, O 0 1.3085899031040071e-10
we O 0 3.237288562218943e-11
used O 0 6.77683353877967e-10
renal B-Disease 1 1.0
cell I-Disease 1 0.9977554678916931
carcinoma I-Disease 1 1.0
cell O 0 5.9635804063873366e-05
lines O 0 7.27302591485568e-08
stably O 0 1.4738818663317943e-06
transfected O 0 6.286624198992286e-08
with O 0 1.714990996437571e-11
wild O 0 6.332113855478383e-08
- O 0 5.3436157720909705e-09
type O 0 9.683094503998291e-08
VHL O 1 0.999431312084198
- O 0 1.2109889212297276e-05
expressing O 0 2.231434592658843e-07
transgenes O 0 1.597167647560127e-05
. O 0 7.861781625706499e-08

Large O 0 3.25182469396168e-07
- O 0 5.2030948438641644e-08
scale O 0 1.047639415219237e-07
RNA O 0 1.326384868605146e-08
differential O 0 3.023196804008421e-09
display O 0 2.2574854485757356e-10
technology O 0 1.6832467641947346e-09
applied O 0 1.3318015579244502e-09
to O 0 1.8414018573831292e-11
these O 0 2.480331218190912e-11
cell O 0 2.4828125666509493e-10
lines O 0 3.691666763949719e-11
identified O 0 3.927778675222315e-12
several O 0 4.711384060662738e-12
differentially O 0 2.2465860283205075e-08
expressed O 0 7.38419991819228e-10
genes O 0 5.880564923899101e-10
, O 0 5.169106028629633e-12
including O 0 6.123975892363687e-12
an O 0 5.490784910078261e-12
alpha O 0 7.043960525976445e-09
carbonic O 0 1.4241485359889339e-06
anhydrase O 0 6.599534117412986e-06
gene O 0 9.534568690128253e-09
, O 0 1.0565359698233578e-09
termed O 0 1.2514655054474133e-06
CA12 O 1 0.9999440908432007
. O 0 5.362668161978945e-06

The O 0 4.3395608884111425e-08
deduced O 0 2.580616431657745e-08
protein O 0 5.499216637616655e-10
sequence O 0 5.289198592994815e-11
was O 0 8.446136151585293e-11
classified O 0 5.366735181255855e-11
as O 0 2.787855016284091e-11
a O 0 8.42103817233486e-12
one O 0 7.452181927103396e-11
- O 0 2.394199327682145e-07
pass O 0 0.006445311009883881
transmembrane O 0 2.2589533728023525e-06
CA O 0 6.414152267097961e-07
possessing O 0 2.040772661970891e-09
an O 0 4.757954447098811e-12
apparently O 0 3.6350031318299614e-10
intact O 0 1.7579278033252876e-09
catalytic O 0 3.25132010203788e-09
domain O 0 8.591941380586832e-09
in O 0 7.790988409972499e-10
the O 0 4.609543413636175e-09
extracellular O 0 7.776725965413789e-07
CA O 0 7.198433740995824e-05
module O 0 6.298146217886824e-07
. O 0 1.925999093543851e-08

Reintroduced O 0 4.64471013401635e-05
wild O 0 6.583610684174346e-06
- O 0 9.864702121831215e-08
type O 0 1.42921237511473e-07
VHL B-Disease 0 0.33385398983955383
strongly O 0 2.0087513874500473e-08
inhibited O 0 2.1907800018539092e-08
the O 0 3.400457415647651e-10
overexpression O 0 3.7222289694938127e-09
of O 0 3.868110345917053e-11
the O 0 1.1914437492155372e-10
CA12 O 0 1.2285092452657409e-05
gene O 0 9.839207226747249e-11
in O 0 1.82070920839994e-11
the O 0 5.77897008025019e-10
parental O 0 5.719448836316587e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 0 0.11249859631061554
lines O 0 1.7579161237790686e-07
. O 0 8.362425063523915e-08

Similar O 0 1.938041727100881e-08
results O 0 5.448427042864523e-09
were O 0 1.737257421252636e-10
obtained O 0 2.2402198152082775e-11
with O 0 1.7706486233823315e-12
CA9 O 0 7.693202860536985e-06
, O 0 1.8818478719762055e-10
encoding O 0 1.91095601564939e-08
another O 0 2.1172377628886352e-08
transmembrane O 0 1.3154259193015605e-07
CA O 0 5.449588229566871e-07
with O 0 6.798965904164511e-12
an O 0 3.7517744987114465e-12
intact O 0 3.939338633074385e-09
catalytic O 0 2.2672356436714836e-08
domain O 0 1.8078982577662828e-07
. O 0 1.0606802902657364e-07

Although O 0 1.447516524422099e-07
both O 0 1.962127793575519e-09
domains O 0 4.784361351539701e-09
of O 0 4.979410661576367e-09
the O 0 3.7799967600449236e-08
VHL B-Disease 0 0.180791437625885
protein O 0 8.604835244341302e-08
contribute O 0 1.0821400442395657e-09
to O 0 3.481433891172614e-11
regulation O 0 3.874555076777142e-08
of O 0 3.002900328397118e-08
CA12 O 1 0.9999653100967407
expression O 0 3.2867124133417747e-08
, O 0 6.5599752192835314e-12
the O 0 1.3957918154616777e-11
elongin O 0 1.0425917018608288e-08
binding O 0 3.2843729957932055e-09
domain O 0 1.6004719327611383e-08
alone O 0 1.509146252409721e-09
could O 0 1.1969650270948762e-10
effectively O 0 5.372947420312357e-09
regulate O 0 4.0942438772617606e-07
CA9 O 0 0.0032945871353149414
expression O 0 7.140436082408996e-06
. O 0 7.91402328559343e-07

We O 0 5.976315833322587e-07
mapped O 0 1.4403423165276763e-06
CA12 O 0 0.02055428735911846
and O 0 7.411637170662289e-07
CA9 O 0 0.001205671695061028
loci O 0 4.4372205820764066e-07
to O 0 3.891268640643375e-09
chromosome O 0 4.151860188983392e-09
bands O 0 3.401823178705854e-08
15q22 O 0 2.748029999111168e-07
and O 0 1.000850291532629e-09
17q21 O 0 2.8831032068410423e-06
. O 0 1.0699498886879155e-07

2 O 0 2.611419915865554e-07
respectively O 0 4.7998202745702656e-08
, O 0 3.8103589727889187e-10
regions O 0 1.7125584506061386e-08
prone O 0 1.8025201597993146e-07
to O 0 3.04127445449609e-10
amplification O 0 4.35822585131973e-06
in O 0 1.0534397354433622e-08
some O 0 1.2545049443701828e-09
human O 0 4.4456747616550274e-08
cancers B-Disease 0 0.0008511900086887181
. O 0 5.296051313052885e-07

Additional O 0 1.1298720181684985e-08
experiments O 0 2.018568245887309e-08
are O 0 1.3148364341741825e-11
needed O 0 1.9744895995987832e-10
to O 0 6.260288294701599e-12
define O 0 3.04324149213997e-10
the O 0 4.1934020145184547e-10
role O 0 7.850760597172268e-10
of O 0 9.61995212378497e-08
CA O 0 0.00031134337768889964
IX O 1 1.0
and O 0 1.4771183032280533e-06
CA O 0 9.512204087513965e-06
XII O 0 0.001084210816770792
enzymes O 0 4.370533712716451e-09
in O 0 7.637596804999092e-11
the O 0 1.1289655842128266e-11
regulation O 0 5.495955912593331e-10
of O 0 6.08448708083742e-11
pH O 0 7.170187554805807e-09
in O 0 5.4021460915709696e-11
the O 0 5.18863736698183e-11
extracellular O 0 9.75486247334345e-10
microenvironment O 0 6.505474630102981e-07
and O 0 7.829701470507544e-11
its O 0 3.488732566725439e-11
potential O 0 1.084927925276702e-09
impact O 0 1.3393533038197347e-07
on O 0 7.139525450838846e-07
cancer B-Disease 0 4.019956577394623e-06
cell O 0 7.179085059760837e-08
growth O 0 1.5756047133663742e-08
. O 0 9.085982632939249e-09

A O 0 5.8317258577744724e-08
gene O 0 1.2646166336338638e-09
encoding O 0 4.9990834583013566e-08
a O 0 4.853988766484463e-09
transmembrane O 0 4.181099200195604e-08
protein O 0 5.6993703090313375e-09
is O 0 6.1626554553884105e-12
mutated O 0 6.868785540348199e-10
in O 0 7.498303193631539e-12
patients O 0 9.55969303717552e-10
with O 0 9.50942311006564e-11
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9999998807907104
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9996815919876099
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 6.019456044725757e-10
. O 0 2.4462847303396984e-09

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 1.2883582485301304e-06
WFS B-Disease 0 0.003526706248521805
; O 0 2.236999563365316e-08
OMIM O 0 0.15170808136463165
222300 O 0 6.318348368949955e-07
) O 0 4.750328602698417e-12
is O 0 8.247892386431532e-13
an O 0 3.090319666831931e-12
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 1.0060202448869404e-08
by O 0 9.498243302985543e-10
young O 0 1.615055396086973e-07
- O 0 1.450898707844317e-06
onset O 1 1.0
non O 1 1.0
- O 1 0.9999903440475464
immune O 0 0.09496410936117172
insulin B-Disease 1 0.8962040543556213
- I-Disease 0 7.234024815261364e-05
dependent I-Disease 0 3.5100813420285704e-06
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 0 3.2603936688246904e-06
progressive O 1 0.9999984502792358
optic B-Disease 1 0.9999938011169434
atrophy I-Disease 1 0.865824818611145
. O 0 0.00020604688324965537

Linkage O 0 3.7164393233979354e-06
to O 0 1.9074921642214804e-09
markers O 0 3.8486437148321784e-08
on O 0 9.789498101042682e-09
chromosome O 0 8.557432096267803e-09
4p O 0 8.43162415549159e-05
was O 0 5.977162320647267e-09
confirmed O 0 3.5063143499769467e-09
in O 0 8.463476031117523e-10
five O 0 3.0519142768525853e-10
families O 0 1.683891359682832e-10
. O 0 2.618445460456087e-09

On O 0 2.7152136539143612e-08
the O 0 1.6529667912212886e-10
basis O 0 1.0102905179110167e-09
of O 0 1.9668677797568535e-09
meiotic O 0 0.2654116749763489
recombinants O 1 0.9999998807907104
and O 0 4.988777391190524e-07
disease O 0 1.546089697512798e-05
- O 0 1.0908754788374608e-08
associated O 0 1.3920584684967707e-08
haplotypes O 0 7.984566252616787e-08
, O 0 3.772370610333198e-11
the O 0 4.6242290552278575e-10
WFS B-Disease 0 1.5537215176664176e-06
gene O 0 2.7406643621219473e-10
was O 0 6.206389291385506e-10
localized O 0 2.9981389815247894e-08
to O 0 7.750214914281628e-10
a O 0 3.833213302328886e-09
BAC O 0 7.496264879591763e-05
/ O 0 2.2997313919859153e-07
P1 O 0 1.0711684126363252e-06
contig O 0 5.925675168327871e-07
of O 0 9.44612055242544e-10
less O 0 1.5259280505830475e-09
than O 0 7.662869644375903e-11
250 O 0 8.38732028274336e-10
kb O 0 1.0780578207914004e-07
. O 0 4.27961452942327e-08

Mutations O 0 3.602862079787883e-07
in O 0 9.079499374564648e-10
a O 0 1.0277471235164981e-10
novel O 0 2.0574968395692395e-09
gene O 0 4.952130927549092e-10
( O 0 2.8996128415004208e-11
WFS1 O 0 0.0002707020612433553
) O 0 9.36987154531721e-11
encoding O 0 6.5957417305639865e-09
a O 0 2.638126828102827e-09
putative O 0 5.724724587707897e-07
transmembrane O 0 8.201110901495667e-10
protein O 0 4.462397673599128e-10
were O 0 1.5113056639481925e-10
found O 0 5.257592972096603e-12
in O 0 1.8022581040402774e-12
all O 0 4.71328011342198e-12
affected O 0 1.5986824364322416e-10
individuals O 0 1.3911274042432975e-11
in O 0 6.809549590869324e-10
six O 0 4.296444089391116e-09
WFS B-Disease 0 0.019557878375053406
families O 0 1.2527164860998141e-09
, O 0 8.499607268008802e-12
and O 0 4.531351422559782e-12
these O 0 3.704313245034285e-11
mutations O 0 1.0484774853880552e-10
were O 0 7.763555770479158e-11
associated O 0 7.925188283408602e-10
with O 0 1.0133894418062894e-10
the O 0 1.4164318429266132e-07
disease O 0 1.2786620573024265e-05
phenotype O 0 5.844704446644755e-06
. O 0 6.957730391832229e-08

WFS1 O 1 0.9513818621635437
appears O 0 1.1793684961958206e-07
to O 0 1.330287685563647e-10
function O 0 3.971445117212369e-10
in O 0 3.5280209309540567e-10
survival O 0 4.2586472659422725e-07
of O 0 3.725837416368449e-09
islet O 0 1.9112569589196937e-06
beta O 0 2.5068555942198145e-07
- O 0 1.480488833749405e-07
cells O 0 1.5777459339005873e-08
and O 0 1.7185118605933525e-10
neurons O 0 6.015301035056098e-10
. O 0 2.652883294984587e-11
. O 0 6.300832078309782e-10

Stable O 0 2.3846108888392337e-05
interaction O 0 1.8728908202092498e-08
between O 0 2.950567568049678e-10
the O 0 1.3965993639342145e-10
products O 0 1.492919565748707e-08
of O 0 2.0333605021960466e-08
the O 0 1.5959244592522737e-07
BRCA1 O 0 3.532253742832836e-07
and O 0 1.0266079542020634e-08
BRCA2 O 0 1.9562176589715818e-07
tumor B-Disease 0 2.7484651354825473e-07
suppressor O 0 1.6077943598702404e-07
genes O 0 4.090024430247752e-10
in O 0 2.103111435003413e-11
mitotic O 0 3.1700377434162874e-08
and O 0 7.162246351555268e-09
meiotic O 0 7.137481134122936e-06
cells O 0 4.355267719802214e-06
. O 0 9.882931806259876e-08

BRCA1 O 0 0.0029267941135913134
and O 0 5.535776494980382e-07
BRCA2 O 0 5.288359261612641e-07
account O 0 1.8432255721734236e-11
for O 0 1.096898722026396e-12
most O 0 6.029949217896402e-13
cases O 0 9.887546510711775e-13
of O 0 1.8585079655797365e-11
familial O 0 3.933032122205304e-09
, O 0 9.32327132163735e-11
early O 0 5.307052788339206e-07
onset O 1 0.9999994039535522
breast B-Disease 1 0.9999998807907104
and I-Disease 1 0.9993450045585632
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 6.939715468945451e-09
encode O 0 3.0078844970304885e-10
products O 0 5.24167065307779e-09
that O 0 1.7691471551617433e-11
each O 0 6.705121700922856e-12
interact O 0 3.016638674968597e-11
with O 0 7.419006381459425e-12
hRAD51 O 0 9.106354781351911e-08
. O 0 1.2347288524949818e-08

Results O 0 1.3041754982623388e-06
presented O 0 2.8662083195740706e-07
here O 0 7.663418344350248e-09
show O 0 4.704895917306828e-10
that O 0 2.397992568403673e-11
BRCA1 O 0 9.25546004282296e-08
and O 0 1.950167138886627e-08
BRCA2 O 0 8.91906211109017e-07
coexist O 0 6.297086407869301e-09
in O 0 1.4188950361870845e-11
a O 0 1.2825979427838474e-12
biochemical O 0 4.181487600618539e-09
complex O 0 5.841455674726603e-08
and O 0 5.815258830033088e-10
colocalize O 0 5.373542080633342e-06
in O 0 1.566740337466399e-08
subnuclear O 0 6.790234328946099e-05
foci O 0 4.63301921627135e-06
in O 0 1.1671235089494303e-09
somatic O 0 3.4836051554520964e-07
cells O 0 3.5815928001170505e-09
and O 0 1.1427702534261286e-11
on O 0 1.1273129998934373e-11
the O 0 3.3173140883552277e-12
axial O 0 1.1081650874711357e-10
elements O 0 2.3208662769391708e-10
of O 0 1.5622515503466161e-09
developing O 0 8.73565895176398e-08
synaptonemal O 0 3.6686564271803945e-05
complexes O 0 3.567611486232636e-07
. O 0 8.039734211706673e-08

Like O 0 3.702566391439177e-05
BRCA1 O 0 6.384922744473442e-05
and O 0 1.9207095647288952e-07
RAD51 O 1 0.8869488835334778
, O 0 5.718804345633544e-07
BRCA2 O 0 8.587006959714927e-06
relocates O 0 2.9593780936920666e-07
to O 0 5.994778895512809e-09
PCNA O 0 1.0631980330799706e-05
+ O 0 1.9339936319084927e-09
replication O 0 1.210942873752785e-10
sites O 0 1.775570142303895e-11
following O 0 4.0113655452866936e-11
exposure O 0 4.0364973585838015e-09
of O 0 1.4716864393804485e-09
S O 0 7.111410923243966e-06
phase O 0 4.185762009001337e-06
cells O 0 2.4842078616416075e-08
to O 0 7.403477830791871e-10
hydroxyurea O 0 8.221249458983948e-07
or O 0 8.283555175125912e-09
UV O 0 0.0035570424515753984
irradiation O 0 5.590815999312326e-05
. O 0 2.0267417255581677e-07

Thus O 0 2.3062023046804825e-06
, O 0 2.7812946612471023e-08
BRCA1 O 0 2.941833372460678e-07
and O 0 8.034671594714382e-09
BRCA2 O 0 5.1716313009819714e-08
participate O 0 3.814991378359167e-10
, O 0 5.176654244154477e-12
together O 0 2.208450653254368e-12
, O 0 6.188058420709963e-13
in O 0 2.273718106154954e-12
a O 0 2.118239394652277e-12
pathway O 0 2.009566513194727e-09
( O 0 1.2530155949277977e-12
s O 0 1.1655455767201062e-10
) O 0 8.172987026738854e-14
associated O 0 1.0355979962461959e-11
with O 0 4.860046826787867e-13
the O 0 1.2051266234935909e-11
activation O 0 3.6170147432734723e-10
of O 0 1.384004244542325e-09
double O 0 2.74786138287908e-10
- O 0 8.461575440321667e-09
strand O 0 5.619663401290609e-09
break O 0 1.5383098128651795e-09
repair O 0 4.3879097688659385e-08
and O 0 1.6422607718169502e-09
/ O 0 9.8856425267968e-09
or O 0 1.4034468032164682e-09
homologous O 0 4.955383214877429e-09
recombination O 0 4.472738268646026e-08
. O 0 2.447980484987511e-08

Dysfunction O 0 0.007265941239893436
of O 0 1.7876740230349242e-06
this O 0 1.0322582788546697e-09
pathway O 0 1.2070331401048406e-08
may O 0 6.661401985574855e-11
be O 0 1.1762733799144942e-12
a O 0 6.590270321647773e-13
general O 0 1.0649317538913294e-10
phenomenon O 0 4.0389136479745957e-10
in O 0 4.874699168627705e-12
the O 0 7.06612589621014e-12
majority O 0 2.9034007186304334e-13
of O 0 3.9937720014773803e-13
cases O 0 8.640655899117e-12
of O 0 4.429689670626402e-10
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.0026648783755263e-08
. O 0 1.6645955724925443e-08

A O 0 3.0330346589835244e-07
novel O 0 8.779238669376355e-08
Arg362Ser O 0 3.953909981646575e-06
mutation O 0 2.3802777526782393e-09
in O 0 2.6746745443451125e-11
the O 0 4.535686062845379e-11
sterol O 0 1.2429545392933505e-07
27 O 0 1.0301959463276944e-07
- O 0 9.948023738104439e-09
hydroxylase O 0 2.0958359527867287e-06
gene O 0 4.223795091462534e-09
( O 0 3.5586481678118176e-11
CYP27 O 1 0.999958872795105
) O 0 4.464114841673528e-11
: O 0 5.688349097310308e-12
its O 0 8.006145225947225e-12
effects O 0 9.490203067841207e-10
on O 0 2.341967508812104e-09
pre O 0 4.15026391920037e-07
- O 0 1.9299005060702257e-08
mRNA O 0 2.0846234960458787e-08
splicing O 0 1.197489218895953e-08
and O 0 2.2526713133741438e-11
enzyme O 0 7.783650946002751e-10
activity O 0 7.105424248976533e-09
. O 0 3.4591511877124503e-09

A O 0 8.490906822089528e-08
novel O 0 6.177047850997042e-08
C O 0 8.069136470112426e-07
to O 0 3.473852455693205e-11
A O 0 2.3192998910293028e-10
mutation O 0 2.782547976754035e-11
in O 0 1.4200097261246603e-12
the O 0 7.679180208386427e-12
sterol O 0 1.4563458883287694e-08
27 O 0 3.799367931378583e-08
- O 0 7.145094738092439e-09
hydroxylase O 0 1.9972001155110775e-06
gene O 0 3.9367549220514775e-09
( O 0 3.910020571207262e-11
CYP27 O 1 0.8250888586044312
) O 0 2.3089613554461152e-11
was O 0 2.211681809916044e-10
identified O 0 1.5119076129943565e-11
by O 0 1.4482055311904052e-11
sequencing O 0 3.8410757241535975e-08
amplified O 0 1.1690695345123459e-07
CYP27 O 0 0.0004049580020364374
gene O 0 4.3357176182645674e-10
products O 0 4.48302772682041e-09
from O 0 4.8831976656726894e-11
a O 0 5.9618390953197764e-12
patient O 0 1.6154559911996103e-09
with O 0 1.3633829308579148e-11
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 1.5169822731309068e-08
CTX B-Disease 0 9.762813715497032e-05
) O 0 1.0047253029554781e-09
. O 0 9.91250992399273e-09

The O 0 1.3309089297308674e-07
mutation O 0 1.280461692232393e-08
changed O 0 4.2943875122603e-09
the O 0 2.1841647934728314e-10
adrenodoxin O 0 1.0856493304345349e-07
cofactor O 0 7.375969168776919e-09
binding O 0 2.891668238191869e-09
residue O 0 7.3724841342937e-08
362Arg O 0 5.2137544059860375e-08
to O 0 2.9458607775367796e-10
362Ser O 0 2.798221601096884e-07
( O 0 3.749868471292217e-10
CGT O 0 5.433036676549818e-06
362Arg O 0 7.835267865630158e-07
to O 0 1.0665264227327498e-08
AGT O 0 4.3343665311113e-05
362Ser O 0 5.730198537889919e-08
) O 0 5.624083664057533e-12
, O 0 1.916259251971697e-12
and O 0 1.2768423471309909e-12
was O 0 6.876621494456003e-11
responsible O 0 1.8577610283454504e-10
for O 0 4.381877083403651e-09
deficiency O 0 0.2585607171058655
in O 0 9.673863843318031e-08
the O 0 2.648311969721817e-08
sterol O 0 6.365447916323319e-06
27 O 0 9.445297450838552e-07
- O 0 1.3734860360159473e-08
hydroxylase O 0 2.1889895833737683e-06
activity O 0 6.199721980237882e-08
, O 0 1.7018517671496536e-12
as O 0 6.945488021520285e-13
confirmed O 0 3.681532509403063e-12
by O 0 3.845701101318211e-12
expression O 0 6.016261794306033e-11
of O 0 9.214616569774847e-11
mutant O 0 5.832410110429009e-10
cDNA O 0 2.1912092140752293e-09
into O 0 1.8919548150364562e-09
COS O 0 2.554700586188119e-06
- O 0 2.2744022487586335e-07
1 O 0 2.665511722454994e-08
cells O 0 3.663947811816115e-09
. O 0 1.3650027774758655e-09

Quantitative O 0 3.243567334720865e-07
analysis O 0 3.0244426962866555e-09
showed O 0 6.384558992600375e-10
that O 0 4.4604931185264485e-13
the O 0 8.799590396624257e-12
expression O 0 8.412806562496655e-11
of O 0 4.178687118550073e-10
CYP27 O 0 8.156904186762404e-06
gene O 0 1.0122380711408141e-10
mRNA O 0 3.797495096158343e-10
in O 0 1.033805940159338e-11
the O 0 4.9316644518127006e-11
patient O 0 5.810250502946701e-09
represented O 0 2.1322352772301656e-09
52 O 0 7.915768662769551e-08
. O 0 4.394954089548264e-08

5 O 0 7.947614477643583e-08
% O 0 2.9385205380094703e-10
of O 0 6.001775465502845e-11
the O 0 1.8311616112320905e-10
normal O 0 1.006024419325513e-07
level O 0 3.5207719406571414e-07
. O 0 4.02898479023861e-08

As O 0 1.3790036668126504e-08
the O 0 2.611242333472319e-10
mutation O 0 7.407994356833925e-11
occurred O 0 5.553564830229618e-10
at O 0 8.721108037124115e-12
the O 0 3.25520578374483e-12
penultimate O 0 6.201292368501754e-09
nucleotide O 0 6.031270483042306e-10
of O 0 1.1937788535476557e-08
exon O 0 1.536342963959214e-08
6 O 0 5.249594536849145e-09
( O 0 6.655527908308589e-13
- O 0 1.2648959657468595e-10
2 O 0 3.3533878451841304e-10
position O 0 1.4191554875697676e-10
of O 0 8.604729151429069e-10
exon O 0 6.351295045448069e-09
6 O 0 3.331930642502812e-08
- O 0 4.954714682980921e-08
intron O 0 1.7325612589047523e-07
6 O 0 2.094663464902169e-08
splice O 0 1.2698502693808678e-08
site O 0 4.526199415266774e-10
) O 0 5.897224440547244e-13
of O 0 8.120509126241515e-11
the O 0 1.202294597213438e-09
gene O 0 2.302313478752538e-10
, O 0 9.240436193991286e-11
we O 0 9.26461268813128e-11
hypothesized O 0 5.141294612265312e-10
that O 0 3.7967578300074356e-13
the O 0 3.6339962289355654e-11
mutation O 0 1.6512682887714902e-10
may O 0 3.605360454628226e-10
partially O 0 2.705328183694178e-09
affect O 0 8.145131236148018e-10
the O 0 5.858887680565417e-11
normal O 0 6.431234989001666e-10
splicing O 0 1.08934661291471e-09
efficiency O 0 7.243054511718583e-08
in O 0 5.249561896292221e-10
exon O 0 1.987705289252517e-08
6 O 0 6.448480638354681e-10
and O 0 1.28981048931609e-12
cause O 0 9.830349208261868e-12
alternative O 0 4.5960824035518044e-10
splicing O 0 6.650994754942019e-10
elsewhere O 0 9.033154779736208e-10
, O 0 1.717300076014422e-13
which O 0 4.611871119914769e-14
resulted O 0 1.2589700115750446e-10
in O 0 3.440932955234288e-11
decreased O 0 1.0295277519389856e-08
transcript O 0 1.0203430322874851e-09
in O 0 3.495946587772636e-11
the O 0 5.129305868933898e-10
patient O 0 1.0866872202086597e-07
. O 0 1.1392094378948059e-08

Transfection O 0 1.90032587852329e-05
of O 0 1.2062119481015543e-07
constructed O 0 3.5682373322742933e-07
minigenes O 0 5.082499046693556e-05
, O 0 1.3671282161897835e-10
with O 0 6.146124733284741e-13
or O 0 3.1823109685608086e-12
without O 0 2.0186191260207487e-11
the O 0 2.178883289072342e-11
mutation O 0 1.026060226366754e-11
, O 0 1.9172317813204165e-12
into O 0 1.6617199283253115e-10
COS O 0 2.0975896859454224e-06
- O 0 7.530967849334047e-08
1 O 0 5.192305252421647e-09
cells O 0 7.513224070665458e-11
confirmed O 0 4.48003743477865e-12
that O 0 1.4871238192704778e-13
the O 0 7.046824929135553e-12
mutant O 0 7.231577003885548e-10
minigene O 0 4.305904965917762e-08
was O 0 4.638097683695719e-10
responsible O 0 3.586729524496235e-11
for O 0 2.061458122259996e-11
a O 0 5.555628179720884e-11
mRNA O 0 5.1158832725661796e-09
species O 0 1.9960796904250344e-11
alternatively O 0 7.800678852865062e-11
spliced O 0 8.912517945880438e-10
at O 0 1.9141972729119772e-10
an O 0 5.972093479467144e-12
activated O 0 1.7074138440875686e-06
cryptic O 0 7.31238344542362e-07
5 O 0 1.4825905836346465e-08
splice O 0 1.5363525562861469e-07
site O 0 3.8224754916882375e-08
88 O 0 9.6580826891568e-08
bp O 0 1.0216970380838575e-08
upstream O 0 1.020728501721635e-09
from O 0 1.3562245076981227e-11
the O 0 6.208635688897957e-11
3 O 0 8.254640859739482e-10
end O 0 1.613928546362331e-09
of O 0 7.884950470327112e-09
exon O 0 4.4860880166197603e-07
6 O 0 2.51190499511722e-07
. O 0 2.6474282321942155e-08

Our O 0 2.075855576322283e-07
data O 0 1.0369232139595397e-09
suggest O 0 1.4109291512909294e-10
that O 0 1.2347122022721146e-12
the O 0 2.1020536700167014e-10
C O 0 2.7991399065285805e-07
to O 0 4.696743688414884e-11
A O 0 4.657814134390037e-10
mutation O 0 4.610136578042656e-11
at O 0 6.058254158752829e-12
the O 0 5.677336639003938e-12
penultimate O 0 1.6978413341917076e-08
nucleotide O 0 8.117973515631149e-10
of O 0 1.6674674974126447e-09
exon O 0 5.185555984610346e-09
6 O 0 8.368863380070479e-10
of O 0 4.681744228407503e-11
the O 0 3.367649492602709e-10
CYP27 O 0 4.871838973485865e-05
gene O 0 1.7596177293022208e-10
not O 0 1.6787241735594094e-11
only O 0 2.1269364741671737e-11
causes O 0 3.043376661793218e-09
the O 0 1.3266650000787195e-09
deficiency B-Disease 0 4.5003613280414356e-08
in I-Disease 0 3.562683759117391e-10
the I-Disease 0 6.090539184100408e-10
sterol I-Disease 0 3.1220045570989896e-07
27 I-Disease 0 1.1590406501227335e-07
- I-Disease 0 1.8406768331757917e-09
hydroxylase I-Disease 0 1.9302214582239685e-07
activity I-Disease 0 3.554366045932511e-08
, O 0 7.113210628156841e-12
but O 0 2.6554498183672948e-11
also O 0 2.606026852647325e-11
partially O 0 4.219849358833017e-09
leads O 0 7.55767809446084e-11
to O 0 3.5433865043510426e-12
alternative O 0 2.417660294184998e-09
pre O 0 4.364777428378375e-09
- O 0 1.4123831271195542e-10
mRNA O 0 2.2741541982895797e-10
splicing O 0 2.4609317361701244e-10
of O 0 7.793867634608986e-11
the O 0 2.0056330207740558e-10
gene O 0 2.7449906236931554e-10
. O 0 3.708905627064496e-09

To O 0 5.3283089052058585e-09
our O 0 1.0355871715717058e-09
knowledge O 0 1.0106258052644534e-09
, O 0 1.3408478971230209e-12
this O 0 4.3851627515821556e-13
is O 0 3.2113694299271134e-13
the O 0 2.029644247808493e-12
first O 0 7.411086501429853e-12
report O 0 3.5619192057662064e-12
regarding O 0 5.900698818450678e-10
effects O 0 9.877345608089172e-10
on O 0 6.340640235080741e-10
pre O 0 3.236446222132372e-09
- O 0 4.5706497614483865e-11
mRNA O 0 5.636253269658553e-11
splicing O 0 5.3028956226164325e-11
of O 0 8.913902602158963e-12
a O 0 3.229403777813694e-13
mutation O 0 1.7343820607126914e-12
at O 0 3.662880328908491e-12
the O 0 4.7701238792274836e-11
- O 0 6.134316943295914e-10
2 O 0 2.2789057307903704e-09
position O 0 3.3333258375733976e-10
of O 0 2.1081486556440154e-10
a O 0 2.35080982458058e-10
5 O 0 1.2344580468948152e-08
splice O 0 1.8341737018090498e-07
site O 0 4.6019994925927676e-08
. O 0 2.3489388212283302e-08

ATM O 0 8.743368380237371e-05
germline O 0 3.5431276046438143e-06
mutations O 0 1.5965196942246962e-09
in O 0 1.8569037973925617e-10
classical O 0 0.00012359475658740848
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 1 1.0
in O 0 2.695751399883761e-10
the O 0 4.1779281423348635e-11
Dutch O 0 1.3525480291320946e-08
population O 0 2.914083557792324e-11
. O 0 6.011974806874321e-10

Germline O 0 0.001295542111620307
mutations O 0 6.27586643986433e-07
in O 0 1.3388106179235137e-09
the O 0 9.086498220511885e-10
ATM O 0 3.754509592113209e-08
gene O 0 4.415749883801556e-12
are O 0 8.182778727609114e-15
responsible O 0 1.6395151092329398e-14
for O 0 1.43515909334542e-13
the O 0 3.196924325266082e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.1890497262356803e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 2.214739280859135e-09
. O 0 2.162231460545172e-08

In O 0 1.2056392506565317e-07
our O 0 7.1807120249900436e-09
study O 0 1.727697845899101e-10
, O 0 8.811816727682942e-12
we O 0 4.087329433244413e-12
have O 0 1.4678463522779794e-12
determined O 0 1.3851259028641039e-10
the O 0 1.1263914800885289e-10
ATM O 0 3.370222856347027e-08
mutation O 0 1.2972403706790203e-10
spectrum O 0 4.321634605730651e-09
in O 0 8.075820394359834e-12
19 O 0 3.1772015574027535e-10
classical O 0 5.42339080311649e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999867677688599
T I-Disease 1 1.0
patients O 0 1.612689629837405e-06
, O 0 4.4299365065982033e-13
including O 0 1.2770974599021767e-13
some O 0 2.8627688869638235e-13
immigrant O 0 9.000490630572955e-11
populations O 0 3.8914184374849725e-12
, O 0 2.7196173373218724e-13
as O 0 3.87007179775134e-12
well O 0 1.951165097546781e-11
as O 0 2.2054420789618945e-11
12 O 0 2.706404024499509e-11
of O 0 1.4967093536766285e-11
Dutch O 0 6.396080554083028e-09
ethnic O 0 3.586422131496292e-11
origin O 0 1.5857188895296304e-09
. O 0 8.45807335281279e-09

Both O 0 1.7820463327211655e-08
the O 0 1.1523627607701314e-09
protein O 0 4.957195764987432e-10
truncation O 0 6.948260988792754e-08
test O 0 5.832393412674719e-07
( O 0 3.6980535300656925e-10
PTT O 0 6.118979172242689e-07
) O 0 3.7380103352913086e-12
and O 0 3.770196394664582e-12
the O 0 9.870781275678198e-12
restriction O 0 2.3979676022634067e-09
endonuclease O 0 4.519802487834568e-08
fingerprinting O 0 3.8471543462037516e-07
( O 0 9.458123173544664e-11
REF O 0 3.187973618423712e-07
) O 0 1.93667434519873e-12
method O 0 1.4109344248502964e-10
were O 0 1.4802261846802445e-11
used O 0 2.1927611636163302e-12
and O 0 7.344792309071924e-12
compared O 0 5.098969579897528e-10
for O 0 1.7322835874078457e-11
their O 0 2.1216327306117222e-11
detection O 0 1.5350358761878624e-09
efficiency O 0 6.1154183939038376e-09
, O 0 2.2369608335820468e-12
identifying O 0 6.468729718545063e-11
76 O 0 5.289728655100134e-09
% O 0 7.231169656118919e-12
and O 0 7.425783078718329e-13
60 O 0 6.664778971765539e-12
% O 0 6.755284265996808e-13
of O 0 3.459330695163021e-12
the O 0 3.1034122494055794e-10
mutations O 0 1.2438475804898985e-09
, O 0 5.607690423126144e-10
respectively O 0 1.6472158392843994e-07
. O 0 2.618969574541552e-07

Most O 0 1.9638329717963643e-07
patients O 0 6.0962400993958e-07
were O 0 6.902814431164472e-10
found O 0 2.2538446803332945e-11
to O 0 1.3170803857265323e-11
be O 0 1.310555691746984e-10
compound O 0 4.426481154951034e-07
heterozygote O 0 1.8716908016358502e-05
. O 0 1.0073339495875189e-07

Seventeen O 0 6.831789960415335e-06
mutations O 0 5.1526779287769386e-08
were O 0 4.353436278137224e-09
distinct O 0 3.824666694463019e-10
, O 0 1.837703773877042e-11
of O 0 8.68646543583651e-11
which O 0 8.358597668178813e-12
10 O 0 4.7792308305316666e-11
were O 0 4.734898931268994e-11
not O 0 1.83137394138555e-11
reported O 0 1.0083552048900657e-10
previously O 0 3.0993261290745977e-09
. O 0 1.7364046200896155e-08

Mutations O 0 1.2545323443191592e-05
are O 0 5.4599120780096655e-09
small O 0 1.6090168086790868e-09
deletions O 0 2.388625262028654e-07
or O 0 3.470315448339534e-07
point O 0 3.955331521865446e-06
mutations O 0 1.24451787542057e-07
frequently O 0 4.4334451665406505e-09
affecting O 0 4.953703580667934e-08
splice O 0 4.632453965314198e-06
sites O 0 2.9017979841228225e-07
. O 0 1.4230158740247134e-07

Moreover O 0 7.642950549779925e-06
, O 0 2.3918009794954287e-09
a O 0 8.846938737150367e-10
16 O 0 5.2814439044368555e-08
. O 0 2.1114708204095223e-08

7 O 0 2.3354084532911656e-06
- O 0 9.197491124268709e-08
kb O 0 1.4400151826521324e-07
genomic O 0 5.207142717011948e-09
deletion O 0 2.5848121421034875e-09
of O 0 5.081282949959132e-09
the O 0 1.3375905938417532e-09
3 O 0 1.0572174247158728e-09
end O 0 5.551160642269792e-10
of O 0 4.018389787585619e-10
the O 0 2.2295854051890274e-10
gene O 0 9.843294582201345e-12
, O 0 3.3727820883400206e-12
most O 0 8.842003518250152e-12
likely O 0 1.7072275537710624e-10
a O 0 6.75836448436884e-13
result O 0 3.241891824434795e-11
of O 0 2.3408053273499263e-10
recombination O 0 9.582653420769915e-11
between O 0 4.490956564962012e-11
two O 0 2.3432564916214815e-11
LINE O 0 2.6220011477562366e-06
elements O 0 3.7546938891352966e-09
, O 0 7.533657725433685e-11
was O 0 1.0816282314252135e-09
identified O 0 1.6955233883564347e-09
. O 0 1.2976303587208804e-08

The O 0 4.4090344886171806e-07
most O 0 4.01547239903266e-09
frequently O 0 1.3442549851028218e-10
found O 0 3.6555871177346155e-12
mutation O 0 6.758187759414724e-12
, O 0 5.873538959887126e-13
identified O 0 1.0936675176598243e-11
in O 0 3.8659197371115894e-11
three O 0 8.122657928211208e-12
unrelated O 0 3.600084896859812e-09
Turkish O 0 7.105034427468127e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999997615814209
T I-Disease 1 1.0
individuals O 0 4.2472370065382847e-10
, O 0 1.2167272397944906e-12
was O 0 1.6485075457484122e-11
previously O 0 7.678199222260762e-12
described O 0 8.892065035681629e-12
to O 0 7.523325495570332e-13
be O 0 2.1550012208743086e-12
a O 0 6.374891066418531e-12
Turkish O 0 5.086521781549891e-08
A B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
T I-Disease 1 1.0
founder O 0 4.091475148015888e-06
mutation O 0 1.3321418634859583e-07
. O 0 1.0314204601513666e-08

The O 0 4.6170338663387156e-08
presence O 0 7.2764088088206336e-09
of O 0 1.601195442901826e-08
a O 0 3.059994480025807e-09
founder O 0 2.2632548279943876e-07
mutation O 0 3.063991016460932e-08
among O 0 5.782553325062167e-10
relatively O 0 8.71639371791133e-10
small O 0 1.0627189232781387e-12
ethnic O 0 3.4146730581996465e-13
population O 0 7.949576327076491e-14
groups O 0 1.0579757285088948e-13
in O 0 8.882923693484535e-13
Western O 0 1.052553488811725e-09
Europe O 0 2.723041792052072e-10
could O 0 2.5858353652763455e-11
indicate O 0 1.2380833858127716e-10
a O 0 4.04607987739003e-12
high O 0 2.174122826215097e-10
carrier O 0 5.735489774089109e-12
frequency O 0 2.139239653475844e-11
in O 0 3.125620422206321e-12
such O 0 2.128711096283098e-10
communities O 0 3.540993498418743e-09
. O 0 1.2326464293721529e-08

In O 0 5.178560869012472e-08
patients O 0 9.992450600293523e-08
of O 0 9.086532637425648e-10
Dutch O 0 5.5080718652789074e-08
ethnic O 0 1.835895845070379e-11
origin O 0 1.8322342254517565e-10
, O 0 8.066625167314767e-13
however O 0 2.319068721778894e-11
, O 0 5.663911180342485e-13
no O 0 9.507110810408337e-13
significant O 0 4.9059579315668955e-11
founder O 0 2.96258595433585e-09
effect O 0 2.825196077083092e-08
could O 0 3.2209519496007033e-09
be O 0 8.672563778233666e-10
identified O 0 5.032660954640278e-09
. O 0 1.0142489514919362e-08

The O 0 3.397472170263427e-08
observed O 0 6.542042019219707e-09
genetic O 0 1.1341854122548511e-09
heterogeneity O 0 4.400739328502823e-09
including O 0 5.2346117024315575e-11
the O 0 3.756618904837694e-10
relative O 0 4.6111992446640215e-07
high O 0 1.4898567997079226e-06
percentage O 0 2.1438301800458248e-08
of O 0 1.034714425252048e-09
splice O 0 4.223171345074661e-06
- O 0 8.675448839312594e-07
site O 0 9.425971825294255e-08
mutations O 0 1.6079184650408251e-09
had O 0 8.438616472261629e-11
no O 0 1.667828375406799e-11
reflection O 0 6.449316636292224e-10
on O 0 6.35269725712817e-10
the O 0 8.912551807682689e-10
phenotype O 0 2.944628931800253e-07
. O 0 1.8831137538199982e-08

All O 0 5.539148251187953e-09
patients O 0 3.4532183779134584e-09
manifested O 0 1.5747356751916186e-09
classical O 0 2.0055399829743692e-07
A B-Disease 1 1.0
- I-Disease 1 0.9999972581863403
T I-Disease 1 1.0
and O 0 7.404876711802899e-10
increased O 0 9.753318153116197e-10
cellular O 0 1.1291216850395358e-09
radioresistant O 0 1.2992747322471132e-08
DNA O 0 3.002875725854892e-09
synthesis O 0 1.7445310973585038e-08
. O 0 1.1559559531804098e-08

Determination O 0 4.147086656303145e-07
of O 0 5.149590087683009e-09
the O 0 3.0049027155421015e-10
genomic O 0 9.888579954875354e-10
structure O 0 2.6817151277391815e-10
of O 0 2.6537905206680534e-10
the O 0 4.1438202869059637e-10
COL4A4 O 0 0.031812530010938644
gene O 0 9.6318730768985e-11
and O 0 1.355256835575136e-12
of O 0 2.6611896714046068e-11
novel O 0 2.527412945596552e-08
mutations O 0 2.9248025157357915e-07
causing O 0 7.947908670757897e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.6084598327288404e-05

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 1.7187486989200806e-09
a O 0 2.73755046409363e-10
progressive O 1 0.6021947264671326
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 0.0001374247221974656
by O 0 1.4641268819559627e-07
glomerular B-Disease 1 0.9999998807907104
basement I-Disease 1 0.9792959690093994
membrane I-Disease 0 6.700506673951168e-07
abnormalities I-Disease 0 1.7639325733398437e-06
and O 0 1.052982701033045e-10
associated O 0 5.999775121168227e-10
with O 0 1.2019454875833446e-10
mutations O 0 1.0451236542863285e-09
in O 0 3.130068149115317e-10
either O 0 7.884765618193512e-10
the O 0 2.2012545120020377e-09
COL4A3 O 1 0.9995347261428833
or O 0 6.195700397171322e-09
the O 0 1.915528713425374e-08
COL4A4 O 0 0.2040305733680725
gene O 0 7.48779149795098e-10
, O 0 6.209437478088553e-12
which O 0 1.441249571944303e-12
encode O 0 4.390221866601429e-11
the O 0 9.008872120519484e-11
alpha3 O 0 3.287897811787843e-07
and O 0 4.922250385064331e-10
alpha4 O 0 1.0634053069225047e-06
type O 0 1.0747282885859022e-06
IV O 1 1.0
collagen O 0 0.00021637110330630094
chains O 0 1.7629774902161444e-06
, O 0 1.0884784185094531e-09
respectively O 0 1.3763548523115787e-08
. O 0 2.279150201900393e-08

To O 0 8.833836995236766e-10
date O 0 3.146490357153198e-08
, O 0 2.5424362268267053e-11
mutation O 0 3.790992693375461e-12
screening O 0 4.0546055402046477e-10
in O 0 7.599699342053512e-11
the O 0 1.1205869565600324e-09
two O 0 1.0618163986952922e-10
genes O 0 1.9987598243176308e-09
has O 0 7.886698238923628e-12
been O 0 1.6119086967969487e-11
hampered O 0 3.336262182074279e-07
by O 0 7.561917064746737e-11
the O 0 3.3922240016970306e-10
lack O 0 3.48186901533154e-09
of O 0 1.0086379648166499e-10
genomic O 0 3.1049396387317074e-10
structure O 0 3.7469014002589063e-10
information O 0 4.5119255553949245e-10
. O 0 9.352257634986927e-09

We O 0 1.4679137017026278e-08
report O 0 3.1054195326341016e-10
here O 0 5.0965363873611835e-11
the O 0 3.166363221965285e-12
complete O 0 8.480535718113913e-11
characterization O 0 1.776595093261335e-09
of O 0 5.774981048922712e-10
the O 0 8.238314475050856e-10
48 O 0 5.063867547505652e-09
exons O 0 9.654519406154805e-10
of O 0 1.5968386335440954e-10
the O 0 9.533981382148227e-10
COL4A4 O 0 0.03597668930888176
gene O 0 1.116363113062846e-09
, O 0 9.151172875032643e-12
a O 0 4.522449689042807e-12
comprehensive O 0 2.0636004016694187e-09
gene O 0 5.838361738508269e-11
screen O 0 6.092598869855692e-09
, O 0 2.1618117018729066e-11
and O 0 1.1106784762737743e-11
the O 0 4.607330142403221e-12
subsequent O 0 2.746660017483027e-11
detection O 0 6.535129104534576e-10
of O 0 8.609386814573128e-11
10 O 0 8.65872581967686e-11
novel O 0 6.126423812702342e-10
mutations O 0 1.961498186098254e-10
in O 0 1.8081123404067867e-11
eight O 0 2.7638566435506107e-10
patients O 0 4.715447943226536e-08
diagnosed O 0 1.556407255520753e-06
with O 0 1.1927799903332925e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.0223899153061211e-05

Furthermore O 0 9.358226975564321e-07
, O 0 2.1570236707901813e-09
we O 0 1.9933377171099664e-10
identified O 0 2.768647255901868e-10
a O 0 2.694572863448652e-11
glycine O 0 9.324075955774447e-10
to O 0 1.7693707610177967e-10
alanine O 0 9.660031885516673e-09
substitution O 0 1.0704617352530477e-06
in O 0 1.3272326349067498e-08
the O 0 1.6896026799884112e-09
collagenous O 0 2.625093316055427e-07
domain O 0 3.337352894039469e-10
that O 0 3.7210713026494813e-13
is O 0 2.9493475803971103e-13
apparently O 0 1.3712014163003161e-11
silent O 0 1.2868285603762075e-10
in O 0 2.855375658139536e-12
the O 0 2.679545821338003e-11
heterozygous O 0 2.2464368906738308e-11
carriers O 0 6.845748967698739e-11
, O 0 3.2114998594484634e-12
in O 0 8.907414389414114e-11
11 O 0 4.351643045907849e-09
. O 0 1.1219306372822757e-08

5 O 0 6.33930383742154e-08
% O 0 2.4909377338566685e-10
of O 0 5.691781768124571e-11
all O 0 3.016568331931646e-12
control O 0 4.7934909513935864e-11
individuals O 0 1.095584213628431e-11
, O 0 2.0595166197456827e-11
and O 0 9.233036557532159e-11
in O 0 9.868866140960719e-11
one O 0 3.6146591362445912e-12
control O 0 2.801313868372457e-11
individual O 0 4.782492978028241e-12
homozygous O 0 2.2426567547473297e-11
for O 0 2.048096718262893e-12
this O 0 1.1561747219335228e-11
glycine O 0 2.723931524784007e-09
substitution O 0 4.4699413592752535e-07
. O 0 1.1488688755889598e-07

There O 0 8.809259099962219e-09
has O 0 6.513172379901677e-12
been O 0 2.2015072057013363e-12
no O 0 1.5270175532031138e-12
previous O 0 1.5264367547729307e-10
finding O 0 2.435097123942853e-10
of O 0 9.094330843950615e-11
a O 0 6.863370115295364e-12
glycine O 0 8.668276513246198e-11
substitution O 0 2.2249018627462647e-08
that O 0 2.218241909601737e-11
is O 0 3.347702757366955e-12
not O 0 1.3597853312091734e-12
associated O 0 2.8639405083574765e-11
with O 0 6.862973730981103e-13
any O 0 1.3611853311168431e-10
obvious O 0 3.946182047798175e-09
phenotype O 0 2.7057062368385232e-08
in O 0 1.5186105151165918e-10
homozygous O 0 1.218368628208566e-09
individuals O 0 9.437616660390447e-11
. O 0 5.623416399203052e-09

Founder O 0 0.005216230172663927
BRCA1 O 0 0.00030517313280142844
and O 0 4.178432391199749e-07
BRCA2 O 0 1.109128334064735e-06
mutations O 0 7.134006718700903e-10
in O 0 2.099556292711746e-11
French O 0 1.491015844123922e-08
Canadian O 0 5.019902346248273e-06
breast B-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.7518043427553494e-07
. O 0 4.380634521794491e-08

We O 0 6.232718874343846e-08
have O 0 3.6016625792889556e-10
identified O 0 2.84680834461426e-10
four O 0 7.785706974960949e-12
mutations O 0 1.1610785249915878e-11
in O 0 2.2964078555398615e-12
each O 0 7.162928019818771e-13
of O 0 3.479178611875966e-10
the O 0 7.583332717331359e-07
breast B-Disease 1 0.9998742341995239
cancer I-Disease 0 0.0020287297666072845
- O 0 0.0042966571636497974
susceptibility O 0 0.3416026532649994
genes O 0 1.639261171249018e-07
, O 0 1.392148063494858e-09
BRCA1 O 0 2.1580454756531253e-08
and O 0 7.545208902115519e-10
BRCA2 O 0 3.990056729463731e-09
, O 0 2.1067224570750498e-13
in O 0 2.6780717942744003e-13
French O 0 2.880431448915033e-10
Canadian O 0 1.0651197257516287e-08
breast B-Disease 0 2.050201601377921e-06
cancer I-Disease 0 1.6704116205801256e-06
and O 0 0.007239053025841713
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 4.296173639062317e-09
from O 0 4.3829451179533407e-10
Quebec O 0 7.995890172196596e-08
. O 0 6.570478827683246e-09

To O 0 3.9390593542520946e-07
identify O 0 1.7690574622974964e-06
founder O 0 5.501317446032772e-06
effects O 0 4.716622242995072e-06
, O 0 2.0343913220699505e-09
we O 0 1.353031714446118e-10
examined O 0 2.6591830959432627e-09
independently O 0 2.425844247699871e-10
ascertained O 0 3.49773934260611e-08
French O 0 7.207840102552154e-09
Canadian O 0 1.4084676536185725e-08
cancer B-Disease 0 2.985037639291477e-08
families O 0 3.3519389520952902e-12
for O 0 3.052718668128396e-13
the O 0 5.609139454992862e-12
distribution O 0 1.2339648747250465e-10
of O 0 3.47056938743151e-10
these O 0 2.252750874731646e-09
eight O 0 3.052620156651642e-09
mutations O 0 3.6554042015524146e-09
. O 0 2.776148377847676e-08

Mutations O 0 7.229444918266381e-07
were O 0 6.924074646974532e-09
found O 0 6.879231212453263e-11
in O 0 4.8934818003276703e-11
41 O 0 2.9857820660339485e-09
of O 0 3.156049588337595e-10
97 O 0 3.4575506902001507e-07
families O 0 1.8132945145410417e-09
. O 0 8.545655738600999e-09

Six O 0 1.0384462001411521e-07
of O 0 1.0111642190224757e-08
eight O 0 1.0861018751029405e-09
mutations O 0 3.8715744499207005e-10
were O 0 4.5889170241508737e-10
observed O 0 1.0738785416464225e-09
at O 0 8.069438450775124e-10
least O 0 2.3795188042186055e-10
twice O 0 9.760916519496732e-09
. O 0 1.541188687781414e-08

The O 0 4.656318196794018e-06
BRCA1 O 0 1.7596549923837301e-06
C4446T O 0 1.0023046570495353e-06
mutation O 0 6.449517364615076e-09
was O 0 3.317684460490966e-10
the O 0 3.2286000262171655e-11
most O 0 1.409970664528748e-11
common O 0 5.195906552235563e-11
mutation O 0 9.517497900901617e-11
found O 0 5.625488790073074e-12
, O 0 6.378183571575935e-13
followed O 0 7.09706043933167e-11
by O 0 1.6869676489061902e-10
the O 0 4.6679485166123413e-08
BRCA2 O 0 6.105037186898699e-07
8765delAG O 0 7.264671921802801e-07
mutation O 0 1.217440512846224e-07
. O 0 2.1138198746939452e-08

Together O 0 8.410636809230709e-08
, O 0 9.551563984189215e-10
these O 0 2.5890245503035203e-10
mutations O 0 1.4405338033540716e-10
were O 0 1.2612484667773316e-10
found O 0 4.058647948973482e-12
in O 0 3.334110982092242e-12
28 O 0 1.4244362356308216e-09
of O 0 3.0799895966993063e-10
41 O 0 2.8640856353234767e-09
families O 0 7.92518047715296e-12
identified O 0 7.155148435550318e-12
to O 0 1.542147833044627e-11
have O 0 4.0047604121795644e-11
a O 0 3.918174951156317e-10
mutation O 0 4.7565123395543196e-08
. O 0 5.847564565897301e-08

The O 0 1.362745933874976e-07
odds O 0 1.0952519602369648e-07
of O 0 1.1652211140411595e-10
detection O 0 2.5105000300840175e-09
of O 0 3.26155435992348e-10
any O 0 1.3210989247003369e-10
of O 0 2.81636025611931e-09
the O 0 6.319309964197828e-09
four O 0 9.97823379478291e-10
BRCA1 O 0 1.4528945158076567e-08
mutations O 0 2.419688893695593e-10
was O 0 2.537332788321578e-09
18 O 0 1.143598460373596e-08
. O 0 3.388366920376029e-08

7x O 0 0.00038496233173646033
greater O 0 2.902274047755782e-07
if O 0 1.3048576441576643e-08
one O 0 1.0216843343568982e-10
or O 0 1.054553926821411e-11
more O 0 6.786562956571929e-13
cases O 0 2.5693960847839037e-10
of O 0 2.8901624318677932e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 8.170540910512614e-10
also O 0 5.479681378789403e-13
present O 0 9.189758329308795e-12
in O 0 2.5785262813826648e-11
the O 0 4.76585215736236e-10
family O 0 2.818239530633093e-10
. O 0 2.291816958432946e-09

The O 0 1.0744858514044608e-07
odds O 0 6.862362056381244e-08
of O 0 4.4403970084205824e-11
detection O 0 2.162560353013987e-09
of O 0 7.115521366563016e-11
any O 0 3.2469665844914175e-11
of O 0 1.451699871424239e-09
the O 0 3.783110269495182e-09
four O 0 1.418149708776184e-09
BRCA2 O 0 6.629520754586338e-08
mutations O 0 6.496540527756167e-10
was O 0 1.8153500924711352e-09
5 O 0 1.6366268340561874e-08
. O 0 7.59588125731625e-09

3x O 0 9.98898030957207e-07
greater O 0 4.395806829649018e-09
if O 0 2.360613648999532e-10
there O 0 1.9647585641768828e-11
were O 0 5.090386792638846e-11
at O 0 1.0848399435714473e-11
least O 0 6.090018355060789e-13
five O 0 8.156059242694566e-14
cases O 0 1.631817077296649e-12
of O 0 2.519200847928005e-09
breast B-Disease 0 0.008017884567379951
cancer I-Disease 0 5.218175283516757e-05
in O 0 1.5412974008199853e-08
the O 0 2.6053703550132923e-07
family O 0 9.077789187017515e-09
. O 0 3.097879641700274e-08

Interestingly O 0 1.5001977544670808e-06
, O 0 6.338427560592663e-10
the O 0 2.2822364831309727e-10
presence O 0 5.078373832567706e-10
of O 0 8.606375168085378e-09
a O 0 9.65130286800786e-09
breast B-Disease 0 4.649289621738717e-06
cancer I-Disease 0 9.723774496706028e-08
case O 0 6.4142349209816985e-09
< O 0 7.891348019484212e-08
36 O 0 1.7276163832846692e-09
years O 0 8.162557435520412e-12
of O 0 1.4229222834727384e-11
age O 0 1.692382067819409e-10
was O 0 2.1037973446658143e-11
strongly O 0 8.224944163248704e-12
predictive O 0 9.79479344853651e-11
of O 0 3.06932673721505e-11
the O 0 7.757927113216656e-12
presence O 0 1.4128747000477504e-12
of O 0 1.2024699812263062e-11
any O 0 4.7016550375200694e-11
of O 0 4.845965850819312e-10
the O 0 2.3552315653319056e-09
eight O 0 2.114960206966998e-09
mutations O 0 1.4554397687049914e-09
screened O 0 4.322221869301757e-08
. O 0 1.969342555696585e-08

Carriers O 0 9.026513936305491e-08
of O 0 2.529258580352689e-09
the O 0 5.571261230130631e-10
same O 0 2.806459786786064e-10
mutation O 0 1.515991360223623e-10
, O 0 1.4088651035734645e-12
from O 0 4.693401049749024e-12
different O 0 7.350496079860935e-12
families O 0 1.511835448497756e-11
, O 0 4.220259666905257e-13
shared O 0 4.528120500085775e-12
similar O 0 3.549482929798842e-11
haplotypes O 0 2.9648530297521347e-09
, O 0 9.458335156753428e-12
indicating O 0 1.0907266062565313e-10
that O 0 5.75524491345375e-13
the O 0 2.602212195723652e-11
mutant O 0 5.707112560315863e-10
alleles O 0 3.0061279854276535e-11
were O 0 1.275726191352078e-10
likely O 0 1.3262038689454414e-10
to O 0 1.8949243216215272e-12
be O 0 1.5524793907026324e-12
identical O 0 3.008634313905745e-11
by O 0 2.0115805722531466e-12
descent O 0 9.481640472763786e-11
for O 0 1.4770948136497153e-12
a O 0 1.0108478724207837e-12
mutation O 0 2.9344755791971266e-11
in O 0 1.373567752593896e-11
the O 0 3.9325950829116607e-10
founder O 0 9.267520972855436e-09
population O 0 6.576138245062424e-11
. O 0 1.7286513331882247e-09

The O 0 1.372859381731928e-09
identification O 0 4.709737488894916e-09
of O 0 8.503285187089205e-09
common O 0 4.7498215280938894e-05
BRCA1 O 0 0.0010690087219700217
and O 0 3.0281439649115782e-06
BRCA2 O 0 2.5429405923205195e-06
mutations O 0 1.5361254490642295e-09
will O 0 5.9275058819641124e-12
facilitate O 0 4.778793333271025e-11
carrier O 0 6.270613368830613e-12
detection O 0 2.5687885152336776e-10
in O 0 8.450756587563557e-12
French O 0 2.8338511537384647e-09
Canadian O 0 8.076528956735274e-08
breast B-Disease 0 0.0001523187238490209
cancer I-Disease 0 0.00036109265056438744
and O 1 0.9367349147796631
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.3970563129723814e-08
. O 0 1.4568098727352208e-08

Are O 0 1.0745494449793114e-07
Dp71 O 0 7.930915307952091e-05
and O 0 1.270291072330565e-08
Dp140 O 0 5.230300757830264e-06
brain O 0 3.375518247139553e-07
dystrophin O 0 1.264701268155477e-06
isoforms O 0 8.684639851708198e-08
related O 0 6.819603726171408e-08
to O 0 1.4968792871883352e-09
cognitive B-Disease 0 2.0183613742119633e-05
impairment I-Disease 1 0.9999988079071045
in O 0 0.004842039663344622
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 1 0.9999732971191406

Molecular O 0 1.936362423293758e-06
study O 0 2.8030482379648447e-09
and O 0 3.486244626316193e-11
neuropsychological O 0 4.409393739024381e-09
analysis O 0 5.665915653318976e-11
were O 0 1.5456647073364138e-10
performed O 0 6.4388175347041e-11
concurrently O 0 5.083565859931305e-11
on O 0 5.493901444886262e-10
49 O 0 2.5061557273886592e-09
patients O 0 3.8312397698803125e-09
with O 0 1.8850532246261764e-09
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.0216715509159258e-06
DMD B-Disease 1 1.0
) O 0 1.5193428112847407e-11
in O 0 3.803972328103589e-12
order O 0 4.413495263699829e-11
to O 0 3.2254778275370155e-12
find O 0 4.472371258057439e-12
a O 0 8.613282206611575e-14
molecular O 0 2.4260836395395557e-11
explanation O 0 2.958918179918335e-11
for O 0 4.147643166418913e-12
the O 0 7.908472765549845e-10
cognitive B-Disease 0 3.8243646827140765e-07
impairment I-Disease 0 1.96597829926759e-06
observed O 0 1.9734786249614444e-08
in O 0 1.6268163482990872e-09
most O 0 1.562007945210553e-08
DMD B-Disease 1 1.0
patients O 0 0.0002775208849925548
. O 0 7.004039304092657e-08

Complete O 0 1.0732852828709838e-08
analysis O 0 8.181659794104235e-10
of O 0 2.306190793888163e-09
the O 0 4.00670474576259e-09
dystrophin O 0 9.108663334700395e-07
gene O 0 9.239564668916955e-09
was O 0 1.5147298526585473e-08
performed O 0 3.2014748629904943e-09
to O 0 6.33267188687725e-11
define O 0 2.1471149302954018e-09
the O 0 9.355251018305921e-10
localization O 0 8.543017884221626e-07
of O 0 3.890081590185446e-09
deletions O 0 1.4031184214502446e-08
and O 0 2.7515956180224066e-10
duplications O 0 2.2743504857203334e-09
in O 0 1.1877453187647546e-10
relation O 0 8.084319880197199e-10
to O 0 4.311453971617141e-11
the O 0 7.332607299126437e-10
different O 0 2.503366758332959e-08
DMD B-Disease 1 1.0
promoters O 0 0.00021328634466044605
. O 0 1.389356043546286e-07

Qualitative O 0 3.811693005673078e-08
analysis O 0 1.3982792701483504e-09
of O 0 1.4842145290572262e-08
the O 0 5.830624871805412e-08
Dp71 O 0 0.00048246074584312737
transcript O 0 4.916766371820813e-08
and O 0 2.4225415076739587e-11
testing O 0 4.662540145639049e-11
for O 0 1.9454153999537427e-12
the O 0 1.0961526825115087e-11
specific O 0 6.664757634666785e-11
first O 0 5.771479405503044e-10
exon O 0 6.349490266899238e-09
of O 0 1.6670158586862271e-09
Dp140 O 0 1.3405523304754752e-06
were O 0 7.500731591392196e-09
also O 0 2.6789018919837204e-11
carried O 0 1.2891057665775918e-10
out O 0 7.150705028102777e-11
. O 0 1.3022387612693365e-09

Neuropsychological O 0 1.9746476027648896e-05
analysis O 0 8.582491162201222e-09
assessed O 0 2.5858619778773573e-07
verbal O 0 1.6138714897806494e-07
and O 0 3.530647996186076e-09
visuospatial O 0 5.923550929765042e-07
intelligence O 0 1.665388826843639e-09
, O 0 1.5437907896487246e-10
verbal O 0 1.399451861061607e-07
memory O 1 0.9951530694961548
, O 0 2.236884100170755e-08
and O 0 1.7309186972624957e-08
reading O 0 2.9282033210620284e-05
skills O 0 4.6861291025379614e-07
. O 0 2.1921927384482842e-08

Comparison O 0 4.036887276015477e-06
of O 0 6.59472476627343e-08
molecular O 0 3.182815646596282e-07
and O 0 5.6046776109042185e-09
psychometric O 0 1.303345288761193e-05
findings O 0 1.1871015459519185e-07
demonstrated O 0 1.2405619642663623e-08
that O 0 2.349378677712899e-11
deletions O 0 8.052100319844158e-09
and O 0 3.851680085986686e-10
duplications O 0 8.997667499954787e-09
that O 0 1.0571055315822253e-11
were O 0 1.629632123689717e-10
localized O 0 2.625557105062626e-09
in O 0 5.154527846218393e-11
the O 0 2.3281375438610752e-10
distal O 0 4.570953038296466e-08
part O 0 4.398742259326127e-09
of O 0 8.456448341576106e-08
the O 0 3.529822549808159e-07
gene O 0 6.546011288577347e-09
seemed O 0 7.59568195007887e-08
to O 0 5.166021256608477e-12
be O 0 1.5325565469459512e-11
preferentially O 0 2.1488273382885836e-09
associated O 0 1.744922983881736e-09
with O 0 6.17124851221007e-10
cognitive B-Disease 0 7.226082379929721e-05
impairment I-Disease 1 0.9191402792930603
. O 0 1.0591397767711896e-05

Two O 0 5.1898727093657726e-08
altered O 0 2.706196937651839e-06
Dp71 O 0 0.0008227574871852994
transcripts O 0 1.229941858582606e-06
and O 0 4.4374464103213995e-09
two O 0 1.1034848729218893e-10
deleted O 0 1.6570871341770044e-09
Dp140 O 0 4.510355466891269e-08
DNA O 0 1.08078679339485e-09
sequences O 0 9.73849386548542e-12
were O 0 1.039052524576256e-11
found O 0 7.058739985750517e-13
in O 0 2.1563952880276904e-12
four O 0 5.527509873426428e-12
patients O 0 3.865509023981417e-10
with O 0 1.5858443030980496e-11
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 1 0.8430648446083069

These O 0 5.289771465299964e-08
findings O 0 5.036223438281695e-09
suggest O 0 7.579350480568792e-10
that O 0 1.13157356748661e-12
some O 0 1.3061847610462696e-12
sequences O 0 8.062010802868669e-13
located O 0 5.187378304682966e-12
in O 0 2.2620043858834205e-12
the O 0 7.988484873600044e-11
distal O 0 3.694715644542157e-08
part O 0 4.226406336016453e-09
of O 0 7.059080786575578e-08
the O 0 1.03953770036469e-08
gene O 0 5.7680867027176674e-11
and O 0 3.75663146423566e-11
, O 0 6.952048528865995e-13
in O 0 7.136281583025594e-13
particular O 0 7.540411003925662e-12
, O 0 1.9353476341053139e-13
some O 0 8.141345128435951e-13
DMD B-Disease 1 0.9997703433036804
isoforms O 0 1.4253529023733336e-08
expressed O 0 2.661395326342131e-09
in O 0 7.410725921808137e-10
the O 0 2.6227591209959655e-09
brain O 0 2.4211411542296446e-08
may O 0 1.251607706365121e-10
be O 0 5.5337756946216565e-12
related O 0 7.550999825411964e-09
to O 0 2.3192556208861959e-10
the O 0 1.0145953410756192e-08
cognitive B-Disease 0 5.409472123574233e-06
impairment I-Disease 0 4.7540306695736945e-05
associated O 0 1.0494007938177674e-06
with O 0 2.8424327780385283e-08
DMD B-Disease 1 1.0
. O 0 9.936043454672472e-08
. O 0 2.0010077150800498e-08

I1307K O 0 0.00016232354391831905
APC O 0 7.788982657075394e-06
and O 0 7.200612106572635e-09
hMLH1 O 0 5.858270242242725e-07
mutations O 0 8.742722101828804e-09
in O 0 3.883071988952658e-11
a O 0 1.2974427088252583e-11
non O 0 2.611295002452607e-08
- O 0 2.38058661672369e-09
Jewish O 0 2.7706876792876756e-09
family O 0 4.199320578768262e-12
with O 0 1.0379011018690765e-12
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.7357115211780183e-05

We O 0 2.6192696900295687e-09
describe O 0 3.72278791127556e-10
a O 0 8.086872317625282e-12
French O 0 1.4728039898770362e-09
Canadian O 0 3.188550934396517e-08
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.0916980386355135e-07
HNPCC B-Disease 1 0.9999984502792358
) O 0 8.786785743453152e-10
kindred O 0 2.866082695618388e-07
which O 0 1.898524740195917e-11
carries O 0 9.628033786901469e-11
a O 0 1.7795190234565217e-12
novel O 0 6.620353709685389e-10
truncating O 0 7.965127224451862e-08
mutation O 0 2.0493424734979726e-09
in O 0 3.1849131665318e-10
hMLH1 O 0 1.0707722140068654e-06
. O 0 8.435281273477813e-08

Interestingly O 0 6.661207976321748e-07
, O 0 7.297809578865611e-10
the O 0 1.1014772427486719e-09
I1307K O 0 6.896437412251544e-07
APC O 0 8.532386175374995e-08
polymorphism O 0 5.3716258108238435e-09
, O 0 9.247378036925102e-12
associated O 0 4.656399224534091e-11
with O 0 7.886739221765748e-13
an O 0 1.7194272806768385e-13
increased O 0 3.411644577955286e-10
risk O 0 5.3985697689995504e-08
of O 0 0.005200713407248259
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 3.875070486714094e-09
is O 0 1.2441755525144371e-12
also O 0 5.707656298547387e-14
present O 0 1.5050447867148709e-12
in O 0 8.256443272125491e-12
this O 0 3.5530186431875777e-11
family O 0 3.1670913114290045e-10
. O 0 2.2032957680551135e-09

The O 0 3.430683079841401e-07
I1307K O 0 6.036879312887322e-06
polymorphism O 0 3.648012807389023e-07
has O 0 2.2759072404454628e-10
previously O 0 5.83674705789683e-11
only O 0 1.8144854108809172e-12
been O 0 3.731108304261266e-12
identified O 0 2.5241174168161296e-12
in O 0 2.211266326296313e-12
individuals O 0 9.63844238796585e-13
of O 0 2.2584285830351547e-10
self O 0 3.0790648253287145e-08
- O 0 4.004781573030414e-08
reported O 0 7.208798558089313e-10
Ashkenazi O 0 3.117244062877944e-08
Jewish O 0 7.2363266490071965e-09
origins O 0 1.997343268556051e-08
. O 0 2.9330291528850694e-09

In O 0 2.504177532003382e-09
addition O 0 3.4815486604777846e-10
, O 0 1.0697233897294378e-11
in O 0 5.3355011381261974e-12
this O 0 9.084305356565903e-12
family O 0 7.945734348258071e-12
, O 0 6.260380126625609e-13
there O 0 7.650959401618584e-13
appears O 0 1.726672450852451e-11
to O 0 1.048496467599691e-12
be O 0 1.9779374318962262e-11
no O 0 4.3714046271681184e-11
relationship O 0 1.2849981495532958e-11
between O 0 7.380872996121113e-11
the O 0 2.0291276991990514e-10
I1307K O 0 5.797719193623152e-09
polymorphism O 0 1.1726974946668633e-09
and O 0 1.4320843122472837e-11
the O 0 1.502578790557596e-11
presence O 0 5.3400242561174593e-11
or O 0 1.7593558554462874e-10
absence O 0 3.5179257906747807e-07
of O 0 1.2188962728032493e-07
cancer B-Disease 0 1.6175462178580347e-06
. O 0 1.3868739490163762e-09
. O 0 1.2243726033034363e-08

Identification O 0 7.243151856073382e-08
of O 0 1.199017551911652e-09
a O 0 1.0940180185381454e-11
novel O 0 1.9968955655702558e-10
mutation O 0 2.1149793028030217e-10
of O 0 7.516753330882864e-10
the O 0 7.381080990853661e-08
CPO O 0 9.785313159227371e-05
gene O 0 1.3704282153526037e-10
in O 0 8.281520434694212e-12
a O 0 1.06751395917426e-11
Japanese O 0 5.4076181754680874e-08
hereditary B-Disease 1 0.52153480052948
coproporphyria I-Disease 1 0.9999796152114868
family O 0 2.1696351382161083e-07
. O 0 6.062948187945949e-08

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 7.565515261376277e-06
HCP B-Disease 1 1.0
) O 0 3.9499453707847465e-10
is O 0 1.619452488776929e-11
an O 0 1.8314854841050554e-11
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 1.607407966730534e-07
by O 0 3.4897923439913825e-10
a O 0 1.2011960870417226e-10
deficiency B-Disease 0 2.662834219790966e-07
of I-Disease 0 8.241968885158713e-08
coproporphyrinogen I-Disease 1 0.9313674569129944
oxidase I-Disease 0 7.775378435326274e-06
( O 0 2.762612638651518e-10
CPO O 0 4.573700351784282e-08
) O 0 7.540258836150754e-14
caused O 0 1.1263474961747955e-12
by O 0 5.164225167289538e-13
a O 0 4.972162005040248e-12
mutation O 0 2.526350240117381e-10
in O 0 2.41227454678139e-10
the O 0 4.9507850263807995e-08
CPO O 0 0.0005010116146877408
gene O 0 3.296518968909368e-08
. O 0 5.487780541102438e-08

Only O 0 1.7030727050837413e-08
11 O 0 6.196007706904538e-09
mutations O 0 4.023182897938682e-10
of O 0 1.071529642793223e-09
the O 0 9.523899890950815e-09
gene O 0 1.515370717797282e-09
have O 0 1.1737734395556032e-10
been O 0 5.9347603220683e-11
reported O 0 2.329750004026465e-10
in O 0 5.741639164114076e-09
HCP B-Disease 1 1.0
patients O 1 0.6424431800842285
. O 0 4.902915975435462e-07

We O 0 1.8375628130229416e-08
report O 0 2.4822444100180974e-10
another O 0 1.6764109198041943e-11
mutation O 0 1.9239117243774473e-10
in O 0 1.1772120604713887e-11
a O 0 8.343719812287098e-12
Japanese O 0 6.579761446801058e-08
family O 0 1.2367928903245229e-09
. O 0 7.976677984800062e-09

Polymerase O 0 2.5657899982434174e-07
chain O 0 2.0515845022828216e-08
reaction O 0 1.0239795678046448e-08
- O 0 1.7325339385365623e-08
single O 0 3.08810144122873e-10
strand O 0 2.404791088483904e-10
conformational O 0 1.1704266722478707e-10
polymorphism O 0 1.9890004920863902e-10
and O 0 9.607276996517755e-13
direct O 0 2.4900329194388338e-12
sequence O 0 3.669551641716229e-12
analyses O 0 5.102644695664793e-11
demonstrated O 0 1.3748423233206353e-10
a O 0 4.4035896457073065e-11
C O 0 7.469326135378651e-08
to O 0 7.256650835785194e-11
T O 0 2.6561921551149226e-09
substitution O 0 1.2650387404278263e-09
in O 0 1.324697157523147e-10
exon O 0 7.915972877192701e-10
1 O 0 1.4939036119265836e-10
of O 0 7.313216698889846e-11
the O 0 1.008688577108785e-09
CPO O 0 1.449988218382714e-07
gene O 0 1.7448180053558637e-11
at O 0 1.0816978562866453e-10
nucleotide O 0 8.733051504172806e-10
position O 0 5.176780337734499e-09
85 O 0 1.7577207245267346e-08
, O 0 1.0526529301002618e-11
which O 0 3.884803503190204e-12
lies O 0 9.227526381883067e-11
in O 0 6.516278402285414e-12
the O 0 2.0318696725141194e-10
putative O 0 1.023315743253761e-08
presequence O 0 9.322749860984914e-08
for O 0 1.4368731204861263e-10
targeting O 0 1.2497141099743203e-09
to O 0 9.704644865493606e-10
mitochondria O 0 1.0817690281328396e-06
. O 0 9.377517784514566e-08

This O 0 3.738815035347898e-09
mutation O 0 1.554461004360519e-09
changes O 0 4.80273654179797e-10
the O 0 6.793515194836175e-10
codon O 0 2.933924214687522e-09
for O 0 8.014506419629086e-11
glutamine O 0 9.236035825033184e-10
to O 0 1.1047710489486828e-11
a O 0 1.2454082903845531e-11
termination O 0 1.7152650855223328e-08
codon O 0 1.9406309448299908e-08
at O 0 1.2912719782320892e-09
amino O 0 1.0979533948685116e-09
acid O 0 4.603463388264117e-09
position O 0 9.91612214562565e-09
29 O 0 1.25280593010757e-07
. O 0 3.6909050038502755e-08

MaeI O 0 7.730273500783369e-05
restriction O 0 7.378391728707356e-07
analysis O 0 8.468340695344523e-09
showed O 0 3.954319538479467e-09
two O 0 3.340712038599203e-12
other O 0 4.645636306199741e-12
carriers O 0 1.1561487878175569e-10
in O 0 7.038285232408015e-11
the O 0 1.4552788973887232e-09
family O 0 1.4970277240067276e-09
. O 0 4.639462147792983e-09

The O 0 1.564174681334407e-06
C O 0 0.000323761923937127
- O 0 2.3827742552384734e-05
T O 0 3.2018390356824966e-06
mutation O 0 2.0772876752062075e-09
is O 0 3.670377803771663e-12
located O 0 6.256181770553093e-12
within O 0 1.4300562470315192e-11
a O 0 2.584197179161807e-12
recently O 0 2.8253803810440736e-11
proposed O 0 1.3840834034439808e-09
putative O 0 1.3232969386933746e-08
alternative O 0 7.118705180886309e-09
translation O 0 1.3102383067398193e-10
initiation O 0 2.1911841230348728e-09
codon O 0 3.834215167586308e-09
( O 0 7.441029563348689e-12
TIC O 0 8.326145883863489e-10
- O 0 4.1262007699494063e-10
1 O 0 8.599802120423661e-11
) O 0 2.3432810054326014e-13
, O 0 7.126134534893303e-13
supporting O 0 3.301722393753148e-12
that O 0 1.2014974518775867e-12
TIC O 0 3.3794067544334894e-09
- O 0 2.0978022874373892e-08
1 O 0 2.8641252924899163e-08
is O 0 3.268788018040425e-12
the O 0 3.195352663021289e-11
real O 0 7.463636930715722e-10
TIC O 0 4.001160736066822e-09
rather O 0 1.0893237423204027e-09
than O 0 5.994159057998161e-10
TIC O 0 1.5358163807377423e-07
- O 0 1.4674608905806963e-07
2 O 0 1.8721335592886135e-08
. O 0 3.1511895870472983e-10
. O 0 3.0065208100893415e-09

Human B-Disease 0 3.3171672075837932e-09
complement I-Disease 0 1.0418803952916278e-07
factor I-Disease 0 6.12444055150263e-05
H I-Disease 1 1.0
deficiency I-Disease 0 0.08923281729221344
associated O 0 4.7145667281256465e-07
with O 0 4.642505473384517e-07
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.000757016590796411

This O 0 1.8005428259471046e-09
study O 0 4.2253966991978587e-10
reports O 0 6.875519598104063e-11
on O 0 7.82880565930455e-11
six O 0 5.299455752699744e-12
cases O 0 1.562390772313904e-10
of O 0 7.961359926866862e-08
deficiency B-Disease 1 0.9821498990058899
in I-Disease 0 1.3910816498707845e-08
the I-Disease 0 4.1258230165652776e-10
human I-Disease 0 2.5314906421103345e-11
complement I-Disease 0 1.33312749728276e-10
regulatory I-Disease 0 2.745489613431573e-09
protein I-Disease 0 1.6777463862638342e-09
Factor I-Disease 0 4.912342177476603e-08
H I-Disease 1 0.9999905824661255
( O 0 2.0792716506901066e-11
FH O 0 4.406461329153899e-08
) O 0 1.31436379250012e-13
in O 0 6.366609306808838e-14
the O 0 8.666676453101055e-14
context O 0 8.462967306110958e-12
of O 0 5.14152479272334e-12
an O 0 9.890305588400317e-12
acute B-Disease 1 0.9999996423721313
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.4603113413613755e-05

Five O 0 1.432343879059772e-07
of O 0 3.3535236809711932e-09
the O 0 2.253170844346286e-10
cases O 0 2.130254583843083e-10
were O 0 3.872620973899288e-11
observed O 0 3.542334134354341e-11
in O 0 9.068201376437324e-13
children O 0 1.4961855810281116e-13
presenting O 0 7.1531695497450976e-12
with O 0 3.6645716842975684e-12
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.2129332794283982e-06
HUS B-Disease 1 1.0
) O 0 1.616504796686513e-08
. O 0 8.44735623672932e-08

Two O 0 2.3676447469256345e-09
of O 0 1.5120792395961757e-09
the O 0 3.3275215916006573e-09
children O 0 1.0081648710302815e-10
exhibited O 0 1.8445920346721323e-09
a O 0 3.4026764739181203e-10
homozygous O 0 2.273450263601262e-07
deficiency O 0 3.0195192834980844e-07
characterized O 0 1.0946077377838037e-09
by O 0 2.2239916852573316e-10
the O 0 7.852232641880619e-09
absence O 0 7.845781055948464e-07
of O 0 2.4882099936007762e-08
the O 0 6.07231598337421e-10
150 O 0 3.952294394538036e-11
- O 0 8.239264305542893e-12
kD O 0 3.230215539495873e-10
form O 0 1.0310923989620413e-11
of O 0 2.397582132829257e-10
Factor O 0 1.6011252768066697e-08
H O 1 0.9999994039535522
and O 0 1.0053612109484078e-10
the O 0 9.838789505334233e-12
presence O 0 1.256993966379516e-12
, O 0 2.7988649267153554e-13
upon O 0 4.680467471929184e-11
immunoblotting O 0 5.2510493731006136e-08
, O 0 9.483335991489206e-12
of O 0 5.97573102112392e-11
the O 0 8.296576620159257e-11
42 O 0 7.294065906826575e-10
- O 0 2.2998160320586436e-10
kD O 0 1.4900975564557939e-08
Factor O 0 1.7287577591673653e-08
H O 1 0.9999967813491821
- O 0 7.645872557304756e-08
like O 0 3.262499992384704e-10
protein O 0 5.941547809307224e-10
1 O 0 2.2201191995918634e-09
( O 0 3.034040683622119e-12
FHL O 0 1.9088561202806886e-06
- O 0 9.025426628284094e-09
1 O 0 2.558867562285627e-09
) O 0 9.083989528473058e-13
and O 0 2.3381836831287695e-12
other O 0 1.1841029892711852e-11
FH O 0 7.117688483049278e-07
- O 0 4.389271612836865e-09
related O 0 3.92101995316807e-08
protein O 0 2.462854631346545e-08
( O 0 3.1059807503730497e-11
FHR O 0 8.481257100356743e-05
) O 0 2.3794868853066475e-10
bands O 0 8.744310520114595e-08
. O 0 8.906777537731614e-09

Southern O 0 1.2062481573593686e-06
blot O 0 1.3338686812858214e-06
and O 0 6.67522773167839e-11
PCR O 0 7.865448847788059e-10
analysis O 0 7.679224443835064e-12
of O 0 1.7299790072700105e-11
DNA O 0 1.7978857291822692e-10
of O 0 5.612205700167294e-10
one O 0 6.608049524237103e-11
patient O 0 7.735468443570426e-08
with O 0 2.5217813948152923e-10
homozygous O 0 1.0498932851987774e-06
deficiency O 0 4.381020971777616e-06
ruled O 0 1.1087084885730292e-06
out O 0 4.514352780482511e-10
the O 0 3.8601798840742774e-11
presence O 0 6.914165854438048e-12
of O 0 3.5328136249734854e-11
a O 0 1.4393212099603203e-12
large O 0 4.3710109316752455e-12
deletion O 0 5.144830741987683e-12
of O 0 4.561356847787579e-11
the O 0 8.532313189313356e-10
FH O 0 6.031195880495943e-07
gene O 0 2.6950866885422364e-11
as O 0 3.0548523780038472e-12
the O 0 3.792758815346353e-11
underlying O 0 5.286362281253787e-08
defect O 0 2.590271996893989e-08
for O 0 1.4329246678101981e-09
the O 0 1.6574773553656996e-06
deficiency O 1 0.864224374294281
. O 0 3.64987863576971e-06

The O 0 1.7580836697561608e-07
other O 0 2.198149662291371e-09
four O 0 1.214498085433391e-10
children O 0 2.5976496995094855e-11
presented O 0 1.0715215381651433e-09
with O 0 9.717907589745778e-10
heterozygous O 0 2.721305918385042e-06
deficiency O 0 7.569498848170042e-06
and O 0 3.290986927417805e-10
exhibited O 0 2.4490207639615846e-09
a O 0 1.4233512805883475e-11
normal O 0 2.912498686669096e-08
immunoblotting O 0 3.1893361551738053e-07
pattern O 0 2.644615859637156e-09
of O 0 1.9202235634896425e-10
proteins O 0 1.2297325484300625e-11
of O 0 1.6241552547313631e-10
the O 0 4.911814954766669e-09
FH O 0 7.232272764667869e-05
family O 0 3.7176171030495198e-09
. O 0 7.511741451082798e-09

Factor B-Disease 1 0.9999997615814209
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999983310699463
is O 0 3.661708436464295e-11
the O 0 3.644609614106287e-11
only O 0 2.359956396968954e-10
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 5.250308277027216e-07
with O 0 1.7284380149362732e-08
HUS B-Disease 1 1.0
. O 0 2.1104107872815803e-05

These O 0 2.4187039926459875e-08
observations O 0 4.184385815619862e-08
suggest O 0 9.172378412358739e-10
a O 0 9.83061115150674e-12
role O 0 8.79779790685653e-11
for O 0 2.9688182467957347e-10
FH O 0 0.003908080048859119
and O 0 1.80350649969796e-08
/ O 0 1.3414675947842625e-07
or O 0 2.056606218658885e-09
FH O 0 6.619209784730629e-07
receptors O 0 9.665882677589721e-11
in O 0 2.818731359433002e-12
the O 0 1.8415389005377314e-11
pathogenesis O 0 1.0205113198935578e-07
of O 0 4.6259964747719096e-09
idiopathic O 0 0.01720440573990345
HUS B-Disease 1 1.0
. O 0 1.1605161631678129e-07
. O 0 4.845102097306153e-08

Further O 0 2.452032177302499e-08
evidence O 0 5.465309538266183e-09
for O 0 2.6009814094174466e-11
a O 0 9.929961367061146e-12
major O 0 7.315675842889391e-10
ancient O 0 2.694644365419663e-07
mutation O 0 1.5728189737274079e-06
underlying O 0 2.2033149434719235e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 1.7122873785524462e-08
linkage O 0 3.815184257405235e-08
disequilibrium O 0 3.67455967875685e-08
studies O 0 1.2426084466943266e-11
in O 0 2.9824919118605353e-13
the O 0 3.1684355659977737e-12
Japanese O 0 2.0428290170571017e-09
population O 0 8.403533077738778e-12
. O 0 4.925415630907537e-10

The O 0 1.5136362890189048e-05
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 4.901924910427624e-08
DM B-Disease 1 1.0
) O 0 3.954883087686767e-10
mutation O 0 9.177453796915813e-10
is O 0 1.6417948814698158e-12
an O 0 5.213770496066694e-13
unstable O 0 1.6481084230690612e-07
( O 0 2.332546655825496e-10
CTG O 0 2.5729746084834915e-06
) O 0 9.356990009201649e-12
n O 0 6.384177908547173e-11
repeat O 0 9.04772090581929e-11
, O 0 1.4566985855404835e-12
present O 0 3.9218650028927105e-12
at O 0 1.1736786889593454e-11
a O 0 2.933386769165408e-13
copy O 0 6.001248803455539e-11
number O 0 9.913157100749359e-12
of O 0 1.5280877257994874e-11
5 O 0 2.857318270876874e-10
- O 0 3.508807966401406e-10
37 O 0 4.568908584801079e-10
repeats O 0 4.870888414831853e-12
on O 0 2.0772024725279614e-11
normal O 0 5.113744427909239e-10
chromosomes O 0 1.9152052166404587e-10
but O 0 9.78463490786119e-11
amplified O 0 6.446319478214946e-09
to O 0 2.1951822304355773e-10
50 O 0 1.3696005440877457e-09
- O 0 4.1254769045373507e-10
3000 O 0 3.8710348815307327e-10
copies O 0 5.1557272340296834e-11
on O 0 2.724825476363435e-09
DM B-Disease 1 0.9999996423721313
chromosomes O 0 4.169401108811144e-07
. O 0 4.622823013278321e-08

Previous O 0 2.329886910956702e-06
findings O 0 8.131510043085655e-08
in O 0 1.3234250362259559e-09
Caucasian O 0 4.3857237841393726e-09
populations O 0 1.6047366560578702e-11
of O 0 1.8055827666341173e-11
a O 0 1.982871644656825e-10
DM B-Disease 1 1.0
founder O 0 0.002840381348505616
chromosome O 0 2.7177783579190873e-08
raise O 0 2.3901864931730188e-09
a O 0 5.732832177723912e-12
question O 0 4.476008799714215e-11
about O 0 1.9530507582282003e-13
the O 0 4.212716059239646e-13
molecular O 0 1.9608266833143206e-12
events O 0 1.0178904160523805e-12
involved O 0 2.1967128636946054e-12
in O 0 9.946832420226759e-12
the O 0 1.547236783139283e-10
expansion O 0 1.4158510452944029e-07
mutation O 0 1.3279923827269613e-08
. O 0 1.7482751246689077e-08

To O 0 1.3102970264355918e-08
investigate O 0 5.948149972567762e-09
whether O 0 2.2265225219086915e-09
a O 0 2.667522869259642e-10
founder O 0 1.3257197117866326e-08
chromosome O 0 3.1177402326498793e-10
for O 0 3.839311854547667e-11
the O 0 1.1546911871107568e-08
DM B-Disease 1 1.0
mutation O 0 5.223236954066124e-09
exists O 0 2.2739274005423304e-11
in O 0 1.944375650070329e-13
the O 0 3.444344148003514e-13
Japanese O 0 8.41123351524864e-11
population O 0 1.9002400835580607e-13
, O 0 2.8606183719546985e-13
we O 0 6.978995940182253e-12
genotyped O 0 4.497898942190659e-08
families O 0 3.364520814730376e-11
using O 0 4.4944700738902554e-11
polymorphic O 0 1.181859676790964e-08
markers O 0 8.874457613217146e-09
near O 0 3.042147866949563e-08
the O 0 4.461863323257376e-09
( O 0 1.1707348979150822e-10
CTG O 0 1.794902004803589e-06
) O 0 3.938418341453698e-11
n O 0 1.4565979533642803e-09
repeat O 0 3.0634108583171837e-09
region O 0 1.2678142979893892e-09
and O 0 7.684210212577369e-11
constructed O 0 2.9472182916379097e-08
haplotypes O 0 1.1649805031765936e-07
. O 0 3.94373103063117e-08

Six O 0 1.3902652540309646e-07
different O 0 1.4488423794034588e-09
haplotypes O 0 6.1578965926401e-08
were O 0 2.2191358473033773e-10
found O 0 3.013964425258031e-11
and O 0 3.316804886299707e-10
DM B-Disease 1 1.0
alleles O 0 2.8529973050694934e-08
were O 0 2.9464748418916997e-09
always O 0 4.1906275671799165e-10
haplotype O 0 3.456605446316985e-09
A O 0 1.4516922774987506e-08
. O 0 2.092838435885369e-08

To O 0 6.6318195379722056e-09
find O 0 1.4709727880202195e-10
an O 0 6.144961113303121e-14
origin O 0 3.7831425492296233e-11
of O 0 3.4188360475972956e-10
the O 0 1.7627089787808359e-09
( O 0 4.387626720281368e-11
CTG O 0 3.490149538265541e-07
) O 0 7.087709325698244e-12
n O 0 1.9502989501152257e-10
repeat O 0 3.633588985252345e-10
mutation O 0 3.72322624120347e-11
and O 0 2.725419065777168e-12
to O 0 2.6618175979348235e-12
investigate O 0 8.909079723951052e-11
the O 0 1.288422424305935e-10
mechanism O 0 2.9125972744736828e-09
of O 0 1.0899410263220943e-09
the O 0 2.6012605958136703e-10
expansion O 0 6.133430652255356e-09
mutation O 0 5.791700452562054e-11
in O 0 2.7167879491224456e-12
the O 0 5.030609175754597e-12
Japanese O 0 6.074007963263739e-10
population O 0 2.117042435453853e-13
we O 0 2.4148535276470595e-13
have O 0 1.3935798045053294e-13
studied O 0 2.23178402841695e-11
90 O 0 6.312689954102169e-11
Japanese O 0 5.206923781031492e-09
DM B-Disease 1 1.0
families O 0 2.080011496374823e-09
comprising O 0 1.481975514527889e-10
190 O 0 9.467725908818281e-11
affected O 0 3.5342576087948885e-10
and O 0 1.0184468546281522e-10
130 O 0 3.991061259256412e-09
unaffected O 0 7.829964943084633e-07
members O 0 1.2888188294368774e-09
. O 0 1.844557750985132e-08

The O 0 2.2324222470615496e-07
results O 0 1.0294515107034385e-07
suggest O 0 1.5750579507312068e-08
that O 0 5.276681001864514e-12
a O 0 2.211128329043799e-11
few O 0 4.2206924066867657e-10
common O 0 2.4324431358024867e-09
ancestral O 0 1.2782123803845025e-07
mutations O 0 3.2743714406535673e-09
in O 0 2.9388122491091906e-10
both O 0 4.057785218947174e-10
Caucasian O 0 8.188106859208233e-10
and O 0 2.9778055021800753e-11
Japanese O 0 2.3115912739513078e-08
populations O 0 1.0858258736590187e-10
have O 0 3.9152706142291105e-13
originated O 0 9.686216238813383e-12
by O 0 7.236532879005553e-13
expansion O 0 1.2687020323198794e-09
of O 0 6.528249468784608e-11
an O 0 9.528458751184576e-13
ancestral O 0 6.286091092100321e-10
n O 0 1.9798521155856008e-10
= O 0 5.278867967750678e-11
5 O 0 5.904275679480264e-11
repeat O 0 2.725773946832266e-11
to O 0 4.5354438954481324e-11
n O 0 1.1119090093103523e-09
= O 0 1.0968628227914223e-09
19 O 0 1.2222935552586023e-08
- O 0 1.093297985477193e-08
37 O 0 1.323627607519029e-08
copies O 0 4.128501540634488e-09
. O 0 6.766685434200781e-09

These O 0 5.359989341258142e-09
data O 0 3.5505817730374645e-10
support O 0 3.576544269079385e-11
multistep O 0 4.151394961127153e-08
models O 0 7.7947079901719e-09
of O 0 1.9336005152581492e-07
triplet O 0 2.9381111744442023e-05
repeat O 0 4.5320263097892166e-08
expansion O 0 9.672498890722636e-08
that O 0 4.151679867947511e-12
have O 0 9.788359359164112e-13
been O 0 4.5155518864012367e-13
proposed O 0 1.2903278272247132e-11
for O 0 5.243082443900926e-12
both O 0 3.7534819696816157e-10
DM B-Disease 1 1.0
and O 0 6.436432187229002e-08
Friedreichs B-Disease 0 0.17219822108745575
ataxia I-Disease 0 0.33551695942878723
. O 0 9.078208762502982e-08
. O 0 9.411545676130117e-08

The O 0 1.7406647234707862e-09
molecular O 0 3.8664471624372254e-09
basis O 0 1.502569624278749e-08
of O 0 8.031386641960125e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.5505049466568721e-09
the O 0 1.3394076125994303e-10
western O 0 1.0011060869175026e-09
Cape O 0 1.8716480809644054e-08
, O 0 6.3199510728917385e-12
South O 0 2.939860577200193e-10
Africa O 0 2.4142768340063014e-10
. O 0 7.167421656184558e-10

Deficiency B-Disease 0 0.07557639479637146
of I-Disease 0 4.50198103862931e-06
the I-Disease 0 1.4174371187891666e-07
sixth I-Disease 0 1.549111175336293e-06
component I-Disease 0 9.609352957795636e-08
of I-Disease 0 2.1965247398725296e-08
human I-Disease 0 1.4412765425575458e-09
complement I-Disease 0 4.3078728140244493e-07
( O 0 4.5857323494047364e-10
C6 O 0 2.216283610323444e-05
) O 0 8.741158838421192e-12
has O 0 1.6301964118892176e-12
been O 0 5.704886216206795e-12
reported O 0 2.914893803759866e-12
in O 0 1.8853093999154913e-12
a O 0 1.8227644870902338e-13
number O 0 3.2389160255739957e-13
of O 0 2.0636129523937674e-12
families O 0 2.889208783243141e-13
from O 0 1.529241468699316e-12
the O 0 6.98448200317503e-12
western O 0 2.893216777266616e-10
Cape O 0 1.2893408118941352e-08
, O 0 1.2709338789718139e-11
South O 0 2.6976701428260697e-10
Africa O 0 2.2245348618721295e-10
. O 0 1.4401362324889533e-09

Meningococcal B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999984502792358
is O 0 1.7140966424022963e-09
endemic O 0 2.0977761194806988e-10
in O 0 9.385463760336332e-12
the O 0 1.2291165307765084e-10
Cape O 0 2.270974874818421e-08
and O 0 3.0921710504616673e-12
almost O 0 5.627224489331006e-13
all O 0 1.8541333019709422e-13
pedigrees O 0 1.324732545882057e-10
of O 0 4.234301451133682e-11
total O 0 1.499155075634917e-07
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 9.16108466864074e-10
C6Q0 O 0 0.04254104942083359
) O 0 2.364948167854486e-11
have O 0 1.820020913492759e-12
been O 0 1.2050202415764266e-12
ascertained O 0 3.5961111866100737e-09
because O 0 1.5748549686556146e-10
of O 0 2.2756956319369692e-09
recurrent O 0 1.6621643226244487e-05
disease O 0 1.7303535059909336e-05
. O 0 3.1062344874044356e-07

We O 0 4.619271010142256e-08
have O 0 3.150726901601786e-10
sequenced O 0 5.783184597873969e-09
the O 0 4.732544356400581e-10
expressed O 0 6.634574556407813e-10
exons O 0 1.606156807554271e-08
of O 0 4.138103637529866e-09
the O 0 1.1334637228799238e-08
C6 O 0 1.0877269232878461e-05
gene O 0 2.257924680559853e-10
from O 0 5.992315671443649e-11
selected O 0 7.085161901621007e-10
cases O 0 1.22350060638432e-10
and O 0 4.007564419206133e-11
have O 0 8.353863607812873e-12
found O 0 1.6474483235939807e-11
three O 0 5.038290964987091e-12
molecular O 0 4.160764888183621e-08
defects O 0 0.05549931526184082
leading O 0 6.53471943223849e-05
to O 0 3.2450518716586885e-08
total O 0 2.5566455406078603e-06
deficiency O 1 0.5813415050506592
879delG O 0 0.00018685770919546485
, O 0 1.5990178625635565e-10
which O 0 9.29226530790861e-13
is O 0 4.06685996727843e-13
the O 0 7.49455619092343e-12
common O 0 8.733068157518176e-10
defect O 0 5.592866614279046e-09
in O 0 6.655309636727225e-10
the O 0 2.6654898288569484e-09
Cape O 0 8.213266511347683e-08
and O 0 3.831403944110079e-11
hitherto O 0 1.550132355809808e-09
unreported O 0 9.254780275469443e-10
, O 0 2.024417092294506e-12
and O 0 7.859278332300601e-12
1195delC O 0 5.735422359265385e-09
and O 0 5.35770705578642e-10
1936delG O 0 1.728377725385144e-07
, O 0 6.114431877479731e-11
which O 0 6.662923251327113e-12
have O 0 1.3929328177009204e-11
been O 0 6.27104687622726e-11
previously O 0 9.027362884994616e-11
reported O 0 1.2329360622731489e-11
in O 0 7.335009682973848e-11
African O 0 2.853310088202221e-10
- O 0 1.6161648686008334e-09
Americans O 0 5.354703902504809e-10
. O 0 2.4985287172540893e-09

We O 0 4.6814568577246973e-07
also O 0 8.930469697077115e-10
show O 0 1.6755060880391248e-11
that O 0 1.0251651957893237e-13
the O 0 5.661290013170284e-12
879delG O 0 2.4753394001209017e-08
and O 0 4.2628520158238814e-10
1195delC O 0 1.0010274991145707e-06
defects O 0 7.106348789420736e-07
are O 0 2.487115027816067e-11
associated O 0 2.7085794718217926e-10
with O 0 1.3241212293291227e-10
characteristic O 0 0.0008294690633192658
C6 O 1 1.0
/ O 0 0.0004771558160427958
C7 O 0 0.0001494631142122671
region O 0 2.2427968815463828e-08
DNA O 0 1.0270074568552445e-08
marker O 0 1.7142937736025488e-08
haplotypes O 0 9.132633316255578e-09
, O 0 1.5234372791050887e-11
although O 0 1.071565822186038e-10
small O 0 3.371883328107117e-11
variations O 0 2.0456050187078745e-09
were O 0 2.2860877080255193e-10
observed O 0 1.2536539806262681e-08
. O 0 3.560296235605165e-08

The O 0 8.162930953403702e-08
1936delG O 0 1.3013030866204645e-06
defect O 0 5.563827585319814e-07
was O 0 1.3213573346604335e-08
observed O 0 5.373928524399219e-10
only O 0 2.3977457172530414e-11
once O 0 3.3213293226808105e-11
in O 0 9.56869479484812e-12
the O 0 9.792850558243416e-11
Cape O 0 5.676752579120148e-08
, O 0 2.1124493213703355e-12
but O 0 2.0536983572072565e-12
its O 0 3.7389874182891525e-12
associated O 0 5.402107650098742e-10
haplotype O 0 2.8283015041097315e-08
could O 0 5.328674834714775e-09
be O 0 1.7509106386981443e-09
deduced O 0 3.976012408202223e-07
. O 0 4.2636695951614456e-08

The O 0 3.5411641619020884e-08
data O 0 1.1362922824886823e-09
from O 0 8.730165895753927e-11
the O 0 2.917883712427738e-10
haplotypes O 0 5.1956043911616234e-09
indicate O 0 2.2943874578018608e-10
that O 0 4.1803946372251377e-13
these O 0 1.709321746645731e-11
three O 0 3.5972169253745134e-12
molecular O 0 7.817543834498508e-10
defects O 0 1.397021787141739e-08
account O 0 7.176747390813532e-11
for O 0 8.953148639134767e-11
the O 0 5.3809909417168456e-08
defects O 0 0.0008939122199080884
in O 0 9.723922289595066e-08
all O 0 3.2902043312077467e-09
the O 0 9.131410072527046e-10
38 O 0 1.0270755357311145e-09
unrelated O 0 3.3939278054617716e-09
C6Q0 O 0 4.7521269152639434e-05
individuals O 0 7.727877365804048e-11
we O 0 2.5965748648437703e-11
have O 0 8.793226563552636e-13
studied O 0 7.454101225157217e-11
from O 0 1.911055341752288e-11
the O 0 5.607604380841735e-10
Cape O 0 1.610154214404247e-07
. O 0 3.927290048721943e-09

We O 0 6.934531171509661e-08
have O 0 1.3938397658286306e-10
also O 0 2.2922024521532247e-12
observed O 0 3.511048743409795e-11
the O 0 8.455823541364538e-11
879delG O 0 1.5589073143473797e-07
defect O 0 2.2302261015738623e-07
in O 0 1.9556267716325237e-09
two O 0 4.0383127397625174e-10
Dutch O 0 0.044797152280807495
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 5.6286839935637545e-06
, O 0 8.223094080661575e-12
but O 0 3.318453151157641e-12
the O 0 3.144769514240586e-11
879delG O 0 3.7467621893938485e-08
defect O 0 9.483824214839842e-08
in O 0 3.3869242965778312e-09
the O 0 6.618312120565406e-09
Cape O 0 4.15571776102297e-07
probably O 0 8.947929619473882e-10
did O 0 2.3308155752688187e-11
not O 0 6.7974488884847695e-12
come O 0 3.571799453427893e-11
from O 0 8.917304394895353e-12
The O 0 6.534615210052053e-11
Netherlands O 0 1.1429829305242833e-09
. O 0 1.2344733568703248e-10
. O 0 3.502664602805794e-09

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.6668227686977843e-08
seven O 0 5.125608826261896e-10
further O 0 6.224907256324741e-10
molecular O 0 2.2896470852629136e-07
defects O 0 1.6229518223553896e-05
and O 0 4.00140498513224e-09
their O 0 2.3165376283884598e-09
associated O 0 4.5490523348235e-08
marker O 0 8.297417366520676e-07
haplotypes O 0 1.2747663049594848e-06
. O 0 5.456167073703e-08

Seven O 0 1.1466147142868977e-08
further O 0 3.6272393422187577e-10
molecular O 0 7.090694698064226e-09
bases O 0 2.1613820067045708e-08
of O 0 0.15140536427497864
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 6.386550666093171e-08
described O 0 1.2060527687651756e-08
. O 0 1.3003556453838883e-08

All O 0 2.7373131317176558e-08
these O 0 4.297941724740184e-10
new O 0 1.1980939573774663e-09
molecular O 0 4.0029162207133595e-09
defects O 0 1.3513541397003337e-08
involve O 0 7.509645683079214e-10
single O 0 4.067277348251963e-10
- O 0 1.3072334326125201e-09
nucleotide O 0 2.1256569837646566e-09
events O 0 1.5918666385061897e-10
, O 0 6.083950183921605e-12
deletions O 0 7.474463825651867e-10
and O 0 2.9623981046000836e-10
substitutions O 0 2.0556580437869343e-08
, O 0 7.356390496759957e-11
some O 0 5.0538274953826345e-11
of O 0 3.756561728351926e-10
which O 0 9.538705936229519e-11
alter O 0 1.6653045520342857e-07
splice O 0 1.38575569508248e-06
sites O 0 2.2761440732210758e-08
, O 0 8.032902121257735e-11
and O 0 5.3291773771668716e-11
others O 0 2.870614024264029e-10
codons O 0 6.946989117295743e-08
. O 0 7.11653527218914e-08

They O 0 4.425454847023502e-08
are O 0 8.258337763633605e-11
distributed O 0 9.397917860587413e-11
along O 0 1.979134772733815e-10
the O 0 6.298825350192772e-10
C7 O 0 1.0951471267617308e-06
gene O 0 1.155619697157384e-10
, O 0 4.387850326137421e-12
but O 0 2.3165432246063933e-12
predominantly O 0 2.739877552268566e-12
towards O 0 2.393506504105858e-10
the O 0 1.6202814090426898e-10
3 O 0 2.1350963219646246e-09
end O 0 1.1053586490561429e-08
. O 0 2.1250825099627946e-08

All O 0 3.279948757040074e-08
were O 0 2.1432975394475307e-09
found O 0 2.967724330171784e-11
in O 0 1.7959519288401893e-11
compound O 0 1.0851374909748301e-08
heterozygous O 0 3.431302131318148e-09
individuals O 0 3.685103264206013e-11
. O 0 6.575141764386672e-09

The O 0 1.4218945580068976e-05
C6 O 1 0.998680055141449
/ O 0 7.93949729995802e-05
C7 O 0 0.00010154138726647943
marker O 0 7.031157167602942e-08
haplotypes O 0 1.1457620630039855e-08
associated O 0 2.3185755537724617e-09
with O 0 2.5237206768835563e-10
most O 0 2.700525385535002e-07
C7 B-Disease 1 1.0
defects I-Disease 1 0.6943677663803101
are O 0 4.8435935262602925e-09
tabulated O 0 2.3426417783412035e-07
. O 0 2.106714802607712e-09
. O 0 6.088567872097883e-09

A O 0 1.1050234206777532e-05
genome O 0 4.232983599194995e-07
- O 0 1.2422957240687538e-07
wide O 0 1.679171823809611e-08
search O 0 5.659654411793724e-10
for O 0 2.2601167465330363e-11
chromosomal O 0 4.790344974026084e-07
loci O 0 3.6572444059856934e-06
linked O 0 3.5006054531550035e-05
to O 0 2.2910839447831677e-08
mental O 1 1.0
health O 1 0.9999974966049194
wellness O 0 0.06010737270116806
in O 0 1.4149931226725698e-10
relatives O 0 4.0715205512631414e-11
at O 0 3.5324544938458713e-12
high O 0 1.3792864073103317e-10
risk O 0 1.0871314265470389e-10
for O 0 2.869294801755018e-10
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 0.1343264877796173
the O 0 2.3392951220557734e-07
Old O 0 3.8555396031370037e-07
Order O 0 3.162944608448015e-07
Amish O 0 9.668759730629972e-07
. O 0 9.958540658772108e-09

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 0.0003354226646479219
BPAD B-Disease 1 1.0
; O 1 1.0
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 1.5480235759923744e-08
is O 0 8.351063590650298e-11
characterized O 0 1.5711677792129564e-10
by O 0 1.5158778746138246e-11
episodes O 0 3.2899092339278013e-09
of O 0 1.4403950920893749e-08
mania B-Disease 0 3.2996045774780214e-05
and O 0 4.52496706770944e-09
/ O 0 8.247960181506642e-08
or O 0 1.980869246409611e-09
hypomania B-Disease 0 1.6375407767554861e-06
interspersed O 0 6.34366448259982e-10
with O 0 3.2262270654483116e-13
periods O 0 2.5070796993986733e-08
of O 0 1.828640172618634e-08
depression B-Disease 0 6.234682950889692e-05
. O 0 3.439456008891284e-07

Compelling O 0 1.7716844240567298e-06
evidence O 0 1.7267311136492935e-08
supports O 0 6.597399293539752e-10
a O 0 7.799901349803129e-12
significant O 0 5.686857651454602e-10
genetic O 0 2.5312626661389004e-08
component O 0 2.806284271628101e-07
in O 0 1.6410897085705756e-09
the O 0 1.921295478268803e-08
susceptibility O 0 1.2195595445518848e-05
to O 0 3.753041966092496e-08
develop O 0 0.000581105996388942
BPAD B-Disease 1 1.0
. O 0 0.003744440386071801

To O 0 9.955877233736032e-10
date O 0 1.9867356115810253e-07
, O 0 8.144552393618554e-11
however O 0 5.872976549525788e-10
, O 0 1.9483125182628847e-11
linkage O 0 3.9789078698504454e-09
studies O 0 6.202303948210641e-11
have O 0 1.0314261380747758e-12
attempted O 0 3.5082456384394334e-10
only O 0 2.39440030302962e-11
to O 0 1.1134831945369683e-10
identify O 0 3.895969769018848e-09
chromosomal O 0 1.0736782769527053e-06
loci O 0 8.73468195550231e-07
that O 0 4.899826100412952e-10
cause O 0 4.6601112302369074e-08
or O 0 6.064142243911164e-11
increase O 0 1.365028090560827e-10
the O 0 1.505540137003436e-10
risk O 0 1.5824225263472158e-09
of O 0 1.0253627946710253e-09
developing O 0 2.135807790182298e-06
BPAD B-Disease 1 1.0
. O 0 0.0004917246988043189

To O 0 1.701731733305678e-08
determine O 0 3.257367708897618e-08
whether O 0 7.739316743027302e-09
there O 0 8.688657571198632e-10
could O 0 1.976369762290986e-10
be O 0 1.0870256778039433e-10
protective O 0 5.295328833199164e-07
alleles O 0 5.858867835328851e-10
that O 0 1.8317153349656223e-12
prevent O 0 3.907687021187378e-11
or O 0 9.848740746554174e-12
reduce O 0 1.6815193681907203e-10
the O 0 7.18688442091775e-11
risk O 0 2.601429072157657e-10
of O 0 2.3475343891021794e-10
developing O 0 1.5486681093079824e-07
BPAD B-Disease 1 1.0
, O 0 5.52361545391733e-10
similar O 0 1.0899280089571306e-10
to O 0 1.5441346118416632e-11
what O 0 1.0609285802307133e-12
is O 0 9.242608035257144e-14
observed O 0 1.6317806481036534e-11
in O 0 2.7859149015485585e-11
other O 0 1.4061591890879299e-08
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 9.963680575042488e-11
we O 0 7.448668418175153e-12
used O 0 1.4028171679836277e-10
mental O 0 0.236992746591568
health O 1 0.928496241569519
wellness O 0 0.06862396746873856
( O 0 2.777488091951219e-12
absence O 0 6.82843503962971e-10
of O 0 1.0145460166421927e-10
any O 0 5.164669580892678e-09
psychiatric B-Disease 1 1.0
disorder I-Disease 0 4.1567553125787526e-05
) O 0 1.4914488047357288e-11
as O 0 8.577065446768728e-11
the O 0 2.412361976844579e-10
phenotype O 0 1.1240146591262601e-08
in O 0 2.0490482921520226e-10
our O 0 1.3619080307947229e-09
genome O 0 5.725112606214111e-10
- O 0 2.999698711647625e-09
wide O 0 2.0509896003773065e-08
linkage O 0 1.3718678637530957e-08
scan O 0 1.0503764258373849e-07
of O 0 2.5838609030159887e-09
several O 0 1.1736749072621677e-10
large O 0 3.444809160146889e-10
multigeneration O 0 2.463696375798463e-07
Old O 0 3.692968064683555e-08
Order O 0 8.15264655784631e-08
Amish O 0 3.7213578707451234e-07
pedigrees O 0 5.573127026536895e-08
exhibiting O 0 6.153042519940755e-10
an O 0 2.8632603015985025e-13
extremely O 0 7.954643610474932e-10
high O 0 2.4663509012867735e-09
incidence O 0 1.506719371491272e-08
of O 0 2.8748800673383812e-08
BPAD B-Disease 1 1.0
. O 0 0.007627830374985933

We O 0 3.222054090201709e-07
have O 0 7.013176706038848e-10
found O 0 1.2409936966939483e-10
strong O 0 4.871439016063128e-11
evidence O 0 1.8099443818697658e-11
for O 0 6.534549377296139e-12
a O 0 1.9261835182415865e-11
locus O 0 3.0934246830760515e-10
on O 0 1.0854910303947918e-09
chromosome O 0 3.3643188235288335e-09
4p O 0 2.297090395586565e-05
at O 0 1.257303416934974e-08
D4S2949 O 0 4.448134802714776e-07
( O 0 3.299703218995198e-11
maximum O 0 7.487309439113687e-09
GENEHUNTER O 0 9.03725522221066e-05
- O 0 1.2177541464097885e-07
PLUS O 0 6.611197989059292e-08
nonparametric O 0 1.612822160268479e-07
linkage O 0 2.4149240829274277e-08
score O 0 2.374283436523683e-09
= O 0 3.2454431503348147e-11
4 O 0 2.0135355188743986e-11
. O 0 1.1009357488156457e-12
05 O 0 5.6346896037950955e-09
, O 0 3.114784472013632e-11
P O 0 8.262241379952684e-08
= O 0 7.699409165784488e-11
5 O 0 4.836489195247928e-11
. O 0 9.520265435367103e-13
22 O 0 6.201274910244692e-11
x O 0 2.5721824670199567e-09
10 O 0 5.499437016887043e-10
( O 0 8.695594591601186e-12
- O 0 2.0354080643159023e-09
4 O 0 6.80263068097986e-10
) O 0 3.1667420422043513e-13
; O 0 5.496621387213185e-12
SIBPAL O 0 7.369879313046113e-06
Pempirical O 0 1.9903806958154746e-07
value O 0 1.2753400557841132e-09
< O 0 8.695172915018645e-10
3 O 0 9.184278337848184e-11
x O 0 4.4859937986529985e-10
10 O 0 1.273552791003496e-10
( O 0 2.393011136470058e-12
- O 0 8.686834584992198e-10
5 O 0 5.543923098372261e-10
) O 0 1.022859097768447e-12
) O 0 1.5019762777263024e-12
and O 0 1.7421343881385276e-11
suggestive O 0 1.5270860964644584e-10
evidence O 0 1.3728370003296408e-11
for O 0 3.3221262112775873e-12
a O 0 2.612735722218318e-11
locus O 0 9.618109642062223e-10
on O 0 1.1970758606594245e-08
chromosome O 0 1.8141948388006313e-08
4q O 0 9.671462066762615e-07
at O 0 7.015976244417743e-09
D4S397 O 0 4.400829993755906e-07
( O 0 3.442771068229433e-11
maximum O 0 7.754655584335524e-09
GENEHUNTER O 0 8.96831916179508e-05
- O 0 8.289374875403155e-08
PLUS O 0 3.830876238453129e-08
nonparametric O 0 4.873509595881842e-08
linkage O 0 2.6037438871640006e-09
score O 0 6.452811618373744e-10
= O 0 1.0984423440274504e-11
3 O 0 1.0593519117474415e-11
. O 0 7.984638341132499e-13
29 O 0 4.938510156371478e-10
, O 0 4.163807146295717e-11
P O 0 1.4014044324994757e-07
= O 0 8.088078817802824e-11
2 O 0 6.381585537784673e-11
. O 0 1.960052562963166e-12
57 O 0 2.4262747366776694e-10
x O 0 2.8470326096652343e-09
10 O 0 9.912108911436235e-10
( O 0 8.488688051089266e-12
- O 0 2.061849579959585e-09
3 O 0 7.857666739496949e-10
) O 0 5.017440456167588e-13
; O 0 6.728540901529412e-12
SIBPAL O 0 3.083172259721323e-06
Pempirical O 0 2.2789637910136662e-07
value O 0 8.355051095421118e-10
< O 0 6.56759313599764e-10
1 O 0 2.5516969093253294e-10
x O 0 1.1479993622387497e-09
10 O 0 3.0060778866136673e-10
( O 0 4.8862047220821214e-12
- O 0 2.142283683781443e-09
3 O 0 5.835013583421755e-10
) O 0 2.694035587062077e-13
) O 0 5.524078509075783e-14
that O 0 6.27085799194578e-14
are O 0 1.3509054985760827e-12
linked O 0 1.2719149067308422e-09
to O 0 5.147783088688129e-09
mental O 1 0.9999988079071045
health O 1 0.9999945163726807
wellness O 1 0.8772442936897278
. O 0 9.420541005056293e-07

These O 0 3.7255617257869744e-08
findings O 0 2.1647238668265345e-08
are O 0 3.6388305563184176e-11
consistent O 0 1.1779387465438163e-09
with O 0 1.2054501277378171e-12
the O 0 5.701114580425326e-11
hypothesis O 0 8.373094440017326e-10
that O 0 4.847585549118405e-13
certain O 0 1.4413837901017246e-09
alleles O 0 3.1286491175563924e-09
could O 0 2.84060330812963e-10
prevent O 0 1.5176991885468283e-09
or O 0 4.0183587013409294e-10
modify O 0 9.332657313620984e-09
the O 0 1.8549498048692215e-10
clinical O 0 2.653984365608153e-09
manifestations O 0 1.2509553926065564e-07
of O 0 2.9441450166700633e-08
BPAD B-Disease 1 1.0
and O 0 1.7896072401768492e-09
perhaps O 0 6.364643256873137e-10
other O 0 6.949218978036242e-11
related O 0 2.3266866264748387e-05
affective B-Disease 1 0.9999998807907104
disorders I-Disease 1 1.0
. O 0 0.0004425171937327832

Segregation O 0 4.761675882036798e-05
distortion O 0 4.27424929512199e-05
in O 0 1.3292032008394017e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 9.245445107808337e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.699077756711631e-06
DM B-Disease 1 1.0
) O 0 1.1992874471289383e-09
is O 0 3.592597400126074e-11
an O 0 9.468442523086207e-12
autosomal B-Disease 1 0.9994688630104065
dominant I-Disease 1 0.9999772310256958
disease I-Disease 1 0.9986629486083984
which O 0 2.281514005497698e-10
, O 0 1.84960597185424e-12
in O 0 1.996653710423235e-12
the O 0 7.728389976591199e-12
typical O 0 3.2080990641780716e-10
pedigree O 0 8.839500242885379e-10
, O 0 1.4206788957055183e-12
shows O 0 5.360124236825081e-12
a O 0 2.8141705545742246e-12
three O 0 2.0805608971774525e-11
generation O 0 1.7658098272477218e-07
anticipation O 0 3.4864212921092985e-06
cascade O 0 1.4041457916391664e-06
. O 0 2.4041696633503307e-08

This O 0 6.674110708537739e-10
results O 0 8.142059471083485e-09
in O 0 3.2752083267695298e-09
infertility B-Disease 0 0.0009175962768495083
and O 0 1.1009152700580671e-07
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 3.1882226636525957e-08
CDM B-Disease 0 4.710355824499857e-06
) O 0 2.88155919481517e-13
with O 0 2.3342242581100153e-14
the O 0 1.723292515631858e-12
disappearance O 0 9.528849931328409e-11
of O 0 5.924825074998807e-09
DM B-Disease 1 1.0
in O 0 1.4319627439363103e-07
that O 0 3.702478601486092e-10
pedigree O 0 1.380891347935176e-07
. O 0 3.07350656036931e-09

The O 0 1.2906300916881719e-08
concept O 0 3.077191834677251e-08
of O 0 1.4334119669001666e-08
segregation O 0 6.127481100293153e-08
distortion O 0 2.7343908470811584e-08
, O 0 8.233609107011208e-12
where O 0 1.1233008880701112e-12
there O 0 4.754828936181024e-14
is O 0 2.8190831965905008e-14
preferential O 0 8.111902122243109e-11
transmission O 0 3.599209125182412e-11
of O 0 1.0331594087198415e-11
the O 0 2.568600887542516e-11
larger O 0 9.267299427850872e-11
allele O 0 2.0742765144410313e-11
at O 0 2.844462165807471e-11
the O 0 2.2182514158863853e-10
DM B-Disease 1 1.0
locus O 0 3.5972225198577235e-09
, O 0 1.758053425060524e-11
has O 0 2.0442447647844864e-12
been O 0 6.731724552788698e-12
put O 0 1.8586046590662875e-10
forward O 0 4.793715202566773e-09
to O 0 3.2104008340638757e-10
explain O 0 1.854667641687513e-09
partially O 0 3.1959472845954906e-09
the O 0 4.508628193011788e-11
maintenance O 0 2.7429052806837717e-08
of O 0 4.757428584412082e-08
DM B-Disease 1 1.0
in O 0 3.814391291712127e-08
the O 0 1.941252047998887e-09
population O 0 1.2658074241556072e-11
. O 0 2.460330827958046e-10

In O 0 1.1122827991982831e-08
a O 0 1.5114960671969158e-10
survey O 0 1.5053736035497423e-10
of O 0 4.688082144710393e-10
DM B-Disease 1 1.0
in O 0 1.4481116750175715e-07
Northern O 0 1.0278014883624564e-07
Ireland O 0 1.3995020253787516e-08
, O 0 1.0249946724716352e-10
59 O 0 3.5902034678514383e-09
pedigrees O 0 1.895510060023753e-08
were O 0 3.2982386266589003e-10
ascertained O 0 3.709290012920974e-07
. O 0 5.520577417428285e-08

Sibships O 0 4.4325639464659616e-05
where O 0 4.382429086291495e-09
the O 0 6.665711038689182e-11
status O 0 1.6849555084519352e-09
of O 0 2.0267885147973175e-09
all O 0 1.7551661513071082e-10
the O 0 2.720363379005164e-10
members O 0 5.051434964764567e-12
had O 0 1.8369887208602442e-11
been O 0 4.0256730240995076e-12
identified O 0 9.388973105928233e-12
were O 0 5.051823195878491e-11
examined O 0 5.812264558535674e-10
to O 0 1.1328569159141377e-11
determine O 0 3.687228300464085e-10
the O 0 2.116331138113381e-10
transmission O 0 4.011346366183943e-09
of O 0 2.24342477928019e-09
the O 0 4.9688818393178735e-08
DM B-Disease 1 1.0
expansion O 0 1.2973790944670327e-05
from O 0 2.415936117827755e-09
affected O 0 1.0489186408335627e-08
parents O 0 2.728667292117848e-10
to O 0 2.9605720652803313e-11
their O 0 1.345694777832307e-09
offspring O 0 8.063660317247923e-08
. O 0 6.104766470116374e-09

Where O 0 8.574685850248898e-09
the O 0 2.3185933173408557e-09
transmitting O 0 3.347129222674994e-07
parent O 0 3.758599209646718e-09
was O 0 1.6328353780181715e-08
male O 0 4.010137999443941e-09
, O 0 1.6486184639674661e-10
58 O 0 1.943319993813475e-08
. O 0 5.6856244157188485e-09

3 O 0 1.6742635011723905e-07
% O 0 5.632247446207828e-10
of O 0 1.879190136833131e-10
the O 0 1.3771439544285613e-10
offspring O 0 2.3730881704153717e-09
were O 0 2.3344784438883437e-10
affected O 0 8.697494391363136e-10
, O 0 9.474874010373391e-12
and O 0 9.133195068289357e-12
in O 0 6.7991601931938206e-12
the O 0 6.447268500325842e-12
case O 0 1.8037722357422403e-11
of O 0 1.2135572061144906e-11
a O 0 8.052517853907037e-12
female O 0 4.729140343218141e-11
transmitting O 0 1.669288351990872e-08
parent O 0 1.15192988481283e-09
, O 0 3.6552488813512696e-10
68 O 0 2.2993978632257495e-07
. O 0 1.3603126092220919e-07

7 O 0 2.311998287041206e-06
% O 0 5.8110045664250265e-09
were O 0 6.33931018789724e-10
affected O 0 1.04967909919651e-08
. O 0 3.53953666376583e-08

Studies O 0 7.919559408264831e-08
on O 0 7.306532268103183e-09
meiotic O 0 4.2935071178362705e-06
drive O 0 3.423150189973967e-07
in O 0 1.040591470768959e-07
DM B-Disease 1 1.0
have O 0 1.4937477921250775e-09
shown O 0 3.9908952878531245e-12
increased O 0 4.429668437611056e-12
transmission O 0 4.518121120289376e-12
of O 0 1.311036891028794e-12
the O 0 1.9045227634545414e-12
larger O 0 2.575105580160386e-11
allele O 0 1.8852527178259137e-11
at O 0 1.2140202905464026e-11
the O 0 1.0634378794227572e-10
DM B-Disease 1 0.9999977350234985
locus O 0 1.9991870381375065e-09
in O 0 1.400194821199463e-10
non O 0 1.473963209264184e-07
- O 0 4.5107256596566003e-07
DM O 1 1.0
heterozygotes O 0 3.879254109051544e-06
for O 0 5.704481775836712e-09
CTGn O 0 4.119066579733044e-05
. O 0 1.3119280595219607e-07

This O 0 1.2515013914082829e-08
study O 0 1.2605252397435152e-09
provides O 0 2.4358052467393643e-12
further O 0 1.5051193798243379e-12
evidence O 0 3.776546089739874e-11
that O 0 3.1371235904159578e-12
the O 0 1.4686699856270025e-08
DM B-Disease 1 1.0
expansion O 1 0.999961256980896
tends O 0 1.2250685585968313e-06
to O 0 1.5541073983271758e-10
be O 0 1.8554309477725184e-10
transmitted O 0 9.489665053763474e-09
preferentially O 0 7.712824867667223e-08
. O 0 1.8584433547630397e-08

Diagnosis O 1 0.999840259552002
of O 0 0.0003098556771874428
hemochromatosis B-Disease 1 1.0
. O 1 0.8501414060592651

If O 0 4.459529372979887e-05
untreated O 1 1.0
, O 0 5.305999906113357e-08
hemochromatosis B-Disease 1 1.0
can O 0 8.845411514357693e-08
cause O 0 1.2279095244593918e-05
serious O 0 5.784489189863962e-07
illness O 0 2.3740054530208e-05
and O 0 1.4027710416864014e-11
early B-Disease 0 1.5491540272805082e-09
death I-Disease 0 1.0413907514106313e-09
, O 0 1.298556097720227e-12
but O 0 2.754795957321532e-12
the O 0 1.6588057316635485e-11
disease O 0 3.856980568262003e-10
is O 0 4.722627996132933e-13
still O 0 2.0417662786181845e-12
substantially O 0 2.1188646393e-09
under O 0 6.958737799322989e-07
- O 0 0.012650378979742527
diagnosed O 0 0.4503224194049835
. O 0 8.411965950472222e-07

The O 0 1.6984412809506466e-07
cornerstone O 0 3.521976395859383e-05
of O 0 1.3011645094707092e-08
screening O 0 1.104437728827179e-06
and O 0 1.6288335957792555e-10
case O 0 2.6323448976128816e-10
detection O 0 1.2122682413462371e-08
is O 0 1.161999641473288e-12
the O 0 2.923903306972786e-12
measurement O 0 9.44154532334096e-10
of O 0 1.0480415840730117e-10
serum O 0 2.4626374273140073e-09
transferrin O 0 2.908263319056914e-08
saturation O 0 9.985588356187236e-09
and O 0 2.5862397293185957e-11
the O 0 7.492158976551977e-11
serum O 0 3.022516459338931e-09
ferritin O 0 1.2438759711130842e-07
level O 0 4.5569983342375053e-08
. O 0 9.071108308944531e-09

Once O 0 2.5429596917092567e-07
the O 0 1.2955843065043382e-09
diagnosis O 0 1.574166162754409e-05
is O 0 1.0908347836124932e-10
suspected O 0 1.4602754561110487e-09
, O 0 5.777467740331055e-11
physicians O 0 3.188129760189895e-09
must O 0 2.750278615959445e-10
use O 0 7.998658402286196e-10
serum O 0 2.4416019073214557e-07
ferritin O 0 2.469559694873169e-05
levels O 0 2.8336635296000168e-06
and O 0 7.633454757183245e-09
hepatic O 0 0.001734405872412026
iron O 0 0.00019303584122098982
stores O 0 2.409481680842873e-07
on O 0 2.005573840335728e-08
liver O 0 1.28493326201351e-07
biopsy O 0 2.6544563880293026e-08
specimens O 0 3.649188451415597e-10
to O 0 6.8568276057057176e-12
assess O 0 6.263940033335302e-09
patients O 0 1.1625095552858511e-08
for O 0 1.4992122127077678e-11
the O 0 2.380803332258097e-10
presence O 0 6.889108727925475e-10
of O 0 7.767477683273682e-08
iron B-Disease 1 0.9999744892120361
overload I-Disease 1 0.743869423866272
. O 0 9.710538506624289e-07

Liver O 1 0.9999855756759644
biopsy O 1 0.9999428987503052
is O 0 3.114181801322502e-09
also O 0 3.984232648662767e-12
used O 0 7.80688187707046e-12
to O 0 1.623566038555513e-11
establish O 0 4.154393218325225e-10
the O 0 1.257443593694063e-10
presence O 0 1.166715613010183e-10
or O 0 9.053404137482346e-10
absence O 0 1.125698872783687e-06
of O 0 3.9153741226982675e-07
cirrhosis B-Disease 1 1.0
, O 0 4.566954800444556e-11
which O 0 3.8696118791897716e-13
can O 0 2.0794449061972697e-12
affect O 0 3.643906154593424e-08
prognosis O 1 0.9999847412109375
and O 0 8.27026269689668e-09
management O 0 3.0972124420713953e-08
. O 0 1.7826241816010224e-08

A O 0 1.6653584111736564e-07
DNA O 0 2.153793587922337e-08
- O 0 5.208334652451185e-09
based O 0 1.4486371824329325e-10
test O 0 9.029244574243478e-10
for O 0 4.6526969776916616e-11
the O 0 8.320875100054081e-10
HFE O 0 6.358146492857486e-05
gene O 0 2.683731292751901e-10
is O 0 1.6006212197675063e-12
commercially O 0 5.820937482026167e-11
available O 0 2.8923254850182767e-12
, O 0 1.3470607550421232e-13
but O 0 3.521769464595592e-13
its O 0 1.871329155002377e-13
place O 0 4.547464401566392e-12
in O 0 3.045774353213626e-13
the O 0 1.573103192847869e-12
diagnosis O 0 1.2548573735671198e-08
of O 0 9.625014563141576e-09
hemochromatosis B-Disease 1 1.0
is O 0 1.983206487921052e-08
still O 0 5.491701537962967e-10
being O 0 2.416234712310228e-10
evaluated O 0 6.246131079024053e-08
. O 0 2.462854631346545e-08

Currently O 0 3.129354908537607e-08
, O 0 1.0760820706723351e-10
the O 0 1.6929567470125306e-10
most O 0 1.6013305265127897e-11
useful O 0 5.068191699653113e-11
role O 0 1.5278486809044978e-11
for O 0 7.557616858722138e-12
this O 0 1.2613704351849275e-11
test O 0 9.84281545157728e-10
is O 0 1.4523040972949652e-12
in O 0 2.9201676341773786e-13
the O 0 3.1129460988099655e-13
detection O 0 1.49140394478664e-10
of O 0 7.289517878206198e-10
hemochromatosis B-Disease 1 1.0
in O 0 1.8600786688693915e-07
the O 0 1.5091726979221676e-08
family O 0 2.1104729075460682e-11
members O 0 4.163056618183836e-13
of O 0 1.5599571981383953e-11
patients O 0 9.555572999531137e-10
with O 0 4.160595750302837e-13
a O 0 1.1059010478209341e-11
proven O 0 3.270326898174858e-09
case O 0 3.625885369729076e-09
of O 0 9.963633473830669e-09
the O 0 4.092010286171899e-08
disease O 0 8.556062880415993e-07
. O 0 4.831158761930965e-08

It O 0 4.783300977528882e-10
is O 0 2.781311812805054e-11
crucial O 0 1.247914038771114e-08
to O 0 1.992278120255264e-09
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 1.0
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 0 3.7517149849009e-06
because O 0 8.078435698166686e-09
phlebotomy O 0 0.0006774124340154231
therapy O 0 7.267353794304654e-07
can O 0 3.152933192307472e-10
avert O 0 1.9844719645334408e-06
serious O 0 0.10808226466178894
chronic O 1 0.9999984502792358
disease O 0 3.095709325862117e-05
and O 0 1.2713199937230968e-10
can O 0 4.417771270331938e-12
even O 0 1.3674072985025987e-10
lead O 0 4.5488026539919346e-11
to O 0 2.020371717148528e-11
normal O 0 8.444747123803609e-08
life O 0 1.9982340226931683e-09
expectancy O 0 4.083704485680073e-09
. O 0 5.413491876993248e-11
. O 0 1.1270712141353556e-09

Prevalence O 0 2.758735263341805e-06
of O 0 1.410489236519652e-08
the O 0 2.1011899775658094e-08
I1307K O 0 4.23615456384141e-05
APC B-Disease 0 6.89793751007528e-07
gene O 0 1.7196791213258678e-10
variant O 0 5.844236206087317e-10
in O 0 1.3569801532442582e-11
Israeli O 0 2.370684759611663e-10
Jews O 0 6.361375315400153e-11
of O 0 3.445594070478064e-12
differing O 0 7.609272240083342e-11
ethnic O 0 1.842553236722222e-12
origin O 0 2.9408350754600576e-11
and O 0 1.6103599356775966e-11
risk O 0 1.190408549511801e-09
for O 0 1.6250433887421423e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 7.699088018853217e-05

BACKGROUND O 0 0.0009448211640119553
& O 0 2.2006254312145757e-06
AIMS O 0 7.67481722618868e-08
Israeli O 0 2.0228763109031433e-09
Jews O 0 4.787827911911791e-10
of O 0 3.212157276277772e-11
European O 0 3.5463784686662336e-10
birth O 0 7.340282337509052e-08
, O 0 3.7810723302333926e-11
i O 0 2.3593297454604922e-11
. O 0 3.410105748127834e-12
e O 0 6.57147123175883e-12
. O 0 2.9393583921011324e-12
, O 0 4.7785633956742846e-12
Ashkenazim O 0 1.325254999073877e-07
, O 0 8.289296332675278e-12
have O 0 2.3049869304903048e-12
the O 0 4.97658803055856e-10
highest O 0 0.040223654359579086
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 1.4720470176143863e-07
of O 0 8.591605205054975e-11
any O 0 7.897087844765949e-11
Israeli O 0 3.7870758973213015e-08
ethnic O 0 1.954973960494044e-09
group O 0 1.7456543155436322e-10
. O 0 6.794085849470832e-10

The O 0 5.22021707638487e-07
I1307K O 0 2.1467885744641535e-05
APC B-Disease 0 6.637953333665791e-07
gene O 0 5.570368610818832e-10
variant O 0 1.4965859662652292e-08
was O 0 6.503523941603362e-09
found O 0 2.0279863899297368e-10
in O 0 2.674624965948169e-10
6 O 0 1.2158207596257853e-07
. O 0 1.1718820580597367e-08

1 O 0 7.36415017854597e-08
% O 0 1.6202876540472033e-10
of O 0 1.0604678593595374e-11
American O 0 3.036912301496164e-12
Jews O 0 8.141942675621294e-11
, O 0 7.446788953709149e-13
28 O 0 2.4853188951290406e-10
% O 0 8.460933342835375e-12
of O 0 3.716408084053491e-11
their O 0 4.017228860675459e-08
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 1.6625685020699166e-05
, O 0 2.533026739748312e-11
but O 0 1.6221730556043035e-11
not O 0 2.2652437217662857e-11
in O 0 2.020060646534816e-10
non O 0 3.9215283464955064e-08
- O 0 2.5013275894991693e-09
Jews O 0 3.530250758387865e-09
. O 0 1.6363981281131146e-09

We O 0 6.773596084030942e-08
assessed O 0 1.7404306618118426e-07
the O 0 6.276414055150781e-09
I1307K O 0 3.761032587590307e-07
prevalence O 0 6.2707545822604516e-09
in O 0 1.9018148601085416e-12
Israeli O 0 1.0463119259895848e-10
Jews O 0 8.101155857254128e-11
of O 0 7.288676606709288e-12
differing O 0 9.241705317686311e-11
ethnic O 0 2.1043060956932313e-12
origin O 0 4.1930320326954984e-11
and O 0 2.3420857267475448e-11
risk O 0 4.079531379375112e-09
for O 0 4.888460836127706e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 8.407377026742324e-05

METHODS O 0 5.291110937832855e-06
DNA O 0 1.0756669865941149e-07
samples O 0 4.153111632376749e-09
from O 0 1.3846267188366568e-10
500 O 0 2.4928425643166996e-11
unrelated O 0 1.0640810454987104e-10
Jews O 0 7.946238805844885e-11
of O 0 6.934323254492725e-11
European O 0 1.5921832741128128e-09
or O 0 2.8372246219099395e-10
non O 0 1.6828300530846718e-08
- O 0 1.6352959264498423e-10
European O 0 9.897254543700384e-11
origin O 0 4.1293479052795234e-11
, O 0 1.414936961000035e-13
with O 0 4.305873352642396e-15
or O 0 2.595804701830545e-13
without O 0 5.950115400388256e-12
a O 0 1.0446219627160969e-12
personal O 0 1.7719138656335787e-10
and O 0 1.9179249854950342e-10
/ O 0 8.505248061396742e-09
or O 0 4.680541509927139e-10
family O 0 1.549507223919111e-11
history O 0 5.759874174837698e-11
of O 0 7.65638316635453e-11
neoplasia B-Disease 0 4.84030806546798e-07
, O 0 2.868237418407471e-11
were O 0 7.197899914990202e-11
examined O 0 3.8395334134300185e-10
for O 0 3.382509767071995e-12
the O 0 4.448220958241933e-11
I1307K O 0 2.362051665372178e-09
variant O 0 1.4429454853193135e-10
by O 0 2.26154841381776e-11
the O 0 5.7221512250738016e-11
allele O 0 1.3688625753738304e-11
- O 0 2.3829190357038676e-11
specific O 0 8.482185787084262e-11
oligonucleotide O 0 1.0746043166420804e-08
( O 0 4.680878254448295e-11
ASO O 0 5.933557531534461e-06
) O 0 1.2717243924598165e-11
method O 0 6.243555450424765e-09
. O 0 7.75999620117318e-09

RESULTS O 0 2.2527539840666577e-05
In O 0 1.879646438496252e-09
persons O 0 7.684986674805216e-11
at O 0 2.6270170067066445e-11
average O 0 6.300432398020916e-11
risk O 0 2.8021326925475876e-10
for O 0 6.179166511799394e-09
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 1.5475247749918708e-08
I1307K O 0 5.445976967166644e-07
was O 0 3.173593166039268e-09
found O 0 3.597850142811332e-11
in O 0 6.858937029452505e-11
5 O 0 3.633092049426523e-09
. O 0 2.0425483526764765e-09

0 O 0 2.561912140208733e-07
% O 0 2.9694410819125494e-10
of O 0 3.5376212376148075e-11
120 O 0 2.8019886411101425e-10
European O 0 1.0691411089780445e-09
and O 0 6.044156286577618e-10
1 O 0 9.854772287098967e-08
. O 0 1.78793282401557e-08

6 O 0 1.441067752239178e-06
% O 0 1.9816326357613434e-09
of O 0 5.948146974965596e-10
188 O 0 1.4556349903216415e-08
non O 0 3.348948851567002e-08
- O 0 1.4899262934520152e-09
European O 0 1.94735982894656e-09
Jews O 0 4.880064796708439e-09
( O 0 1.1825862337999649e-11
P O 0 6.159588394893944e-08
= O 0 7.729926421173872e-11
0 O 0 1.159567511455073e-10
. O 0 4.283476351396587e-12
08 O 0 2.5970776640349413e-09
) O 0 2.011056078610185e-11
. O 0 1.4193511921334334e-09

It O 0 1.791177983712089e-09
occurred O 0 7.847968674923322e-08
in O 0 2.1077113387946156e-09
15 O 0 1.594365883761384e-08
. O 0 1.0042813691768515e-08

4 O 0 3.3802601251409214e-07
% O 0 1.3107013252522393e-09
of O 0 2.798895837319293e-10
52 O 0 3.3369280671990964e-09
Ashkenazi O 0 1.1624718077030138e-08
Israelis O 0 3.699981654392559e-09
with O 0 5.76239056471195e-11
familial O 0 3.3783112485252786e-06
cancer B-Disease 0 0.00460191210731864
( O 0 1.4157382210999714e-10
P O 0 1.2573641470225994e-06
= O 0 5.7547459852980154e-11
0 O 0 6.393219981193354e-11
. O 0 1.4110138838591135e-12
02 O 0 1.5589762814016694e-10
) O 0 9.950560883077719e-14
and O 0 1.4627459399979559e-12
was O 0 2.5041463694308597e-11
not O 0 9.133682525586106e-12
detected O 0 8.196892942180511e-09
in O 0 1.3425542899625498e-09
51 O 0 1.4458755082102925e-08
non O 0 1.1439282587843991e-07
- O 0 1.8506922661032377e-09
European O 0 6.118821560541221e-10
Jews O 0 8.437848197928588e-10
at O 0 6.455516676773243e-11
increased O 0 5.838033168004131e-09
cancer B-Disease 0 2.839973376467242e-07
risk O 0 1.399945226410182e-08
. O 0 1.632374591054031e-08

Colorectal B-Disease 1 0.9998032450675964
neoplasia I-Disease 0 0.01078765094280243
occurred O 0 4.0115148294717073e-05
personally O 0 6.100555083321524e-08
or O 0 9.348110480145166e-11
in O 0 2.4348452073996718e-11
the O 0 2.5247399657035707e-11
families O 0 9.146251464531296e-12
of O 0 5.299286356952315e-11
13 O 0 1.3675845178529045e-10
of O 0 1.585152425986891e-10
20 O 0 4.487054894308784e-10
Ashkenazi O 0 1.1798793053685586e-09
I1307K O 0 8.969943010583847e-09
carriers O 0 2.1543787587230412e-10
, O 0 3.255658980252929e-12
8 O 0 1.112839750905259e-10
of O 0 3.122078429118602e-10
whom O 0 3.0993556610070527e-09
also O 0 4.823950613963568e-11
had O 0 1.7009674224688354e-10
a O 0 1.4371685265468503e-11
personal O 0 3.4692737571617727e-09
or O 0 4.64801641619772e-10
family O 0 2.1025257923579233e-11
history O 0 1.11128932445137e-10
of O 0 4.735325465077267e-10
noncolonic O 0 4.437140160007402e-05
neoplasia B-Disease 0 0.0046583302319049835
. O 0 1.980833985726349e-06

CONCLUSIONS O 0 5.929584222030826e-05
The O 0 1.8756760766791558e-07
I1307K O 0 1.3275867786433082e-05
APC O 0 3.079405814787606e-07
variant O 0 3.092112521585477e-08
may O 0 2.0133004596800674e-08
represent O 0 1.1272646149862453e-09
a O 0 1.627703111184431e-10
susceptibility O 0 5.6753560073730114e-08
gene O 0 1.0601454158987167e-09
for O 0 6.919532946625395e-09
colorectal B-Disease 1 1.0
, I-Disease 0 3.7505701584450435e-06
or I-Disease 0 1.108677906813682e-06
other I-Disease 0 1.0866437349932312e-07
, I-Disease 0 1.3674732457502614e-09
cancers I-Disease 0 3.93309028368094e-06
in O 0 6.731705748386219e-10
Ashkenazi O 0 1.5095787730956545e-08
Jews O 0 6.844894873125895e-09
, O 0 2.1110689585324138e-11
and O 0 6.977641381356037e-11
partially O 0 1.721521258879477e-09
explains O 0 2.1883293788160785e-11
the O 0 3.2934891792957277e-12
higher O 0 5.30973987000749e-10
incidence O 0 2.9582101213065926e-09
of O 0 5.2315549226022995e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 8.748343383047086e-09
European O 0 1.3670827136991193e-08
Israelis O 0 9.130631362097574e-09
. O 0 2.4365665041159446e-09

Systematic O 0 1.0523507620874284e-09
analysis O 0 8.769518444751156e-11
of O 0 6.022349841039443e-10
coproporphyrinogen O 0 2.7883679649676196e-05
oxidase O 0 9.834427146415692e-06
gene O 0 2.2166682356328238e-07
defects O 0 8.428818546235561e-06
in O 0 1.0954959606124248e-08
hereditary B-Disease 1 0.9999971389770508
coproporphyria I-Disease 1 0.9999992847442627
and O 0 7.220625661830127e-07
mutation O 0 9.546910462177038e-08
update O 0 2.483502612449229e-07
. O 0 1.2582226815993636e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 4.812548922927817e-06
HC B-Disease 1 1.0
) O 0 1.6760544063743055e-09
is O 0 1.92110181929106e-11
an O 0 3.09745393396732e-12
acute O 0 0.0005296993185766041
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 0 3.458625883467903e-07
autosomal O 1 1.0
dominant O 1 1.0
inheritance O 0 0.08241340517997742
caused O 0 4.080677484807893e-08
by O 0 7.725770023725431e-11
deficient B-Disease 0 5.371718181379492e-09
activity I-Disease 0 2.2745619276953732e-10
of I-Disease 0 4.9651421862861866e-11
coproporphyrinogen I-Disease 0 3.626344096119283e-07
III I-Disease 1 1.0
oxidase I-Disease 0 4.541843736660667e-05
( O 0 4.102065354061324e-09
CPO O 0 5.598137704510009e-06
) O 0 1.3021313194361284e-10
. O 0 4.6271608766801364e-09

Clinical O 0 4.212242492940277e-05
manifestations O 0 0.0007943756645545363
of O 0 1.8424308336761896e-06
the O 0 1.7052269640771556e-07
disease O 0 8.817582966003101e-06
are O 0 4.924461879940445e-12
characterized O 0 2.7411527908638433e-12
by O 0 4.683293683416245e-13
acute O 0 1.839498509070836e-08
attacks O 0 7.2256721439512e-11
of O 0 2.566411694715498e-06
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 1.7608388702683442e-07
precipitated O 0 2.3017745487408092e-09
by O 0 5.0565051278039785e-12
drugs O 0 6.093269777629473e-10
, O 0 2.1350074486115034e-12
fasting O 0 9.068945594492561e-09
, O 0 1.9173286569529324e-10
cyclical O 0 1.9363642422831617e-06
hormonal O 0 2.712000082283339e-07
changes O 0 2.0836059988482702e-08
, O 0 1.9314463362007928e-09
or O 0 4.3011323214159347e-07
infectious B-Disease 0 0.006431980524212122
diseases I-Disease 0 7.46201612855657e-06
. O 0 6.560475185324322e-08

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 9.610057895770296e-05
also O 0 1.3425184297588544e-09
be O 0 1.5756151938717267e-10
present O 0 6.880786607155187e-09
. O 0 3.5495425265708036e-08

The O 0 3.9230104675880284e-07
seven O 0 2.2159573731528326e-08
exons O 0 1.8926884948200495e-08
, O 0 8.381958321868055e-11
the O 0 1.0673888439782786e-09
exon O 0 1.860912135498438e-08
/ O 0 7.292052739416022e-09
intron O 0 2.7066198171610267e-08
boundaries O 0 3.3719635972317974e-09
and O 0 1.1426793539159874e-10
part O 0 7.95427543276439e-11
of O 0 1.2353619238680835e-09
3 O 0 1.2354797185309963e-09
noncoding O 0 8.183673183559392e-10
sequence O 0 5.881153203324274e-12
of O 0 4.974244349753576e-10
the O 0 1.539023664065553e-08
CPO O 0 3.3300045743089868e-06
gene O 0 3.141288063002179e-10
were O 0 2.1647547643333098e-10
systematically O 0 1.1191382542907746e-10
analyzed O 0 1.9152077493367337e-11
by O 0 1.4420038080276143e-11
an O 0 7.505800668494711e-12
exon O 0 5.798471036655428e-09
- O 0 1.8549577429638475e-09
by O 0 2.7953386272372427e-09
- O 0 8.456140108137333e-07
exon O 0 6.038170567990164e-07
denaturing O 0 9.575707736075856e-06
gradient O 0 4.6445870793832e-07
gel O 0 1.4905188550073944e-07
electrophoresis O 0 1.1387163212361884e-08
( O 0 4.3817390688039026e-11
DGGE O 0 1.1619569704635069e-05
) O 0 1.28084322661981e-11
strategy O 0 2.2749091499463248e-10
followed O 0 9.799870984150694e-12
by O 0 5.576780899053946e-13
direct O 0 2.965375861530006e-11
sequencing O 0 4.1033487718777906e-09
in O 0 5.384054868606825e-10
seven O 0 3.1378508125179394e-10
unrelated O 0 1.282806465496833e-07
heterozygous O 0 1.5496278038540368e-08
HC B-Disease 0 0.029995495453476906
patients O 0 1.0066825097965193e-06
from O 0 2.7300053884182773e-10
France O 0 1.0478162781879519e-09
, O 0 1.4389870371667168e-11
Holland O 0 2.5657648450305715e-08
, O 0 2.6724256488308562e-11
and O 0 6.861802792634819e-11
Czech O 0 1.5176658507698448e-07
Republic O 0 2.723580507790757e-07
. O 0 7.840006901460583e-07

Seven O 0 6.330972155410564e-07
novel O 0 3.6264063396629354e-07
mutations O 0 3.0831195374503295e-08
and O 0 7.344309049805986e-10
two O 0 4.056382313377682e-11
new O 0 2.735923265717588e-09
polymorphisms O 0 1.49419506101367e-07
were O 0 5.485821130690738e-09
detected O 0 1.2200557364394626e-07
. O 0 3.365052236858901e-08

Among O 0 9.42763165312499e-07
these O 0 1.0943891126657945e-08
mutations O 0 3.0720062049738317e-09
two O 0 5.924932072742806e-11
are O 0 7.621866332518934e-11
missense O 0 3.4453186970040406e-08
( O 0 1.4947664633835345e-11
G197W O 0 4.7212164844268045e-08
, O 0 3.814974725013798e-11
W427R O 0 1.592627363322663e-08
) O 0 5.542194307650572e-12
, O 0 4.740209526982175e-12
two O 0 1.4225497949743593e-12
are O 0 2.6653334487397595e-12
nonsense O 0 1.2048864128644254e-09
( O 0 2.83952809182475e-12
Q306X O 0 1.8902101217577183e-08
, O 0 3.099636519676707e-11
Q385X O 0 4.466566139171846e-08
) O 0 1.8031461740397603e-11
, O 0 1.4086239119581734e-11
two O 0 3.497285360615221e-12
are O 0 3.2271023960722678e-12
small O 0 1.1069604434477132e-11
deletions O 0 3.7741140768154935e-10
( O 0 1.1458127849306443e-11
662de14bp O 0 4.8579554601246855e-08
; O 0 9.142995388566888e-11
1168del3bp O 0 1.451763438353737e-07
removing O 0 1.1871536287344497e-07
a O 0 4.232454386965401e-10
glycine O 0 7.706288385200821e-10
at O 0 1.2976345553639135e-09
position O 0 6.984662292985888e-10
390 O 0 4.811501752577385e-10
) O 0 9.316346522361685e-13
, O 0 1.3020953672920887e-12
and O 0 2.2708577639835026e-12
one O 0 4.875998693351646e-13
is O 0 1.1758599465210712e-13
a O 0 1.037928857444692e-12
splicing O 0 2.7492152998576103e-09
mutation O 0 2.4283359767451884e-09
( O 0 1.4377524344688641e-11
IVS1 O 0 9.596065865480341e-06
- O 0 1.1450105752430773e-08
15c O 0 4.238142139456613e-07
- O 0 4.069211634316616e-09
- O 0 1.4286019034415176e-09
> O 0 8.449834609791651e-09
g O 0 1.5804768604965602e-09
) O 0 4.867013367847173e-13
which O 0 3.8815503003615526e-13
creates O 0 1.3855161809517291e-11
a O 0 3.0018119066832494e-12
new O 0 4.0823006086654345e-10
acceptor O 0 1.063500150166874e-07
splice O 0 1.4704701243317686e-06
site O 0 1.324047218531632e-07
. O 0 2.8392520334818983e-08

The O 0 4.879425219428413e-08
pathological O 0 9.820197419685428e-07
significance O 0 1.8588090711091354e-07
of O 0 1.600007948354687e-08
the O 0 3.085171007555232e-09
point O 0 3.863100950241005e-09
mutations O 0 8.846782334481773e-11
G197W O 0 1.913206304493542e-08
, O 0 5.266849456564415e-11
W427R O 0 1.2903991830626182e-07
, O 0 1.3460303704970755e-10
and O 0 5.846875761328363e-11
the O 0 4.4831111045695593e-10
in O 0 2.6876037506617934e-10
- O 0 1.2120502379531217e-09
frame O 0 3.6436820227692124e-09
deletion O 0 1.7058321422069866e-09
390delGly O 0 9.414325319312411e-09
were O 0 1.300592550323998e-10
assessed O 0 5.277903669664852e-10
by O 0 2.3422198208722378e-11
their O 0 8.502648030095372e-10
respective O 0 8.318196798029476e-09
expression O 0 2.469098536739267e-10
in O 0 2.776350677136108e-11
a O 0 6.577189314016518e-12
prokaryotic O 0 1.8952388103343765e-08
system O 0 1.8485790675981661e-09
using O 0 1.3511078367223206e-10
site O 0 3.4585971864231624e-09
- O 0 1.994958864770524e-09
directed O 0 1.700468765797325e-09
mutagenesis O 0 6.334182671707822e-06
. O 0 5.8320598128602796e-08

These O 0 1.0081427248564978e-08
mutations O 0 1.0529550564797319e-09
resulted O 0 1.1216476636377593e-09
in O 0 6.153696302524381e-11
the O 0 2.1964595420254085e-10
absence O 0 1.6476331410331113e-08
or O 0 8.677143031876611e-11
a O 0 8.342240960523828e-12
dramatic O 0 7.537182544758991e-10
decrease O 0 1.204101778284894e-07
of O 0 9.501827662461437e-07
CPO O 0 0.09669949859380722
activity O 0 1.3303140349307796e-06
. O 0 9.340210738173482e-08

The O 0 1.90261729926533e-07
two O 0 1.7081698278076374e-09
polymorphisms O 0 1.0618705914566817e-07
were O 0 1.1350727024961316e-09
localized O 0 1.503102708966253e-08
in O 0 7.000600654727407e-10
noncoding O 0 4.298659206369848e-08
part O 0 3.9107014848660526e-10
of O 0 3.2089881862873426e-09
the O 0 1.845344987927433e-09
gene O 0 1.6132588320783015e-11
1 O 0 3.220962663252891e-10
) O 0 2.0670864651038678e-13
a O 0 8.595419515033953e-12
C O 0 1.1125756316232582e-08
/ O 0 2.5864282937604344e-10
G O 0 2.433946821867039e-09
polymorphism O 0 4.3594833298854496e-10
in O 0 2.6283001816618246e-11
the O 0 4.2525710730600963e-10
promotor O 0 9.311569328929181e-07
region O 0 7.2830315112071276e-09
, O 0 1.585947900784035e-10
142 O 0 1.3985921754056108e-08
bp O 0 8.514515315027893e-09
upstream O 0 3.836314377281269e-09
from O 0 3.497640718719275e-11
the O 0 3.709503190729713e-11
transcriptional O 0 4.749393767156107e-09
initiation O 0 1.8644010779667042e-08
site O 0 4.758696992013256e-09
( O 0 1.918106081952309e-12
- O 0 2.654175212946086e-10
142C O 0 2.4578708845979236e-08
/ O 0 1.3749426042153345e-09
G O 0 1.671091531818547e-08
) O 0 1.0314989964607668e-12
, O 0 1.7779685059296502e-12
and O 0 1.0109640555255872e-11
2 O 0 4.59358495685791e-10
) O 0 8.919561053297165e-13
a O 0 3.6029731281805866e-11
6 O 0 1.6872935271194933e-09
bp O 0 2.3023540851596636e-09
deletion O 0 1.7729043233494224e-10
polymorphism O 0 1.0044263198949466e-09
in O 0 1.5512437168130333e-10
the O 0 2.06519398804339e-10
3 O 0 7.446587235726554e-10
noncoding O 0 7.0869763391101515e-09
part O 0 1.0141937983876304e-10
of O 0 4.817078291807775e-09
the O 0 2.3070306554018316e-07
CPO O 0 3.4028875234071165e-05
gene O 0 1.361276980027526e-09
, O 0 1.7283208197937938e-10
574 O 0 4.0026890246736e-08
bp O 0 7.348768704673603e-09
downstream O 0 1.9540021156672083e-08
of O 0 2.9050004068942314e-10
the O 0 6.00272540007829e-11
last O 0 2.5262137867687606e-11
base O 0 7.18310202985073e-11
of O 0 4.4211960481543855e-11
the O 0 3.453372657280518e-11
normal O 0 3.305741458348166e-09
termination O 0 2.2245625785899392e-08
codon O 0 1.5740907244321534e-08
( O 0 6.323547935283003e-11
+ O 0 1.9905421755339603e-09
574 O 0 1.3004624044299362e-08
delATTCTT O 0 1.029149103715099e-07
) O 0 1.52225870797551e-10
. O 0 4.0505572229676545e-09

Five O 0 6.033456543264037e-07
intragenic O 0 3.805259257205762e-05
dimorphisms O 0 8.060886466410011e-05
are O 0 1.4171303019949733e-09
now O 0 9.72366839824268e-11
well O 0 1.8164289516953147e-11
characterized O 0 2.8574585406171416e-11
and O 0 9.6323461359904e-12
the O 0 1.2138767421787655e-11
high O 0 2.6100371863790883e-10
degree O 0 4.163603073426003e-10
of O 0 2.780978780592136e-10
allelic O 0 3.3346708505632705e-08
heterogeneity O 0 5.011771264662457e-08
in O 0 2.8687328068599527e-09
HC B-Disease 1 0.995604395866394
is O 0 8.894482372845403e-10
demonstrated O 0 1.9733534806221087e-09
with O 0 3.6275331696811186e-12
seven O 0 5.491318771227993e-12
new O 0 5.047765590932007e-12
different O 0 1.6223454871178156e-12
mutations O 0 9.583119887912606e-13
making O 0 1.1614345553009886e-12
a O 0 1.2750796241339096e-13
total O 0 2.5808474281296956e-12
of O 0 1.983537362137966e-10
nineteen O 0 1.2203121286802343e-06
CPO O 0 0.003307226812466979
gene B-Disease 0 8.431018727605988e-08
defects I-Disease 0 5.379951744544087e-06
reported O 0 8.796464889826439e-09
so O 0 1.2904866064644693e-09
far O 0 2.756739725384705e-09
. O 0 2.1629922852817174e-10
. O 0 3.129186243455706e-09

Coincidence O 0 4.967677796230419e-06
of O 0 8.930376083071678e-08
two O 0 5.316266316057749e-10
novel O 0 1.164038287981839e-08
arylsulfatase O 0 1.3683056749869138e-06
A O 0 2.3278023064676745e-08
alleles O 0 2.3400430482212187e-09
and O 0 9.945945456113492e-11
mutation O 0 3.032030460037305e-10
459 O 0 1.9133330475540333e-09
+ O 0 3.427467754058e-10
1G O 0 4.4656803765974473e-07
> O 0 9.377121301668012e-09
A O 0 4.873179082487411e-10
within O 0 5.384411319586668e-11
a O 0 4.069158638514425e-12
family O 0 1.0045231139954591e-11
with O 0 1.7969728136058016e-11
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 1.5999757074780518e-10
molecular O 0 1.0001379585622416e-10
basis O 0 5.83292997236029e-11
of O 0 2.715561456256843e-11
phenotypic O 0 5.223538934728822e-08
heterogeneity O 0 1.1418738722568378e-05
. O 0 1.468952405048185e-06

In O 0 3.030854145436024e-08
a O 0 3.025479589080504e-10
family O 0 5.5009240218506505e-11
with O 0 9.280862536820145e-12
three O 0 3.2696767515716374e-10
siblings O 0 5.732472274644351e-08
, O 0 3.552827086347743e-12
one O 0 3.407711396050117e-13
developed O 0 2.3064262305583227e-11
classical O 0 9.918467824832078e-09
late O 0 1.0982012099702843e-05
infantile O 0 0.004017403814941645
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 3.015731553368539e-10
MLD B-Disease 1 1.0
) O 0 3.7852866674459307e-11
, O 0 3.5747622310206006e-12
fatal O 0 2.0441959236450202e-10
at O 0 6.295904075859227e-11
age O 0 2.2727504322972436e-09
5 O 0 2.0821976087770366e-10
years O 0 8.928842908095813e-12
, O 0 1.0091853568094944e-12
with O 0 3.5046911119746005e-12
deficient O 0 7.576915322715649e-06
arylsulfatase O 1 0.6636438369750977
A O 0 0.0003320859104860574
( O 0 8.726574463047143e-10
ARSA O 0 7.365255441982299e-06
) O 0 2.4753391610760067e-12
activity O 0 8.776981919034199e-11
and O 0 2.582531410944e-12
increased O 0 7.047638583834726e-10
galactosylsulfatide O 0 1.7435653717257082e-05
( O 0 4.748451409852805e-09
GS O 1 0.9999998807907104
) O 0 1.14562159758691e-09
excretion O 0 3.4078377098012425e-07
. O 0 8.17951040232856e-09

The O 0 2.847963287422317e-07
two O 0 6.248615513904099e-10
other O 0 4.657325636259202e-10
siblings O 0 1.5945362363822824e-08
, O 0 4.852317506132131e-11
apparently O 0 1.51152352856343e-08
healthy O 0 1.0885958090511849e-07
at O 0 3.318053165557444e-09
12 O 0 7.953930847293122e-10
( O 0 1.0908379234619847e-12
1 O 0 9.210737728082563e-10
/ O 0 7.977476318421495e-11
2 O 0 5.161512883766761e-11
) O 0 5.353477264356116e-14
and O 0 1.3752342363851366e-12
15 O 0 6.131222266003711e-12
years O 0 3.4037245678214534e-12
, O 0 2.779415423943138e-13
respectively O 0 2.265321610850357e-11
, O 0 8.264411290731521e-13
and O 0 3.914555745526682e-12
their O 0 6.244787326137313e-11
father O 0 1.6311256789691697e-09
, O 0 7.828745984816976e-11
apparently O 0 4.1351707835701745e-08
healthy O 0 8.915888471960898e-09
as O 0 4.7695056237806455e-11
well O 0 2.715877522874166e-11
, O 0 6.031378955301259e-12
presented O 0 6.883360104126268e-09
ARSA O 0 0.00012539549788925797
and O 0 8.286542119151363e-09
GS O 1 0.9999997615814209
values O 0 7.809171975736717e-09
within O 0 1.5980726464359662e-10
the O 0 1.472929070378548e-11
range O 0 6.025785426189145e-10
of O 0 1.3216390204462414e-09
MLD B-Disease 1 1.0
patients O 0 0.003072274848818779
. O 0 1.1424379664504158e-07

Mutation O 0 1.7394948770288465e-07
screening O 0 5.622539589467124e-08
and O 0 5.309535103248386e-11
sequence O 0 8.530481876434237e-12
analysis O 0 4.087095679256025e-12
disclosed O 0 8.935581163882489e-10
the O 0 1.5052817325944545e-10
involvement O 0 3.95042748513319e-10
of O 0 3.096330525309554e-09
three O 0 4.690389743267076e-10
different O 0 7.038279736804043e-09
ARSA O 0 0.0025256802327930927
mutations O 0 2.2148829437185213e-09
being O 0 2.2516960518359497e-11
the O 0 2.7304465979871573e-11
molecular O 0 1.7088988557567575e-10
basis O 0 3.8822742243205255e-10
of O 0 3.9862893541631195e-10
intrafamilial O 0 4.429455202625832e-06
phenotypic O 0 2.9869852369301952e-06
heterogeneity O 0 4.343022737884894e-05
. O 0 1.3830557463734294e-06

The O 0 3.3576281310843115e-08
late O 0 9.333314665127546e-06
infantile O 0 3.946806100429967e-05
patient O 0 1.4450642083829734e-05
inherited O 0 7.299720437003998e-06
from O 0 1.3935414244770072e-07
his O 0 4.653259111364605e-07
mother O 0 4.93271592461042e-08
the O 0 8.009757856974886e-10
frequent O 0 1.5533961617020253e-10
0 O 0 7.65819851977767e-10
- O 0 7.450633165984044e-11
type O 0 4.773776374200622e-10
mutation O 0 6.408496511234318e-10
459 O 0 6.918882688999872e-10
+ O 0 2.527717618550085e-11
1G O 0 2.153834621765327e-08
> O 0 2.0685408941290007e-10
A O 0 5.888733251024902e-11
, O 0 2.8755689778121873e-13
and O 0 4.638232072723403e-13
from O 0 1.0773691834498056e-11
his O 0 9.983711773964288e-11
father O 0 3.224466249562852e-10
a O 0 4.087664668556146e-12
novel O 0 1.7218387826645198e-10
, O 0 1.5160158284982517e-12
single O 0 1.3072222124210775e-11
basepair O 0 1.8183486716338848e-08
microdeletion O 0 8.008848340068653e-08
of O 0 1.3009552324305673e-09
guanine O 0 2.851461511355069e-09
at O 0 4.112153118018824e-10
nucleotide O 0 6.058272217224214e-10
7 O 0 1.5988539381339706e-09
in O 0 1.658850973251802e-10
exon O 0 9.48067313544243e-09
1 O 0 8.591105604693894e-09
( O 0 2.011842602234193e-11
7delG O 0 1.1215416861887206e-07
) O 0 2.945422794553565e-10
. O 0 1.3149963784542251e-08

The O 0 2.5152755256385717e-07
two O 0 1.0447016585146685e-08
clinically O 0 0.0030538958963006735
unaffected O 0 0.00013209928874857724
siblings O 0 9.119930410861343e-08
carried O 0 1.424810547323574e-10
the O 0 1.4251176627677609e-10
maternal O 0 3.044040042254892e-08
mutation O 0 6.069100333405686e-09
459 O 0 1.3872926807323438e-08
+ O 0 1.0892219348690446e-09
1G O 0 8.587854836150655e-07
> O 0 7.958001368990608e-09
A O 0 1.0541487682758088e-09
and O 0 1.3083321752371813e-11
, O 0 5.846389995387002e-13
on O 0 7.46878427160258e-12
their O 0 1.2781537980788293e-11
paternal O 0 3.0283968666111605e-09
allele O 0 2.533965259843285e-10
, O 0 3.809722936426452e-12
a O 0 3.1452718034230553e-12
novel O 0 2.036564389351625e-10
cytosine O 0 4.219984361952811e-10
to O 0 1.9552817698276215e-11
thymidine O 0 1.7277358210776583e-08
transition O 0 9.066732253870669e-09
at O 0 1.009702987886385e-09
nucleotide O 0 2.1614479095433126e-08
2435 O 0 3.1404160836245865e-06
in O 0 3.4729414899459243e-09
exon O 0 8.902094350560219e-08
8 O 0 2.709376722975776e-09
, O 0 2.339477353160979e-12
resulting O 0 4.197641192971169e-11
in O 0 5.2447729319282654e-12
substitution O 0 3.511534840683339e-09
of O 0 8.916241078793519e-10
alanine O 0 7.348656350103511e-09
464 O 0 1.418983774925664e-08
by O 0 5.740716235713705e-10
valine O 0 1.1263839496677974e-06
( O 0 2.7630395194044866e-10
A464V O 0 3.1805035405341187e-07
) O 0 3.1510996589823037e-10
. O 0 8.741555035385318e-09

The O 0 9.096685715803687e-08
fathers O 0 2.984053537602449e-07
genotype O 0 5.3191424598253434e-08
thus O 0 1.415771389012832e-09
was O 0 2.12604622795709e-09
7delG O 0 1.1290370593997068e-06
/ O 0 4.6038434220463387e-07
A464V O 0 7.563899544038577e-06
. O 0 1.2357165246612567e-07

Mutation O 0 2.2863880531076575e-06
A464V O 0 3.0452445116679883e-06
was O 0 2.548007138614139e-09
not O 0 1.94448138146619e-11
found O 0 8.086609507018672e-12
in O 0 1.032769356146268e-11
18 O 0 6.731859514275129e-10
unrelated O 0 8.273357252619462e-07
MLD B-Disease 1 1.0
patients O 1 0.9999591112136841
and O 0 2.000515486599852e-08
50 O 0 9.711648374377546e-09
controls O 0 1.2124717230221904e-08
. O 0 6.442339639534111e-08

A464V O 0 1.4629947145294864e-05
, O 0 1.5149198562269817e-09
although O 0 3.316813046438938e-09
clearly O 0 1.9246256144356266e-08
modifying O 0 6.788186055928236e-06
ARSA O 1 0.999997615814209
and O 0 5.711948233511066e-06
GS O 1 1.0
levels O 0 3.4198787034256384e-05
, O 0 1.623080697621404e-10
apparently O 0 7.066739415861889e-10
bears O 0 2.214004535261438e-09
little O 0 1.0810847009268265e-11
significance O 0 8.835669695894666e-11
for O 0 5.23681575534396e-12
clinical O 0 8.653776584210959e-10
manifestation O 0 7.985510563912612e-08
of O 0 7.300307913737925e-08
MLD B-Disease 1 1.0
, O 0 2.790512487749197e-09
mimicking O 0 1.652026071496948e-08
the O 0 1.0304170849906313e-09
frequent O 0 7.94324694908255e-09
ARSA O 0 6.947219662833959e-05
pseudodeficiency O 0 2.2504973458126187e-05
allele O 0 1.3097818509777426e-06
. O 0 1.53179371409351e-07

Our O 0 2.8480394576035906e-07
results O 0 6.7631238387377834e-09
demonstrate O 0 2.940045429333793e-10
that O 0 2.8185686748970207e-13
in O 0 1.2000246716464824e-12
certain O 0 8.93317433914298e-11
genetic O 0 1.6488898024746845e-09
conditions O 0 7.22887762094615e-06
MLD B-Disease 1 1.0
- O 0 0.35603588819503784
like O 0 8.993072242446942e-08
ARSA O 0 0.10646862536668777
and O 0 3.826916117333212e-09
GS O 1 1.0
values O 0 2.12502460072983e-09
need O 0 1.3848900325130753e-11
not O 0 1.645512204143454e-13
be O 0 4.704224748457164e-13
paralleled O 0 1.837287544326216e-10
by O 0 9.211079815552026e-12
clinical O 0 8.999387546282378e-08
disease O 0 5.138613445865303e-08
, O 0 6.3665552864355934e-12
a O 0 4.754081243257824e-12
finding O 0 5.170028294365636e-10
with O 0 5.548931973631266e-12
serious O 0 2.7544862390982416e-08
diagnostic O 0 3.716424771482707e-06
and O 0 4.37222027471762e-08
prognostic O 1 0.9999754428863525
implications O 0 0.00010694527009036392
. O 0 5.255618589217192e-07

Moreover O 0 3.486653895379277e-06
, O 0 3.812992588336783e-09
further O 0 1.0746990852794625e-07
ARSA O 0 0.0006009738426655531
alleles O 0 1.0824733465142344e-07
functionally O 0 1.9168187037621465e-08
similar O 0 5.904962629976751e-11
to O 0 3.4256621844752644e-11
A464V O 0 9.678386447831144e-08
might O 0 1.262767890253258e-09
exist O 0 1.1773046426633016e-10
which O 0 3.750644326366848e-12
, O 0 1.4272733385792269e-12
together O 0 8.879585977096538e-13
with O 0 2.577722106947289e-13
0 O 0 1.0445657672164543e-09
- O 0 2.469235094171296e-10
type O 0 1.5533673236589607e-09
mutations O 0 1.0777978509679542e-09
, O 0 3.843684051596519e-12
may O 0 1.9719124111361452e-09
cause O 0 1.1252114973103744e-06
pathological O 1 0.971096932888031
ARSA O 1 0.9998455047607422
and O 0 7.329244766651755e-08
GS O 1 1.0
levels O 0 5.5718516023262055e-08
, O 0 2.540402512917622e-13
but O 0 3.196646438763211e-14
not O 0 9.023613426568586e-14
clinical O 0 2.2320053791324845e-11
outbreak O 0 2.250181707630361e-10
of O 0 2.972365131803656e-10
the O 0 1.5951500120792161e-09
disease O 0 4.1386506666185596e-08
. O 0 9.275563095378914e-10
. O 0 1.1244349451544622e-08

Human O 0 0.0032513027545064688
MLH1 O 1 1.0
deficiency O 1 0.9999997615814209
predisposes O 0 0.00010154719348065555
to O 0 5.980551520679e-08
hematological B-Disease 1 0.9999995231628418
malignancy I-Disease 1 0.9999960660934448
and O 0 1.8847451599413034e-08
neurofibromatosis B-Disease 0 0.0009945741621777415
type I-Disease 0 2.3413758754031733e-06
1 I-Disease 0 7.395760803774465e-06
. O 0 5.977997119543943e-08

Heterozygous O 0 7.72169187257532e-07
germ O 0 3.752287739189342e-05
- O 0 4.86007763811358e-07
line O 0 1.1655583875835873e-07
mutations O 0 4.458169666765599e-10
in O 0 7.124534469327148e-12
the O 0 2.4989312702450306e-11
DNA O 0 8.677747409535641e-09
mismatch O 0 6.831047357991338e-05
repair O 0 0.01572655886411667
genes O 0 8.672363378536829e-07
lead O 0 9.672204015487296e-08
to O 0 3.2697922591751194e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.495801709301304e-05

The O 0 2.6621583160135742e-08
disease O 0 3.65309880123732e-08
susceptibility O 0 7.079764685613554e-08
of O 0 1.3633746576147132e-08
individuals O 0 1.0335231559466251e-09
who O 0 4.280012344537454e-09
constitutionally O 0 3.5838606891047675e-06
lack O 0 3.3291828003712e-05
both O 0 2.551591160582234e-09
wild O 0 2.6911354922276587e-08
- O 0 1.5966253319454893e-10
type O 0 1.088470202859071e-09
alleles O 0 4.3000733529474644e-10
is O 0 5.35221693354071e-12
unknown O 0 2.0574968395692395e-09
. O 0 1.9335952838872572e-09

We O 0 1.7211773339909087e-08
have O 0 4.5350976446423275e-11
identified O 0 1.7860019019266815e-10
three O 0 1.044811806516499e-11
offspring O 0 3.557970862377857e-10
in O 0 5.1087090287282866e-12
a O 0 4.038218023860729e-11
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.567809158586897e-05
who O 0 3.112802515747859e-10
developed O 0 7.51016493438783e-09
hematological B-Disease 1 0.9999935626983643
malignancy I-Disease 1 0.9999403953552246
at O 0 1.6569291494406002e-09
a O 0 2.216088207038225e-12
very O 0 3.119200210621731e-12
early O 0 9.628919883652998e-10
age O 0 3.7264180630103283e-10
, O 0 2.014210629883162e-12
and O 0 3.9843926769034255e-12
at O 0 1.3683641025830084e-11
least O 0 2.7808382766641992e-12
two O 0 2.942487020100165e-13
of O 0 1.927752011840478e-12
them O 0 8.644096181030514e-13
displayed O 0 5.825002979964466e-11
signs O 0 4.5931292103063015e-10
of O 0 5.657387891488952e-10
neurofibromatosis B-Disease 0 2.2972333226789488e-06
type I-Disease 0 1.8925481981568737e-07
1 I-Disease 0 5.7843675449476e-07
( O 0 2.2666452048625274e-10
NF1 B-Disease 0 3.750960240722634e-05
) O 0 1.3715690805327085e-09
. O 0 2.5645418233466444e-08

DNA O 0 6.535756380543489e-09
sequence O 0 5.156140098216966e-11
analysis O 0 9.426835180514903e-12
and O 0 6.700825658234599e-12
allele O 0 2.1305256170389697e-11
- O 0 1.2144510223854876e-11
specific O 0 8.690355726703736e-12
amplification O 0 2.8971280929823706e-09
in O 0 1.5539060316260844e-10
two O 0 1.001395841249142e-10
siblings O 0 9.601727413155459e-09
revealed O 0 8.375218851774946e-10
a O 0 1.9199050682594532e-10
homozygous O 0 8.190644962269289e-08
MLH1 O 0 0.005203463137149811
mutation O 0 5.963897820038255e-08
( O 0 2.2297162380335855e-11
C676T O 0 4.1741426315411445e-08
- O 0 1.2352542100302344e-08
- O 0 1.4663075198484421e-08
> O 0 7.478006835981432e-08
Arg226Stop O 0 1.5207141359496745e-06
) O 0 1.1135596611477894e-10
. O 0 2.7139539504617005e-09

Thus O 0 6.159682470752159e-07
, O 0 3.336544651677542e-10
a O 0 7.407076341170438e-11
homozygous O 0 1.7047465661335082e-08
germ O 0 0.00012110343232052401
- O 0 1.717303462100972e-06
line O 0 5.224587766861077e-06
MLH1 O 1 0.9998372793197632
mutation O 0 4.665162975925341e-07
and O 0 4.877345194387317e-10
consequent O 0 0.3056502640247345
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 0.9998038411140442
results O 0 1.8385640032647643e-06
in O 0 1.6937714564235762e-09
a O 0 2.3997692721877684e-10
mutator O 0 0.0001214076328324154
phenotype O 0 7.102053700691613e-08
characterized O 0 3.5831466266289524e-11
by O 0 5.70643185482389e-12
leukemia B-Disease 1 0.9997273087501526
and O 0 9.139765211330086e-08
/ O 1 0.7302685379981995
or O 0 3.9259306504391134e-05
lymphoma B-Disease 1 1.0
associated O 0 1.472981966799125e-05
with O 0 2.6544955122886904e-09
neurofibromatosis B-Disease 1 0.9880343079566956
type I-Disease 0 6.9010893639642745e-06
1 I-Disease 0 1.1726040156645468e-06
. O 0 1.2795503545603992e-09
. O 0 5.412207126909152e-09

Missense O 0 0.0019819121807813644
mutations O 0 8.78291189110314e-07
in O 0 2.0991219873423006e-09
the O 0 1.1084574369490952e-09
most O 0 9.91893026047741e-11
ancient O 0 2.9964735137610887e-09
residues O 0 1.2613218913770652e-08
of O 0 1.7525946249818958e-09
the O 0 4.564120636985081e-09
PAX6 O 0 0.00014277642185334116
paired O 0 1.2320822584399593e-08
domain O 0 1.9475974166738297e-09
underlie O 0 7.056062401034069e-09
a O 0 2.1828058457962207e-11
spectrum O 0 2.1753368173449417e-07
of O 0 7.377333854918788e-09
human O 0 2.3882090317783877e-05
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 0.41344618797302246

Mutations O 0 6.396230105565337e-07
of O 0 3.4906861845485082e-09
the O 0 7.900451959308441e-10
human O 0 2.823815403729668e-09
PAX6 O 0 0.004278354346752167
gene O 0 2.1452497378504631e-07
underlie O 0 0.22860687971115112
aniridia B-Disease 1 1.0
( O 0 9.011751899379306e-06
congenital B-Disease 1 1.0
absence I-Disease 0 0.19744190573692322
of I-Disease 0 4.117162825423293e-05
the I-Disease 0 4.210935458104359e-07
iris I-Disease 0 2.119408054568339e-05
) O 0 7.24159057371998e-12
, O 0 1.2651430467483515e-12
a O 0 1.4995173071991053e-12
rare O 0 1.4193735964340704e-08
dominant O 0 0.17846271395683289
malformation B-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 1 0.9999991655349731
eye I-Disease 1 1.0
. O 0 8.131988579407334e-06

The O 0 2.254699893455836e-07
spectrum O 0 1.390587021887768e-05
of O 0 5.694498668162851e-07
PAX6 O 1 0.9999828338623047
mutations O 0 1.918441057568998e-06
in O 0 1.798539095432261e-08
aniridia B-Disease 1 1.0
patients O 0 0.03762456774711609
is O 0 3.393620107150497e-11
highly O 0 1.0138887507338268e-09
biased O 0 3.5606459447556915e-10
, O 0 1.4058023408564102e-12
with O 0 3.052509146058563e-13
92 O 0 4.160857880464164e-09
% O 0 1.4242148259346887e-11
of O 0 1.9943251911014315e-11
all O 0 1.9598704603662753e-11
reported O 0 9.803428208110532e-11
mutations O 0 3.666350834041765e-10
leading O 0 1.2505010360541746e-09
to O 0 6.331899587985745e-11
premature O 0 4.6156337418779e-08
truncation O 0 1.5864659985709295e-07
of O 0 6.24374862923105e-08
the O 0 8.83149997576993e-09
protein O 0 3.758843014622926e-09
( O 0 4.8312313351284164e-12
nonsense O 0 7.859060624504366e-10
, O 0 7.898119549869242e-13
splicing O 0 1.9504478587784035e-10
, O 0 5.368042815812046e-12
insertions O 0 3.016623062457313e-10
and O 0 2.1500962468778972e-11
deletions O 0 3.5622760297115974e-10
) O 0 6.1459045318235095e-12
and O 0 1.854252723587635e-10
just O 0 1.887948963830155e-10
2 O 0 1.0723495424969087e-09
% O 0 9.944196507905012e-12
leading O 0 2.2202216194006086e-12
to O 0 2.2136494568815446e-13
substitution O 0 6.773231753243181e-09
of O 0 3.6496912159122985e-09
one O 0 1.5430335828514607e-11
amino O 0 1.4187651053987338e-11
acid O 0 6.307490640899971e-11
by O 0 3.094343878351502e-11
another O 0 2.0921819832153687e-10
( O 0 9.910572362770154e-11
missense O 0 2.0667295075327274e-07
) O 0 4.702123690414339e-10
. O 0 2.320970438063341e-08

The O 0 1.3266506115883203e-08
extraordinary O 0 1.1312089043258311e-08
conservation O 0 1.2221863521233445e-08
of O 0 2.2956438139321023e-10
the O 0 1.2873693222559268e-09
PAX6 O 0 5.3291485528461635e-05
protein O 0 1.0409026529600851e-08
at O 0 2.0682214274536648e-10
the O 0 1.3646687946344827e-10
amino O 0 1.6183303586103648e-09
acid O 0 2.402166643378223e-08
level O 0 1.6422859516751487e-07
amongst O 0 1.2019540918117855e-07
vertebrates O 0 2.3387195824398077e-07
predicts O 0 2.102876761611583e-09
that O 0 2.7211403269555845e-11
pathological O 0 6.796651632612338e-06
missense O 0 3.848537744488567e-06
mutations O 0 1.5929797925196e-08
should O 0 5.199616848194921e-10
in O 0 6.616172193441017e-11
fact O 0 3.3864751280976435e-11
be O 0 1.7615577399543447e-11
common O 0 2.697232437398611e-10
even O 0 2.6694963947693218e-11
though O 0 2.121984706004998e-11
they O 0 2.535896622898881e-12
are O 0 1.9131842377700936e-12
hardly O 0 6.095571269959521e-10
ever O 0 1.0100278946545416e-10
seen O 0 8.767717107893702e-10
in O 0 2.431088885757049e-09
aniridia B-Disease 1 1.0
patients O 1 0.6864272356033325
. O 0 2.66706337015421e-07

This O 0 2.437379853503785e-09
indicates O 0 3.0806843742681167e-09
that O 0 1.6743040330904901e-12
there O 0 2.405192364718367e-12
is O 0 2.4958182222312164e-13
a O 0 6.68907474982855e-13
heavy O 0 2.8697849430159295e-08
ascertainment O 0 5.769696599600138e-06
bias O 0 2.0176635473490023e-08
in O 0 6.531238744278411e-11
the O 0 5.598753058388972e-11
selection O 0 5.194266794461555e-09
of O 0 3.0389435412558896e-10
patients O 0 2.5691229144086947e-09
for O 0 3.9700041865042834e-11
PAX6 O 0 2.1003797883167863e-05
mutation O 0 2.0912174214515744e-09
analysis O 0 2.494289774723768e-10
and O 0 2.5019692914685088e-11
that O 0 6.6562293871141875e-12
the O 0 2.3242385793764697e-09
missing O 0 2.891003134664061e-07
PAX6 O 1 0.9998999834060669
missense O 0 0.0005648846854455769
mutations O 0 1.7010380304327555e-07
frequently O 0 4.4396705756177823e-10
may O 0 1.3412566612913679e-09
underlie O 0 2.2353366091465432e-07
phenotypes O 0 2.710122828375461e-07
distinct O 0 6.342865677133602e-10
from O 0 1.99690319835355e-10
textbook O 0 3.771585284084722e-07
aniridia B-Disease 1 1.0
. O 0 9.191386425300152e-07

Here O 0 1.492080485832048e-07
we O 0 9.259759070623375e-10
present O 0 8.71034466776166e-10
four O 0 1.4126093350608215e-10
novel O 0 2.4165091261352245e-08
PAX6 O 0 0.45823824405670166
missense O 0 0.00014666827337350696
mutations O 0 1.4090257138832385e-07
, O 0 1.4513697188522912e-10
two O 0 7.292097481403914e-12
in O 0 2.3753410696714106e-11
association O 0 9.256099359200576e-11
with O 0 2.4794311569154015e-12
atypical O 0 5.979530669719679e-06
phenotypes O 0 0.00010383182961959392
ectopia B-Disease 0 0.00037659102235920727
pupillae I-Disease 0 0.0015651502180844545
( O 0 9.909721654377535e-11
displaced B-Disease 0 7.769396792589589e-10
pupils I-Disease 0 1.4445405982499437e-09
) O 0 9.471622271217672e-12
and O 0 1.8240304822114695e-09
congenital B-Disease 1 1.0
nystagmus I-Disease 1 0.9989168643951416
( O 0 1.0357925628312614e-09
searching B-Disease 0 3.668620962571367e-08
gaze I-Disease 0 7.494110221273331e-09
) O 0 1.6101932070675118e-12
, O 0 3.915152924083287e-12
and O 0 1.250759738835594e-11
two O 0 2.685003261393426e-12
in O 0 3.000708709288702e-11
association O 0 3.7920791506884655e-11
with O 0 2.082020753718661e-12
more O 0 4.5420577021726416e-11
recognizable O 0 6.895503474879661e-07
aniridia B-Disease 1 1.0
phenotypes O 0 0.000352886418113485
. O 0 3.6171081774227787e-07

Strikingly O 0 5.9581176174106076e-05
, O 0 5.460359719933194e-09
all O 0 6.073579417176234e-10
four O 0 1.4784944102341768e-10
mutations O 0 2.183098424257679e-10
are O 0 1.0524641921860756e-11
located O 0 4.1998356181682794e-11
within O 0 2.445770530545843e-10
the O 0 6.157353737989979e-09
PAX6 O 1 0.5079932808876038
paired O 0 1.5577600720462215e-07
domain O 0 7.933313561636623e-09
and O 0 1.1159452528719527e-10
affect O 0 4.6982178147914055e-09
amino O 0 1.5863843572105907e-09
acids O 0 1.3378355090409855e-09
which O 0 2.3201569138153744e-11
are O 0 6.750947023625997e-12
highly O 0 6.492960058501751e-10
conserved O 0 1.348508305021312e-09
in O 0 5.890530424546014e-11
all O 0 1.32272776065534e-10
known O 0 9.33893740118208e-10
paired O 0 5.201266084498002e-09
domain O 0 2.014321154319987e-09
proteins O 0 1.2512215707971563e-09
. O 0 6.356433157606034e-09

Our O 0 2.2313281533570262e-07
results O 0 2.025838874430974e-08
support O 0 1.8383645716824049e-09
the O 0 4.56551102478997e-10
hypothesis O 0 7.419155290122603e-10
that O 0 3.6235530770584515e-14
the O 0 7.157629523801834e-13
under O 0 1.1468709662509902e-11
- O 0 1.3384882091571626e-10
representation O 0 1.86907844756945e-09
of O 0 7.34418659220637e-09
missense O 0 7.684212164349447e-07
mutations O 0 1.487030387714583e-09
is O 0 1.4134893342593324e-12
caused O 0 1.0800362687524157e-10
by O 0 1.1312099174043411e-10
ascertainment O 0 1.9004000932909548e-05
bias O 0 5.322532103946287e-08
and O 0 1.6325472917966266e-10
suggest O 0 9.586931942751065e-11
that O 0 6.560706567858982e-14
a O 0 1.9192319174882178e-13
substantial O 0 1.5836988664919005e-10
burden O 0 1.7761493609214085e-07
of O 0 7.689490075790673e-07
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9998953342437744
related I-Disease 1 0.9999995231628418
disease I-Disease 1 1.0
remains O 0 2.4342205051652854e-07
to O 0 5.884519434229407e-12
be O 0 1.7773863977832427e-11
uncovered O 0 4.06093825233711e-09
. O 0 4.89434326400584e-10
. O 0 6.476908787078628e-09

The O 0 1.0480945888957649e-08
chromosomal O 0 8.70819363285591e-08
order O 0 6.665402452199487e-08
of O 0 9.130170610660571e-07
genes O 0 1.6205990505113732e-07
controlling O 0 1.0015481421987715e-07
the O 0 1.954583517260744e-08
major O 0 8.63246987137245e-06
histocompatibility O 1 0.9999966621398926
complex O 0 1.0933315024885815e-05
, O 0 4.156959151901951e-11
properdin O 0 2.7029054550098408e-08
factor O 0 7.170351423724242e-09
B O 0 4.009431449958356e-06
, O 0 4.6226199951204805e-12
and O 0 1.114944681718244e-11
deficiency B-Disease 0 1.2301590857077827e-08
of I-Disease 0 1.2606172106188751e-08
the I-Disease 0 3.5254011265806184e-08
second I-Disease 0 7.595536999360775e-08
component I-Disease 0 2.512206833671371e-07
of I-Disease 0 6.182056466741415e-08
complement I-Disease 0 6.933055942681676e-07
. O 0 2.8063780632692215e-07

The O 0 2.2731590831881476e-08
relationship O 0 1.7088737092052497e-09
of O 0 3.925822333883389e-09
the O 0 1.2273437821619382e-09
genes O 0 1.0122650634381003e-10
coding O 0 2.9093033537819224e-10
for O 0 3.904394169085279e-11
HLA O 0 4.85348664369667e-07
to O 0 1.036630087325463e-10
those O 0 2.3855384681525926e-11
coding O 0 2.6181383450119e-11
for O 0 2.387631325290185e-12
properdin O 0 4.010529863762713e-08
Factor O 0 1.639319968660402e-08
B O 0 3.0238044246289064e-07
allotypes O 0 1.4925666036447183e-08
and O 0 4.021966353712214e-12
for O 0 4.871055815647285e-12
deficiency B-Disease 0 2.0357509455948275e-08
of I-Disease 0 3.19370023760257e-08
the I-Disease 0 6.907454164206683e-09
second I-Disease 0 1.0709050535240294e-08
component I-Disease 0 5.2661139449128314e-08
of I-Disease 0 1.5311920265048684e-07
complement I-Disease 0 1.0732564987847582e-06
( O 0 3.2391739290815735e-10
C2 O 0 1.599894972059701e-08
) O 0 1.4268535626030948e-13
was O 0 4.171643065709052e-12
studied O 0 1.3213453768645689e-11
in O 0 4.316485320218777e-13
families O 0 1.0990306971783714e-12
of O 0 6.4965467901079155e-12
patients O 0 5.469042108074973e-09
with O 0 8.221000546981827e-10
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 7.293734233826399e-05

Patients O 0 0.00016402303299400955
were O 0 3.42316575085988e-08
selected O 0 8.286368924359522e-09
because O 0 5.932101337924323e-11
they O 0 1.871866550651191e-11
were O 0 1.588539300101388e-10
heterozygous O 0 1.47151721363592e-10
or O 0 6.513523054252346e-11
homozygous O 0 5.1094207975665995e-08
for O 0 4.3489657741702104e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 6.297045274550328e-06

12 O 0 5.087361500955012e-07
families O 0 1.9559922570522303e-09
with O 0 3.329041556310308e-11
15 O 0 2.579296332072545e-09
matings O 0 4.744936632050667e-06
informative O 0 7.05893796748569e-07
for O 0 2.669114280706708e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 3.1648539788875496e-08
found O 0 1.2095792145672135e-09
. O 0 4.1451819754456665e-09

Of O 0 6.001021574775223e-06
57 O 0 3.050732402698486e-06
informative O 0 1.0676178163748773e-07
meioses O 0 2.2577175968763186e-06
, O 0 3.115921132224031e-10
two O 0 1.170626963420407e-11
crossovers O 0 1.9294248421175553e-09
were O 0 2.1807013139696352e-10
noted O 0 9.331704159398768e-11
between O 0 6.08502359611407e-10
the O 0 8.71553856995888e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 4.755573712600381e-10
and O 0 8.82830752946262e-11
the O 0 9.580465309966257e-10
HLA O 0 2.8947574719495606e-06
- O 0 0.4299065172672272
B O 0 0.014792854897677898
gene O 0 4.483750176698109e-11
, O 0 2.8581642803372775e-13
with O 0 1.1145262061070926e-14
a O 0 8.176214561081072e-14
recombinant O 0 1.001118979382376e-10
fraction O 0 2.8401552221168913e-09
of O 0 2.0572887837744247e-09
0 O 0 2.8407146857034604e-08
. O 0 3.844731200075557e-09

035 O 0 0.01777840033173561
. O 0 1.6528931155335158e-05

A O 0 1.2360959544821526e-07
lod O 0 2.225339449068997e-05
score O 0 3.073021659361075e-08
of O 0 3.371576073885052e-10
13 O 0 9.711083326369163e-11
was O 0 5.4973551752435235e-12
calculated O 0 6.003424146694414e-11
for O 0 2.3732127374387346e-11
linkage O 0 2.8880106128781335e-07
between O 0 0.00037970353150740266
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 1.4418299443264004e-08
HLA O 0 1.9854223864967935e-06
- O 0 3.944193395000184e-06
B O 0 7.97572920419043e-06
at O 0 2.5680805138678098e-12
a O 0 1.8526441841683512e-14
maximum O 0 1.0710049383813591e-12
likelihood O 0 2.5578600001963103e-11
value O 0 2.6069365416381274e-11
of O 0 8.054883149366532e-12
the O 0 4.116590315156321e-12
recombinant O 0 1.311045716434478e-10
fraction O 0 6.625962556405796e-10
of O 0 6.017435993932452e-10
0 O 0 8.261654471652946e-09
. O 0 1.1729077709077274e-09

04 O 0 0.0032761585898697376
. O 0 9.123335985350423e-06

18 O 0 1.254421476915013e-06
families O 0 3.3646911923312928e-09
with O 0 7.00524499519517e-11
21 O 0 9.236004849810797e-09
informative O 0 1.9304959852917136e-09
matings O 0 1.1885736839190031e-08
for O 0 2.446809595213484e-11
both O 0 5.076947542925758e-11
properdin O 0 5.098551696391951e-07
Factor O 0 3.2969282415251655e-07
B O 0 2.937705176009331e-06
allotype O 0 1.0756485124829851e-07
and O 0 4.921978380423297e-10
HLA O 0 2.6280995371052995e-06
- O 0 7.347360951825976e-05
B O 0 0.000566915434319526
were O 0 1.1740330929654874e-10
found O 0 2.731926143639818e-11
. O 0 4.64513594256033e-10

Of O 0 1.0066028153232764e-05
72 O 0 3.191056748619303e-06
informative O 0 1.2931674575611396e-07
meioses O 0 6.426449090213282e-06
, O 0 6.063994861804645e-10
three O 0 5.1375279030985155e-11
recombinants O 0 1.2429491107468493e-06
were O 0 4.248957186092639e-09
found O 0 1.0301237640675254e-10
, O 0 2.5016720466009e-12
giving O 0 4.258167169562954e-12
a O 0 6.003715320029857e-13
recombinant O 0 2.7744304076371407e-10
fraction O 0 5.229696675712603e-09
of O 0 8.416570551617042e-09
0 O 0 1.083115606093088e-07
. O 0 5.608066899753794e-09

042 O 0 0.003013244131579995
. O 0 8.74107536219526e-06

A O 0 1.1394424603849984e-07
lod O 0 8.440159035671968e-06
score O 0 3.736613862770355e-08
of O 0 1.731043419717082e-09
16 O 0 1.4984961049790968e-09
between O 0 2.7410196334898274e-10
HLA O 0 5.6777007557684556e-06
- O 0 3.71097594324965e-05
B O 0 2.167278762499336e-05
and O 0 9.894040448044095e-12
Factor O 0 9.405382028759846e-10
B O 0 5.366651478766471e-08
allotypes O 0 8.358115088924478e-09
was O 0 3.727703215550271e-11
calculated O 0 2.418710787210898e-10
at O 0 1.0448236893723095e-11
a O 0 3.0745672392577805e-13
maximum O 0 1.465992258142812e-11
likelihood O 0 1.07913837588125e-10
value O 0 1.9381136973084523e-10
of O 0 2.3807567028910626e-11
the O 0 9.925549965261737e-12
recombinant O 0 1.6619101927961566e-10
fraction O 0 1.1592716786523738e-09
of O 0 2.787489405964294e-10
0 O 0 8.324736455733728e-09
. O 0 1.4242977908196508e-09

04 O 0 0.006097772624343634
. O 0 1.3714326087210793e-05

A O 0 4.449857442523353e-07
crossover O 0 1.5354399351963366e-07
was O 0 3.4732130504977476e-09
shown O 0 7.387140205095122e-11
to O 0 1.1209129978373422e-11
have O 0 4.4589644476733525e-12
occurred O 0 1.7791237927333725e-10
between O 0 3.68785037230257e-12
genes O 0 1.0203668422345546e-12
for O 0 3.3345545834111145e-13
Factor O 0 9.5628660545799e-10
B O 0 9.949602741698982e-08
and O 0 3.5424625038915636e-11
HLA O 0 5.1713552551291286e-08
- O 0 1.4165602806315292e-06
D O 0 2.151109015358088e-07
, O 0 5.3201562079385756e-12
in O 0 3.5189177960415208e-12
which O 0 4.4841756176305925e-12
HLA O 0 8.355888070354922e-08
- O 0 3.674749450510717e-06
D O 0 4.567318967474421e-07
segregared O 0 5.263784714770736e-07
with O 0 1.1439833802473487e-10
HLA O 0 1.2603459254023619e-05
- O 0 8.276385415229015e-06
A O 0 5.832482088408142e-07
and O 0 2.379429098198216e-09
B O 0 6.898503215779783e-06
. O 0 1.3162504419739207e-09

These O 0 6.577826283660215e-09
studies O 0 3.3944311250699855e-10
suggest O 0 5.169749697775394e-11
that O 0 2.0164389092931084e-13
the O 0 1.0026414594410671e-11
genes O 0 4.130488052284109e-12
for O 0 4.680250978439382e-12
Factor O 0 1.423417870682897e-06
B O 1 0.9999998807907104
and O 0 8.459229547952418e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
are O 0 8.579290750043711e-11
located O 0 1.1394054970359502e-11
outside O 0 8.343577564962068e-12
those O 0 2.3499691775841214e-12
for O 0 1.172832837792459e-11
HLA O 0 1.7176083133563225e-07
, O 0 1.6970260266480075e-11
that O 0 4.6649705989386045e-14
the O 0 8.245643209024711e-13
order O 0 4.72549811780798e-11
of O 0 2.653345321235179e-10
genese O 0 2.0103733788801037e-07
is O 0 2.477092662933611e-11
HLA O 0 7.7618320659667e-09
- O 0 5.6775295576017015e-09
A O 0 3.505425061334222e-09
, O 0 6.185524314972213e-12
- O 0 2.671270427079264e-10
B O 0 7.104478783048762e-08
, O 0 5.383317489698891e-13
- O 0 1.7054366599489335e-11
D O 0 1.1254465415166948e-10
, O 0 1.6657220036891268e-13
Factor O 0 7.269801427511879e-10
B O 0 9.835213859332725e-06
allotype O 0 6.289009616011754e-05
, O 0 6.861315000605828e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 3.437167911402028e-11
that O 0 6.782215847961348e-13
the O 0 9.901635067421921e-11
genes O 0 4.439061063177263e-10
coding O 0 5.6856599428556365e-08
for O 0 6.223227728696656e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 6.1150333685588976e-09
Factor O 0 2.5921304214193697e-08
B O 0 2.2480288919268787e-07
allotypes O 0 1.4735831221912576e-08
are O 0 1.3617553265565796e-12
approximately O 0 3.681284877626867e-13
3 O 0 9.783398917384556e-12
- O 0 2.757252412499689e-11
- O 0 4.1583966825520235e-10
5 O 0 4.228984662457691e-10
centimorgans O 0 1.893768164507037e-08
from O 0 9.62702417783845e-11
the O 0 3.629488654066648e-10
HLA O 0 1.631584609640413e-07
- O 0 6.475590197396741e-08
A O 0 2.4134736875680574e-08
and O 0 2.1237755998271268e-10
HLA O 0 1.670327520741921e-07
- O 0 1.1347614190526656e-06
B O 0 1.5402769122374593e-06
loci O 0 8.540824991687401e-11
, O 0 1.9436339202590774e-13
and O 0 3.2116741585002176e-14
that O 0 2.0221293782767165e-15
the O 0 3.8352678780224914e-13
apparent O 0 1.0071807970968294e-10
lack O 0 2.609818472443237e-10
of O 0 7.257301704033381e-11
recombinants O 0 1.0307989128932604e-08
between O 0 2.881232405438361e-11
the O 0 7.847014010797793e-11
Factor O 0 3.332007025846906e-08
B O 0 9.325044084107503e-05
gene O 0 8.390096439825356e-08
and O 0 6.751681667083176e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 5.068737873870077e-09
suggests O 0 5.294328309091156e-10
that O 0 3.6174020593207623e-13
these O 0 5.440484868168838e-12
two O 0 4.9425945107539615e-12
genes O 0 6.936863583550945e-11
lie O 0 2.399586085388705e-10
in O 0 1.0203810019149273e-11
close O 0 3.7525371698876597e-10
proximity O 0 6.226920135077307e-08
to O 0 3.490446598419794e-09
one O 0 1.038637398309561e-09
another O 0 2.0098387398803652e-09
. O 0 3.498606560015105e-08

Distribution O 0 3.5990499469562565e-08
of O 0 2.3191651266074587e-08
emerin O 0 7.240236300276592e-05
and O 0 1.98395930794959e-08
lamins O 0 0.00027715147007256746
in O 0 1.1854781600817432e-09
the O 0 6.573270261434061e-10
heart O 0 9.301983183718221e-09
and O 0 4.341582648947906e-11
implications O 0 3.6156300176060086e-09
for O 0 3.8922762235493735e-10
Emery B-Disease 0 0.0035995321813970804
- I-Disease 1 0.9999974966049194
Dreifuss I-Disease 1 0.999997615814209
muscular I-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
. O 0 0.0017742806812748313

Emerin O 1 0.9953988194465637
is O 0 1.2945179150847252e-08
a O 0 1.7394226337064111e-10
nuclear O 0 1.5121052854283334e-07
membrane O 0 3.4960319084120783e-08
protein O 0 4.660053454230706e-10
which O 0 7.468666527246648e-13
is O 0 1.0960685484229238e-12
missing O 0 3.726117678293228e-11
or O 0 1.239812506131921e-11
defective O 0 8.833255549234309e-08
in O 0 1.393588711096072e-08
Emery B-Disease 1 0.9837309122085571
- I-Disease 1 0.9999998807907104
Dreifuss I-Disease 1 0.9999998807907104
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 7.265483077389945e-07
EDMD B-Disease 1 1.0
) O 0 1.6478153952448338e-08
. O 0 2.9652333921603713e-08

It O 0 1.4402536108182318e-10
is O 0 9.821577579005591e-12
one O 0 2.3554751898968718e-12
member O 0 7.125037539135182e-12
of O 0 5.685293208435027e-11
a O 0 2.6177738796095973e-11
family O 0 9.627170588499823e-11
of O 0 7.193597717503053e-09
lamina O 1 1.0
- O 0 7.49525788705796e-05
associated O 0 1.186523604701506e-06
proteins O 0 1.2679133298831857e-09
which O 0 2.0894997971449003e-12
includes O 0 2.793303782722134e-12
LAP1 O 0 1.5109235391719267e-05
, O 0 2.832450107792539e-10
LAP2 O 0 0.0003784841683227569
and O 0 2.2515061814942783e-08
lamin O 0 8.613686986791436e-06
B O 0 2.3515676730312407e-05
receptor O 0 5.159365201734545e-08
( O 0 5.509516176616103e-10
LBR O 0 9.177081665256992e-06
) O 0 8.734518108788336e-10
. O 0 1.997541509979328e-08

A O 0 1.1415213521104306e-06
panel O 0 6.693506549027006e-08
of O 0 1.2899656454123942e-08
16 O 0 2.0091805552624464e-08
monoclonal O 0 1.2998452803003602e-07
antibodies O 0 1.6676088421263557e-07
( O 0 2.256219933105541e-10
mAbs O 0 1.6459158302950527e-07
) O 0 2.182855805832329e-11
has O 0 3.208977137833524e-12
been O 0 1.0827995618190034e-11
mapped O 0 5.854947082717388e-10
to O 0 1.0204340844532922e-10
six O 0 1.409955208142577e-10
specific O 0 1.1780219022483607e-09
sites O 0 5.869160712990151e-09
throughout O 0 2.7178699291141584e-09
the O 0 1.6272196923239335e-09
emerin O 0 3.2742238431637816e-07
molecule O 0 2.0271015976902618e-09
using O 0 3.4307379159770335e-10
phage O 0 5.467811536874478e-09
- O 0 2.859357195461598e-10
displayed O 0 4.999679004136226e-10
peptide O 0 7.978317451140526e-10
libraries O 0 1.0974006148245508e-09
and O 0 3.3813569999541215e-11
has O 0 7.946473340458837e-13
been O 0 7.591086505047417e-13
used O 0 7.57119367200687e-12
to O 0 1.678449879083388e-10
localize O 0 9.264631444239058e-07
emerin O 0 7.438328339048894e-06
in O 0 1.166440277700076e-09
human O 0 8.449765886986427e-10
and O 0 3.411587679025274e-09
rabbit O 0 3.615894001995912e-07
heart O 0 8.000158686627401e-07
. O 0 6.263955043550595e-08

Several O 0 2.553148590322962e-07
mAbs O 0 1.1501449989737011e-05
against O 0 4.311353762886938e-08
different O 0 5.441084915958072e-09
emerin O 0 9.46737145568477e-06
epitopes O 0 6.12229484886484e-07
did O 0 1.3533524301223565e-09
not O 0 5.435581845736337e-11
recognize O 0 2.394218712176155e-10
intercalated O 0 2.1988935827721434e-07
discs O 0 2.8874698188019465e-08
in O 0 3.251609814736156e-10
the O 0 1.52652779306095e-09
heart O 0 2.2214756256744295e-08
, O 0 1.1487581719205053e-11
though O 0 3.493940206600321e-11
they O 0 7.1354415431823526e-12
recognized O 0 8.194071116074397e-11
cardiomyocyte O 0 7.619726005714256e-08
nuclei O 0 1.613742171002741e-07
strongly O 0 3.888798172368979e-09
, O 0 1.7814897126933182e-11
both O 0 2.0432556688265713e-11
at O 0 6.277308672864024e-10
the O 0 1.4893949407124296e-09
rim O 0 2.953470179534179e-08
and O 0 4.593593561086351e-10
in O 0 1.4095552502979558e-09
intranuclear O 0 3.2965661375783384e-05
spots O 0 6.206205398484599e-07
or O 0 6.017300879790355e-09
channels O 0 1.2896555823260769e-08
. O 0 5.9881282155060944e-09

A O 0 1.9037257743548253e-06
polyclonal O 0 3.347427264088765e-05
rabbit O 0 8.364815471395559e-07
antiserum O 0 2.166289050364867e-06
against O 0 1.5234629557880908e-08
emerin O 0 2.405172745056916e-05
did O 0 3.400052150936972e-08
recognize O 0 7.284727043810335e-09
both O 0 7.863963924492623e-10
nuclear O 0 6.807088936966466e-08
membrane O 0 6.596358126387258e-09
and O 0 2.872392775021826e-11
intercalated O 0 7.015160008450039e-09
discs O 0 5.31527266645071e-10
but O 0 3.3840475560653616e-11
, O 0 1.0044862077535077e-12
after O 0 1.6965406510194292e-11
affinity O 0 1.6394058333091266e-10
purification O 0 2.6768221417228233e-08
against O 0 5.392667423720354e-10
a O 0 1.8599158671528393e-11
pure O 0 7.107471056144732e-09
- O 0 7.510304600444329e-10
emerin O 0 1.3154483724520105e-07
band O 0 2.548031341476076e-09
on O 0 4.9928249035158245e-11
a O 0 1.860656377236647e-12
western O 0 3.536361481426553e-10
blot O 0 1.0110932890938784e-07
, O 0 2.339844290544235e-11
it O 0 3.220443226328862e-12
stained O 0 6.568063071199504e-08
only O 0 7.559754211516889e-11
the O 0 1.9068435719304944e-10
nuclear O 0 1.396718545265685e-07
membrane O 0 2.2588235992770933e-07
. O 0 6.68476429765974e-09

These O 0 2.3131702775458507e-08
results O 0 1.6413661541037072e-08
would O 0 3.2351854528656077e-10
not O 0 4.1352123114624106e-11
be O 0 4.634133701775234e-11
expected O 0 1.0705353936657502e-08
if O 0 4.501146955160351e-10
immunostaining O 0 9.47127546169213e-07
at O 0 6.419849651884135e-10
intercalated O 0 3.690539074341359e-08
discs O 0 7.324476136716385e-09
were O 0 2.155003536730149e-10
due O 0 1.2079843791923395e-08
to O 0 1.1124959981012594e-10
a O 0 1.686358865049531e-11
product O 0 1.6171917138763092e-09
of O 0 3.0239004633614286e-09
the O 0 1.997243259665993e-09
emerin O 0 5.55788290057535e-07
gene O 0 1.4366566269963243e-10
and O 0 3.4405391730052415e-11
, O 0 2.9878454311377256e-12
therefore O 0 3.552383665006431e-10
, O 0 9.432536349218701e-12
cast O 0 2.7507768285417455e-10
some O 0 3.986848177983671e-12
doubt O 0 1.7167789412297907e-10
upon O 0 6.220940429457755e-11
the O 0 2.9344027208111356e-11
hypothesis O 0 1.597390775209817e-09
that O 0 1.191342597489653e-12
cardiac B-Disease 0 6.671578830719227e-06
defects I-Disease 0 6.141332960396539e-06
in O 0 6.785944606235716e-07
EDMD B-Disease 1 1.0
are O 0 1.354143197573876e-08
caused O 0 2.4918753727121157e-09
by O 0 3.766144687777917e-11
absence O 0 8.796385486675717e-08
of O 0 3.6655784185768425e-08
emerin O 0 2.2629063096246682e-05
from O 0 1.5115492857376012e-08
intercalated O 0 2.2718406853527995e-06
discs O 0 3.530192600464943e-07
. O 0 4.4894477468915284e-08

Although O 0 8.10399399142625e-07
emerin O 0 8.453457121504471e-05
was O 0 3.9941021157119394e-08
abundant O 0 2.1017591222971532e-08
in O 0 3.3695043283321624e-11
the O 0 5.291175830812733e-11
membranes O 0 1.886473061096794e-10
of O 0 1.8690134162557825e-10
cardiomyocyte O 0 7.413149916146722e-08
nuclei O 0 1.057282901228973e-07
, O 0 9.125864126879879e-12
it O 0 3.2895761852350103e-13
was O 0 6.208931979667653e-11
absent O 0 2.5531976532988665e-09
from O 0 6.28328292173741e-11
many O 0 3.2728257604031086e-11
non O 0 1.1323919579808717e-08
- O 0 2.8265096929658284e-09
myocyte O 0 5.341743758435769e-07
cells O 0 4.084841798146499e-09
in O 0 3.5140636928110425e-11
the O 0 1.5763124139311913e-10
heart O 0 2.2149684753003385e-08
. O 0 1.3416538990895788e-08

This O 0 8.83262352147085e-10
distribution O 0 3.5591265490353408e-09
of O 0 3.1652509502322346e-09
emerin O 0 1.0961597581626847e-05
was O 0 7.875871510520938e-09
similar O 0 6.269779140311016e-11
to O 0 8.253877616104521e-12
that O 0 8.173832162332306e-13
of O 0 3.95461136060149e-10
lamin O 0 8.980491372767574e-08
A O 0 1.6766523724953686e-09
, O 0 3.0950916742739087e-12
a O 0 3.8599353748003384e-12
candidate O 0 8.894041059193114e-10
gene O 0 4.731925788703517e-12
for O 0 2.8096064971089296e-12
an O 0 1.1121066090594156e-12
autosomal O 0 1.3672860177393886e-08
form O 0 1.5819892951185466e-07
of O 1 0.9868027567863464
EDMD B-Disease 1 1.0
. O 1 0.6301359534263611

In O 0 1.5474066472620507e-08
contrast O 0 2.9086406172496027e-08
, O 0 3.486540833819163e-09
lamin O 0 3.1273109925678e-05
B1 O 0 8.053733472479507e-05
was O 0 2.3431740991952665e-09
absent O 0 3.3461009962820754e-08
from O 0 6.697613019746029e-10
cardiomyocyte O 0 7.370293133135419e-06
nuclei O 0 2.3912010874482803e-05
, O 0 3.3993680093047374e-10
showing O 0 1.2846491648232927e-09
that O 0 2.747227167976263e-10
lamin O 0 0.0001372260885545984
B1 O 0 1.4488781744148582e-05
is O 0 1.957646501501986e-12
not O 0 7.852515838090157e-13
essential O 0 3.742685328322892e-11
for O 0 4.356179479636513e-12
localization O 0 5.274749526051892e-08
of O 0 3.8422900416890116e-09
emerin O 0 2.7311023131915135e-06
to O 0 4.3461084731077904e-10
the O 0 1.4346611676430143e-09
nuclear O 0 3.020172471224214e-06
lamina O 1 0.9993869066238403
. O 0 2.673868380043132e-07

Lamin O 1 0.9999570846557617
B1 O 1 0.9995057582855225
is O 0 5.316063700355755e-10
also O 0 2.7658271506414422e-11
almost O 0 7.40201996918266e-11
completely O 0 6.1734763967535855e-09
absent O 0 9.744270812461764e-08
from O 0 2.330902360014875e-09
skeletal O 0 1.0107401067216415e-06
muscle O 0 1.2908984899695497e-05
nuclei O 1 0.9999700784683228
. O 0 6.94408072376973e-06

In O 0 2.475040048466326e-07
EDMD B-Disease 1 1.0
, O 0 8.905822190818924e-10
the O 0 4.783745621850244e-11
additional O 0 7.074570790299717e-11
absence O 0 1.844965957786826e-08
of O 0 2.0451074078664533e-07
lamin O 1 0.568821907043457
B1 O 1 0.9940897226333618
from O 0 2.7600137286754034e-08
heart O 1 0.7891886830329895
and O 0 5.282552706376009e-07
skeletal O 1 0.8761534094810486
muscle O 1 0.9986686706542969
nuclei O 1 1.0
which O 0 2.0800766264983395e-07
already O 0 1.2357538103913157e-08
lack O 0 1.936161595494923e-07
emerin O 0 2.6015518415078986e-06
may O 0 1.7688250864011934e-09
offer O 0 6.059540369474092e-11
an O 0 1.6580758033929444e-14
alternative O 0 3.024006739460461e-11
explanation O 0 1.0386606852375024e-10
of O 0 3.8171583949253574e-11
why O 0 6.166833016463258e-11
these O 0 1.1724368871590674e-11
tissues O 0 3.4229812317931874e-09
are O 0 1.4420367677736579e-11
particularly O 0 4.751203319663944e-10
affected O 0 4.260692243462927e-09
. O 0 1.3289545020001015e-09
. O 0 1.126884718871679e-08

Genetic O 0 4.828100372833433e-07
mapping O 0 4.1069448286634724e-08
of O 0 2.0320035432064287e-08
the O 0 2.2467516203050764e-07
copper B-Disease 0 0.010692356154322624
toxicosis I-Disease 0 0.32345324754714966
locus O 0 1.5427245614318963e-07
in O 0 1.1712161018806455e-08
Bedlington O 0 1.2133169775552233e-06
terriers O 0 1.226502348572467e-07
to O 0 1.310353214822868e-10
dog O 0 5.157974936054188e-09
chromosome O 0 3.64570984512369e-10
10 O 0 1.4314624485756156e-10
, O 0 2.7590501498059306e-12
in O 0 8.093615187776404e-12
a O 0 1.5394647362443337e-11
region O 0 4.831626210233253e-09
syntenic O 0 2.4250846308859764e-06
to O 0 9.506816445181698e-10
human O 0 5.2753601487154356e-09
chromosome O 0 8.928924266626836e-09
region O 0 2.7334314367521984e-08
2p13 O 0 4.156163413426839e-06
- O 0 7.110321007530729e-07
p16 O 0 9.93611593003152e-07
. O 0 6.449052136758837e-08

Abnormal O 1 0.9998924732208252
hepatic B-Disease 1 0.9999997615814209
copper I-Disease 0 6.354245670081582e-06
accumulation I-Disease 0 3.088923961058754e-07
is O 0 9.030888883931887e-12
recognized O 0 8.612536031571416e-12
as O 0 7.38908066677535e-12
an O 0 7.268338708676936e-12
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 0.00015130861720535904
man O 0 1.693766620292081e-07
, O 0 1.6641685252061222e-10
mouse O 0 3.8886664555093375e-08
, O 0 1.6035196781505334e-10
rat O 0 1.3408400718617486e-06
and O 0 2.2874977467779445e-09
dog O 0 1.2138609690737212e-06
. O 0 1.310614976546276e-07

The O 0 5.000141811706271e-08
major O 0 1.8116782030119793e-07
cause O 0 1.8230075511382893e-06
of O 0 3.5314500564709306e-05
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9922486543655396
accumulation I-Disease 1 0.9945911169052124
in O 0 8.484140323616884e-08
man O 0 6.228426219223593e-09
is O 0 1.7067547028459806e-11
a O 0 4.808242692888598e-11
dysfunctional O 0 2.2954803569064097e-07
ATP7B O 1 0.9990035891532898
gene O 0 2.5543535286942642e-08
, O 0 1.6378307043929397e-10
causing O 0 1.7249756467663246e-07
Wilson B-Disease 0 2.1731982997152954e-05
disease I-Disease 0 1.4060865396459121e-05
( O 0 1.151754136508032e-09
WD B-Disease 0 0.0019869976677000523
) O 0 4.580428480949195e-09
. O 0 6.573013422439544e-08

Mutations O 0 1.0202559224126162e-06
in O 0 5.81703663016242e-09
the O 0 1.9074711588018545e-08
ATP7B O 1 0.9999986886978149
genes O 0 2.5221356736437883e-07
have O 0 1.0496139374316371e-10
also O 0 9.454366109440393e-12
been O 0 1.9653282473663936e-11
demonstrated O 0 1.4370520329265446e-09
in O 0 1.304506058730226e-09
mouse O 0 1.9562961028896098e-07
and O 0 6.413965802920529e-09
rat O 0 2.529757921365672e-06
. O 0 3.013118288208716e-08

The O 0 1.863914008026768e-06
ATP7B O 1 0.999962329864502
gene O 0 6.759618997875805e-08
has O 0 1.4291428283852436e-11
been O 0 5.8022900720211545e-12
excluded O 0 9.221126084923981e-10
in O 0 3.4062572640963795e-12
the O 0 3.0011763473697384e-12
much O 0 3.1517170817618734e-11
rarer O 0 4.780752078659134e-06
human O 0 5.74326804780867e-07
copper B-Disease 1 0.9999929666519165
overload I-Disease 1 0.9999985694885254
disease O 1 0.9999943971633911
non B-Disease 0 0.000576251361053437
- I-Disease 0 1.2189985909571988e-07
Indian I-Disease 0 9.054203609082379e-09
childhood I-Disease 0 1.3273267995828064e-07
cirrhosis I-Disease 1 0.6232185959815979
, O 0 7.651157485355498e-11
indicating O 0 3.711580376375423e-09
genetic O 0 1.5395491104186476e-08
heterogeneity O 0 1.2860112974522053e-06
. O 0 1.322184886021205e-07

By O 0 4.2240749786870424e-10
investigating O 0 2.2070729688294932e-09
the O 0 1.617509459705957e-09
common O 0 3.8317756434480543e-07
autosomal O 1 0.9198452830314636
recessive O 1 0.9999871253967285
copper B-Disease 1 0.9997227787971497
toxicosis I-Disease 1 0.9999890327453613
( O 0 1.5045676926561669e-09
CT B-Disease 0 2.8488530006143264e-05
) O 0 1.1571747032812496e-10
in O 0 1.7327148604806553e-09
Bedlington O 0 1.1960314623138402e-06
terriers O 0 6.429524432860489e-07
, O 0 1.8340794161186835e-11
we O 0 9.249071127037656e-12
have O 0 6.256799006849889e-13
identified O 0 2.4049902694334158e-12
a O 0 7.460305702193526e-14
new O 0 3.6941157598169294e-12
locus O 0 1.1110768555200323e-11
involved O 0 1.0212045618851473e-11
in O 0 4.557909161206908e-09
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 9.606073035683949e-06

We O 0 2.173756108447833e-08
examined O 0 2.2569322410959103e-08
whether O 0 2.566654444535743e-09
the O 0 3.081026633822148e-08
WD B-Disease 1 0.6328567266464233
gene O 0 3.0714576837453933e-07
ATP7B O 1 1.0
was O 0 1.6715385697807505e-07
also O 0 6.030277666102535e-11
causative O 0 2.2305266522693046e-09
for O 0 8.307676768737338e-11
CT B-Disease 0 1.793659691884386e-07
by O 0 2.6772979666578323e-11
investigating O 0 1.064105914494462e-09
the O 0 1.5650012397117052e-09
chromosomal O 0 3.266834767146065e-07
co O 0 1.5154182619880885e-07
- O 0 2.871488504752051e-07
localization O 0 0.0013513960875570774
of O 0 1.9241138033976313e-06
ATP7B O 1 0.9999943971633911
and O 0 3.4680298632849826e-09
C04107 O 0 2.528435238957627e-08
, O 0 2.1734075043161605e-12
using O 0 2.593203212927775e-12
fluorescence O 0 1.5126417896027533e-09
in O 0 3.9104700033654183e-10
situ O 0 1.8355071063069772e-07
hybridization O 0 2.67809383558415e-08
( O 0 1.6949987247105724e-10
FISH O 0 3.7786276152473874e-07
) O 0 5.446966835909173e-11
. O 0 3.738458431712388e-09

C04107 O 0 0.0002609466027934104
is O 0 1.6927541590661122e-09
an O 0 8.550991512090711e-12
anonymous O 0 1.9001498152704244e-09
microsatellite O 0 3.9233546544892306e-07
marker O 0 8.636718007437594e-08
closely O 0 1.104665159346041e-08
linked O 0 1.819787343038115e-07
to O 0 5.519250834140621e-08
CT B-Disease 1 0.9999805688858032
. O 0 5.5513050938316155e-06

However O 0 1.853554931585677e-05
, O 0 2.8527367135211534e-07
BAC O 0 0.0004952247836627066
clones O 0 2.8326153369562235e-06
containing O 0 4.10903666647755e-08
ATP7B O 1 0.7743169665336609
and O 0 1.3967073719811651e-08
C04107 O 0 9.776866818356211e-07
mapped O 0 2.6709519929113412e-08
to O 0 3.2827743301488965e-10
the O 0 2.4319188884902587e-09
canine O 0 5.2937885186565836e-08
chromosome O 0 7.362643827946158e-09
regions O 0 1.614144728989686e-08
CFA22q11 O 0 3.5342734918231145e-05
and O 0 2.9698052905757777e-09
CFA10q26 O 0 1.5485793483094312e-05
, O 0 5.5129612680504536e-11
respectively O 0 1.3322385417069427e-09
, O 0 6.074129046962362e-12
demonstrating O 0 1.1584997544611397e-10
that O 0 1.6452533779798273e-11
WD B-Disease 0 1.1589803534661769e-06
cannot O 0 3.751587485112395e-09
be O 0 6.971020427570807e-10
homologous O 0 7.077453290094127e-09
to O 0 1.6994741613984843e-08
CT B-Disease 0 0.0004726223414763808
. O 0 2.9844972004866577e-07

The O 0 1.6682737395967706e-06
copper O 0 5.633323780784849e-06
transport O 0 3.0807855182501953e-06
genes O 0 2.3324427900206501e-07
CTR1 O 1 0.8487978577613831
and O 0 2.813908039911439e-08
CTR2 O 1 0.9999897480010986
were O 0 2.9005740032062022e-08
also O 0 6.527265533629034e-11
excluded O 0 4.144454557319932e-09
as O 0 3.1787411591821524e-10
candidate O 0 5.740083963701181e-09
genes O 0 9.029859499021242e-11
for O 0 3.013326393963567e-11
CT B-Disease 0 1.3836131984135136e-05
since O 0 1.464077392654417e-08
they O 0 7.079474784177364e-10
both O 0 1.3273097898558461e-10
mapped O 0 1.7903446503098053e-09
to O 0 6.351025261253085e-10
canine O 0 2.496501281257224e-07
chromosome O 0 6.366203564311945e-08
region O 0 1.5458940083590278e-07
CFA11q22 O 0 0.0017271001124754548
. O 0 1.4885587233948172e-06

2 O 0 4.7832527343416587e-05
- O 0 6.827165634604171e-06
22 O 0 9.201472153108625e-07
. O 0 9.387683519435086e-08

5 O 0 2.784671596600674e-05
. O 0 8.27952874260518e-07

A O 0 1.2609568500465684e-07
transcribed O 0 2.0237562736724612e-09
sequence O 0 3.20225304606403e-11
identified O 0 2.0634879221992364e-11
from O 0 1.6796529445084474e-11
the O 0 1.9564166953145445e-10
C04107 O 0 2.2401766841539938e-07
- O 0 8.965170827934799e-09
containing O 0 4.182429069743421e-09
BAC O 0 5.005217190046096e-06
was O 0 1.1618838113847119e-09
found O 0 1.6289632837063195e-11
to O 0 5.289397392305162e-12
be O 0 2.082943366399359e-11
homologous O 0 2.5506896594862383e-10
to O 0 1.5957393739718384e-10
a O 0 1.0055127563912691e-10
gene O 0 2.1455498488975877e-10
expressed O 0 2.9282651303752516e-10
from O 0 1.0754480639363351e-10
human O 0 1.7874365876302534e-10
chromosome O 0 2.480001204396842e-10
2p13 O 0 5.0907434712144095e-08
- O 0 4.908144113358048e-09
p16 O 0 1.1327159654683783e-08
, O 0 8.065152712344315e-12
a O 0 2.7839000635992983e-12
region O 0 1.0170569247902606e-10
devoid O 0 2.1470329958361845e-09
of O 0 3.0152755292611744e-11
any O 0 1.2465044274545534e-10
positional O 0 6.335961302283977e-07
candidate O 0 3.0489231903629843e-06
genes O 0 6.828909704381658e-08
. O 0 3.5020917721340084e-08

Molecular O 0 3.6926637303480447e-09
analysis O 0 2.030234869110359e-10
of O 0 1.942763283580007e-09
the O 0 3.343644650044553e-08
APC B-Disease 0 1.512481588861192e-07
gene O 0 1.977991381796329e-10
in O 0 7.780514427180307e-11
205 O 0 8.413243990368358e-10
families O 0 2.0092962016438065e-11
: O 0 1.324776659900051e-12
extended O 0 1.3208049098878405e-09
genotype O 0 7.824994696647991e-08
- O 0 8.449096355889196e-08
phenotype O 0 2.4634144324409135e-07
correlations O 0 1.7640148897157815e-08
in O 0 6.385347112169981e-11
FAP B-Disease 0 1.1095452556730834e-08
and O 0 4.4855761357869006e-13
evidence O 0 9.34906449132078e-13
for O 0 7.555245220679935e-14
the O 0 3.006963384885597e-12
role O 0 1.0064332180148572e-11
of O 0 2.959896217014091e-10
APC B-Disease 0 9.962815461506125e-09
amino O 0 4.078681836716669e-10
acid O 0 1.3448659963444243e-09
changes O 0 2.618297223477839e-08
in O 0 3.606143582146615e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999831914901733
. O 0 3.7258362226566533e-06

BACKGROUND O 0 0.0017341665225103498
/ O 0 1.643346513446886e-05
AIMS O 0 1.3466733435052447e-06
The O 0 1.8459083150901279e-09
development O 0 2.7808967573150767e-08
of O 0 3.1477231914323056e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.1542612421422405e-09
a O 0 6.580351281232355e-12
variable O 0 7.667724094551076e-11
range O 0 5.992806945132045e-11
of O 0 1.5788332446975417e-11
extracolonic O 0 4.238590634031425e-07
manifestations O 0 3.731589686140069e-06
in O 0 4.022776920464821e-07
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 3.3156553058688587e-09
FAP B-Disease 0 7.566515591861389e-07
) O 0 4.144558828078626e-12
is O 0 1.9547650173881714e-13
the O 0 1.4817159543593916e-13
result O 0 6.533963474442128e-12
of O 0 2.712916176428326e-11
the O 0 1.018153547582834e-10
dominant O 0 3.921319091659825e-08
inheritance O 0 1.8649525657110644e-07
of O 0 8.626853968962678e-07
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 0.9999996423721313
coli I-Disease 1 1.0
( O 0 2.081222838512531e-08
APC B-Disease 0 3.941565864806762e-07
) O 0 7.928287470981843e-10
gene O 0 6.129372565055746e-09
mutations O 0 4.7336058628388855e-08
. O 0 4.578963341828057e-08

In O 0 3.4658347303206938e-09
this O 0 1.4701280123818883e-11
study O 0 5.237874804026044e-12
, O 0 1.9835900568030036e-14
direct O 0 1.377401881788587e-13
mutation O 0 2.3303597549914623e-13
analysis O 0 6.827460688821341e-13
of O 0 1.8440071691827598e-10
the O 0 1.2555827488824889e-08
APC B-Disease 0 1.6378204747979908e-07
gene O 0 7.217659248048847e-10
was O 0 4.451696788976278e-09
performed O 0 1.7057540935283555e-09
to O 0 4.4189284176265886e-11
determine O 0 3.930812564334474e-09
genotype O 0 1.248866283276584e-06
- O 0 7.552298484370112e-07
phenotype O 0 6.174621489662968e-07
correlations O 0 1.2888121680987297e-08
for O 0 2.010741746716338e-11
nine O 0 2.063504783711423e-10
extracolonic O 0 2.698511991638952e-07
manifestations O 0 2.7985097972305084e-07
and O 0 7.541191282545157e-11
to O 0 3.1752718943761638e-12
investigate O 0 9.38168726732913e-12
the O 0 4.617667359596567e-12
incidence O 0 3.4080543942494046e-10
of O 0 7.850221583893813e-10
APC B-Disease 0 7.159530213129983e-08
mutations O 0 5.35436939230749e-09
in O 0 1.9494642344852764e-08
non O 1 0.9999996423721313
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.144322479580296e-06

METHODS O 0 2.442595905449707e-05
The O 0 2.3003747173788724e-06
APC B-Disease 0 1.7177604831886129e-06
gene O 0 1.7532599816405536e-09
was O 0 6.776433303379292e-10
analysed O 0 2.6845874412373405e-09
in O 0 1.771777863313062e-11
190 O 0 2.9296001735623634e-10
unrelated O 0 4.1412069329282986e-09
FAP B-Disease 0 2.8922332262482087e-07
and O 0 5.208977138515536e-10
15 O 0 9.138892664850573e-08
non O 1 0.9999909400939941
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 5.833249815623276e-06
using O 0 3.350740795937668e-10
denaturing O 0 7.54190637053398e-07
gradient O 0 5.231385458159821e-08
gel O 0 2.5042647067152757e-08
electrophoresis O 0 1.396099347239499e-09
, O 0 4.6306611323210234e-11
the O 0 1.34598165946187e-10
protein O 0 5.529487423494572e-10
truncation O 0 2.5437204342892983e-08
test O 0 1.2682430217125784e-08
, O 0 2.4682308280565834e-11
and O 0 5.740349168226189e-12
direct O 0 1.2887468869848817e-10
sequencing O 0 2.8123574580263266e-08
. O 0 1.9539088569331398e-08

RESULTS O 0 0.0002234896383015439
Chain O 0 1.6516786160991614e-07
terminating O 0 1.4900186329214193e-07
signals O 0 2.48616061071516e-08
were O 0 1.971505458886469e-10
only O 0 3.6253402623670494e-12
identified O 0 8.89732471726079e-12
in O 0 9.678496719345286e-12
patients O 0 4.935402642125553e-10
belonging O 0 2.3152764427880612e-11
to O 0 1.4990635469058766e-11
the O 0 9.545850332415284e-09
FAP B-Disease 0 0.001142497407272458
group O 0 8.124820816135525e-10
( O 0 1.2180328794186845e-11
105 O 0 7.63884671073356e-08
patients O 0 1.484010692109905e-08
) O 0 2.1662241445064012e-11
. O 0 6.411752018209427e-09

Amino O 0 1.1629424534476129e-07
acid O 0 2.2737129956595936e-09
changes O 0 8.341580759463341e-10
were O 0 2.512922647746052e-10
identified O 0 1.7812551780793662e-11
in O 0 7.2544470430813135e-12
four O 0 2.920124428720805e-12
patients O 0 8.070173002083791e-11
, O 0 3.892448700599377e-13
three O 0 4.62632211185865e-13
of O 0 2.056425696395081e-09
whom O 0 3.0445860943473235e-08
belonged O 0 6.772562954893147e-08
to O 0 2.1168478081534658e-10
the O 0 3.415424387753774e-08
non O 1 0.5708459615707397
- O 0 9.056182170752436e-05
FAP O 0 0.00013663734716828912
group O 0 4.462184788334156e-10
of O 0 4.211231896533718e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.4432361423969269
. O 0 5.915997292049724e-08

Genotype O 0 0.0011665961937978864
- O 0 5.8355559303890914e-05
phenotype O 0 3.0197920750651974e-06
correlations O 0 3.952330374090707e-08
identified O 0 3.3420474720990967e-10
significant O 0 5.672633474063105e-10
differences O 0 3.1092810104382806e-08
in O 0 1.4778269719073478e-09
the O 0 9.176071014138643e-10
nature O 0 1.5682126430771604e-10
of O 0 5.671084088443301e-11
certain O 0 1.8159943548923252e-09
extracolonic O 0 2.6887350941251498e-06
manifestations O 0 2.863022814381111e-07
in O 0 1.0312743992102469e-09
FAP B-Disease 0 4.516652722941217e-07
patients O 0 4.337457060188399e-09
belonging O 0 2.4725327688046583e-11
to O 0 1.1456248276420222e-11
three O 0 1.1454069637206743e-10
mutation O 0 4.446692258852636e-08
subgroups O 0 1.8648064497028827e-06
. O 0 3.002385184913692e-08

CONCLUSIONS O 0 2.043017593678087e-05
Extended O 0 3.2606051263428526e-06
genotype O 0 3.921083134628134e-06
- O 0 6.455414904849022e-07
phenotype O 0 2.42130766991977e-07
correlations O 0 3.031131612374338e-08
made O 0 3.9932578077550573e-11
in O 0 2.8585799092401e-12
this O 0 1.2097596145330125e-12
study O 0 3.053780535736128e-12
may O 0 2.6592615262610586e-11
have O 0 5.600138408556887e-12
the O 0 3.471448128955501e-11
potential O 0 6.139089236967266e-11
to O 0 1.1741309313695325e-11
determine O 0 5.902578981142881e-10
the O 0 8.550131436191322e-11
most O 0 3.490409697382013e-11
appropriate O 0 9.374183651544854e-10
surveillance O 0 2.77397682602043e-09
and O 0 1.4024506556076233e-10
prophylactic O 0 6.961351755307987e-05
treatment O 0 1.4997090147517156e-05
regimens O 0 9.843234920481336e-07
for O 0 2.617675243232753e-10
those O 0 8.280107710589846e-10
patients O 0 1.1169934976962281e-09
with O 0 1.4565318352463552e-12
mutations O 0 6.481709613481712e-11
associated O 0 4.218093097030362e-10
with O 0 4.923046345584048e-11
life O 0 1.2178650976579775e-08
threatening O 0 1.3275972321480367e-08
conditions O 0 0.00033342401729896665
. O 0 2.5356027322231967e-07

This O 0 2.4208178572848738e-08
study O 0 2.9589890537806696e-09
also O 0 2.0751698970311594e-12
provided O 0 7.489322747036842e-13
evidence O 0 3.884344235149939e-12
for O 0 3.750028933213745e-12
the O 0 6.650551220843681e-10
pathological O 0 8.037945917749312e-06
nature O 0 2.9330291528850694e-09
of O 0 1.8272436341781884e-10
amino O 0 2.196512936813999e-11
acid O 0 3.2351836487531926e-11
changes O 0 3.6683514559321395e-10
in O 0 1.0705327735394121e-09
APC O 0 6.243436878605735e-09
associated O 0 2.4651833352429264e-10
with O 0 6.740461053894586e-12
both O 0 2.4514823504517835e-10
FAP B-Disease 0 2.240023832200677e-06
and O 0 1.6828076709884954e-08
non O 1 0.9999986886978149
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.0002476192603353411
. O 0 7.524183498475168e-10
. O 0 2.8016424735710643e-09

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 0 7.404065399896353e-05
cancer B-Disease 0 0.05933018773794174
risk O 0 9.665303224437594e-09
of O 0 2.0948183188096436e-09
the O 0 2.209778138251295e-08
APC O 0 3.4797736248037836e-07
I1307K O 0 3.857897183934256e-07
polymorphism O 0 1.4119096647391416e-07
. O 0 2.7123460810685174e-08

Germ O 0 0.0017153394874185324
- O 0 3.385936452104943e-06
line O 0 2.2865005178118736e-07
and O 0 1.462161502985282e-10
somatic O 0 7.716223393572363e-08
truncating O 0 6.674663666217384e-08
mutations O 0 3.801350345611354e-10
of O 0 4.4073228400165476e-10
the O 0 3.869605080808469e-09
APC B-Disease 0 7.144211622289731e-08
gene O 0 1.4748975651901475e-10
are O 0 8.690853592341341e-12
thought O 0 4.7697509136801486e-11
to O 0 4.468962352954797e-11
initiate O 0 1.084926850580814e-07
colorectal B-Disease 1 1.0
tumor I-Disease 0 0.0008256460423581302
formation O 0 2.151288754248526e-06
in O 0 1.1418370604587835e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 1.225521941705665e-06
sporadic O 0 0.0013947503175586462
colorectal O 1 1.0
carcinogenesis O 1 0.9999891519546509
, O 0 7.330457130194645e-09
respectively O 0 6.549585407356062e-08
. O 0 5.406576519817463e-08

Recently O 0 1.208288267662283e-06
, O 0 3.927752290078246e-10
an O 0 1.4689227265107796e-11
isoleucine O 0 3.9627622072657687e-08
- O 0 4.1208803480685674e-08
- O 0 2.6268606845292197e-08
> O 0 4.99863546110646e-08
lysine O 0 4.0482013297094e-09
polymorphism O 0 2.959839595639835e-10
at O 0 1.9299640011127828e-11
codon O 0 3.882518750941699e-10
1307 O 0 4.929461638880639e-08
( O 0 5.1423683020135336e-12
I1307K O 0 4.704557188262015e-09
) O 0 3.368705921852344e-12
of O 0 4.1144751494748277e-10
the O 0 1.0959725571524359e-08
APC B-Disease 0 1.1671812671920634e-07
gene O 0 6.518733886018424e-10
has O 0 1.5537449798985747e-11
been O 0 1.3351575053888176e-11
identified O 0 1.3362810857842078e-11
in O 0 2.243037353077959e-11
6 O 0 9.606851980592523e-10
% O 0 9.29434307295196e-12
- O 0 3.204208426366151e-11
7 O 0 9.581611892794939e-11
% O 0 7.267392525441008e-13
of O 0 1.2362086181105791e-12
the O 0 3.644581858530671e-11
Ashkenazi O 0 8.029952702770515e-09
Jewish O 0 9.130213030061896e-09
population O 0 3.1807407402384413e-11
. O 0 9.580867210701172e-10

To O 0 1.305320651567854e-08
assess O 0 2.30818187674231e-07
the O 0 7.547785729755674e-10
risk O 0 6.024394871850802e-10
of O 0 3.2216920103911306e-11
this O 0 2.8724200101803987e-11
common O 0 1.815164019092208e-08
APC B-Disease 0 3.004074926593603e-07
allelic O 0 4.224276892728085e-07
variant O 0 1.0510954098208458e-06
in O 0 8.599574812251376e-07
colorectal O 1 1.0
carcinogenesis O 1 0.9999988079071045
, O 0 2.1582758691351955e-08
we O 0 6.766449067718838e-10
have O 0 1.5755603419154163e-11
analyzed O 0 1.6126598667565162e-10
a O 0 1.7856765328547186e-12
large O 0 4.243299808748269e-11
cohort O 0 2.8734095103288837e-09
of O 0 5.322087215375859e-11
unselected O 0 0.00023410815629176795
Ashkenazi O 0 4.3388661197241163e-07
Jewish O 0 6.68920563384745e-08
subjects O 0 8.789375272044708e-08
with O 0 3.5057240443947535e-10
adenomatous B-Disease 0 3.53147042915225e-05
polyps I-Disease 0 1.5642730204490363e-06
and O 0 7.56528617529284e-09
. O 0 4.537475462029761e-08
or O 1 0.9815570116043091
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 1.6363194133006687e-10
for O 0 4.352933985485308e-11
the O 0 5.957699222847168e-09
APC O 0 1.930795860971557e-07
I1307K O 0 8.447193522442831e-07
polymorphism O 0 4.068205328167096e-07
. O 0 3.1671671507638166e-08

The O 0 8.628861678516841e-07
APC O 0 1.4805722230448737e-06
I1307K O 0 9.242226042260882e-07
allele O 0 1.1370061336890558e-08
was O 0 1.0714908960096636e-09
identified O 0 1.6101826816328213e-10
in O 0 5.2294918395645595e-11
48 O 0 4.3906616120636954e-09
( O 0 2.3606969243999965e-12
10 O 0 6.535833506349231e-12
. O 0 6.883030929070999e-13
1 O 0 5.0492027225956804e-11
% O 0 8.92526233042118e-13
) O 0 5.414867501867676e-14
of O 0 2.5021793664814496e-11
476 O 0 2.7201230068385485e-07
patients O 0 8.330663376909797e-07
. O 0 6.29210674674141e-08

Compared O 0 3.37117427307021e-08
with O 0 5.477124396385813e-12
the O 0 1.8745676885756346e-11
frequency O 0 1.522409698306859e-10
in O 0 4.192414210929529e-12
two O 0 3.246232492884471e-13
separate O 0 7.285907445940543e-13
population O 0 2.2663477811015603e-13
control O 0 8.165873359444742e-12
groups O 0 4.629058638142003e-13
, O 0 6.08977440957198e-13
the O 0 2.8601426782515205e-10
APC O 0 2.4058165237761386e-08
I1307K O 0 1.4965324623972265e-07
allele O 0 1.481210376574893e-09
is O 0 2.432188998813256e-12
associated O 0 5.940204925170001e-12
with O 0 1.9210705888474816e-13
an O 0 1.0964102889476912e-14
estimated O 0 1.5867259491996605e-13
relative O 0 9.429681341321938e-11
risk O 0 5.526408219935774e-10
of O 0 2.1274253469982796e-09
1 O 0 2.330708497311207e-07
. O 0 2.7409074121464982e-08

5 O 0 1.1971307685598731e-05
- O 0 1.972451173060108e-06
1 O 0 4.4773861418434535e-07
. O 0 3.505620682631161e-08

7 O 0 1.1562909776330343e-06
for O 0 1.4994146368962902e-08
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.9999985694885254
( O 0 1.9489576619236004e-09
both O 0 2.580575531041518e-09
P O 0 1.929192694660742e-05
= O 0 1.095821433594324e-09
. O 0 8.121469469157816e-11
01 O 0 9.111738030753713e-09
) O 0 1.4466925053746582e-11
. O 0 1.82504311663223e-09

Furthermore O 0 1.3876928051104187e-07
, O 0 2.438522439529578e-10
compared O 0 6.771419536200085e-10
with O 0 2.318405190049333e-11
noncarriers O 0 2.5362911401316524e-05
, O 0 4.94335639089627e-09
APC O 0 2.8457370149226335e-07
I1307K O 0 3.8106503552626236e-07
carriers O 0 3.105314450024821e-09
had O 0 3.701092904373482e-11
increased O 0 5.977714850891047e-11
numbers O 0 8.18276349456859e-11
of O 0 4.3614795108837257e-10
adenomas B-Disease 0 0.008608500473201275
and O 0 2.0481477349676425e-06
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.999954104423523
per O 0 4.4814058242081956e-07
patient O 0 1.789172711141873e-05
( O 0 2.5248216711792892e-11
P O 0 1.317422118063405e-07
= O 0 2.8244481406480837e-11
. O 0 4.6866469038953085e-12
03 O 0 2.947850574752664e-10
) O 0 3.612727521654091e-13
, O 0 5.106309797740793e-13
as O 0 3.2740041146922527e-12
well O 0 7.585301310675252e-12
as O 0 3.391192058069259e-12
a O 0 5.944239458294254e-12
younger O 0 2.491794548475923e-09
age O 0 2.4269375398233706e-09
at O 0 1.1578508152254585e-09
diagnosis O 0 1.189489694297663e-06
. O 0 5.004893566251667e-08

We O 0 2.8346255120936803e-08
conclude O 0 4.665020369998274e-08
that O 0 3.356393635245425e-11
the O 0 1.2363093881972986e-09
APC O 0 2.263796403667584e-07
I1307K O 0 7.715905780969479e-07
variant O 0 6.817730309194303e-07
leads O 0 4.7115552348486744e-08
to O 0 7.142376273749917e-11
increased O 0 5.207562381315256e-08
adenoma B-Disease 1 1.0
formation O 0 9.50223966356134e-06
and O 0 1.41123124297593e-09
directly O 0 2.3869689558253526e-10
contributes O 0 1.9728019565179444e-11
to O 0 4.7465243541156e-12
3 O 0 1.2535857074613688e-10
% O 0 4.818789464677842e-12
- O 0 9.820116074477081e-12
4 O 0 2.0940013611969732e-11
% O 0 2.436022575064839e-13
of O 0 1.899866711434911e-13
all O 0 5.998361096021254e-12
Ashkenazi O 0 1.7854527811778098e-07
Jewish O 0 0.0001638995308894664
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 9.902458941724035e-07

The O 0 4.664584096758517e-08
estimated O 0 8.407388674136484e-10
relative O 0 3.8510158617555135e-08
risk O 0 2.4093054218354837e-09
for O 0 4.363790578887361e-11
carriers O 0 6.546132524931636e-10
may O 0 3.096712608563479e-10
justify O 0 2.9796878853183273e-10
specific O 0 6.019200415874337e-11
clinical O 0 6.241346328650366e-11
screening O 0 7.456906758740445e-10
for O 0 2.913377872282297e-11
the O 0 6.42662478789191e-10
360 O 0 8.226271330791235e-10
, O 0 2.874123031584852e-12
000 O 0 3.777043261488089e-11
Americans O 0 1.4742344172681554e-13
expected O 0 3.9762312366298236e-12
to O 0 1.3237814707259266e-12
harbor O 0 1.4501390088739186e-09
this O 0 2.768327667795889e-12
allele O 0 3.4744023630350895e-11
, O 0 8.206152771195185e-13
and O 0 1.7257323228856564e-13
genetic O 0 6.438159467353488e-13
testing O 0 1.0296341036719614e-11
in O 0 6.8691059784686814e-12
the O 0 5.5323433334475425e-11
setting O 0 3.970417328247322e-09
of O 0 1.1592850013286693e-09
long O 0 2.491608031007786e-10
- O 0 2.6318883183940045e-10
term O 0 1.8766883158605197e-08
- O 0 8.69917082813032e-10
outcome O 0 2.6838566924425322e-08
studies O 0 6.009885644697732e-11
may O 0 7.276855333582244e-12
impact O 0 2.252556335902156e-10
significantly O 0 2.856880314539012e-07
on O 0 0.02330033853650093
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 9.807115930016153e-06
in O 0 9.723403505967898e-12
this O 0 3.754272934197722e-12
population O 0 2.1719323388402767e-12
. O 0 1.7291616749570693e-10

Localization O 0 3.6645128602685872e-06
of O 0 3.3672478139123996e-08
human O 0 8.871563039747343e-09
BRCA1 O 0 8.145558894057103e-08
and O 0 3.3341016059118544e-10
its O 0 1.1042364245206215e-10
loss O 0 5.188147689239031e-09
in O 0 8.729770795135039e-10
high O 0 1.978774207600509e-06
- O 0 2.085546313423947e-08
grade O 0 4.7596981289643736e-07
, O 0 7.521110123587249e-11
non B-Disease 0 1.336204877588898e-05
- I-Disease 0 0.00012707416317425668
inherited I-Disease 1 0.999998927116394
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 0.00035968399606645107

Although O 0 5.964828186932891e-09
the O 0 6.371919103465018e-10
link O 0 4.917539708770846e-10
between O 0 5.528274504840169e-10
the O 0 3.0922890914553136e-08
BRCA1 O 0 6.718909162373166e-07
tumour B-Disease 1 1.0
- O 0 6.4664282035664655e-06
suppressor O 0 2.45015371547197e-06
gene O 0 2.167557022758615e-09
and O 0 1.5631635985613457e-09
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 3.75581475642317e-11
established O 0 8.688901681486172e-11
, O 0 4.771520635202253e-13
the O 0 7.158233207571474e-12
role O 0 1.2076599269217336e-11
, O 0 7.052200078246085e-13
if O 0 6.658245461053924e-13
any O 0 4.764084092501175e-12
, O 0 1.90516591218326e-12
of O 0 1.7729112622433263e-10
BRCA1 O 0 9.499769859644402e-09
in O 0 1.0259262328560226e-09
non B-Disease 1 0.9825794696807861
- I-Disease 1 0.9887356162071228
familial I-Disease 1 0.9999226331710815
cancers I-Disease 1 1.0
is O 0 1.6140515590734594e-09
unclear O 0 2.5646599510764645e-07
. O 0 5.520271884051908e-08

BRCA1 O 0 6.606859096791595e-05
mutations O 0 4.832541122823386e-08
are O 0 6.172869854159657e-11
rare O 0 4.609892745310873e-10
in O 0 3.7654640516748827e-10
sporadic B-Disease 0 5.19430204803939e-06
cancers I-Disease 0 0.0748218521475792
, O 0 2.190919806688285e-10
but O 0 8.849778687647358e-09
loss O 0 4.6730629037483595e-06
of O 0 0.00043498899322003126
BRCA1 O 0 1.973968721813435e-07
resulting O 0 2.365135198800772e-09
from O 0 4.645744899889337e-11
reduced O 0 5.663498559016489e-10
expression O 0 3.264758255405731e-11
or O 0 6.401086691948388e-12
incorrect O 0 2.0319085303199813e-10
subcellular O 0 7.283854586148664e-08
localization O 0 4.457238844679523e-08
is O 0 4.240902767849164e-12
postulated O 0 1.394996756998168e-10
to O 0 4.4452224019775333e-13
be O 0 3.072040777145346e-13
important O 0 2.1291119908783962e-11
in O 0 5.87594278789183e-11
non B-Disease 0 0.00013899418991059065
- I-Disease 1 0.8302187919616699
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 0.007134376559406519

Epigenetic O 0 0.019664129242300987
loss O 0 0.00015158846508711576
, O 0 3.1690567947606496e-09
however O 0 1.6198722363469642e-08
, O 0 1.489396279918953e-11
has O 0 6.373997466987968e-14
not O 0 9.460219608549425e-14
received O 0 2.4672739979553215e-12
general O 0 2.1843937769716604e-10
acceptance O 0 1.085508039011529e-08
due O 0 1.23526122663975e-08
to O 0 3.0051763161287326e-11
controversy O 0 9.228990904830425e-10
regarding O 0 4.4635981022445037e-10
the O 0 1.048711534279434e-10
subcellular O 0 2.0255227184406976e-07
localization O 0 1.6934869790929952e-06
of O 0 8.249172367413848e-08
BRCA1 O 0 8.688446406779349e-09
proteins O 0 1.96418541154042e-11
, O 0 1.2448876565013256e-12
reports O 0 7.155694439764382e-12
of O 0 1.8239104671025075e-11
which O 0 4.700074964641976e-12
have O 0 9.885589742630874e-12
ranged O 0 3.013187210854085e-08
from O 0 4.896142866139819e-11
exclusively O 0 5.059364038828562e-11
nuclear O 0 3.3882747718649853e-09
, O 0 1.5345894693874484e-11
to O 0 2.229592725722096e-11
conditionally O 0 2.5259287994572333e-08
nuclear O 0 3.1363462937861186e-08
, O 0 1.6980946163092092e-11
to O 0 1.4097931155809817e-11
the O 0 1.902049628910163e-09
ER O 0 6.938149454072118e-05
/ O 0 5.470794928186251e-09
golgi O 0 2.5116466417784977e-07
, O 0 1.4499329688277829e-11
to O 0 1.6914388292765814e-11
cytoplasmic O 0 3.010428573091417e-09
invaginations O 0 4.0978687820825144e-07
into O 0 1.1157009760509595e-09
the O 0 5.775686040543349e-10
nucleus O 0 3.819640426172555e-08
. O 0 1.2015547667942883e-08

In O 0 2.543342070282506e-08
an O 0 2.920427094599276e-11
attempt O 0 2.821833877675317e-09
to O 0 2.557329348285009e-10
resolve O 0 7.84355069782805e-09
this O 0 1.272336402902141e-10
issue O 0 1.533052795821277e-08
, O 0 1.9061262984676475e-11
we O 0 3.104357743088926e-11
have O 0 2.0731256988870683e-11
comprehensively O 0 2.510889771656366e-07
characterized O 0 3.53624365345695e-08
19 O 0 2.1154539808776462e-07
anti O 0 2.3603208319400437e-05
- O 0 0.0001661217538639903
BRCA1 O 0 1.0537290791035048e-06
antibodies O 0 9.586469928990482e-08
. O 0 3.655740599128876e-08

These O 0 1.6076127096198434e-08
reagents O 0 8.953372230280365e-07
detect O 0 4.584731527756958e-08
a O 0 2.9784488764228456e-10
220 O 0 8.311885402179087e-09
- O 0 1.2295750195789878e-08
kD O 0 3.068793148486293e-07
protein O 0 4.359136163145649e-09
localized O 0 1.4098276324148173e-08
in O 0 1.4597011099848345e-10
discrete O 0 2.4663744380148955e-09
nuclear O 0 7.260177881107666e-08
foci O 0 3.697740567076835e-07
in O 0 4.4009029059877136e-11
all O 0 2.0473673104093315e-11
epithelial O 0 6.344405889535665e-09
cell O 0 2.367373852507626e-09
lines O 0 4.235569533994621e-11
, O 0 1.7169333446295787e-13
including O 0 3.4174356053351396e-13
those O 0 4.522346039315117e-12
derived O 0 1.450413011916396e-09
from O 0 1.89140720863179e-08
breast B-Disease 0 4.088697551196674e-06
malignancies I-Disease 0 1.404885551892221e-05
. O 0 1.0355090296343405e-07

Immunohistochemical O 0 4.10671163990628e-05
staining O 0 1.8505012121750042e-05
of O 0 3.287026117959613e-07
human O 0 1.518415757573166e-07
breast O 0 1.774802694853861e-05
specimens O 0 5.710689379156975e-07
also O 0 1.0194171062849477e-09
revealed O 0 1.4016237059877312e-07
BRCA1 O 0 4.5187380237621255e-07
nuclear O 0 8.170997602974239e-07
foci O 0 7.446476502082078e-06
in O 0 9.37354460717188e-09
benign O 1 0.9999583959579468
breast O 1 0.6695907115936279
, O 0 2.7378144196177345e-08
invasive B-Disease 1 0.9999997615814209
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 0.005674471613019705
low B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
grade I-Disease 1 1.0
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 4.522037215792807e-06

Conversely O 0 8.751292625674978e-06
, O 0 3.164510076203442e-08
BRCA1 O 0 5.691073567959393e-08
expression O 0 4.413809040482164e-10
was O 0 1.162437437973729e-10
reduced O 0 3.7349925929852645e-10
or O 0 7.87220982845227e-12
undetectable O 0 1.3333266712933778e-09
in O 0 7.207073045994994e-12
the O 0 9.053325797370171e-12
majority O 0 4.976801522976748e-12
of O 0 1.356830620080629e-10
high O 0 3.438524913690344e-07
- O 0 1.5635495742571948e-07
grade O 0 6.089498128858395e-05
, O 0 3.1190325877616942e-09
ductal B-Disease 1 0.9999842643737793
carcinomas I-Disease 1 1.0
, O 0 4.162348521408177e-10
suggesting O 0 7.149821845686688e-10
that O 0 1.1622994233739803e-11
absence O 0 3.5538042197913455e-07
of O 0 2.684909645722655e-07
BRCA1 O 0 2.4943492604734274e-08
may O 0 1.1815654010760568e-10
contribute O 0 1.7254378481545984e-11
to O 0 2.2139967810475003e-12
the O 0 3.704666434733994e-11
pathogenesis O 0 3.8696512660862936e-08
of O 0 8.844099758098523e-11
a O 0 4.048542751045048e-12
significant O 0 9.127631428462735e-10
percentage O 0 1.675082899055269e-07
of O 0 4.490920701982759e-08
sporadic B-Disease 1 0.9997884631156921
breast I-Disease 1 0.9999991655349731
cancers I-Disease 1 0.9995284080505371
. O 0 7.31307352452859e-07
. O 0 9.99837766357814e-07

